
<html lang="en"     class="pb-page"  data-request-id="53fc207f-9ebf-4343-8a02-52a3b038c0de"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-6;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00315"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry" /></meta><meta name="dc.Creator" content="Tanaji T.  Talele" /></meta><meta name="dc.Description" content="The gem-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpe..." /></meta><meta name="Description" content="The gem-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 29, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00315" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00315" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00315" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00315" /></link>
        
    
    

<title>Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00315" /></meta><meta property="og:title" content="Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0084.jpeg" /></meta><meta property="og:description" content="The gem-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpenes, noviose deoxysugar, and antibiotics derived from β-lactams, macrolides, and aminocoumarins. Inspired by this time-tested moiety, medicinal chemists have widely explored its use in developing bioactive molecules because of the possibility to (1) increase target engagement, potency, and selectivity through van der Waals interactions and entropically favorable restriction to a bioactive conformation, (2) mitigate toxicity, (3) obtain superior DMPK profile, (4) modulate the pKa of nearby functionality, (5) induce symmetry into a monomethyl substituted chiral center, and (6) apply the Thorpe–Ingold conformational effect in an o-hydroxydihydrocinnamic acid based prodrug design. The aim of this Perspective is to illustrate how medicinal chemists have elegantly employed the gem-dimethyl group to obtain clinically useful drugs and to provide synthetic methods to install a gem-dimethyl group." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The gem-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpenes, noviose deoxysugar, and antibiotics derived from β-lactams, macrolides, and aminocoumarins. Inspired by this time-tested moiety, medicinal chemists have widely explored its use in developing bioactive molecules because of the possibility to (1) increase target engagement, potency, and selectivity through van der Waals interactions and entropically favorable restriction to a bioactive conformation, (2) mitigate toxicity, (3) obtain superior DMPK profile, (4) modulate the pKa of nearby functionality, (5) induce symmetry into a monomethyl substituted chiral center, and (6) apply the Thorpe–Ingold conformational effect in an o-hydroxydihydrocinnamic acid based prodrug design. The aim of this Perspective is to illustrate how medicinal chemists have elegantly employed the gem-dimethyl group to obtain clinically useful drugs and to provide synthetic methods to install a gem-dimethyl group." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0084.jpeg" /></meta><meta name="twitter:title" content="Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00315"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00315">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00315&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00315&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00315&amp;href=/doi/10.1021/acs.jmedchem.7b00315" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2166-2210</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01827" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00734" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Natural-Products-Inspired Use of the <i>gem</i>-Dimethyl Group in Medicinal Chemistry</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Tanaji T. Talele</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tanaji T. Talele</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York 11439, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (718) 990-5405. Fax: (718) 990-1877. E-mail: <a href="/cdn-cgi/l/email-protection#87f3e6ebe2ebe2f3c7f4f3ede8efe9f4a9e2e3f2"><span class="__cf_email__" data-cfemail="91e5f0fdf4fdf4e5d1e2e5fbfef9ffe2bff4f5e4">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tanaji+T.++Talele">Tanaji T. Talele</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5938-6505" title="Orcid link">http://orcid.org/0000-0002-5938-6505</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00315&amp;href=/doi/10.1021%2Facs.jmedchem.7b00315" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2166–2210</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 29, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 February 2017</li><li><span class="item_label"><b>Published</b> online</span>29 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 March 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00315" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00315</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2166%26pageCount%3D45%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTanaji%2BT.%2BTalele%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D6%26contentID%3Dacs.jmedchem.7b00315%26title%3DNatural-Products-Inspired%2BUse%2Bof%2Bthe%2Bgem-Dimethyl%2BGroup%2Bin%2BMedicinal%2BChemistry%26numPages%3D45%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2210%26publicationDate%3DMarch%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00315"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8469</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00315" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tanaji&quot;,&quot;last_name&quot;:&quot;T. Talele&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2166-2210&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00315&quot;},&quot;abstract&quot;:&quot;The gem-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpenes, noviose deoxysugar, and antibiotics derived from β-lactams, macrolides, and aminocoumarins. Inspired by this time-tested moiety, medicinal chemists have widely explored its use in developing bioactive molecules because of the possibility to (1) increase target engagement, potency, and selectivity through van der Waals interactions and entropically favorable restriction to a bioactive conformation, (2) mitigate toxicity, (3) obtain superior DMPK profile, (4) modulate the pKa of nearby functionality, (5) induce symmetry into a monomethyl substituted chiral center, and (6) apply the Thorpe–Ingold conformational effect in an o-hydroxydihydrocinnamic acid based prodrug design. The aim of this Perspective is to illustrate how medicinal chemists have elegantly employed the gem-dimethyl group to obtain clinically usefu&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00315&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00315" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00315&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00315" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00315&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00315" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00315&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00315&amp;href=/doi/10.1021/acs.jmedchem.7b00315" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00315" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00315" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (15 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00315%26sid%3Dliteratum%253Aachs%26pmid%3D28850227%26genre%3Darticle%26aulast%3DTalele%26date%3D2018%26atitle%3DNatural-Products-Inspired%2BUse%2Bof%2Bthe%2Bgem-Dimethyl%2BGroup%2Bin%2BMedicinal%2BChemistry%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D6%26spage%3D2166%26epage%3D2210%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/6" title="Go to Volume 61, Issue 6"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/jmcmar.2018.61.issue-6/20180322/jmcmar.2018.61.issue-6.largecover.jpg" alt="Go to Volume 61, Issue 6"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0084.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0084.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The <i>gem</i>-dimethyl moiety is a structural feature frequently found in many natural products of clinical interest, including, but not limited to, taxanes, epothilones, statins, retinoids, di-/triterpenes, noviose deoxysugar, and antibiotics derived from β-lactams, macrolides, and aminocoumarins. Inspired by this time-tested moiety, medicinal chemists have widely explored its use in developing bioactive molecules because of the possibility to (1) increase target engagement, potency, and selectivity through van der Waals interactions and entropically favorable restriction to a bioactive conformation, (2) mitigate toxicity, (3) obtain superior DMPK profile, (4) modulate the p<i>K</i><sub>a</sub> of nearby functionality, (5) induce symmetry into a monomethyl substituted chiral center, and (6) apply the Thorpe–Ingold conformational effect in an <i>o</i>-hydroxydihydrocinnamic acid based prodrug design. The aim of this Perspective is to illustrate how medicinal chemists have elegantly employed the <i>gem</i>-dimethyl group to obtain clinically useful drugs and to provide synthetic methods to install a <i>gem</i>-dimethyl group.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">A Synopsis of Natural Products Containing the <i>gem</i>-Dimethyl Moiety</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Natural products and their semisynthetic/synthetic derivatives have served as a consistent source of valuable new drug leads for centuries.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Since ancient times, humans have relied on the treatment of diseases with plants and/or plant extracts.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For example, cinchona bark has long been used to treat fever and willow bark has efficacy as an anti-inflammatory and analgesic. In general, natural products display an exceptionally wide range of structural diversity, dense arrays of functional groups, stereochemical complexity, and a large number of sp<sup>3</sup>-hybridized centers, features that can lead to an enhanced three-dimensional molecular diversity and thus to a unique molecular shape.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> A unique feature of many of these natural products is the presence of a <i>gem</i>-dimethyl group that is directly connected either to an oxygen atom or to a −C–O functionality, as highlighted in red in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>–<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. <named-content content-type="anchor" rid="fig2" type="simple"></named-content><named-content content-type="anchor" rid="fig3" type="simple"></named-content>A bibliographical search in the SciFinder,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> using “<i>gem</i>-dimethyl” as the search key, revealed 439 articles as of August 10, 2017. Representatives of numerous known <i>gem</i>-dimethyl-containing natural products and their synthetic analogues (<b>1</b>–<b>22</b>),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> categorized based on their source (plant, microbe, or marine organism) are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>–<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30">(9−30)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative plant-derived natural and semisynthetic products (<b>1</b>–<b>13</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative microbe-derived natural products (<b>14</b>–<b>19</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of representative marine-derived natural products (<b>20</b>–<b>22</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The purpose of this article is to provide an insight into how medicinal chemists have recognized the importance of a <i>gem</i>-dimethyl group and have successfully incorporated this group into biologically active small molecules as a way to enhance a specific therapeutic effect. This strategy can be traced back to the 1920s when the <i>gem</i>-dimethyl-containing penicillins were accidentally isolated by Alexander Fleming from the fungus <i>Penicillium notatum</i>. Interestingly, about 64% of the new small molecule drugs introduced between 1981 and 2010 were modified natural products.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently, there are 12 <i>gem</i>-dimethyl-containing compounds in clinical trials, about 30 in preclinical development, and at least 51 drugs, which amounts to 3.7% of the total number of U.S. FDA approved drug molecules (1391) (based on DrugBank version 5.0 database<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> search on May 25, 2017, and examples described in this article).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Physicochemical, Structural, and Biological Properties Imparted by a <i>gem</i>-Dimethyl Group</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A <i>gem</i>-dimethyl group, being electronically neutral as well as lacking polarity, can be considered as two small lipophilic lobes projecting out of the bioactive conformation of the molecule. Importantly, however, these small lipophilic lobes can have a significant bearing on several desirable pharmacodynamics (PD), structural, toxicity, and drug metabolism and pharmacokinetics (DMPK) properties that are required to develop a successful drug as illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and briefly described in the following sections.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Impact of a <i>gem</i>-dimethyl group on pharmacodynamics, structural, toxicity, and DMPK properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Impact of the <i>gem</i>-Dimethyl Group on Pharmacodynamics, Structural, and Toxicity Properties</h3><div class="NLM_p last">Insertion of a <i>gem</i>-dimethyl group at the methylene of bioactive compounds can considerably modify the rotational barriers about a rotatable bond, enforce a bioactive conformation, and provide favorable van der Waals interactions with the binding site of the target protein. Furthermore, the open chain <i>gem</i>-dimethyl quaternary carbon considerably reduces the conformational flexibility and facilitates entropically favorable binding to the target receptor. Consequently, the <i>gem</i>-dimethyl group substitution may lead to increased binding affinity toward the target protein as long as it enforces a bioactive conformation. Further, a <i>gem</i>-dimethyl group can also contribute to increased selectivity and extended target engagement. Introduction of symmetry at the chiral center tends to simplify molecular complexity, synthesis, and characterization and ensuing candidate drug development efforts. To achieve this goal, symmetry can be induced by the addition of the second methyl group at monomethylated chiral centers in bioactive compounds. Installation of a <i>gem</i>-dimethyl group α to the carboxylate moiety can significantly reduce reactivity of the glucuronide ester metabolite and subsequent idiosyncratic toxicity. Additionally, insertion of a <i>gem</i>-dimethyl group in a planar tricyclic ring structure can mitigate genotoxic effects (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Impact of the <i>gem</i>-Dimethyl Group on DMPK Profile</h3><div class="NLM_p last">Phase 1 and phase 2 metabolic stability is one of the key parameters in establishing the bioavailable amount and duration of action of an administered drug. One of the many strategies to delay or prevent metabolic degradation of labile functional groups in a drug molecule is to install a <i>gem</i>-dimethyl group next to the primary alcohol leading to masking of the alcohol group from oxidizing enzymes with simultaneous prevention of oxidation of the methylene carbon.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Moreover, this molecular modification also prevents potential phase 2 conjugation of the alcohol group as a consequence of steric crowding.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Increased chemical and plasma stability of an unstable functional group can be achieved by insertion of a <i>gem</i>-dimethyl steric bulk next to the labile groups.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> The <i>gem</i>-dimethylation at the benzylic carbon can considerably prevent oxidative metabolism.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a> The three interacting methyl groups in an <i>o</i>-hydroxydihydrocinnamic acid promoiety imposes a conformational restriction that significantly increases the rate of cyclization (lactonization) and subsequent release of pharmacologically active drug.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Incorporation of a <i>gem</i>-dimethyl group can moderately modulate the p<i>K</i><sub>a</sub> of nearby acidic and basic functional groups to modify plasma membrane permeability.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> The <i>gem</i>-dimethylation at the methylene precursor increases molecular lipophilicity by ∼1 log<sub>10</sub> unit, which can contribute to increased brain permeability.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Insertion of a <i>gem</i>-dimethyl group in bioactive molecules can impact number of other PK parameters such as increased half-life,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> area under the curve (AUC),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> bioavailability,<a onclick="showRef(event, 'ref46 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref48">(46,48)</a> CNS exposure,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> decreased plasma clearance,<a onclick="showRef(event, 'ref39 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref39 ref46 ref47 ref48 ref49">(39,46−49)</a> CYP450 inhibition,<a onclick="showRef(event, 'ref33 ref38'); return false;" href="javascript:void(0);" class="ref ref33 ref38">(33,38)</a> pregnane X receptor (PXR) activation,<a onclick="showRef(event, 'ref38 ref50'); return false;" href="javascript:void(0);" class="ref ref38 ref50">(38,50)</a> and P-glycoprotein (P-gp) efflux ratio (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref33 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref33 ref51 ref52">(33,51,52)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Pharmacodynamics Contribution of a <i>gem</i>-Dimethyl Group</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> To Achieve Efficient Target Engagement, Potency, and Selectivity. β-Lactam Antibiotics (<b>23</b>–<b>28</b>)</h3><div class="NLM_p">Penicillin antibiotics have been widely used in treating bacterial infections. One of the first fermentation-derived β-lactam antibiotics was <b>23</b> (benzylpenicillin/penicillin G, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). To improve the chemical/enzymatic stability and activity against resistant bacterial strains, several new chemically modified penicillin antibiotics were subsequently synthesized.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This review will only discuss a representative group of β-lactams such as <b>24</b> (methicillin), <b>25</b> (ampicillin), <b>26</b> (amoxicillin), and a third generation example, a <i>gem</i>-dimethyl substituted aminothiazole oxime (highlighted in red) derivative, <b>27</b> (ceftazidime), as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. β-Lactam antibiotics irreversibly acylate a serine residue in the active site of the bacterial transpeptidase enzyme (penicillin binding proteins/PBPs), whose activity is critical for bacterial cell wall synthesis.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The <i>gem</i>-dimethyl group in compounds <b>24</b>–<b>26</b> has been shown to engage in intramolecular van der Waals interactions with the side chain R group (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and via intermolecular van der Waals interactions with the side chain of Tyr707 of PBP1.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The <i>gem</i>-dimethyl substituted aminothiazole oxime moiety present in the antibiotic, <b>27</b>, demonstrated enhanced acylation efficiency toward the active site serine residue of PBP, a result attributed to favorable hydrophobic interactions between the <i>gem</i>-dimethyl group and hydrophobic aromatic wall created by Tyr503, Tyr532, and Phe533 residues.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Since metallo-β-lactamase is responsible for bacterial resistance to penicillins, the <i>gem</i>-dimethyl substituted irreversible metallo-β-lactamase inhibitors such as <b>28</b> (sulbactam) were developed for use in combination with certain β-lactams (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The <i>gem</i>-dimethyl group of metallo-β-lactamase inhibitors forms the hydrophobic interactions with the side chains of active site residues Trp64 and Val67.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of β-lactam antibiotics <b>23</b>–<b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Monobactam Antibiotic <b>29</b> (Aztreonam/Cayston)</h3><div class="NLM_p">In 1986, the arginine salt of aztreonam (<b>29</b>/SQ 26776)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> was approved to treat bacterial infections (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In 2010, the U.S. FDA approved the lysine salt of aztreonam for use as a nebulized inhalation to improve respiratory symptoms in cystic fibrosis patients infected with <i>Pseudomonas aeruginosa</i>.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> It appears that the antibacterial activity of <b>29</b> is exerted through inhibition of PBP3 in Gram-negative bacteria. Removal of a <i>gem</i>-dimethyl substituent in a structurally related monobactam siderophore antibiotic, <b>30</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>),<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> eliminated the antibacterial efficacy against <i>P. aeruginosa</i> and produced a 10-fold reduction in acylation efficiency toward the active site serine residue. This observation was rationalized based on analysis of the crystal structure of <b>29</b> bound in complex with PBP3 from <i>P. aeruginosa</i> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBS">3PBS</a>), which indicated stabilization of the <i>gem</i>-dimethyl group through hydrophobic interactions with an aromatic wall formed by Tyr503, Tyr532, and Phe533.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of monobactam antibacterial drug <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures and antibacterial efficacy of siderophore-conjugated monobactam antibiotics <b>30</b> and <b>31</b> and a positive reference monobactam <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Siderophore-Conjugated Monobactam Antibiotic <b>31</b></h3><div class="NLM_p last">This class of antibiotics is stable in the presence of metallo-β-lactamases and readily penetrates across the membrane of susceptible bacteria, respectively contributed by monobactam and iron-chelating siderophore (highlighted in blue) structural features. Insertion of a <i>gem</i>-dimethyl moiety on the aminothiazole oxime (highlighted in red) region of the monobactam siderophore in <b>30</b> produced <b>31</b>, with a significant increase in the efficacy against <i>P. aeruginosa</i>, as well as a 10-fold increase in acylation efficiency (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In addition to showing antibacterial profile superior to the U.S. FDA approved <b>29</b>, <b>31</b> also had an excellent pharmacokinetic profile.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Dehydropeptidase I (DHP-I) Inhibitor <b>32</b> (Cilastatin)</h3><div class="NLM_p">Compound <b>32</b> is a reversible inhibitor of renal enzyme DHP-I that is used in combination with the antibiotic <b>33</b> (imipenem/primaxin) to increase the in vivo stability of <b>33</b>, resulting in a longer duration of antibacterial efficacy by preventing the metabolic degradation of <b>33</b> to inactive compounds (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a><b>32</b> binds to DHP-I in a similar fashion to that of substrate <b>33</b>. Moreover, the conformation of <b>32</b> is also nicely juxtaposed for attack by the active site zinc-bound water/hydroxide nucleophile to form the tetrahedral intermediate. However, a tetrahedral intermediate is resistant toward cleavage of the amide bond as a consequence of tight binding of the <i>gem</i>-dimethylcyclopropane moiety to the side chains of Trp25 and Tyr68.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> Consequently, <b>32</b> functions as an inhibitor of renal DHP-I.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0008.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of dehydropeptidase I inhibitor <b>32</b> and antibiotic <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Antitubercular Compound <b>36</b></h3><div class="NLM_p">An increased rate of multidrug resistant and extensively drug resistant tuberculosis has augmented the stimulus to create new classes of antitubercular drugs. Toward this goal, Kondreddi and co-workers<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> optimized a cell-based screening hit into a highly potent, indole-2-carboxamide scaffold as antitubercular compounds. One analogue, <b>34</b>, that had a promising antitubercular potency and metabolic stability (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) is a mixture of <i>cis</i> and <i>trans</i> isomers (38:62). It was observed that the pure <i>cis</i> (data not shown) and pure <i>trans</i> (<b>35</b>) compounds had comparable antitubercular potency but different metabolic stability, being poor for the former. Subsequently, <b>35</b> was subjected to SAR optimization by exploration of hydrophobic space surrounding the 4-position of the cyclohexane moiety. Installation of a <i>gem</i>-dimethyl group (compound <b>36</b>) led to increased lipophilicity and gave a 10-fold increase in potency compared to <b>35</b>. Additionally, this modification removed the complexity arising from the <i>cis</i>/<i>trans</i> isomerism of <b>34</b>. <b>36</b> also exhibited a favorable PK profile (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) and showed potent oral efficacy in a mouse model of acute TB (a 25 mg/kg oral dose produced a 2.6 log lung colony forming unit reduction).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0009.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures, in vitro potency, and DMPK properties of antitubercular compounds <b>34</b>–<b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor <b>37</b> (Boceprevir/Victrelis)</h3><div class="NLM_p">Compound <b>37</b> (SCH 503034)<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> is the first U.S. FDA approved HCV NS3/4A protease inhibitor (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>); however, it was voluntarily withdrawn from the U.S. market as a result of availability of other superior treatment options. One of the major structural modifications leading to <b>37</b> was the introduction of a <i>gem</i>-dimethylcyclopropanoproline P<sub>2</sub> moiety as a leucine surrogate. The improved potency of <b>37</b> as compared to the corresponding leucine substituted analogue is a consequence of a favorable interaction between the <i>gem</i>-dimethylcyclopropanoproline P<sub>2</sub> moiety and the side chain of Ala156 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX">3LOX</a>).<a onclick="showRef(event, 'ref64 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref66">(64,66)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0010.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of HCV NS3/4A protease inhibitor <b>37</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> HIV-1 Integrase Inhibitor <b>41</b> (Raltegravir/Isentress)</h3><div class="NLM_p">HIV-1 integrase serves as an important therapeutic target to treat HIV-1 infection. Since the active site of HIV-1 integrase contains divalent metal ions that are critical for catalysis, inhibitors of this enzyme should contain a metal chelating functionality such as diketo acid or a dihydroxypyrimidine. Pace and co-workers<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> synthesized <i>N</i>-benzyl-5,6-dihydroxypyrimidine-4-carboxamides as early lead compounds, with variation at the C2-position of the dihydroxypyrimidine core (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). A C2-dimethylaminomethyl substituent led to <b>38</b>, which had an acceptable inhibitory potency. The branching of the methylene linker with a monomethyl group resulted in compounds with increased potency, <b>39</b>. Interestingly, insertion of a <i>gem</i>-dimethyl group at the methylene linker yielded inhibitor, <b>40</b>, with significantly increased cell-based potency. Since any modification to the <i>gem</i>-dimethyl substituent produced a significant loss in potency, it is possible that this group is playing a critical role in the antiviral activity of <b>40</b>.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Having established the <i>gem</i>-dimethyl group as an optimal C2-substituent of compounds in the dihydroxypyrimidine series, Summa and colleagues<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> reported a related <i>N</i>-methylpyrimidone scaffold with similar or enhanced activity in the HIV-1 integrase assay, as exemplified by the U.S. FDA approved <b>41</b> (raltegravir, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Moreover, <b>40</b> and <b>41</b>, in the presence of 10% and 50% fetal bovine serum (FBS), were significantly more potent compared to <b>38</b> and <b>39</b>, which may suggest a lower propensity to bind to the serum proteins.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0011.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures and in vitro potency of HIV-1 integrase inhibitors <b>38</b>–<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Human Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitors <b>44</b> and <b>45</b></h3><div class="NLM_p">RSV is responsible for acute upper and lower respiratory tract infections in infants and young children. Zheng and co-workers<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> developed novel RSV inhibitors based on a piperazinylquinoline scaffold that was derived from a similarity-based virtual screening of more than one million small molecules present in the Roche Smart library against known RSV fusion inhibitors. Optimization of lead compounds obtained from this library led to the identification of <b>42</b>, with significantly enhanced cellular efficacy (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). Considering the benzylic carbon as a metabolic hot spot, these investigators inserted small alkyl groups at the benzylic carbon position. Insertion of a monomethyl group at the benzylic carbon yielded <b>43</b>, which exhibited comparable potency to that observed for <b>42</b>. However, <i>gem</i>-dimethyl substitution at the benzylic carbon resulted in <b>44</b>, with a 3-fold increase in potency compared to <b>43</b>. Also, <b>44</b> was reduced in complexity by removal of the stereocenter present in <b>43</b>. Methylation of the primary amine head group gave <b>45</b>, with cell-based efficacy that was comparable to that observed for <b>44</b>. Since both <b>44</b> and <b>45</b> had excellent liver microsomal stability and PK profile, they were considered suitable for further preclinical development as anti-RSV drugs.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0012.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures, in vitro potency, and DMPK properties of RSV fusion protein inhibitors <b>42</b>–<b>45</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Plasmepsin Inhibitor <b>50</b></h3><div class="NLM_p">Digestive vacuole plasmepsins (Plm I, II, and IV) have been considered as antimalarial drug discovery targets. Genetic knockout studies have suggested a role for Plm IV in reducing hemozoin accumulation, resulting from impaired hemoglobin digestion.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Jaudzems and co-workers<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> selected a hydroxyethylamine scaffold (compound <b>46</b>) as a starting lead to optimize selective plasmepsin inhibitors (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). X-ray cocrystal structure of <b>46</b>-Plm II suggested that one methyl group is exposed to the polar environment and that a second methyl group is located within the hydrophobic pocket of Plm II. Despite this insight, these investigators installed a symmetric <i>gem</i>-dimethyl group at the benzylic carbon to avoid chiral complexity. Moreover, the benzylic carbon can be made metabolically stable if modified to contain the <i>gem</i>-dimethyl group. The plasmepsin inhibitory data of compounds <b>46</b>–<b>49</b> suggest that the <i>gem</i>-dimethyl substitution is critical for potency (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). In addition, the <i>gem</i>-dimethyl substituted compounds significantly inhibited the growth of the 3D7 strain of <i>Plasmodium falciparum</i>. Finally, replacing a piperidine ring with a phenyl ring yielded <b>50</b>, which was 9-fold more selective toward Plm IV compared to the human aspartyl protease, cathepsin D.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0013.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures and in vitro potency of plasmepsin inhibitors <b>46</b>–<b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Nonsteroidal Androgen Receptor (AR) Antagonists <b>51</b> (Nilutamide/Nilandron) and <b>55</b> (Enzalutamide/Xtandi)</h3><div class="NLM_p">Castration-resistant prostate cancer is characterized by approximately 3- to 5-fold increase in expression of the AR gene.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The first generation of AR antagonists produced partial agonism; therefore, to remove this pharmacological liability, there is a need to develop a second generation of AR antagonists to provide AR antagonism in cells that express high levels of AR.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Toward this goal, Jung and co-workers<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> synthesized AR antagonists that produced antagonistic action in the AR-upregulated castration resistant disease state, based on lead compound <b>51</b> (nilutamide, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). An early lead structure is exemplified by the <i>gem</i>-dimethyl substituted thiohydantoin ring system (<b>52</b>), which produced significant reduction not only in luciferase reporter activity but also in the down-regulation of prostate-specific antigen (PSA) levels. Removal of both methyl groups as in compound <b>53</b> or the inclusion of one methyl group (as in compound <b>54</b>) at the C5-position of the thiohydantoin ring resulted in a significant decrease in potency. Since the <i>gem</i>-dimethyl group proved beneficial, it was kept constant while performing SAR studies on the N<sub>1</sub>-phenyl ring. Ultimately, insertion of a 3-fluoro-4-<i>N</i>-methylcarboxamide group onto the N<sub>1</sub>-phenyl ring (as in compound <b>55</b>/MDV3100/enzalutamide) proved optimal (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a><b>55</b> competitively binds to the ligand-binding domain of the AR and inhibits translocation of the AR to the nucleus, recruitment of AR cofactors, and AR binding to DNA.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The role of the C5-<i>gem</i>-dimethyl group in <b>55</b> in conferring antagonism was verified by removal of this moiety, which led to an analogue that elicited undesirable agonistic activities against both wild-type and the F876L mutant of the AR.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Docking and molecular dynamics simulations of <b>55</b> within the ligand binding domain of AR (wild-type and F876L mutant) suggested a steric interaction between the C5-<i>gem</i>-dimethyl group and helix H12, which appeared to prevent H12 from adopting an agonist-like conformation (this was observed more so with the wild-type AR than with the mutant AR).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a><b>55</b> received U.S. FDA approval in 2012 for the treatment of patients with metastatic castrate-resistant prostate cancer.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0014.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures and in vitro potency of AR antagonists <b>51</b>–<b>55</b>. <sup><i>a</i></sup>Reduction in luciferase activity is a desirable end point. <sup><i>b</i></sup>PSA: prostate specific antigen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Insulin-like Growth Factor 1 Receptor (IGF-1R) Inhibitor <b>59</b></h3><div class="NLM_p">The development of small molecule inhibitors of the IGF-1R signaling pathway has been hypothesized to be an effective strategy to treat cancer.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Stauffer and colleagues<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> reported the discovery of <b>56</b>, an ATP competitive IGF-1R inhibitor with acceptable inhibitory activity, as well as selectivity over a panel of kinases (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> However, its oxidative O-debenzylated metabolite <b>57</b>, while preserving the IGF-1R inhibitory action, was devoid of selectivity over related kinases. These results accentuated the role of the <i>O</i>-benzyl moiety in conferring selectivity. To overcome the metabolic liability of the benzylic carbon in <b>56</b>, these investigators performed SAR studies that led to the discovery of (<i>S</i>)-<b>58</b>, with an IGF-1R inhibitory potency comparable to that of <b>56</b>. A gain in IGF-1R inhibitory power of 1 order of magnitude was realized when a <i>gem</i>-dimethyl group was inserted in lieu of the methylene linker (compound (<i>S</i>)-<b>59</b>), as shown in <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>. Both (<i>S</i>)-<b>58</b> and (<i>S</i>)-<b>59</b> produced a kinase selectivity profile that was significantly better than that of <b>57</b>.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> (<i>S</i>)-<b>59</b> had good water solubility, showed high permeability under basic conditions through a parallel artificial membrane permeability (PAMPA) assay, and had no significant effect on drug metabolizing CYP450 isoforms (CYP3A4, CYP2D6, and CYP2C9).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0015.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures and in vitro potency of IGF-1R inhibitors <b>56</b>–<b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> MutT Homolog 1 (MTH1) Inhibitor <b>62</b></h3><div class="NLM_p">MTH1 plays an important role in preventing insertion of oxidized purines into DNA through the hydrolytic cleavage of 8-oxo-dGTP and 2-hydroxy-dATP to their corresponding monophosphates.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Consequently, MTH1 is an important target for oncologic drug discovery. Subsequent work by Petrocchi and colleagues<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> used a crystal structure and molecular modeling data to design a 2,4-disubstituted pyrimidine scaffold, exemplified by <b>60</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). They installed a <i>gem</i>-dimethyl group on the C2-position of the hydroxypropoxy substituent in <b>60</b> for two reasons: first to obviate the desolvation penalty of the ligand and second to occupy the lipophilic pocket of MTH1. These efforts led to <b>61</b>, which increased MTH1 inhibition by an order of magnitude (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). A further increase in MTH1 inhibitory activity to the picomolar range occurred when a methyl group was installed at C5 on the pyrimidine ring to yield <b>62</b>. Compound <b>62</b> showed an exceptionally low efflux ratio, a high aqueous solubility, a high free fraction in human plasma, a long plasma half-life, and no off-target activity at 1 μM when tested against 97 kinases from KinomeEdge panel of kinases. It also inhibited MTH1 in MTH1 overexpressing U2OS cells at nanomolar concentrations.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0016.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures, in vitro potency, and physicochemical and PK properties of MTH1 inhibitors <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Sirtuin (SIRT) Inhibitors <b>63</b> and <b>64</b></h3><div class="NLM_p">Recently, SIRT1 and SIRT2 have been evaluated as molecular targets for anticancer drug discovery.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Consequently, Therrien and co-workers<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> designed a novel tetrahydroindazole scaffold for exploration of SIRT1 and SIRT2 inhibition. Compound <b>63</b> was developed to show preferential inhibition of SIRT1 over SIRT2 (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). Substitution of a <i>gem</i>-dimethyl group at the 5-position of the tetrahydroindazole ring of <b>63</b> led to <b>64</b>, which was as potent as <b>63</b> at inhibiting SIRT1 but lost selectivity over SIRT2. Moving a <i>gem</i>-dimethyl group from the 5- to the 4-position led to the regioisomer <b>65</b>, which proved inactive against both SIRT1 and SIRT2 (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0017.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures, in vitro potency, and PK profiles of SIRT inhibitors <b>63</b>–<b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Isoprenylcysteine Carboxyl Methyltransferase (ICMT) Inhibitor <b>68</b></h3><div class="NLM_p">The enzyme ICMT plays an important role in Ras localization and transformation in human cell-based models.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Therefore, it is possible that small molecule ICMT inhibitors may be useful in treating certain types of cancers. Toward this objective, Judd and colleagues<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> screened a library of compounds against human recombinant ICMT and identified a submicromolar ICMT inhibitory lead compound containing a <i>gem</i>-dimethyl tetrahydropyranyl scaffold. Subsequently, they determined the effect of a <i>gem</i>-dimethyl group on the tetrahydropyran ring (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). Compound <b>66</b>, lacking a <i>gem</i>-dimethyl group on the tetrahydropyran ring, had moderate inhibitory action on ICMT. Insertion of a <i>gem</i>-dimethyl moiety at the C2-position of the tetrahydropyran ring resulted in chiral compound <b>67</b>, with a > 50-fold improvement in ICMT inhibitory efficacy. To eliminate chiral complexity, another <i>gem</i>-dimethyl group was installed at the C6-position of the tetrahydropyran ring, a modification that led to <b>68</b> and a further increase in ICMT inhibition efficacy. In addition, <b>68</b> was also cytotoxic against several cancer cell lines as evidenced from IC<sub>50</sub> values ranging from 0.3 to >100 μM.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0018.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures and in vitro potency of ICMT inhibitors <b>66</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Matrix Metalloprotease (MMP) Inhibitors <b>69</b>–<b>75</b></h3><div class="NLM_p">The abnormal expression of MMPs has been postulated to play a role in tumor invasion and metastasis.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Almstead and colleagues<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> developed compounds with a broad spectrum of MMP inhibitory activity by synthesizing derivatives of thiazine and thiazepine. They began by inserting a <i>gem</i>-dimethyl steric shielding group in the vicinity of a metal chelating hydroxamic acid functionality as a way to reduce metabolic inactivation of the pharmacophoric hydroxamic acid moiety (data not shown). Installation of a <i>gem</i>-dimethyl group in thiazine <b>69</b> and thiazepine <b>71</b> respectively produced <b>70</b> and <b>72</b>, with a significant improvement in the in vitro inhibitory potency against all of the tested MMP isoforms (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). Since sulfides are prone to undergo oxidative metabolism (data not shown), the ring sulfur was oxidized to a sulfone derivative (as in <b>73</b>) to improve metabolic stability, in vitro potency, and aqueous solubility compared to the sulfide analogues. Data indicated that the sulfone group was tolerated as evidenced from potent broad spectrum inhibition of all tested isoforms of MMPs, with an appreciable aqueous solubility of 0.8 mg/mL at physiological pH. A cocrystal structure of <b>72</b> with truncated stromelysin indicated that the high potency of <b>72</b> resulted from hydrophobic interactions between one of the methyl groups of its <i>gem</i>-dimethyl moiety and the side chain of Val163.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0019.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures and in vitro potency of MMP inhibitors <b>69</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pikul and colleagues<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> also developed new MMP inhibitors bearing a plane of symmetry to avoid the complexities posed by chiral centers. To achieve this goal, they first developed the symmetric lead compound <b>74</b>, showing a moderate inhibition of certain MMPs (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). Insertion of a <i>gem</i>-dimethyl substituent at the C5-position of the 1,3-piperazine ring led to compound <b>75</b> with improved MMP inhibition (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). The crystal structure of <b>75</b> and the truncated stromelysin complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BQO">1BQO</a>) showed favorable van der Waals interactions between the <i>gem</i>-dimethyl group and the side chains of Val163 and Pro221, thus explaining the potency-enhancing nature of hydrophobic <i>gem</i>-dimethyl group in <b>75</b>.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0020.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures and in vitro potency of MMP inhibitors <b>74</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Heat Shock Protein 90 (HSP90) Inhibitors (<b>76</b>–<b>81</b>)</h3><div class="NLM_p">HSP90 serves as an anticancer drug target;<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> therefore, Huang and colleagues<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> started an HSP90 inhibitor development program with an optimized lead, <b>76</b>, derived from an ATP-binding site focused library screening effort. <b>76</b> blocked the degradation of Her-2 and also inhibited HSP90 bioactivity at a low micromolar concentration (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>). Installation of a <i>gem</i>-dimethyl group at the C6-position of the indolone ring led to compound <b>77</b>, which was significantly more efficacious than <b>76</b> at inhibiting both Her-2 degradation and HSP90 bioactivity. An X-ray crystal structure of a compound related to <b>77</b> with the N-terminal domain of HSP90 indicated a significant displacement of the active site Leu107 residue from its original position due to the steric demands of the C6-<i>gem</i>-dimethyl group. Although <b>77</b> was a very potent compound, it was unsuitable for further development because of its (a) high lipophilicity, (b) poor aqueous solubility, (c) undetectable oral bioavailability, (d) lack of sufficient efficacy in mouse tumor xenograft models, (e) pyrrole and trimethoxyaniline metabolic liabilities, and (f) aniline ring producing a toxic and reactive quinone metabolite. Consequently, SAR optimization was conducted on <b>77</b> while keeping the optimized <i>gem</i>-dimethyl group constant. Specifically, <b>77</b> was modified by replacing the 3-methylpyrrole ring with the solubility-enhancing 3-trifluoromethylpyrazole ring and the planar trimethoxyaniline ring with a <i>trans</i>-4-hydroxycyclohexylamine. These modifications produced <b>78</b>, which had a lower in vitro potency but improved oral bioavailability and efficacy in mouse xenograft models compared to <b>77</b>. While the amorphous form of <b>78</b> had good aqueous solubility (170 μM) at pH 7.4 and oral bioavailability, its crystalline forms showed only a limited solubility (6 μM) at physiological pH. To avoid further formulation development problems and to prepare a candidate suitable for both oral and parenteral administration, <b>78</b> was converted into the highly water-soluble (∼1 mg/mL at pH 4–6) glycine ester mesylate prodrug <b>79</b>, which had reasonable inhibitory action in both Her-2 degradation and HSP90 bioactivity assays. It is of interest to note that <b>79</b> underwent rapid and complete hydrolysis to the parent molecule, <b>78</b>. Compound <b>79</b>, when administered orally, had excellent antitumor efficacy in the HT-29 colon tumor xenograft model.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0021.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures and in vitro potency of HSP90 inhibitors <b>76</b>–<b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Shi and co-workers<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> began a HSP90 inhibitor development program with the pyrrolopyrimidine scaffold that was considered suitable for improving the PK profile through modification of the solvent-exposed region. The optimized lead compound, <b>80</b>, had a sterically unhindered propargyl moiety with a primary alcohol group. Steric crowding, adjacent to the primary alcohol group in the form of a <i>gem</i>-dimethyl substitution, led to <b>81</b> (EC144),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which had excellent potency and in vitro ADME profile (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). Moreover, <b>81</b> demonstrated an excellent in vivo oral PK profile in CD-1 mice (<i>C</i><sub>max</sub> = 1556 ng/mL, <i>T</i><sub>max</sub> = 0.5 h, AUC = 4419 ng·h/mL, and <i>t</i><sub>1/2</sub> = 1.5 h) and it was able to completely inhibit the growth of the N87 gastric tumors at a dose of 5 mg/kg (po, qd×5).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0022.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures, in vitro potency, and PK profiles of HSP90 inhibitors <b>80</b> and <b>81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Phosphoinositide 3-Kinase (PI3K) Inhibitor <b>85</b> (Taselisib)</h3><div class="NLM_p">Aberrant PI3K signaling has been associated with certain cancers, and therefore, PI3K serves as a therapeutic target to develop anticancer drugs. Ndubaku and colleagues<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> began PI3K inhibitor development program with a thiazolobenzoxepin-containing lead compound <b>82</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>); however, compound <b>82</b> had a very poor antitumor efficacy, which was attributed to its low water solubility and limited in vivo exposure to its unbound fraction. Consequently, these investigators optimized <b>82</b> to obtain new PI3K inhibitors with increased water solubility and minimal unbound clearance. These investigators recognized that a higher calculated distribution coefficient (clogD) led to more rapid clearance of unbound fraction. Therefore, it was envisioned that reducing clogD would lower the clearance of unbound fraction. This strategy resulted in replacement of the tricyclic lipophilic thiazolobenzoxepin ring (clogD = 2.7) system with the less lipophilic imidazolobenzoxazepin ring (clogD = 2.0), which resulted in <b>83</b>, with marginal improvement in measured properties (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>). Insertion of a <i>gem</i>-dimethyl group adjacent to the primary alcohol present in <b>83</b> led to <b>84</b> with improved potency and selectivity. Finally replacement of the hydroxyl group in R<sub>1</sub> substituent with a primary carboxamide group resulted in clinical candidate <b>85</b> (GDC-0032/taselisib).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The mouse PK profile of <b>84</b> and <b>85</b> was significantly improved compared to starting lead compound <b>82</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0023.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures, in vitro potency, and DMPK profiles of PI3K inhibitors <b>82</b>–<b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Retinoid X Receptor (RXR) Selective Activator Compound <b>88</b> (Bexarotene/Targretin)</h3><div class="NLM_p">Compound <b>88</b> (LGD1069),<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> is a highly selective RXR activator that is used to treat refractory or persistent early and refractory advanced stage cutaneous T-cell lymphoma. Since retinoids are essential to the modulation of proliferation and differentiation of normal and malignant cells, synthetic retinoids have the potential to treat dermatological diseases and cancer. On the basis of this premise, Boehm and colleagues<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> developed retinoids possessing both high potency and larger selectivity for the RXR versus retinoic acid receptors (RARs). The EC<sub>50</sub> values of compounds <b>86</b>–<b>88</b> indicated the loss of potency for compounds <b>86</b> (8-des-<i>gem</i>-dimethyl analogue) and <b>87</b> (5-des-<i>gem</i>-dimethyl analogue) as compared to <b>88</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Increased potency and selectivity was realized when the <i>gem</i>-dimethyl group was incorporated to the 5- and 8-positions of the tetrahydronaphthalene scaffold as in <b>88</b>.<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> Both the C5- and C8-<i>gem</i>-dimethyl groups have favorable van der Waals interactions with helix H11 residues of the RXR receptor.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0024.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures and in vitro potency of RXR selective compounds <b>86</b>–<b>88</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Natural and Synthetic Retinoids</h3><div class="NLM_p">Compound <b>89</b> (tazarotene/tazorac) is a conformationally restricted, nonisomerizable member of the acetylenic class of topical retinoids for the treatment of acne and features the <i>gem</i>-dimethyl substituted thiocroman ring.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The presence of alternate double bonds in <b>90</b> (tretinoin/retin-A) and <b>91</b> (isotretinoin/accutane) confers flexibility and receptor nonselectivity. This flexibility has been elegantly addressed by incorporating alternate double bonds within two (thiocroman and pyridine) ring structures and a linear acetylene bond (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a><b>89</b> is an ethyl ester prodrug that rapidly undergoes hydrolysis to release the pharmacologically active tazarotenic acid.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a><b>89</b> regulates gene transcription by selectively binding to the nuclear receptors, RARβ and RARγ, which in turn leads to inhibition of terminal differentiation of keratinocytes and regulation of keratinocyte proliferation and apoptosis.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Hence, it is topically used for the treatment of psoriasis. While <b>90</b> is an all-<i>trans</i> retinoic acid, <b>91</b> is a 13-<i>cis</i> retinoic acid (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>). The <i>gem</i>-dimethyl group present in these retinoids formed favorable van der Waals interactions with helix H11 residues Cys432, His435, Leu436, and Phe439 of the retinoid receptor.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0025.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of retinoids <b>89</b>–<b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Phosphoinositide 3-Kinase (PI3K) δ Specific Inhibitor <b>92</b></h3><div class="NLM_p">PI3Kδ is predominantly expressed in immune cells such as B cells where PI3Kδ is activated downstream of the B cell receptor.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Since aberration in B cell signaling is essential to the pathophysiology of rheumatoid arthritis, targeting PI3Kδ could represent a strategy to develop drugs for the treatment of rheumatoid arthritis. Toward this end, Safina and colleagues<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> developed potent, yet selective, inhibitors of PI3Kδ because nonselective inhibition of the α- and β-isoforms of PI3K causes embryonic lethality in knockout mice, and they are critical to insulin action and platelet aggregation. A potent and selective <i>gem</i>-dimethyl group-bearing PI3Kδ inhibitor, <b>92</b>, was eventually identified using a structure-based drug design approach (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>). The potency and selectivity of <b>92</b> were rationalized based on the structural analysis of the PI3Kδ active site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP">2WXP</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In the active site of PI3Kδ, Thr750, a smaller size residue, was observed above Trp760 in lieu of a larger size residue Arg as observed in PI3Kα and of a Lys in PI3Kβ and PI3Kγ isoforms. Consequently, PI3Kδ offers a vacant surface above Trp760, which is referred to as the tryptophan shelf. Insertion of a <i>gem</i>-dimethylpiperazine moiety, as in <b>92</b>, was intended to exploit the tryptophan shelf to achieve a larger selectivity toward PI3Kδ over the other PI3K isoforms.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0026.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure, in vitro potency, and CYP450 inhibition data for PI3Kδ inhibitor <b>92</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Anticonvulsant Compound <b>93</b> (Topiramate/Topamax)</h3><div class="NLM_p">Compound <b>93</b> was discovered through a standard in vivo screening test, the maximal electroshock seizure test.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a><b>93</b> is derived from a monosaccharide that has an unusual C1-sulfamate group (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>). Replacement of a <i>gem</i>-dimethyl protected C4- and C5-ketal group with a spirocyclohexane ring or a complete removal of the <i>gem</i>-dimethyl group (thus generating free hydroxyl groups at the C4–C5) led to a complete loss of efficacy in the maximal electroshock seizure test. This result established the essential contribution of a <i>gem</i>-dimethyl ketal functionality at C4–C5 in <b>93</b>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0027.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structure of <b>93</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Nicotinic Acetylcholine Receptor Antagonist (nAChR) <b>96</b></h3><div class="NLM_p">The antagonism of nAChR produces antidepressant effects in patients with major depressive disorders (MDD).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The importance of the methyl groups in (±)<b>-</b>mecamylamine (<b>94</b>) is highlighted in <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>. The relative potencies of the pure (−)- and (+)-enantiomers in <b>94</b> (compounds <b>95</b> and <b>96</b>, respectively) and of racemic <b>97</b> (lacking methyl at C2 and C3) are compared to racemic <b>94</b> (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Compound <b>94</b> was able to antagonize the effect of nicotine in an assay for spontaneous activity and antinociception, with AD<sub>50</sub> values of 0.24 mg/kg and 0.08 mg/kg, respectively. Compounds <b>94</b> and <b>95</b> were equipotent with respect to spontaneous depression activity.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Conversely, <b>96</b> ((<i>S</i>)-(+)-mecamylamine/TC-5214/targacept)<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> did not produce any antagonism at 3 mg/kg.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Both <b>95</b> and <b>96</b> were able to antagonize nicotine-induced nociception to a magnitude similar to that of <b>94</b>. In contrast, <b>97</b>, a C2- and C3-desmethyl analogue of <b>94</b>, was inactive up to 10 mg/kg in both assays. SAR studies on these compounds indicated the essential role of the C3-<i>gem</i>-dimethyl and C2-methyl groups in nicotine antagonism.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In 2010, (<i>S</i>)-(+)-<b>96</b> entered into phase III clinical trial as an adjuvant treatment for MDD.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0028.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structures and in vitro potency of nAChR antagonists <b>94</b>–<b>97</b>. <sup><i>a</i></sup>Potency relative to (rac) <b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-Hydroxytryptamine 1A (5-HT<sub>1A</sub>) Receptor Agonist <b>98</b> (Gepirone/Travivo)</h3><div class="NLM_p">Compound <b>98</b>, a long-chain heteroaryl piperazine derivative, is structurally related to the anxiolytic drug buspirone (<b>99</b>/buspar, <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>). In March 2016, the U.S. FDA ruled favorably on the efficacy of <b>98</b> to treat MDD. Compound <b>98</b> was discovered in an effort to increase the affinity of <b>99</b> for the 5-HT<sub>1A</sub> receptor while minimizing its affinity for the D<sub>2</sub> dopamine receptor. Replacement of a spirocyclopentane moiety at the C4-position of the piperidinedione scaffold in <b>99</b> with a <i>gem</i>-dimethyl group yielded <b>98</b>, which had a higher affinity for the 5-HT<sub>1A</sub> receptor<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> compared to the 5-HT<sub>2A</sub> receptor<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and D<sub>2</sub> receptor.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The binding affinity (<i>K</i><sub>i</sub>) of <b>99</b> for the 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and D<sub>2</sub> receptors is shown in <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0029.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of 5-HT<sub>1A</sub> receptor agonists <b>98</b> and <b>99</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Human Renin Inhibitor <b>102</b> (Aliskiren/Tekturna)</h3><div class="NLM_p">Blocking the interaction between renin and its substrate, angiotensinogen, is considered an attractive approach to treat hypertension.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> On the basis of prior work related to renin inhibitors,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Maibaum and colleagues<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> noted that the N-terminal carboxamide as P<sub>2′</sub> groups had favorable in vitro and oral efficacy. Consequently, they modified the P<sub>2′</sub> moiety in lead scaffold <b>100</b>, with a carboxamide cap at the C-terminus. They obtained lead compound <b>100</b> and a high in vitro binding affinity for renin (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>). To improve the in vitro and in vivo efficacy, further modifications were performed at the α-carbon of the carboxamide group. Insertion of a methyl group at the α-carboxamide position gave <b>101</b> (with either the (<i>S</i>) or (<i>R</i>) absolute configuration) with comparable binding affinity. Since both (<i>S</i>)- and (<i>R</i>)-stereochemistry at the α-carboxamide position produced similar binding affinity, it was predicted that insertion of a <i>gem</i>-dimethyl group would lead to a higher binding affinity and eliminate the chiral complexity associated with <b>101</b>. This strategy led to the discovery of <b>102</b> (CGP060536B/SPP100/aliskiren),<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> a subnanomolar renin inhibitor with good selectivity, excellent oral bioavailability, and a sustained duration of action. <b>102</b> was approved by the U.S. FDA to treat hypertension. An X-ray cocrystal structure of recombinant glycosylated human renin and <b>102</b> indicated a novel P<sub>2′</sub> moiety in the S<sub>2′</sub> pocket of the enzyme. In contrast to the earlier series with renin inhibitors containing an alkyl group as the P<sub>2′</sub> moiety, the <i>gem</i>-dimethyl bearing P<sub>2′</sub> moiety, as in <b>102</b>, formed additional van der Waals interactions with the S<sub>2′</sub> pocket of the enzyme, which could be responsible for the subnanomolar affinity of <b>102</b> toward renin.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0030.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures and in vitro potency of renin inhibitors <b>100</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Hydroxymethyl Glutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor <b>105</b> (Simvastatin/Zocor)</h3><div class="NLM_p">Compound <b>105</b> is a semisynthetic statin and a close analogue of <b>103</b> (lovastatin/mevacor), a known inhibitor of HMG-CoA reductase, an essential enzyme that catalyzes the biosynthesis of cholesterol in mammalian cells. <b>105</b> was discovered by Hoffman and colleagues,<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> starting from <b>103</b> (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>). The α-methyl branching on the C1-butanoate moiety resulted in a new chiral center. Since both enantiomers (<b>103</b> and <b>104</b>) showed similar potency, the α-<i>gem</i>-dimethyl group was installed at the C1-butanoate to produce <b>105</b>, with a >2-fold increase in potency. Moreover, the modification of <b>103</b> eliminated one chiral center and the ensuing complexity.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> The improved potency of <b>105</b> compared to <b>103</b> was attributed to a better filling of the hydrophobic pocket of the enzyme by a <i>gem</i>-dimethyl moiety as evidenced from X-ray crystallographic studies.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0031.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Structures and in vitro potency of HMG-CoA reductase inhibitors <b>103</b>–<b>105</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Potassium Ion Channel Opener <b>109</b> (Cromakalim)</h3><div class="NLM_p">Potassium ion channel openers, by enhancing the efflux of potassium ions,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> have been shown to hyperpolarize the membrane potential of vascular smooth muscle cells.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> This action leads to vasodilation and a reduction in blood pressure.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Consequently, Ashwood and co-workers<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> developed benzopyran-3-ol derivatives as potent activators of the potassium ion channel. The importance of a <i>gem</i>-dimethyl substitution at the C2-position of the benzopyran scaffold is evident based on the successive increase in potency observed in analogues <b>106</b>–<b>108</b> (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>). They hypothesized that the increased potency of <b>108</b> could be a result of the <i>gem</i>-dimethyl group’s contribution toward preventing its metabolic degradation (increased half-life). Since a C2-<i>gem</i>-dimethyl group was optimal, further SAR was focused on finding a replacement for the electron withdrawing nitro group, such as a cyano. These efforts led to discovery of the cyano substituted <i>gem</i>-dimethyl racemic analogue <b>109</b> (BRL34915/cromakalim)<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> with improved potency. The chiral resolution of racemic <b>109</b> produced the corresponding levo- [(−)-<b>110</b>] and dextro- [(+)-<b>111</b>] enantiomers and established the potency of <b>109</b> resided primarily with the levorotatory enantiomer (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0032.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures and in vivo potency of potassium ion channel openers <b>106</b>–<b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Liver X Receptor (LXR) Agonists <b>114</b> and <b>115</b></h3><div class="NLM_p">LXR agonists elicit an increase in reverse cholesterol transport and anti-inflammatory actions.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> One of the major concerns associated with LXR agonist development is the induction of targets implicated in lipogenesis, which eventually will also increase the production of VLDL in the liver and triglycerides in the liver and plasma.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> On the basis of this background, Kick and colleagues<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> developed new compounds exhibiting a weak partial activity toward LXRα and enhanced activity toward LXRβ to achieve favorable reverse cholesterol transport and anti-inflammatory action, with concomitant reduction in lipogenesis. Early SAR studies led to identification of the pyrazole analogue, <b>112</b>, with a 5-fold selectivity toward LXRβ over LXRα (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>). Replacement of the trifluoromethyl group with the <i>gem</i>-dimethyl carbinol led to <b>113</b> and an 18-fold selectivity for LXRβ over LXRα. Since the <i>gem</i>-dimethyl carbinol-containing <b>113</b> exhibited high (4 h) plasma exposure and a 3-fold liver/plasma exposure ratio at 24 h, it was considered a favorable scaffold for the next round of SAR investigations. Compound <b>114</b>, possessing an unsubstituted benzylic carbon that was appended to the C2-position of the imidazole core, showed impressive selectivity toward LXRβ. Insertion of a <i>gem</i>-dimethyl group into the benzylic carbon led to <b>115</b> and an improved PK profile (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0033.jpeg" id="gr39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures, in vitro potency, and PK profiles of LXR agonists <b>112</b>–<b>115</b>. <sup><i>a</i></sup>Human whole blood ABC transporter family A1 induction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Sodium Hydrogen Exchanger 1 (NHE-1) Inhibitors <b>116</b> and <b>117</b></h3><div class="NLM_p">NHE-1, expressed predominantly in myocardial cells, is responsible for exchanging intracellular protons for extracellular sodium ions, a process that occurs during ischemia.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Since selective inhibition of NHE-1 is an attractive strategy to treat myocardial ischemia and hypertension, Ahmad and co-workers<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> developed potent and selective NHE-1 inhibitors bearing an acyl guanidine functionality. Optimized lead compound <b>116</b> showed submicromolar inhibition of hNHE-1. Insertion of a <i>gem</i>-dimethyl group in the cyclopropane ring of <b>116</b> led to <b>117</b> (BMS-284640),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> with a 13-fold improved inhibition of hNHE-1. This increase in potency by the <i>gem</i>-dimethyl group insertion could have resulted from (1) enhanced hydrophobic interactions with the NHE-1 binding site and/or (2) steric bulk at the cyclopropane ring that sterically locked the free rotation about the aromatic ring and the acyl guanidine group.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><b>117</b> was also highly selective toward NHE-1 versus NHE-2, NHE-3, and NHE-5 (data not shown). In addition, <b>117</b> had an improved PK profile compared to <b>116</b> (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0034.jpeg" id="gr40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures, in vitro potency, and PK profiles of NHE1 inhibitors <b>116</b> and <b>117</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Mammalian Target of Rapamycin (mTOR) Inhibitor <b>120</b></h3><div class="NLM_p">Dysregulation of mTOR is essential in the pathophysiology of metabolic disorders, cancer, and inflammation.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Compounds <b>118</b> and <b>119</b>, developed by Lynch and co-workers,<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117,118)</a> had submicromolar affinity for mTOR, with a >100-fold selectivity over related lipid kinases. Subsequently, Cansfield and co-workers<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> used a molecular hybrid design strategy of inserting the sulfone moiety of <b>118</b> into the fused pyrrolopyrimidine scaffold of <b>119</b> (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>). These efforts led to a series of cyclic sulfones; however, interesting results were obtained when one of the benzylic carbons in the five-membered cyclic sulfone was subjected to methylation. For instance, insertion of a <i>gem</i>-dimethyl substituent led to discovery of <b>120</b> (Z415) and showed a significant improvement in mTOR inhibition, selectivity, excellent cell-based potency, and an improved PK/PD profile.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a><b>120</b> had a low molecular weight, high aqueous solubility, lack of CYP inhibition, low clearance, moderate plasma protein binding, acceptable oral bioavailability, and hERG inhibition with an IC<sub>50</sub> of 48 μM.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0035.jpeg" id="gr41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Structures of mTOR inhibitors <b>118</b>–<b>120</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> CC Chemokine Receptor 1 (CCR1) Antagonist <b>121</b></h3><div class="NLM_p">The antagonism of CCR1, a G-protein coupled receptor, in rodent models of inflammation suggests that its blockade is a viable strategy to develop anti-inflammatory drugs.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Consequently, Santella and colleagues<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> proceeded to develop a CCR1 antagonist possessing desirable properties such as (a) target affinity, (b) functional potency, (c) selectivity, (d) metabolic stability, (e) availability as a large free fraction in plasma, (f) favorable pharmacokinetics, (g) no PXR transactivation, and (h) no QT prolongation/cardiovascular effects. Ultimately, they synthesized <b>121</b> (BMS-817399),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> a clinical candidate, shown in <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>, that demonstrated potent inhibitory action against CCR1 and macrophage inflammatory protein (MIP)-1α-induced chemotaxis, along with a bioavailability of 79%, 46%, 100%, and 40%, respectively, in mouse, rat, dog, and monkey, 19% free fraction in serum, and no PXR activation up to 25 μM. Structurally, <b>121</b> features two <i>gem</i>-dimethyl groups, each one playing a significant role in its therapeutic efficacy. First, the C3-<i>gem</i>-dimethyl substituent on the piperidine ring contributes toward the potency against both CCR1 and chemotaxis as evident from poor activity of the C3-unsubstituted piperidine analogues prepared by the same group.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Second, the <i>gem</i>-dimethyl of isopropanol moiety produces a steric clash with Phe288 in the PXR ligand-binding pocket to markedly lower the affinity of the <i>gem</i>-dimethyl carbinol-bearing CCR1 antagonists toward PXR. None of the low-energy conformers of <b>121</b> are in a position to escape this steric clash.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Furthermore, with a single methyl adjacent to the hydroxyl group (as a secondary alcohol), the chiral analogues were metabolically unstable in liver microsomal preparations. This metabolic liability was addressed by the addition of a second methyl group, leading to a tertiary alcohol that was stable in microsomal preparations compared to the secondary alcohol analogues.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0036.jpeg" id="gr42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structure, in vitro potency, and liver microsomal profile of CCR1 antagonist <b>121</b>. <sup><i>a</i></sup>MIP: macrophage inflammatory protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Inhibitors of <i>Porphyromonas gingivalis</i> Induced Proinflammatory Effects (<b>123</b>)</h3><div class="NLM_p">Since higher doses of muramyl dipeptide (MDP/compound <b>122</b>) produced an anti-inflammatory response,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> the synthesis of MDP analogues appears to be a viable strategy to develop new anti-inflammatory drugs. Toward this end, Cai and co-workers<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> developed a conformationally biased bicyclic MDP analogue such as <b>123</b> (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>). Analogue <b>123</b> dose-dependently reduced TNF-α levels in macrophages exposed to <i>P. gingivalis</i>. Compared to MDP, <b>123</b> significantly reduced the severity of the endotoxic shock in mice produced by injection with <i>P. gingivalis</i>. Interestingly both in vitro and in vivo effects of <b>123</b> were superior to those produced by low and high doses of MDP. The contributory role of a <i>gem</i>-dimethyl moiety was evident from the lack of anti-inflammatory activity by <b>124</b>, which was devoid of the <i>gem</i>-dimethyl ketal functionality (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><figure id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0037.jpeg" id="gr43" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Structures of MDP <b>122</b> and its analogues <b>123</b> and <b>124</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitor <b>128</b></h3><div class="NLM_p">ITK serves as a target to develop drugs for the treatment of inflammatory disorders such as asthma.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Burch and colleagues<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> developed potent and selective ITK inhibitors. They began discovery efforts with an optimized high throughput screening (HTS) hit compound that had problematic in vivo properties, such as poor aqueous solubility and suboptimal permeability, ascribed to a high aromatic ring count and a high topological polar surface area. Consequently, one of the aromatic rings (indazole) was partially saturated to the corresponding tetrahydroindazole ring, yielding lead compound <b>125</b> (<a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a></a>) to (a) enhance aqueous solubility, (b) exploit the out-of-plane hydrophobic interactions between the tetrahydroindazole ring and a lipophilic pocket comprising mostly aliphatic amino acids Val377, Ala389, and Lys391 and aromatic gatekeeper residue Phe435, and (c) increase selectivity because Phe435 is a rare aromatic amino acid to be present as a gatekeeper residue in kinases. Considering the proximity of aliphatic hydrophobic amino acids to C6 of the tetrahydroindazole ring, they installed a single methyl group at the C6-position, thus obtaining <b>126</b> with comparable potency to <b>125</b> but no additional benefits. However, by inserting a <i>gem</i>-dimethyl group at the C6-position, potency was increased by 6-fold in <b>127</b> compared to <b>125</b>. It may be noted that the cyano group in <b>125</b> was not beneficial. Conversely, the increased potency of <b>127</b> is a result of specific lipophilic interactions because moving the <i>gem</i>-dimethyl group from C6 to C5 resulted in a loss of potency. Further optimization of <b>127</b> was based on earlier observations<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> indicating that a basic amino tail on a benzylic carbon tended to increase ITK potency, as well as aqueous solubility. These efforts culminated in <b>128</b> (GNE-9822)<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> as a preclinical candidate. The positive impact of a C6-<i>gem</i>-dimethyl group to the efficacy of <b>128</b> was verified by solution of X-ray cocrystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PQN">4PQN</a>) and analysis of compound <b>128</b> within the active site of ITK. Indeed, the C6-axial and the equatorial methyl groups produced lipophilic interactions with Phe435.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><figure id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0038.jpeg" id="gr44" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structures, in vitro potency, and physicochemical properties of ITK inhibitors <b>125</b>–<b>128</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Muscarinic M<sub>3</sub> Receptor Antagonist <b>132</b></h3><div class="NLM_p">Activation of muscarinic receptor on airway smooth muscle cells has been linked to certain pulmonary diseases, such as asthma and COPD.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Furthermore, antagonism of M<sub>3</sub> cholinergic receptors significantly decreases acetylcholine-induced airway smooth muscle contraction, an effect referred to as bronchodilation. The development of selective M<sub>3</sub> receptor antagonists with a prolonged efficacy would be useful for the pharmacotherapy of asthma and COPD. To this end, Glossop and colleagues<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> used an inhalation by design approach to discover muscarinic antagonists with long-acting action on the M<sub>3</sub> receptor and reduced systemic absorption to curtail the incidence of adverse systemic effects. The screening of an in-house compound library to find M<sub>3</sub> receptor antagonists with high affinity for and slow dissociation from the M<sub>3</sub> receptor, led to identification of <b>129</b>. It had a high binding affinity but an unacceptably rapid dissociation (half-life 38 min) for the M<sub>3</sub> receptor (<a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">39</a></a>). Interestingly, installation of a <i>gem</i>-dimethyl group next to the basic tertiary amine moiety led to <b>130</b>, with a significant improvement in M<sub>3</sub> receptor binding affinity, as well as a slow rate of dissociation. It was rationalized that a <i>gem</i>-dimethyl substitution may have restricted the conformational freedom adjacent to the key basic amine pharmacophore. This conformational restriction may have induced a major reordering of <b>130</b> and the M<sub>3</sub> receptor for a productive binding complex to occur, which in turn contributed to reduced rates of association and dissociation by <b>130</b>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> The slow dissociation of the ligand from the receptor was easily translated when the pyrrolidine ring of a chiral molecule <b>130</b> was replaced with a nonchiral azetidine ring (e.g., compound <b>131</b>). Since inhaled anticholinergic drugs tend to produce adverse effects as a result of systemic exposure, these investigators focused their attention on optimizing the PK profile of <b>131</b>. Toward this goal, a <i>m</i>-hydroxy group was added on the eastern phenyl ring, leading to discovery of the phase II clinical candidate <b>132</b> (PF-3635659).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Compound <b>132</b> was suitable for once daily inhalation due to high affinity for the M<sub>3</sub> receptor and a long dissociation half-life. In addition, <b>132</b> underwent rapid clearance by human liver microsomes and hepatocytes (Cl<sub>int</sub> = 96 μL min<sup>–1</sup> million<sup>–1</sup>) and was biotransformed to a significant extent by glucuronide conjugation (Cl<sub>int</sub> = 221 μL min<sup>–1</sup> mg<sup>–1</sup>), as shown in <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">39</a></a>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0039.jpeg" id="gr45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Structures, in vitro potency, physicochemical properties, and HLM clearance profiles of muscarinic M<sub>3</sub> receptor antagonists <b>129</b>–<b>132</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Phosphodiesterase 4 (PDE4) Type 4 Inhibitors <b>133</b> and <b>134</b></h3><div class="NLM_p">Since PDE4 is primarily expressed in proinflammatory immune and airway smooth muscle cells, it may serve as a therapeutic target to develop anti-inflammatory drugs for respiratory disorders.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Selective inhibitors of PDE4A and -B are likely safer than nonselective inhibitors because the inhibition of PDE4D produces heart failure and arrhythmias.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Taltavull and colleagues<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> initiated the development of selective inhibitors of PDE4 based on a pyridothienopyrimidine lead scaffold. On the basis of PDE4 inhibitory activity profile for compounds <b>133</b> and <b>134</b>, it became evident that insertion of a <i>gem</i>-dimethyl group onto a pyran ring was critical for the potency of this series (<a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">40</a></a>). Compound <b>134</b> also showed appreciable inhibition of LPS-induced TNF-α production in the human whole blood (HWB) assay.</div><figure id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0040.jpeg" id="gr46" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Structures and in vitro potency of PDE4 inhibitors <b>133</b> and <b>134</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Lysosomal Cysteine Protease (Cathepsin K) Inhibitor <b>136</b> (Odanacatib)</h3><div class="NLM_p">Since cathepsin K is essential in proteolytic cleavage/degradation of collagen and other bone- and cartilage-resident proteins, it serves as a therapeutic target for the development of osteoporosis drugs.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Replacement of the two fluorine atoms in <b>135</b> with an isosteric methyl group led to fluoroisobutyl P<sub>2</sub> moiety, as in <b>136</b> (MK-0822/odanacatib),<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> with improved potency and selectivity toward cathepsin K versus other cysteine cathepsins (<a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a></a>). In addition, <b>136</b> also had an excellent PK profile in the rhesus monkey.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><figure id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0041.jpeg" id="gr47" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Structures, in vitro potency, and PK profile of cathepsin K inhibitors <b>135</b> and <b>136</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> To Enforce a Bioactive Conformation. Adenoviral Protease (AVP) Inhibitor <b>142</b></h3><div class="NLM_p">AVP is a cysteine protease adenain<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and is involved in several steps of the adenovirus life cycle.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Since humans lack a corresponding adenain homolog, it represents a target to develop antiadenoviral drugs. Consequently, Grosche and co-workers<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> used a crystal-structure-based and molecular-modeling-based approach to develop peptidomimetic/nonpeptidic scaffolds as useful, cell-based, potent inhibitors of AVP. Compound <b>137</b>, with an unsubstituted benzylic position, had weak AVP inhibitory activity (<a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a></a>). The substitution of one methyl group at the benzylic position gave <b>138</b>, with ∼3-fold improvement in AVP inhibition. Insertion of a second methyl group at the benzylic position led to the AVP inhibitor, <b>139</b>, whose potency was similar to that of prior peptidic analogues (IC<sub>50</sub>(AVP8) = 40 nM and IC<sub>50</sub>(AVP5) = 30 nM).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> It was hypothesized that the <i>gem</i>-dimethyl moiety forces <b>139</b> to adopt a preferred binding conformation within the active site of AVP. Although <b>139</b> had good cell permeability, it had an unacceptable aqueous solubility. Since molecular modeling studies suggested tolerance for larger groups in the methoxy binding pocket of AVP, the methoxy group was replaced with the water-solubilizing <i>N</i>,<i>N</i>-dimethylethoxy group, yielding <b>140</b>, which manifested a slight enhancement in potency and a significantly higher aqueous solubility than <b>139</b>. Both <b>139</b> and <b>140</b> had weak efficacy when tested using the antiviral cytopathic effect (CPE) assay (data not shown). Further SAR optimization was performed to depeptidize analogues <b>137</b>–<b>140</b> with the intention of obtaining cell-active compounds. Specifically, the cyanocarboxamide side chain was replaced with a surrogate cyanopyrimidine ring to obtain <b>141</b> and <b>142</b>, with significant potency against AVP. Compound <b>142</b> possessed acceptable aqueous solubility and permeability and produced low micromolar efficacy in the CPE assay. These compounds did not significantly bind to plasma proteins and were >1700-fold more selective toward AVP8 over a panel of five human cysteine proteases (cathepsins).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0042.jpeg" id="gr48" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Structures, in vitro potency, and physicochemical properties of adenoviral protease inhibitors <b>137</b>–<b>142</b>. <sup><i>a</i></sup>CPE: cytopathic effect. <sup><i>b</i></sup>PAMPA: parallel artificial membrane permeability assay. n.d.: not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists <b>143</b> (Clofibrate/Atromid S), <b>144</b> (Fenofibrate/Triglide), and <b>145</b> (Gemfibrozil/Lopid)</h3><div class="NLM_p">Fibrates are a class of lipid lowering drugs that activate PPARα.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> The mechanism of action of fibrates involves reduction in plasma lipid levels through induction of hepatomegaly and hepatic peroxisome proliferation in a PPARα-dependent manner. Consequently, fibrates may be of use for the treatment of obesity, cardiovascular diseases, and type 2 diabetes. An account of the evolution of fibrates, along with the role of the α-<i>gem</i>-dimethyl carboxylic acid pharmacophore, is briefly described here (<a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">43</a></a>). Among several oxyisobutyric acid derivatives, compound <b>143</b> decreased total lipid and cholesterol concentrations in rat plasma and liver and had minimal toxicity.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Although <b>143</b> was approved in 1967 by the U.S. FDA for the treatment of hyperlipidemias, it was later withdrawn due to hepatomegaly and concerns regarding hepatic peroxisome proliferation toxicity.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> To develop more potent antilipidemic drugs with minimum toxicity, <b>143</b> underwent further optimization. Specifically, two molecular modifications were performed: (1) replacing the <i>p</i>-chloro group with a <i>p</i>-chlorobenzoyl group and (2) replacing the ethyl ester functionality with an isopropyl ester to provide <b>144</b>, which was introduced to the U.S. market in late 1970s to treat hyperlipidemia.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Compound <b>145</b>, discovered in 1976, is another fibrate belonging to the phenoxy-α,α-dimethylpentanoic acid class.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><figure id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0043.jpeg" id="gr49" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Structures and in vitro potency of PPARα agonists <b>143</b>–<b>147</b>. NA: not active.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In a related phenoxyacetic acid series of fibrates (compounds <b>146</b> and <b>147</b>), Sierra and colleagues<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> reported that removal of the α-<i>gem</i>-dimethyl group (phenoxyisobutyric acid to phenoxyacetic acid) resulted in a 5- to 10-fold loss of affinity toward two PPAR subtypes (<a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">43</a></a>). This effect was rationalized by X-ray crystal structure studies on structurally related PPARα agonists, which suggested contribution of the α-<i>gem</i>-dimethyl moiety in facilitating adoption of a conformation wherein the carboxylate and phenyl ring assumed a bioactive global minimum gauche relationship, as highlighted in <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">43</a></a>.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Furthermore, a <i>gem</i>-dimethyl group was involved in favorable hydrophobic interactions within the receptor pocket formed by hydrophobic residues (Phe273, Val444, and Leu456) from helices 3, 7, 10, and 11 of PPAR.<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142,143)</a></div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Glycoprotein IIb/IIIa (GPIIb/IIIa) Integrin Antagonist <b>148</b></h3><div class="NLM_p">Since binding of fibrinogen to the GPIIb/IIIa platelet surface receptor is the final common pathway for platelet aggregation through the cross-linking of platelets, development of GPIIb/IIIa antagonists is an attractive strategy to obtain antithrombotic drugs.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Toward this goal, Hayashi and colleagues<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> developed a potent and orally effective GPIIb/IIIa antagonist prodrug <b>148</b> (racemate, <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">44</a></a>). The <i>C</i><sub>max</sub> value in <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig44" id="" class=" internalNav">44</a></a> indicates a maximum concentration of active drug, i.e., an ethyl ester hydrolyzed to a carboxylic acid active metabolite. Compound <b>148</b> was found to achieve a bioactive cup-shaped and rigid conformation with the help of α-<i>gem</i>-dimethyl and β-ethyl trisubstituted β-alanine central spacer.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Enantiomerically pure (<i>R</i>)-<b>148</b> was a highly potent platelet aggregation inhibitor with an IC<sub>50</sub> of 22 nM, whereas (<i>S</i>)-<b>148</b> had an IC<sub>50</sub> of 3100 nM.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></div><figure id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0044.jpeg" id="gr50" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Structures, in vitro potency, and PK profile of GPIIb/IIIa antagonist <b>148</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Three-Dimensionality/Conformational Bias/Favorable Binding Entropy</h3><div class="NLM_p">A <i>gem</i>-dimethyl substituent can have two effects: (i) local conformational restriction to a bioactive conformation and (ii) van der Waals interactions within the target active site. A sterically restricted α-aminoisobutyric acid (Aib, <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig45" id="" class=" internalNav">45</a></a>) is a natural, noncoded amino acid that is abundant in peptide antibiotics that exhibit antiviral and anticancer efficacies.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a> Further Aib-containing peptides impose a decreased rotational freedom of the two peptide backbone angles φ and ψ compared to glycine or alanine.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> A <i>gem</i>-dimethyl substitution at the α-carbon is thoroughly documented to impart stable helical and β-turn conformations of the polypeptides.<a onclick="showRef(event, 'ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref149 ref150">(149,150)</a> For example, Zuniga and colleagues<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> designed, synthesized, tested, and determined the cocrystal structure of peptide-like inhibitors of botulinum neurotoxic serotype A light chain protease. Their design strategy incorporated a <i>gem</i>-dimethyl substitution at the glycine residue to enhance the 3<sub>10</sub> helical conformation and to decrease binding entropy. X-ray cocrystal structure data revealed the formation of van der Waals contacts between the side chain of Val70 and the <i>gem</i>-dimethyl group. This structure also showed a sharp turn at an adjacent residue that results from the steric constraint imposed by a <i>gem</i>-dimethyl moiety.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></div><figure id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0045.jpeg" id="gr51" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Steric restriction imposed by the α-aminoisobutyric acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Contribution of the <i>gem</i>-Dimethyl Group toward Drug Metabolism and Pharmacokinetics (Dmpk)/Toxicity Properties</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Antimalarial Compound <b>153</b></h3><div class="NLM_p">Wu and colleagues<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> synthesized a novel class of small molecules that was efficacious at inhibiting both wild-type and drug-resistant strains of the malarial strain <i>P. falciparum</i>. Subsequently, they optimized their cell-based HTS-derived imidazolopiperazine hit compound to obtain the glycine derivative <b>149</b>. This compound inhibited both wild-type and drug-resistant <i>P. falciparum</i> at low nanomolar concentrations (<a data-tab="pane-pcw-Figures" href="#fig46" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig46" id="" class=" internalNav">46</a></a>). Among the various examined amino acid side chains (i.e., alanine, valine, and phenylalanine) present at the 7-position of the imidazolopiperazine scaffold, the α-methylalanine (<i>gem</i>-dimethyl glycine/Aib) yielded the highest potency compound, <b>150</b>, which was comparable to <b>149</b>. Two noticeable advantages of <b>150</b> over <b>149</b> and other compounds with a different amino acid component in the 7-side chain were lack of a chiral center and the presence of a metabolically stable <i>gem</i>-dimethyl substituted glycine side chain. Further SAR exploration was centered on the substitution pattern of the aniline ring at the 3-position of the imidazolopiperazine scaffold. These SAR experiments yielded the glycine and Aib derivatives <b>151</b> and <b>152</b>, with potencies comparable to <b>149</b> and <b>150</b>, respectively. The iv and oral PK properties in mice indicated a favorable profile for the <i>gem</i>-dimethyl glycine analogues, <b>150</b> and <b>152</b>, compared to their glycine counterparts, <b>149</b> and <b>151</b>. When subjected to biological testing, <b>150</b> and <b>152</b> proved highly efficacious in a rodent model of malaria, most likely due to their more favorable PK profiles. Furthermore, both <b>150</b> and <b>152</b> had an IC<sub>50</sub> > 9 μM against drug metabolizing CYP450 isoforms and had a CC<sub>50</sub> > 12 μM against mammalian cell lines. Therefore, this class of compounds warranted further development. Metabolite experiments with <b>152</b> revealed the formation of a cyclized inactive metabolite, <b>152m</b>, resulting from an intramolecular nucleophilic attack by Aib amine onto the sensitive benzylic C8 in the imidazolopiperazine ring. Consequently, Nagle and co-workers<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> optimized <b>152</b> to improve the in vitro and in vivo potencies but also to obviate formation of the inactive cyclic metabolite, <b>152m</b>. Consequently, insertion of a <i>gem</i>-dimethyl group at the benzylic C8 position led to a clinical candidate <b>153</b> (KAF156),<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> which is presently undergoing phase II clinical trials.</div><figure id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0046.jpeg" id="gr52" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Structures, in vitro potency, and PK profiles of antimalarial compounds <b>149</b>–<b>153</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Benzoxaboroles as a Treatment for Stage 2 Human African Trypanosomiasis (HAT)</h3><div class="NLM_p">HAT is a human disease caused by the single cell protozoan parasite <i>Trypanosoma brucei brucei</i> (<i>T. b. brucei</i>) spp.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> The first stage of the disease is characterized by the presence of trypanosomes in the hemolymphatic system, whereas the second stage occurs when the parasite permeates through the blood–brain barrier, causing neurological dysfunction, disturbance of the sleep/wake cycle, and psychological changes.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Due to limited treatment options for the second stage of HAT, there is an urgent medical need for new drugs to treat this human disease. The screening of approximately 50 benzoxaboroles in whole cell <i>T. b. brucei</i> led to disclosure of the first lead compound, <b>154</b> (SCYX-6759),<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> which had good efficacy against HAT stages 1 and 2; however, in the brain its concentration fell below the MIC within 15 h (<a data-tab="pane-pcw-Figures" href="#fig47" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig47" id="" class=" internalNav">47</a></a>). Thus, to modulate the PK profile and particularly the CNS exposure of <b>154</b>, the C3-position was subjected to substitution. Among the many C3-substitutions explored, the one that led to a desirable extended brain exposure occurred upon insertion of the C3-<i>gem</i>-dimethyl substituent as found in the clinical candidate, <b>155</b> (SCYX-7158).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In mice, <b>155</b> demonstrated brain exposure above the MIC for 24 h as compared to 15 h observed for <b>154</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0047.jpeg" id="gr53" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Structures and in vitro potency of benzoxaboroles <b>154</b> and <b>155</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Wee1 Kinase Inhibitor <b>158</b></h3><div class="NLM_p">The negative regulation of Cdk1 by Wee1 kinase leads to repair of damaged DNA in the G<sub>2</sub> phase prior to mitosis. Consequently, inhibitors of Wee1 kinase lead to premature mitosis of tumor cells, mitotic catastrophe, and ultimately to cell death.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> On the basis of this mechanism, Tong and co-workers<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> started a Wee1 kinase inhibitor development program with a promising tricyclic core structure exemplified by compound <b>156</b> (<a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">48</a></a>). Since <b>156</b> had excellent cellular activity, it was the subject of further SAR experiments that focused on structural modifications of the tetrahydroisoquinoline ring. Installation of a <i>gem</i>-dimethyl group at the C4-methylene of the tetrahydroisoquinoline ring resulted in <b>157</b>, which had improved enzymatic activity and cellular efficacy.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> PK studies in mice clearly indicated a favorable contribution by the <i>gem</i>-dimethyl substituent toward half-life, clearance, oral exposure, and bioavailability (<a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig48" id="" class=" internalNav">48</a></a>). After optimization of the <i>gem</i>-dimethyl substituted tetrahydroisoquinoline ring, these investigators conducted SAR experiments that were directed toward the vacant second ortho-position of the chlorophenyl ring. Data indicated that the fluoro substituted analogue <b>158</b>, compared to the chlorine substituted analogue, had significantly greater enzymatic and cellular efficacies and a better PK profile.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0048.jpeg" id="gr54" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. Structures, in vitro potency, and PK profiles of Wee1 kinase inhibitors <b>156</b>–<b>158</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Leucine-Rich Repeat Kinase <b>2</b> (LRRK2) Inhibitor <b>163</b></h3><div class="NLM_p">Modulation of the kinase activity of LRRK2 could represent a therapeutic strategy to treat Parkinson’s disease.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Consequently, Chan and colleagues<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> synthesized a novel aminopyrazole class of LRRK2 inhibitors, starting from <b>159</b>, a previously identified LRRK2 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig49" id="" class=" internalNav">49</a></a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Compound <b>159</b> had moderate to poor aqueous solubility, the potential to generate a toxic and reactive <i>o</i>-quinoneimine metabolite and contained a metabolically unstable morpholinocarboxamide moiety. Therefore, efforts were directed at eliminating these liabilities by installation of a bioisosteric group in lieu of the aniline moiety. Since the aminopyrimidine moiety and its trifluoromethyl substituent were critical to binding to the active site of LRRK2, efforts were directed toward identifying a successful aniline surrogate. Early on, a 4-aminopyrazole was identified as an efficient surrogate for the aniline moiety (compound <b>160</b>), but with a cyanoethyl substituent it showed a high efflux ratio and a time-dependent inhibition (TDI) of the CYP1A2 isoform. On the basis of molecular modeling studies,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> it was evident that the pyrazole-N-capping group was located in a solvent-exposed region and could tolerate bulky substituents. As a result, a <i>gem</i>-dimethyl group was inserted adjacent to the cyano group of <b>160</b>, leading to analogue <b>161</b>, whose efficacy was comparable to that of <b>160</b> but with a slight reduction in human and rat liver microsomal clearance, significant reduction in efflux ratio, and no evidence of TDI of the CYP1A2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Replacement of the cyano group with a hydroxyl (compound <b>162</b>) resulted in improved metabolic stability. Replacement of the C5-methyl group with an isosteric and isolipophilic chloro substituent led to <b>163</b>, which had excellent cell-based potency (cell IC<sub>50</sub> = 28 nM), excellent selectivity over 185 kinases, and aqueous solubility of 20 μg/mL at physiological pH. The intraperitoneal administration of 10 mg/kg of <b>163</b> to mice produced significant concentration-dependent inhibition of phospho-LRRK2 levels in the brain.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0049.jpeg" id="gr55" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Structures, in vitro potency, and DMPK profiles of LRRK2 inhibitors <b>159</b>–<b>163</b>. <sup><i>a</i></sup>ER: efflux ratio. <sup><i>b</i></sup>TDI: time-dependent inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> N-Type Calcium Channel (Ca<sub>v</sub>2.2) Inhibitors <b>169</b> and <b>170</b></h3><div class="NLM_p">Dysfunction of the Ca<sub>v</sub>2.2 channel in the spinal cord is involved in the development of chronic pain;<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> thus it serves as a therapeutic target for the development of new drugs to treat pain. Shao and co-workers<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> conducted experiments to improve the inhibitory activity of their previously reported aminopiperidine sulfonamide analogue, <b>164</b>,<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> that showed selective inhibitory activity for the Ca<sub>v</sub>2.2 compared to the hERG and Ca<sub>v</sub>1.2 channels. Although it demonstrated a dose-dependent efficacy in preclinical models of hyperalgesia and neuropathic allodynia, it inhibited CYP3A4, activated PXR, and was metabolized to the circulating inactive sulfonamide metabolite, <b>165</b>. An initial SAR exploration of the benzamide portion led to identification of <b>166</b>, with greater potency than <b>164</b> and also an improved profile with respect to CYP3A4 inhibition and PXR activation (<a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig50" id="" class=" internalNav">50</a></a>). Further SAR, focused on modifying the hydrolytically unstable sulfonamide group, yielded a sulfone analogue <b>167</b> with a potency comparable to that of <b>164</b>. Insertion of one methyl group at the α-position of the sulfone gave the chiral compound <b>168</b>, with enantiospecific inhibition of the Ca<sub>v</sub>2.2 channel. Removal of chirality by insertion of a <i>gem</i>-dimethyl group at the α-position led to <b>169</b>, with inhibitory action on Ca<sub>v</sub>2.2 that was comparable to that of the most active enantiomer of <b>168</b>. In addition, <b>169</b> provided significantly reduced PXR activation. Retention of the benzamide portion of <b>164</b> allowed for the synthesis of <b>170</b>, which, however, showed a significantly reduced inhibitory power toward Ca<sub>v</sub>2.2. In rats, <b>169</b> demonstrated a PK profile comparable to that of <b>164</b>; however, it had a high efflux ratio by the human P-gp. Conversely, <b>170</b> showed a poor PK profile and elicited significant PXR activation, but its efflux ratio by the human P-gp was lower.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Although <b>169</b> and <b>170</b> are far from becoming candidates for further development, they are devoid of metabolic conversion to an inactive sulfonamide metabolite and therefore can serve as interesting leads for further medicinal chemistry studies.</div><figure id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0050.jpeg" id="gr56" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. Structures, in vitro potency, and PK profiles of Ca<sub>v</sub>2.2 inhibitors <b>164</b>–<b>170</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Metabotropic Glutamate 2 (mGlu2) Receptor Allosteric Modulator <b>173</b></h3><div class="NLM_p">Selective activation of mGlu2 receptors could attenuate glutamatergic neurotransmission and, thus, serve as a viable approach to treat schizophrenia.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Layton and colleagues<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> conducted a study aimed at developing positive allosteric modulators of mGlu2 based on the HTS optimized lead compound <b>171</b>. Compound <b>171</b> had an acceptable balance between pan mGlu2 potency and improved solubility at pH 7.0, compared to the original HTS-derived compound (<a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig51" id="" class=" internalNav">51</a></a>). Incorporation of a 2-methyl substituent on the phenyl ring led to the 2,5-disubstituted analogue, <b>172</b>, with potency and aqueous solubility at pH 7.0 comparable to <b>171</b>. More importantly, <b>172</b> had an improved profile against the drug metabolizing enzyme CYP2C9 and a significantly reduced PXR activation compared to <b>171</b>. To eliminate oxidative metabolic “hot spot” (a benzylic alcohol), these investigators incorporated a <i>gem</i>-dimethyl moiety, which led to <b>173</b> and improved potency and lower CYP2C9 liability. Compound <b>173</b> also demonstrated significant selectivity over the highly homologous mGlu3 receptor and other mGlu receptors, such as mGlu4, mGlu5, and mGlu6 (EC<sub>50</sub> > 30 μM).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0051.jpeg" id="gr57" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Structures, in vitro potency, and physicochemical profiles of mGlu2 receptor allosteric modulators <b>171</b>–<b>173</b>. <sup><i>a</i></sup>PAM: positive allosteric modulator.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-Lipoxygenase Activating Protein (FLAP) Inhibitor <b>174</b></h3><div class="NLM_p">Interaction of 5-lipoxygenase (5-LO) with the FLAP protein facilitates the binding of arachidonic acid within the active site of 5-LO to stimulate production of inflammatory leukotrienes. Consequently, FLAP protein inhibitors have been developed for treating diseases characterized by inflammation, including asthma, because inhibition of the FLAP protein reduces the biosynthesis of inflammatory leukotrienes.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Lemurell and co-workers<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> developed a <i>gem</i>-dimethyl-containing compound <b>174</b> (AZD6642), shown in <a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">52</a></a>, as a clinical candidate with excellent physicochemical and PK properties. The <i>gem</i>-dimethyl moiety adjacent to the hydroxyl group not only transformed the metabolically susceptible primary alcohol into a <i>tert</i>-alcohol but also sterically hindered potential phase 2 conjugation, as evidenced from rat and dog PK profile (<a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig52" id="" class=" internalNav">52</a></a>).<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><figure id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0052.jpeg" id="gr58" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Structure, in vitro potency, and physicochemical and DMPK properties of FLAP inhibitor <b>174</b>. <sup><i>a</i></sup>hWB: human whole blood. <sup><i>b</i></sup>RM: reactive metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Leukotriene D<sub>4</sub> (LTD<sub>4</sub>) Antagonist <b>175</b></h3><div class="NLM_p">Compound <b>175</b> (montelukast/MK-476/singulair)<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> is a <i>gem</i>-dimethyl carbinol substituted analogue approved by the U.S. FDA for the treatment of asthma and allergic rhinitis (<a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig53" id="" class=" internalNav">53</a></a>). Among various hydrogen bonding groups explored at the 2-position of the eastern phenyl ring, a <i>tert</i>-alcohol (<i>gem</i>-dimethyl carbinol) substitution provided a good balance of potent LTD<sub>4</sub> antagonism and rat plasma clearance.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The ortho-<i>gem</i>-dimethyl group seemed to play three roles: (i) blockade of benzylic carbon oxidation, (ii) prevention of alcohol oxidation, and (iii) making the alcohol group sterically hindered to prevent phase 2 glucuronide conjugation.</div><figure id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0053.jpeg" id="gr59" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. Structure of LTD<sub>4</sub> antagonist <b>175</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Sphingosine 1-Phosphate 2 (S1P<sub>2</sub>) Antagonist <b>179</b></h3><div class="NLM_p">S1P<sub>2</sub> antagonists are of particular interest since they could be used for the treatment of a broad range of disorders, including cancer<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> and inflammation.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Kusumi and colleagues<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> began optimization at the aromatic carboxy-bearing phenoxy moiety of an early lead compound possessing significant acidic character (p<i>K</i><sub>a</sub> of 3.85). Initially, this optimization program led to identification of a phenoxy acetic acid analogue, <b>176</b>, with reduced acidic character and moderate potency but desirable large values for AUC and <i>C</i><sub>max</sub> parameters (<a data-tab="pane-pcw-Figures" href="#fig54" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig54" id="" class=" internalNav">54</a></a>). An in vivo metabolic study with <b>176</b> indicated that this compound formed an acyl glucuronide as the major metabolite. Since acyl glucuronide conjugates of the phenyl acetic acid analogues are prone to produce idiosyncratic toxicity, it was hypothesized that steric crowding at the α-position of the acetic acid group in <b>176</b> would attenuate or obviate this concern.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Subsequently, a monomethyl group was installed at the α-position of <b>176</b> to obtain <b>177</b>, with a >2-fold increase in potency compared to <b>176</b>. Further substitution at the α-position of <b>176</b> with a <i>gem</i>-dimethyl moiety led to <b>178</b>, demonstrating >8-fold improvement in potency over <b>176</b>. Investigation of the stability of the acyl glucuronide conjugates of <b>176</b> and <b>178</b> led authors to conclude that the acyl glucuronide conjugate of <b>178</b> was more stable than that of <b>176</b>. These data suggest that <b>178</b> is less likely to cause idiosyncratic toxicity as compared to <b>176</b>. Since <b>178</b> had limited oral exposure, as evidenced from the poor AUC value, its western part was modified to improve oral absorption. Toward this goal, the piperidine ring was replaced with various saturated N-containing heterocyclic moieties. Among these a pyrrolidine ring (as found in compound <b>179</b>) was shown to exhibit desirable potency and a significantly improved oral absorption and <i>C</i><sub>max</sub> value (<a data-tab="pane-pcw-Figures" href="#fig54" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig54" id="" class=" internalNav">54</a></a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig54" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Figure 54</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0054.jpeg" id="gr60" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 54. Structures, in vitro potency, and physicochemical/PK profiles of S1P<sub>2</sub> antagonists <b>176</b>–<b>179</b>. nt: not tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig54"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Prostaglandin E1 Analogue <b>180</b> (Gemeprost)</h3><div class="NLM_p">Compound <b>180</b> (gemeprost/ONO 802) is a structural analogue of prostaglandin E<sub>1</sub> that has abortifacient efficacy (<a data-tab="pane-pcw-Figures" href="#fig55" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig55" id="" class=" internalNav">55</a></a>).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Insertion of a <i>gem</i>-dimethyl group onto the C16-position of the prostaglandin scaffold resulted in longer-acting prostaglandins because a <i>gem</i>-dimethyl steric bulk prevented access of prostaglandin-15-hydroxy dehydrogenase to the allylic C15-OH group present in <b>180</b>.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><figure id="fig55" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Figure 55</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0055.jpeg" id="gr61" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 55. Structure of PGE<sub>1</sub> analogue <b>180</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig55"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Niacin Receptor Agonist <b>183</b></h3><div class="NLM_p">It has been shown that niacin (nicotinic acid) decreases the hydrolysis of adipocyte triglycerides by binding to and activation of a high affinity nicotinic acid G-protein-coupled receptor (GPR109A).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> This mechanism leads to a reduction in plasma free fatty acid; however, niacin use is accompanied by side effects, including severe cutaneous flushing.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Consequently, the development of new GPR109A agonists is an attractive strategy for the treatment of atherosclerosis without the side effects of niacin. Toward this goal, Shen and colleagues<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> developed tetrahydroanthranilamide derivatives with high potency as GPR109A agonists with superior reduction of free fatty acids but significantly less cutaneous flushing than niacin. An SAR study was aimed at establishing whether the linker connecting the 1,2,4-oxadiazole with the anthranilamide moieties had a substantial impact on potency, serum shift, and PK properties. <b>181</b>, an early stage lead compound, possessed reasonable binding affinity toward GPR109A and functional activity in the guanine nucleotide exchange (GTPγS) assay (<a data-tab="pane-pcw-Figures" href="#fig56" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig56" id="" class=" internalNav">56</a></a>) but with a significant serum shift. This latter effect could be the result of <b>181</b> being a lipophilic weak acid. Insertion of a methyl group at the α-position of the linker led to identification of chiral compound <b>182</b> (enantiomer B), with a potency comparable to that of <b>181</b>. Since the other enantiomer of <b>182</b> had a comparable binding affinity toward GPR109A, it was anticipated that a <i>gem</i>-dimethyl substitution at the α-position of the linker would produce a potency similar to that of <b>182</b>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Indeed, the α-<i>gem</i>-dimethyl analogue <b>183</b> (MK-6892)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> had GPR109A binding affinity similar to that of <b>182</b>, with even more improved half-life and reduced clearance values in the rat.</div><figure id="fig56" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Figure 56</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0056.jpeg" id="gr62" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 56. Structures, in vitro potency, and DMPK profiles of niacin receptor agonists <b>181</b>–<b>183</b>. <sup><i>a</i></sup>AUCN: normalized area under the curve.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig56"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Disrupters of Glucokinase–Glucokinase Regulatory Protein (GK-GKRP) Binding</h3><div class="NLM_p">Elevated levels of intracellular glucose have been shown to disrupt the inactive GK-GKRP complex (sequestered in the nucleus) and facilitate translocation of activated GK from the nucleus to the cytoplasm.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Consequently, selective disrupters of the GK-GKRP complex may represent a novel strategy to treat type 2 diabetes. Pennington and co-workers<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> developed a unique class of GKRP-selective disrupters of the GK-GKRP complex. <b>184</b> was an early analogue that had neither measurable disrupting ability on the hGK-hGKRP complex nor quantifiable activity in mouse hepatocytes (<a data-tab="pane-pcw-Figures" href="#fig57" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig57" id="" class=" internalNav">57</a></a>). In addition, <b>184</b> was significantly metabolized by rat liver microsomes. To increase the potency and in vitro PK properties of <b>184</b>, investigators inserted a carbinol-bearing aromatic/heteroaromatic ring at the C7-position of the central benzothiophene scaffold to obtain <b>185</b>. This compound had a significant enhancement in disrupting potency, moderate to high nanomolar GKRP-binding affinity, and desirable in vitro PK properties. However, <b>185</b> failed to produce measurable activity in mouse hepatocytes, a result that was linked to its high lipophilicity and molecular weight. To overcome these drawbacks, a <i>gem</i>-dimethyl carbinol analogue <b>186</b> was designed to be less lipophilic and to have a lower molecular weight than <b>185</b>. In addition, <b>186</b> had added advantage of containing one less chiral center. Although <b>186</b> showed disruption of the GK-GKRP complex comparable to <b>185</b>, it also had excellent cell-based potency and a reduced efflux ratio, albeit with a slightly compromised clearance in rat liver microsomes. To increase biochemical and cellular potencies, these investigators implemented a structure-based drug design approach using the cocrystal structure of hGKRP and <b>186</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PXS">4PXS</a>). Specifically, they replaced the chlorophenyl ring with a 2-amino-5-chloropyrimidine ring (e.g., <b>187</b>) and a 2-amino-5-chloro-3-fluoropyridine ring (e.g., <b>188</b>) to increase overall efficacy and PK profile. Although both of these compounds demonstrated an excellent PK profile in the rat, <b>188</b> was more efficacious than <b>187</b> at lowering blood glucose in the db/db mouse model of obesity, diabetes, and dyslipidemia. The crystal structures of <b>186</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PXS">4PXS</a>) and <b>188</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PX5">4PX5</a>) bound to GKRP indicated the presence of an intermolecular hydrogen bond between the <i>gem</i>-dimethyl carbinol moiety and gaunidinium side chain of Arg525.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig57" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Figure 57</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0057.jpeg" id="gr63" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 57. Structures, in vitro potency, and physicochemical/DMPK profiles of GK-GKRP disrupters <b>184</b>–<b>188</b>. <sup><i>a</i></sup>TL: translocation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig57"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Hydroxytryptamine 2C (5-HT<sub>2C</sub>) Receptor Agonist <b>190</b></h3><div class="NLM_p">The 5-HT<sub>2C</sub> receptor serves as an important drug target for several CNS disorders such as obesity, schizophrenia, and drug addiction.<a onclick="showRef(event, 'ref173 ref174 ref175'); return false;" href="javascript:void(0);" class="ref ref173 ref174 ref175">(173−175)</a> The 5-HT<sub>2C</sub> receptor agonist <b>189</b>, discovered by Bos and colleagues,<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> has been shown to produce genotoxicity and DNA unwinding liabilities (<a data-tab="pane-pcw-Figures" href="#fig58" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig58" id="" class=" internalNav">58</a></a>). Albertini and colleagues<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> successfully mitigated these liabilities by insertion of a <i>gem</i>-dimethyl group at the methylene bridge of the tricyclic pyrazoloindene ring (compound <b>190</b>), possibly due to a decrease in planarity induced by the <i>gem</i>-dimethyl substitution.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a></div><figure id="fig58" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 58</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0058.jpeg" id="gr64" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 58. Structures and in vitro potency of 5-HT<sub>2C</sub> agonists <b>189</b> and <b>190</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig58"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> To Enhance Plasma Stability. Broad Spectrum Antifungal Compounds <b>194</b> and <b>195</b></h3><div class="NLM_p">Antifungal compounds with fungicidal activity are preferred over compounds with fungistatic activity. Toward this end, Bardiot and colleagues<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> screened a compound library comprising ∼34 000 compounds. This led to the identification of novel 2-oxomorpholinoacetamide lead compound <b>191</b>, which had significant fungicidal activity against <i>Candida</i> strains and fungistatic activity against <i>Aspergillus</i> strains (<a data-tab="pane-pcw-Figures" href="#fig59" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig59" id="" class=" internalNav">59</a></a>). Since <b>191</b> contains a hydrolytically labile lactone functional group, these investigators performed a human plasma stability study of this compound, which indicated a very poor plasma stability (<i>t</i><sub>1/2</sub> = 22 min). To circumvent the poor plasma stability while retaining antifungal efficacy, the morpholine carbonyl group in <b>191</b> was replaced with a methylene, a change that decreased the potency of <b>191</b> by 4-fold. These data suggested the lactone moiety was critical for the antifungal activity of <b>191</b>. Therefore, in the next structural modifications, steric bulk was incorporated into the C6 of the morpholin-2-one ring with the notion that steric bulk next to the lactone would reduce susceptibility of the lactone ring to hydrolytic cleavage. Therefore, the sterically hindered monomethyl analogues <b>192</b> and <b>193</b> were prepared and found to possess antifungal efficacies similar to that of <b>191</b> but with a more than 2-fold increase in plasma stability. A further increase in steric bulk at the C6 of the morpholin-2-one ring in the form of a <i>gem</i>-dimethyl substitution (compound <b>194</b>) also resulted in similar antifungal efficacy and an improved plasma stability (<i>t</i><sub>1/2</sub> > 240 min) relative to <b>191</b> (<a data-tab="pane-pcw-Figures" href="#fig59" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig59" id="" class=" internalNav">59</a></a>). Since aniline-containing compounds can occasionally induce toxicity, compound <b>194</b> was further optimized at the acetamide portion through replacement of the <i>p</i>-isopropylaniline moiety with a <i>m</i>-biphenylmethylamine, which led to the identification of <b>195</b>. As with <b>194</b>, compound <b>195</b> had good antifungal activity and an excellent plasma stability. The screening of compounds <b>194</b> and <b>195</b> against a panel of fungal strains suggested these compounds have broad-spectrum antifungal action.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a></div><figure id="fig59" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 59</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0059.jpeg" id="gr65" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 59. Structures, in vitro potency, and DMPK profiles of antifungal compounds <b>191</b>–<b>195</b>. <sup><i>a</i></sup>SGF: simulated gastric fluid. <sup><i>b</i></sup>SIF: simulated intestinal fluid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig59"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Antibody–Drug Conjugates (ADCs)</h3><div class="NLM_p">ADC therapeutic strategy that involves selective targeting of tumor cells is a highly sought after field in the pharmaceutical industry. Anticancer ADC is comprised of a monoclonal antibody, suitable linker, and a cytotoxic drug (<a data-tab="pane-pcw-Figures" href="#fig60" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig60" id="" class=" internalNav">60</a></a>). ADCs are also useful for treating nononcologic diseases.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The steric hindrance of a <i>gem</i>-dimethyl substitution adjacent to the disulfide linker leads to increased disulfide bond stability, with ensuing slow reduction of the disulfide bond by glutathione in plasma when compared to the corresponding monomethyl substituted disulfide linkers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig60" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 60</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0060.jpeg" id="gr66" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 60. General structure of antibody drug conjugate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig60"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_15_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> To Enhance Chemical Stability. Sodium-Dependent Glucose Cotransporters (SGLTs) Inhibitor <b>198</b></h3><div class="NLM_p">The SGLTs actively transport sugars across a cell membrane with concomitant sodium ion transport.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> This mechanism plays an important role in glycemic control. Consequently, SGLTs serve as therapeutic targets to develop antidiabetic drugs. Goodwin and colleagues<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> focused on developing orally nonabsorbable selective SGLT1 inhibitors that can reside longer in the GI tract as a result of poor oral bioavailability. The SAR began with a xyloside-bearing scaffold in which structural modifications were conducted on substituents at the distal aryl ring. These efforts led to the <i>N</i>-methylpiperazine-containing lead compound, <b>196</b>, with dual inhibition of SGLT1 and SGLT2; however, the carboxamide group was unstable to acid-catalyzed hydrolytic cleavage (<a data-tab="pane-pcw-Figures" href="#fig61" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig61" id="" class=" internalNav">61</a></a>). To circumvent this problem, Gly was replaced with Aib to produce <b>197</b> with comparable inhibition profile but a greater hydrolytic stability. Finally an open chain analogue of a piperazine derivative, <b>197</b>, led to identification of the dimethylaminoethyl analogue <b>198</b> (LX2761),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> which showed potent and similar inhibition of both SGLT1 and SGLT2 and was also stable to hydrolysis. <b>198</b> demonstrated excellent in vivo PK and efficacy profile in a C57 mouse model.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig61" data-index="61" class="article__inlineFigure"><h2 class="fig-label">Figure 61</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0061.jpeg" id="gr67" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 61. Structures, in vitro potency, and hydrolytic stability of SGLT inhibitors <b>196</b>–<b>198</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig61"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Modulate the p<i>K</i><sub>a</sub> of Nearby Functionality</h3><div class="NLM_p">Since introduction of the first boron-containing drug (velcade/bortezomib) to the U.S. market, the use of boronic acids as pharmacophores has been actively pursued by medicinal chemists. Consequently, the need to fine-tune the physicochemical properties of these compounds, such as their acid strength, has become apparent. Tomsho and co-workers<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> assessed the effect of varying the structure of the ring substituents to modulate the acid strength of the benzoxaboroles. For example, compound <b>199</b>, lacking steric bulk at C3, had an aqueous p<i>K</i><sub>a</sub> of 7.3, but insertion of a steric bulk in the form of a <i>gem</i>-dimethyl group at this position of the benzoxaborole ring produced <b>200</b>, which had a one log unit higher p<i>K</i><sub>a</sub> (i.e., decreased acid strength), as shown in <a data-tab="pane-pcw-Figures" href="#fig62" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig62" id="" class=" internalNav">62</a></a>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig62" data-index="62" class="article__inlineFigure"><h2 class="fig-label">Figure 62</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0062.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0062.jpeg" id="gr68" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 62. Structures and p<i>K</i><sub>a</sub> values of benzoxaboroles <b>199</b> and <b>200</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig62"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Structural Role of a <i>gem</i>-Dimethyl Group</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> To Induce Symmetry into a Chiral Center</h3><div class="NLM_p last">Insertion of a <i>gem</i>-dimethyl group to induce symmetry at the chiral center is evidenced in previously described examples. These include plasmepsin inhibitors (compounds <b>46</b> and <b>47</b>), ICMT inhibitors (compounds <b>67</b> and <b>68</b>), renin inhibitors (compounds <b>101</b> and <b>102</b>), HMG-CoA reductase inhibitors (compounds <b>103</b> and <b>105</b>), and Cav2.2 inhibitors (compounds <b>168</b> and <b>169</b>). Other specific examples are described in the following section.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Thrombin Inhibitors <b>201</b>–<b>205</b></h3><div class="NLM_p">Thrombin inhibitors are used for the treatment of venous and arterial thrombosis. Consequently, Brundish and colleagues<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> initiated a thrombin inhibitor development program that relied upon the tetrahydroquinolinesulfonyl-Arg-piperidine peptidomimetic lead scaffold <b>201</b> (MD-805).<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> Since the number of stereogenic centers in a molecule can hinder further chemical and clinical development efforts, these investigators attempted to develop more potent thrombin inhibitors along with a lower number of stereogenic centers compared to <b>201</b>. Optimization of the P<sub>3</sub> moiety led to identification of an achiral C3-unsubstituted derivative <b>202</b>, with decreased potency compared to <b>201</b> (<a data-tab="pane-pcw-Figures" href="#fig63" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig63" id="" class=" internalNav">63</a></a>). The racemic C3-methyl substituted P<sub>3</sub> moiety-bearing analogue <b>203</b> was ∼10-fold more potent at inhibiting thrombin compared to <b>202</b>. An enantiomerically pure C3-methyl P<sub>3</sub> moiety, as in <b>204</b>, was equipotent to the racemate <b>203</b>. X-ray crystal structure studies have revealed the presence of an unoccupied space around the C3-position of the P<sub>3</sub> moiety, an observation that prompted insertion of a second methyl group (that made C3 a nonstereogenic carbon), leading to compound <b>205</b>, with a potency comparable to that of <b>204</b>. Similarly, the two stereogenic centers present in the P<sub>2</sub> moiety of lead scaffold <b>201</b> were removed by inserting a nonstereogenic hydroxyethylpiperidine P<sub>2</sub> moiety. <b>205</b> produced dose-dependent inhibition of thrombus formation in both venous and arterial thrombosis animal models and proved better than <b>201</b> in an arterial thrombosis model.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div><figure id="fig63" data-index="63" class="article__inlineFigure"><h2 class="fig-label">Figure 63</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0063.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0063.jpeg" id="gr69" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 63. Structures and in vitro potency of thrombin inhibitors <b>201</b>–<b>205</b>. <sup><i>a</i></sup>b: bovine. <sup><i>b</i></sup>h: human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0063.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig63"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Glucokinase (GK) Activator <b>209</b></h3><div class="NLM_p">GK serves as a physiologic glucose sensor and is strictly regulated by plasma glucose levels.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Consequently, GK could be a therapeutic target for the development of small molecule GK activators to treat diabetes. Dransfield and co-workers<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> developed 4,5-disubstituted-2-pyridyl ureas as GK activators. Extensive SAR studies around the 4- and 5-positions of the pyridine ring led to the identification of compound <b>206</b>, with the desired potency and a minimal shift in the presence of 4% human serum albumin (HSA), as shown in <a data-tab="pane-pcw-Figures" href="#fig64" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig64" id="" class=" internalNav">64</a></a>. However, <b>206</b> exhibited poor PK properties in mice (<i>F</i> = 6%) and poor solubility (<1 μM) in simulated intestinal fluid (SIF) (pH 6.8). These problems led to the synthesis of a secondary alcohol derivative, which upon chiral separation yielded the stereoisomers <b>207</b> and <b>208</b>, both of which exhibited potency comparable to that of <b>206</b>. Since both <b>207</b> and <b>208</b> showed similar potency, these investigators removed the chiral center by inclusion of a <i>gem</i>-dimethyl group. These efforts led to discovery of <b>209</b> (AM-2394),<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> with an excellent biochemical, PK, and in vivo profile.</div><figure id="fig64" data-index="64" class="article__inlineFigure"><h2 class="fig-label">Figure 64</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0064.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0064.jpeg" id="gr70" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 64. Structures, in vitro potency, and physicochemical properties of GK activators <b>206</b>–<b>209</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0064.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig64"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Dipeptidyl Peptidase IV (DPP-IV) Inhibitor <b>212</b></h3><div class="NLM_p">DPP-IV is a therapeutically validated target for the development of drugs to treat diabetes. The selectivity of ligands toward DPP-IV over DPP-II and DPP8 is highly desirable since inhibition of DPP-II leads to the apoptosis of quiescent T-cells<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> and inhibition of DPP8 has been shown to produce significant toxicity.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Hence, Tsu and co-workers<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> developed highly selective DPP-IV inhibitors containing a novel P<sub>2</sub> pharmacophore (tetrahydroisoquinoline) linked to the P<sub>2</sub> site amine via a β-alanine spacer group and a P<sub>1</sub> moiety (cyanopyrrolidine) attached to the carboxyl group of glycine. This strategy led to the synthesis of <b>210</b> that produced DPP-IV inhibition with an IC<sub>50</sub> of 116 nM, a 31-fold selectivity over DPP8, and no inhibition of DPP-II (<a data-tab="pane-pcw-Figures" href="#fig65" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig65" id="" class=" internalNav">65</a></a>). A subsequent branching at the α position of the glycine amine was investigated by insertion of a single methyl group to obtain <b>211</b>, with a ∼2-fold improvement in DPP-IV inhibition compared to <b>210</b> and >99-fold selectivity over DPP8. The promising effect resulting from a single methyl insertion prompted these investigators to increase steric bulk, as observed in a <i>gem</i>-dimethyl analogue <b>212</b>. Although <b>212</b> had similar DPP-IV inhibition activity to that of <b>211</b>, it lacked an additional chiral center and thus simplified it for further development. Moreover, <b>212</b> had a >2000-fold selectivity over DPP8 and only weakly inhibited DPP-II.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div><figure id="fig65" data-index="65" class="article__inlineFigure"><h2 class="fig-label">Figure 65</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0065.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0065.jpeg" id="gr71" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 65. Structures and in vitro potency of DPP-IV inhibitors <b>210</b>–<b>212</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0065.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig65"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Negative Allosteric Modulators (NAM) of Metabotropic Glutamate Receptors 1 and 5 (mGlu1 and mGlu5)</h3><div class="NLM_p">Since the mGlu1 and mGlu5 subtypes of the mGlu receptor are involved in many CNS disorders, they are of interest for the development of dual NAMs to treat CNS disorders. Toward this goal, Felts and co-workers<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> initiated discovery chemistry work around a tricyclic pyridopyrazolopyrimidine-4-amine scaffold. They hypothesized that installation of the cycloalkyl substitutions at the 4-amino functionality of the tricyclic scaffold would exhibit improved druglike properties due to increased sp<sup>3</sup>-hybridized carbon count and also enhance potency. Subsequently, cyclohexyl analogue <b>213</b> was identified but manifested low affinity for both mGlu1 and mGlu5 receptors (<a data-tab="pane-pcw-Figures" href="#fig66" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig66" id="" class=" internalNav">66</a></a>). A methyl substitution at the 4-position of the cyclohexyl ring led to the <i>trans</i>-4-methylcyclohexyl amine derivative <b>214</b> and a significant increase in NAM activity against mGlu1 and a 13-fold increase in NAM activity against mGlu5. On the basis of these results, they proceeded to insert a second methyl group at the 4-position of the cyclohexyl amine to generate the nonstereogenic C4-<i>gem</i>-dimethylcyclohexyl amine analogue <b>215</b> (VU0467558).<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Compound <b>215</b> displayed significant NAM activity toward both mGlu1 and mGlu5 receptors. In addition, <b>215</b> also had a good DMPK profile (<a data-tab="pane-pcw-Figures" href="#fig66" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig66" id="" class=" internalNav">66</a></a>).</div><figure id="fig66" data-index="66" class="article__inlineFigure"><h2 class="fig-label">Figure 66</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0066.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0066.jpeg" id="gr72" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 66. Structures, in vitro potency, and DMPK profiles of mGlu1/mGlu5 negative allosteric modulators <b>213</b>–<b>215</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0066.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig66"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> β<sub>2</sub>-Adrenoceptor Agonist <b>218</b></h3><div class="NLM_p">β<sub>2</sub>-Adrenoceptor agonists have been a mainstay in the pharmacotherapy of asthma and COPD. Glossop and co-workers<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> developed an ultralong-acting β<sub>2</sub>-adrenoceptor agonist suitable for use as a once-a-day inhalation treatment as well as a drug that had intrinsic crystallinity that would simplify solid state identification and candidate selection. The first analogue of this kind, <b>216</b>, bearing a (<i>R</i>)-methyl group adjacent to the basic amine group, had excellent potency and selectivity; however, it was too polar, as evidenced from the clogP/log <i>D</i> value (<a data-tab="pane-pcw-Figures" href="#fig67" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig67" id="" class=" internalNav">67</a></a>). It was observed that the (<i>R</i>)-methyl group formed key interactions with a β<sub>2</sub>-adrenoceptor to achieve potency and selectivity over the β<sub>1</sub>-adrenoceptor. Conversely, the (<i>S</i>)-methyl group was neither positively nor negatively involved in ligand–receptor interactions. Thus, it was logical to install a <i>gem</i>-dimethyl group next to the basic amine, yielding <b>217</b>, with retention of the potency and selectivity reported for <b>216</b>; however, unlike <b>216</b>, <b>217</b> had one less stereogenic center, thus making this compound simpler in terms of synthesis and future developmental work. These investigators hypothesized that an increase in lipophilicity would lead to an increase in duration of action. Moreover, they also intended to develop a drug with a lower incidence of adverse effects by the addition of “a phenolic handle” for glucuronide conjugation, to increase clearance following its systemic absorption via inhalation. To achieve these goals, they appended a phenol to the benzyl group and obtained <b>218</b> (PF-610355)<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> with acceptable potency, selectivity, and more importantly, a 2-fold increase in duration of action. Furthermore, the solid form of <b>218</b> had properties that made it suitable for use as an inhalation powder dosage form.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></div><figure id="fig67" data-index="67" class="article__inlineFigure"><h2 class="fig-label">Figure 67</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0067.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0067.jpeg" id="gr73" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 67. Structures, in vitro/in vivo potency, and physicochemical properties of β<sub>2</sub>-adrenoceptor agonists <b>216</b>–<b>218</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0067.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig67"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Anticancer Synthetic Analogues of Apratoxin A (<b>219</b>) and E (<b>220</b>)</h3><div class="NLM_p">Apratoxins are cyanobacterial cyclodepsipeptides with significant cytotoxicity against certain types of cancer cells.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Hence, they can serve as a novel template for further SAR studies. Although <b>219</b> (<a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">68</a></a>) demonstrated a broad range of antitumor efficacy,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> it also exhibited irreversible toxicity in vivo and was not well tolerated.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Subsequently, Chen and co-workers<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> linked the irreversible toxicity of <b>219</b> to the presence of a Michael acceptor group at C29, which was shown in vitro to form a covalent bond with glutathione. The only natural apratoxin that does not possess an α,β-unsaturated carbonyl group is <b>220</b>; however, this compound suffers from poor cytotoxic efficacy, possibly due to lack of a C35-hydroxy group. Therefore, a new analogue, <b>221</b>, which is a hybrid of <b>219</b> and <b>220</b>, was designed and synthesized (<a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">68</a></a>).<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Compound <b>221</b> contains the potency-enhancing C35-hydroxy group as in <b>219</b> but lacks the Michael acceptor toxicophore of <b>219</b>, as in <b>220</b>. Compound <b>222</b>, a nonmethyl C34 derivative, was prepared to eliminate the chiral center, thus making the molecule simpler. Compound <b>223</b>, a <i>gem</i>-dimethyl-C34 derivative, also removed the C34-chiral center, but the <i>gem</i>-dimethyl group reduced the possibility of dehydration at C35 and subsequent formation of a double bond conjugated to the thiazoline ring system. All of the newly prepared apratoxin analogues, <b>221</b>–<b>223</b>, demonstrated excellent antiproliferative efficacy against HCT116 cells (<a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig68" id="" class=" internalNav">68</a></a>). In addition, these compounds inhibited angiogenic vascular endothelial growth factor A (VEGF-A) at subnanomolar concentrations. Compound <b>223</b>, though slightly less potent than <b>221</b> and <b>222</b>, was selected for in vivo studies because of its resistance to undergo inactivating C35-dehydration. Compound <b>223</b> produced a significant dose-dependent decrease in tumor growth in an HCT116 xenograft mouse model.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><figure id="fig68" data-index="68" class="article__inlineFigure"><h2 class="fig-label">Figure 68</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0068.jpeg" id="gr74" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 68. Structures and in vitro potency of apratoxin analogues <b>219</b>–<b>223</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig68"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Thorpe-Ingold Effect (<i>gem</i>-Dialkyl Effect)</h3><div class="NLM_p">Beesley, Ingold, and Thorpe were the first investigators to notice a correlation between alterations in the bond angles of the carbon atoms of an open chain structure with the formation and stability of a cyclized product.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Replacement of the methylene hydrogens with the sterically more demanding methyl group resulted in reduction of the internal bond angle α as shown in <a data-tab="pane-pcw-Figures" href="#fig69" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig69" id="" class=" internalNav">69</a></a>. Consequently, the two reactive groups attached to the central carbon move toward each other (compression of angle α from 112.2° to 109.5°) to facilitate ring closure, thereby forming a cyclized product.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Subsequently, this strategy has been applied to design <i>o</i>-hydroxydihydrocinnamic acid based prodrugs as described in the following section.</div><figure id="fig69" data-index="69" class="article__inlineFigure"><h2 class="fig-label">Figure 69</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0069.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0069.jpeg" id="gr75" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 69. Thorpe–Ingold conformational effect by a <i>gem</i>-dimethyl substituent at the noncyclic methylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0069.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig69"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Application of the Thorpe–Ingold Conformational Effect in Prodrug Design</h3><div class="NLM_p">The three interacting methyl groups (highlighted red in <a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">70</a></a>) present in an <i>o</i>-hydroxydihydrocinnamic acid produce a conformational restriction that significantly increases the rate of cyclization (lactonization). Milstien and colleagues<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> reported an increase in the kinetic and thermodynamic favorability of the lactonization of a three methyl locked <i>o</i>-hydroxydihydrocinnamic acid, <b>227</b>, compared to derivatives <b>224</b>–<b>226</b>. Consequently, a three methyl lock-bearing <i>o</i>-hydroxydihydrocinnamic acid was used to prepare prodrugs. The application of a three methyl lock in prodrug development is illustrated using paclitaxel (<a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">70</a></a>). Paclitaxel (compound <b>7</b>) has an extremely poor aqueous solubility, and as a result, it poses a concern for intravenous administration. To solve this problem, Ueda and colleagues<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> prepared a water-soluble prodrug that was capable of releasing the active drug, i.e., paclitaxel, upon administration (<a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig70" id="" class=" internalNav">70</a></a>). A paclitaxel prodrug derived from the corresponding three methyl-lock-lacking promoiety is thought to undergo the first step, i.e., hydrolysis as expected; however, the cyclization (lactonization) step was too slow to efficiently release paclitaxel.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a></div><figure id="fig70" data-index="70" class="article__inlineFigure"><h2 class="fig-label">Figure 70</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0070.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0070.jpeg" id="gr76" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 70. A three methyl lock <i>o</i>-hydroxydihydrocinnamic acid-derived promoiety and its influence on the rapid formation of δ-lactone with simultaneous release of paclitaxel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0070.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig70"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>gem</i>-Dimethyl Substituted Bioreductive Prodrugs of Phenstatin (<b>228</b>)</h3><div class="NLM_p">Development of bioreductive prodrugs of anticancer drugs is a useful strategy to target hypoxic tumors. Bioreductive prodrugs preferentially undergo reductive cleavage to release an active anticancer drug inside hypoxic tumors. Consequently, Winn and colleagues<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> developed bioreductive prodrugs of phenstatin (<b>228</b>), a disrupter of microtubule assembly, for selective targeting of hypoxic tumors. To this end, the 3-hydroxyl group of <b>228</b> was linked to the 5-nitrothiophene and 5-nitrofuran promoieties through a <i>gem</i>-dimethyl substituted methylene linker to produce <b>229</b> and <b>230</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig71" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig71" id="" class=" internalNav">71</a></a>). When <b>229</b> and <b>230</b> were subjected to CYP450 oxidoreductase enzyme, it was observed that both were completely cleaved to produce the parent drug <b>228</b> and a bystander promoiety.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The <i>gem</i>-dimethyl-containing phenstatin prodrugs were more efficiently cleaved than their normethyl and monomethyl counterparts.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><figure id="fig71" data-index="71" class="article__inlineFigure"><h2 class="fig-label">Figure 71</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0071.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0071.jpeg" id="gr77" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 71. Structures of microtubule assembly disrupter <b>228</b> and its bioreductive prodrugs <b>229</b> and <b>230</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0071.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig71"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Various Synthetic Approaches to Installation of the <i>gem</i>-Dimethyl Group</h3><div class="NLM_p">A large number of <i>gem</i>-dimethyl substituted building blocks (<b>231</b>–<b>268</b>) are commercially available for direct use in the synthesis of a wide range of bioactive compounds (<a data-tab="pane-pcw-Figures" href="#fig72" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig72" id="" class=" internalNav">72</a></a>); however, these building blocks may not be suitable for certain drug discovery programs. Therefore, synthetic strategies for installation of the <i>gem</i>-dimethyl group are critical for them to be useful to medicinal chemists. A brief account of major <i>gem</i>-dimethylation strategies is highlighted in this section and is no way intended to be exhaustive.</div><figure id="fig72" data-index="72" class="article__inlineFigure"><h2 class="fig-label">Figure 72</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0072.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0072.jpeg" id="gr78" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 72. Structures of some commercially available <i>gem</i>-dimethyl containing building blocks (<b>231</b>–<b>268</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0072.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig72"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Representative base-catalyzed reactions for the <i>gem</i>-dimethylation of a carbonyl-activated benzylic carbon are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The <i>gem</i>-dimethylation of the aryl benzyl ketone (<b>269</b>) using potassium <i>tert</i>-butoxide and methyl iodide in THF furnished a <i>gem</i>-dimethyl substituted ketone (<b>270</b>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Similarly the treatment of the aryl acetate (<b>271</b>) with sodium hydride and methyl iodide in DMF yielded a <i>gem</i>-dimethyl substituted aryl acetate (<b>272</b>) as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a><i>Gem</i>-dimethylation of keto-methylene functionalities is depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Regioselective <i>gem</i>-dimethylation of the cyclopentanone derivative (<b>273</b>) using an excess of methyl iodide and a slow addition of potassium <i>tert</i>-butoxide yielded a <i>gem</i>-dimethyl substituted cyclopentanone derivative (<b>274</b>).<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> The <i>gem</i>-dimethylation of bicyclic unsaturated ketone (<b>275</b>) occurred efficiently upon treatment with potassium <i>tert</i>-butoxide and methyl iodide to produce <b>276</b>. Highly efficient <i>gem</i>-dimethylation was observed when the <i>tert</i>-alcohol group was temporarily silylated using trimethylsilyl chloride, with subsequent removal by treatment with tetrabutylammonium fluoride.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Ketone <b>277</b> was subjected to <i>gem</i>-dimethylation using sodium hydride and methyl iodide in dimethoxyethane to produce a <i>gem</i>-dimethyl derivative <b>278</b>.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Regioselective <i>gem</i>-dimethylation of the enone <b>279</b> using potassium <i>tert</i>-butoxide and methyl iodide in <i>tert</i>-butanol led to the <i>gem</i>-dimethylated ketone <b>280</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div><figure id="sch1" data-index="73" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0073.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0073.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Examples of Base-Catalyzed Reactions for the <i>gem</i>-Dimethylation of the Benzylic Carbon</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0073.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="74" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0074.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0074.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Base-Catalyzed <i>gem</i>-Dimethylation of the Keto-Methylene Functionality</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An alternative strategy employs regioselective opening of a spirocyclopropane ring (derived from exocyclic alkenes by following the modified Simmons–Smith reaction conditions), as in <b>281</b><a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> and <b>282</b>,<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> using hydrogen over platinum oxide, providing the <i>gem</i>-dimethyl derivatives <b>283</b> and <b>284</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The <i>gem</i>-dimethyl cyclopropanation of the alkenes <b>285</b>,<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a><b>286</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and <b>287</b><a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> led, respectively, to the <i>gem</i>-dimethyl cyclopropane analogues <b>288</b>, <b>289</b>, and <b>290</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch3" data-index="75" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0075.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0075.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Regioselective Opening of a Spirocyclopropane Ring To Produce <i>gem</i>-Dimethyl Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0075.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="76" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0076.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0076.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Examples of the <i>gem</i>-Dimethylcyclopropanation of Alkenes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0076.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several examples of addition of two methyl anions to the carbonyl carbon of ester, amide, and ketone groups are depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Treatment of the methyl ester <b>291</b> with the methyl Grignard reagent in THF led to a <i>gem</i>-dimethyl carbinol substituted derivative <b>292</b>,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> while reaction with the monoester <b>293</b> in THF furnished the <i>tert</i>-alcohol <b>294</b>.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> Similarly the ethyl ester <b>295</b> was treated with the methyl Grignard reagent to produce <i>tert</i>-alcohol <b>296</b>.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Treatment of the <i>tert</i>-amide <b>297</b> with either titanium tetrachloride or zirconium tetrachloride and subsequently with the methyl Grignard reagent produced a <i>gem</i>-dimethyl pyrrolidine derivative <b>298</b>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Reaction of the acetyl substituted thiophene, <b>299</b>, with either methyllithium in the presence of titanium tetrachloride or with trimethylaluminum yielded a <i>gem</i>-dimethyl carbinol substituted thiophene derivative <b>300</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><figure id="sch5" data-index="77" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0077.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0077.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Addition of Methyl Anions to the Carbonyl Carbon of the Ester, Amide, and Ketone Groups</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0077.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Installation of a <i>gem</i>-dimethyl carbinol, a group frequently appearing in bioactive compounds, via nucleophilic additions to acetone is illustrated in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The quenching of the lithium anion of the benzylic carbon in <b>301</b> with acetone led to a <i>gem</i>-dimethyl carbinol <b>302</b>.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> A lithium–iodine exchange of 2-chloro-4-iodopyridine (<b>303</b>) using <i>n</i>-butyllithium followed by reaction with acetone furnished a <i>gem</i>-dimethyl carbinol <b>304</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Treatment of the purine derivative <b>305</b> with <i>n</i>-butyllithium followed by the addition of acetone yielded the C8-<i>gem</i>-dimethyl carbinol <b>306</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Some of the reactions described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a> lack information on the percent yields of products because these products were used in the crude state for further chemical transformations.</div><figure id="sch6" data-index="78" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0078.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0078.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Examples of Installation of the Carbinol Functionality via Nucleophilic Additions to Acetone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0078.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of the examples provided in this review, insertion of a natural-product-inspired <i>gem</i>-dimethyl moiety can be considered a useful structural feature in a wide range of lead optimization efforts. In this Perspective, numerous clinically useful compounds have been discussed (summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) to illustrate how a <i>gem</i>-dimethyl moiety can significantly contribute to favorable drug properties. For example, insertion of a <i>gem</i>-dimethyl group can (a) increase target engagement, potency, and selectivity, (b) induce symmetry at a monomethyl substituted chiral center, (c) modulate the p<i>K</i><sub>a</sub> of nearby acidic and basic functional groups, (d) delay or prevent phase 1 and phase 2 drug metabolism, (e) increase membrane permeability, chemical and plasma stability, oral bioavailability, AUC, CNS exposure, and <i>t</i><sub>1/2</sub>, (f) decrease plasma clearance, CYP450 inhibition, PXR activation, P-gp efflux ratio, Ames genotoxicity, and hERG inhibition, (g) facilitate cyclative release of active drug from a three methyl lock prodrug, (h) accelerate release of cytotoxic drug from a bioreductive prodrug, and (i) decrease the reactivity of a glucuronide ester metabolite toward endogenous nucleophilic proteins and associated idiosyncratic toxicity. Furthermore, the <i>gem</i>-dimethyl moiety serves as an integral component of a myriad of natural products that have the potential for therapeutic use against a wide range of diseases.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the Contributions of the <i>gem</i>-Dimethyl Group toward the PK/PD/Physicochemical Properties of Selected Compounds Described in This Article</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0079.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0080.gif" alt="" id="GRAPHIC-d59e5876-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0081.gif" alt="" id="GRAPHIC-d59e5877-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0082.gif" alt="" id="GRAPHIC-d59e5878-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0083.gif" alt="" id="GRAPHIC-d59e5879-autogenerated" /></img><div></div></div><div class="NLM_p">The <i>gem</i>-dimethylation of a 1,2-disubstituted bridged cyclopropane ring may be an effective way of increasing half-life and bioavailability while simultaneously reducing plasma clearance. Insertion of a <i>gem</i>-dimethyl group at the open chain methylene next to a labile functional group could potentially enhance chemical, plasma, and metabolic drug stability. While <i>gem</i>-dimethyl substitution may be a useful way to mitigate time-dependent inhibition of drug metabolizing CYP450 enzymes, the <i>gem</i>-dimethyl steric lobes could be exploited to achieve longer target residence time. Furthermore, it would be of interest to evaluate the impact of bioisosteric replacement of a <i>gem</i>-dimethyl group with the spirocyclopropane, spirocyclobutane, spirooxetane, and spiroazetidine moieties as determinants of PK/PD-related parameters.</div><div class="NLM_p last">A successful drug is the result of combining a wide range of physicochemical and biological properties governing the drug’s PD/DMPK/toxicity profile, properties that could be addressed by the judicious use of a <i>gem</i>-dimethyl group. Although the number of U.S. FDA approved drugs containing a <i>gem</i>-dimethyl group is large, the exact role of a <i>gem</i>-dimethyl group in many of these examples is still not apparent. Therefore, studies aimed at understanding the role of a <i>gem</i>-dimethyl moiety in drug action will be needed using the additional <i>gem</i>-dimethyl/non-<i>gem</i>-dimethyl matched molecular pairs. Moreover, the development of new synthetic strategies for installation of a <i>gem</i>-dimethyl group will continue to enable <i>gem</i>-dimethyl group insertion into medicinally useful compounds. It is hoped that this Perspective will inspire medicinal chemists to use the <i>gem</i>-dimethyl moiety in developing useful and effective preclinical and clinical drug candidates.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00315" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00315" class="ext-link">10.1021/acs.jmedchem.7b00315</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and associated biological data reported in this study (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00315/suppl_file/jm7b00315_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00315/suppl_file/jm7b00315_si_001.csv">jm7b00315_si_001.csv (24.22 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00315" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanaji T. Talele</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical
Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York 11439, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5938-6505" title="Orcid link">http://orcid.org/0000-0002-5938-6505</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b5f4a474e474e5f6b585f4144434558054e4f5e"><span class="__cf_email__" data-cfemail="3743565b525b52437744435d585f594419525342">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The author declares no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="79" class="article__inlineFigure"><h2 class="fig-label">Tanaji T. Talele</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=BIO-d59e5947-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tanaji T. Talele</b> obtained his Ph.D. (1998) in Medicinal Chemistry from the University of Mumbai, India. He was a postdoctoral fellow at UMD-New Jersey Medical School, Louisiana State University, and Moffitt Cancer Center (1999–2005). He joined the SJU’s College of Pharmacy and Health Sciences in 2005 where he is currently a Full Professor. He has authored/coauthored 88 peer-reviewed research papers. He has served as a reviewer for three grant agencies: Campbell Foundation FL, National Health and Medical Research Council (NHMRC) of the Government of Australia, and Fondazione Telethon, Italy. Since January 2016 he has been serving as an editorial advisory board member of the <i>European Journal of Medicinal Chemistry</i>. His current research interests include development of small molecule inhibitors of poly(ADP-ribose)polymerase and P-glycoprotein.</p></figure></div><div class="ack" id="ACK-d59e5955-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The author is thankful to Drs. Charles R. Ashby, Jr., Cesar A. Lau-Cam, Uday Kiran Velagapudi (St. John’s University), Sanjai Kumar (Queens College, CUNY, NY), Mark McLaughlin (West Virginia University), and Vijay Gokhale (The University of Arizona) for their insights and critical review of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AVP</td><td class="NLM_def"><p class="first last">adenoviral protease</p></td></tr><tr><td class="NLM_term">Aib</td><td class="NLM_def"><p class="first last">α-aminoisobutyric acid</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">antibody–drug conjugate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">CCR1</td><td class="NLM_def"><p class="first last">CC chemokine receptor 1</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DHP-I</td><td class="NLM_def"><p class="first last">dehydropeptidase I</p></td></tr><tr><td class="NLM_term">DPP-IV</td><td class="NLM_def"><p class="first last">dipeptidylpeptidase IV</p></td></tr><tr><td class="NLM_term">GK</td><td class="NLM_def"><p class="first last">glucokinase</p></td></tr><tr><td class="NLM_term">GK-GKRP</td><td class="NLM_def"><p class="first last">glucokinase–glucokinase regulatory protein</p></td></tr><tr><td class="NLM_term">GPIIb/IIIa</td><td class="NLM_def"><p class="first last">glycoprotein IIb/IIIa</p></td></tr><tr><td class="NLM_term">HSP90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene encoded potassium channel</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HMG-CoA</td><td class="NLM_def"><p class="first last">3-hydroxy-3-methylglutaryl-CoA</p></td></tr><tr><td class="NLM_term">HWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">IGF-1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor 1 receptor</p></td></tr><tr><td class="NLM_term">ITK</td><td class="NLM_def"><p class="first last">interleukin-2 inducible T-cell kinase</p></td></tr><tr><td class="NLM_term">ICMT</td><td class="NLM_def"><p class="first last">isoprenylcysteine carboxyl methyltransferase</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">LTD<sub>4</sub></td><td class="NLM_def"><p class="first last">leukotriene D<sub>4</sub></p></td></tr><tr><td class="NLM_term">FLAP</td><td class="NLM_def"><p class="first last">5-lipoxygenase activating protein</p></td></tr><tr><td class="NLM_term">LXR</td><td class="NLM_def"><p class="first last">liver X receptor</p></td></tr><tr><td class="NLM_term">LHMDS</td><td class="NLM_def"><p class="first last">lithium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">cathepsin K</td><td class="NLM_def"><p class="first last">lysosomal cysteine protease</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloprotease</p></td></tr><tr><td class="NLM_term">mGlu</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor</p></td></tr><tr><td class="NLM_term">MIP</td><td class="NLM_def"><p class="first last">macrophage inflammatory protein</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">MDP</td><td class="NLM_def"><p class="first last">muramyl dipeptide</p></td></tr><tr><td class="NLM_term">MTH1</td><td class="NLM_def"><p class="first last">mutT homolog 1</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">PBP</td><td class="NLM_def"><p class="first last">penicillin binding protein</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PDE4</td><td class="NLM_def"><p class="first last">phosphodiesterase 4</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">Plm</td><td class="NLM_def"><p class="first last">plasmepsin</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">prostate specific antigen</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">RSV</td><td class="NLM_def"><p class="first last">respiratory syncytial virus</p></td></tr><tr><td class="NLM_term">RAR</td><td class="NLM_def"><p class="first last">retinoic acid receptor</p></td></tr><tr><td class="NLM_term">RXR</td><td class="NLM_def"><p class="first last">retinoid X receptor</p></td></tr><tr><td class="NLM_term">SIRT</td><td class="NLM_def"><p class="first last">silent information regulator</p></td></tr><tr><td class="NLM_term">NHE</td><td class="NLM_def"><p class="first last">sodium hydrogen exchanger</p></td></tr><tr><td class="NLM_term">S1P<sub>2</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate 2</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">VEGF-A</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor A</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 207 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/np068054v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years&doi=10.1021%2Fnp068054v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0lj1a8PjDNlp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477%26doi%3D10.1021%2Fnp068054v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural products: a continuing source of novel drug leads</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1830</i></span>,  <span class="NLM_fpage">3670</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bbagen.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23428572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=3670-3695&author=G.+M.+Craggauthor=D.+J.+Newman&title=Natural+products%3A+a+continuing+source+of+novel+drug+leads&doi=10.1016%2Fj.bbagen.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products: A continuing source of novel drug leads</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3670-3695</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nature has been a source of medicinal products for millennia, with many useful drugs developed from plant sources.  Following discovery of the penicillins, drug discovery from microbial sources occurred and diving techniques in the 1970s opened the seas.  Combinatorial chem. (late 1980s), shifted the focus of drug discovery efforts from Nature to the lab. bench.  This review traces natural products drug discovery, outlining important drugs from natural sources that revolutionized treatment of serious diseases.  It is clear Nature will continue to be a major source of new structural leads, and effective drug development depends on multidisciplinary collaborations.  The explosion of genetic information led not only to novel screens, but the genetic techniques permitted the implementation of combinatorial biosynthetic technol. and genome mining.  The knowledge gained has allowed unknown mols. to be identified.  These novel bioactive structures can be optimized by using combinatorial chem. generating new drug candidates for many diseases.  The advent of genetic techniques that permitted the isolation /expression of biosynthetic cassettes from microbes may well be the new frontier for natural products lead discovery.  It is now apparent that biodiversity may be much greater in those organisms.  The nos. of potential species involved in the microbial world are many orders of magnitude greater than those of plants and multi-celled animals.  Coupling these nos. to the no. of currently unexpressed biosynthetic clusters now identified (> 10 per species) the potential of microbial diversity remains essentially untapped.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zi-u3aGY-7Vg90H21EOLACvtfcHk0lhTvbwFYP79UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D&md5=f3242db81842ceeaca0dc51a0c741c23</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%253A%2520a%2520continuing%2520source%2520of%2520novel%2520drug%2520leads%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D3670%26epage%3D3695%26doi%3D10.1016%2Fj.bbagen.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Natural product and natural product derived drugs in clinical trials</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1039/C4NP00064A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FC4NP00064A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25204227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1612-1661&author=M.+S.+Butlerauthor=A.+A.+Robertsonauthor=M.+A.+Cooper&title=Natural+product+and+natural+product+derived+drugs+in+clinical+trials&doi=10.1039%2FC4NP00064A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product and natural product derived drugs in clinical trials</span></div><div class="casAuthors">Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1612-1661</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 2008-2013.  Previous review: 2008, 25, 475There are a significant no. of natural product (NP) drugs in development.  We review the 100 NP and NP-derived compds. and 33 Antibody Drug Conjugates (ADCs) with a NP-derived cytotoxic component being evaluated in clin. trials or in registration at the end of 2013. 38 of these compds. and 33 ADCs are being investigated as potential oncol. treatments, 26 as anti-infectives, 19 for the treatment of cardiovascular and metabolic diseases, 11 for inflammatory and related diseases and 6 for neurol.  There was a spread of the NP and NP-derived compds. through the different development phases (17 in phase I, 52 in phase II, 23 in phase III and 8 NDA and/or MAA filed), while there were 23 ADCs in phase I and 10 in phase II. 50 of these 100 compds. were either NPs or semi-synthetic (SS) NPs, which indicated the original NP still plays an important role.  NP and NP-derived compds. for which clin. trials have been halted or discontinued since 2008 are listed in the Supplementary Information.  The 25 NP and NP-derived drugs launched since 2008 are also reviewed, and late stage development candidates and new NP drug pharmacophores analyzed.  The short term prospect for new NP and NP-derived drug approvals is bright, with 31 compds. in phase III or in registration, which should ensure a steady stream of approvals for at least the next five years.  However, there could be future issues for new drug types as only five new drug pharmacophores discovered in the last 15 years are currently being evaluated in clin. trials.  The next few years will be crit. for NP-driven lead discovery, and a concerted effort is required to identify new biol. active pharmacophores and to progress these and existing compds. through pre-clin. drug development into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ZulhKpZ6PbVg90H21EOLACvtfcHk0lhTvbwFYP79UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF&md5=05f9fafdbe8dd7c1407fb7b4afab0587</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FC4NP00064A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00064A%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DNatural%2520product%2520and%2520natural%2520product%2520derived%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1612%26epage%3D1661%26doi%3D10.1039%2FC4NP00064A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodycombe, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrinski, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">18787</span>– <span class="NLM_lpage">18792</span>, <span class="refDoi"> DOI: 10.1073/pnas.1012741107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1012741107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20956335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVCqsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18787-18792&author=P.%0AA.+Clemonsauthor=N.+E.+Bodycombeauthor=H.+A.+Carrinskiauthor=J.+A.+Wilsonauthor=A.+F.+Shamjiauthor=B.+K.+Wagnerauthor=A.+N.+Koehlerauthor=S.+L.+Schreiber&title=Small+molecules+of+different+origins+have+distinct+distributions+of+structural+complexity+that+correlate+with+protein-binding+profiles&doi=10.1073%2Fpnas.1012741107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles</span></div><div class="casAuthors">Clemons, Paul A.; Bodycombe, Nicole E.; Carrinski, Hyman A.; Wilson, J. Anthony; Shamji, Alykhan F.; Wagner, Bridget K.; Koehler, Angela N.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18787-18792, S18787/1-S18787/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using a diverse collection of small mols. generated from a variety of sources, we measured protein-binding activities of each individual compd. against each of 100 diverse (sequence-unrelated) proteins using small-mol. microarrays.  We also analyzed structural features, including complexity, of the small mols.  We found that compds. from different sources (com., academic, natural) have different protein-binding behaviors and that these behaviors correlate with general trends in stereochem. and shape descriptors for these compd. collections.  Increasing the content of sp3-hybridized and stereogenic atoms relative to compds. from com. sources, which comprise the majority of current screening collections, improved binding selectivity and frequency.  The results suggest structural features that synthetic chemists can target when synthesizing screening collections for biol. discovery.  Because binding proteins selectively can be a key feature of high-value probes and drugs, synthesizing com- pounds having features identified in this study may result in improved performance of screening collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBrE7Js72yZrVg90H21EOLACvtfcHk0lg_sIk9U8L7Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCqsb%252FN&md5=198e298ca5391d7dfd91184680e3c2ec</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1012741107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1012741107%26sid%3Dliteratum%253Aachs%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DBodycombe%26aufirst%3DN.%2BE.%26aulast%3DCarrinski%26aufirst%3DH.%2BA.%26aulast%3DWilson%26aufirst%3DJ.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DSmall%2520molecules%2520of%2520different%2520origins%2520have%2520distinct%2520distributions%2520of%2520structural%2520complexity%2520that%2520correlate%2520with%2520protein-binding%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D18787%26epage%3D18792%26doi%3D10.1073%2Fpnas.1012741107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warriner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of natural-product-like molecules with over eighty distinct scaffolds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1002/anie.200804486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.200804486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=104-109&author=D.+Mortonauthor=S.+Leachauthor=C.+Cordierauthor=S.+Warrinerauthor=A.+Nelson&title=Synthesis+of+natural-product-like+molecules+with+over+eighty+distinct+scaffolds&doi=10.1002%2Fanie.200804486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of natural-product-like molecules with over eighty distinct scaffolds</span></div><div class="casAuthors">Morton, Daniel; Leach, Stuart; Cordier, Christopher; Warriner, Stuart; Nelson, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-109</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A synthetic approach for the combinatorial variation of the scaffolds of small mols. is described.  Using just six basic reaction types, compds. with 84 distinct scaffolds were prepd.  The compds. had many natural-product-like structural features including rich stereochem., heterocyclic and unsatd. ring systems, and dense functionalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobT4OodbtpkbVg90H21EOLACvtfcHk0lg_sIk9U8L7Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFGmsQ%253D%253D&md5=a50405150961afb4a8067bf8610b6a1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fanie.200804486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200804486%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DS.%26aulast%3DCordier%26aufirst%3DC.%26aulast%3DWarriner%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520natural-product-like%2520molecules%2520with%2520over%2520eighty%2520distinct%2520scaffolds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D104%26epage%3D109%26doi%3D10.1002%2Fanie.200804486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>SciFinder;
Chemical Abstracts Service: P.O. Box 3012, Columbus, OH 43210, U.S. <a href="https://scifinder.cas.org" class="extLink">https://scifinder.cas.org</a> (accessed
August 12, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SciFinder%3B%0AChemical+Abstracts+Service%3A+P.O.+Box+3012%2C+Columbus%2C+OH+43210%2C+U.S.+https%3A%2F%2Fscifinder.cas.org+%28accessed%0AAugust+12%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blunt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyzers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsep, M. R.</span></span> <span> </span><span class="NLM_article-title">Marine natural products</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1039/C4NP00144C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FC4NP00144C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25620233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=116-211&author=J.+W.+Bluntauthor=B.+R.+Coppauthor=R.+A.+Keyzersauthor=M.+H.+Munroauthor=M.+R.+Prinsep&title=Marine+natural+products&doi=10.1039%2FC4NP00144C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Marine natural products</span></div><div class="casAuthors">Blunt, John W.; Copp, Brent R.; Keyzers, Robert A.; Munro, Murray H. G.; Prinsep, Michele R.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-211</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This review covers the literature published in 2013 for marine natural products (MNPs), with 982 citations (644 for the period Jan. to Dec. 2013) referring to compds. isolated from marine microorganisms and phytoplankton, green, brown and red algae, sponges, cnidarians, bryozoans, molluscs, tunicates, echinoderms, mangroves and other intertidal plants and microorganisms.  The emphasis is on new compds. (1163 for 2013), together with the relevant biol. activities, source organisms and country of origin.  Reviews, biosynthetic studies, first syntheses, and syntheses that lead to the revision of structures or stereochemistries, have been included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKlmlmJV9PLVg90H21EOLACvtfcHk0liZ1VqQw0h0zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSju74%253D&md5=2011d5cdb341df91eeb107e44ded56e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FC4NP00144C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00144C%26sid%3Dliteratum%253Aachs%26aulast%3DBlunt%26aufirst%3DJ.%2BW.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DKeyzers%26aufirst%3DR.%2BA.%26aulast%3DMunro%26aufirst%3DM.%2BH.%26aulast%3DPrinsep%26aufirst%3DM.%2BR.%26atitle%3DMarine%2520natural%2520products%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2015%26volume%3D32%26spage%3D116%26epage%3D211%26doi%3D10.1039%2FC4NP00144C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkas, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R.</span></span> <span> </span><span class="NLM_article-title">Photochemical approaches to complex chemotypes: applications in natural product synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9683</span>– <span class="NLM_lpage">9747</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslWhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=9683-9747&author=M.+D.+Karkasauthor=J.+A.+Porcoauthor=C.+R.+Stephenson&title=Photochemical+approaches+to+complex+chemotypes%3A+applications+in+natural+product+synthesis&doi=10.1021%2Facs.chemrev.5b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis</span></div><div class="casAuthors">Karkas, Markus D.; Porco, John A.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9683-9747</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of photochem. transformations is a powerful strategy that allows for the formation of a high degree of mol. complexity from relatively simple building blocks in a single step.  A central feature of all light-promoted transformations is the involvement of electronically excited states, generated upon absorption of photons.  This produces transient reactive intermediates and significantly alters the reactivity of a chem. compd.  The input of energy provided by light thus offers a means to produce strained and unique target compds. that cannot be assembled using thermal protocols.  This review aims at highlighting photochem. transformations as a tool for rapidly accessing structurally and stereochem. diverse scaffolds.  Synthetic designs based on photochem. transformations have the potential to afford complex polycyclic carbon skeletons with impressive efficiency, which are of high value in total synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp-nECA9probVg90H21EOLACvtfcHk0liZ1VqQw0h0zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslWhsr8%253D&md5=a8b206f9f59a2b945c0e91ae15eedf96</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00760%26sid%3Dliteratum%253Aachs%26aulast%3DKarkas%26aufirst%3DM.%2BD.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%26atitle%3DPhotochemical%2520approaches%2520to%2520complex%2520chemotypes%253A%2520applications%2520in%2520natural%2520product%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D9683%26epage%3D9747%26doi%3D10.1021%2Facs.chemrev.5b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neve, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijesekera, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripper, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de A. Leone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrae, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Euodenine A: a small-molecule agonist of human TLR4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/jm401321v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401321v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1252-1275&author=J.+E.+Neveauthor=H.+P.+Wijesekeraauthor=S.+Duffyauthor=I.+D.+Jenkinsauthor=J.+A.+Ripperauthor=S.+J.+Teagueauthor=M.+Campitelliauthor=A.+Garavelasauthor=G.+Nikolakopoulosauthor=P.+V.+Leauthor=P.+de+A.+Leoneauthor=N.+B.+Phamauthor=P.+Sheltonauthor=N.+Fraserauthor=A.+R.+Carrollauthor=V.+M.+Averyauthor=C.+McCraeauthor=N.+Williamsauthor=R.+J.+Quinn&title=Euodenine+A%3A+a+small-molecule+agonist+of+human+TLR4&doi=10.1021%2Fjm401321v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Euodenine A: A Small-Molecule Agonist of Human TLR4</span></div><div class="casAuthors">Neve, Juliette E.; Wijesekera, Hasanthi P.; Duffy, Sandra; Jenkins, Ian D.; Ripper, Justin A.; Teague, Simon J.; Campitelli, Marc; Garavelas, Agatha; Nikolapoulos, George; Le, Phuc V.; de A. Leone, Priscila; Pham, Ngoc B.; Shelton, Philip; Fraser, Neil; Carroll, Anthony R.; Avery, Vicky M.; McCrae, Christopher; Williams, Nicola; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1252-1275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small-mol. natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor.  Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure.  It was synthesized along with a series of analogs that exhibit potent and selective agonism of the TLR4 receptor.  SAR development around the cyclobutane ring resulted in a 10-fold increase in potency.  The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-κB reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy.  Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compds. like 1 could modulate the Th2 immune response without causing lung damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq274es6aNxRrVg90H21EOLACvtfcHk0lhPh1KxjVzu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCmtro%253D&md5=7f314cfcb025af818709cf4e025cd917</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401321v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401321v%26sid%3Dliteratum%253Aachs%26aulast%3DNeve%26aufirst%3DJ.%2BE.%26aulast%3DWijesekera%26aufirst%3DH.%2BP.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DJenkins%26aufirst%3DI.%2BD.%26aulast%3DRipper%26aufirst%3DJ.%2BA.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DCampitelli%26aufirst%3DM.%26aulast%3DGaravelas%26aufirst%3DA.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DLe%26aufirst%3DP.%2BV.%26aulast%3Dde%2BA.%2BLeone%26aufirst%3DP.%26aulast%3DPham%26aufirst%3DN.%2BB.%26aulast%3DShelton%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DN.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DMcCrae%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DN.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DEuodenine%2520A%253A%2520a%2520small-molecule%2520agonist%2520of%2520human%2520TLR4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1252%26epage%3D1275%26doi%3D10.1021%2Fjm401321v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(00)82054-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0968-0896%2800%2982054-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=1051-1056&author=T.+T.+Leeauthor=Y.+Kashiwadaauthor=L.+Huangauthor=J.+Sniderauthor=M.+Cosentinoauthor=K.+H.+Lee&title=Suksdorfin%3A+an+anti-HIV+principle+from+Lomatium+suksdorfii%2C+its+structure-activity+correlation+with+related+coumarins%2C+and+synergistic+effects+with+anti-AIDS+nucleosides&doi=10.1016%2FS0968-0896%2800%2982054-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2982054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252982054-4%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSnider%26aufirst%3DJ.%26aulast%3DCosentino%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DSuksdorfin%253A%2520an%2520anti-HIV%2520principle%2520from%2520Lomatium%2520suksdorfii%252C%2520its%2520structure-activity%2520correlation%2520with%2520related%2520coumarins%252C%2520and%2520synergistic%2520effects%2520with%2520anti-AIDS%2520nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D1051%26epage%3D1056%26doi%3D10.1016%2FS0968-0896%2800%2982054-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuk, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis-Long, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span> <span> </span><span class="NLM_article-title">Novel chromenedione derivatives displaying inhibition of protein tyrosine phosphatase 1B (PTP1B) from Flemingia philippinensis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2015.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=318-321&author=Y.+Wangauthor=H.+J.+Yukauthor=J.+Y.+Kimauthor=D.+W.+Kimauthor=Y.+H.+Songauthor=X.+F.+Tanauthor=M.+J.+Curtis-Longauthor=K.+H.+Park&title=Novel+chromenedione+derivatives+displaying+inhibition+of+protein+tyrosine+phosphatase+1B+%28PTP1B%29+from+Flemingia+philippinensis&doi=10.1016%2Fj.bmcl.2015.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYuk%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DY.%2BH.%26aulast%3DTan%26aufirst%3DX.%2BF.%26aulast%3DCurtis-Long%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BH.%26atitle%3DNovel%2520chromenedione%2520derivatives%2520displaying%2520inhibition%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%2520%2528PTP1B%2529%2520from%2520Flemingia%2520philippinensis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D318%26epage%3D321%26doi%3D10.1016%2Fj.bmcl.2015.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J. H.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span> <span> </span><span class="NLM_article-title">The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2743</span>, <span class="refDoi"> DOI: 10.1021/jm00093a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00093a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK38XltVyisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2735-2743&author=Y.+Kashmanauthor=K.+R.+Gustafsonauthor=R.+W.+Fullerauthor=J.+H.+Cardellinaauthor=J.+B.+McMahonauthor=M.+J.+Currensauthor=R.+W.+Buckheitauthor=S.+H.+Hughesauthor=G.+M.+Craggauthor=M.+R.+Boyd&title=The+calanolides%2C+a+novel+HIV-inhibitory+class+of+coumarin+derivatives+from+the+tropical+rainforest+tree%2C+Calophyllum+lanigerum&doi=10.1021%2Fjm00093a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HIV inhibitory natural products.  Part 7.  The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum</span></div><div class="casAuthors">Kashman, Yoel; Gustafson, Kirk R.; Fuller, Richard W.; Cardellina, John H., II; McMahon, James B.; Currens, Michael J.; Buckheit, Robert W., Jr.; Hughes, Stephen H.; Cragg, Gordon M.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2735-43</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight new coumarin compds. were isolated by anti-HIV bioassay-guided fractionation of an ext. of C. lanigerum.  The structures of calanolide A (I), 12-acetoxycalanolide A, 12-methoxycalanolide A, calanolide B, II, 12-methoxycaloanilide B, calanolide C, and related derivs. were solved by extensive spectroscopic analyses, particularly HMQC, HMBC, and difference nOe NMR expts.  The abs. stereochem. of I and II was established by a modified Mosher's method.  I and II were completely protective against HIV-1 replication and cytopathicity (EC50 values of 0.1 and 0.4 μM, resp.), but were inactive against HIV-2.  Some of the related compds. also showed evidence of anti-HIV-1 activity.  Studies with purified bacterial recombinant reverse transcriptases (RT) revealed that the calanolides are HIV-1 specific RT inhibitors.  Moreover, I was active not only against the AZT-resistant G-9106 strain of HIV-1 but also against the pyridinone-resistant A17 strain.  This was of particular interest since the A17 virus is highly resistant to previously known HIV-1 specific, non-nucleoside RT inhibitors (e.g., TIBP; BI-RG-587l; L693,593) which comprise a structurally diverse but apparently common pharmacol. class.  The calanolides represent a substantial departure from the known class and therefore provide a novel new anti-HIV chemotype for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe79cb1KWQ3rVg90H21EOLACvtfcHk0lgH3kuXcBW6yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVyisr8%253D&md5=fca56996f9343579501adcd20e02eea6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00093a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00093a004%26sid%3Dliteratum%253Aachs%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26aulast%3DFuller%26aufirst%3DR.%2BW.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DCurrens%26aufirst%3DM.%2BJ.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DThe%2520calanolides%252C%2520a%2520novel%2520HIV-inhibitory%2520class%2520of%2520coumarin%2520derivatives%2520from%2520the%2520tropical%2520rainforest%2520tree%252C%2520Calophyllum%2520lanigerum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2735%26epage%3D2743%26doi%3D10.1021%2Fjm00093a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, S. F.</span></span> <span> </span><span class="NLM_article-title">Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2987</span>, <span class="refDoi"> DOI: 10.1021/ja207662w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja207662w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=2981-2987&author=Z.+Fengauthor=D.+Chakrabortyauthor=S.+B.+Dewellauthor=B.+V.+Reddyauthor=S.+F.+Brady&title=Environmental+DNA-encoded+antibiotics+fasamycins+A+and+B+inhibit+FabF+in+type+II+fatty+acid+biosynthesis&doi=10.1021%2Fja207662w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis</span></div><div class="casAuthors">Feng, Zhiyang; Chakraborty, Debjani; Dewell, Scott B.; Reddy, Boojala Vijay B.; Brady, Sean F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2981-2987</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a study of polyketide biosynthetic gene clusters cloned directly from soil, the authors isolated two antibiotics, fasamycins A and B, which showed activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.  To identify the target of the fasamycins, mutants with elevated fasamycin A min. inhibitory concns. were selected from a wild-type culture of E. faecalis OG1RF.  Next-generation sequencing of these mutants, in conjunction with in vitro biochem. assays, showed that the fasamycins inhibit FabF of type II fatty acid biosynthesis (FASII).  Candidate gene overexpression studies also showed that fasamycin resistance is conferred by fabF overexpression.  On the basis of comparisons with known FASII inhibitors and in silico docking studies, the chloro-gem-dimethyl-anthracenone substructure seen in the fasamycins is predicted to represent a naturally occurring FabF-specific antibiotic pharmacophore.  Optimization of this pharmacophore should yield FabF-specific antibiotics with increased potencies and differing spectra of activity.  This study demonstrates that culture-independent antibiotic discovery methods have the potential to provide access to novel metabolites with modes of action that differ from those of antibiotics currently in clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoucmexTsiROrVg90H21EOLACvtfcHk0lgH3kuXcBW6yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGltA%253D%253D&md5=8ee39d947dfb9dbe44d670eb5985e83a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja207662w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207662w%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DDewell%26aufirst%3DS.%2BB.%26aulast%3DReddy%26aufirst%3DB.%2BV.%26aulast%3DBrady%26aufirst%3DS.%2BF.%26atitle%3DEnvironmental%2520DNA-encoded%2520antibiotics%2520fasamycins%2520A%2520and%2520B%2520inhibit%2520FabF%2520in%2520type%2520II%2520fatty%2520acid%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D2981%26epage%3D2987%26doi%3D10.1021%2Fja207662w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R.</span></span> <span> </span><span class="NLM_article-title">Elansolid A, a unique macrolide antibiotic from Chitinophaga sancti isolated as two stable atropisomers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1002/anie.201005226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.201005226" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=532-536&author=H.+Steinmetzauthor=K.+Gerthauthor=R.+Jansenauthor=N.+Schlagerauthor=R.+Dehnauthor=S.+Reineckeauthor=A.+Kirschningauthor=R.+Muller&title=Elansolid+A%2C+a+unique+macrolide+antibiotic+from+Chitinophaga+sancti+isolated+as+two+stable+atropisomers&doi=10.1002%2Fanie.201005226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005226%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetz%26aufirst%3DH.%26aulast%3DGerth%26aufirst%3DK.%26aulast%3DJansen%26aufirst%3DR.%26aulast%3DSchlager%26aufirst%3DN.%26aulast%3DDehn%26aufirst%3DR.%26aulast%3DReinecke%26aufirst%3DS.%26aulast%3DKirschning%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DR.%26atitle%3DElansolid%2520A%252C%2520a%2520unique%2520macrolide%2520antibiotic%2520from%2520Chitinophaga%2520sancti%2520isolated%2520as%2520two%2520stable%2520atropisomers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D532%26epage%3D536%26doi%3D10.1002%2Fanie.201005226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otoguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunazuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, Y.</span></span> <span> </span><span class="NLM_article-title">Arisugacin, a novel and selective inhibitor of acetylcholinesterase from <i>Penicillium</i> sp. FO-4259</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.48.745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7164%2Fantibiotics.48.745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1995&pages=745-746&author=S.+Omuraauthor=F.+Kunoauthor=K.+Otoguroauthor=T.+Sunazukaauthor=K.+Shiomiauthor=R.+Masumaauthor=Y.+Iwai&title=Arisugacin%2C+a+novel+and+selective+inhibitor+of+acetylcholinesterase+from+Penicillium+sp.+FO-4259&doi=10.7164%2Fantibiotics.48.745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.48.745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.48.745%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DS.%26aulast%3DKuno%26aufirst%3DF.%26aulast%3DOtoguro%26aufirst%3DK.%26aulast%3DSunazuka%26aufirst%3DT.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DMasuma%26aufirst%3DR.%26aulast%3DIwai%26aufirst%3DY.%26atitle%3DArisugacin%252C%2520a%2520novel%2520and%2520selective%2520inhibitor%2520of%2520acetylcholinesterase%2520from%2520Penicillium%2520sp.%2520FO-4259%26jtitle%3DJ.%2520Antibiot.%26date%3D1995%26volume%3D48%26spage%3D745%26epage%3D746%26doi%3D10.7164%2Fantibiotics.48.745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span> <span> </span><span class="NLM_article-title">The interaction between coumarin drugs and DNA gyrase</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01728.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1365-2958.1993.tb01728.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=8231802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1993&pages=681-686&author=A.+Maxwell&title=The+interaction+between+coumarin+drugs+and+DNA+gyrase&doi=10.1111%2Fj.1365-2958.1993.tb01728.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction between coumarin drugs and DNA gyrase</span></div><div class="casAuthors">Maxwell, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">681-6</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A review with 49 refs.  The coumarin group of antibiotics have as their target bacterial DNA gyrase (I).  The drugs bind to the B subunit of I and inhibit DNA supercoiling by blocking the ATPase activity.  Recent data show that the binding site for the drugs lies within the N-terminal part of the B protein, and individual amino acids involved in coumarin interaction are being identified.  The mode of inhibition of the I ATPase reaction by coumarins is unlikely to be simple competitive inhibition, and the drugs may act by stabilizing a conformation of the enzyme with low affinity for ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVp_qVeuKqgbVg90H21EOLACvtfcHk0lio1FQcRZZcZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCjsr8%253D&md5=936de9ec8f1f199de584ec2cedb941b6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01728.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01728.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DThe%2520interaction%2520between%2520coumarin%2520drugs%2520and%2520DNA%2520gyrase%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D9%26spage%3D681%26epage%3D686%26doi%3D10.1111%2Fj.1365-2958.1993.tb01728.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcote, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battershill, C. N.</span></span> <span> </span><span class="NLM_article-title">Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/jo991296y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo991296y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=445-449&author=L.+M.+Westauthor=P.+T.+Northcoteauthor=C.+N.+Battershill&title=Peloruside+A%3A+a+potent+cytotoxic+macrolide+isolated+from+the+New+Zealand+marine+sponge+Mycale+sp&doi=10.1021%2Fjo991296y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo991296y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991296y%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DL.%2BM.%26aulast%3DNorthcote%26aufirst%3DP.%2BT.%26aulast%3DBattershill%26aufirst%3DC.%2BN.%26atitle%3DPeloruside%2520A%253A%2520a%2520potent%2520cytotoxic%2520macrolide%2520isolated%2520from%2520the%2520New%2520Zealand%2520marine%2520sponge%2520Mycale%2520sp%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D445%26epage%3D449%26doi%3D10.1021%2Fjo991296y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talpir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benayahu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleyer, M.</span></span> <span> </span><span class="NLM_article-title">Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge <i>Hemiasterella minor</i> (Kirkpatrick)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4453</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)73382-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0040-4039%2800%2973382-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=4453-4456&author=R.+Talpirauthor=Y.+Benayahuauthor=Y.+Kashmanauthor=L.+Pannellauthor=M.+Schleyer&title=Hemiasterlin+and+geodiamolide+TA%3B+two+new+cytotoxic+peptides+from+the+marine+sponge+Hemiasterella+minor+%28Kirkpatrick%29&doi=10.1016%2FS0040-4039%2800%2973382-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2973382-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252973382-X%26sid%3Dliteratum%253Aachs%26aulast%3DTalpir%26aufirst%3DR.%26aulast%3DBenayahu%26aufirst%3DY.%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DPannell%26aufirst%3DL.%26aulast%3DSchleyer%26aufirst%3DM.%26atitle%3DHemiasterlin%2520and%2520geodiamolide%2520TA%253B%2520two%2520new%2520cytotoxic%2520peptides%2520from%2520the%2520marine%2520sponge%2520Hemiasterella%2520minor%2520%2528Kirkpatrick%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D4453%26epage%3D4456%26doi%3D10.1016%2FS0040-4039%2800%2973382-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Silva, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, T. M.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic peptides from the marine sponge <i>Cymbastela</i> sp</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">10653</span>– <span class="NLM_lpage">10662</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(95)00646-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0040-4020%2895%2900646-P" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=10653-10662&author=J.+E.+Colemanauthor=E.+D.+de+Silvaauthor=F.+Kongauthor=R.+J.+Andersenauthor=T.+M.+Allen&title=Cytotoxic+peptides+from+the+marine+sponge+Cymbastela+sp&doi=10.1016%2F0040-4020%2895%2900646-P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2895%2900646-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252895%252900646-P%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DJ.%2BE.%26aulast%3Dde%2BSilva%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DF.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26atitle%3DCytotoxic%2520peptides%2520from%2520the%2520marine%2520sponge%2520Cymbastela%2520sp%26jtitle%3DTetrahedron%26date%3D1995%26volume%3D51%26spage%3D10653%26epage%3D10662%26doi%3D10.1016%2F0040-4020%2895%2900646-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doubek, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of bryostatin 1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">6846</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1021/ja00388a092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00388a092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL38XmtFejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=6846-6848&author=G.+R.+Pettitauthor=C.+L.+Heraldauthor=D.+L.+Doubekauthor=D.+L.+Heraldauthor=E.+Arnoldauthor=J.+Clardy&title=Isolation+and+structure+of+bryostatin+1&doi=10.1021%2Fja00388a092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of bryostatin 1</span></div><div class="casAuthors">Pettit, George R.; Herald, Cherry L.; Doubek, Dennis L.; Herald, Delbert L.; Arnold, Edward; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6846-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new exceptionally potent antineoplastic agent designated bryostatin 1 (I) has been isolated from the marine animal Bugula neritina (phylum Bryozoa).  An x-ray crystallog. anal. led to the assignment of the novel structure I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryBD1PR44a7rVg90H21EOLACvtfcHk0lhI-CeHurfplA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XmtFejsbs%253D&md5=70346431271c1334ea9159bd9f9c7d61</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00388a092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00388a092%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DDoubek%26aufirst%3DD.%2BL.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bryostatin%25201%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1982%26volume%3D104%26spage%3D6846%26epage%3D6848%26doi%3D10.1021%2Fja00388a092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span> <span> </span><span class="NLM_article-title">Harringtonine, an inhibitor of initiation of protein biosynthesis</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1975&pages=511-519&author=M.+T.+Huang&title=Harringtonine%2C+an+inhibitor+of+initiation+of+protein+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%2BT.%26atitle%3DHarringtonine%252C%2520an%2520inhibitor%2520of%2520initiation%2520of%2520protein%2520biosynthesis%26jtitle%3DMol.%2520Pharmacol.%26date%3D1975%26volume%3D11%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, A. T.</span></span> <span> </span><span class="NLM_article-title">Plant antitumor agents. VI. the isolation and structure of taxol, a novel antileukemic and antitumor agent from <i>Taxus brevifolia</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/ja00738a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00738a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaE3MXktVKisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1971&pages=2325-2327&author=M.+C.+Waniauthor=H.+L.+Taylorauthor=M.+E.+Wallauthor=P.+Coggonauthor=A.+T.+McPhail&title=Plant+antitumor+agents.+VI.+the+isolation+and+structure+of+taxol%2C+a+novel+antileukemic+and+antitumor+agent+from+Taxus+brevifolia&doi=10.1021%2Fja00738a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Plant antitumor agents.  VI.  Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia</span></div><div class="casAuthors">Wani, Mansukhlal C.; Taylor, Harold Lawrence; Wall, Monroe E.; Coggon, Philip; McPhail, Andrew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2325-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Taxol (I), a complex ester with a taxane ring system exhibiting potent antileukemic and antitumor properties, was isolated from Taxus brevifolia (yew).  BzNHCH(Ph)CH(OH)CO2Me and 5β,16-epoxy-1β,-2α,4α,7β,10β,13α-hexahydroxytax-11-en-9-one 4α-acetate 2α-benzoate are obtained by methanolysis of I.  Based on chem. evidence, I is 5β,16-epoxy-1β,2α,4α,7β,10β,13α-hexahydroxytax-11-en-9-one 4α,10β-diacetate 2α-benzoate 13α-(3-benzamido-2-hydroxy-3-phenylpropionate).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpexINv4qMTjbVg90H21EOLACvtfcHk0lizuyPxwIkr8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXktVKisLc%253D&md5=50c59ef3bf2ae493408bed2a76ca0c2e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00738a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00738a045%26sid%3Dliteratum%253Aachs%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DTaylor%26aufirst%3DH.%2BL.%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DCoggon%26aufirst%3DP.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DPlant%2520antitumor%2520agents.%2520VI.%2520the%2520isolation%2520and%2520structure%2520of%2520taxol%252C%2520a%2520novel%2520antileukemic%2520and%2520antitumor%2520agent%2520from%2520Taxus%2520brevifolia%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1971%26volume%3D93%26spage%3D2325%26epage%3D2327%26doi%3D10.1021%2Fja00738a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gueritte-Voegelein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Goff, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangatal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">Relationships between the structure of taxol analogues and their antimitotic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1021/jm00107a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00107a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=992-998&author=F.+Gueritte-Voegeleinauthor=D.+Guenardauthor=F.+Lavelleauthor=M.+T.+Le+Goffauthor=L.+Mangatalauthor=P.+Potier&title=Relationships+between+the+structure+of+taxol+analogues+and+their+antimitotic+activity&doi=10.1021%2Fjm00107a017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00107a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00107a017%26sid%3Dliteratum%253Aachs%26aulast%3DGueritte-Voegelein%26aufirst%3DF.%26aulast%3DGuenard%26aufirst%3DD.%26aulast%3DLavelle%26aufirst%3DF.%26aulast%3DLe%2BGoff%26aufirst%3DM.%2BT.%26aulast%3DMangatal%26aufirst%3DL.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3DRelationships%2520between%2520the%2520structure%2520of%2520taxol%2520analogues%2520and%2520their%2520antimitotic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D992%26epage%3D998%26doi%3D10.1021%2Fjm00107a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaigneau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiery-Vuillemin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cals, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivot, X.</span></span> <span> </span><span class="NLM_article-title">Cabazitaxel: a novel microtubule inhibitor</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.2165/11591390-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2165%2F11591390-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1251-1258&author=C.+Villanuevaauthor=F.+Bazanauthor=S.+Kimauthor=M.+Demarchiauthor=L.+Chaigneauauthor=A.+Thiery-Vuilleminauthor=T.+Nguyenauthor=L.+Calsauthor=E.+Dobiauthor=X.+Pivot&title=Cabazitaxel%3A+a+novel+microtubule+inhibitor&doi=10.2165%2F11591390-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2165%2F11591390-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11591390-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DVillanueva%26aufirst%3DC.%26aulast%3DBazan%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDemarchi%26aufirst%3DM.%26aulast%3DChaigneau%26aufirst%3DL.%26aulast%3DThiery-Vuillemin%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DCals%26aufirst%3DL.%26aulast%3DDobi%26aufirst%3DE.%26aulast%3DPivot%26aufirst%3DX.%26atitle%3DCabazitaxel%253A%2520a%2520novel%2520microtubule%2520inhibitor%26jtitle%3DDrugs%26date%3D2011%26volume%3D71%26spage%3D1251%26epage%3D1258%26doi%3D10.2165%2F11591390-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedorf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichenbach, H.</span></span> <span> </span><span class="NLM_article-title">Epothilons A and B: antifungal and cytotoxic compounds from <i>Sorangium cellulosum</i> (Myxobacteria). production, physico-chemical and biological properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.49.560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7164%2Fantibiotics.49.560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=8698639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK28XjvFSgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=560-563&author=K.+Gerthauthor=N.+Bedorfauthor=G.+Hofleauthor=H.+Irschikauthor=H.+Reichenbach&title=Epothilons+A+and+B%3A+antifungal+and+cytotoxic+compounds+from+Sorangium+cellulosum+%28Myxobacteria%29.+production%2C+physico-chemical+and+biological+properties&doi=10.7164%2Fantibiotics.49.560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics from gliding bacteria. 74. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria): production, physico-chemical and biological properties</span></div><div class="casAuthors">Gerth, Klaus; Bedorf, Norbert; Hoefle, Gerhard; Irschik, Herbert; Reichenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">560-563</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">An antifungal activity against Mucor hiemalis was detected in the culture broth of Sorangium cellulosum (Myxococcales) strain So ce90.  The activity was excreted into the supernatant during the log and early stationary phase.  When the adsorbent resin XAD-16 was added to the culture, the active metabolites were quant. bound to the resin.  The epothilons showed a high cytotoxicity for animal cells and mimic the biol. effects of taxol (Bollag, D. M., et al., 1995).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr68sVlgUO7Vg90H21EOLACvtfcHk0liR9E03v8cGRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFSgsr8%253D&md5=c1d3b6017f6e66b8ab83e4ed9fdcd396</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.49.560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.49.560%26sid%3Dliteratum%253Aachs%26aulast%3DGerth%26aufirst%3DK.%26aulast%3DBedorf%26aufirst%3DN.%26aulast%3DHofle%26aufirst%3DG.%26aulast%3DIrschik%26aufirst%3DH.%26aulast%3DReichenbach%26aufirst%3DH.%26atitle%3DEpothilons%2520A%2520and%2520B%253A%2520antifungal%2520and%2520cytotoxic%2520compounds%2520from%2520Sorangium%2520cellulosum%2520%2528Myxobacteria%2529.%2520production%252C%2520physico-chemical%2520and%2520biological%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1996%26volume%3D49%26spage%3D560%26epage%3D563%26doi%3D10.7164%2Fantibiotics.49.560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of ixabepilone</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1158%2F1535-7163.MCT-08-0999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19174552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=275-281&author=J.+T.+Hunt&title=Discovery+of+ixabepilone&doi=10.1158%2F1535-7163.MCT-08-0999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ixabepilone</span></div><div class="casAuthors">Hunt, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-281</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The discovery of the antineoplastic agent paclitaxel and its unique activity as a microtubule-stabilizing agent resulted in dramatic improvements in the treatment of breast, ovarian, and non-small cell lung cancers.  Despite the potent antitumor activity of taxanes such as paclitaxel, efficacy of these agents has been limited by development of taxane-resistant tumors in patients.  This review describes, with some historical context, our successful efforts to discover a next-generation microtubule-stabilizing agent for the treatment of cancer.  In collaboration with the Gesellschaft fuer Biotechnologische Forschung, we evaluated the epothilones, originally isolated from the myxobacterium Sorangium cellulosum, as potential anticancer agents.  Expts. performed at Bristol-Myers Squibb confirmed the ability of these agents to induce tubulin polymn., cell cycle arrest, and apoptosis.  Epothilones A and B showed potent cytotoxic activity toward paclitaxel-sensitive and paclitaxel-resistant cells expressing P-glycoprotein or mutant tubulin.  Because the parent epothilones were subject to inactivation via esterase cleavage, we used semisynthetic approaches to prep. analogs without this liability.  BMS-247550 (ixabepilone), the lactam analog of epothilone B, showed increased metabolic stability, potent tubulin polymn. activity, and retained activity against paclitaxel-resistant lines.  Based on its shown efficacy in clin. trials, ixabepilone was approved by the Food and Drug Administration in 2007 for treatment of drug-resistant/refractory metastatic or locally advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JCt13kq2MbVg90H21EOLACvtfcHk0liR9E03v8cGRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFams7k%253D&md5=df8576d7b3b1299d55cee362aa92ad1e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0999%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520ixabepilone%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D275%26epage%3D281%26doi%3D10.1158%2F1535-7163.MCT-08-0999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, E.</span></span> <span> </span><span class="NLM_article-title">Cocarcinogenic principles from the seed oil of <i>Croton tiglium</i> and from other <i>Euphorbiaceae</i></span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2338</span>– <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=5723975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaF1MXksVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1968&pages=2338-2349&author=E.+Hecker&title=Cocarcinogenic+principles+from+the+seed+oil+of+Croton+tiglium+and+from+other+Euphorbiaceae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae</span></div><div class="casAuthors">Hecker, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2338-49</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A review on the isolation and identification of tumor-promoting principles of seed oil from Croton and other Euphorbiaceae.  The active principle of Croton oil was diesters of phorbol.  44 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqJ-3SuKUcrVg90H21EOLACvtfcHk0liR9E03v8cGRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXksVOruw%253D%253D&md5=a97b2452c3c8b023528250a902194660</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DE.%26atitle%3DCocarcinogenic%2520principles%2520from%2520the%2520seed%2520oil%2520of%2520Croton%2520tiglium%2520and%2520from%2520other%2520Euphorbiaceae%26jtitle%3DCancer%2520Res.%26date%3D1968%26volume%3D28%26spage%3D2338%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grue-Sorensen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogberg, T.</span></span> <span> </span><span class="NLM_article-title">Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5624</span>– <span class="NLM_lpage">5629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2013.08.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5624-5629&author=X.+Liangauthor=G.+Grue-Sorensenauthor=K.+Manssonauthor=P.+Vedsoauthor=A.+Soorauthor=M.+Stahlhutauthor=M.+Bertelsenauthor=K.+M.+Engellauthor=T.+Hogberg&title=Syntheses%2C+biological+evaluation+and+SAR+of+ingenol+mebutate+analogues+for+treatment+of+actinic+keratosis+and+non-melanoma+skin+cancer&doi=10.1016%2Fj.bmcl.2013.08.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DGrue-Sorensen%26aufirst%3DG.%26aulast%3DMansson%26aufirst%3DK.%26aulast%3DVedso%26aufirst%3DP.%26aulast%3DSoor%26aufirst%3DA.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DBertelsen%26aufirst%3DM.%26aulast%3DEngell%26aufirst%3DK.%2BM.%26aulast%3DHogberg%26aufirst%3DT.%26atitle%3DSyntheses%252C%2520biological%2520evaluation%2520and%2520SAR%2520of%2520ingenol%2520mebutate%2520analogues%2520for%2520treatment%2520of%2520actinic%2520keratosis%2520and%2520non-melanoma%2520skin%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5624%26epage%3D5629%26doi%3D10.1016%2Fj.bmcl.2013.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span> <span> </span><span class="NLM_article-title">Fidaxomicin (OPT-80) for the treatment of <i>Clostridium difficile</i> infection</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1517/14656566.2010.485614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14656566.2010.485614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20446864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt12lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1569-1578&author=M.+Miller&title=Fidaxomicin+%28OPT-80%29+for+the+treatment+of+Clostridium+difficile+infection&doi=10.1517%2F14656566.2010.485614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection</span></div><div class="casAuthors">Miller, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Clostridium difficile infection (CDI) has become an increasingly important healthcare-assocd. complication in many countries.  CDI outbreaks, a new hypervirulent' form and increased worldwide rates have underscored four urgent unmet needs for this disease: (i) effective prevention of CDI; (ii) therapies to produce faster resoln. of CDI symptoms; (iii) therapies to treat severe CDI more effectively and reduce its mortality; and (iv) therapies to reduce the CDI recurrence rate following treatment.  Areas covered in this review: Fidaxomicin, a new macrocyclic antibiotic, has demonstrated potent in vitro activity against C. difficile with limited or no activity against normal fecal flora.  It is minimally absorbed from the intestinal tract, even in the presence of intestinal inflammation.  When tested against oral vancomycin in clin. studies of CDI therapy, it has equiv. efficacy for curing CDI at end of treatment and a comparable safety profile to that agent.  However, fidaxomicin therapy of CDI is assocd. with significantly fewer CDI recurrences in the 28 days following treatment.  Symptom resoln. is also slightly quicker in some CDI patients.  Addnl. fecal flora anal. in the CDI trials showed that fewer individuals developed intestinal colonization with vancomycin-resistant enterococci (VRE) among the fidaxomicin-treated group.  This new mol., which has just completed two large Phase III multicenter studies, successfully addresses two of the four urgent and unmet needs for dealing with CDI.  What the reader will gain: Fidaxomicin is as effective and as safe as vancomycin therapy for treating CDI but is assocd. with far fewer recurrences post-treatment and a decreased risk of VRE acquisition.  Take home message: Fidaxomicin is a potential new therapy for CDI which has the capacity to substantially decrease post-treatment recurrences and is as safe and well-tolerated as std. vancomycin treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUooatd_u3bVg90H21EOLACvtfcHk0lipJfIgKec1MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt12lt7w%253D&md5=1771c8a57dd04bfb4c206456d96a9bd9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.485614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.485614%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%26atitle%3DFidaxomicin%2520%2528OPT-80%2529%2520for%2520the%2520treatment%2520of%2520Clostridium%2520difficile%2520infection%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2010%26volume%3D11%26spage%3D1569%26epage%3D1578%26doi%3D10.1517%2F14656566.2010.485614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shue, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbach, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, R. A.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.1128/AAC.01045-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.01045-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1391-1395&author=Y.+K.+Shueauthor=P.+S.+Searsauthor=S.+Shangleauthor=R.+B.+Walshauthor=C.+Leeauthor=S.+L.+Gorbachauthor=F.+Okumuauthor=R.+A.+Preston&title=Safety%2C+tolerance%2C+and+pharmacokinetic+studies+of+OPT-80+in+healthy+volunteers+following+single+and+multiple+oral+doses&doi=10.1128%2FAAC.01045-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.01045-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01045-07%26sid%3Dliteratum%253Aachs%26aulast%3DShue%26aufirst%3DY.%2BK.%26aulast%3DSears%26aufirst%3DP.%2BS.%26aulast%3DShangle%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26aulast%3DOkumu%26aufirst%3DF.%26aulast%3DPreston%26aufirst%3DR.%2BA.%26atitle%3DSafety%252C%2520tolerance%252C%2520and%2520pharmacokinetic%2520studies%2520of%2520OPT-80%2520in%2520healthy%2520volunteers%2520following%2520single%2520and%2520multiple%2520oral%2520doses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1391%26epage%3D1395%26doi%3D10.1128%2FAAC.01045-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolsey, J.</span></span> <span> </span><span class="NLM_article-title">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">D668</span>– <span class="NLM_lpage">D672</span>, <span class="refDoi"> DOI: 10.1093/nar/gkj067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fnar%2Fgkj067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16381955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=D668-D672&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=S.+Shrivastavaauthor=M.+Hassanaliauthor=P.+Stothardauthor=Z.+Changauthor=J.+Woolsey&title=DrugBank%3A+a+comprehensive+resource+for+in+silico+drug+discovery+and+exploration&doi=10.1093%2Fnar%2Fgkj067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Shrivastava, Savita; Hassanali, Murtaza; Stothard, Paul; Chang, Zhan; Woolsey, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D668-D672</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chem.) data with comprehensive drug target (i.e. protein) information.  The database contains >4100 drug entries including >800 FDA approved small mol. and biotech drugs as well as >3200 exptl. drugs.  Addnl., >14 000 protein or drug target sequences are linked to these drug entries.  Each DrugCard entry contains >80 data fields with half of the information being devoted to drug/chem. data and the other half devoted to drug target or protein data.  Many data fields are hyperlinked to other databases (KEGG, PubChem, ChEBI, PDB, Swiss-Prot and GenBank) and a variety of structure viewing applets.  The database is fully searchable supporting extensive text, sequence, chem. structure and relational query searches.  Potential applications of DrugBank include in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  DrugBank is available at http://redpoll.pharmacy.ualberta.ca/drugbank/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNy9WiVtlu7Vg90H21EOLACvtfcHk0lgdbfuBqGpl5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D&md5=c3f4ad2fc489440be5b16f91bc9cf7db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkj067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkj067%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DHassanali%26aufirst%3DM.%26aulast%3DStothard%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DWoolsey%26aufirst%3DJ.%26atitle%3DDrugBank%253A%2520a%2520comprehensive%2520resource%2520for%2520in%2520silico%2520drug%2520discovery%2520and%2520exploration%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3DD668%26epage%3DD672%26doi%3D10.1093%2Fnar%2Fgkj067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span> <span> </span><span class="NLM_article-title">EC144 is a potent inhibitor of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7786</span>– <span class="NLM_lpage">7795</span>, <span class="refDoi"> DOI: 10.1021/jm300810x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300810x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7786-7795&author=J.+Shiauthor=R.+Van+de+Waterauthor=K.+Hongauthor=R.+B.+Lamerauthor=K.+W.+Weichertauthor=C.+M.+Sandovalauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=J.+Chaoauthor=K.+Lundgrenauthor=N.+Timpleauthor=R.+Loughauthor=G.+Ibanezauthor=C.+Boykinauthor=F.+J.+Burrowsauthor=M.+R.+Kehryauthor=T.+J.+Yunauthor=E.+K.+Harningauthor=C.+Ambroseauthor=J.+Thompsonauthor=S.+A.+Bixlerauthor=A.+Dunahauthor=P.+Snodgrass-Beltauthor=J.+Arndtauthor=I.+J.+Enyedyauthor=P.+Liauthor=V.+S.+Hongauthor=A.+McKenzieauthor=M.+A.+Biamonte&title=EC144+is+a+potent+inhibitor+of+the+heat+shock+protein+90&doi=10.1021%2Fjm300810x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90</span></div><div class="casAuthors">Shi, Jiandong; Van de Water, Ryan; Hong, Kevin; Lamer, Ryan B.; Weichert, Kenneth W.; Sandoval, Cristina M.; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Chao, Jianhua; Lundgren, Karen; Timple, Noelito; Lough, Rachel; Ibanez, Gerardo; Boykin, Christina; Burrows, Francis J.; Kehry, Marilyn R.; Yun, Theodore J.; Harning, Erin K.; Ambrose, Christine; Thompson, Jeffrey; Bixler, Sarah A.; Dunah, Anthone; Snodgrass-Belt, Pamela; Arndt, Joseph; Enyedy, Istvan J.; Li, Ping; Hong, Victor S.; McKenzie, Andres; Biamonte, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7786-7795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkyne 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor (BIIB021) that completed phase II clin. trials.  Alkyne (EC144) is more potent than (BIIB021) in an Hsp90α binding assay (IC50 = 1.1 vs. 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs. 38 nM).  In a mouse model of gastric tumors (N87), (EC144) stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qd×5).  Under the same conditions, (BIIB021) stops tumor growth only at 120 mg/kg, and does not induce partial regressions.  Thus, alkyne (EC144) is approx. 20-fold more efficacious than (BIIB021) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRtKyDCD2OLVg90H21EOLACvtfcHk0lgdbfuBqGpl5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE&md5=201153ad61f71af267f1e1ba2ca7c2e7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300810x%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLamer%26aufirst%3DR.%2BB.%26aulast%3DWeichert%26aufirst%3DK.%2BW.%26aulast%3DSandoval%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DLough%26aufirst%3DR.%26aulast%3DIbanez%26aufirst%3DG.%26aulast%3DBoykin%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DAmbrose%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DDunah%26aufirst%3DA.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26atitle%3DEC144%2520is%2520a%2520potent%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7786%26epage%3D7795%26doi%3D10.1021%2Fjm300810x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker-Glenn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pichon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly selective, brain-penetrant aminopyrazole LRRK2 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/ml3003007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=85-90&author=B.+K.+Chanauthor=A.+A.+Estradaauthor=H.+Chenauthor=J.+Atherallauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=S.+L.+Dominguezauthor=J.+Drummondauthor=A.+Gillauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=A.+D.+Medhurstauthor=X.+Liuauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=H.+Van+de+Poelauthor=S.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+a+highly+selective%2C+brain-penetrant+aminopyrazole+LRRK2+inhibitor&doi=10.1021%2Fml3003007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003007%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DVan%2Bde%2BPoel%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520selective%252C%2520brain-penetrant%2520aminopyrazole%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D85%26epage%3D90%26doi%3D10.1021%2Fml3003007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strobel, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mseeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, D. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of LX2761, a sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor restricted to the intestinal lumen, for the treatment of diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01541</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1yqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=710-721&author=N.+C.+Goodwinauthor=Z.+M.+Dingauthor=B.+A.+Harrisonauthor=E.+D.+Strobelauthor=A.+L.+Harrisauthor=M.+Smithauthor=A.+Y.+Thompsonauthor=W.+Xiongauthor=F.+Mseehauthor=D.+J.+Bruceauthor=D.+Diazauthor=S.+Gopinathanauthor=L.+Liauthor=E.+O%E2%80%99Neillauthor=M.+Thielauthor=A.+G.+Wilsonauthor=K.+G.+Carsonauthor=D.+R.+Powellauthor=D.+B.+Rawlins&title=Discovery+of+LX2761%2C+a+sodium-dependent+glucose+cotransporter+1+%28SGLT1%29+inhibitor+restricted+to+the+intestinal+lumen%2C+for+the+treatment+of+diabetes&doi=10.1021%2Facs.jmedchem.6b01541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes</span></div><div class="casAuthors">Goodwin, Nicole C.; Ding, Zhi-Ming; Harrison, Bryce A.; Strobel, Eric D.; Harris, Angela L.; Smith, Melinda; Thompson, Andrea Y.; Xiong, Wendy; Mseeh, Faika; Bruce, Debra J.; Diaz, Damaris; Gopinathan, Suma; Li, Ling; O'Neill, Emily; Thiel, Mary; Wilson, Alan G. E.; Carson, Kenneth G.; Powell, David R.; Rawlins, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing no. of people afflicted with diabetes throughout the world is a major health issue.  Inhibitors of the sodium-dependent glucose cotransporters (SGLT) have appeared as viable therapeutics to control blood glucose levels in diabetic patients.  Herein the authors report the discovery of LX2761, a locally-acting SGLT1 inhibitor that is highly potent in vitro and delays intestinal glucose absorption in vivo to improve glycemic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_jImP-MX5y7Vg90H21EOLACvtfcHk0libpY30Py1vWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1yqtA%253D%253D&md5=d07c28561e0bb9be4320391a94020d5c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01541%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DDing%26aufirst%3DZ.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BY.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DBruce%26aufirst%3DD.%2BJ.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DGopinathan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DThiel%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DA.%2BG.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520LX2761%252C%2520a%2520sodium-dependent%2520glucose%2520cotransporter%25201%2520%2528SGLT1%2529%2520inhibitor%2520restricted%2520to%2520the%2520intestinal%2520lumen%252C%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D710%26epage%3D721%26doi%3D10.1021%2Facs.jmedchem.6b01541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chari, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widdison, W. C.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates: an emerging concept in cancer therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3796</span>– <span class="NLM_lpage">3827</span>, <span class="refDoi"> DOI: 10.1002/anie.201307628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.201307628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVGmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3796-3827&author=R.+V.+Chariauthor=M.+L.+Millerauthor=W.+C.+Widdison&title=Antibody-drug+conjugates%3A+an+emerging+concept+in+cancer+therapy&doi=10.1002%2Fanie.201307628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy</span></div><div class="casAuthors">Chari, Ravi V. J.; Miller, Michael L.; Widdison, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3796-3827</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Traditional cancer chemotherapy is often accompanied by systemic toxicity to the patient.  Monoclonal antibodies against antigens on cancer cells offer an alternative tumor-selective treatment approach.  However, most monoclonal antibodies are not sufficiently potent to be therapeutically active on their own.  Antibody-drug conjugates (ADCs) use antibodies to deliver a potent cytotoxic compd. selectively to tumor cells, thus improving the therapeutic index of chemotherapeutic agents.  The recent approval of two ADCs, brentuximab vedotin and ado-trastuzumab emtansine, for cancer treatment has spurred tremendous research interest in this field.  This Review touches upon the early efforts in the field, and describes how the lessons learned from the first-generation ADCs have led to improvements in every aspect of this technol., i.e., the antibody, the cytotoxic compd., and the linker connecting them, leading to the current successes.  The design of ADCs currently in clin. development, and results from mechanistic studies and preclin. and clin. evaluation are discussed.  Emerging technologies that seek to further advance this exciting area of research are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4T2rhmji6DLVg90H21EOLACvtfcHk0lg1Ql22o3EWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVGmsr0%253D&md5=fbfb2f843f516654ea7c0eb98949604c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307628%26sid%3Dliteratum%253Aachs%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BL.%26aulast%3DWiddison%26aufirst%3DW.%2BC.%26atitle%3DAntibody-drug%2520conjugates%253A%2520an%2520emerging%2520concept%2520in%2520cancer%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D3796%26epage%3D3827%26doi%3D10.1002%2Fanie.201307628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperazinylquinoline derivatives as novel respiratory syncytial virus fusion inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVamsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=558-562&author=X.+Zhengauthor=L.+Wangauthor=B.+Wangauthor=K.+Miaoauthor=K.+Xiangauthor=S.+Fengauthor=L.+Gaoauthor=H.+C.+Shenauthor=H.+Yun&title=Discovery+of+piperazinylquinoline+derivatives+as+novel+respiratory+syncytial+virus+fusion+inhibitors&doi=10.1021%2Facsmedchemlett.5b00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors</span></div><div class="casAuthors">Zheng, Xiufang; Wang, Lisha; Wang, Baoxia; Miao, Kun; Xiang, Kunlun; Feng, Song; Gao, Lu; Shen, Hong C.; Yun, Hongying</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-562</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of piperazinylquinoline derivs. were discovered as respiratory syncytial virus (RSV) fusion inhibitors by the ligand-based screening approach.  Among 3000 hits, 1-amino-3-[[2-(4-phenyl-1-piperidyl)-4-quinolyl]amino]propan-2-ol was proven to be active against the RSV long (A) strain.  The anti-RSV activity was improved by converting piperidine to benzylcarbonyl substituted piperazine.  The basic side chain was also found to be crucial for anti-RSV activity.  The selected analogs, I and II, demonstrated anti-RSV activities up to EC50 = 0.028 μM and 0.033 μM, resp.  A direct anti-RSV effect was confirmed by a plaque redn. assay and a fusion inhibition assay.  Both I and II showed promising DMPK properties with good oral bioavailability, and could potentially lead to novel therapeutic agents targeting the RSV fusion process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr98VDNFO7a27Vg90H21EOLACvtfcHk0lg1Ql22o3EWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVamsb8%253D&md5=086def8b4fdde5bad248aa1f65106c9e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00234%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMiao%26aufirst%3DK.%26aulast%3DXiang%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DYun%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520piperazinylquinoline%2520derivatives%2520as%2520novel%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D558%26epage%3D562%26doi%3D10.1021%2Facsmedchemlett.5b00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plonowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchgessner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span> <span> </span><span class="NLM_article-title">Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRbeta</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25435151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=372-377&author=E.+Kickauthor=R.+Martinauthor=Y.+Xieauthor=B.+Flattauthor=E.+Schweigerauthor=T.+L.+Wangauthor=B.+Buschauthor=M.+Nymanauthor=X.+H.+Guauthor=G.+Yanauthor=B.+Wagnerauthor=M.+Nanaoauthor=L.+Nguyenauthor=T.+Stoutauthor=A.+Plonowskiauthor=I.+Schulmanauthor=J.+Ostrowskiauthor=T.+Kirchgessnerauthor=R.+Wexlerauthor=R.+Mohan&title=Liver+X+receptor+%28LXR%29+partial+agonists%3A+biaryl+pyrazoles+and+imidazoles+displaying+a+preference+for+LXRbeta&doi=10.1016%2Fj.bmcl.2014.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ</span></div><div class="casAuthors">Kick, Ellen; Martin, Richard; Xie, Yinong; Flatt, Brenton; Schweiger, Edwin; Wang, Tie-Lin; Busch, Brett; Nyman, Michael; Gu, Xiao-Hui; Yan, Grace; Wagner, Brandee; Nanao, Max; Nguyen, Lam; Stout, Thomas; Plonowski, Artur; Schulman, Ira; Ostrowski, Jacek; Kirchgessner, Todd; Wexler, Ruth; Mohan, Raju</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of biaryl pyrazole and imidazole Liver X Receptor (LXR) partial agonists was synthesized displaying LXRβ selectivity.  The LXRβ selective partial agonist I was identified with potent induction of ATP binding transporters ABCA1 and ABCG1 in human whole blood (EC50 = 1.2 μM, 55% efficacy).  In mice I displayed peripheral induction of ABCA1 at 3 and 10 mpk doses with no significant elevation of plasma or hepatic triglycerides at these doses, showing an improved profile compared to a full pan-agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZYnRJNuyKHbVg90H21EOLACvtfcHk0ljbTvnpmYeUmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitbvO&md5=c51402388c6900b89fbe5ea21ba636c6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DKick%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DFlatt%26aufirst%3DB.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DBusch%26aufirst%3DB.%26aulast%3DNyman%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DX.%2BH.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DNanao%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSchulman%26aufirst%3DI.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DKirchgessner%26aufirst%3DT.%26aulast%3DWexler%26aufirst%3DR.%26aulast%3DMohan%26aufirst%3DR.%26atitle%3DLiver%2520X%2520receptor%2520%2528LXR%2529%2520partial%2520agonists%253A%2520biaryl%2520pyrazoles%2520and%2520imidazoles%2520displaying%2520a%2520preference%2520for%2520LXRbeta%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D372%26epage%3D377%26doi%3D10.1016%2Fj.bmcl.2014.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartingh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodzinak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillgrove, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1264</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1260-1264&author=M.+E.+Laytonauthor=A.+J.+Reifauthor=T.+J.+Hartinghauthor=K.+Rodzinakauthor=V.+Dudkinauthor=C.+Wangauthor=K.+Arringtonauthor=M.+J.+Kellyauthor=R.+M.+Garbaccioauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+5-aryl-1%2C3-dihydro-2H-imidazo%5B4%2C5-b%5Dpyridin-2-ones+as+positive+allosteric+modulators+of+metabotropic+glutamate+subtype-2+%28mGlu2%29+receptors+with+efficacy+in+a+preclinical+model+of+psychosis&doi=10.1016%2Fj.bmcl.2016.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DReif%26aufirst%3DA.%2BJ.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DRodzinak%26aufirst%3DK.%26aulast%3DDudkin%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DArrington%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%25205-aryl-1%252C3-dihydro-2H-imidazo%255B4%252C5-b%255Dpyridin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520subtype-2%2520%2528mGlu2%2529%2520receptors%2520with%2520efficacy%2520in%2520a%2520preclinical%2520model%2520of%2520psychosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1260%26epage%3D1264%26doi%3D10.1016%2Fj.bmcl.2016.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blouin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLuca, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufresne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenette, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarlane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouimet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Hutchinson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span> <span> </span><span class="NLM_article-title">The discovery of a new structural class of potent orally active leukotriene D4 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1146</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80635-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0960-894X%2800%2980635-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=1141-1146&author=M.+Labelleauthor=P.+Prasitauthor=M.+Belleyauthor=M.+Blouinauthor=E.+Championauthor=L.+Charetteauthor=J.+G.+DeLucaauthor=C.+Dufresneauthor=R.+Frenetteauthor=J.+Y.+Gauthierauthor=E.+Grimmauthor=S.+J.+Grossmanauthor=D.+Guayauthor=E.+G.+Heroldauthor=T.+R.+Jonesauthor=C.+K.+Lauauthor=Y.+Leblancauthor=S.+L%C3%A9gerauthor=A.+Lordauthor=M.+McAuliffeauthor=C.+McFarlaneauthor=P.+Massonauthor=K.+M.+Mettersauthor=N.+Ouimetauthor=D.+H.+Patrickauthor=H.+Perrierauthor=C.+B.+Pickettauthor=H.+Piechutaauthor=P.+Royauthor=H.+Williamsauthor=Z.+Wangauthor=Y.+B.+Xiangauthor=R.+J.+Zamboniauthor=A.+W.+Ford-Hutchinsonauthor=R.+N.+Young&title=The+discovery+of+a+new+structural+class+of+potent+orally+active+leukotriene+D4+antagonists&doi=10.1016%2FS0960-894X%2800%2980635-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980635-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980635-6%26sid%3Dliteratum%253Aachs%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DBlouin%26aufirst%3DM.%26aulast%3DChampion%26aufirst%3DE.%26aulast%3DCharette%26aufirst%3DL.%26aulast%3DDeLuca%26aufirst%3DJ.%2BG.%26aulast%3DDufresne%26aufirst%3DC.%26aulast%3DFrenette%26aufirst%3DR.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGrimm%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DHerold%26aufirst%3DE.%2BG.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DLau%26aufirst%3DC.%2BK.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DA.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DPatrick%26aufirst%3DD.%2BH.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DRoy%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DY.%2BB.%26aulast%3DZamboni%26aufirst%3DR.%2BJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DThe%2520discovery%2520of%2520a%2520new%2520structural%2520class%2520of%2520potent%2520orally%2520active%2520leukotriene%2520D4%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26spage%3D1141%26epage%3D1146%26doi%3D10.1016%2FS0960-894X%2800%2980635-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, L. A.</span></span> <span> </span><span class="NLM_article-title">Rate acceleration by stereopopulation control: models for enzyme action</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1073/pnas.67.3.1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.67.3.1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=5274444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaE3MXktFOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=1143-1147&author=S.+Milstienauthor=L.+A.+Cohen&title=Rate+acceleration+by+stereopopulation+control%3A+models+for+enzyme+action&doi=10.1073%2Fpnas.67.3.1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Rate acceleration by stereopopulation control.  Models for enzyme action</span></div><div class="casAuthors">Milstien, Sheldon; Cohen, Louis Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1143-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">As a result of alkyl substitution in both aromatic ring and side chain, the rate const. for acid-catalyzed lactonization of hydrocoumaric acid is increased by factors as high as 1011 and, in comparison with the bimol. esterification of phenol and HOAc, by ∼1016.  In the most favorable case studied, the half-life of the phenolic acid (imidazole buffer, pH 7, 30°) is 6 sec, with 90% of the total rate being due to catalysis by the buffer species.  The effect is attributed to a unique interlocking of Me groups, which produces a severe conformational restriction of the side chain and increases the population of the most productive conformer.  This phenomenon is presented as a model for the conformational restraint imposed by an enzyme on its substrate.  The magnitude of the effect suggests that the contribution of substrate freezing to total rate enhancement by an enzyme can be considerably greater than previously supposed and may in fact be sufficient to complete the justification for enzyme catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBGFOSh-Inw7Vg90H21EOLACvtfcHk0ljzyFbMOTJe-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXktFOnuw%253D%253D&md5=3cb620d59a84adb1a75ec73652042bd3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.67.3.1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.67.3.1143%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DL.%2BA.%26atitle%3DRate%2520acceleration%2520by%2520stereopopulation%2520control%253A%2520models%2520for%2520enzyme%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1970%26volume%3D67%26spage%3D1143%26epage%3D1147%26doi%3D10.1073%2Fpnas.67.3.1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkilineni, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casazza, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D. M.</span></span> <span> </span><span class="NLM_article-title">Novel water soluble phosphate prodrugs of taxol® possessing in vivo antitumor activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80058-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0960-894X%2800%2980058-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=1761-1766&author=Y.+Uedaauthor=A.+B.+Mikkilineniauthor=J.+O.+Knipeauthor=W.+C.+Roseauthor=A.+M.+Casazzaauthor=D.+M.+Vyas&title=Novel+water+soluble+phosphate+prodrugs+of+taxol%C2%AE+possessing+in+vivo+antitumor+activity&doi=10.1016%2FS0960-894X%2800%2980058-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980058-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980058-X%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DCasazza%26aufirst%3DA.%2BM.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26atitle%3DNovel%2520water%2520soluble%2520phosphate%2520prodrugs%2520of%2520taxol%25C2%25AE%2520possessing%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D1761%26epage%3D1766%26doi%3D10.1016%2FS0960-894X%2800%2980058-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinozaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakuuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seko, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1209</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26794040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1elurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1209-1213&author=K.+Kusumiauthor=K.+Shinozakiauthor=Y.+Yamauraauthor=A.+Hashimotoauthor=H.+Kurataauthor=A.+Naganawaauthor=K.+Otsukiauthor=T.+Matsushitaauthor=T.+Sekiguchiauthor=A.+Kakuuchiauthor=H.+Yamamotoauthor=T.+Seko&title=Discovery+of+novel+S1P2+antagonists%2C+part+3%3A+Improving+the+oral+bioavailability+of+a+series+of+1%2C3-bis%28aryloxy%29benzene+derivatives&doi=10.1016%2Fj.bmcl.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives</span></div><div class="casAuthors">Kusumi, Kensuke; Shinozaki, Koji; Yamaura, Yoshiyuki; Hashimoto, Ai; Kurata, Haruto; Naganawa, Atsushi; Otsuki, Kazuhiro; Matsushita, Takeshi; Sekiguchi, Tetsuya; Kakuuchi, Akito; Yamamoto, Hiroshi; Seko, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1209-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure of the S1P2 antagonist 1 has been modified with the aim of improving its oral bioavailability.  The chem. modification of the alkyl chain and carboxylic acid moieties of 1 led to significant improvements in the oral exposure of compds. belonging to this series.  The optimization of the ring size of the urea portion of these mols. also led to remarkable improvements in the oral exposure.  Based on these changes, the pyrrolidine deriv. I was identified as a suitable candidate compd. and showed excellent pharmacokinetic profiles in rat and dog, while maintaining high levels of potency and selective antagonistic activity toward S1P2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5Oh4Cs44RLVg90H21EOLACvtfcHk0lgXgpg5AZf5Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1elurs%253D&md5=afaf3444a370c35cd6ec6301850bc90a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DShinozaki%26aufirst%3DK.%26aulast%3DYamaura%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DMatsushita%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DKakuuchi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DSeko%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%2520S1P2%2520antagonists%252C%2520part%25203%253A%2520Improving%2520the%2520oral%2520bioavailability%2520of%2520a%2520series%2520of%25201%252C3-bis%2528aryloxy%2529benzene%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1209%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomsho, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span> <span> </span><span class="NLM_article-title">Ring structure and aromatic substituent effects on the p<i>K</i><sub>a</sub> of the benzoxaborole pharmacophore</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1021/ml200215j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200215j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlems73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=48-52&author=J.+W.+Tomshoauthor=A.+Palauthor=D.+G.+Hallauthor=S.+J.+Benkovic&title=Ring+structure+and+aromatic+substituent+effects+on+the+pKa+of+the+benzoxaborole+pharmacophore&doi=10.1021%2Fml200215j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Ring Structure and Aromatic Substituent Effects on the pKa of the Benzoxaborole Pharmacophore</span></div><div class="casAuthors">Tomsho, John W.; Pal, Arnab; Hall, Dennis G.; Benkovic, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, we present an investigation into the phys. properties of a unique class of arom. boronic acids, the benzoxaboroles.  Using spectrophotometric methods, the ionization consts. of a family of substituted benzoxaboroles are detd.  Heterocyclic ring modifications are examd. to det. their effects on the ionization of the boronic acid moiety.  It is also shown that the substituent effects about the arom. ring follow a Hammett relationship with the compds.' measured pKa values.  Finally, these substituent effects are also shown to extend to the sugar binding properties of these compds. under physiol. relevant conditions.  Combined, these data will inform medicinal chemists wishing to tailor the ionization and/or ability of this class of compd. to bind diol-contg. biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrppQMrsyB2_7Vg90H21EOLACvtfcHk0liJ1K4A2JVYqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlems73I&md5=efa7f7211cc046b3b1b1bd7ab3355ec4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml200215j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200215j%26sid%3Dliteratum%253Aachs%26aulast%3DTomsho%26aufirst%3DJ.%2BW.%26aulast%3DPal%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26atitle%3DRing%2520structure%2520and%2520aromatic%2520substituent%2520effects%2520on%2520the%2520pKa%2520of%2520the%2520benzoxaborole%2520pharmacophore%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml200215j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattendi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4388</span>, <span class="refDoi"> DOI: 10.1128/AAC.00498-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.00498-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4379-4388&author=B.+Nareauthor=S.+Wringauthor=C.+Bacchiauthor=B.+Beaudetauthor=T.+Bowlingauthor=R.+Brunauthor=D.+Chenauthor=C.+Dingauthor=Y.+Freundauthor=E.+Gaukelauthor=A.+Hussainauthor=K.+Jarnaginauthor=M.+Jenksauthor=M.+Kaiserauthor=L.+Mercerauthor=E.+Mejiaauthor=A.+Noeauthor=M.+Orrauthor=R.+Parhamauthor=J.+Plattnerauthor=R.+Randolphauthor=D.+Rattendiauthor=C.+Rewertsauthor=J.+Sligarauthor=N.+Yarlettauthor=R.+Donauthor=R.+Jacobs&title=Discovery+of+novel+orally+bioavailable+oxaborole+6-carboxamides+that+demonstrate+cure+in+a+murine+model+of+late-stage+central+nervous+system+African+trypanosomiasis&doi=10.1128%2FAAC.00498-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FAAC.00498-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00498-10%26sid%3Dliteratum%253Aachs%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%26aulast%3DBacchi%26aufirst%3DC.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DK.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DL.%26aulast%3DMejia%26aufirst%3DE.%26aulast%3DNoe%26aufirst%3DA.%26aulast%3DOrr%26aufirst%3DM.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DPlattner%26aufirst%3DJ.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DRattendi%26aufirst%3DD.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DSligar%26aufirst%3DJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DDon%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520novel%2520orally%2520bioavailable%2520oxaborole%25206-carboxamides%2520that%2520demonstrate%2520cure%2520in%2520a%2520murine%2520model%2520of%2520late-stage%2520central%2520nervous%2520system%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4379%26epage%3D4388%26doi%3D10.1128%2FAAC.00498-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span> <span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1151</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0lj0GJ5Oo7r8Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrent, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florjancic, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasko, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. D.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1021/ml5002745</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5002745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=58-62&author=Y.+Tongauthor=M.+Torrentauthor=A.+S.+Florjancicauthor=K.+D.+Brombergauthor=F.+G.+Buchananauthor=D.+C.+Fergusonauthor=E.+F.+Johnsonauthor=L.+M.+Laskoauthor=D.+Maagauthor=P.+J.+Mertaauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=N.+Soniauthor=A.+R.+Shoemakerauthor=T.+D.+Penning&title=Pyrimidine-based+tricyclic+molecules+as+potent+and+orally+efficacious+inhibitors+of+wee1+kinase&doi=10.1021%2Fml5002745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml5002745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5002745%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DFlorjancic%26aufirst%3DA.%2BS.%26aulast%3DBromberg%26aufirst%3DK.%2BD.%26aulast%3DBuchanan%26aufirst%3DF.%2BG.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DLasko%26aufirst%3DL.%2BM.%26aulast%3DMaag%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26atitle%3DPyrimidine-based%2520tricyclic%2520molecules%2520as%2520potent%2520and%2520orally%2520efficacious%2520inhibitors%2520of%2520wee1%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D58%26epage%3D62%26doi%3D10.1021%2Fml5002745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo-Jane, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsie, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krsmanovic, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2666</span>– <span class="NLM_lpage">2670</span>, <span class="refDoi"> DOI: 10.1021/jm100022r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100022r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2666-2670&author=H.+C.+Shenauthor=F.+X.+Dingauthor=S.+Raghavanauthor=Q.+Dengauthor=S.+Luellauthor=M.+J.+Forrestauthor=E.+Carballo-Janeauthor=L.+C.+Wilsieauthor=M.+L.+Krsmanovicauthor=A.+K.+Taggartauthor=K.+K.+Wuauthor=T.+J.+Wuauthor=K.+Chengauthor=N.+Renauthor=T.+Q.+Caiauthor=Q.+Chenauthor=J.+Wangauthor=M.+S.+Wolffauthor=X.+Tongauthor=T.+G.+Holtauthor=M.+G.+Watersauthor=M.+L.+Hammondauthor=J.+R.+Tataauthor=S.+L.+Colletti&title=Discovery+of+a+biaryl+cyclohexene+carboxylic+acid+%28MK-6892%29%3A+a+potent+and+selective+high+affinity+niacin+receptor+full+agonist+with+reduced+flushing+profiles+in+animals+as+a+preclinical+candidate&doi=10.1021%2Fjm100022r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100022r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100022r%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DDing%26aufirst%3DF.%2BX.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DWilsie%26aufirst%3DL.%2BC.%26aulast%3DKrsmanovic%26aufirst%3DM.%2BL.%26aulast%3DTaggart%26aufirst%3DA.%2BK.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DWu%26aufirst%3DT.%2BJ.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DCai%26aufirst%3DT.%2BQ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolff%26aufirst%3DM.%2BS.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DHolt%26aufirst%3DT.%2BG.%26aulast%3DWaters%26aufirst%3DM.%2BG.%26aulast%3DHammond%26aufirst%3DM.%2BL.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520biaryl%2520cyclohexene%2520carboxylic%2520acid%2520%2528MK-6892%2529%253A%2520a%2520potent%2520and%2520selective%2520high%2520affinity%2520niacin%2520receptor%2520full%2520agonist%2520with%2520reduced%2520flushing%2520profiles%2520in%2520animals%2520as%2520a%2520preclinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2666%26epage%3D2670%26doi%3D10.1021%2Fjm100022r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doweyko, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gougoutas, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarco, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorso, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, K. S.</span></span> <span> </span><span class="NLM_article-title">Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3310</span>, <span class="refDoi"> DOI: 10.1021/jm010100v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010100v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3302-3310&author=S.+Ahmadauthor=L.+M.+Doweykoauthor=S.+Dugarauthor=N.+Grazierauthor=K.+Nguauthor=S.+C.+Wuauthor=K.+J.+Yostauthor=B.+C.+Chenauthor=J.+Z.+Gougoutasauthor=J.+D.+DiMarcoauthor=S.+J.+Lanauthor=B.+J.+Gavinauthor=A.+Y.+Chenauthor=C.+R.+Dorsoauthor=R.+Serafinoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Arylcyclopropanecarboxyl+guanidines+as+novel%2C+potent%2C+and+selective+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1&doi=10.1021%2Fjm010100v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm010100v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010100v%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%2BM.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DGrazier%26aufirst%3DN.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DYost%26aufirst%3DK.%2BJ.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DLan%26aufirst%3DS.%2BJ.%26aulast%3DGavin%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DArylcyclopropanecarboxyl%2520guanidines%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3302%26epage%3D3310%26doi%3D10.1021%2Fjm010100v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larouche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacBeth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deziel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahhab, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2514</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2015.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2514-2518&author=E.+Therrienauthor=G.+Laroucheauthor=N.+Nguyenauthor=J.+Rahilauthor=A.+M.+Lemieuxauthor=Z.+Liauthor=M.+Fournelauthor=T.+P.+Yanauthor=A.+J.+Landryauthor=S.+Lefebvreauthor=J.+J.+Wangauthor=K.+MacBethauthor=C.+Heiseauthor=A.+Nguyenauthor=J.+M.+Bestermanauthor=R.+Dezielauthor=A.+Wahhab&title=Discovery+of+bicyclic+pyrazoles+as+class+III+histone+deacetylase+SIRT1+and+SIRT2+inhibitors&doi=10.1016%2Fj.bmcl.2015.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DLarouche%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLemieux%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DLandry%26aufirst%3DA.%2BJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DMacBeth%26aufirst%3DK.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DWahhab%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520bicyclic%2520pyrazoles%2520as%2520class%2520III%2520histone%2520deacetylase%2520SIRT1%2520and%2520SIRT2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2514%26epage%3D2518%26doi%3D10.1016%2Fj.bmcl.2015.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santella, J. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncia, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briceno, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafstrom, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caceres-Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporuscio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7550</span>– <span class="NLM_lpage">7564</span>, <span class="refDoi"> DOI: 10.1021/jm5003167</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003167" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7550-7564&author=J.+B.+Santellaauthor=D.+S.+Gardnerauthor=J.+V.+Dunciaauthor=H.+Wuauthor=M.+Dharauthor=C.+Cavallaroauthor=A.+J.+Tebbenauthor=P.+H.+Carterauthor=J.+C.+Barrishauthor=M.+Yardeauthor=S.+W.+Bricenoauthor=M.+E.+Cvijicauthor=R.+R.+Grafstromauthor=R.+Liuauthor=S.+R.+Patelauthor=A.+J.+Watsonauthor=G.+Yangauthor=A.+V.+Roseauthor=R.+D.+Vickeryauthor=J.+Caceres-Cortesauthor=C.+Caporuscioauthor=D.+M.+Camacauthor=J.+A.+Khanauthor=Y.+Anauthor=W.+R.+Fosterauthor=P.+Daviesauthor=J.+Hynes&title=Discovery+of+the+CCR1+antagonist%2C+BMS-817399%2C+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Fjm5003167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm5003167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003167%26sid%3Dliteratum%253Aachs%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DGardner%26aufirst%3DD.%2BS.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDhar%26aufirst%3DM.%26aulast%3DCavallaro%26aufirst%3DC.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DBriceno%26aufirst%3DS.%2BW.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DGrafstrom%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DA.%2BV.%26aulast%3DVickery%26aufirst%3DR.%2BD.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DCaporuscio%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DFoster%26aufirst%3DW.%2BR.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHynes%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520the%2520CCR1%2520antagonist%252C%2520BMS-817399%252C%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7550%26epage%3D7564%26doi%3D10.1021%2Fjm5003167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyna, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mseeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardenhagen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marszalek, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniatti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. T.</span></span> <span> </span><span class="NLM_article-title">Identification of potent and selective MTH1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.02.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26898335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1503-1507&author=A.+Petrocchiauthor=E.+Leoauthor=N.+J.+Reynaauthor=M.+M.+Hamiltonauthor=X.+Shiauthor=C.+A.+Parkerauthor=F.+Mseehauthor=J.+P.+Bardenhagenauthor=P.+Leonardauthor=J.+B.+Crossauthor=S.+Huangauthor=Y.+Jiangauthor=M.+Cardozoauthor=G.+Draettaauthor=J.+R.+Marszalekauthor=C.+Toniattiauthor=P.+Jonesauthor=R.+T.+Lewis&title=Identification+of+potent+and+selective+MTH1+inhibitors&doi=10.1016%2Fj.bmcl.2016.02.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potent and selective MTH1 inhibitors</span></div><div class="casAuthors">Petrocchi, Alessia; Leo, Elisabetta; Reyna, Naphtali J.; Hamilton, Matthew M.; Shi, Xi; Parker, Connor A.; Mseeh, Faika; Bardenhagen, Jennifer P.; Leonard, Paul; Cross, Jason B.; Huang, Sha; Jiang, Yongying; Cardozo, Mario; Draetta, Giulio; Marszalek, Joseph R.; Toniatti, Carlo; Jones, Philip; Lewis, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1503-1507</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure based design of a novel class of aminopyrimidine MTH1 (MutT homolog 1) inhibitors is described.  Optimization led to identification of I, a sub-nanomolar inhibitor of MTH1 with excellent cell permeability and good metabolic stability in microsomes.  This compd. robustly inhibited MTH1 activity in cells and proved to be an excellent tool for interrogation of the utility of MTH1 inhibition in the context of oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIlGQc2jKu2bVg90H21EOLACvtfcHk0lgVqNqMEx2I8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVCiu7g%253D&md5=6c94121f3b47ce2a7dd4375bc5311fbb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DReyna%26aufirst%3DN.%2BJ.%26aulast%3DHamilton%26aufirst%3DM.%2BM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DC.%2BA.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DBardenhagen%26aufirst%3DJ.%2BP.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DCross%26aufirst%3DJ.%2BB.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520MTH1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1503%26epage%3D1507%26doi%3D10.1016%2Fj.bmcl.2016.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croghan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmait, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupples, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Jean, D. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-guided optimization of diarylmethanesulfonamide disrupters of glucokinase-glucokinase regulatory protein (GK-GKRP) binding: strategic use of a N → S (n<sub>N</sub> → σ*<sub>S–X</sub>) interaction for conformational constraint</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9663</span>– <span class="NLM_lpage">9679</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9663-9679&author=L.+D.+Penningtonauthor=M.+D.+Bartbergerauthor=M.+D.+Croghanauthor=K.+L.+Andrewsauthor=K.+S.+Ashtonauthor=M.+P.+Bourbeauauthor=J.+Chenauthor=S.+Chmaitauthor=R.+Cupplesauthor=C.+Fotschauthor=J.+Helmeringauthor=F.+T.+Hongauthor=R.+W.+Hungateauthor=S.+R.+Jordanauthor=K.+Kongauthor=L.+Liuauthor=K.+Michelsenauthor=C.+Moyerauthor=N.+Nishimuraauthor=M.+H.+Normanauthor=A.+Reicheltauthor=A.+C.+Siegmundauthor=G.+Sivitsauthor=S.+Tadesseauthor=C.+M.+Tegleyauthor=G.+Vanauthor=K.+C.+Yangauthor=G.+Yaoauthor=J.+Zhangauthor=D.+J.+Lloydauthor=C.+Haleauthor=D.+J.+St.+Jean&title=Discovery+and+structure-guided+optimization+of+diarylmethanesulfonamide+disrupters+of+glucokinase-glucokinase+regulatory+protein+%28GK-GKRP%29+binding%3A+strategic+use+of+a+N+%E2%86%92+S+%28nN+%E2%86%92+%CF%83*S%E2%80%93X%29+interaction+for+conformational+constraint&doi=10.1021%2Facs.jmedchem.5b01367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01367%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DAshton%26aufirst%3DK.%2BS.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DHelmering%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%2BT.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DJordan%26aufirst%3DS.%2BR.%26aulast%3DKong%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DMoyer%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DSivits%26aufirst%3DG.%26aulast%3DTadesse%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DVan%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLloyd%26aufirst%3DD.%2BJ.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-guided%2520optimization%2520of%2520diarylmethanesulfonamide%2520disrupters%2520of%2520glucokinase-glucokinase%2520regulatory%2520protein%2520%2528GK-GKRP%2529%2520binding%253A%2520strategic%2520use%2520of%2520a%2520N%2520%25E2%2586%2592%2520S%2520%2528nN%2520%25E2%2586%2592%2520%25CF%2583%252AS%25E2%2580%2593X%2529%2520interaction%2520for%2520conformational%2520constraint%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9663%26epage%3D9679%26doi%3D10.1021%2Facs.jmedchem.5b01367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panunzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, S.</span></span> <span> </span><span class="NLM_article-title">Beta-lactam antibiotics renaissance</span>. <i>Antibiotics (Basel, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.3390/antibiotics3020193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.3390%2Fantibiotics3020193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=27025744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1CmtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=193-215&author=W.+Qinauthor=M.+Panunzioauthor=S.+Biondi&title=Beta-lactam+antibiotics+renaissance&doi=10.3390%2Fantibiotics3020193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">β-lactam antibiotics renaissance</span></div><div class="casAuthors">Qin, Wenling; Panunzio, Mauro; Biondi, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-215, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">ABSNC4</span>;
        ISSN:<span class="NLM_cas:issn">2079-6382</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Since the 1940s β-lactam antibiotics have been used to treat bacterial infections.  However, emergence and dissemination of β-lactam resistance has reached the point where many marketed β-lactams no longer are clin. effective.  The increasing prevalence of multidrug-resistant bacteria and the progressive withdrawal of pharmaceutical companies from antibiotic research have evoked a strong reaction from health authorities, who have implemented initiatives to encourage the discovery of new antibacterials.  Despite this gloomy scenario, several novel β-lactam antibiotics and β-lactamase inhibitors have recently progressed into clin. trials, and many more such compds. are being investigated.  Here we seek to provide highlights of recent developments relating to the discovery of novel β-lactam antibiotics and β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLs1Ib1L3CdrVg90H21EOLACvtfcHk0ljo1y8Yg5ZX8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1CmtbrP&md5=1a6c0d2bea7b714af75ecb1ceff3237e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3390%2Fantibiotics3020193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantibiotics3020193%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DW.%26aulast%3DPanunzio%26aufirst%3DM.%26aulast%3DBiondi%26aufirst%3DS.%26atitle%3DBeta-lactam%2520antibiotics%2520renaissance%26jtitle%3DAntibiotics%2520%2528Basel%252C%2520Switz.%2529%26date%3D2014%26volume%3D3%26spage%3D193%26epage%3D215%26doi%3D10.3390%2Fantibiotics3020193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josephine, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of complexes of bacterial DD-peptidases with peptidoglycan-mimetic ligands: the substrate specificity puzzle</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.jmb.2008.06.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2008&pages=383-393&author=E.+Sauvageauthor=A.+J.+Powellauthor=J.+Heilemannauthor=H.+R.+Josephineauthor=P.+Charlierauthor=C.+Daviesauthor=R.+F.+Pratt&title=Crystal+structures+of+complexes+of+bacterial+DD-peptidases+with+peptidoglycan-mimetic+ligands%3A+the+substrate+specificity+puzzle&doi=10.1016%2Fj.jmb.2008.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DSauvage%26aufirst%3DE.%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DHeilemann%26aufirst%3DJ.%26aulast%3DJosephine%26aufirst%3DH.%2BR.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DCrystal%2520structures%2520of%2520complexes%2520of%2520bacterial%2520DD-peptidases%2520with%2520peptidoglycan-mimetic%2520ligands%253A%2520the%2520substrate%2520specificity%2520puzzle%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D381%26spage%3D383%26epage%3D393%26doi%3D10.1016%2Fj.jmb.2008.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniewski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span> <span> </span><span class="NLM_article-title">Distinctive attributes of beta-lactam target proteins in <i>Acinetobacter baumannii</i> relevant to development of new antibiotics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">20536</span>– <span class="NLM_lpage">20545</span>, <span class="refDoi"> DOI: 10.1021/ja208835z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja208835z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=20536-20545&author=S.+Hanauthor=N.+Caspersauthor=R.+P.+Zaniewskiauthor=B.+M.+Laceyauthor=A.+P.+Tomarasauthor=X.+Fengauthor=K.+F.+Geogheganauthor=V.+Shanmugasundaram&title=Distinctive+attributes+of+beta-lactam+target+proteins+in+Acinetobacter+baumannii+relevant+to+development+of+new+antibiotics&doi=10.1021%2Fja208835z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja208835z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208835z%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DZaniewski%26aufirst%3DR.%2BP.%26aulast%3DLacey%26aufirst%3DB.%2BM.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26atitle%3DDistinctive%2520attributes%2520of%2520beta-lactam%2520target%2520proteins%2520in%2520Acinetobacter%2520baumannii%2520relevant%2520to%2520development%2520of%2520new%2520antibiotics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D20536%26epage%3D20545%26doi%3D10.1021%2Fja208835z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniewski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evdokimov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of <i>Pseudomonas aeruginosa</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">22002</span>– <span class="NLM_lpage">22007</span>, <span class="refDoi"> DOI: 10.1073/pnas.1013092107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1013092107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21135211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVKq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=22002-22007&author=S.+Hanauthor=R.+P.+Zaniewskiauthor=E.+S.+Marrauthor=B.+M.+Laceyauthor=A.+P.+Tomarasauthor=A.+Evdokimovauthor=J.+R.+Millerauthor=V.+Shanmugasundaram&title=Structural+basis+for+effectiveness+of+siderophore-conjugated+monocarbams+against+clinically+relevant+strains+of+Pseudomonas+aeruginosa&doi=10.1073%2Fpnas.1013092107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa</span></div><div class="casAuthors">Han, Seungil; Zaniewski, Richard P.; Marr, Eric S.; Lacey, Brian M.; Tomaras, Andrew P.; Evdokimov, Artem; Miller, J. Richard; Shanmugasundaram, Veerabahu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">22002-22007, S22002/1-S22002/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is an opportunistic Gram-neg. pathogen that causes nosocomial infections for which there are limited treatment options.  Penicillin-binding protein PBP3, a key therapeutic target, is an essential enzyme responsible for the final steps of peptidoglycan synthesis and is covalently inactivated by β-lactam antibiotics.  Here we disclose the first high resoln. cocrystal structures of the P. aeruginosa PBP3 with both novel and marketed β-lactams.  These structures reveal a conformational rearrangement of Tyr532 and Phe533 and a ligand-induced conformational change of Tyr409 and Arg489.  The well-known affinity of the monobactam aztreonam for P. aeruginosa PBP3 is due to a distinct hydrophobic arom. wall composed of Tyr503, Tyr532, and Phe533 interacting with the gem-di-Me group.  The structure of MC-1, a new siderophore-conjugated monocarbam complexed with PBP3 provides mol. insights for lead optimization.  Importantly, we have identified a novel conformation that is distinct to the high-mol.-wt. class B PBP subfamily, which is identifiable by common features such as a hydrophobic arom. wall formed by Tyr503, Tyr532, and Phe533 and the structural flexibility of Tyr409 flanked by two glycine residues.  This is also the first example of a siderophore-conjugated triazolone-linked monocarbam complexed with any PBP.  Energetic anal. of tightly and loosely held computed hydration sites indicates protein desolvation effects contribute significantly to PBP3 binding, and anal. of hydration site energies allows rank ordering of the second-order acylation rate consts.  Taken together, these structural, biochem., and computational studies provide a mol. basis for recognition of P. aeruginosa PBP3 and open avenues for future design of inhibitors of this class of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUiVSdnGL3r7Vg90H21EOLACvtfcHk0lj2zDOgHgqOWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVKq&md5=1f2733cc057fc464b7bd3570cf1f9968</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1013092107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1013092107%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DZaniewski%26aufirst%3DR.%2BP.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DLacey%26aufirst%3DB.%2BM.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520for%2520effectiveness%2520of%2520siderophore-conjugated%2520monocarbams%2520against%2520clinically%2520relevant%2520strains%2520of%2520Pseudomonas%2520aeruginosa%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D22002%26epage%3D22007%26doi%3D10.1073%2Fpnas.1013092107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">Cross-class metallo-beta-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E3745</span>– <span class="NLM_lpage">E3754</span>, <span class="refDoi"> DOI: 10.1073/pnas.1601368113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1601368113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=27303030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E3745-E3754&author=P.+Hinchliffeauthor=M.+M.+Gonzalezauthor=M.+F.+Mojicaauthor=J.+M.+Gonzalezauthor=V.+Castilloauthor=C.+Saizauthor=M.+Kosmopoulouauthor=C.+L.+Tookeauthor=L.+I.+Llarrullauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=A.+J.+Vilaauthor=J.+Spencer&title=Cross-class+metallo-beta-lactamase+inhibition+by+bisthiazolidines+reveals+multiple+binding+modes&doi=10.1073%2Fpnas.1601368113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span></div><div class="casAuthors">Hinchliffe, Philip; Gonzalez, Mariano M.; Mojica, Maria F.; Gonzalez, Javier M.; Castillo, Valerie; Saiz, Cecilia; Kosmopoulou, Magda; Tooke, Catherine L.; Llarrull, Leticia I.; Mahler, Graciela; Bonomo, Robert A.; Vila, Alejandro J.; Spencer, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E3745-E3754</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze almost all β-lactam antibiotics and are unaffected by clin. available β-lactamase inhibitors (βLIs).  Active site architecture divides MBLs into 3 classes (B1, B2, and B3), complicating the development of βLIs effective against all enzymes.  Bisthiazolidines (BTZs) are carboxylate-contg., bicyclic compds., considered as penicillin analogs with an addnl. free thiol.  Here, the authors show both L- and D-BTZ enantiomers are micromolar competitive βLIs of all MBL classes in vitro, with Ki values of 6-15 or 36-84 μM for subclass B1 MBLs (IMP-1 and BcII, resp.), and 10-12 μM for B3 enzyme L1.  Against B2 MBL Sfh-I, the L-BTZ enantiomers exhibited 100-fold lower Ki values (0.26-0.36 μM) than D-BTZs (26-29 μM).  Importantly, cell-based time-kill assays showed BTZs restored β-lactam susceptibility of Escherichia coli-producing MBLs (IMP-1, Sfh-1, BcII, and GOB-18) and, significantly, an extensively drug-resistant Stenotrophomonas maltophilia clin. isolate expressing L1.  BTZs therefore inhibit the full range of MBLs and potentiate β-lactam activity against producer pathogens.  X-ray crystal structures revealed insights into diverse BTZ binding modes, varying with orientation of the carboxylate and thiol moieties.  BTZs bound the di-zinc centers of B1 (IMP-1; BcII) and B3 (L1) MBLs via the free thiol, but oriented differently depending upon stereochem.  In contrast, the L-BTZ carboxylate dominated interactions with the mono-zinc B2 MBL Sfh-I, with the thiol uninvolved.  The D-BTZ complexes most closely resembled β-lactam binding to B1 MBLs, but featured an unprecedented disruption of the Asp-120-zinc interaction.  Cross-class MBL inhibition therefore arises from the unexpected versatility of BTZ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql0OqimvaJmrVg90H21EOLACvtfcHk0li1tUT2MtVsEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D&md5=8b663adf29172ac32d41f6aad7d13513</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1601368113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1601368113%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DGonzalez%26aufirst%3DJ.%2BM.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DSaiz%26aufirst%3DC.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DTooke%26aufirst%3DC.%2BL.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DCross-class%2520metallo-beta-lactamase%2520inhibition%2520by%2520bisthiazolidines%2520reveals%2520multiple%2520binding%2520modes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE3745%26epage%3DE3754%26doi%3D10.1073%2Fpnas.1601368113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N. H.</span></span> <span> </span><span class="NLM_article-title">Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic Gram-negative bacteria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1128/AAC.21.1.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.21.1.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=6979307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL38XhtFyrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=85-92&author=R.+B.+Sykesauthor=D.+P.+Bonnerauthor=K.+Bushauthor=N.+H.+Georgopapadakou&title=Azthreonam+%28SQ+26%2C776%29%2C+a+synthetic+monobactam+specifically+active+against+aerobic+Gram-negative+bacteria&doi=10.1128%2FAAC.21.1.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria</span></div><div class="casAuthors">Sykes, R. B.; Bonner, D. P.; Bush, K.; Georgopapadakou, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-92</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Azthreonam (I) is a synthetic monocyclic β-lactam antimicrobial agent belonging to the monobactam family, members of which are characterized by having the 2-oxoazetidine-1-sulfonic acid moiety.  I exhibits a high degree of stability to β-lactamases and is specifically active against aerobic gram-neg. bacteria, including Pseudomonas aeruginosa.  Its activity against these organisms was in general equal or superior to that obsd. with the 3rd-generation cephalosporins, cefotaxime and ceftazidime.  Like penicillins and cephalosporins, I interacts with essential penicillin-binding proteins of gram-neg. bacteria.  I protected mice against exptl. infections produced by a range of gram-neg. bacteria, exhibiting efficacy comparable to that of cefotaxime and ceftazidime.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMJm6Sw7SM7rVg90H21EOLACvtfcHk0li1tUT2MtVsEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtFyrtrw%253D&md5=b48091de5681c798b86321fbf81752d2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAAC.21.1.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.21.1.85%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DR.%2BB.%26aulast%3DBonner%26aufirst%3DD.%2BP.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26atitle%3DAzthreonam%2520%2528SQ%252026%252C776%2529%252C%2520a%2520synthetic%2520monobactam%2520specifically%2520active%2520against%2520aerobic%2520Gram-negative%2520bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1982%26volume%3D21%26spage%3D85%26epage%3D92%26doi%3D10.1128%2FAAC.21.1.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, B.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasothan, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, P.</span></span> <span> </span><span class="NLM_article-title">Inhaled aztreonam</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1038/nrd3170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrd3170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=357-358&author=B.%0AP.+O%E2%80%99Sullivanauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Inhaled+aztreonam&doi=10.1038%2Fnrd3170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnrd3170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3170%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DB.%2BP.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DInhaled%2520aztreonam%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D357%26epage%3D358%26doi%3D10.1038%2Fnrd3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy-Benenato, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagunde, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatoum-Mokdad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uria-Nickelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of efficacious <i>Pseudomonas aeruginosa</i>-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1021/jm501506f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501506f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2195-2205&author=K.+E.+Murphy-Benenatoauthor=P.+R.+Bhagundeauthor=A.+Chenauthor=H.+E.+Davisauthor=T.+F.+Durand-Revilleauthor=D.+E.+Ehmannauthor=V.+Galulloauthor=J.+J.+Harrisauthor=H.+Hatoum-Mokdadauthor=H.+Jahicauthor=A.+Kimauthor=M.+R.+Manjunathaauthor=E.+L.+Manyakauthor=J.+Muellerauthor=S.+Pateyauthor=O.+Quirogaauthor=M.+Rooneyauthor=L.+Shaauthor=A.+B.+Shapiroauthor=M.+Sylvesterauthor=B.+Tanauthor=A.+S.+Tsaiauthor=M.+Uria-Nickelsenauthor=Y.+Wuauthor=M.+Zambrowskiauthor=S.+X.+Zhao&title=Discovery+of+efficacious+Pseudomonas+aeruginosa-targeted+siderophore-conjugated+monocarbams+by+application+of+a+semi-mechanistic+pharmacokinetic%2Fpharmacodynamic+model&doi=10.1021%2Fjm501506f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm501506f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501506f%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DBhagunde%26aufirst%3DP.%2BR.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BE.%26aulast%3DDurand-Reville%26aufirst%3DT.%2BF.%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DJ.%2BJ.%26aulast%3DHatoum-Mokdad%26aufirst%3DH.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DManyak%26aufirst%3DE.%2BL.%26aulast%3DMueller%26aufirst%3DJ.%26aulast%3DPatey%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DO.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DA.%2BS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZambrowski%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520efficacious%2520Pseudomonas%2520aeruginosa-targeted%2520siderophore-conjugated%2520monocarbams%2520by%2520application%2520of%2520a%2520semi-mechanistic%2520pharmacokinetic%252Fpharmacodynamic%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2195%26epage%3D2205%26doi%3D10.1021%2Fjm501506f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, J. S.</span></span> <span> </span><span class="NLM_article-title">Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/0002-9343(85)90097-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0002-9343%2885%2990097-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=3859213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL2MXlvVyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1985&pages=3-21&author=J.+Birnbaumauthor=F.+M.+Kahanauthor=H.+Kroppauthor=J.+S.+MacDonald&title=Carbapenems%2C+a+new+class+of+beta-lactam+antibiotics.+Discovery+and+development+of+imipenem%2Fcilastatin&doi=10.1016%2F0002-9343%2885%2990097-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems, a new class of beta-lactam antibiotics.  Discovery and development of imipenem/cilastatin</span></div><div class="casAuthors">Birnbaum, Jerome; Kahan, Frederick M.; Kropp, Helmut; Macdonald, James S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6A</span>),
    <span class="NLM_cas:pages">3-21</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    </div><div class="casAbstract">A review with 48 refs.  Cilastatin  [82009-34-5], coadministered with imipenem  [64221-86-9] in a 1:1 ratio, provided prolonged, reversible blockade of imipenem metab. and improved urinary recoveries to therapeutically significant levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNK07atRIa7Vg90H21EOLACvtfcHk0lgPCeugEBv2AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvVyrtb8%253D&md5=592664766841f1479bae6f0d68b46a50</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2885%2990097-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252885%252990097-X%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DJ.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DMacDonald%26aufirst%3DJ.%2BS.%26atitle%3DCarbapenems%252C%2520a%2520new%2520class%2520of%2520beta-lactam%2520antibiotics.%2520Discovery%2520and%2520development%2520of%2520imipenem%252Fcilastatin%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1985%26volume%3D78%26spage%3D3%26epage%3D21%26doi%3D10.1016%2F0002-9343%2885%2990097-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundelof, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, J.</span></span> <span> </span><span class="NLM_article-title">MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1128/AAC.17.6.993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.17.6.993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1980&pages=993-1000&author=H.+Kroppauthor=J.+G.+Sundelofauthor=J.+S.+Kahanauthor=F.+M.+Kahanauthor=J.+Birnbaum&title=MK0787+%28N-formimidoyl+thienamycin%29%3A+evaluation+of+in+vitro+and+in+vivo+activities&doi=10.1128%2FAAC.17.6.993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2FAAC.17.6.993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.17.6.993%26sid%3Dliteratum%253Aachs%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DSundelof%26aufirst%3DJ.%2BG.%26aulast%3DKahan%26aufirst%3DJ.%2BS.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DBirnbaum%26aufirst%3DJ.%26atitle%3DMK0787%2520%2528N-formimidoyl%2520thienamycin%2529%253A%2520evaluation%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1980%26volume%3D17%26spage%3D993%26epage%3D1000%26doi%3D10.1128%2FAAC.17.6.993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satow, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human renal dipeptidase involved in beta-lactam hydrolysis</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(02)00632-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0022-2836%2802%2900632-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2002&pages=177-184&author=Y.+Nitanaiauthor=Y.+Satowauthor=H.+Adachiauthor=M.+Tsujimoto&title=Crystal+structure+of+human+renal+dipeptidase+involved+in+beta-lactam+hydrolysis&doi=10.1016%2FS0022-2836%2802%2900632-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900632-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900632-0%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DSatow%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DTsujimoto%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520renal%2520dipeptidase%2520involved%2520in%2520beta-lactam%2520hydrolysis%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D321%26spage%3D177%26epage%3D184%26doi%3D10.1016%2FS0022-2836%2802%2900632-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “cyclopropyl fragment” is a versatile player that frequently appears in preclinical/clinical drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%9Ccyclopropyl+fragment%E2%80%9D+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0ljdETzq1uMXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259Ccyclopropyl%2520fragment%25E2%2580%259D%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kondreddi, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8859</span>, <span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents</span></div><div class="casAuthors">Kondreddi, Ravinder Reddy; Jiricek, Jan; Rao, Srinivasa P. S.; Lakshminarayana, Suresh B.; Camacho, Luis R.; Rao, Ranga; Herve, Maxime; Bifani, Pablo; Ma, Ngai Ling; Kuhen, Kelli; Goh, Anne; Chatterjee, Arnab K.; Dick, Thomas; Diagana, Thierry T.; Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8849-8859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-2-carboxamides have been identified as a promising class of antituberculosis agents from phenotypic screening against mycobacteria.  One of the hits, indole-2-carboxamide analog (I), had low micromolar potency against Mycobacterium tuberculosis (Mtb), high mouse liver microsomal clearance, and low aq. soly.  Structure-activity relationship studies revealed that attaching alkyl groups to the cyclohexyl ring significantly improved Mtb activity but reduced soly.  Furthermore, chloro, fluoro, or cyano substitutions on the 4- and 6-positions of the indole ring as well as Me substitution on the cyclohexyl ring significantly improved metabolic stability.  II and III, the lead candidates, displayed improved in vitro activity compared to most of the current std. TB drugs.  The low aq. soly. could not be mitigated because of the pos. correlation of lipophilicity with Mtb potency.  However, both compds. displayed favorable oral pharmacokinetic properties in rodents and demonstrated in vivo efficacy.  Thus, indole-2-carboxamides represent a promising new class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KW8om-6fZ7Vg90H21EOLACvtfcHk0lgsW-F6Box5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL&md5=ab732bc84632b1f9f364e45610bcbc1b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanowich-Knipp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6074</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm060325b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlOlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.+C.+Chengauthor=Y.+Hsiehauthor=J.+M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-+3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection&doi=10.1021%2Fjm060325b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span></div><div class="casAuthors">Venkatraman, Srikanth; Bogen, Stephane L.; Arasappan, Ashok; Bennett, Frank; Chen, Kevin; Jao, Edwin; Liu, Yi-Tsung; Lovey, Raymond; Hendrata, Siska; Huang, Yuhua; Pan, Weidong; Parekh, Tejal; Pinto, Patrick; Popov, Veljko; Pike, Russel; Ruan, Sumei; Santhanam, Bama; Vibulbhan, Bancha; Wu, Wanli; Yang, Weiying; Kong, Jianshe; Liang, Xiang; Wong, Jesse; Liu, Rong; Butkiewicz, Nancy; Chase, Robert; Hart, Andrea; Agrawal, Sony; Ingravallo, Paul; Pichardo, John; Kong, Rong; Baroudy, Bahige; Malcolm, Bruce; Guo, Zhuyan; Prongay, Andrew; Madison, Vincent; Broske, Lisa; Cui, Xiaoming; Cheng, Kuo-Chi; Hsieh, Tony Y.; Brisson, Jean-Marc; Prelusky, Danial; Korfmacher, Walter; White, Ronald; Bogdanowich-Knipp, Susan; Pavlovsky, Anastasia; Bradley, Prudence; Saksena, Anil K.; Ganguly, Ashit; Piwinski, John; Girijavallabhan, Viyyoor; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6074-6086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, which affects more than 170 million people worldwide.  Currently the only therapeutic regimens are s.c. interferon-α or polyethylene glycol (PEG)-interferon-α alone or in combination with oral ribavirin.  Although combination therapy is reasonably successful with the majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virol. response.  Herein, the SAR leading to the discovery of SCH 503034 (I), a novel, potent, selective, orally bioavailable NS3 protease inhibitor that has been advanced to clin. trials in human beings for the treatment of hepatitis C viral infections is described.  X-ray structure of I complexed with the NS3 protease and biol. data are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjAR2KjtnJV7Vg90H21EOLACvtfcHk0ljC8q8YWdCGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlOlsLg%253D&md5=e48b2e2d3eb19f7f28aaa76f96d03414</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.%2BM.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-%25203-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086%26doi%3D10.1021%2Fjm060325b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2225</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1021/jm070027u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070027u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFegsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2225-2239&author=P.+Paceauthor=M.+E.+Di+Francescoauthor=C.+Gardelliauthor=S.+Harperauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=A.+Petrocchiauthor=M.+Pomaauthor=M.+Rowleyauthor=R.+Scarpelliauthor=R.+Lauferauthor=O.+Gonzalez+Pazauthor=E.+Monteagudoauthor=F.+Bonelliauthor=D.+Hazudaauthor=K.+A.+Stillmockauthor=V.+Summa&title=Dihydroxypyrimidine-4-carboxamides+as+novel+potent+and+selective+HIV+integrase+inhibitors&doi=10.1021%2Fjm070027u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors</span></div><div class="casAuthors">Pace, Paola; Di Francesco, M. Emilia; Gardelli, Cristina; Harper, Steven; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Petrocchi, Alessia; Poma, Marco; Rowley, Michael; Scarpelli, Rita; Laufer, Ralph; Gonzalez Paz, Odalys; Monteagudo, Edith; Bonelli, Fabio; Hazuda, Daria; Stillmock, Kara A.; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2225-2239</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase, one of the three constitutive viral enzymes required for replication, is a rational target for chemotherapeutic intervention in the treatment of AIDS that has also recently been confirmed in the clin. setting.  We report here on the design and synthesis of N-benzyl-5,6-dihydroxypyrimidine-4-carboxamides as a class of agents which exhibits potent inhibition of the HIV-integrase-catalyzed strand transfer process.  In the current study, structural modifications on these mols. were made in order to examine effects on HIV-integrase inhibitory potencies.  One of the most interesting compds. for this series is 2-[1-(dimethylamino)-1-methylethyl]-N-(4-fluorobenzyl)-5,6-dihydroxypyrimidine-4-carboxamide, with a CIC95 of 78 nM in the cell-based assay in the presence of serum proteins.  The compd. has favorable pharmacokinetic properties in preclin. species (rats, dogs, and monkeys) and shows no liabilities in several counterscreening assays, highlighting its potential as a clin. useful antiviral agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE58S95gF84rVg90H21EOLACvtfcHk0ljC8q8YWdCGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFegsLw%253D&md5=7ce7ac1563655da2f025b5fee1e166fa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm070027u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070027u%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDihydroxypyrimidine-4-carboxamides%2520as%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2225%26epage%3D2239%26doi%3D10.1021%2Fjm070027u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0lgT6i3P5YsXyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dame, J. B.</span></span> <span> </span><span class="NLM_article-title">Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of <i>Plasmodium falciparum</i></span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.ijpara.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.ijpara.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17207486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=317-327&author=J.+A.+Bonillaauthor=P.+A.+Mouraauthor=T.+D.+Bonillaauthor=C.+A.+Yowellauthor=D.+A.+Fidockauthor=J.+B.+Dame&title=Effects+on+growth%2C+hemoglobin+metabolism+and+paralogous+gene+expression+resulting+from+disruption+of+genes+encoding+the+digestive+vacuole+plasmepsins+of+Plasmodium+falciparum&doi=10.1016%2Fj.ijpara.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum</span></div><div class="casAuthors">Bonilla, J. Alfredo; Moura, Pedro A.; Bonilla, Tonya D.; Yowell, Charles A.; Fidock, David A.; Dame, John B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">317-327</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four of the plasmepsins of Plasmodium falciparum are localized in the digestive vacuole (DV) of the asexual blood stage parasite (PfPM1, PfPM2, PfPM4 and PfHAP), and each of these aspartic proteinases has been successfully targeted by gene disruption.  This study describes further characterization of the single-plasmepsin knockout mutants, and the creation and characterization of double-plasmepsin knockout mutants lacking complete copies of pfpm2 and pfpm1 or pfhap and pfpm2.  Double-plasmepsin knockout mutants were created by transfecting pre-existing knockout mutants with a second plasmid knockout construct.  PCR and Southern blot anal. demonstrate the integration of a large concatamer of each plasmid construct into the targeted gene.  All mutants have been characterized to assess the involvement of the DV plasmepsins in sustaining growth during the asexual blood stage.  Analyses reaffirmed that knockout mutants Δpfpm1 and Δpfpm4 had lower replication rates in the asexual erythrocytic stage than the parental line (Dd2), but double-plasmepsin knockout mutants lacking intact copies of either pfpm2 and pfpm1, or pfpm2 and pfhap, had normal growth rates compared with Dd2.  The amt. of cryst. hemozoin produced per parasite during the asexual cycle was measured in each single-plasmepsin knockout to est. the effect of each DV plasmepsin on Hb digestion.  Only Δpfpm4 had a statistically significant redn. in hemozoin accumulation, indicating that Hb digestion was impaired in this mutant.  In the single-plasmepsin knockouts, no statistically significant differences were found in the steady state levels of mRNA from the remaining intact DV plasmepsin genes.  Disruption of a DV plasmepsin gene does not affect the accumulation of mRNA encoding the remaining paralogous plasmepsins, and Western blot anal. confirmed that the accumulation of the paralogous plasmepsins in each knockout mutant was similar among all clones examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCHAOP3nWIXbVg90H21EOLACvtfcHk0lj1HsjvISmIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOjsbw%253D&md5=db3469d3312bc21f9e95700de9ff96cb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpara.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpara.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DBonilla%26aufirst%3DJ.%2BA.%26aulast%3DMoura%26aufirst%3DP.%2BA.%26aulast%3DBonilla%26aufirst%3DT.%2BD.%26aulast%3DYowell%26aufirst%3DC.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDame%26aufirst%3DJ.%2BB.%26atitle%3DEffects%2520on%2520growth%252C%2520hemoglobin%2520metabolism%2520and%2520paralogous%2520gene%2520expression%2520resulting%2520from%2520disruption%2520of%2520genes%2520encoding%2520the%2520digestive%2520vacuole%2520plasmepsins%2520of%2520Plasmodium%2520falciparum%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2007%26volume%3D37%26spage%3D317%26epage%3D327%26doi%3D10.1016%2Fj.ijpara.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaudzems, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tars, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurops, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivdra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otikovs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanepe-Lapsa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domraceva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutule, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapencieris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirgensons, A.</span></span> <span> </span><span class="NLM_article-title">Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1021/ml4004952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=373-377&author=K.+Jaudzemsauthor=K.+Tarsauthor=G.+Mauropsauthor=N.+Ivdraauthor=M.+Otikovsauthor=J.+Leitansauthor=I.+Kanepe-Lapsaauthor=I.+Domracevaauthor=I.+Mutuleauthor=P.+Trapencierisauthor=M.+J.+Blackmanauthor=A.+Jirgensons&title=Plasmepsin+inhibitory+activity+and+structure-guided+optimization+of+a+potent+hydroxyethylamine-based+antimalarial+hit&doi=10.1021%2Fml4004952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit</span></div><div class="casAuthors">Jaudzems, Kristaps; Tars, Kaspars; Maurops, Gundars; Ivdra, Natalija; Otikovs, Martins; Leitans, Janis; Kanepe-Lapsa, Iveta; Domraceva, Ilona; Mutule, Ilze; Trapencieris, Peteris; Blackman, Michael J.; Jirgensons, Aigars</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-377</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimalarial hit 1SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign was evaluated for inhibitory activity against the digestive vacuole plasmepsins (Plm I, II, and IV).  It was found to be a potent Plm IV inhibitor with no selectivity over Cathepsin D.  A cocrystal structure of 1SR bound to Plm II was solved, providing structural insight for the design of more potent and selective analogs.  Structure-guided optimization led to the identification of structurally simplified analogs 17 and 18 as low nanomolar inhibitors of both, plasmepsin Plm IV activity and P. falciparum growth in erythrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodPy3QEt5GubVg90H21EOLACvtfcHk0lj1HsjvISmIGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKjtA%253D%253D&md5=6ee7872a473db6d9b6020096e32a1a81</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fml4004952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004952%26sid%3Dliteratum%253Aachs%26aulast%3DJaudzems%26aufirst%3DK.%26aulast%3DTars%26aufirst%3DK.%26aulast%3DMaurops%26aufirst%3DG.%26aulast%3DIvdra%26aufirst%3DN.%26aulast%3DOtikovs%26aufirst%3DM.%26aulast%3DLeitans%26aufirst%3DJ.%26aulast%3DKanepe-Lapsa%26aufirst%3DI.%26aulast%3DDomraceva%26aufirst%3DI.%26aulast%3DMutule%26aufirst%3DI.%26aulast%3DTrapencieris%26aufirst%3DP.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26aulast%3DJirgensons%26aufirst%3DA.%26atitle%3DPlasmepsin%2520inhibitory%2520activity%2520and%2520structure-guided%2520optimization%2520of%2520a%2520potent%2520hydroxyethylamine-based%2520antimalarial%2520hit%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D373%26epage%3D377%26doi%3D10.1021%2Fml4004952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8253</span>– <span class="NLM_lpage">8261</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.03.4777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1200%2FJCO.2005.03.4777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16278481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=8253-8261&author=H.+I.+Scherauthor=C.+L.+Sawyers&title=Biology+of+progressive%2C+castration-resistant+prostate+cancer%3A+directed+therapies+targeting+the+androgen-receptor+signaling+axis&doi=10.1200%2FJCO.2005.03.4777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis</span></div><div class="casAuthors">Scher, Howard I.; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8253-8261</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Prostate cancers that are progressing on medical and surgical therapies designed to ablate the action of androgens continue to express androgen receptor (AR) and to depend on signaling through the receptor for growth.  A more clin. relevant classification of castration-resistant disease focuses on the mechanisms of receptor activation, which include (1) changes in the level of ligand(s) in tumor tissue; (2) increased levels of the protein due to gene amplification or altered mRNA expression; (3) activating mutations in the receptor that affect structure and function; (4) changes in coregulatory mols. including coactivators and corepressors; and (5) factors that lead to activation of the receptor independent of the level of ligand or receptor allowing kinase cross talk.  From an AR perspective, the term "hormone refractory" is inappropriate.  On the basis of this schema, we discuss strategies that are focused on the AR either directly or indirectly, as single agents or in combination, that are in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLGcoIg3SiLVg90H21EOLACvtfcHk0lim3v7S62LKog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yntbnL&md5=c07e9cfd7453af7535cbabf7529ee7dc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.4777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.4777%26sid%3Dliteratum%253Aachs%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DBiology%2520of%2520progressive%252C%2520castration-resistant%2520prostate%2520cancer%253A%2520directed%2520therapies%2520targeting%2520the%2520androgen-receptor%2520signaling%2520axis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D8253%26epage%3D8261%26doi%3D10.1200%2FJCO.2005.03.4777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span> <span> </span><span class="NLM_article-title">Steroid hormone withdrawal syndromes. pathophysiology and clinical significance</span>. <i>Urol. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S0094-0143(05)70389-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0094-0143%2805%2970389-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9126240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaK2s3ntFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=421-431&author=W.+K.+Kellyauthor=S.+Slovinauthor=H.+I.+Scher&title=Steroid+hormone+withdrawal+syndromes.+pathophysiology+and+clinical+significance&doi=10.1016%2FS0094-0143%2805%2970389-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance</span></div><div class="casAuthors">Kelly W K; Slovin S; Scher H I</div><div class="citationInfo"><span class="NLM_cas:title">The Urologic clinics of North America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-31</span>
        ISSN:<span class="NLM_cas:issn">0094-0143</span>.
    </div><div class="casAbstract">The steroid withdrawal syndrome has brought a new dimension to the treatment of advanced prostate cancer not only in the way we treat androgen-independent disease but also in terms of insights into the development of hormonal resistance.  The data now confirm that 30% of cases have a meaningful subjective, biochemical, and objective response to the withdrawal of a steroid hormone as the first maneuver after primary hormonal therapy failure.  Larger studies are needed to define further the withdrawal effect related to the other steroid hormone family members and to determine the objective response proportions.  Although controversy surrounds the cause of the steroid withdrawal phenomenon, studies suggest that the androgen receptor plays a pivotal role.  Molecular studies of the androgen receptors involving larger number of patients are paramount if we are going to develop a better understanding of the evolution of the withdrawal effect and hormone resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8ldcF10bnhiXXDYhVZBdlfW6udTcc2eailPDLdUXLY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3ntFaruw%253D%253D&md5=eb4e6f84e774e98bf320d89c2c28c0e6</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0094-0143%2805%2970389-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0094-0143%252805%252970389-X%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DSlovin%26aufirst%3DS.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DSteroid%2520hormone%2520withdrawal%2520syndromes.%2520pathophysiology%2520and%2520clinical%2520significance%26jtitle%3DUrol.%2520Clin.%2520North%2520Am.%26date%3D1997%26volume%3D24%26spage%3D421%26epage%3D431%26doi%3D10.1016%2FS0094-0143%2805%2970389-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2796</span>, <span class="refDoi"> DOI: 10.1021/jm901488g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901488g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVyhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2779-2796&author=M.+E.+Jungauthor=S.+Oukauthor=D.+Yooauthor=C.+L.+Sawyersauthor=C.+Chenauthor=C.+Tranauthor=J.+Wongvipat&title=Structure-activity+relationship+for+thiohydantoin+androgen+receptor+antagonists+for+castration-resistant+prostate+cancer+%28CRPC%29&doi=10.1021%2Fjm901488g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)</span></div><div class="casAuthors">Jung, Michael E.; Ouk, Samedy; Yoo, Dongwon; Sawyers, Charles L.; Chen, Charlie; Tran, Chris; Wongvipat, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2779-2796</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship study was carried out on a series of thiohydantoins and their analogs 14 which led to the discovery of 92 (MDV3100) as the clin. candidate for the treatment of hormone refractory prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWTaotH9EH7Vg90H21EOLACvtfcHk0lim3v7S62LKog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVyhur4%253D&md5=f2f08b31060db468966d62582db81ebd</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm901488g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901488g%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DOuk%26aufirst%3DS.%26aulast%3DYoo%26aufirst%3DD.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWongvipat%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520for%2520thiohydantoin%2520androgen%2520receptor%2520antagonists%2520for%2520castration-resistant%2520prostate%2520cancer%2520%2528CRPC%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2779%26epage%3D2796%26doi%3D10.1021%2Fjm901488g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clegg, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Jones, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasielewska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsbie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higano, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Development of a second-generation antiandrogen for treatment of advanced prostate cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1126/science.1168175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1126%2Fscience.1168175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19359544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=787-790&author=C.+Tranauthor=S.+Oukauthor=N.+J.+Cleggauthor=Y.+Chenauthor=P.+A.+Watsonauthor=V.+Aroraauthor=J.+Wongvipatauthor=P.+M.+Smith-Jonesauthor=D.+Yooauthor=A.+Kwonauthor=T.+Wasielewskaauthor=D.+Welsbieauthor=C.+D.+Chenauthor=C.+S.+Higanoauthor=T.+M.+Beerauthor=D.+T.+Hungauthor=H.+I.+Scherauthor=M.+E.+Jungauthor=C.+L.+Sawyers&title=Development+of+a+second-generation+antiandrogen+for+treatment+of+advanced+prostate+cancer&doi=10.1126%2Fscience.1168175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer</span></div><div class="casAuthors">Tran, Chris; Ouk, Samedy; Clegg, Nicola J.; Chen, Yu; Watson, Philip A.; Arora, Vivek; Wongvipat, John; Smith-Jones, Peter M.; Yoo, Dongwon; Kwon, Andrew; Wasielewska, Teresa; Welsbie, Derek; Chen, Charlie Degui; Higano, Celestia S.; Beer, Tomasz M.; Hung, David T.; Scher, Howard I.; Jung, Michael E.; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">787-790</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Metastatic prostate cancer is treated with drugs that antagonize androgen action, but most patients progress to a more aggressive form of the disease called castration-resistant prostate cancer, driven by elevated expression of the androgen receptor.  Here we characterize the diarylthiohydantoins RD162 and MDV3100, two compds. optimized from a screen for nonsteroidal antiandrogens that retain activity in the setting of increased androgen receptor expression.  Both compds. bind to the androgen receptor with greater relative affinity than the clin. used antiandrogen bicalutamide, reduce the efficiency of its nuclear translocation, and impair both DNA binding to androgen response elements and recruitment of coactivators.  RD162 and MDV3100 are orally available and induce tumor regression in mouse models of castration-resistant human prostate cancer.  Of the first 30 patients treated with MDV3100 in a Phase I/II clin. trial, 13 of 30 (43%) showed sustained declines (by >50%) in serum concns. of prostate-specific antigen, a biomarker of prostate cancer.  These compds. thus appear to be promising candidates for treatment of advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7UUC3dSP_LVg90H21EOLACvtfcHk0liRx-awSEHIMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksro%253D&md5=1190646660b670c6d490b2c7ca73e48b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168175%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DC.%26aulast%3DOuk%26aufirst%3DS.%26aulast%3DClegg%26aufirst%3DN.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWatson%26aufirst%3DP.%2BA.%26aulast%3DArora%26aufirst%3DV.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DYoo%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DA.%26aulast%3DWasielewska%26aufirst%3DT.%26aulast%3DWelsbie%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BD.%26aulast%3DHigano%26aufirst%3DC.%2BS.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DHung%26aufirst%3DD.%2BT.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520second-generation%2520antiandrogen%2520for%2520treatment%2520of%2520advanced%2520prostate%2520cancer%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D787%26epage%3D790%26doi%3D10.1126%2Fscience.1168175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balbas, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Overcoming mutation-based resistance to antiandrogens with rational drug design</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e00499</span>, <span class="refDoi"> DOI: 10.7554/eLife.00499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7554%2FeLife.00499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23580326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e00499&author=M.+D.+Balbasauthor=M.+J.+Evansauthor=D.+J.+Hosfieldauthor=J.+Wongvipatauthor=V.+K.+Aroraauthor=P.+A.+Watsonauthor=Y.+Chenauthor=G.+L.+Greeneauthor=Y.+Shenauthor=C.+L.+Sawyers&title=Overcoming+mutation-based+resistance+to+antiandrogens+with+rational+drug+design&doi=10.7554%2FeLife.00499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming mutation-based resistance to antiandrogens with rational drug design</span></div><div class="casAuthors">Balbas, Minna D.; Evans, Michael J.; Hosfield, David J.; Wongvipat, John; Arora, Vivek K.; Watson, Philip A.; Chen, Yu; Greene, Geoffrey L.; Shen, Yang; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e00499/1-e00499/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">The second-generation antiandrogen enzalutamide was recently approved for patients with castration-resistant prostate cancer.  Despite its success, the duration of response is often limited.  For previous antiandrogens, one mechanism of resistance is mutation of the androgen receptor (AR).  To prospectively identify AR mutations that might confer resistance to enzalutamide, we performed a reporter-based mutagenesis screen and identified a novel mutation, F876L, which converted enzalutamide into an AR agonist.  Ectopic expression of AR F876L rescued the growth inhibition of enzalutamide treatment.  Mol. dynamics simulations performed on antiandrogen-AR complexes suggested a mechanism by which the F876L substitution alleviates antagonism through repositioning of the coactivator recruiting helix 12.  This model then provided the rationale for a focused chem. screen which, based on existing antiandrogen scaffolds, identified three novel compds. that effectively antagonized AR F876L (and AR WT) to suppress the growth of prostate cancer cells resistant to enzalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nauKhIbQtbVg90H21EOLACvtfcHk0ljHdQk-LwuMTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWhug%253D%253D&md5=37385bb995c28582a86e20533c79fb93</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.7554%2FeLife.00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.00499%26sid%3Dliteratum%253Aachs%26aulast%3DBalbas%26aufirst%3DM.%2BD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DWatson%26aufirst%3DP.%2BA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DOvercoming%2520mutation-based%2520resistance%2520to%2520antiandrogens%2520with%2520rational%2520drug%2520design%26jtitle%3DeLife%26date%3D2013%26volume%3D2%26spage%3De00499%26doi%3D10.7554%2FeLife.00499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tognon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, P. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1517/14728222.2011.638626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14728222.2011.638626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22239439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=33-48&author=C.+E.+Tognonauthor=P.+H.+Sorensen&title=Targeting+the+insulin-like+growth+factor+1+receptor+%28IGF1R%29+signaling+pathway+for+cancer+therapy&doi=10.1517%2F14728222.2011.638626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy</span></div><div class="casAuthors">Tognon, Cristina E.; Sorensen, Poul H. B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-48</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The IGF system controls growth, differentiation, and development at the cellular, organ and organismal levels.  IGF1 receptor (IGF1R) signaling is dysregulated in many cancers.  Numerous clin. trials are currently assessing therapies that inhibit either growth factor binding or IGF1R itself.  Therapeutic benefit, often in the form of stable disease, has been reported for many different cancer types.Areas covered: Canonical IGF signaling and non-canonical pathways involved in carcinogenesis.  Three recent insights into IGF1R signaling, namely hybrid receptor formation with insulin receptor (INSR), insulin receptor substrate 1 nuclear translocation, and evidence for IGF1R/INSR as dependence receptors.  Different approaches to targeting IGF1R and mechanisms of acquired resistance.  Possible mechanisms by which IGF1R signaling supports carcinogenesis and specific examples in different human tumors.Expert opinion: Pre-clin. data justifies IGF1R as a target and early clin. trials have shown modest efficacy in selected tumor types.  Future work will focus upon assessing the usefulness or disadvantages of simultaneously targeting the IGF1R and INSR, biomarker development to identify potentially responsive patients, and the use of IGF1R inhibitors in combination therapies or as an adjunct to conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDumNQ4RQmrVg90H21EOLACvtfcHk0ljHdQk-LwuMTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1WksQ%253D%253D&md5=71848860ad474559f866b13da525f7d4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1517%2F14728222.2011.638626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2011.638626%26sid%3Dliteratum%253Aachs%26aulast%3DTognon%26aufirst%3DC.%2BE.%26aulast%3DSorensen%26aufirst%3DP.%2BH.%26atitle%3DTargeting%2520the%2520insulin-like%2520growth%2520factor%25201%2520receptor%2520%2528IGF1R%2529%2520signaling%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2012%26volume%3D16%26spage%3D33%26epage%3D48%26doi%3D10.1517%2F14728222.2011.638626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span> <span> </span><span class="NLM_article-title">Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.02.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2065-2067&author=F.+Staufferauthor=S.+W.+Cowan-Jacobauthor=C.+Scheuflerauthor=P.+Furet&title=Identification+of+a+5-%5B3-phenyl-%282-cyclic-ether%29-methylether%5D-4-aminopyrrolo%5B2%2C3-d%5Dpyrimidine+series+of+IGF-1R+inhibitors&doi=10.1016%2Fj.bmcl.2016.02.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.074%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%25205-%255B3-phenyl-%25282-cyclic-ether%2529-methylether%255D-4-aminopyrrolo%255B2%252C3-d%255Dpyrimidine%2520series%2520of%2520IGF-1R%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2065%26epage%3D2067%26doi%3D10.1016%2Fj.bmcl.2016.02.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capraro, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebetanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, F.</span></span> <span> </span><span class="NLM_article-title">In vivo antitumor activity of NVP-AEW541-a novel, potent, and selective inhibitor of the IGF-IR kinase</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(04)00051-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS1535-6108%2804%2900051-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=231-239&author=C.+Garcia-Echeverriaauthor=M.+A.+Pearsonauthor=A.+Martiauthor=T.+Meyerauthor=J.+Mestanauthor=J.+Zimmermannauthor=J.+Gaoauthor=J.+Brueggenauthor=H.+G.+Capraroauthor=R.+Cozensauthor=D.+B.+Evansauthor=D.+Fabbroauthor=P.+Furetauthor=D.+G.+Portaauthor=J.+Liebetanzauthor=G.+Martiny-Baronauthor=S.+Ruetzauthor=F.+Hofmann&title=In+vivo+antitumor+activity+of+NVP-AEW541-a+novel%2C+potent%2C+and+selective+inhibitor+of+the+IGF-IR+kinase&doi=10.1016%2FS1535-6108%2804%2900051-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900051-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900051-0%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DPearson%26aufirst%3DM.%2BA.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCapraro%26aufirst%3DH.%2BG.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DPorta%26aufirst%3DD.%2BG.%26aulast%3DLiebetanz%26aufirst%3DJ.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DRuetz%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DF.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520NVP-AEW541-a%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520the%2520IGF-IR%2520kinase%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D231%26epage%3D239%26doi%3D10.1016%2FS1535-6108%2804%2900051-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakabeppu, Y.</span></span> <span> </span><span class="NLM_article-title">An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">37965</span>– <span class="NLM_lpage">37973</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306201200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M306201200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=37965-37973&author=D.+Yoshimuraauthor=K.+Sakumiauthor=M.+Ohnoauthor=Y.+Sakaiauthor=M.+Furuichiauthor=S.+Iwaiauthor=Y.+Nakabeppu&title=An+oxidized+purine+nucleoside+triphosphatase%2C+MTH1%2C+suppresses+cell+death+caused+by+oxidative+stress&doi=10.1074%2Fjbc.M306201200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306201200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306201200%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DD.%26aulast%3DSakumi%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DY.%26aulast%3DFuruichi%26aufirst%3DM.%26aulast%3DIwai%26aufirst%3DS.%26aulast%3DNakabeppu%26aufirst%3DY.%26atitle%3DAn%2520oxidized%2520purine%2520nucleoside%2520triphosphatase%252C%2520MTH1%252C%2520suppresses%2520cell%2520death%2520caused%2520by%2520oxidative%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D37965%26epage%3D37973%26doi%3D10.1074%2Fjbc.M306201200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posakony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loe, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalhofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span> <span> </span><span class="NLM_article-title">Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3283</span>– <span class="NLM_lpage">3294</span>, <span class="refDoi"> DOI: 10.1021/jm4018064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4018064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3283-3294&author=S.+S.+Mahajanauthor=M.+Scianauthor=S.+Sripathyauthor=J.+Posakonyauthor=U.+Laoauthor=T.+K.+Loeauthor=V.+Lekoauthor=A.+Thalhoferauthor=A.+D.+Schulerauthor=A.+Bedalovauthor=J.+A.+Simon&title=Development+of+pyrazolone+and+isoxazol-5-one+cambinol+analogues+as+sirtuin+inhibitors&doi=10.1021%2Fjm4018064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm4018064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4018064%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DScian%26aufirst%3DM.%26aulast%3DSripathy%26aufirst%3DS.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLao%26aufirst%3DU.%26aulast%3DLoe%26aufirst%3DT.%2BK.%26aulast%3DLeko%26aufirst%3DV.%26aulast%3DThalhofer%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DBedalov%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520pyrazolone%2520and%2520isoxazol-5-one%2520cambinol%2520analogues%2520as%2520sirtuin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3283%26epage%3D3294%26doi%3D10.1021%2Fjm4018064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroziak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span> <span> </span><span class="NLM_article-title">Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">17605</span>– <span class="NLM_lpage">17610</span>, <span class="refDoi"> DOI: 10.1074/jbc.C000079200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.C000079200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=17605-17610&author=M.+O.+Bergoauthor=G.+K.+Leungauthor=P.+Ambroziakauthor=J.+C.+Ottoauthor=P.+J.+Caseyauthor=S.+G.+Young&title=Targeted+inactivation+of+the+isoprenylcysteine+carboxyl+methyltransferase+gene+causes+mislocalization+of+K-Ras+in+mammalian+cells&doi=10.1074%2Fjbc.C000079200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C000079200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C000079200%26sid%3Dliteratum%253Aachs%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DLeung%26aufirst%3DG.%2BK.%26aulast%3DAmbroziak%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DJ.%2BC.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26atitle%3DTargeted%2520inactivation%2520of%2520the%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520gene%2520causes%2520mislocalization%2520of%2520K-Ras%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D17605%26epage%3D17610%26doi%3D10.1074%2Fjbc.C000079200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Judd, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slattum, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoite, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valppu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5047</span>, <span class="refDoi"> DOI: 10.1021/jm200249a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200249a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5031-5047&author=W.+R.+Juddauthor=P.+M.+Slattumauthor=K.+C.+Hoangauthor=L.+Bhoiteauthor=L.+Valppuauthor=G.+Albertsauthor=B.+Brownauthor=B.+Rothauthor=K.+Ostaninauthor=L.+Huangauthor=D.+Wettsteinauthor=B.+Richardsauthor=J.+A.+Willardsen&title=Discovery+and+SAR+of+methylated+tetrahydropyranyl+derivatives+as+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1021%2Fjm200249a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)</span></div><div class="casAuthors">Judd, Weston R.; Slattum, Paul M.; Hoang, Khanh C.; Bhoite, Leena; Valppu, Liisa; Alberts, Glen; Brown, Brita; Roth, Bruce; Ostanin, Kirill; Huang, Liwen; Wettstein, Daniel; Richards, Burt; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5031-5047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydropyranyl (THP) derivs. has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents.  Structural modification of the submicromolar hit compd. I led to the potent 3-methoxy substituted analog II [R = H].  Further SAR development around the THP ring resulted in an addnl. 10-fold increase in potency, exemplified by analog II [R = Me] with an IC50 of 1.3 nM.  Active and potent compds. demonstrated a dose-dependent increase in Ras cytosolic protein.  Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 μM.  However, none of the cellular effects obsd. using ICMT inhibitors were as pronounced as those resulting from a farnesyl-transferase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtJBz5EBh_LVg90H21EOLACvtfcHk0li4mufL1NwsIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D&md5=70c861a9d4ef4efcde4b94a2e0a88de9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm200249a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200249a%26sid%3Dliteratum%253Aachs%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DHoang%26aufirst%3DK.%2BC.%26aulast%3DBhoite%26aufirst%3DL.%26aulast%3DValppu%26aufirst%3DL.%26aulast%3DAlberts%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520methylated%2520tetrahydropyranyl%2520derivatives%2520as%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5031%26epage%3D5047%26doi%3D10.1021%2Fjm200249a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Changing views of the role of matrix metalloproteinases in metastasis</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1093/jnci/89.17.1260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fjnci%2F89.17.1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9293916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1Squ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=1260-1270&author=A.+F.+Chambersauthor=L.+M.+Matrisian&title=Changing+views+of+the+role+of+matrix+metalloproteinases+in+metastasis&doi=10.1093%2Fjnci%2F89.17.1260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Changing views of the role of matrix metalloproteinases in metastasis</span></div><div class="casAuthors">Chambers, Ann F.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1260-1270</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 127 refs. Metastatic spread of cancer continues to be the greatest barrier to cancer cure.  Understanding the mol. mechanisms of metastasis is crucial for the design and effective use of novel therapeutic strategies to combat metastases.  One class of mols. that has been repeatedly implicated in metastasis is the matrix metalloproteinases (MMPs).  In this review, we re-examine the evidence that MMPs are assocd. with metastasis and that they make a functional contribution to the process.  Initially, it was believed that the major role of MMPs in metastasis was to facilitate the breakdown of phys. barriers to metastasis, thus promoting invasion and entry into and out of blood or lymphatic vessels (intravasation, extravasation).  However, recent evidence suggests that MMPs may have a more complex role in metastasis and that they may make important contributions at other steps in the metastatic process.  Studies using intravital videomicroscopy, as well as expts. in which levels of MMPs or their inhibitors (tissue inhibitors of metalloproteinases [TIMPs]) are manipulated genetically or pharmacol., suggest that MMPs are key regulators of growth of tumors, at both primary and metastatic sites.  On the basis of this evidence, a new view of the functional role of MMPs in metastasis is presented, which suggests that MMPs are important in creating and maintaining an environment that supports the initiation and maintenance of growth of primary and metastatic tumors.  Further clarification of the mechanisms by which MMPs regulate growth of primary and metastatic tumors will be important in the development of novel therapeutic strategies against metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRMtb4MCIotbVg90H21EOLACvtfcHk0li4mufL1NwsIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1Squ7g%253D&md5=6b5d40c3ee3af13e6c66f634242219f7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F89.17.1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F89.17.1260%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DA.%2BF.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DChanging%2520views%2520of%2520the%2520role%2520of%2520matrix%2520metalloproteinases%2520in%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1997%26volume%3D89%26spage%3D1260%26epage%3D1270%26doi%3D10.1093%2Fjnci%2F89.17.1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynd, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janusz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieling, G. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4547</span>– <span class="NLM_lpage">4562</span>, <span class="refDoi"> DOI: 10.1021/jm990330y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990330y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4547-4562&author=N.+G.+Almsteadauthor=R.+S.+Bradleyauthor=S.+Pikulauthor=B.+Deauthor=M.+G.+Natchusauthor=Y.+O.+Taiwoauthor=F.+Guauthor=L.+E.+Williamsauthor=B.+A.+Hyndauthor=M.+J.+Januszauthor=C.+M.+Dunawayauthor=G.+E.+Mieling&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+thiazine-+and+thiazepine-based+matrix+metalloproteinase+inhibitors&doi=10.1021%2Fjm990330y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Potent Thiazine- and Thiazepine-Based Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Almstead, Neil G.; Bradley, Rimma S.; Pikul, Stanislaw; De, Biswanath; Natchus, Michael G.; Taiwo, Yetunde O.; Gu, Fei; Williams, Lisa E.; Hynd, Barbara A.; Janusz, Michael J.; Dunaway, C. Michelle; Mieling, Glen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4547-4562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and enzyme inhibition data for a series of thiazine- and thiazepine-based matrix metalloproteinase (MMP) inhibitors are described.  The thiazine- and thiazepine-based inhibitors were discovered by optimization of hetererocyclic sulfonamide-based inhibitors.  The most potent series of inhibitors was obtained by modification of the amino acid D-penicillamine.  This amino acid provides a gem-di-Me group on the thiazine or thiazepine ring which has a dramatic effect on the in vitro potency of this series.  In particular, the sulfide I [n = 0] and the sulfone I [n = 2] were potent, broad-spectrum inhibitors of the MMPs with IC50's against MMP-1 of 0.8 and 1.9 nM, resp.  The binding mode of this novel thiazepine-based series of MMP inhibitors was established based on X-ray crystallog. of the complex of stromelysin and I [n = 0].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPuU9hhJl0nLVg90H21EOLACvtfcHk0ljbBvcUGqd3uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ejtr8%253D&md5=44effffb64806a081861133b0c0a254c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm990330y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990330y%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DBradley%26aufirst%3DR.%2BS.%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DL.%2BE.%26aulast%3DHynd%26aufirst%3DB.%2BA.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26aulast%3DDunaway%26aufirst%3DC.%2BM.%26aulast%3DMieling%26aufirst%3DG.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520thiazine-%2520and%2520thiazepine-based%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4547%26epage%3D4562%26doi%3D10.1021%2Fjm990330y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDow Dunham, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snider, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieling, G. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, achiral matrix metalloproteinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3568</span>– <span class="NLM_lpage">3571</span>, <span class="refDoi"> DOI: 10.1021/jm980253r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980253r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3568-3571&author=S.+Pikulauthor=K.+L.+McDow+Dunhamauthor=N.+G.+Almsteadauthor=B.+Deauthor=M.+G.+Natchusauthor=M.+V.+Anastasioauthor=S.+J.+McPhailauthor=C.+E.+Sniderauthor=Y.+O.+Taiwoauthor=T.+Rydelauthor=C.+M.+Dunawayauthor=F.+Guauthor=G.+E.+Mieling&title=Discovery+of+potent%2C+achiral+matrix+metalloproteinase+inhibitors&doi=10.1021%2Fjm980253r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Pikul, Stanislaw; Dunham, Kelly L. McDow; Almstead, Neil G.; De, Biswanath; Natchus, Michael G.; Anastasio, Melanie V.; McPhail, Sara J.; Snider, Catherine E.; Taiwo, Yetunde O.; Rydel, Timothy; Dunaway, C. Michelle; Gu, Fei; Mieling, Glen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3568-3571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study the authors have introduced a symmetry element to the design of metalloproteinase (MMP) inhibitors which led to the discovery of a novel series of MMP inhibitors that are both nonchiral and very easy to synthesize.  The compds. based on the 1,3-piperazine heterocycle are potent inhibitors of collagenase, stromelysin, and gelatinase-B and moderate inhibitors of matrilysin.  On the basis of X-ray crystallog. of the inhibitor-enzyme complex, the binding of one of the compds. with stromelysin was found to involve several novel interactions at the S1/S2 pocket in addn. to the interactions commonly obsd. for an arylsulfonamide-hydroxamic acid framework.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBb-88vj3ux7Vg90H21EOLACvtfcHk0lgomTWmfSq5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVKmt70%253D&md5=b8ceb9be6ac6c6a3f615ec28e41d0528</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm980253r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980253r%26sid%3Dliteratum%253Aachs%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DMcDow%2BDunham%26aufirst%3DK.%2BL.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DAnastasio%26aufirst%3DM.%2BV.%26aulast%3DMcPhail%26aufirst%3DS.%2BJ.%26aulast%3DSnider%26aufirst%3DC.%2BE.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26aulast%3DRydel%26aufirst%3DT.%26aulast%3DDunaway%26aufirst%3DC.%2BM.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DMieling%26aufirst%3DG.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252C%2520achiral%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3568%26epage%3D3571%26doi%3D10.1021%2Fjm980253r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span> <span> </span><span class="NLM_article-title">Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1177/153537020322800201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1177%2F153537020322800201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1amtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2003&pages=111-133&author=W.+B.+Prattauthor=D.+O.+Toft&title=Regulation+of+signaling+protein+function+and+trafficking+by+the+hsp90%2Fhsp70-based+chaperone+machinery&doi=10.1177%2F153537020322800201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery</span></div><div class="casAuthors">Pratt, William B.; Toft, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-133</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  Nearly 100 proteins are known to be regulated by hsp90.  Most of these substrates or "client proteins" are involved in signal transduction, and they are brought into complex with hsp90 by a multiprotein hsp90/hsp70-based chaperone machinery.  In addn. to binding substrate proteins at the chaperone site(s), hsp90 binds cofactors at other sites that are part of the hetero-complex assembly machinery as well as immunophilins that connect assembled substrate·hsp90 complexes to protein-trafficking systems.  In the 5 yr since we last reviewed this subject, much has been learned about hsp90 structure, nucleotide-binding, and cochaperone interactions; the most important concept is that ATP hydrolysis by an intrinsic ATPase activity results in a conformational change in hsp90 that is required to induce conformational change in a substrate protein.  The conformational change induced in steroid receptors is an opening of the steroid-binding cleft so that it can be accessed by steroid.  We have now developed a minimal system of five purified proteins-hsp90, hsp70, Hop, hsp40, and p23-that assembles stable receptor·hsp90 heterocomplexes.  An hsp90·Hop·hsp70·hsp40 complex opens the cleft in an ATP-dependent process to produce a receptor·hsp90 heterocomplex with hsp90 in its ATP-bound conformation, and p23 then interacts with the hsp90 to stabilize the complex.  Stepwise assembly expts. have shown that hsp70 and hsp40 first interact with the receptor in an ATP-dependent reaction to produce a receptor·hsp70·hsp40 complex that is "primed" to be activated to the steroid-binding state in a second ATP-dependent step with hsp90, Hop, and p23.  Successful use of the five-protein system with other substrates indicates that it can assemble signal protein·hsp90 heterocomplexes whether the substrate is a receptor, a protein kinase, or a transcription factor.  This purified system should facilitate understanding of how eukaryotic hsp70 and hsp90 work together as essential components of a process that alters the conformations of substrate proteins to states that respond in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8dwfmDdBC9bVg90H21EOLACvtfcHk0lgomTWmfSq5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1amtbY%253D&md5=40af7769cad8b9d2dd13b6a5515c6656</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1177%2F153537020322800201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153537020322800201%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DToft%26aufirst%3DD.%2BO.%26atitle%3DRegulation%2520of%2520signaling%2520protein%2520function%2520and%2520trafficking%2520by%2520the%2520hsp90%252Fhsp70-based%2520chaperone%2520machinery%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2003%26volume%3D228%26spage%3D111%26epage%3D133%26doi%3D10.1177%2F153537020322800201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0lgx0X_JRPMJcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nannini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-{3-[2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): a beta-sparing phosphoinositide 3-kinase inhibitor with high unbound exposure and robust in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4597</span>– <span class="NLM_lpage">4610</span>, <span class="refDoi"> DOI: 10.1021/jm4003632</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4003632" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4597-4610&author=C.+O.+Ndubakuauthor=T.+P.+Heffronauthor=S.+T.+Stabenauthor=M.+Baumgardnerauthor=N.+Blaquiereauthor=E.+Bradleyauthor=R.+Bullauthor=S.+Doauthor=J.+Dotsonauthor=D.+Dudleyauthor=K.+A.+Edgarauthor=L.+S.+Friedmanauthor=R.+Goldsmithauthor=R.+A.+Healdauthor=A.+Kolesnikovauthor=L.+Leeauthor=C.+Lewisauthor=M.+Nanniniauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=J.+J.+Wallinauthor=L.+Wangauthor=B.+Weiauthor=D.+Sampathauthor=A.+G.+Olivero&title=Discovery+of+2-%7B3-%5B2-%281-isopropyl-3-methyl-1H-1%2C2-4-triazol-5-yl%29-5%2C6-dihydrobenzo%5Bf%5Dimidazo%5B1%2C2-d%5D%5B1%2C4%5Doxazepin-9-yl%5D-1H-pyrazol-1-yl%7D-2-methylpropanamide+%28GDC-0032%29%3A+a+beta-sparing+phosphoinositide+3-kinase+inhibitor+with+high+unbound+exposure+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Fjm4003632"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm4003632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4003632%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDudley%26aufirst%3DD.%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNannini%26aufirst%3DM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%25202-%257B3-%255B2-%25281-isopropyl-3-methyl-1H-1%252C2-4-triazol-5-yl%2529-5%252C6-dihydrobenzo%255Bf%255Dimidazo%255B1%252C2-d%255D%255B1%252C4%255Doxazepin-9-yl%255D-1H-pyrazol-1-yl%257D-2-methylpropanamide%2520%2528GDC-0032%2529%253A%2520a%2520beta-sparing%2520phosphoinositide%25203-kinase%2520inhibitor%2520with%2520high%2520unbound%2520exposure%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4597%26epage%3D4610%26doi%3D10.1021%2Fjm4003632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badea, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mais, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2930</span>– <span class="NLM_lpage">2941</span>, <span class="refDoi"> DOI: 10.1021/jm00044a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00044a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFKjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2930-2941&author=M.+F.+Boehmauthor=L.+Zhangauthor=B.+A.+Badeaauthor=S.+K.+Whiteauthor=D.+E.+Maisauthor=E.+Bergerauthor=C.+M.+Sutoauthor=M.+E.+Goldmanauthor=R.+A.+Heyman&title=Synthesis+and+structure-activity+relationships+of+novel+retinoid+X+receptor-selective+retinoids&doi=10.1021%2Fjm00044a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids</span></div><div class="casAuthors">Boehm, Marcus F.; Zhang, Lin; Badea, Beth Ann; White, Steven K.; Mais, Dale E.; Berger, Elaine; Suto, Carla M.; Goldman, Mark E.; Heyman, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2930-41</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two series of potent retinoid X receptor (RXR)-selective compds. were designed and synthesized based upon recent observation that(E)-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propenyl]benzoic acid binds and transactivates only the retinoic acid receptor (RAR) subtypes whereas its 3-Me deriv. binds and transactivates both the RAR and RXR subfamilies.  Functional groups in the 3-position of the tetrahydronaphthalenes I [R = H, alkyl, halo, OH, OMe; X = O, CH2] results in compds. which elicit potent and selective activation of the RXR class.  Such RXR-selective compds. offer pharmacol. tools for elucidating the biol. role of the individual retinoid receptors with which they interact.  Activation profiles in cotransfection and competitive binding assays as well as mol. modeling calcns. demonstrate crit. structural determinants that confer selectivity for members of the RXR subfamily.  The most potent compd. of these series, I [R = Me, X = CH2], is the first RXR-selective retinoid (designated as LGD1069) to enter clin. trials for cancer indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Mdx7TqZ18bVg90H21EOLACvtfcHk0lhbKKzi2suACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFKjt7g%253D&md5=90003c75aa4fd4934ad3aeb0773119f2</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm00044a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00044a014%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBadea%26aufirst%3DB.%2BA.%26aulast%3DWhite%26aufirst%3DS.%2BK.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DC.%2BM.%26aulast%3DGoldman%26aufirst%3DM.%2BE.%26aulast%3DHeyman%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520novel%2520retinoid%2520X%2520receptor-selective%2520retinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2930%26epage%3D2941%26doi%3D10.1021%2Fjm00044a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClurg, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagoner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mais, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadzan, A. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">3146</span>– <span class="NLM_lpage">3155</span>, <span class="refDoi"> DOI: 10.1021/jm00016a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00016a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXmvF2htLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3146-3155&author=M.+F.+Boehmauthor=L.+Zhangauthor=L.+Zhiauthor=M.+R.+McClurgauthor=E.+Bergerauthor=M.+Wagonerauthor=D.+E.+Maisauthor=C.+M.+Sutoauthor=J.+A.+Daviesauthor=R.+A.+Heymanauthor=A.+M.+Nadzan&title=Design+and+synthesis+of+potent+retinoid+X+receptor+selective+ligands+that+induce+apoptosis+in+leukemia+cells&doi=10.1021%2Fjm00016a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells</span></div><div class="casAuthors">Boehm, Marcus F.; Zhang, Lin; Zhi, Lin; McClurg, Michael R.; Berger, Elain; Wagoner, Murriel; Mais, Dale E.; Suto, Carla M.; Davies, Peter J. A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3146-55</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural modifications of the retinoid X receptor (RXR) selective compd. 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl]benzoic acid (LGD1069), which is currently in phase I/IIA clin. trials for cancer and dermatol. indications, have resulted in the identification of increasingly potent retinoids with >1000-fold selectivity for the RXRs.  The prepn. of a series of RXR selective retinoids as well as the biol. data obtained from cotransfection and competitive binding assays which were used to evaluate their potency and selectivity are reported.  The most potent and selective of the analogs is 6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]nicotinic acid (I, LG100268).  This compd. has proven useful for investigating RXR-dependent biol. pathways including the induction of programmed cell death (PCD) and transglutaminase (TGase) activity.  These studies indicate that the induction of PCD and TGase in human leukemic myeloid cells is dependent upon activation of RXR-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKBnqaIZ7EkrVg90H21EOLACvtfcHk0lhbKKzi2suACg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvF2htLg%253D&md5=c9bcc1f2449517cf62406151376ccedd</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00016a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00016a018%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhi%26aufirst%3DL.%26aulast%3DMcClurg%26aufirst%3DM.%2BR.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DWagoner%26aufirst%3DM.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DSuto%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DJ.%2BA.%26aulast%3DHeyman%26aufirst%3DR.%2BA.%26aulast%3DNadzan%26aufirst%3DA.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520retinoid%2520X%2520receptor%2520selective%2520ligands%2520that%2520induce%2520apoptosis%2520in%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3146%26epage%3D3155%26doi%3D10.1021%2Fjm00016a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boerma, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo-Ruppert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccio, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrow, M. B.</span></span> <span> </span><span class="NLM_article-title">Defining the communication between agonist and coactivator binding in the retinoid X receptor alpha ligand binding domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.476861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M113.476861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24187139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=814-826&author=L.+J.+Boermaauthor=G.+Xiaauthor=C.+Quiauthor=B.+D.+Coxauthor=M.+J.+Chalmersauthor=C.+D.+Smithauthor=S.+Lobo-Ruppertauthor=P.+R.+Griffinauthor=D.+D.+Muccioauthor=M.+B.+Renfrow&title=Defining+the+communication+between+agonist+and+coactivator+binding+in+the+retinoid+X+receptor+alpha+ligand+binding+domain&doi=10.1074%2Fjbc.M113.476861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding Domain</span></div><div class="casAuthors">Boerma, LeeAnn J.; Xia, Gang; Qui, Cheng; Cox, Bryan D.; Chalmers, Michael J.; Smith, Craig D.; Lobo-Ruppert, Susan; Griffin, Patrick R.; Muccio, Donald D.; Renfrow, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-826</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Retinoid X receptors (RXRs) are obligate partners for several other nuclear receptors, and they play a key role in several signaling processes.  Despite being a promiscuous heterodimer partner, this nuclear receptor is a target of therapeutic intervention through activation using selective RXR agonists (rexinoids).  Agonist binding to RXR initiates a large conformational change in the receptor that allows for coactivator recruitment to its surface and enhanced transcription.  Here we reveal the structural and dynamical changes produced when a coactivator peptide binds to the human RXRα ligand binding domain contg. two clin. relevant rexinoids, Targretin and 9-cis-UAB30.  Our results show that the structural changes are very similar for each rexinoid and similar to those for the pan-agonist 9-cis-retinoic acid.  The four structural changes involve key residues on helix 3, helix 4, and helix 11 that move from a solvent-exposed environment to one that interacts extensively with helix 12.  Hydrogen-deuterium exchange mass spectrometry reveals that the dynamics of helixes 3, 11, and 12 are significantly decreased when the two rexinoids are bound to the receptor.  When the pan-agonist 9-cis-retinoic acid is bound to the receptor, only the dynamics of helixes 3 and 11 are reduced.  The four structural changes are conserved in all x-ray structures of the RXR ligand-binding domain in the presence of agonist and coactivator peptide.  They serve as hallmarks for how RXR changes conformation and dynamics in the presence of agonist and coactivator to initiate signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt9u19MPXxk7Vg90H21EOLACvtfcHk0ljF9BE11Tf52g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFymtg%253D%253D&md5=b84926e04bb7b8850fca96b213fa0da8</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.476861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.476861%26sid%3Dliteratum%253Aachs%26aulast%3DBoerma%26aufirst%3DL.%2BJ.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DChalmers%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DLobo-Ruppert%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DMuccio%26aufirst%3DD.%2BD.%26aulast%3DRenfrow%26aufirst%3DM.%2BB.%26atitle%3DDefining%2520the%2520communication%2520between%2520agonist%2520and%2520coactivator%2520binding%2520in%2520the%2520retinoid%2520X%2520receptor%2520alpha%2520ligand%2520binding%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D814%26epage%3D826%26doi%3D10.1074%2Fjbc.M113.476861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandraratna, R. A.</span></span> <span> </span><span class="NLM_article-title">Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">S12</span>– <span class="NLM_lpage">S17</span>, <span class="refDoi"> DOI: 10.1016/S0190-9622(97)80395-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0190-9622%2897%2980395-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9270551" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=S12-S17&author=R.+A.+Chandraratna&title=Tazarotene%3A+the+first+receptor-selective+topical+retinoid+for+the+treatment+of+psoriasis&doi=10.1016%2FS0190-9622%2897%2980395-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0190-9622%2897%2980395-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0190-9622%252897%252980395-7%26sid%3Dliteratum%253Aachs%26aulast%3DChandraratna%26aufirst%3DR.%2BA.%26atitle%3DTazarotene%253A%2520the%2520first%2520receptor-selective%2520topical%2520retinoid%2520for%2520the%2520treatment%2520of%2520psoriasis%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D1997%26volume%3D37%26spage%3DS12%26epage%3DS17%26doi%3D10.1016%2FS0190-9622%2897%2980395-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojadinovic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzyzanowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vouthounis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic-Canic, M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-responsive transcriptional changes in epidermal keratinocytes</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1002/jcp.21784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fjcp.21784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19388012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2009&pages=427-439&author=D.+D.+Leeauthor=O.+Stojadinovicauthor=A.+Krzyzanowskaauthor=C.+Vouthounisauthor=M.+Blumenbergauthor=M.+Tomic-Canic&title=Retinoid-responsive+transcriptional+changes+in+epidermal+keratinocytes&doi=10.1002%2Fjcp.21784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-responsive transcriptional changes in epidermal keratinocytes</span></div><div class="casAuthors">Lee, Ding-Dar; Stojadinovic, Olivera; Krzyzanowska, Agata; Vouthounis, Constantinos; Blumenberg, Miroslav; Tomic-Canic, Marjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-439</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Retinoids (RA) have been used as therapeutic agents for numerous skin diseases, from psoriasis to acne and wrinkles.  While RA is known to inhibit keratinocyte differentiation, the mol. effects of RA in epidermis have not been comprehensively defined.  To identify the transcriptional targets of RA in primary human epidermal keratinocytes, we compared the transcriptional profiles of cells grown in the presence or absence of all-trans retinoic acid for 1, 4, 24, 48, and 72 h, using large DNA microarrays.  As expected, RA suppresses the protein markers of cornification; however the genes responsible for biosynthesis of epidermal lipids, long-chain fatty acids, cholesterol, and sphingolipids, are also suppressed.  Importantly, the pathways of RA synthesis, esterification and metab. are activated by RA; therefore, RA regulates its own bioavailability.  Unexpectedly, RA regulates many genes assocd. with the cell cycle and programmed cell death.  This led us to reveal novel effects of RA on keratinocyte proliferation and apoptosis.  The response to RA is very fast: 315 genes were regulated already after 1 h.  More than one-third of RA-regulated genes function in signal transduction and regulation of transcription.  Using in silico anal., we identified a set of over-represented transcription factor binding sites in the RA-regulated genes.  Many psoriasis-related genes are regulated by RA, some induced, others suppressed.  These results comprehensively document the transcriptional changes caused by RA in keratinocytes, add new insights into the mol. mechanism influenced by RA in the epidermis and demonstrate the hypothesis-generating power of DNA microarray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSnti3sNXZ5rVg90H21EOLACvtfcHk0ljF9BE11Tf52g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFags7g%253D&md5=ed59ef62de758688fe4e4d7eb44b56ad</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21784%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BD.%26aulast%3DStojadinovic%26aufirst%3DO.%26aulast%3DKrzyzanowska%26aufirst%3DA.%26aulast%3DVouthounis%26aufirst%3DC.%26aulast%3DBlumenberg%26aufirst%3DM.%26aulast%3DTomic-Canic%26aufirst%3DM.%26atitle%3DRetinoid-responsive%2520transcriptional%2520changes%2520in%2520epidermal%2520keratinocytes%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D220%26spage%3D427%26epage%3D439%26doi%3D10.1002%2Fjcp.21784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1038/nri2036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnri2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17290298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=191-201&author=C.+Rommelauthor=M.+Campsauthor=H.+Ji&title=PI3K+delta+and+PI3K+gamma%3A+partners+in+crime+in+inflammation+in+rheumatoid+arthritis+and+beyond%3F&doi=10.1038%2Fnri2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?</span></div><div class="casAuthors">Rommel, Christian; Camps, Montserrat; Ji, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-201</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated signal transduction in innate and adaptive immune cells is known to be assocd. with the development of various autoimmune and inflammatory diseases.  Consequently, targeting intracellular signaling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs.  Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signaling pathways that are known to have important roles in leukocytes.  In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, the authors discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSAduhwUrPrVg90H21EOLACvtfcHk0lg5q09_OHhxtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D&md5=2fdb3507d06ddf7d5485185f4573790f</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnri2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2036%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DPI3K%2520delta%2520and%2520PI3K%2520gamma%253A%2520partners%2520in%2520crime%2520in%2520inflammation%2520in%2520rheumatoid%2520arthritis%2520and%2520beyond%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D191%26epage%3D201%26doi%3D10.1038%2Fnri2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheguillaume, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krintel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel PI3-kinase delta specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5887</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1021/jm3003747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5887-5900&author=B.+S.+Safinaauthor=S.+Bakerauthor=M.+Baumgardnerauthor=P.+M.+Blaneyauthor=B.+K.+Chanauthor=Y.+H.+Chenauthor=M.+W.+Cartwrightauthor=G.+Castanedoauthor=C.+Chabotauthor=A.+J.+Cheguillaumeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=B.+Goyalauthor=T.+Hancoxauthor=R.+K.+Handaauthor=P.+S.+Iyerauthor=J.+Kaurauthor=R.+Kondruauthor=J.+R.+Kennyauthor=S.+L.+Krintelauthor=J.+Liauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=S.+Mukadamauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=F.+Padillaauthor=W.+S.+Palmerauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=P.+A.+Savyauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=S.+Tayauthor=P.+Tivitmahaisoonauthor=B.+Waszkowyczauthor=B.+Weiauthor=Q.+Yueauthor=C.+Zhangauthor=D.+P.+Sutherlin&title=Discovery+of+novel+PI3-kinase+delta+specific+inhibitors+for+the+treatment+of+rheumatoid+arthritis%3A+taming+CYP3A4+time-dependent+inhibition&doi=10.1021%2Fjm3003747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm3003747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003747%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DCartwright%26aufirst%3DM.%2BW.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCheguillaume%26aufirst%3DA.%2BJ.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DHanda%26aufirst%3DR.%2BK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSavy%26aufirst%3DP.%2BA.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520novel%2520PI3-kinase%2520delta%2520specific%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%253A%2520taming%2520CYP3A4%2520time-dependent%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5887%26epage%3D5900%26doi%3D10.1021%2Fjm3003747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nortey, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shank, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupsky, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortegon, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. enhanced potency with cyclic sulfate derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/jm970790w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970790w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1315-1343&author=B.+E.+Maryanoffauthor=M.+J.+Costanzoauthor=S.+O.+Norteyauthor=M.+N.+Grecoauthor=R.+P.+Shankauthor=J.+J.+Schupskyauthor=M.+P.+Ortegonauthor=J.+L.+Vaught&title=Structure-activity+studies+on+anticonvulsant+sugar+sulfamates+related+to+topiramate.+enhanced+potency+with+cyclic+sulfate+derivatives&doi=10.1021%2Fjm970790w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm970790w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970790w%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DNortey%26aufirst%3DS.%2BO.%26aulast%3DGreco%26aufirst%3DM.%2BN.%26aulast%3DShank%26aufirst%3DR.%2BP.%26aulast%3DSchupsky%26aufirst%3DJ.%2BJ.%26aulast%3DOrtegon%26aufirst%3DM.%2BP.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DStructure-activity%2520studies%2520on%2520anticonvulsant%2520sugar%2520sulfamates%2520related%2520to%2520topiramate.%2520enhanced%2520potency%2520with%2520cyclic%2520sulfate%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1315%26epage%3D1343%26doi%3D10.1021%2Fjm970790w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shytle, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanberg, P. R.</span></span> <span> </span><span class="NLM_article-title">Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine</span>. <i>Depression Anxiety</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1002/da.10035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fda.10035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=12415531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BD38nosVartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=89-92&author=R.+D.+Shytleauthor=A.+A.+Silverauthor=K.+H.+Sheehanauthor=D.+V.+Sheehanauthor=P.+R.+Sanberg&title=Neuronal+nicotinic+receptor+inhibition+for+treating+mood+disorders%3A+preliminary+controlled+evidence+with+mecamylamine&doi=10.1002%2Fda.10035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine</span></div><div class="casAuthors">Shytle R Douglas; Silver Archie A; Sheehan Kathy H; Sheehan David V; Sanberg Paul R</div><div class="citationInfo"><span class="NLM_cas:title">Depression and anxiety</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">89-92</span>
        ISSN:<span class="NLM_cas:issn">1091-4269</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTHvOKj69vImgRQsDqrjW_fW6udTcc2ebiKFZ0RlEWjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nosVartw%253D%253D&md5=adb0e0961e3acd56254767e706947e0e</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fda.10035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fda.10035%26sid%3Dliteratum%253Aachs%26aulast%3DShytle%26aufirst%3DR.%2BD.%26aulast%3DSilver%26aufirst%3DA.%2BA.%26aulast%3DSheehan%26aufirst%3DK.%2BH.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520inhibition%2520for%2520treating%2520mood%2520disorders%253A%2520preliminary%2520controlled%2520evidence%2520with%2520mecamylamine%26jtitle%3DDepression%2520Anxiety%26date%3D2002%26volume%3D16%26spage%3D89%26epage%3D92%26doi%3D10.1002%2Fda.10035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suchocki, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/jm00107a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00107a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1003-1010&author=J.%0AA.+Suchockiauthor=E.+L.+Mayauthor=T.+J.+Martinauthor=C.+Georgeauthor=B.+R.+Martin&title=Synthesis+of+2-exo-+and+2-endo-mecamylamine+analogues.+Structure-activity+relationships+for+nicotinic+antagonism+in+the+central+nervous+system&doi=10.1021%2Fjm00107a019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm00107a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00107a019%26sid%3Dliteratum%253Aachs%26aulast%3DSuchocki%26aufirst%3DJ.%2BA.%26aulast%3DMay%26aufirst%3DE.%2BL.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520of%25202-exo-%2520and%25202-endo-mecamylamine%2520analogues.%2520Structure-activity%2520relationships%2520for%2520nicotinic%2520antagonism%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1003%26epage%3D1010%26doi%3D10.1021%2Fjm00107a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">(S)-(+)-Mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1021/cn100070s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100070s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSju7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=530-531&author=C.+W.+Lindsley&title=%28S%29-%28%2B%29-Mecamylamine+%28TC-5214%29%3A+a+neuronal+nicotinic+receptor+modulator+enters+phase+III+trials+as+an+adjunct+treatment+for+major+depressive+disorder+%28MDD%29&doi=10.1021%2Fcn100070s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-(+)-Mecamylamine (TC-5214): A Neuronal Nicotinic Receptor Modulator Enters Phase III Trials as an Adjunct Treatment for Major Depressive Disorder (MDD)</span></div><div class="casAuthors">Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">530-531</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJhp0iwDmqrVg90H21EOLACvtfcHk0liQzfCxzZF5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSju7vL&md5=7eb9a45f1840c9b40db4ab6a5dbd4443</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fcn100070s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100070s%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3D%2528S%2529-%2528%252B%2529-Mecamylamine%2520%2528TC-5214%2529%253A%2520a%2520neuronal%2520nicotinic%2520receptor%2520modulator%2520enters%2520phase%2520III%2520trials%2520as%2520an%2520adjunct%2520treatment%2520for%2520major%2520depressive%2520disorder%2520%2528MDD%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D530%26epage%3D531%26doi%3D10.1021%2Fcn100070s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrasiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegla, M. T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of central nervous system agents. 5. effect of the hydrocarbon chain on the affinity of 4-substituted 1-(3-chlorophenyl)piperazines for 5-HT1A receptor site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2369</span>– <span class="NLM_lpage">2374</span>, <span class="refDoi"> DOI: 10.1021/jm00091a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00091a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2369-2374&author=J.+L.+Mokroszauthor=M.+Pietrasiewiczauthor=B.+Duszynskaauthor=M.+T.+Cegla&title=Structure-activity+relationship+studies+of+central+nervous+system+agents.+5.+effect+of+the+hydrocarbon+chain+on+the+affinity+of+4-substituted+1-%283-chlorophenyl%29piperazines+for+5-HT1A+receptor+site&doi=10.1021%2Fjm00091a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm00091a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00091a004%26sid%3Dliteratum%253Aachs%26aulast%3DMokrosz%26aufirst%3DJ.%2BL.%26aulast%3DPietrasiewicz%26aufirst%3DM.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DCegla%26aufirst%3DM.%2BT.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520central%2520nervous%2520system%2520agents.%25205.%2520effect%2520of%2520the%2520hydrocarbon%2520chain%2520on%2520the%2520affinity%2520of%25204-substituted%25201-%25283-chlorophenyl%2529piperazines%2520for%25205-HT1A%2520receptor%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2369%26epage%3D2374%26doi%3D10.1021%2Fjm00091a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strekowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of CNS agents. Part 14: structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=801-806&author=J.+L.+Mokroszauthor=L.+Strekowskiauthor=B.+Duszynskaauthor=D.+B.+Hardenauthor=M.+J.+Mokroszauthor=A.+J.+Bojarski&title=Structure-activity+relationship+studies+of+CNS+agents.+Part+14%3A+structural+requirements+for+the+5-HT1A+and+5-HT2A+receptor+selectivity+of+simple+1-%282-pyrimidinyl%29piperazine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMokrosz%26aufirst%3DJ.%2BL.%26aulast%3DStrekowski%26aufirst%3DL.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DHarden%26aufirst%3DD.%2BB.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520CNS%2520agents.%2520Part%252014%253A%2520structural%2520requirements%2520for%2520the%25205-HT1A%2520and%25205-HT2A%2520receptor%2520selectivity%2520of%2520simple%25201-%25282-pyrimidinyl%2529piperazine%2520derivatives%26jtitle%3DPharmazie%26date%3D1994%26volume%3D49%26spage%3D801%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paluchowska, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charakchieva-Minol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatarczynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klodzinska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chojnacka-Wojcik, E.</span></span> <span> </span><span class="NLM_article-title">Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmc.2004.11.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1195-1200&author=M.+H.+Paluchowskaauthor=R.+Bugnoauthor=A.+J.+Bojarskiauthor=S.+Charakchieva-Minolauthor=B.+Duszynskaauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=K.+Stachowiczauthor=E.+Chojnacka-Wojcik&title=Novel%2C+flexible%2C+and+conformationally+defined+analogs+of+gepirone%3A+synthesis+and+5-HT1A%2C+5-HT2A%2C+and+D2+receptor+activity&doi=10.1016%2Fj.bmc.2004.11.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DPaluchowska%26aufirst%3DM.%2BH.%26aulast%3DBugno%26aufirst%3DR.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DStachowicz%26aufirst%3DK.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DNovel%252C%2520flexible%252C%2520and%2520conformationally%2520defined%2520analogs%2520of%2520gepirone%253A%2520synthesis%2520and%25205-HT1A%252C%25205-HT2A%252C%2520and%2520D2%2520receptor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1195%26epage%3D1200%26doi%3D10.1016%2Fj.bmc.2004.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1017/S1461145712000661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1017%2FS1461145712000661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22827916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=445-458&author=J.+Bergmanauthor=R.+A.+Roofauthor=C.+A.+Furmanauthor=J.+L.+Conroyauthor=N.+K.+Melloauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Modification+of+cocaine+self-administration+by+buspirone+%28buspar%C2%AE%29%3A+potential+involvement+of+D3+and+D4+dopamine+receptors&doi=10.1017%2FS1461145712000661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors</span></div><div class="casAuthors">Bergman, Jack; Roof, Rebecca A.; Furman, Cheryse A.; Conroy, Jennie L.; Mello, Nancy K.; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence indicate that elevations in synaptic dopamine levels play a pivotal role in the reinforcing effects of cocaine, which are assocd. with its abuse liability.  This evidence has led to the exploration of dopamine receptor blockers as pharmacotherapy for cocaine addiction.  While neither D1 nor D2 receptor antagonists have proven effective, medications acting at two other potential targets, D3 and D4 receptors, have yet to be explored for this indication in the clinic.  Buspirone, a 5-HT1A partial agonist approved for the treatment of anxiety, has been reported to also bind with high affinity to D3 and D4 receptors.  In view of this biochem. profile, the present research was conducted to examine both the functional effects of buspirone on these receptors and, in non-human primates, its ability to modify the reinforcing effects of i.v. cocaine in a behaviorally selective manner.  Radioligand binding studies confirmed that buspirone binds with high affinity to recombinant human D3 and D4 receptors (∼98 and ∼29 nm resp.).  Live cell functional assays also revealed that buspirone, and its metabolites, function as antagonists at both D3 and D4 receptors.  In behavioral studies, doses of buspirone that had inconsistent effects on food-maintained responding (0.1 or 0.3 mg/kg i.m.) produced a marked downward shift in the dose-effect function for cocaine-maintained behavior, reflecting substantial decreases in self-administration of one or more unit doses of i.v. cocaine in each subject.  These results support the further evaluation of buspirone as a candidate medication for the management of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69I6VSGbSerVg90H21EOLACvtfcHk0lgOBZEl6-2EJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D&md5=977dd2218df7db5300b1e4c1865dafd9</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000661%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DModification%2520of%2520cocaine%2520self-administration%2520by%2520buspirone%2520%2528buspar%25C2%25AE%2529%253A%2520potential%2520involvement%2520of%2520D3%2520and%2520D4%2520dopamine%2520receptors%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D445%26epage%3D458%26doi%3D10.1017%2FS1461145712000661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skeggs, L. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumway, N. P.</span></span> <span> </span><span class="NLM_article-title">The preparation, purification, and amino acid sequence of a polypeptide renin substrate</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1084/jem.106.3.439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1084%2Fjem.106.3.439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=K.+Lentzauthor=N.+P.+Shumway&title=The+preparation%2C+purification%2C+and+amino+acid+sequence+of+a+polypeptide+renin+substrate&doi=10.1084%2Fjem.106.3.439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1084%2Fjem.106.3.439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.106.3.439%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%252C%2520purification%252C%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453%26doi%3D10.1084%2Fjem.106.3.439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goschke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigollier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgiarini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruetter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Novel 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4818</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/jm070314y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070314y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4818-4831&author=R.+Goschkeauthor=S.+Stutzauthor=V.+Rasettiauthor=N.+C.+Cohenauthor=J.+Rahuelauthor=P.+Rigollierauthor=H.+P.+Baumauthor=P.+Forgiariniauthor=C.+R.+Schnellauthor=T.+Wagnerauthor=M.+G.+Gruetterauthor=W.+Fuhrerauthor=W.+Schillingauthor=F.+Cuminauthor=J.+M.+Woodauthor=J.+Maibaum&title=Novel+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamide+transition+state+peptidomimetics+are+potent+and+orally+active+inhibitors+of+human+renin&doi=10.1021%2Fjm070314y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm070314y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070314y%26sid%3Dliteratum%253Aachs%26aulast%3DGoschke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DGruetter%26aufirst%3DM.%2BG.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DNovel%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamide%2520transition%2520state%2520peptidomimetics%2520are%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4818%26epage%3D4831%26doi%3D10.1021%2Fjm070314y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goschke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigollier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruetter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span> <span> </span><span class="NLM_article-title">Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4832</span>– <span class="NLM_lpage">4844</span>, <span class="refDoi"> DOI: 10.1021/jm070316i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4832-4844&author=J.+Maibaumauthor=S.+Stutzauthor=R.+Goschkeauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=J.+Rahuelauthor=H.+P.+Baumauthor=N.+C.+Cohenauthor=C.+R.+Schnellauthor=W.+Fuhrerauthor=M.+G.+Gruetterauthor=W.+Schillingauthor=J.+M.+Wood&title=Structural+modification+of+the+P2%E2%80%B2+position+of+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides%3A+the+discovery+of+aliskiren%2C+a+potent+nonpeptide+human+renin+inhibitor+active+after+once+daily+dosing+in+marmosets&doi=10.1021%2Fjm070316i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DGoschke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGruetter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520modification%2520of%2520the%2520P2%25E2%2580%25B2%2520position%2520of%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%253A%2520the%2520discovery%2520of%2520aliskiren%252C%2520a%2520potent%2520nonpeptide%2520human%2520renin%2520inhibitor%2520active%2520after%2520once%2520daily%2520dosing%2520in%2520marmosets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844%26doi%3D10.1021%2Fjm070316i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, A. K.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. side chain ester derivatives of mevinolin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1021/jm00155a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00155a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=849-852&author=W.+F.+Hoffmanauthor=A.+W.+Albertsauthor=P.+S.+Andersonauthor=J.+S.+Chenauthor=R.+L.+Smithauthor=A.+K.+Willard&title=3-Hydroxy-3-methylglutaryl-coenzyme+A+reductase+inhibitors.+4.+side+chain+ester+derivatives+of+mevinolin&doi=10.1021%2Fjm00155a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm00155a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00155a040%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26aulast%3DWillard%26aufirst%3DA.%2BK.%26atitle%3D3-Hydroxy-3-methylglutaryl-coenzyme%2520A%2520reductase%2520inhibitors.%25204.%2520side%2520chain%2520ester%2520derivatives%2520of%2520mevinolin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D849%26epage%3D852%26doi%3D10.1021%2Fjm00155a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deisenhofer, J.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism for statin inhibition of HMG-CoA reductase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">1160</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1126/science.1059344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1126%2Fscience.1059344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11349148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Cgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=1160-1164&author=E.+S.+Istvanauthor=J.+Deisenhofer&title=Structural+mechanism+for+statin+inhibition+of+HMG-CoA+reductase&doi=10.1126%2Fscience.1059344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for statin inhibition of HMG-CoA reductase</span></div><div class="casAuthors">Istvan, Eva S.; Deisenhofer, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5519</span>),
    <span class="NLM_cas:pages">1160-1164</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase (HMGR) catalyzes the committed step in cholesterol biosynthesis.  Statins are HMGR inhibitors with inhibition const. values in the nanomolar range that effectively lower serum cholesterol levels and are widely prescribed in the treatment of hypercholesterolemia.  We have detd. structures of the catalytic portion of human HMGR complexed with six different statins.  The statins occupy a portion of the binding site of HMG-CoA, thus blocking access of this substrate to the active site.  Near the carboxyl terminus of HMGR, several catalytically relevant residues are disordered in the enzyme-statin complexes.  If these residues were not flexible, they would sterically hinder statin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDsSOnK9675bVg90H21EOLACvtfcHk0lhRl7FyskcXDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Cgtbo%253D&md5=235644ee8cca3d2e061093e93bd1d702</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059344%26sid%3Dliteratum%253Aachs%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DDeisenhofer%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520statin%2520inhibition%2520of%2520HMG-CoA%2520reductase%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D1160%26epage%3D1164%26doi%3D10.1126%2Fscience.1059344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coldwell, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span> <span> </span><span class="NLM_article-title">Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. comparison with nicorandil</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3669</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(87)90017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0006-2952%2887%2990017-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=3663-3669&author=M.+C.+Coldwellauthor=D.+R.+Howlett&title=Specificity+of+action+of+the+novel+antihypertensive+agent%2C+BRL+34915%2C+as+a+potassium+channel+activator.+comparison+with+nicorandil&doi=10.1016%2F0006-2952%2887%2990017-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2887%2990017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252887%252990017-7%26sid%3Dliteratum%253Aachs%26aulast%3DColdwell%26aufirst%3DM.%2BC.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26atitle%3DSpecificity%2520of%2520action%2520of%2520the%2520novel%2520antihypertensive%2520agent%252C%2520BRL%252034915%252C%2520as%2520a%2520potassium%2520channel%2520activator.%2520comparison%2520with%2520nicorandil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1987%26volume%3D36%26spage%3D3663%26epage%3D3669%26doi%3D10.1016%2F0006-2952%2887%2990017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, A. H.</span></span> <span> </span><span class="NLM_article-title">Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1986.tb09476.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1476-5381.1986.tb09476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=3708211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL28XktVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1986&pages=103-111&author=T.+C.+Hamiltonauthor=S.+W.+Weirauthor=A.+H.+Weston&title=Comparison+of+the+effects+of+BRL+34915+and+verapamil+on+electrical+and+mechanical+activity+in+rat+portal+vein&doi=10.1111%2Fj.1476-5381.1986.tb09476.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein</span></div><div class="casAuthors">Hamilton, T. C.; Weir, Sheila W.; Weston, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-11</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The effects of the novel anti-hypertensive agent BRL 34915 (I)  [94470-67-4] were compared with those of verapamil  [52-53-9] on rat isolated portal vein.  I produced a concn.-dependent redn. in mech. responses to (-)-noradrenaline bitartrate  [51-40-1] monohydrate but had relatively little inhibitory effect on K+-induced contractions.  Verapamil reduced the magnitude of both noradrenaline and K+-induced mech. responses.  I delayed the appearance of the reduced noradrenaline contractions, a property not shared by verapamil.  I abolished spontaneous elec. and mech. discharges and hyperpolarized the portal vein cells close to their calcd. K equil. potential.  Verapamil inhibited spontaneous elec. and mech. discharges, effects assocd. with a small depolarization.  I produced a significant increase in the 86Rb efflux rate coeff., whereas verapamil was without effect on this parameter.  The inhibitory effects of I were rapid in onset and readily reversible by washing, whereas those of verapamil were slower in onset and only slowly reversible.  Thus, the inhibitory effects of I in rat portal vein are produced by the opening of K channels in the smooth muscle cells.  This inhibits spike activity and in sufficient concn. holds the membrane potential at or close to the K equil. potential, thereby reducing the effects of excitatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3lf_-z69xXbVg90H21EOLACvtfcHk0lhRl7FyskcXDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVSgtb4%253D&md5=bf1c1005520866e9a4a675fcb86ec1bf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb09476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb09476.x%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DWeir%26aufirst%3DS.%2BW.%26aulast%3DWeston%26aufirst%3DA.%2BH.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520BRL%252034915%2520and%2520verapamil%2520on%2520electrical%2520and%2520mechanical%2520activity%2520in%2520rat%2520portal%2520vein%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D88%26spage%3D103%26epage%3D111%26doi%3D10.1111%2Fj.1476-5381.1986.tb09476.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapham, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longman, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poyser, R. H.</span></span> <span> </span><span class="NLM_article-title">BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=798-804&author=R.+E.+Buckinghamauthor=J.+C.+Claphamauthor=T.+C.+Hamiltonauthor=S.+D.+Longmanauthor=J.+Nortonauthor=R.+H.+Poyser&title=BRL+34915%2C+a+novel+antihypertensive+agent%3A+comparison+of+effects+on+blood+pressure+and+other+haemodynamic+parameters+with+those+of+nifedipine+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DClapham%26aufirst%3DJ.%2BC.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DLongman%26aufirst%3DS.%2BD.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DPoyser%26aufirst%3DR.%2BH.%26atitle%3DBRL%252034915%252C%2520a%2520novel%2520antihypertensive%2520agent%253A%2520comparison%2520of%2520effects%2520on%2520blood%2520pressure%2520and%2520other%2520haemodynamic%2520parameters%2520with%2520those%2520of%2520nifedipine%2520in%2520animal%2520models%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1986%26volume%3D8%26spage%3D798%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faruk, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willcocks, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2194</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/jm00161a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2194-2201&author=V.+A.+Ashwoodauthor=R.+E.+Buckinghamauthor=F.+Cassidyauthor=J.+M.+Evansauthor=E.+A.+Farukauthor=T.+C.+Hamiltonauthor=D.+J.+Nashauthor=G.+Stempauthor=K.+Willcocks&title=Synthesis+and+antihypertensive+activity+of+4-%28cyclic+amido%29-2H-1-benzopyrans&doi=10.1021%2Fjm00161a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a011%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DJ.%2BM.%26aulast%3DFaruk%26aufirst%3DE.%2BA.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DNash%26aufirst%3DD.%2BJ.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DWillcocks%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%2528cyclic%2520amido%2529-2H-1-benzopyrans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D2194%26epage%3D2201%26doi%3D10.1021%2Fjm00161a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macphee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billheimer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothblat, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rader, D. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.105.560177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1161%2FCIRCULATIONAHA.105.560177" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=90-97&author=S.+U.+Naikauthor=X.+Wangauthor=J.+S.+Da+Silvaauthor=M.+Jayeauthor=C.+H.+Macpheeauthor=M.+P.+Reillyauthor=J.+T.+Billheimerauthor=G.+H.+Rothblatauthor=D.+J.+Rader&title=Pharmacological+activation+of+liver+X+receptors+promotes+reverse+cholesterol+transport+in+vivo&doi=10.1161%2FCIRCULATIONAHA.105.560177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.105.560177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.105.560177%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DS.%2BU.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDa%2BSilva%26aufirst%3DJ.%2BS.%26aulast%3DJaye%26aufirst%3DM.%26aulast%3DMacphee%26aufirst%3DC.%2BH.%26aulast%3DReilly%26aufirst%3DM.%2BP.%26aulast%3DBillheimer%26aufirst%3DJ.%2BT.%26aulast%3DRothblat%26aufirst%3DG.%2BH.%26aulast%3DRader%26aufirst%3DD.%2BJ.%26atitle%3DPharmacological%2520activation%2520of%2520liver%2520X%2520receptors%2520promotes%2520reverse%2520cholesterol%2520transport%2520in%2520vivo%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D90%26epage%3D97%26doi%3D10.1161%2FCIRCULATIONAHA.105.560177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repa, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwendner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoolen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span> <span> </span><span class="NLM_article-title">Role of LXRs in control of lipogenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1101/gad.850400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1101%2Fgad.850400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11090131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2831-2838&author=J.+R.+Schultzauthor=H.+Tuauthor=A.+Lukauthor=J.+J.+Repaauthor=J.+C.+Medinaauthor=L.+Liauthor=S.+Schwendnerauthor=S.+Wangauthor=M.+Thoolenauthor=D.+J.+Mangelsdorfauthor=K.+D.+Lustigauthor=B.+Shan&title=Role+of+LXRs+in+control+of+lipogenesis&doi=10.1101%2Fgad.850400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Role of LXRs in control of lipogenesis</span></div><div class="casAuthors">Schultz, Joshua R.; Tu, Hua; Luk, Alvin; Repa, Joyce J.; Medina, Julio C.; Li, Leping; Schwendner, Susan; Wang, Shelley; Thoolen, Martin; Mangelsdorf, David J.; Lustig, Kevin D.; Shan, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2831-2838</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metab.  The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiol. role of LXR.  Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species.  Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo890ssLC9jpLVg90H21EOLACvtfcHk0lgEiQQ5EJQyvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ehsLg%253D&md5=85a46e3313f736fe71de7c0da69f51c4</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1101%2Fgad.850400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.850400%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DJ.%2BR.%26aulast%3DTu%26aufirst%3DH.%26aulast%3DLuk%26aufirst%3DA.%26aulast%3DRepa%26aufirst%3DJ.%2BJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSchwendner%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DThoolen%26aufirst%3DM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26aulast%3DLustig%26aufirst%3DK.%2BD.%26aulast%3DShan%26aufirst%3DB.%26atitle%3DRole%2520of%2520LXRs%2520in%2520control%2520of%2520lipogenesis%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2831%26epage%3D2838%26doi%3D10.1101%2Fgad.850400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, P. S.</span></span> <span> </span><span class="NLM_article-title">Kinetic properties of the plasma membrane Na<sup>+</sup>-H<sup>+</sup> exchanger</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1146/annurev.ph.47.030185.002553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1146%2Fannurev.ph.47.030185.002553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1985&pages=545-560&author=P.+S.+Aronson&title=Kinetic+properties+of+the+plasma+membrane+Na%2B-H%2B+exchanger&doi=10.1146%2Fannurev.ph.47.030185.002553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ph.47.030185.002553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ph.47.030185.002553%26sid%3Dliteratum%253Aachs%26aulast%3DAronson%26aufirst%3DP.%2BS.%26atitle%3DKinetic%2520properties%2520of%2520the%2520plasma%2520membrane%2520Na%252B-H%252B%2520exchanger%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D1985%26volume%3D47%26spage%3D545%26epage%3D560%26doi%3D10.1146%2Fannurev.ph.47.030185.002553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoncu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efeyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">mTOR: from growth signal integration to cancer, diabetes and ageing</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nrm3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrm3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21157483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=21-35&author=R.+Zoncuauthor=A.+Efeyanauthor=D.+M.+Sabatini&title=mTOR%3A+from+growth+signal+integration+to+cancer%2C+diabetes+and+ageing&doi=10.1038%2Fnrm3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR: from growth signal integration to cancer, diabetes and ageing</span></div><div class="casAuthors">Zoncu, Roberto; Efeyan, Alejo; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors.  Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.  In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfHzFJues0NLVg90H21EOLACvtfcHk0lgEiQQ5EJQyvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK&md5=3631307dc34df2ecc2eb79900c10b74c</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrm3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3025%26sid%3Dliteratum%253Aachs%26aulast%3DZoncu%26aufirst%3DR.%26aulast%3DEfeyan%26aufirst%3DA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DmTOR%253A%2520from%2520growth%2520signal%2520integration%2520to%2520cancer%252C%2520diabetes%2520and%2520ageing%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D21%26epage%3D35%26doi%3D10.1038%2Fnrm3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span>; <span class="NLM_string-name">Cansfield, A.</span>; <span class="NLM_string-name">Niblock, H. S.</span>; <span class="NLM_string-name">Hardy, D.</span>; <span class="NLM_string-name">Scanlon, J. E.</span>; <span class="NLM_string-name">Adrego, R.</span>; <span class="NLM_string-name">Ramsden, N.</span></span> <span> </span><span class="NLM_article-title">4-Morpholin-4-yl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines and Related Compounds as mTOR Inhibitors and Their Preparation and Use for the Treatment of Diseases</span>. International Patent <span class="NLM_patent">WO2010/103094 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=R.+Lynch&author=A.+Cansfield&author=H.+S.+Niblock&author=D.+Hardy&author=J.+E.+Scanlon&author=R.+Adrego&author=N.+Ramsden&title=4-Morpholin-4-yl-6%2C7-dihydro-5H-pyrrolo%5B3%2C4-d%5Dpyrimidines+and+Related+Compounds+as+mTOR+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DR.%26atitle%3D4-Morpholin-4-yl-6%252C7-dihydro-5H-pyrrolo%255B3%252C4-d%255Dpyrimidines%2520and%2520Related%2520Compounds%2520as%2520mTOR%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span>; <span class="NLM_string-name">Cansfield, A.</span>; <span class="NLM_string-name">Niblock, H. S.</span>; <span class="NLM_string-name">Hardy, D.</span>; <span class="NLM_string-name">Taylor, J.</span></span> ((<span> </span><span class="NLM_article-title">Morpholinopyrimidinyl) phenyl) Urea Derivatives as mTOR Inhibitors and Their Preparation and Use for the Treatment of mTOR-Associated Diseases</span>. International Patent <span class="NLM_patent">WO2011/107585 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Lynch&author=A.+Cansfield&author=H.+S.+Niblock&author=D.+Hardy&author=J.+Taylor&title=Morpholinopyrimidinyl%29+phenyl%29+Urea+Derivatives+as+mTOR+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+mTOR-Associated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DR.%26atitle%3DMorpholinopyrimidinyl%2529%2520phenyl%2529%2520Urea%2520Derivatives%2520as%2520mTOR%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520mTOR-Associated%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladduwahetty, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruger, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feutrill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rausch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span> <span> </span><span class="NLM_article-title">CZ415, a highly selective mTOR inhibitor showing in vivo efficacy in a collagen induced arthritis model</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=768-773&author=A.+D.+Cansfieldauthor=T.+Ladduwahettyauthor=M.+Sunoseauthor=K.+Ellardauthor=R.+Lynchauthor=A.+L.+Newtonauthor=A.+Lewisauthor=G.+Bennettauthor=N.+Zinnauthor=D.+W.+Thomsonauthor=A.+J.+Rugerauthor=J.+T.+Feutrillauthor=O.+Rauschauthor=A.+P.+Wattauthor=G.+Bergamini&title=CZ415%2C+a+highly+selective+mTOR+inhibitor+showing+in+vivo+efficacy+in+a+collagen+induced+arthritis+model&doi=10.1021%2Facsmedchemlett.6b00149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model</span></div><div class="casAuthors">Cansfield, Andrew D.; Ladduwahetty, Tammy; Sunose, Mihiro; Ellard, Katie; Lynch, Rosemary; Newton, Anthea L.; Lewis, Ann; Bennett, Gavin; Zinn, Nico; Thomson, Douglas W.; Ruger, Anne J.; Feutrill, John T.; Rausch, Oliver; Watt, Alan P.; Bergamini, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">768-773</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CZ415, a potent ATP-competitive mTOR inhibitor with unprecedented selectivity over any other kinase is described.  In addn. to a comprehensive characterization of its activities in vitro, in vitro ADME, and in vivo pharmacokinetic data are reported.  The suitability of this inhibitor for studying in vivo mTOR biol. is demonstrated in a mechanistic mouse model monitoring mTOR proximal downstream phosphorylation signaling.  Furthermore, the compd. reported here is the first ATP-competitive mTOR inhibitor described to show efficacy in a semitherapeutic collagen induced arthritis (CIA) mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbe5cXmsLsLVg90H21EOLACvtfcHk0lj98iO4UcEScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mtr4%253D&md5=75b75c43427a76438e110251abd052b4</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00149%26sid%3Dliteratum%253Aachs%26aulast%3DCansfield%26aufirst%3DA.%2BD.%26aulast%3DLadduwahetty%26aufirst%3DT.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DA.%2BL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DG.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DRuger%26aufirst%3DA.%2BJ.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DRausch%26aufirst%3DO.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DBergamini%26aufirst%3DG.%26atitle%3DCZ415%252C%2520a%2520highly%2520selective%2520mTOR%2520inhibitor%2520showing%2520in%2520vivo%2520efficacy%2520in%2520a%2520collagen%2520induced%2520arthritis%2520model%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D768%26epage%3D773%26doi%3D10.1021%2Facsmedchemlett.6b00149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horuk, R.</span></span> <span> </span><span class="NLM_article-title">Targeting CCR1</span>. In  <i>Chemokine Receptors as Drug Targets</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span>, <span class="NLM_string-name">Lira, S. A.</span>, <span class="NLM_string-name">Leurs, R.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">338</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F9783527631995.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=323-338&author=R.+Horukauthor=M.+J.+Smit&author=S.+A.+Lira&author=R.+Leurs&title=Chemokine+Receptors+as+Drug+Targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2F9783527631995.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527631995.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DTargeting%2520CCR1%26btitle%3DChemokine%2520Receptors%2520as%2520Drug%2520Targets%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26pub%3DWiley-VCH%26date%3D2011%26spage%3D323%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santella, J. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncia, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kirk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briceno, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafstrom, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The discovery of BMS-457, a potent and selective CCR1 antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2013.04.079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3833-3840&author=D.+S.+Gardnerauthor=J.+B.+Santellaauthor=J.+V.+Dunciaauthor=P.+H.+Carterauthor=T.+G.+Dharauthor=H.+Wuauthor=W.+Guoauthor=C.+Cavallaroauthor=K.+Van+Kirkauthor=M.+Yardeauthor=S.+W.+Bricenoauthor=R.+R.+Grafstromauthor=R.+Liuauthor=S.+R.+Patelauthor=A.+J.+Tebbenauthor=D.+Camacauthor=J.+Khanauthor=A.+Watsonauthor=G.+Yangauthor=A.+Roseauthor=W.+R.+Fosterauthor=M.+E.+Cvijicauthor=P.+Daviesauthor=J.+Hynes&title=The+discovery+of+BMS-457%2C+a+potent+and+selective+CCR1+antagonist&doi=10.1016%2Fj.bmcl.2013.04.079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.079%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DD.%2BS.%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DCavallaro%26aufirst%3DC.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DBriceno%26aufirst%3DS.%2BW.%26aulast%3DGrafstrom%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DW.%2BR.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHynes%26aufirst%3DJ.%26atitle%3DThe%2520discovery%2520of%2520BMS-457%252C%2520a%2520potent%2520and%2520selective%2520CCR1%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3833%26epage%3D3840%26doi%3D10.1016%2Fj.bmcl.2013.04.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hedl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, C.</span></span> <span> </span><span class="NLM_article-title">Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">26440</span>– <span class="NLM_lpage">26449</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.237495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M111.237495" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=26440-26449&author=M.+Hedlauthor=C.+Abraham&title=Distinct+roles+for+Nod2+protein+and+autocrine+interleukin-1beta+in+muramyl+dipeptide-induced+mitogen-activated+protein+kinase+activation+and+cytokine+secretion+in+human+macrophages&doi=10.1074%2Fjbc.M111.237495"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237495%26sid%3Dliteratum%253Aachs%26aulast%3DHedl%26aufirst%3DM.%26aulast%3DAbraham%26aufirst%3DC.%26atitle%3DDistinct%2520roles%2520for%2520Nod2%2520protein%2520and%2520autocrine%2520interleukin-1beta%2520in%2520muramyl%2520dipeptide-induced%2520mitogen-activated%2520protein%2520kinase%2520activation%2520and%2520cytokine%2520secretion%2520in%2520human%2520macrophages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D26440%26epage%3D26449%26doi%3D10.1074%2Fjbc.M111.237495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, S.</span></span> <span> </span><span class="NLM_article-title">Convergent synthesis of novel muramyl dipeptide analogues: inhibition of <i>Porphyromonas gingivalis</i>-induced pro-inflammatory effects by high doses of muramyl dipeptide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6878</span>– <span class="NLM_lpage">6890</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00681</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00681" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6878-6890&author=B.+Caiauthor=J.+S.+Panekauthor=S.+Amar&title=Convergent+synthesis+of+novel+muramyl+dipeptide+analogues%3A+inhibition+of+Porphyromonas+gingivalis-induced+pro-inflammatory+effects+by+high+doses+of+muramyl+dipeptide&doi=10.1021%2Facs.jmedchem.6b00681"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00681%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DB.%26aulast%3DPanek%26aufirst%3DJ.%2BS.%26aulast%3DAmar%26aufirst%3DS.%26atitle%3DConvergent%2520synthesis%2520of%2520novel%2520muramyl%2520dipeptide%2520analogues%253A%2520inhibition%2520of%2520Porphyromonas%2520gingivalis-induced%2520pro-inflammatory%2520effects%2520by%2520high%2520doses%2520of%2520muramyl%2520dipeptide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6878%26epage%3D6890%26doi%3D10.1021%2Facs.jmedchem.6b00681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, A.</span></span> <span> </span><span class="NLM_article-title">Differential sensitivity to ITK kinase signals for T helper 2 cytokine production and chemokine-mediated migration</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3838</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.6.3833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.4049%2Fjimmunol.180.6.3833" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=3833-3838&author=N.+Sahuauthor=C.+Muellerauthor=A.+Fischerauthor=A.+August&title=Differential+sensitivity+to+ITK+kinase+signals+for+T+helper+2+cytokine+production+and+chemokine-mediated+migration&doi=10.4049%2Fjimmunol.180.6.3833"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.6.3833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.6.3833%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DDifferential%2520sensitivity%2520to%2520ITK%2520kinase%2520signals%2520for%2520T%2520helper%25202%2520cytokine%2520production%2520and%2520chemokine-mediated%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D3833%26epage%3D3838%26doi%3D10.4049%2Fjimmunol.180.6.3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookfield, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellebrandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKinnon, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span> <span> </span><span class="NLM_article-title">Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5714</span>– <span class="NLM_lpage">5727</span>, <span class="refDoi"> DOI: 10.1021/jm500550e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500550e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Srtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5714-5727&author=J.+D.+Burchauthor=K.+Lauauthor=J.+J.+Barkerauthor=F.+Brookfieldauthor=Y.+Chenauthor=Y.+Chenauthor=C.+Eigenbrotauthor=C.+Ellebrandtauthor=M.+H.+Ismailiauthor=A.+Johnsonauthor=D.+Kordtauthor=C.+H.+MacKinnonauthor=P.+A.+McEwanauthor=D.+F.+Ortwineauthor=D.+B.+Steinauthor=X.+Wangauthor=D.+Winklerauthor=P.+W.+Yuenauthor=Y.+Zhangauthor=A.+A.+Zarrinauthor=Z.+Pei&title=Property-+and+structure-guided+discovery+of+a+tetrahydroindazole+series+of+interleukin-2+inducible+T-cell+kinase+inhibitors&doi=10.1021%2Fjm500550e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors</span></div><div class="casAuthors">Burch, Jason D.; Lau, Kevin; Barker, John J.; Brookfield, Fred; Chen, Yong; Chen, Yuan; Eigenbrot, Charles; Ellebrandt, Claire; Ismaili, M. Hicham A.; Johnson, Adam; Kordt, Daniel; MacKinnon, Colin H.; McEwan, Paul A.; Ortwine, Daniel F.; Stein, Daniel B.; Wang, Xiaolu; Winkler, Dirk; Yuen, Po-Wai; Zhang, Yamin; Zarrin, Ali A.; Pei, Zhonghua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5714-5727</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays a major role in T-cell signaling downstream of the T-cell receptor (TCR), and considerable efforts have been directed toward discovery of ITK-selective inhibitors as potential treatments of inflammatory disorders such as asthma.  Using a previously disclosed indazole series of inhibitors as a starting point, and using x-ray crystallog. and soly. forecast index (SFI) as guides, we evolved a series of tetrahydroindazole inhibitors with improved potency, selectivity, and pharmaceutical properties.  Highlights include identification of a selectivity pocket above the ligand plane, and identification of appropriate lipophilic substituents to occupy this space.  This effort culminated in identification of a potent and selective ITK inhibitor (GNE-9822) with good ADME properties in preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdD-rop1z7rVg90H21EOLACvtfcHk0liJL2Yw0QLqDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Srtrs%253D&md5=636420d73f6ad55bf5391b6c6aeb3dbd</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm500550e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500550e%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBrookfield%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllebrandt%26aufirst%3DC.%26aulast%3DIsmaili%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKordt%26aufirst%3DD.%26aulast%3DMacKinnon%26aufirst%3DC.%2BH.%26aulast%3DMcEwan%26aufirst%3DP.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DStein%26aufirst%3DD.%2BB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZarrin%26aufirst%3DA.%2BA.%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DProperty-%2520and%2520structure-guided%2520discovery%2520of%2520a%2520tetrahydroindazole%2520series%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5714%26epage%3D5727%26doi%3D10.1021%2Fjm500550e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Torre, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24767842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2448-2452&author=R.+M.+Pastorauthor=J.+D.+Burchauthor=S.+Magnusonauthor=D.+F.+Ortwineauthor=Y.+Chenauthor=K.+De+La+Torreauthor=X.+Dingauthor=C.+Eigenbrotauthor=A.+Johnsonauthor=M.+Liimattaauthor=Y.+Liuauthor=S.+Shiaauthor=X.+Wangauthor=L.+C.+Wuauthor=Z.+Pei&title=Discovery+and+optimization+of+indazoles+as+potent+and+selective+interleukin-2+inducible+T+cell+kinase+%28ITK%29+inhibitors&doi=10.1016%2Fj.bmcl.2014.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors</span></div><div class="casAuthors">Pastor, Richard M.; Burch, Jason D.; Magnuson, Steven; Ortwine, Daniel F.; Chen, Yuan; De La Torre, Kelly; Ding, Xiao; Eigenbrot, Charles; Johnson, Adam; Liimatta, Marya; Liu, Yichin; Shia, Steven; Wang, Xiaolu; Wu, Lawren C.; Pei, Zhonghua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2448-2452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is evidence that small mol. inhibitors of the nonreceptor tyrosine kinase ITK, a component of the T-cell receptor signaling cascade, could represent a novel asthma therapeutic class.  Moreover, given the expected chronic dosing regimen of any asthma treatment, highly selective as well as potent inhibitors would be strongly preferred in any potential therapeutic.  Here the authors report hit-to-lead optimization of a series of indazoles, e.g. I [R = Et, HOCH2, Me2NCH2CH2, etc.] that demonstrate sub-nanomolar inhibitory potency against ITK with strong cellular activity and good kinase selectivity.  The authors also elucidate the binding mode of these inhibitors by solving the x-ray crystal structures of the complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFUTanEeKSybVg90H21EOLACvtfcHk0liJL2Yw0QLqDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWqsr8%253D&md5=e5dbbbfae256bcf2caae83e093f76c65</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520indazoles%2520as%2520potent%2520and%2520selective%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528ITK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2448%26epage%3D2452%26doi%3D10.1016%2Fj.bmcl.2014.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gosens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaagsma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halayko, A. J.</span></span> <span> </span><span class="NLM_article-title">Muscarinic receptor signaling in the pathophysiology of asthma and COPD</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">73</span>, <span class="refDoi"> DOI: 10.1186/1465-9921-7-73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1186%2F1465-9921-7-73" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16684353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BD28zmvVaqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=73&author=R.+Gosensauthor=J.+Zaagsmaauthor=H.+Meursauthor=A.+J.+Halayko&title=Muscarinic+receptor+signaling+in+the+pathophysiology+of+asthma+and+COPD&doi=10.1186%2F1465-9921-7-73"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor signaling in the pathophysiology of asthma and COPD</span></div><div class="casAuthors">Gosens Reinoud; Zaagsma Johan; Meurs Herman; Halayko Andrew J</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anticholinergics are widely used for the treatment of COPD, and to a lesser extent for asthma.  Primarily used as bronchodilators, they reverse the action of vagally derived acetylcholine on airway smooth muscle contraction.  Recent novel studies suggest that the effects of anticholinergics likely extend far beyond inducing bronchodilation, as the novel anticholinergic drug tiotropium bromide can effectively inhibit accelerated decline of lung function in COPD patients.  Vagal tone is increased in airway inflammation associated with asthma and COPD; this results from exaggerated acetylcholine release and enhanced expression of downstream signaling components in airway smooth muscle.  Vagally derived acetylcholine also regulates mucus production in the airways.  A number of recent research papers also indicate that acetylcholine, acting through muscarinic receptors, may in part regulate pathological changes associated with airway remodeling.  Muscarinic receptor signalling regulates airway smooth muscle thickening and differentiation, both in vitro and in vivo.  Furthermore, acetylcholine and its synthesizing enzyme, choline acetyl transferase (ChAT), are ubiquitously expressed throughout the airways.  Most notably epithelial cells and inflammatory cells generate acetylcholine, and express functional muscarinic receptors.  Interestingly, recent work indicates the expression and function of muscarinic receptors on neutrophils is increased in COPD.  Considering the potential broad role for endogenous acetylcholine in airway biology, this review summarizes established and novel aspects of muscarinic receptor signaling in relation to the pathophysiology and treatment of asthma and COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7JcCG51YgJwxyojvcjibhfW6udTcc2eYzCb3YneSaVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmvVaqsQ%253D%253D&md5=ec95fb19a9182fc8e1aa55b9e6ec1fbb</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-7-73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-7-73%26sid%3Dliteratum%253Aachs%26aulast%3DGosens%26aufirst%3DR.%26aulast%3DZaagsma%26aufirst%3DJ.%26aulast%3DMeurs%26aufirst%3DH.%26aulast%3DHalayko%26aufirst%3DA.%2BJ.%26atitle%3DMuscarinic%2520receptor%2520signaling%2520in%2520the%2520pathophysiology%2520of%2520asthma%2520and%2520COPD%26jtitle%3DRespir.%2520Res.%26date%3D2006%26volume%3D7%26spage%3D73%26doi%3D10.1186%2F1465-9921-7-73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entwistle, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel tertiary amine muscarinic M(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6888</span>– <span class="NLM_lpage">6904</span>, <span class="refDoi"> DOI: 10.1021/jm200884j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200884j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6888-6904&author=P.+A.+Glossopauthor=C.+A.+Watsonauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=D.+S.+Middletonauthor=A.+Woodauthor=K.+Jamesauthor=D.+Robertsauthor=R.+S.+Strangauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=N.+P.+Clarkeauthor=M.+A.+Trevethickauthor=I.+Machinauthor=E.+F.+Stuartauthor=S.+M.+Evansauthor=A.+C.+Harrisonauthor=D.+A.+Fairmanauthor=B.+Agoramauthor=J.+L.+Burrowsauthor=N.+Feederauthor=C.+K.+Fultonauthor=B.+R.+Dillonauthor=D.+A.+Entwistleauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+tertiary+amine+muscarinic+M%283%29+receptor+antagonists+with+slow+off-rate+binding+kinetics+for+inhaled+once-daily+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200884j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm200884j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200884j%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DMachin%26aufirst%3DI.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DEvans%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DAgoram%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DDillon%26aufirst%3DB.%2BR.%26aulast%3DEntwistle%26aufirst%3DD.%2BA.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520tertiary%2520amine%2520muscarinic%2520M%25283%2529%2520receptor%2520antagonists%2520with%2520slow%2520off-rate%2520binding%2520kinetics%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6888%26epage%3D6904%26doi%3D10.1021%2Fjm200884j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipworth, B. J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)17708-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0140-6736%2805%2917708-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=167-175&author=B.+J.+Lipworth&title=Phosphodiesterase-4+inhibitors+for+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1016%2FS0140-6736%2805%2917708-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2917708-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252917708-3%26sid%3Dliteratum%253Aachs%26aulast%3DLipworth%26aufirst%3DB.%2BJ.%26atitle%3DPhosphodiesterase-4%2520inhibitors%2520for%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D167%26epage%3D175%26doi%3D10.1016%2FS0140-6736%2805%2917708-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehnart, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrens, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belevych, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.cell.2005.07.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=25-35&author=S.+E.+Lehnartauthor=X.+H.+Wehrensauthor=S.+Reikenauthor=S.+Warrierauthor=A.+E.+Belevychauthor=R.+D.+Harveyauthor=W.+Richterauthor=S.+L.+Jinauthor=M.+Contiauthor=A.+R.+Marks&title=Phosphodiesterase+4D+deficiency+in+the+ryanodine-receptor+complex+promotes+heart+failure+and+arrhythmias&doi=10.1016%2Fj.cell.2005.07.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DLehnart%26aufirst%3DS.%2BE.%26aulast%3DWehrens%26aufirst%3DX.%2BH.%26aulast%3DReiken%26aufirst%3DS.%26aulast%3DWarrier%26aufirst%3DS.%26aulast%3DBelevych%26aufirst%3DA.%2BE.%26aulast%3DHarvey%26aufirst%3DR.%2BD.%26aulast%3DRichter%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%2BL.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DA.%2BR.%26atitle%3DPhosphodiesterase%25204D%2520deficiency%2520in%2520the%2520ryanodine-receptor%2520complex%2520promotes%2520heart%2520failure%2520and%2520arrhythmias%26jtitle%3DCell%26date%3D2005%26volume%3D123%26spage%3D25%26epage%3D35%26doi%3D10.1016%2Fj.cell.2005.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavalda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordoba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6912</span>– <span class="NLM_lpage">6922</span>, <span class="refDoi"> DOI: 10.1021/jm100524j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100524j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFehu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6912-6922&author=J.+Taltavullauthor=J.+Serratauthor=J.+Graciaauthor=A.+Gavaldaauthor=M.+Andresauthor=M.+Cordobaauthor=M.+Miralpeixauthor=D.+Vilellaauthor=J.+Beletaauthor=H.+Ryderauthor=L.+Pages&title=Synthesis+and+biological+activity+of+pyrido%5B3%E2%80%B2%2C2%E2%80%B2%3A4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidines+as+phosphodiesterase+type+4+inhibitors&doi=10.1021%2Fjm100524j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Activity of Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors</span></div><div class="casAuthors">Taltavull, Joan; Serrat, Jordi; Gracia, Jordi; Gavalda, Amadeu; Andres, Miriam; Cordoba, Monica; Miralpeix, Montserrat; Vilella, Dolors; Beleta, Jorge; Ryder, Hamish; Pages, Lluis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6912-6922</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines, e.g., I, were synthesized and tested as phosphodiesterase IV inhibitors (PDE4), a target for the treatment of asthma and chronic obstructive pulmonary disease.  Structure-activity relationships within this series, leading to an increase of potency on the enzyme, were presented.  The gem-dimethylcycloalkyl moiety fused to the pyridine ring proved to be a key element of the scaffold in order to get a higher affinity with the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXI_ZU_858PLVg90H21EOLACvtfcHk0livzCTgIxEcwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFehu7zE&md5=9c0901f43f7471f241a5636f7a39591b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm100524j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100524j%26sid%3Dliteratum%253Aachs%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DSerrat%26aufirst%3DJ.%26aulast%3DGracia%26aufirst%3DJ.%26aulast%3DGavalda%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DPages%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520pyrido%255B3%25E2%2580%25B2%252C2%25E2%2580%25B2%253A4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidines%2520as%2520phosphodiesterase%2520type%25204%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6912%26epage%3D6922%26doi%3D10.1021%2Fjm100524j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keysser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyszer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromme, D.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">2167</span>– <span class="NLM_lpage">2177</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63068-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0002-9440%2810%2963068-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11733367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2001&pages=2167-2177&author=W.+S.+Houauthor=Z.+Liauthor=R.+E.+Gordonauthor=K.+Chanauthor=M.+J.+Kleinauthor=R.+Levyauthor=M.+Keysserauthor=G.+Keyszerauthor=D.+Bromme&title=Cathepsin+K+is+a+critical+protease+in+synovial+fibroblast-mediated+collagen+degradation&doi=10.1016%2FS0002-9440%2810%2963068-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation</span></div><div class="casAuthors">Hou, Wu-Shiun; Li, Zhenqiang; Gordon, Ronald E.; Chan, Kyle; Klein, Michael J.; Levy, Roger; Keysser, Martin; Keyszer, Gernot; Bromme, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2167-2177</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Synovial fibroblasts (SFs) play a crit. role in the pathogenesis of rheumatoid arthritis (RA) and are directly involved in joint destruction.  Both SF-resident matrix metalloproteases and cathepsins have been implicated in cartilage degrdn. although their identities and individual contributions remain unclear.  The aims of this study were to investigate the expression of cathepsin K in SFs, the correlation between cathepsin K expression and disease severity, and the contribution of cathepsin K to fibroblast-mediated collagen degrdn.  Immunostaining of joint specimens of 21 patients revealed high expression of cathepsin K in SFs in the synovial lining and the stroma of synovial villi, and to a lesser extent in CD68-pos. cells of the synovial lining.  Cathepsin K-pos. SFs were consistently obsd. at sites of cartilage and bone degrdn.  Expression levels of cathepsin K in the sublining and vascularized areas of inflamed synovia showed a highly significant neg. correlation with results derived from the Hannover Functional Capacity Questionnaire (r = 0.78, P = 0.003; and r = 0.70, P = 0.012, resp.) as a measure of the severity of RA in individual patients.  For comparison, there was no correlation between Hannover Functional Capacity Questionnaire and cathepsin S whose expression is limited to CD-68-pos. macrophage-like synoviocytes.  The expression of cathepsin K was also demonstrated in primary cell cultures of RA-SFs.  Co-cultures of SFs on cartilage disks revealed the ability of fibroblast-like cells to phagocytose collagen fibrils whose intralysosomal hydrolysis was prevented in the presence of a potent cathepsin K inhibitor but not by an inhibitor effective against cathepsins L, B, and S.  The selective and crit. role of cathepsin K in articular cartilage and subchondral bone erosion was further corroborated by the finding that cathepsin K has a potent aggrecan-degrading activity and that cathepsin K-generated aggrecan cleavage products specifically potentiate the collagenolytic activity of cathepsin K toward type I and II collagens.  This study demonstrates for the first time a crit. role of cathepsin K in cartilage degrdn. by SFs in RA that is comparable to its well-known activity in osteoclasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlDcWxCV2YYrVg90H21EOLACvtfcHk0lg6vdEbDLEcuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslaqtQ%253D%253D&md5=63086f32fbd8dbc2d53cd9655dc47bfe</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963068-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963068-4%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGordon%26aufirst%3DR.%2BE.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DM.%2BJ.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DKeysser%26aufirst%3DM.%26aulast%3DKeyszer%26aufirst%3DG.%26aulast%3DBromme%26aufirst%3DD.%26atitle%3DCathepsin%2520K%2520is%2520a%2520critical%2520protease%2520in%2520synovial%2520fibroblast-mediated%2520collagen%2520degradation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D159%26spage%3D2167%26epage%3D2177%26doi%3D10.1016%2FS0002-9440%2810%2963068-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauret, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRiche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venuti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lg6vdEbDLEcuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J. M.</span></span> <span> </span><span class="NLM_article-title">Adenain, the adenovirus endoprotease (a review)</span>. <i>Acta Microbiol. Immunol. Hung.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1556/AMicr.50.2003.1.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1556%2FAMicr.50.2003.1.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=95-101&author=J.+M.+Weber&title=Adenain%2C+the+adenovirus+endoprotease+%28a+review%29&doi=10.1556%2FAMicr.50.2003.1.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1556%2FAMicr.50.2003.1.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1556%252FAMicr.50.2003.1.9%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DJ.%2BM.%26atitle%3DAdenain%252C%2520the%2520adenovirus%2520endoprotease%2520%2528a%2520review%2529%26jtitle%3DActa%2520Microbiol.%2520Immunol.%2520Hung.%26date%3D2003%26volume%3D50%26spage%3D95%26epage%3D101%26doi%3D10.1556%2FAMicr.50.2003.1.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greber, U. F.</span></span> <span> </span><span class="NLM_article-title">Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor</span>. <i>Rev. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-1654(1998100)8:4<213::AID-RMV225>3.0.CO;2-W</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10398510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Kgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=213-222&author=U.+F.+Greber&title=Virus+assembly+and+disassembly%3A+the+adenovirus+cysteine+protease+as+a+trigger+factor&doi=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor</span></div><div class="casAuthors">Greber, Urs F.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Medical Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">RMVIEW</span>;
        ISSN:<span class="NLM_cas:issn">1052-9276</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  Viruses are efficient carriers of genetic material between cells.  They specifically recognize a target cell and utilize host functions for genome delivery to the replication site.  A mature viral capsid emerging from an infected cell serves at least three distinct functions.  It enables virus egress from the infected cell, protects the extracellular genome against chem. and phys. stress and mediates virus entry into a non-infected cell.  How can a virus particle be stably assembled in an infected cell and moments later-after passing through the extracellular milieu-be disintegrated by a non-infected cell.  The author discusses how adenovirus, a DNA virus, recruits cellular and viral factors and makes use of its own cysteine protease to regulate capsid assembly and disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwF0ihoa137Vg90H21EOLACvtfcHk0ljkQVI3IGfeDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Kgug%253D%253D&md5=c3e5f8b97468d05a7f7d577c07a3bec2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1654%25281998100%25298%253A4%253C213%253A%253AAID-RMV225%253E3.0.CO%253B2-W%26sid%3Dliteratum%253Aachs%26aulast%3DGreber%26aufirst%3DU.%2BF.%26atitle%3DVirus%2520assembly%2520and%2520disassembly%253A%2520the%2520adenovirus%2520cysteine%2520protease%2520as%2520a%2520trigger%2520factor%26jtitle%3DRev.%2520Med.%2520Virol.%26date%3D1998%26volume%3D8%26spage%3D213%26epage%3D222%26doi%3D10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirockin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combrink, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarousse, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, E.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and optimization of potent inhibitors of the adenoviral protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.12.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=438-443&author=P.+Groscheauthor=F.+Sirockinauthor=A.+Mac+Sweeneyauthor=P.+Ramageauthor=P.+Erbelauthor=S.+Melkkoauthor=A.+Bernardiauthor=N.+Hughesauthor=D.+Ellisauthor=K.+D.+Combrinkauthor=N.+Jarousseauthor=E.+Altmann&title=Structure-based+design+and+optimization+of+potent+inhibitors+of+the+adenoviral+protease&doi=10.1016%2Fj.bmcl.2014.12.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGrosche%26aufirst%3DP.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DCombrink%26aufirst%3DK.%2BD.%26aulast%3DJarousse%26aufirst%3DN.%26aulast%3DAltmann%26aufirst%3DE.%26atitle%3DStructure-based%2520design%2520and%2520optimization%2520of%2520potent%2520inhibitors%2520of%2520the%2520adenoviral%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D438%26epage%3D443%26doi%3D10.1016%2Fj.bmcl.2014.12.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallongeville, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitersdorf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2088</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.98.19.2088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1161%2F01.CIR.98.19.2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9808609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=2088-2093&author=B.+Staelsauthor=J.+Dallongevilleauthor=J.+Auwerxauthor=K.+Schoonjansauthor=E.+Leitersdorfauthor=J.+C.+Fruchart&title=Mechanism+of+action+of+fibrates+on+lipid+and+lipoprotein+metabolism&doi=10.1161%2F01.CIR.98.19.2088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span></div><div class="casAuthors">Staels, Bart; Dallongeville, Jean; Auwerx, Johan; Schoonjans, Kristina; Leitersdorf, Eran; Fruchart, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2088-2093</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 78 refs.  Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually assocd. with a moderate decrease in LDL cholesterol and an increase in HDL cholesterol concns.  Recent investigations indicate that the effects of fibrates are mediated, at least in part, through alterations in transcription of genes encoding for proteins that control lipoprotein metab.  Fibrates activate specific transcription factors belonging to the nuclear hormone receptor superfamily, termed peroxisome proliferator-activated receptors (PPARs).  The PPAR-α form mediates fibrate action on HDL cholesterol levels via transcriptional induction of synthesis of the major HDL apolipoproteins, apoA-I and apoA-II.  Fibrates lower hepatic apoC-III prodn. and increase lipoprotein lipase-mediated lipolysis via PPAR.  Fibrates stimulate cellular fatty acid uptake, conversion to acyl-CoA derivs., and catabolism by the β-oxidn. pathways, which, combined with a redn. in fatty acid and triglyceride synthesis, results in a decrease in VLDL prodn.  In summary, both enhanced catabolism of triglyceride-rich particles and reduced secretion of VLDL underlie the hypotriglyceridemic effect of fibrates, whereas their effect on HDL metab. is assocd. with changes in HDL apolipoprotein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohY0hG-dzaaLVg90H21EOLACvtfcHk0ljC6B8prLtbmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D&md5=79c83a6524388cfa813c633fdbffc720</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.98.19.2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.98.19.2088%26sid%3Dliteratum%253Aachs%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDallongeville%26aufirst%3DJ.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DLeitersdorf%26aufirst%3DE.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26atitle%3DMechanism%2520of%2520action%2520of%2520fibrates%2520on%2520lipid%2520and%2520lipoprotein%2520metabolism%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D2088%26epage%3D2093%26doi%3D10.1161%2F01.CIR.98.19.2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorp, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, W. S.</span></span> <span> </span><span class="NLM_article-title">Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1038/194948a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2F194948a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1962&pages=948-949&author=J.+M.+Thorpauthor=W.+S.+Waring&title=Modification+of+metabolism+and+distribution+of+lipids+by+ethyl+chlorophenoxyisobutyrate&doi=10.1038%2F194948a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2F194948a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F194948a0%26sid%3Dliteratum%253Aachs%26aulast%3DThorp%26aufirst%3DJ.%2BM.%26aulast%3DWaring%26aufirst%3DW.%2BS.%26atitle%3DModification%2520of%2520metabolism%2520and%2520distribution%2520of%2520lipids%2520by%2520ethyl%2520chlorophenoxyisobutyrate%26jtitle%3DNature%26date%3D1962%26volume%3D194%26spage%3D948%26epage%3D949%26doi%3D10.1038%2F194948a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Salguero, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3022</span>, <span class="refDoi"> DOI: 10.1128/MCB.15.6.3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FMCB.15.6.3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=7539101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXlslyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3012-3022&author=S.+S.+Leeauthor=T.+Pineauauthor=J.+Dragoauthor=E.+J.+Leeauthor=J.+W.+Owensauthor=D.+L.+Kroetzauthor=P.+M.+Fernandez-Salgueroauthor=H.+Westphalauthor=F.+J.+Gonzalez&title=Targeted+disruption+of+the+alpha+isoform+of+the+peroxisome+proliferator-activated+receptor+gene+in+mice+results+in+abolishment+of+the+pleiotropic+effects+of+peroxisome+proliferators&doi=10.1128%2FMCB.15.6.3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators</span></div><div class="casAuthors">Lee, Susanna S.-T.; Pineau, Thierry; Drago, John; Lee, Eric J.; Owens, Jennie W.; Kroetz, Deanna L.; Fernandez-Salguero, Pedro M.; Westphal, Heiner; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3012-22</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To gain insight into the function of peroxisome proliferator-activated receptor (PPAR) isoforms in rodents, we disrupted the ligand-binding domain of the α isoform of mouse PPAR (mPPARα) by homologous recombination.  Mice homozygous for the mutation lack expression of mPPARα protein and yet are viable and fertile and exhibit no detectable gross phenotypic defects.  Remarkably, these animals do not display the peroxisome proliferator pleiotropic response when challenged with the classical peroxisome proliferators, clofibrate and Wy-14,643.  Following exposure to these chems., hepatomegaly, peroxisome proliferation, and transcriptional activation of target genes were not obsd.  These results clearly demonstrate that mPPARα is the major isoform required for mediating the pleiotropic response resulting from the actions of peroxisome proliferators.  MPPARα-deficient animals should prove useful to further investigate the role of this receptor in hepatocarcinogenesis, fatty acid metab., and cell cycle regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmuvZOaH07Vg90H21EOLACvtfcHk0li3Fs6nTo92TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslyit70%253D&md5=9a0485489134ea86cd92e3e1a7eb8431</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.6.3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.6.3012%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BS.%26aulast%3DPineau%26aufirst%3DT.%26aulast%3DDrago%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DOwens%26aufirst%3DJ.%2BW.%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26aulast%3DFernandez-Salguero%26aufirst%3DP.%2BM.%26aulast%3DWestphal%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520alpha%2520isoform%2520of%2520the%2520peroxisome%2520proliferator-activated%2520receptor%2520gene%2520in%2520mice%2520results%2520in%2520abolishment%2520of%2520the%2520pleiotropic%2520effects%2520of%2520peroxisome%2520proliferators%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D3012%26epage%3D3022%26doi%3D10.1128%2FMCB.15.6.3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzkies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, G.</span></span> <span> </span><span class="NLM_article-title">Procetofen, a new lipid- and urine-acid-reducing substance</span>. <i>Fortschr. Med.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1939</span>– <span class="NLM_lpage">1941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=700582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaE1M%252FisFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1978&pages=1939-1941&author=F.+Matzkiesauthor=D.+Schulzkyauthor=G.+Berg&title=Procetofen%2C+a+new+lipid-+and+urine-acid-reducing+substance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Procetofen, a new lipid- and urine-acid-reducing substance</span></div><div class="casAuthors">Matzkies F; Schulzky D; Berg G</div><div class="citationInfo"><span class="NLM_cas:title">Fortschritte der Medizin</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">1939-41</span>
        ISSN:<span class="NLM_cas:issn">0015-8178</span>.
    </div><div class="casAbstract">23 patients with different forms of hyperlipidemias received procetofen (3 X 100 mg/day) over a period of fourteen days.  The cholesterol concentration in blood showed a significant reduction from 322 +/- 30 mg/dl to 227 +/- 37 mg/dl, triglycerides dropped from 221 +/- 84 mg/dl to 129 +/- 34 mg/dl and uric acid diminished from 6,1 +/- 1,4 mg/dl to 4,6 +/- 0,8 mg/dl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ41fTQ3ZZ6EuWhZTslLrfffW6udTcc2eZBKjz2e99Xbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FisFyrsg%253D%253D&md5=3d1304a47ca8a8ff66e892e868fa93be</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatzkies%26aufirst%3DF.%26aulast%3DSchulzky%26aufirst%3DD.%26aulast%3DBerg%26aufirst%3DG.%26atitle%3DProcetofen%252C%2520a%2520new%2520lipid-%2520and%2520urine-acid-reducing%2520substance%26jtitle%3DFortschr.%2520Med.%26date%3D1978%26volume%3D96%26spage%3D1939%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creger, P.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moersch, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuklis, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of gemfibrozil (CI-719) and related compounds</span>. <i>Proc. R. Soc. Med.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1976&pages=3-5&issue=Suppl.+2&author=P.%0AL.+Cregerauthor=G.+W.+Moerschauthor=W.+A.+Neuklis&title=Structure-activity+relationship+of+gemfibrozil+%28CI-719%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreger%26aufirst%3DP.%2BL.%26aulast%3DMoersch%26aufirst%3DG.%2BW.%26aulast%3DNeuklis%26aufirst%3DW.%2BA.%26atitle%3DStructure-activity%2520relationship%2520of%2520gemfibrozil%2520%2528CI-719%2529%2520and%2520related%2520compounds%26jtitle%3DProc.%2520R.%2520Soc.%2520Med.%26date%3D1976%26volume%3D69%26issue%3DSuppl.%25202%26spage%3D3%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forest, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellibert, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laroze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Grumelec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linget, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfornis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pianetti, P. M.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. discovery of a novel series of potent HDLc raising agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/jm058056x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058056x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=685-695&author=M.+L.+Sierraauthor=V.+Benetonauthor=A.+B.+Boullayauthor=T.+Boyerauthor=A.+G.+Brewsterauthor=F.+Doncheauthor=M.+C.+Forestauthor=M.+H.+Fouchetauthor=F.+J.+Gellibertauthor=D.+A.+Grillotauthor=M.+H.+Lambertauthor=A.+Larozeauthor=C.+Le+Grumelecauthor=J.+M.+Lingetauthor=V.+G.+Montanaauthor=V.+L.+Nguyenauthor=E.+Nicodemeauthor=V.+Patelauthor=A.+Penfornisauthor=O.+Pineauauthor=D.+Pohinauthor=F.+Potvainauthor=G.+Poulainauthor=C.+B.+Ruaultauthor=M.+Saundersauthor=J.+Toumauthor=H.+E.+Xuauthor=R.+X.+Xuauthor=P.+M.+Pianetti&title=Substituted+2-%5B%284-aminomethyl%29phenoxy%5D-2-methylpropionic+acid+PPARalpha+agonists.+1.+discovery+of+a+novel+series+of+potent+HDLc+raising+agents&doi=10.1021%2Fjm058056x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents</span></div><div class="casAuthors">Sierra, Michael L.; Beneton, Veronique; Boullay, Anne-Benedict; Boyer, Thierry; Brewster, Andrew G.; Donche, Frederic; Forest, Marie-Claire; Fouchet, Marie-Helene; Gellibert, Francoise J.; Grillot, Didier A.; Lambert, Millard H.; Laroze, Alain; Le Grumelec, Christelle; Linget, Jean Michel; Montana, Valerie G.; Nguyen, Van-Loc; Nicodeme, Edwige; Patel, Vipul; Penfornis, Annie; Pineau, Olivier; Pohin, Danig; Potvain, Florent; Poulain, Geraldine; Ruault, Cecile Bertho; Saunders, Michael; Toum, Jerome; Xu, H. Eric; Xu, Robert X.; Pianetti, Pascal M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peroxisome proliferator activated receptors PPARα, PPARγ, and PPARδ are ligand-activated transcription factors that play a key role in lipid homeostasis.  The fibrates raise circulating levels of high-d. lipoprotein cholesterol and lower levels of triglycerides in part through their activity as PPARα agonists; however, the low potency and restricted selectivity of the fibrates may limit their efficacy, and it would be desirable to develop more potent and selective PPARα agonists.  Modification of the selective PPARδ agonist 1 (GW501516) so as to incorporate the 2-aryl-2-methylpropionic acid group of the fibrates led to a marked shift in potency and selectivity toward PPARα agonism.  Optimization of the series gave 25a, which shows EC50 = 4 nM on PPARα and at least 500-fold selectivity vs. PPARδ and PPARγ.  Compd. 25a (GW590735) has been progressed to clin. trials for the treatment of diseases of lipid imbalance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPdGikEnfYWrVg90H21EOLACvtfcHk0lgVDeHP010Qzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wgtw%253D%253D&md5=6ee61f7619db5025c20ff2ff83c7ba71</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm058056x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058056x%26sid%3Dliteratum%253Aachs%26aulast%3DSierra%26aufirst%3DM.%2BL.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoyer%26aufirst%3DT.%26aulast%3DBrewster%26aufirst%3DA.%2BG.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DForest%26aufirst%3DM.%2BC.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DGrillot%26aufirst%3DD.%2BA.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DLaroze%26aufirst%3DA.%26aulast%3DLe%2BGrumelec%26aufirst%3DC.%26aulast%3DLinget%26aufirst%3DJ.%2BM.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DPenfornis%26aufirst%3DA.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DPohin%26aufirst%3DD.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DRuault%26aufirst%3DC.%2BB.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DXu%26aufirst%3DR.%2BX.%26aulast%3DPianetti%26aufirst%3DP.%2BM.%26atitle%3DSubstituted%25202-%255B%25284-aminomethyl%2529phenoxy%255D-2-methylpropionic%2520acid%2520PPARalpha%2520agonists.%25201.%2520discovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520HDLc%2520raising%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D685%26epage%3D695%26doi%3D10.1021%2Fjm058056x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS1097-2765%2800%2980467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10198642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=397-403&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=J.+M.+Lehmannauthor=G.+B.+Wiselyauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+V.+Milburn&title=Molecular+recognition+of+fatty+acids+by+peroxisome+proliferator-activated+receptors&doi=10.1016%2FS1097-2765%2800%2980467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Parks, Derek J.; Blanchard, Steven G.; Brown, Peter J.; Sternbach, Daniel D.; Lehmann, Jurgen M.; Wisely, G. Bruce; Willson, Timothy M.; Kliewer, Steven A.; Milburn, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids (FAs) that regulate glucose and lipid homeostasis.  We report the crystal structure of the PPARδ ligand-binding domain (LBD) bound to either the FA eicosapentaenoic acid (EPA) or the synthetic fibrate GW2433.  The carboxylic acids of EPA and GW2433 interact directly with the activation function 2 (AF-2) helix.  The hydrophobic tail of EPA adopts two distinct conformations within the large hydrophobic cavity.  GW2433 occupies essentially the same space as EPA bound in both conformations.  These structures provide mol. insight into the propensity for PPARs to interact with a variety of synthetic and natural compds., including FAs that vary in both chain length and degree of satn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMNTuvvB2z5LVg90H21EOLACvtfcHk0lgVDeHP010Qzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D&md5=890b5f9178bbe6ceb4959a069889fc5c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26atitle%3DMolecular%2520recognition%2520of%2520fatty%2520acids%2520by%2520peroxisome%2520proliferator-activated%2520receptors%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D3%26spage%3D397%26epage%3D403%26doi%3D10.1016%2FS1097-2765%2800%2980467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charo, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, L. A.</span></span> <span> </span><span class="NLM_article-title">The platelet membrane glycoprotein IIb-IIIa complex</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1988&pages=831-843&author=D.+R.+Phillipsauthor=I.+F.+Charoauthor=L.+V.+Pariseauthor=L.+A.+Fitzgerald&title=The+platelet+membrane+glycoprotein+IIb-IIIa+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DParise%26aufirst%3DL.%2BV.%26aulast%3DFitzgerald%26aufirst%3DL.%2BA.%26atitle%3DThe%2520platelet%2520membrane%2520glycoprotein%2520IIb-IIIa%2520complex%26jtitle%3DBlood%26date%3D1988%26volume%3D71%26spage%3D831%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tachiki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asari, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span> <span> </span><span class="NLM_article-title">GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2345</span>– <span class="NLM_lpage">2360</span>, <span class="refDoi"> DOI: 10.1021/jm980126v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980126v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2345-2360&author=Y.+Hayashiauthor=J.+Katadaauthor=T.+Haradaauthor=A.+Tachikiauthor=K.+Iijimaauthor=Y.+Takiguchiauthor=M.+Muramatsuauthor=H.+Miyazakiauthor=T.+Asariauthor=T.+Okazakiauthor=Y.+Satoauthor=E.+Yasudaauthor=M.+Yanoauthor=I.+Unoauthor=I.+Ojima&title=GPIIb%2FIIIa+integrin+antagonists+with+the+new+conformational+restriction+unit%2C+trisubstituted+beta-amino+acid+derivatives%2C+and+a+substituted+benzamidine+structure&doi=10.1021%2Fjm980126v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm980126v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980126v%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKatada%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DTachiki%26aufirst%3DA.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DTakiguchi%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DAsari%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DM.%26aulast%3DUno%26aufirst%3DI.%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DGPIIb%252FIIIa%2520integrin%2520antagonists%2520with%2520the%2520new%2520conformational%2520restriction%2520unit%252C%2520trisubstituted%2520beta-amino%2520acid%2520derivatives%252C%2520and%2520a%2520substituted%2520benzamidine%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2345%26epage%3D2360%26doi%3D10.1021%2Fjm980126v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E.</span></span> <span> </span><span class="NLM_article-title">Cationic host defense (antimicrobial) peptides</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.coi.2005.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.coi.2005.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16337365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=24-30&author=K.+L.+Brownauthor=R.+E.+Hancock&title=Cationic+host+defense+%28antimicrobial%29+peptides&doi=10.1016%2Fj.coi.2005.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic host defense (antimicrobial) peptides</span></div><div class="casAuthors">Brown, Kelly L.; Hancock, Robert EW</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-30</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the cationic host defense (antimicrobial) peptide family are widely distributed in nature, existing in organisms from insects to plants to mammals and non-mammalian vertebrates.  Although many demonstrate direct antimicrobial activity against bacteria, fungi, eukaryotic parasites and/or viruses, it has been established that cationic peptides have a key modulatory role in the innate immune response.  More recent evidence suggests that host defense peptides are effective adjuvants, are synergistic with other immune effectors, polarize the adaptive response, and support wound healing.  In addn., the mechanisms of action are being unraveled, which support more effective implementation of derivs. of these endogenous peptides as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqD-PAvdCM7Vg90H21EOLACvtfcHk0lgo_pQgMYcQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOhtQ%253D%253D&md5=a1634204d5a2b5ea3c6170ece8268ef6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2005.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2005.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%2BL.%26aulast%3DHancock%26aufirst%3DR.%2BE.%26atitle%3DCationic%2520host%2520defense%2520%2528antimicrobial%2529%2520peptides%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2006%26volume%3D18%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.coi.2005.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bally, M. B.</span></span> <span> </span><span class="NLM_article-title">In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and P-glycoprotein over-expressing tumor cell lines</span>. <i>Anti-Cancer Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10901303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=151-160&author=S.+A.+Johnstoneauthor=K.+Gelmonauthor=L.+D.+Mayerauthor=R.+E.+Hancockauthor=M.+B.+Bally&title=In+vitro+characterization+of+the+anticancer+activity+of+membrane-active+cationic+peptides.+I.+peptide-mediated+cytotoxicity+and+peptide-enhanced+cytotoxic+activity+of+doxorubicin+against+wild-type+and+P-glycoprotein+over-expressing+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines</span></div><div class="casAuthors">Johnstone, Sharon A.; Gelmon, Karen; Mayer, Lawrence D.; Hancock, Robert E.; Bally, Marcel B.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cationic amphipathic peptides, such as the defensins and cecropins, induce cell death in prokaryotic and eukaryotic cells by increasing membrane permeability.  Increased permeability may lead to cell lysis or, alternatively, may produce subtle changes in the membrane's barrier function that promote cell death.  The in vitro cytotoxic and lytic activity of short mammalian-derived extended-helical cationic peptides and insect-derived alpha-helical peptides was measured in this study with the objective of establishing the anticancer potential of these agents.  Two specific aims were addressed: (i) to assess the activity of peptides against non-malignant cells (sheep erythrocytes and human umbilical vein endothelial cells) vs. tumor cells; and (ii) to characterize the cytotoxic activity using multidrug-resistant tumor cell lines in the presence and absence of the anthracycline doxorubicin.  Cell lysis assays demonstrated that the lytic activity of the peptides tested was 2->50 times more cytotoxic to tumor cells than to non-malignant cells.  Further, the cytotoxic activity of these peptides was equiv. when tested against sensitive and multidrug-resistant cell lines.  In addn. to their inherent cytotoxic activity, these membrane-active peptides can also augment the in vitro cytotoxic activity of doxorubicin against multidrug-resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7mmlTM9IH7Vg90H21EOLACvtfcHk0lgSrRAR0EBGDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVymsb4%253D&md5=da07329282b9fa4418273bcb2cfefacd</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DS.%2BA.%26aulast%3DGelmon%26aufirst%3DK.%26aulast%3DMayer%26aufirst%3DL.%2BD.%26aulast%3DHancock%26aufirst%3DR.%2BE.%26aulast%3DBally%26aufirst%3DM.%2BB.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520the%2520anticancer%2520activity%2520of%2520membrane-active%2520cationic%2520peptides.%2520I.%2520peptide-mediated%2520cytotoxicity%2520and%2520peptide-enhanced%2520cytotoxic%2520activity%2520of%2520doxorubicin%2520against%2520wild-type%2520and%2520P-glycoprotein%2520over-expressing%2520tumor%2520cell%2520lines%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2000%26volume%3D15%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karle, I. L.</span></span> <span> </span><span class="NLM_article-title">Flexibility in peptide molecules and restraints imposed by hydrogen bonds, the Aib residue, and core inserts</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(1996)40:1<157::AID-BIP7>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=157-180&author=I.+L.+Karle&title=Flexibility+in+peptide+molecules+and+restraints+imposed+by+hydrogen+bonds%2C+the+Aib+residue%2C+and+core+inserts&doi=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%25281996%252940%253A1%253C157%253A%253AAID-BIP7%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DKarle%26aufirst%3DI.%2BL.%26atitle%3DFlexibility%2520in%2520peptide%2520molecules%2520and%2520restraints%2520imposed%2520by%2520hydrogen%2520bonds%252C%2520the%2520Aib%2520residue%252C%2520and%2520core%2520inserts%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D40%26spage%3D157%26epage%3D180%26doi%3D10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karle, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaram, P.</span></span> <span> </span><span class="NLM_article-title">Structural characteristics of alpha-helical peptide molecules containing Aib residues</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">6747</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/bi00481a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00481a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3cXksFCnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=6747-6756&author=I.+L.+Karleauthor=P.+Balaram&title=Structural+characteristics+of+alpha-helical+peptide+molecules+containing+Aib+residues&doi=10.1021%2Fbi00481a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characteristics of α-helical peptide molecules containing Aib residues</span></div><div class="casAuthors">Karle, Isabella L.; Balaram, Padmanabhan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6747-56</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A review and discussion with 45 refs.  α-Aminoisobutyric acid (Aib) is a common residue in microbial proteins.  Replacement of the proton on the Cα atom of alanine with a Me group severely restricts the possible rotations about the N-Cα and Cα-C bonds.  Aib readily fits into right- and left-handed α and 310 helixes and stabilizes helical peptide conformation; thus, Aib is useful for construction of stereochem. rigid helical segments.  The effects of Aib residue no. and position on helix formation, hydrogen bonding, and water of hydration in Aib-contg. helical peptides are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-mpabYAClhLVg90H21EOLACvtfcHk0lgSrRAR0EBGDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFCnsr4%253D&md5=544835633a23c2fb27572c10be14c114</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fbi00481a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00481a001%26sid%3Dliteratum%253Aachs%26aulast%3DKarle%26aufirst%3DI.%2BL.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DStructural%2520characteristics%2520of%2520alpha-helical%2520peptide%2520molecules%2520containing%2520Aib%2520residues%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D6747%26epage%3D6756%26doi%3D10.1021%2Fbi00481a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formaggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaptein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broxterman, Q. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniolo, C.</span></span> <span> </span><span class="NLM_article-title">Turn stabilization in short peptides by C(alpha)-methylated alpha-amino acids</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1002/bip.20181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fbip.20181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=279-293&author=M.+Crismaauthor=A.+Morettoauthor=M.+De+Zottiauthor=F.+Formaggioauthor=B.+Kapteinauthor=Q.+B.+Broxtermanauthor=C.+Toniolo&title=Turn+stabilization+in+short+peptides+by+C%28alpha%29-methylated+alpha-amino+acids&doi=10.1002%2Fbip.20181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fbip.20181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20181%26sid%3Dliteratum%253Aachs%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DMoretto%26aufirst%3DA.%26aulast%3DDe%2BZotti%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DKaptein%26aufirst%3DB.%26aulast%3DBroxterman%26aufirst%3DQ.%2BB.%26aulast%3DToniolo%26aufirst%3DC.%26atitle%3DTurn%2520stabilization%2520in%2520short%2520peptides%2520by%2520C%2528alpha%2529-methylated%2520alpha-amino%2520acids%26jtitle%3DBiopolymers%26date%3D2005%26volume%3D80%26spage%3D279%26epage%3D293%26doi%3D10.1002%2Fbip.20181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drory, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunger, A. T.</span></span> <span> </span><span class="NLM_article-title">Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e11378</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0011378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1371%2Fjournal.pone.0011378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e11378&author=J.+E.+Zunigaauthor=J.+T.+Hammillauthor=O.+Droryauthor=J.+E.+Nussauthor=J.+C.+Burnettauthor=R.+Gussioauthor=P.+Wipfauthor=S.+Bavariauthor=A.+T.+Brunger&title=Iterative+structure-based+peptide-like+inhibitor+design+against+the+botulinum+neurotoxin+serotype+A&doi=10.1371%2Fjournal.pone.0011378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011378%26sid%3Dliteratum%253Aachs%26aulast%3DZuniga%26aufirst%3DJ.%2BE.%26aulast%3DHammill%26aufirst%3DJ.%2BT.%26aulast%3DDrory%26aufirst%3DO.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26atitle%3DIterative%2520structure-based%2520peptide-like%2520inhibitor%2520design%2520against%2520the%2520botulinum%2520neurotoxin%2520serotype%2520A%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De11378%26doi%3D10.1371%2Fjournal.pone.0011378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: hit to lead optimization of new antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5116</span>– <span class="NLM_lpage">5130</span>, <span class="refDoi"> DOI: 10.1021/jm2003359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5116-5130&author=T.+Wuauthor=A.+Nagleauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=A.+Gohauthor=S.+B.+Lakshminarayanaauthor=J.+Wuauthor=H.+Q.+Angauthor=P.+Zengauthor=M.+L.+Kangauthor=W.+Tanauthor=M.+Tanauthor=N.+Yeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=C.+Fischliauthor=R.+Brunauthor=M.+Rottmannauthor=V.+Dartoisauthor=T.+Kellerauthor=T.+Diaganaauthor=E.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+hit+to+lead+optimization+of+new+antimalarial+agents&doi=10.1021%2Fjm2003359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents</span></div><div class="casAuthors">Wu, Tao; Nagle, Advait; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Goh, Anne; Lakshminarayana, Suresh B.; Wu, Jeanette; Ang, Hui Qing; Zeng, Peiting; Kang, Min Low; Tan, William; Tan, Maria; Ye, Nicole; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Fischli, Christoph; Brun, Reto; Rottmann, Matthias; Dartois, Veronique; Keller, Thomas; Diagana, Thierry; Winzeler, Elizabeth; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5116-5130</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from a hit series from a GNF compd. library collection and based on a cell-based proliferation assay of Plasmodium falciparum, a novel imidazolopiperazine scaffold was optimized.  SAR for this series of compds. is discussed, focusing on optimization of cellular potency against wild-type and drug resistant parasites and improvement of physiochem. and pharmacokinetic properties.  The lead compds. in this series showed good potencies in vitro and decent oral exposure levels in vivo.  In a Plasmodium berghei mouse infection model, one lead compd. lowered the parasitemia level by 99.4% after administration of 100 mg/kg single oral dose and prolonged mice survival by an av. of 17.0 days.  The lead compds. were also well-tolerated in the preliminary in vitro toxicity studies and represents an interesting lead for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaD1QipkA-QLVg90H21EOLACvtfcHk0lhM0SBnYZx8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D&md5=eab02c18fda60302ffbcc581256cf149</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm2003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DH.%2BQ.%26aulast%3DZeng%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520hit%2520to%2520lead%2520optimization%2520of%2520new%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5116%26epage%3D5130%26doi%3D10.1021%2Fjm2003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: lead optimization of the second-generation antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4244</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/jm300041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4244-4273&author=A.+Nagleauthor=T.+Wuauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=B.+Liuauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=T.+Chuanauthor=P.+B.+Alperauthor=C.+Fischliauthor=R.+Brunauthor=S.+B.+Lakshminarayanaauthor=M.+Rottmannauthor=T.+T.+Diaganaauthor=E.+A.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+lead+optimization+of+the+second-generation+antimalarial+agents&doi=10.1021%2Fjm300041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents</span></div><div class="casAuthors">Nagle, Advait; Wu, Tao; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Liu, Bo; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Chuan, Tiffany; Alper, Philip B.; Fischli, Christoph; Brun, Reto; Lakshminarayana, Suresh B.; Rottmann, Matthias; Diagana, Thierry T.; Winzeler, Elizabeth A.; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4244-4273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the initial success of optimization of a novel series of imidazolopiperazines, a second generation of compds. involving changes in the core piperazine ring was synthesized to improve antimalarial properties.  These changes were carried out to further improve the potency and metabolic stability of the compds. by leveraging the outcome of a set of in vitro metabolic identification studies.  The optimized 8,8-di-Me imidazolopiperazine analogs I(R = 4-F, 4-Me, 3,4-F2) and II(R = 4-Me, 3-Cl-4-F) III(R = Me, F) exhibited improved potency, in vitro metabolic stability profile and, as a result, enhanced oral exposure in vivo in mice.  The optimized compds. were found to be more efficacious than the current antimalarials in a malaria mouse model.  They exhibit moderate oral exposure in rat pharmacokinetic studies to achieve sufficient multiples of the oral exposure at the efficacious dose in toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonl3aXJKMqObVg90H21EOLACvtfcHk0lj-oE6MOSrcAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D&md5=6c46f2f5ca76ae5a5089b542ec15e2ac</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm300041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300041e%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DChuan%26aufirst%3DT.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520lead%2520optimization%2520of%2520the%2520second-generation%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4244%26epage%3D4273%26doi%3D10.1021%2Fjm300041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug discovery - approaches and progress towards new medicines</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrmicro3138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24217412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=849-862&author=E.+L.+Flanneryauthor=A.+K.+Chatterjeeauthor=E.+A.+Winzeler&title=Antimalarial+drug+discovery+-+approaches+and+progress+towards+new+medicines&doi=10.1038%2Fnrmicro3138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - approaches and progress towards new medicines</span></div><div class="casAuthors">Flannery, Erika L.; Chatterjee, Arnab K.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task.  Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure.  To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compds. that target multiple parasite species at multiple stages of the parasite life cycle.  In this Review, we discuss the cell-, chem.- and target-based approaches used to discover new drug candidates that are currently in clin. trials or undergoing preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZRHIU_Rei97Vg90H21EOLACvtfcHk0liKJDNzjDM8gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L&md5=0ebf2e2f81cce7ac4de3fe19524a6ed9</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3138%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520approaches%2520and%2520progress%2520towards%2520new%2520medicines%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D849%26epage%3D862%26doi%3D10.1038%2Fnrmicro3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, C.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(09)60829-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0140-6736%2809%2960829-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=148-159&author=R.+Brunauthor=J.+Blumauthor=F.+Chappuisauthor=C.+Burri&title=Human+African+trypanosomiasis&doi=10.1016%2FS0140-6736%2809%2960829-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960829-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960829-1%26sid%3Dliteratum%253Aachs%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DChappuis%26aufirst%3DF.%26aulast%3DBurri%26aufirst%3DC.%26atitle%3DHuman%2520African%2520trypanosomiasis%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D148%26epage%3D159%26doi%3D10.1016%2FS0140-6736%2809%2960829-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis: pharmacological re-engagement with a neglected disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fsj.bjp.0707354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17618313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=1155-1171&author=M.+P.+Barrettauthor=D.+W.+Boykinauthor=R.+Brunauthor=R.+R.+Tidwell&title=Human+African+trypanosomiasis%3A+pharmacological+re-engagement+with+a+neglected+disease&doi=10.1038%2Fsj.bjp.0707354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Human African trypanosomiasis: pharmacological re-engagement with a neglected disease</span></div><div class="casAuthors">Barrett, M. P.; Boykin, D. W.; Brun, R.; Tidwell, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1155-1171</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This review discusses the challenges of chemotherapy for human African trypanosomiasis (HAT).  The few drugs registered for use against the disease are unsatisfactory for a no. of reasons.  HAT has two stages.  In stage 1 the parasites proliferate in the hemolymphatic system.  In stage 2 they invade the central nervous system and brain provoking progressive neurol. dysfunction leading to symptoms that include the disrupted sleep wake patterns that give HAT its more common name of sleeping sickness.  Targeting drugs to the central nervous system offers many challenges.  However, it is the cost of drug development for diseases like HAT, that afflict exclusively people of the world's poorest populations, that has been the principal barrier to new drug development and has led to them becoming neglected.  Here we review drugs currently registered for HAT, and also discuss the few compds. progressing through clin. trials.  Finally we report on new initiatives that might allow progress to be made in developing new and satisfactory drugs for this terrible disease.  Published online 9 July 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9CYvEA1bgbVg90H21EOLACvtfcHk0liKJDNzjDM8gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtbbE&md5=1f48697e5814d1e40fa7f54c95f8f7ff</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707354%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DHuman%2520African%2520trypanosomiasis%253A%2520pharmacological%2520re-engagement%2520with%2520a%2520neglected%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D1155%26epage%3D1171%26doi%3D10.1038%2Fsj.bjp.0707354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noorden, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurdinger, T.</span></span> <span> </span><span class="NLM_article-title">WEE1 inhibition and genomic instability in cancer</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1836</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bbcan.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23727417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1836&publication_year=2013&pages=227-235&author=L.+E.+Vriendauthor=P.+C.+De+Witt+Hamerauthor=C.+J.+Van+Noordenauthor=T.+Wurdinger&title=WEE1+inhibition+and+genomic+instability+in+cancer&doi=10.1016%2Fj.bbcan.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">WEE1 inhibition and genomic instability in cancer</span></div><div class="casAuthors">Vriend, Lianne E. M.; De Witt Hamer, Philip C.; Van Noorden, Cornelis J. F.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1836</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  One of the hallmarks of cancer is genomic instability controlled by cell cycle checkpoints.  The G1 and G2 checkpoints allow DNA damage responses, whereas the mitotic checkpoint enables correct segregation of the sister chromosomes to prevent aneuploidy.  Cancer cells often lack a functional G1 arrest and rely on G2 arrest for DNA damage responses.  WEE1 kinase is an important regulator of the G2 checkpoint and is overexpressed in various cancer types.  Inhibition of WEE1 is a promising strategy in cancer therapy in combination with DNA-damaging agents, esp. when cancer cells harbor p53 mutations, as it causes mitotic catastrophe when DNA is not repaired during G2 arrest.  Cancer cell response to WEE1 inhibition monotherapy has also been demonstrated in various types of cancer, including p53 wild-type cancers.  The authors postulate that chromosomal instability can explain tumor response to WEE1 monotherapy.  Therefore, chromosomal instability may need to be taken into account when detg. the most effective strategy for the use of WEE1 inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5xXCFyxOs7Vg90H21EOLACvtfcHk0lg6OFPQyd6bjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vL&md5=7471124cf9e92b09b0dce7e481ae05dc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DL.%2BE.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DVan%2BNoorden%26aufirst%3DC.%2BJ.%26aulast%3DWurdinger%26aufirst%3DT.%26atitle%3DWEE1%2520inhibition%2520and%2520genomic%2520instability%2520in%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1836%26spage%3D227%26epage%3D235%26doi%3D10.1016%2Fj.bbcan.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biskup, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachergus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulihan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoessl, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patenge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajal, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieregge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Myhsok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meitinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wszolek, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, T.</span></span> <span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology&doi=10.1016%2Fj.neuron.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0lg6OFPQyd6bjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.neuron.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker-Glenn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunzner-Toste, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pichon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9416</span>– <span class="NLM_lpage">9433</span>, <span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0lgSx9-ulAYJ6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. D.</span></span> <span> </span><span class="NLM_article-title">Calcium channel functions in pain processing</span>. <i>Channels</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.4161/chan.4.6.12869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.4161%2Fchan.4.6.12869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21150297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=510-517&author=J.+Parkauthor=Z.+D.+Luo&title=Calcium+channel+functions+in+pain+processing&doi=10.4161%2Fchan.4.6.12869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel functions in pain processing</span></div><div class="casAuthors">Park, John F.; Luo, Z. David</div><div class="citationInfo"><span class="NLM_cas:title">Channels</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">510-517</span>CODEN:
                <span class="NLM_cas:coden">CHANCC</span>;
        ISSN:<span class="NLM_cas:issn">1933-6950</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Voltage-gated calcium channels (VGCC) play obligatory physiol. roles, including modulation of neuronal functions, synaptic plasticity, neurotransmitter release and gene transcription.  Dysregulation and maladaptive changes in VGCC expression and activities may occur in the sensory pathway under various pathol. conditions that could contribute to the development of pain.  In this review, we summarized the most recent findings on the regulation of VGCC expression and physiol. functions in the sensory pathway, and in dysregulation and maladaptive changes of VGCC under pain-inducing conditions.  The implications of these changes in understanding the mechanisms of pain transduction and in new drug design are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT0bpi0sPeM7Vg90H21EOLACvtfcHk0lgQvsOXcKQ9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSls74%253D&md5=1e3a763bf7770fd11f45d5bd3975c2d9</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.4161%2Fchan.4.6.12869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fchan.4.6.12869%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DZ.%2BD.%26atitle%3DCalcium%2520channel%2520functions%2520in%2520pain%2520processing%26jtitle%3DChannels%26date%3D2010%26volume%3D4%26spage%3D510%26epage%3D517%26doi%3D10.4161%2Fchan.4.6.12869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugianesi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haedo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swensen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. L.</span></span> <span> </span><span class="NLM_article-title">Improved Cav2.2 channel inhibitors through a gem-dimethylsulfone bioisostere replacement of a labile sulfonamide</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1021/ml4002612</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1064-1068&author=P.+P.+Shaoauthor=F.+Yeauthor=P.+K.+Chakravartyauthor=J.+B.+Herringtonauthor=G.+Daiauthor=R.+M.+Bugianesiauthor=R.+J.+Haedoauthor=A.+M.+Swensenauthor=V.+A.+Warrenauthor=M.+M.+Smithauthor=M.+L.+Garciaauthor=O.+B.+McManusauthor=K.+A.+Lyonsauthor=X.+Liauthor=M.+Greenauthor=N.+Jochnowitzauthor=E.+McGowanauthor=S.+Mistryauthor=S.+Y.+Sunauthor=C.+Abbadieauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=Improved+Cav2.2+channel+inhibitors+through+a+gem-dimethylsulfone+bioisostere+replacement+of+a+labile+sulfonamide&doi=10.1021%2Fml4002612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fml4002612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002612%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DP.%2BP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DHerrington%26aufirst%3DJ.%2BB.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DBugianesi%26aufirst%3DR.%2BM.%26aulast%3DHaedo%26aufirst%3DR.%2BJ.%26aulast%3DSwensen%26aufirst%3DA.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMcManus%26aufirst%3DO.%2BB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DImproved%2520Cav2.2%2520channel%2520inhibitors%2520through%2520a%2520gem-dimethylsulfone%2520bioisostere%2520replacement%2520of%2520a%2520labile%2520sulfonamide%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1064%26epage%3D1068%26doi%3D10.1021%2Fml4002612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varughese, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugianesi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haedo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swensen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. L.</span></span> <span> </span><span class="NLM_article-title">Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9847</span>– <span class="NLM_lpage">9855</span>, <span class="refDoi"> DOI: 10.1021/jm301056k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301056k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9847-9855&author=P.+P.+Shaoauthor=F.+Yeauthor=P.+K.+Chakravartyauthor=D.+J.+Varugheseauthor=J.+B.+Herringtonauthor=G.+Daiauthor=R.+M.+Bugianesiauthor=R.+J.+Haedoauthor=A.+M.+Swensenauthor=V.+A.+Warrenauthor=M.+M.+Smithauthor=M.+L.+Garciaauthor=O.+B.+McManusauthor=K.+A.+Lyonsauthor=X.+Liauthor=M.+Greenauthor=N.+Jochnowitzauthor=E.+McGowanauthor=S.+Mistryauthor=S.+Y.+Sunauthor=C.+Abbadieauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=Aminopiperidine+sulfonamide+Cav2.2+channel+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Fjm301056k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm301056k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301056k%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DP.%2BP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DVarughese%26aufirst%3DD.%2BJ.%26aulast%3DHerrington%26aufirst%3DJ.%2BB.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DBugianesi%26aufirst%3DR.%2BM.%26aulast%3DHaedo%26aufirst%3DR.%2BJ.%26aulast%3DSwensen%26aufirst%3DA.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMcManus%26aufirst%3DO.%2BB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DAminopiperidine%2520sulfonamide%2520Cav2.2%2520channel%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9847%26epage%3D9855%26doi%3D10.1021%2Fjm301056k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morozova, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J. C.</span></span> <span> </span><span class="NLM_article-title">A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia</span>. <i>BMC Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">351</span>, <span class="refDoi"> DOI: 10.1186/s12888-014-0351-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1186%2Fs12888-014-0351-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=351&author=A.+M.+Downingauthor=B.+J.+Kinonauthor=B.+A.+Millenauthor=L.+Zhangauthor=L.+Liuauthor=M.+A.+Morozovaauthor=R.+Brennerauthor=T.+J.+Rayleauthor=L.+Nisenbaumauthor=F.+Zhaoauthor=J.+C.+Gomez&title=A+double-blind%2C+placebo-controlled+comparator+study+of+LY2140023+monohydrate+in+patients+with+schizophrenia&doi=10.1186%2Fs12888-014-0351-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1186%2Fs12888-014-0351-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12888-014-0351-3%26sid%3Dliteratum%253Aachs%26aulast%3DDowning%26aufirst%3DA.%2BM.%26aulast%3DKinon%26aufirst%3DB.%2BJ.%26aulast%3DMillen%26aufirst%3DB.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DBrenner%26aufirst%3DR.%26aulast%3DRayle%26aufirst%3DT.%2BJ.%26aulast%3DNisenbaum%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGomez%26aufirst%3DJ.%2BC.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520comparator%2520study%2520of%2520LY2140023%2520monohydrate%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DBMC%2520Psychiatry%26date%3D2014%26volume%3D14%26spage%3D351%26doi%3D10.1186%2Fs12888-014-0351-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemurell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emtenas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broddefalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovdal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryden-Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herslof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigfridsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whatling, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1021/jm501531v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501531v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=897-911&author=M.+Lemurellauthor=J.+Ulanderauthor=S.+Winiwarterauthor=A.+Dahlenauthor=O.+Davidssonauthor=H.+Emtenasauthor=J.+Broddefalkauthor=M.+Swansonauthor=D.+Hovdalauthor=A.+T.+Plowrightauthor=A.+Pettersenauthor=M.+Ryden-Landergrenauthor=J.+Barlindauthor=A.+Llinasauthor=M.+Herslofauthor=T.+Drmotaauthor=K.+Sigfridssonauthor=S.+Mosesauthor=C.+Whatling&title=Discovery+of+AZD6642%2C+an+inhibitor+of+5-lipoxygenase+activating+protein+%28FLAP%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm501531v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm501531v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501531v%26sid%3Dliteratum%253Aachs%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDahlen%26aufirst%3DA.%26aulast%3DDavidsson%26aufirst%3DO.%26aulast%3DEmtenas%26aufirst%3DH.%26aulast%3DBroddefalk%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DM.%26aulast%3DHovdal%26aufirst%3DD.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DRyden-Landergren%26aufirst%3DM.%26aulast%3DBarlind%26aufirst%3DJ.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DSigfridsson%26aufirst%3DK.%26aulast%3DMoses%26aufirst%3DS.%26aulast%3DWhatling%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520AZD6642%252C%2520an%2520inhibitor%2520of%25205-lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D897%26epage%3D911%26doi%3D10.1021%2Fjm501531v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareau, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarlane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouimet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Hutchinson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00023-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0960-894X%2895%2900023-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFGnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=283-288&author=M.+Labelleauthor=M.+Belleyauthor=Y.+Gareauauthor=J.+Y.+Gauthierauthor=D.+Guayauthor=R.+Gordonauthor=S.+G.+Grossmanauthor=T.+R.+Jonesauthor=Y.+Leblancauthor=M.+McAuliffeauthor=C.+McFarlaneauthor=P.+Massonauthor=K.+M.+Mettersauthor=N.+Ouimetauthor=D.+H.+Patrickauthor=H.+Piechutaauthor=C.+Rochetteauthor=N.+Sawyerauthor=Y.+B.+Xiangauthor=C.+B.+Pickettauthor=A.+W.+Ford-Hutchinsonauthor=R.+J.+Zamboniauthor=R.+N.+Young&title=Discovery+of+MK-0476%2C+a+potent+and+orally+active+leukotriene+D4+receptor+antagonist+devoid+of+peroxisomal+enzyme+induction&doi=10.1016%2F0960-894X%2895%2900023-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction</span></div><div class="casAuthors">Labelle, M.; Belley, M.; Gareau, Y.; Gauthier, J. Y.; Guay, D.; Gordon, R.; Grossman, S. G.; Jones, T. R.; Leblanc, Y.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-8</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Structure-activity studies leading to the discovery of MK-0476 are described.  The initial compd. of this series was a potent leukotriene D4 (LTD4) antagonist, but was also a peroxisomal enzyme inducer in the mouse.  Structure-activity relationships around the thioether chain were explored to remove this undesirable feature.  It was found that alkyl substituents in the β-position relative to the carboxylic acid reduce the potency as a peroxisomal enzyme inducer while preserving the LTD4 antagonistic properties.  Dialkyl substitution essentially eliminates the enzyme induction.  The optimal styryl quinoline, MK-0476, exhibited high in vitro potency and in vivo activity on oral dosing without significant liver enzyme induction in the mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmcviqVzx4LLVg90H21EOLACvtfcHk0lhBtRR0xdMuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFGnurc%253D&md5=8a4aba26af3212766d88ff79d19f4d8e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900023-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900023-M%26sid%3Dliteratum%253Aachs%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGrossman%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DPatrick%26aufirst%3DD.%2BH.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DRochette%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DY.%2BB.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DZamboni%26aufirst%3DR.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DDiscovery%2520of%2520MK-0476%252C%2520a%2520potent%2520and%2520orally%2520active%2520leukotriene%2520D4%2520receptor%2520antagonist%2520devoid%2520of%2520peroxisomal%2520enzyme%2520induction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D283%26epage%3D288%26doi%3D10.1016%2F0960-894X%2895%2900023-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/nrc2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer&doi=10.1038%2Fnrc2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0lhBtRR0xdMuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrc2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span> <span> </span><span class="NLM_article-title">The outs and the ins of sphingosine-1-phosphate in immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1038/nri2974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnri2974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21546914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=403-415&author=S.+Spiegelauthor=S.+Milstien&title=The+outs+and+the+ins+of+sphingosine-1-phosphate+in+immunity&doi=10.1038%2Fnri2974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">The outs and the ins of sphingosine-1-phosphate in immunity</span></div><div class="casAuthors">Spiegel, Sarah; Milstien, Sheldon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">403-415</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The potent lipid mediator sphingosine-1-phosphate (S1P) is produced inside cells by two closely related kinases, sphingosine kinase 1 (SPHK1) and SPHK2, and has emerged as a crucial regulator of immunity.  Many of the actions of S1P in innate and adaptive immunity are mediated by its binding to five G protein-coupled receptors, designated S1PR1-5, but recent findings have also identified important roles for S1P as a second messenger during inflammation.  In this Review, we discuss recent advances in our understanding of the roles of S1P receptors and describe the newly identified intracellular targets of S1P that are crucial for immune responses.  Finally, we discuss the therapeutic potential of new drugs that target S1P signalling and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxp8-U05q-frVg90H21EOLACvtfcHk0lhBtRR0xdMuqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kgurk%253D&md5=b1bf1c4a321a768a12f82a1fcdeb6d69</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnri2974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2974%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26atitle%3DThe%2520outs%2520and%2520the%2520ins%2520of%2520sphingosine-1-phosphate%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26spage%3D403%26epage%3D415%26doi%3D10.1038%2Fnri2974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D. T.</span></span> <span> </span><span class="NLM_article-title">The use of 16-16 dimethyl <i>trans</i> delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. a comparative study</span>. <i>Br. J. Obstet. Gynaecol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1111/j.1471-0528.1980.tb04605.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1471-0528.1980.tb04605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=7426533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaL3M%252FjvFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1980&pages=712-717&author=S.+K.+Smithauthor=D.+T.+Baird&title=The+use+of+16-16+dimethyl+trans+delta+2+PGE1+methyl+ester+%28ONO+802%29+vaginal+suppositories+for+the+termination+of+early+pregnancy.+a+comparative+study&doi=10.1111%2Fj.1471-0528.1980.tb04605.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study</span></div><div class="casAuthors">Smith S K; Baird D T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of obstetrics and gynaecology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">712-7</span>
        ISSN:<span class="NLM_cas:issn">0306-5456</span>.
    </div><div class="casAbstract">Vaginal suppositories containing the 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) were used for the induction of abortion in early pregnancy, and this non-surgical technique was compared with suction termination performed under local anaesthesia or general anaesthesia.  Ninety patients were recruited to the study and divided equally between the three groups.  Complete abortion was induced in 87 per cent of the patients treated with ONO 802 suppositories, which compared favourably with 87 and 100 per cent for the patients who had suction terminations under local anaesthesia and general anaesthesia respectively.  The vaginal suppositories induced uterine bleeding in all patients and the mean time of onset of lower abdominal pain was 2 hours 55 minutes.  The average numbers of episodes of vomiting and diarrhoea for patients given ONO 802 suppositories were 0.9 and 0.7 respectively.  Menstrual blood loss was measured objectively in all groups and no significant differences between the three methods could be found.  In selected cases, ONO 802 vaginal suppositories would seem to be safe and reasonably effective for the termination of early pregnancy.  Vaginal suppositories containing the 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) were used for the induction of abortion in early pregnancy, and this nonsurgical technique was compared with suction termination performed under local anesthesia or general anesthesia.  90 patients were recruited to the study and divided equally between the 3 groups.  Complete abortion was induced in 87% of the patients treated with ONO 802 suppositories, which compared favourably with 87 and 100% for the patients who had suction terminations under local anesthesia, and general anesthesia, respectively.  The vaginal suppositories induced uterine bleeding in all patients and the mean time of onset of lower abdominal pain was 2 hours 55 minutes.  The average numbers of episodes of vomiting and diarrhea for patients given ONO 802 suppositories were 0.9 and 0.7, respectively.  Menstrual blood loss was measured objectively in all groups and no significant differences between the 3 methods could be found.  In selected cases, ONO 802 vaginal suppositories would seem to be safe and reasonably effective for the termination of early pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQs243MjX93Is-crCu0nI_sfW6udTcc2eZvfE5qGgIy87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M%252FjvFymtQ%253D%253D&md5=6b5ed7099c3862dcda23b3ea16f605a5</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-0528.1980.tb04605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-0528.1980.tb04605.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BK.%26aulast%3DBaird%26aufirst%3DD.%2BT.%26atitle%3DThe%2520use%2520of%252016-16%2520dimethyl%2520trans%2520delta%25202%2520PGE1%2520methyl%2520ester%2520%2528ONO%2520802%2529%2520vaginal%2520suppositories%2520for%2520the%2520termination%2520of%2520early%2520pregnancy.%2520a%2520comparative%2520study%26jtitle%3DBr.%2520J.%2520Obstet.%2520Gynaecol.%26date%3D1980%26volume%3D87%26spage%3D712%26epage%3D717%26doi%3D10.1111%2Fj.1471-0528.1980.tb04605.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bygdeman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, N. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=494-502&author=V.+Dimovauthor=K.+Greenauthor=M.+Bygdemanauthor=N.+J.+Christensen&title=Metabolism+of+16%2C16-dimethyl-trans-delta+2-prostaglandin+E1+methyl+ester+%28ONO-802%29+following+intravenous+and+vaginal+administration+to+pregnant+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDimov%26aufirst%3DV.%26aulast%3DGreen%26aufirst%3DK.%26aulast%3DBygdeman%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DN.%2BJ.%26atitle%3DMetabolism%2520of%252016%252C16-dimethyl-trans-delta%25202-prostaglandin%2520E1%2520methyl%2520ester%2520%2528ONO-802%2529%2520following%2520intravenous%2520and%2520vaginal%2520administration%2520to%2520pregnant%2520women%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1986%26volume%3D14%26spage%3D494%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foord, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elshourbagy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steplewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular identification of high and low affinity receptors for nicotinic acid</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">9869</span>– <span class="NLM_lpage">9874</span>, <span class="refDoi"> DOI: 10.1074/jbc.M210695200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M210695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=12522134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvV2hsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=9869-9874&author=A.+Wiseauthor=S.+M.+Foordauthor=N.+J.+Fraserauthor=A.+A.+Barnesauthor=N.+Elshourbagyauthor=M.+Eilertauthor=D.+M.+Ignarauthor=P.+R.+Murdockauthor=K.+Steplewskiauthor=A.+Greenauthor=A.+J.+Brownauthor=S.+J.+Dowellauthor=P.+G.+Szekeresauthor=D.+G.+Hassallauthor=F.+H.+Marshallauthor=S.+Wilsonauthor=N.+B.+Pike&title=Molecular+identification+of+high+and+low+affinity+receptors+for+nicotinic+acid&doi=10.1074%2Fjbc.M210695200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular identification of high and low affinity receptors for nicotinic acid</span></div><div class="casAuthors">Wise, Alan; Foord, Steven M.; Fraser, Neil J.; Barnes, Ashley A.; Elshourbagy, Nabil; Eilert, Michelle; Ignar, Diane M.; Murdock, Paul R.; Steplewski, Klaudia; Green, Andrew; Brown, Andrew J.; Dowell, Simon J.; Szekeres, Philip G.; Hassall, David G.; Marshall, Fiona H.; Wilson, Shelagh; Pike, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">9869-9874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acid has been used clin. for over 40 yr in the treatment of dyslipidemia producing a desirable normalization of a range of cardiovascular risk factors, including a marked elevation of high d. lipoprotein and a redn. in mortality.  The precise mechanism of action of nicotinic acid is unknown, although it is believed that activation of a Gi-G protein-coupled receptor may contribute.  Utilizing available information on the tissue distribution of nicotinic acid receptors, the authors identified candidate orphan receptors.  The selected orphan receptors were screened for responses to nicotinic acid, in an assay for activation of Gi-G proteins.  Here the authors describe the identification of the G protein-coupled receptor HM74 as a low affinity receptor for nicotinic acid.  The authors then describe the subsequent identification of HM74A in follow-up bioinformatics searches and demonstrate that it acts as a high affinity receptor for nicotinic acid and other compds. with related pharmacol.  The discovery of HM74A as a mol. target for nicotinic acid may facilitate the discovery of superior drug mols. to treat dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1fm8ypokRV7Vg90H21EOLACvtfcHk0ljzAFJbJ5FlcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvV2hsbo%253D&md5=980d4d6a2edd6468828eecd885c2f0ca</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M210695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M210695200%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DA.%26aulast%3DFoord%26aufirst%3DS.%2BM.%26aulast%3DFraser%26aufirst%3DN.%2BJ.%26aulast%3DBarnes%26aufirst%3DA.%2BA.%26aulast%3DElshourbagy%26aufirst%3DN.%26aulast%3DEilert%26aufirst%3DM.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DMurdock%26aufirst%3DP.%2BR.%26aulast%3DSteplewski%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DSzekeres%26aufirst%3DP.%2BG.%26aulast%3DHassall%26aufirst%3DD.%2BG.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520identification%2520of%2520high%2520and%2520low%2520affinity%2520receptors%2520for%2520nicotinic%2520acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D9869%26epage%3D9874%26doi%3D10.1074%2Fjbc.M210695200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benyo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csiky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchankova, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusing, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3634</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1172/JCI23626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1172%2FJCI23626" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=3634-3640&author=Z.+Benyoauthor=A.+Gilleauthor=J.+Keroauthor=M.+Csikyauthor=M.+C.+Suchankovaauthor=R.+M.+Nusingauthor=A.+Moersauthor=K.+Pfefferauthor=S.+Offermanns&title=GPR109A+%28PUMA-G%2FHM74A%29+mediates+nicotinic+acid-induced+flushing&doi=10.1172%2FJCI23626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1172%2FJCI23626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI23626%26sid%3Dliteratum%253Aachs%26aulast%3DBenyo%26aufirst%3DZ.%26aulast%3DGille%26aufirst%3DA.%26aulast%3DKero%26aufirst%3DJ.%26aulast%3DCsiky%26aufirst%3DM.%26aulast%3DSuchankova%26aufirst%3DM.%2BC.%26aulast%3DNusing%26aufirst%3DR.%2BM.%26aulast%3DMoers%26aufirst%3DA.%26aulast%3DPfeffer%26aufirst%3DK.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DGPR109A%2520%2528PUMA-G%252FHM74A%2529%2520mediates%2520nicotinic%2520acid-induced%2520flushing%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D3634%26epage%3D3640%26doi%3D10.1172%2FJCI23626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandercammen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaftingen, E.</span></span> <span> </span><span class="NLM_article-title">The mechanism by which rat liver glucokinase is inhibited by the regulatory protein</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1990.tb19147.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1432-1033.1990.tb19147.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=2384095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFeru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1990&pages=483-489&author=A.+Vandercammenauthor=E.+Van+Schaftingen&title=The+mechanism+by+which+rat+liver+glucokinase+is+inhibited+by+the+regulatory+protein&doi=10.1111%2Fj.1432-1033.1990.tb19147.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism by which rat liver glucokinase is inhibited by the regulatory protein</span></div><div class="casAuthors">Vandercammen, Annick; Van Schaftingen, Emile</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-9</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The fructose-6-phosphate-sensitive and fructose-1-phosphate-sensitive protein that inhibits rat liver glucokinase was purified close to homogeneity by a procedure involving poly(ethyleneglycol) pptn., chromatog. on anion-exchangers and hydroxylapatite, gel filtration and chromatog. on Mono S, a cation exchanger.  In the last chromatog. step, the regulatory protein coeluted with a 62-kDa peptide.  From the elution vol. of the gel-filtration column a mol. mass of 60 kDa was detd., allowing the conclusion that the regulator is a monomer.  The decrease in the apparent affinity of glucokinase for glucose, which the regulator induced, disappeared upon sepn. of the 2 proteins.  Furthermore, the regulator did not appear to catalyze the formation of a heat-stable or a trypsin-resistant inhibitor of glucokinase.  Finally, the inhibition exerted by the regulatory protein reached a steady value 1-2 min after the addn. of the regulator.  These results indicate that the regulator does not act by causing a covalent modification of glucokinase nor by catalyzing the formation of a low-mol.-mass inhibitor.  Raising the concn. of glucokinase in the assay from 6 to 120 mU/mL caused a 2.5-fold increase in the concn. of regulator required to half-maximally inhibit the enzyme.  The apparent mass of glucokinase, as detd. by centrifugation in isokinetic sucrose gradient, was 55 kDa, and this value was unaffected by the sep. presence of fructose 6-phosphate or of the regulatory protein.  However, the apparent mass of the enzyme increased to 105 kDa when glucokinase was centrifuged together with both fructose 6-phosphate and the regulatory protein, although not when fructose 1-phosphate was also present.  Conversely, the presence of glucokinase increased the apparent mol. mass of the regulator in the presence of fructose 6-phosphate.  From these results, it is concluded that the regulatory protein inhibits glucokinase by forming a complex with this enzyme in the presence of fructose 6-phosphate, and that fructose 1-phosphate antagonizes this inhibition by preventing the formation of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop3Cq5M_P20bVg90H21EOLACvtfcHk0ljzAFJbJ5FlcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFeru7o%253D&md5=1705aa9bb9b757eb5b61d9220fc74c16</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1990.tb19147.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1990.tb19147.x%26sid%3Dliteratum%253Aachs%26aulast%3DVandercammen%26aufirst%3DA.%26aulast%3DVan%2BSchaftingen%26aufirst%3DE.%26atitle%3DThe%2520mechanism%2520by%2520which%2520rat%2520liver%2520glucokinase%2520is%2520inhibited%2520by%2520the%2520regulatory%2520protein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1990%26volume%3D191%26spage%3D483%26epage%3D489%26doi%3D10.1111%2Fj.1432-1033.1990.tb19147.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, B. M.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4023</span>– <span class="NLM_lpage">4034</span>, <span class="refDoi"> DOI: 10.1021/jm058240i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058240i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4023-4034&author=B.+M.+Nilsson&title=5-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents&doi=10.1021%2Fjm058240i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span></div><div class="casAuthors">Nilsson, Bjoern M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4023-4034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 5-HT 2C receptor agonists as potential antiobesity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39FDBz-7CqrVg90H21EOLACvtfcHk0ljSY_48zR21fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D&md5=ec5788cfe273b9cf7ccbdfc39fc8a7b2</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm058240i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058240i%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM.%26atitle%3D5-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4023%26epage%3D4034%26doi%3D10.1021%2Fjm058240i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span> <span> </span><span class="NLM_article-title">5-HT(2C) agonists as therapeutics for the treatment of schizophrenia</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-25758-2_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1007%2F978-3-642-25758-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23027415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2012&pages=147-165&author=S.+Rosenzweig-Lipsonauthor=T.+A.+Comeryauthor=K.+L.+Marquisauthor=J.+Grossauthor=J.+Dunlop&title=5-HT%282C%29+agonists+as+therapeutics+for+the+treatment+of+schizophrenia&doi=10.1007%2F978-3-642-25758-2_6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C agonists as therapeutics for the treatment of schizophrenia</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Comery, Thomas A.; Marquis, Karen L.; Gross, Jonathan; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">147-165</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The 5-HT2C receptor is a highly complex, highly regulated receptor which is widely distributed throughout the brain.  The 5-HT2C receptor couples to multiple signal transduction pathways leading to engagement of a no. of intracellular signaling mols.  Moreover, there are multiple allelic variants of the 5-HT2C receptor and the receptor is subject to RNA editing in the coding regions.  The complexity of this receptor is further emphasized by the studies suggesting the utility of either agonists or antagonists in the treatment of schizophrenia.  While several 5-HT2C agonists have demonstrated clin. efficacy in obesity (lorcaserin, PRX-000933), the focus of this review is on the therapeutic potential of 5-HT2C agonists in schizophrenia.  To this end, the preclin. profile of 5-HT2C agonists from a neurochem., electrophysiol., and a behavioral perspective is indicative of antipsychotic-like efficacy without extrapyramidal symptoms or wt. gain.  Recently, the selective 5-HT2C agonist vabicaserin demonstrated clin. efficacy in a Phase II trial in schizophrenia patients without wt. gain and with low EPS liability.  These data are highly encouraging and suggest that 5-HT2C agonists are potential therapeutics for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuqzYsH56GbVg90H21EOLACvtfcHk0lg7LaHvBojHBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D&md5=17bdc34317a7d966bc6038bca83ec5b3</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3D5-HT%25282C%2529%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D213%26spage%3D147%26epage%3D165%26doi%3D10.1007%2F978-3-642-25758-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P. J.</span></span> <span> </span><span class="NLM_article-title">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.tips.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24041919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=560-570&author=G.+A.+Higginsauthor=E.+M.+Sellersauthor=P.+J.+Fletcher&title=From+obesity+to+substance+abuse%3A+therapeutic+opportunities+for+5-HT2C+receptor+agonists&doi=10.1016%2Fj.tips.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span></div><div class="casAuthors">Higgins, Guy A.; Sellers, Edward M.; Fletcher, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent US Food and Drug Administration (FDA) approval of the serotonin (5-hydroxytryptamine, 5-HT) 5-HT2C receptor agonist lorcaserin for the treatment of obesity represents a new therapeutic drug class available to the clinic.  Preclin. evidence supports the potential for this drug class to treat other related conditions such as substance abuse.  In the present article we review this evidence and further suggest that overlapping neurobiol. systems may contribute to an anti-addictive and anti-obesity profile.  The availability of selective 5-HT2C agonists provides an opportunity to evaluate their potential as treatments for nicotine dependence or psychostimulant abuse, conditions for which there is significant medical need but only limited available treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjiS3n6R_5trVg90H21EOLACvtfcHk0lg7LaHvBojHBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK&md5=cf21273e52cb1ba62821886489381717</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DFrom%2520obesity%2520to%2520substance%2520abuse%253A%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520agonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.tips.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleight, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, U.</span></span> <span> </span><span class="NLM_article-title">Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2762</span>– <span class="NLM_lpage">2769</span>, <span class="refDoi"> DOI: 10.1021/jm970030l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970030l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2762-2769&author=M.+Bosauthor=F.+Jenckauthor=J.+R.+Martinauthor=J.+L.+Moreauauthor=A.+J.+Sleightauthor=J.+Wichmannauthor=U.+Widmer&title=Novel+agonists+of+5HT2C+receptors.+Synthesis+and+biological+evaluation+of+substituted+2-%28indol-1-yl%29-1-methylethylamines+and+2-%28indeno%5B1%2C2-b%5Dpyrrol-1-yl%29-1-methylethylamines.+Improved+therapeutics+for+obsessive+compulsive+disorder&doi=10.1021%2Fjm970030l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Fjm970030l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970030l%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DSleight%26aufirst%3DA.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DWidmer%26aufirst%3DU.%26atitle%3DNovel%2520agonists%2520of%25205HT2C%2520receptors.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-%2528indol-1-yl%2529-1-methylethylamines%2520and%25202-%2528indeno%255B1%252C2-b%255Dpyrrol-1-yl%2529-1-methylethylamines.%2520Improved%2520therapeutics%2520for%2520obsessive%2520compulsive%2520disorder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2762%26epage%3D2769%26doi%3D10.1021%2Fjm970030l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albertini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span> <span> </span><span class="NLM_article-title">Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay</span>. <i>Mutagenesis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1093/mutage/13.4.397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fmutage%2F13.4.397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=397-403&author=S.+Albertiniauthor=M.+Bosauthor=E.+Gockeauthor=S.+Kirchnerauthor=W.+Musterauthor=J.+Wichmann&title=Suppression+of+mutagenic+activity+of+a+series+of+5HT2c+receptor+agonists+by+the+incorporation+of+a+gem-dimethyl+group%3A+SAR+using+the+Ames+test+and+a+DNA+unwinding+assay&doi=10.1093%2Fmutage%2F13.4.397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2F13.4.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252F13.4.397%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DS.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DGocke%26aufirst%3DE.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DMuster%26aufirst%3DW.%26aulast%3DWichmann%26aufirst%3DJ.%26atitle%3DSuppression%2520of%2520mutagenic%2520activity%2520of%2520a%2520series%2520of%25205HT2c%2520receptor%2520agonists%2520by%2520the%2520incorporation%2520of%2520a%2520gem-dimethyl%2520group%253A%2520SAR%2520using%2520the%2520Ames%2520test%2520and%2520a%2520DNA%2520unwinding%2520assay%26jtitle%3DMutagenesis%26date%3D1998%26volume%3D13%26spage%3D397%26epage%3D403%26doi%3D10.1093%2Fmutage%2F13.4.397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardiot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevissen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brucker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborda, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaltin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammue, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, A.</span></span> <span> </span><span class="NLM_article-title">2-(2-Oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1021/jm501814x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501814x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1502-1512&author=D.+Bardiotauthor=K.+Thevissenauthor=K.+De+Bruckerauthor=A.+Peetersauthor=P.+Cosauthor=C.+P.+Tabordaauthor=M.+McNaughtonauthor=L.+Maesauthor=P.+Chaltinauthor=B.+P.+Cammueauthor=A.+Marchand&title=2-%282-Oxo-morpholin-3-yl%29-acetamide+derivatives+as+broad-spectrum+antifungal+agents&doi=10.1021%2Fjm501814x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents</span></div><div class="casAuthors">Bardiot, Dorothee; Thevissen, Karin; De Brucker, Katrijn; Peeters, Annelies; Cos, Paul; Taborda, Carlos P.; McNaughton, Michael; Maes, Louis; Chaltin, Patrick; Cammue, Bruno P. A.; Marchand, Arnaud</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1502-1512</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a fungicidal screen, we identified 2-(2-oxo-morpholin-3-yl)-acetamide derivs. as fungicidal agents against Candida species, addnl. characterized by antifungal activity against Aspergillus species.  However, development of this series was hampered by low plasmatic stability.  Introduction of a gem-di-Me on the 6-position of the morpholin-2-one core led to considerable improvement in plasmatic stability while maintaining in vitro antifungal activity.  Further optimization of the series resulted in the discovery of N-(biphenyl-3-ylmethyl)-2-(4-ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)acetamide (I), which, in addn. to fungicidal activity against Candida species, shows promising and broad antifungal in vitro activity against various fungi species, such as molds and dermatophytes.  In vivo efficacy was also demonstrated in a murine model of systemic Candida albicans infection with a significant fungal load redn. in kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-9EVKzoxBbVg90H21EOLACvtfcHk0ljx-a9LV48M_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGhug%253D%253D&md5=a24c883b667b0b514fd543795b319f07</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fjm501814x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501814x%26sid%3Dliteratum%253Aachs%26aulast%3DBardiot%26aufirst%3DD.%26aulast%3DThevissen%26aufirst%3DK.%26aulast%3DDe%2BBrucker%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DA.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DTaborda%26aufirst%3DC.%2BP.%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DChaltin%26aufirst%3DP.%26aulast%3DCammue%26aufirst%3DB.%2BP.%26aulast%3DMarchand%26aufirst%3DA.%26atitle%3D2-%25282-Oxo-morpholin-3-yl%2529-acetamide%2520derivatives%2520as%2520broad-spectrum%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1502%26epage%3D1512%26doi%3D10.1021%2Fjm501814x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates for non-oncological indications</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1517/14712598.2016.1161753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14712598.2016.1161753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26937991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BC28jms12guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=591-593&author=R.+Liuauthor=R.+E.+Wangauthor=F.+Wang&title=Antibody-drug+conjugates+for+non-oncological+indications&doi=10.1517%2F14712598.2016.1161753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-drug conjugates for non-oncological indications</span></div><div class="casAuthors">Liu Renhe; Wang Rongsheng E; Wang Feng</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on biological therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">591-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-E7aPT1YIc2xpATR2EQURfW6udTcc2eZyWMxEXTvFarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jms12guw%253D%253D&md5=23789ace05502869a83cfd81e2ef0263</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1517%2F14712598.2016.1161753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2016.1161753%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%2BE.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DAntibody-drug%2520conjugates%2520for%2520non-oncological%2520indications%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2016%26volume%3D16%26spage%3D591%26epage%3D593%26doi%3D10.1517%2F14712598.2016.1161753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, S.</span></span> <span> </span><span class="NLM_article-title">Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.2133/dmpk.20.452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2133%2Fdmpk.20.452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16415531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVOmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=452-477&author=M.+Nishimuraauthor=S.+Naito&title=Tissue-specific+mRNA+expression+profiles+of+human+ATP-binding+cassette+and+solute+carrier+transporter+superfamilies&doi=10.2133%2Fdmpk.20.452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies</span></div><div class="casAuthors">Nishimura, Masuhiro; Naito, Shinsaku</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">452-477</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">Pairs of forward and reverse primers and TaqMan probes specific to each of 46 human ATP-binding cassette (ABC) transporters and 108 human solute carrier (SLC) transporters were prepd.  The mRNA expression level of each target transporter was analyzed in total RNA from single and pooled specimens of various human tissues (adrenal gland, bone marrow, brain, colon, heart, kidney, liver, lung, pancreas, peripheral leukocytes, placenta, prostate, salivary gland, skeletal muscle, small intestine, spinal cord, spleen, stomach, testis, thymus, thyroid gland, trachea, and uterus) by real-time reverse transcription PCR using an ABI PRISM 7700 sequence detector system.  In contrast to previous methods for analyzing the mRNA expression of single ABC and SLC genes such as Northern blotting, the method allowed the authors' to perform sensitive, semiautomatic, rapid, and complete anal. of ABC and SLC transporters in total RNA samples.  The newly detd. expression profiles were then used to study the gene expression in 23 different human tissues, and tissues with high transcriptional activity for human ABC and SLC transporters were identified.  These results are expected to be valuable for establishing drug transport-mediated screening systems for new chem. entities in new drug development and for research concerning the clin. diagnosis of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84NMaLwnvqrVg90H21EOLACvtfcHk0lj-OhAl-ZiIxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVOmsbk%253D&md5=eaa00db131c7f3335e1cbd9e89900d04</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.20.452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.20.452%26sid%3Dliteratum%253Aachs%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DS.%26atitle%3DTissue-specific%2520mRNA%2520expression%2520profiles%2520of%2520human%2520ATP-binding%2520cassette%2520and%2520solute%2520carrier%2520transporter%2520superfamilies%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2005%26volume%3D20%26spage%3D452%26epage%3D477%26doi%3D10.2133%2Fdmpk.20.452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brundish, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyle, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4584</span>– <span class="NLM_lpage">4603</span>, <span class="refDoi"> DOI: 10.1021/jm9811209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9811209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4584-4603&author=D.+Brundishauthor=A.+Bullauthor=V.+Donovanauthor=J.+D.+Fullertonauthor=S.+M.+Garmanauthor=J.+F.+Haylerauthor=D.+Janusauthor=P.+D.+Kaneauthor=M.+McDonnellauthor=G.+P.+Smithauthor=R.+Wakefordauthor=C.+V.+Walkerauthor=G.+Howarthauthor=W.+Hoyleauthor=M.+C.+Allenauthor=J.+Amblerauthor=K.+Butlerauthor=M.+D.+Talbot&title=Design+and+synthesis+of+thrombin+inhibitors%3A+analogues+of+MD-805+with+reduced+stereogenicity+and+improved+potency&doi=10.1021%2Fjm9811209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm9811209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811209%26sid%3Dliteratum%253Aachs%26aulast%3DBrundish%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DA.%26aulast%3DDonovan%26aufirst%3DV.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DGarman%26aufirst%3DS.%2BM.%26aulast%3DHayler%26aufirst%3DJ.%2BF.%26aulast%3DJanus%26aufirst%3DD.%26aulast%3DKane%26aufirst%3DP.%2BD.%26aulast%3DMcDonnell%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DWakeford%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DC.%2BV.%26aulast%3DHowarth%26aufirst%3DG.%26aulast%3DHoyle%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DM.%2BC.%26aulast%3DAmbler%26aufirst%3DJ.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DTalbot%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thrombin%2520inhibitors%253A%2520analogues%2520of%2520MD-805%2520with%2520reduced%2520stereogenicity%2520and%2520improved%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4584%26epage%3D4603%26doi%3D10.1021%2Fjm9811209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijikata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikumoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonomura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamao, Y.</span></span> <span> </span><span class="NLM_article-title">Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. the importance of stereo-structure of its hydrophobic carboxamide portion</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(81)91279-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0006-291X%2881%2991279-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1981&pages=440-446&author=S.+Okamotoauthor=A.+Hijikataauthor=R.+Kikumotoauthor=S.+Tonomuraauthor=H.+Haraauthor=K.+Ninomiyaauthor=A.+Maruyamaauthor=M.+Suganoauthor=Y.+Tamao&title=Potent+inhibition+of+thrombin+by+the+newly+synthesized+arginine+derivative+No.+805.+the+importance+of+stereo-structure+of+its+hydrophobic+carboxamide+portion&doi=10.1016%2F0006-291X%2881%2991279-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2881%2991279-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252881%252991279-1%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DHijikata%26aufirst%3DA.%26aulast%3DKikumoto%26aufirst%3DR.%26aulast%3DTonomura%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DH.%26aulast%3DNinomiya%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DSugano%26aufirst%3DM.%26aulast%3DTamao%26aufirst%3DY.%26atitle%3DPotent%2520inhibition%2520of%2520thrombin%2520by%2520the%2520newly%2520synthesized%2520arginine%2520derivative%2520No.%2520805.%2520the%2520importance%2520of%2520stereo-structure%2520of%2520its%2520hydrophobic%2520carboxamide%2520portion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1981%26volume%3D101%26spage%3D440%26epage%3D446%26doi%3D10.1016%2F0006-291X%2881%2991279-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matschinsky, F. M.</span></span> <span> </span><span class="NLM_article-title">Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.2337/diab.39.6.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2337%2Fdiab.39.6.647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=647-652&author=F.+M.+Matschinsky&title=Glucokinase+as+glucose+sensor+and+metabolic+signal+generator+in+pancreatic+beta-cells+and+hepatocytes&doi=10.2337%2Fdiab.39.6.647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.2337%2Fdiab.39.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.39.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26atitle%3DGlucokinase%2520as%2520glucose%2520sensor%2520and%2520metabolic%2520signal%2520generator%2520in%2520pancreatic%2520beta-cells%2520and%2520hepatocytes%26jtitle%3DDiabetes%26date%3D1990%26volume%3D39%26spage%3D647%26epage%3D652%26doi%3D10.2337%2Fdiab.39.6.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komorowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWolf, W. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinklin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraser, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veniant-Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coward, P.</span></span> <span> </span><span class="NLM_article-title">Novel series of potent glucokinase activators leading to the discovery of AM-2394</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=714-718&author=P.+J.+Dransfieldauthor=V.+Pattaropongauthor=S.+Laiauthor=Z.+Fuauthor=T.+J.+Kohnauthor=X.+Duauthor=A.+Chengauthor=Y.+Xiongauthor=R.+Komorowskiauthor=L.+Jinauthor=M.+Connauthor=E.+Tienauthor=W.+E.+DeWolfauthor=R.+J.+Hinklinauthor=T.+D.+Aicherauthor=C.+F.+Kraserauthor=S.+A.+Boydauthor=W.+C.+Voegtliauthor=K.+R.+Condroskiauthor=M.+Veniant-Ellisonauthor=J.+C.+Medinaauthor=J.+Houzeauthor=P.+Coward&title=Novel+series+of+potent+glucokinase+activators+leading+to+the+discovery+of+AM-2394&doi=10.1021%2Facsmedchemlett.6b00140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00140%26sid%3Dliteratum%253Aachs%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DConn%26aufirst%3DM.%26aulast%3DTien%26aufirst%3DE.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DKraser%26aufirst%3DC.%2BF.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DVeniant-Ellison%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DCoward%26aufirst%3DP.%26atitle%3DNovel%2520series%2520of%2520potent%2520glucokinase%2520activators%2520leading%2520to%2520the%2520discovery%2520of%2520AM-2394%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D714%26epage%3D718%26doi%3D10.1021%2Facsmedchemlett.6b00140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiravuri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, B. T.</span></span> <span> </span><span class="NLM_article-title">A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: a candidate target protease, quiescent cell proline dipeptidase</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">3092</span>– <span class="NLM_lpage">3099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=3092-3099&author=M.+Chiravuriauthor=T.+Schmitzauthor=K.+Yardleyauthor=R.+Underwoodauthor=Y.+Dayalauthor=B.+T.+Huber&title=A+novel+apoptotic+pathway+in+quiescent+lymphocytes+identified+by+inhibition+of+a+post-proline+cleaving+aminodipeptidase%3A+a+candidate+target+protease%2C+quiescent+cell+proline+dipeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiravuri%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DT.%26aulast%3DYardley%26aufirst%3DK.%26aulast%3DUnderwood%26aufirst%3DR.%26aulast%3DDayal%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26atitle%3DA%2520novel%2520apoptotic%2520pathway%2520in%2520quiescent%2520lymphocytes%2520identified%2520by%2520inhibition%2520of%2520a%2520post-proline%2520cleaving%2520aminodipeptidase%253A%2520a%2520candidate%2520target%2520protease%252C%2520quiescent%2520cell%2520proline%2520dipeptidase%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D3092%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woollatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaughan, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrell, M. D.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6150</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1046%2Fj.1432-1327.2000.01617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11012666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=6140-6150&author=C.+A.+Abbottauthor=D.+M.+Yuauthor=E.+Woollattauthor=G.+R.+Sutherlandauthor=G.+W.+McCaughanauthor=M.+D.+Gorrell&title=Cloning%2C+expression+and+chromosomal+localization+of+a+novel+human+dipeptidyl+peptidase+%28DPP%29+IV+homolog%2C+DPP8&doi=10.1046%2Fj.1432-1327.2000.01617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8</span></div><div class="casAuthors">Abbott, Catherine A.; Yu, Denise M. T.; Woollatt, Erica; Sutherland, Grant R.; McCaughan, Geoffrey W.; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6140-6150</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP) IV has roles in T-cell costimulation, chemokine biol., type-II diabetes and tumor biol.  Fibroblast activation protein (FAP) has been implicated in tumor growth and cirrhosis.  Here we describe DPP8, a novel human postproline dipeptidyl aminopeptidase that is homologous to DPPIV and FAP.  Northern-blot hybridization showed that the tissue expression of DPP8 mRNA is ubiquitous, similar to that of DPPIV.  The DPP8 gene was localized to chromosome 15q22, distinct from a closely related gene at 19p13.3 which we named DPP9.  The full-length DPP8 cDNA codes for an 882-amino-acid protein that has about 27% identity and 51% similarity to DPPIV and FAP, but no transmembrane domain and no N-linked or O-linked glycosylation.  Western blots and confocal microscopy of transfected COS-7 cells showed DPP8 to be a 100-kDa monomeric protein expressed in the cytoplasm.  Purified recombinant DPP8 hydrolyzed the DPPIV substrates Ala-Pro, Arg-Pro and Gly-Pro.  Thus recombinant DPP8 shares a postproline dipeptidyl aminopeptidase activity with DPPIV and FAP.  DPP8 enzyme activity had a neutral pH optimum consistent with it being nonlysosomal.  The similarities between DPP8 and DPPIV in tissue expression pattern and substrates suggests a potential role for DPP8 in T-cell activation and immune function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql4MaO3x94pLVg90H21EOLACvtfcHk0lgJzAcFlHYsig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLk%253D&md5=fdbd2f452b82c806a36dda9e5c646fe3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01617.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%2BM.%26aulast%3DWoollatt%26aufirst%3DE.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DCloning%252C%2520expression%2520and%2520chromosomal%2520localization%2520of%2520a%2520novel%2520human%2520dipeptidyl%2520peptidase%2520%2528DPP%2529%2520IV%2520homolog%252C%2520DPP8%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D6140%26epage%3D6150%26doi%3D10.1046%2Fj.1432-1327.2000.01617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coumar, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiaang, W. T.</span></span> <span> </span><span class="NLM_article-title">2-[3-[2-[(2<i>S</i>)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1021/jm0507781</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507781" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=373-380&author=H.+Tsuauthor=X.+Chenauthor=C.+T.+Chenauthor=S.+J.+Leeauthor=C.+N.+Changauthor=K.+H.+Kaoauthor=M.+S.+Coumarauthor=Y.+T.+Yehauthor=C.+H.+Chienauthor=H.+S.+Wangauthor=K.+T.+Linauthor=Y.+Y.+Changauthor=S.+H.+Wuauthor=Y.+S.+Chenauthor=I.+L.+Luauthor=S.+Y.+Wuauthor=T.+Y.+Tsaiauthor=W.+C.+Chenauthor=H.+P.+Hsiehauthor=Y.+S.+Chaoauthor=W.+T.+Jiaang&title=2-%5B3-%5B2-%5B%282S%29-2-Cyano-1-pyrrolidinyl%5D-2-oxoethylamino%5D-3-methyl-1-oxobutyl%5D-+1%2C2%2C3%2C4-tetrahydroisoquinoline%3A+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptide-derived+inhibitor+of+dipeptidyl+peptidase+IV&doi=10.1021%2Fjm0507781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fjm0507781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507781%26sid%3Dliteratum%253Aachs%26aulast%3DTsu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DKao%26aufirst%3DK.%2BH.%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DYeh%26aufirst%3DY.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DH.%2BS.%26aulast%3DLin%26aufirst%3DK.%2BT.%26aulast%3DChang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BS.%26aulast%3DLu%26aufirst%3DI.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26atitle%3D2-%255B3-%255B2-%255B%25282S%2529-2-Cyano-1-pyrrolidinyl%255D-2-oxoethylamino%255D-3-methyl-1-oxobutyl%255D-%25201%252C2%252C3%252C4-tetrahydroisoquinoline%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptide-derived%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D373%26epage%3D380%26doi%3D10.1021%2Fjm0507781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">N-Alkylpyrido[1′,2′:1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.03.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1894-1900&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=N-Alkylpyrido%5B1%E2%80%B2%2C2%E2%80%B2%3A1%2C5%5Dpyrazolo-%5B4%2C3-d%5Dpyrimidin-4-amines%3A+A+new+series+of+negative+allosteric+modulators+of+mGlu1%2F5+with+CNS+exposure+in+rodents&doi=10.1016%2Fj.bmcl.2016.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DN-Alkylpyrido%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%253A1%252C5%255Dpyrazolo-%255B4%252C3-d%255Dpyrimidin-4-amines%253A%2520A%2520new%2520series%2520of%2520negative%2520allosteric%2520modulators%2520of%2520mGlu1%252F5%2520with%2520CNS%2520exposure%2520in%2520rodents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1894%26epage%3D1900%26doi%3D10.1016%2Fj.bmcl.2016.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting beta(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>– <span class="NLM_lpage">6652</span>, <span class="refDoi"> DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+beta%282%29-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520beta%25282%2529-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, T. H.</span></span> <span> </span><span class="NLM_article-title">Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">5418</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.1021/ja010453j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja010453j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=5418-5423&author=H.+Lueschauthor=W.+Y.+Yoshidaauthor=R.+E.+Mooreauthor=V.+J.+Paulauthor=T.+H.+Corbett&title=Total+structure+determination+of+apratoxin+A%2C+a+potent+novel+cytotoxin+from+the+marine+cyanobacterium+Lyngbya+majuscula&doi=10.1021%2Fja010453j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fja010453j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja010453j%26sid%3Dliteratum%253Aachs%26aulast%3DLuesch%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DW.%2BY.%26aulast%3DMoore%26aufirst%3DR.%2BE.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DCorbett%26aufirst%3DT.%2BH.%26atitle%3DTotal%2520structure%2520determination%2520of%2520apratoxin%2520A%252C%2520a%2520potent%2520novel%2520cytotoxin%2520from%2520the%2520marine%2520cyanobacterium%2520Lyngbya%2520majuscula%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D5418%26epage%3D5423%26doi%3D10.1021%2Fja010453j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raya, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeJesus, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izpisua Belmonte, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A functional genomics approach to the mode of action of apratoxin A</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1038/nchembio769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnchembio769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16474387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVOjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=158-167&author=H.+Lueschauthor=S.+K.+Chandaauthor=R.+M.+Rayaauthor=P.+D.+DeJesusauthor=A.+P.+Orthauthor=J.+R.+Walkerauthor=J.+C.+Izpisua+Belmonteauthor=P.+G.+Schultz&title=A+functional+genomics+approach+to+the+mode+of+action+of+apratoxin+A&doi=10.1038%2Fnchembio769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">A functional genomics approach to the mode of action of apratoxin A</span></div><div class="casAuthors">Luesch, Hendrik; Chanda, Sumit K.; Raya, R. Marina; DeJesus, Paul D.; Orth, Anthony P.; Walker, John R.; Izpisua Belmonte, Juan Carlos; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-167</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cyanobacterial metabolite apratoxin A (1) demonstrates potent cytotoxicity against tumor cell lines by a hitherto unknown mechanism.  We have used functional genomics to elucidate the mol. basis for this activity.  Gene expression profiling and DNA content anal. showed that apratoxin A induces G1-phase cell cycle arrest and apoptosis.  Cell-based functional assays with a genome-wide collection of expression cDNAs showed that ectopic induction of fibroblast growth factor receptor (FGFR) signaling attenuates the apoptotic activity of apratoxin A. This natural product inhibited phosphorylation and activation of STAT3, a downstream effector of FGFR signaling.  It also caused defects in FGF-dependent processes during zebrafish development, with concomitant redns. in expression levels of the FGF target gene mkp3.  We conclude that apratoxin A mediates its antiproliferative activity through the induction of G1 cell cycle arrest and an apoptotic cascade, which is at least partially initiated through antagonism of FGF signaling via STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbXPD982PdrVg90H21EOLACvtfcHk0liQOb_xr1j23Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVOjsro%253D&md5=67aa1691124ab7452986c3ad59a3020a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1038%2Fnchembio769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio769%26sid%3Dliteratum%253Aachs%26aulast%3DLuesch%26aufirst%3DH.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DRaya%26aufirst%3DR.%2BM.%26aulast%3DDeJesus%26aufirst%3DP.%2BD.%26aulast%3DOrth%26aufirst%3DA.%2BP.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DIzpisua%2BBelmonte%26aufirst%3DJ.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520functional%2520genomics%2520approach%2520to%2520the%2520mode%2520of%2520action%2520of%2520apratoxin%2520A%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D158%26epage%3D167%26doi%3D10.1038%2Fnchembio769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Systematic chemical mutagenesis identifies a potent novel apratoxin A/E hybrid with improved in vivo antitumor activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1021/ml200176m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200176m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=861-865&author=Q.+Y.+Chenauthor=Y.+Liuauthor=H.+Luesch&title=Systematic+chemical+mutagenesis+identifies+a+potent+novel+apratoxin+A%2FE+hybrid+with+improved+in+vivo+antitumor+activity&doi=10.1021%2Fml200176m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity</span></div><div class="casAuthors">Chen, Qi-Yin; Liu, Yanxia; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">861-865</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apratoxins are cytotoxic marine natural products that prevent cotranslational translocation early in the secretory pathway.  We showed that apratoxins downregulate receptors and growth factor ligands, giving a one-two punch to cancer cells, particularly those that rely on autocrine loops.  Through total synthesis, we tested the effects of amino acid substitutions, including alanine scanning, on the downregulation of receptor tyrosine kinases and vascular endothelial growth factor A (VEGF-A) and probed the stereospecificity of target engagement by epimerization of selected chiral centers.  Differential effects on two types of secretory mols. suggest that the apratoxins' substrate selectivity with respect to inhibition of secretion may be tuned through structural modifications to provide tailored therapy.  Our structure-activity relation studies and medicinal chem. efforts led to a potent inhibitor with in vivo efficacy in a colorectal tumor xenograft model without irreversible toxicity exerted by apratoxin A, demonstrating that this novel mechanism of action has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIaTwsj3nxzrVg90H21EOLACvtfcHk0liQOb_xr1j23Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7%252FL&md5=d0eb91f607a63e065cc005b123f524bf</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fml200176m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200176m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DSystematic%2520chemical%2520mutagenesis%2520identifies%2520a%2520potent%2520novel%2520apratoxin%2520A%252FE%2520hybrid%2520with%2520improved%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D861%26epage%3D865%26doi%3D10.1021%2Fml200176m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3011</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1021/jm4019965</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4019965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3011-3029&author=Q.+Y.+Chenauthor=Y.+Liuauthor=W.+Caiauthor=H.+Luesch&title=Improved+total+synthesis+and+biological+evaluation+of+potent+apratoxin+S4+based+anticancer+agents+with+differential+stability+and+further+enhanced+activity&doi=10.1021%2Fjm4019965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity</span></div><div class="casAuthors">Chen, Qi-Yin; Liu, Yanxia; Cai, Weijing; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3011-3029</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apratoxins are cytotoxic natural products originally isolated from marine cyanobacteria that act by preventing cotranslational translocation early in the secretory pathway to downregulate receptor levels and inhibit growth factor secretion, leading to potent antiproliferative activity.  Through rational design and total synthesis of an apratoxin A/E hybrid, apratoxin S4 (1a), the authors have previously improved the antitumor activity and tolerability in vivo.  Compd. 1a and newly designed analogs apratoxins S7-S9 (1b-d), with various degrees of methylation at C34 (1b,c) or epimeric configuration at C30 (1d), were efficiently synthesized utilizing improved procedures.  Optimizations have been applied to the synthesis of key intermediate aldehyde 7 and further include the application of Leighton's silanes and modifications of Kelly's methods to induce thiazoline ring formation in other crucial steps of the apratoxin synthesis.  Apratoxin S9 (1d) exhibited increased activity with subnanomolar potency.  Apratoxin S8 (1c) lacks the propensity to be deactivated by dehydration and showed efficacy in a human HCT116 xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCVt6ZWY8MirVg90H21EOLACvtfcHk0lhTO6w5gWRCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamtL4%253D&md5=7f33d6cb7d827d4c58becd49326c4873</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm4019965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4019965%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DImproved%2520total%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520potent%2520apratoxin%2520S4%2520based%2520anticancer%2520agents%2520with%2520differential%2520stability%2520and%2520further%2520enhanced%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3011%26epage%3D3029%26doi%3D10.1021%2Fjm4019965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beesley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. F.</span></span> <span> </span><span class="NLM_article-title">CXIX.—The formation and stability of spiro-compounds. Part I. spiro-compounds from cyclohexane</span>. <i>J. Chem. Soc., Trans.</i> <span class="NLM_year" style="font-weight: bold;">1915</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1039/CT9150701080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FCT9150701080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaC2MXhvVGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1915&pages=1080-1106&author=R.+M.+Beesleyauthor=C.+K.+Ingoldauthor=J.+F.+Thorpe&title=CXIX.%E2%80%94The+formation+and+stability+of+spiro-compounds.+Part+I.+spiro-compounds+from+cyclohexane&doi=10.1039%2FCT9150701080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and stability of spiro-compounds. I. Spiro-compounds from cyclohexano</span></div><div class="casAuthors">Beesley, Richard M.; Ingold, Christopher K.; Thorpe, Jocelyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Transactions</span>
        (<span class="NLM_cas:date">1915</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1080-1106</span>CODEN:
                <span class="NLM_cas:coden">JCHTA3</span>;
        ISSN:<span class="NLM_cas:issn">0368-1645</span>.
    </div><div class="casAbstract">A series of investigations has been undertaken with the object of ascertaining "the effect produced by the alteration of the tetrahedral angle consequent on ring formation, on the formation and stability of a 2nd ring joined to the existing ring by a quaternary C atom common to both."  The hypothesis was advanced that the angle formed by the 2 side chains attached to any 1 C atom of the cyclohexane ring will be altered in proportion to any change in angle between those valencies which participate in ring formation; i. e., the groups attached to 2 side chains emanating from the same C atom of a cyclohexane deriv., type (I), will be closer together than in a corresponding compd. having the open chain structure, type (II).  Expts. show that this hypothesis is probably correct.  For example a trans-spiro-acid, derived from a compd. of type (I) is more stable than trans-caronic acid, derived from a compd. of type (II).  The above hypothesis and another untenable one are presented and discussed in some detail and diagrammatically represented by showing the effect of "strain" on the angles between the valencies (represented by the apices of an inscribed tetrahedron) of a (spherical) C atom.  The bromination of CH2(CH2)4C(CH2CO2H)2 by means of PBr5 and Br led to the formation of a mixt. containing an acid product, probably C5H10>C(CHBrCO2H)(CH2CO2Et) (A), and a neutral product (B).  The latter was shown to be a mixt. of cis-diethyl α,α'-dibromocyclohexane-1,1-diacetate (C) (not obtained in the pure state) and the trans-lactone (D), C5H10>C.CH(CO2Et).O.CO.CHBr, prisms from petroleum or alc., m. 96°, b20 225-30°. (D) was sepd. from the mixt. (B) by the addition of an equal vol. of petroleum (b. 60-70°) and was also synthesized by boiling (C) with C5H5N [whereby only the trans-form of (C) was converted into (D)] or by distg. (C), whereby both the cis- and trans-forms were converted.  The isomeric cis-lactone (D'), microneedles, m. 69-70°, was formed in 25% yield upon distg. (C) from which (D) had been previously removed by means of C5H5N.  α-Hydroxycyclohexane-1,1-diacetic acid lactone (E), C5H10>C.CH(CO2H).O.CO.CH2, b13 240-1°, crystg. after long standing and seeding, microneedles, m. 91-2° (silver salt, amorphous), was formed from (A) by the action of boiling Na2CO3.  The free acid (F) corresponding to (E) could not be isolated and was found to be stable only in the form of its salts.  The amorphous silver salt and cryst. sodium salt of (F) were prepd.  The dianilide of (F), C5H10>C(CH2CONHPh)CH(OH)CONHPh, needles, m. 97°.  The aniline salt of (E), silky needles, m. 104°.  When (A) was added to boiling concd. KOH and the reaction mixt. cooled and acidified, trans-cyclohexane-spiro-cyclopropane-1,2-dicarboxylic acid (G), C5H10>C.CH(CO2H).CHCO2H, flattened needles, m. 237°, was formed.  Its silver salt sepd. in the form of a cryst. powder: its dianilide, needles, m. 292°.  The filtrate from (G) after extn. with Et2O and fractionation under reduced pressure yielded the cis-isomer (H) of (G), needles, m. 198°, more readily formed by distg. (G) which is first converted into the anhydride (J), C5H10>C.CH.CO.O.CO.CH, needles, m. 102°, which on treatment with alkali and subsequent acidification yields (H).  (J) was also readily prepd. by the interaction of (H) and AcCl, whereas (G) is not acted upon by this reagent.  The anilic acid, C5H10>C.CH(CO2H).CHCONHPh, derived from (J), small needles,m. 207° (decompn.); the corresponding anil, m. 119°.  When heated in a sealed tube with 50% concd. HCl at 180° for 5 hrs., (H) is partially reconverted into (G).  On attempting to replace the Br in (D) by an OH group, by means of moist Ag2O, ethyl α-hydroxycyclohexane-1,1-diacetate lactone, C5H10> C.CH2CO.O.CHCO2Et, b21 210°, was obtained and yielded (E) on hydrolysis.  The following hydrolysis products were formed when (D) was treated with boiling 15% aq. NaOH:C5H10>C:CHCO2H (K), m. 92° (identical with Wallach's acid as shown by the formation of the dibromide, m. 135-6°; ref. not given), and the trans-lactonic acid of α,α'-dihydroxycyclohexane-1,1-diacetic acid (L), C5H10>C.CH(OH).CO.O.CHCO2H.H2O, prisms, 100°, anhydrous, m. 145°.  (D') when subjected to a similar hydrolysis gave rise to a mixt. of (K), the cis-isomer (M) of (L), prisms, m. 168°, and cyclohexane-spiro-cyclopropanol-2,3-dicarboxylic acid (N), C5H10>C.C(OH)(CO2H).CHCO2H, pearly plates, m. 217°.  Boiling alc. KOH, reacting with (D), yielded (K), (L) and (N).  The action of 64% aq. KOH on (D) gave rise to a mixt. of (L), (N) and Δ1-cyclohexeneacetic acid, (O), CH2(CH2)3CH:C.CH2CO2H, m. 38° (identical with Wallach's compd.; also quant. formed by boiling (K) with 64% KOH, thus indicating that it was a byproduct in the above reaction).  The Et ester of (O), b25 118-2° (cf. Auwers and Ellinger, C. A. 6, 1147).  A similar reaction between 64% KOH and (D') gave rise to (O), (M) and (N).  (K) and (N) were sepd. by treatment with dry Et2O in which (N) is insol.  (L) was ordinarily sepd. from hydrolysis mixts. by esterifying and fractionating the ethyl ester, b25 206-10°.  The following derivs. of (L) are described: disodium salt, cryst.; disilver salt, powder; aniline salt, microcrystals, m. 133-4°; dianilide, C5H10>C[CH(OH)CONHPh]2, short needles, m. 169°.  (L) does not react with AcCl, is not reduced by AgOH, and when heated with H2O in a sealed tube or when distd., passes into (M).  The isolation of (M) was effected by esterifying hydrolysis mixts. and collecting the fraction of highest b. p., which was subsequently hydrolyzed with HCl.  (M) was readily acetylated.  The following derivs. of (M) were prepd.: disilver salt; dianilide, needles, m. 169° (not identical with the dianilide derived from (L)); acetate, C5H10>CH(OAc).CO.O.CHCO2H, m. 156° (silver salt of the acetate, cryst. powder).  The spiro-acid (N), which like (L) could not be acetylated, which is not converted into the lactone on heating and is otherwise stable, gave rise to the following compds.: silver salt, cryst. powder; anilide, needles, m. 202°.  Concd. H2SO4 acting upon (L) at 95-100°, gave rise to small amts. of cyclohexane-spiro-cyclopentanone, oil (forming a semicarbazone, needles, m. 175°), and an unidentified compd., m. 105°.  When heated with an equal amt. of H2O in a sealed tube at 240° for 0.5 hr., (L) yielded the lactonic acid of α-hydroxy-α'-cyclohexan-1-olsuccinic acid, C5H10>C.O.CO.CH(OH).CHCO2H, cubical prisms, m. 131°, whose disodium salt, disilver salt and aniline salt, m. 123°, were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLfaoba7kGULVg90H21EOLACvtfcHk0lhTO6w5gWRCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaC2MXhvVGiuw%253D%253D&md5=de4306fddc79f71809a8556525abc983</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1039%2FCT9150701080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FCT9150701080%26sid%3Dliteratum%253Aachs%26aulast%3DBeesley%26aufirst%3DR.%2BM.%26aulast%3DIngold%26aufirst%3DC.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BF.%26atitle%3DCXIX.%25E2%2580%2594The%2520formation%2520and%2520stability%2520of%2520spiro-compounds.%2520Part%2520I.%2520spiro-compounds%2520from%2520cyclohexane%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Trans.%26date%3D1915%26volume%3D107%26spage%3D1080%26epage%3D1106%26doi%3D10.1039%2FCT9150701080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkilineni, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casazza, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D. M.</span></span> <span> </span><span class="NLM_article-title">Novel, water-soluble phosphate derivatives of 2′-ethoxy carbonylpaclitaxel as potential prodrugs of paclitaxel: Synthesis and antitumor evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00018-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0960-894X%2895%2900018-O" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=247-252&author=Y.+Uedaauthor=J.+D.+Matiskellaauthor=A.+B.+Mikkilineniauthor=V.+Farinaauthor=J.+O.+Knipeauthor=W.+C.+Roseauthor=A.+M.+Casazzaauthor=D.+M.+Vyas&title=Novel%2C+water-soluble+phosphate+derivatives+of+2%E2%80%B2-ethoxy+carbonylpaclitaxel+as+potential+prodrugs+of+paclitaxel%3A+Synthesis+and+antitumor+evaluation&doi=10.1016%2F0960-894X%2895%2900018-O"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900018-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900018-O%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatiskella%26aufirst%3DJ.%2BD.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DCasazza%26aufirst%3DA.%2BM.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26atitle%3DNovel%252C%2520water-soluble%2520phosphate%2520derivatives%2520of%25202%25E2%2580%25B2-ethoxy%2520carbonylpaclitaxel%2520as%2520potential%2520prodrugs%2520of%2520paclitaxel%253A%2520Synthesis%2520and%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D247%26epage%3D252%26doi%3D10.1016%2F0960-894X%2895%2900018-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.11.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=636-641&author=B.+A.+Winnauthor=Z.+Shiauthor=G.+J.+Carlsonauthor=Y.+Wangauthor=B.+L.+Nguyenauthor=E.+M.+Kellyauthor=R.+D.+Rossauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Bioreductively+activatable+prodrug+conjugates+of+phenstatin+designed+to+target+tumor+hypoxia&doi=10.1016%2Fj.bmcl.2016.11.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.093%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DCarlson%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DKelly%26aufirst%3DE.%2BM.%26aulast%3DRoss%26aufirst%3DR.%2BD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DBioreductively%2520activatable%2520prodrug%2520conjugates%2520of%2520phenstatin%2520designed%2520to%2520target%2520tumor%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D636%26epage%3D641%26doi%3D10.1016%2Fj.bmcl.2016.11.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knabb, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3345</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.05.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3341-3345&author=M.+J.+Orwatauthor=J.+X.+Qiaoauthor=K.+Heauthor=A.+R.+Rendinaauthor=J.+M.+Luettgenauthor=K.+A.+Rossiauthor=B.+Xinauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=P.+Y.+Lamauthor=D.+J.+Pinto&title=Orally+bioavailable+factor+Xa+inhibitors+containing+alpha-substituted+gem-dimethyl+P4+moieties&doi=10.1016%2Fj.bmcl.2014.05.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.101%26sid%3Dliteratum%253Aachs%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26atitle%3DOrally%2520bioavailable%2520factor%2520Xa%2520inhibitors%2520containing%2520alpha-substituted%2520gem-dimethyl%2520P4%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3341%26epage%3D3345%26doi%3D10.1016%2Fj.bmcl.2014.05.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matcha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnaard, A. J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed asymmetric quaternary stereocenter formation</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6907</span>– <span class="NLM_lpage">6914</span>, <span class="refDoi"> DOI: 10.1002/chem.201200694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fchem.201200694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22532469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6907-6914&author=A.+L.+Gottumukkalaauthor=K.+Matchaauthor=M.+Lutzauthor=J.+G.+de+Vriesauthor=A.+J.+Minnaard&title=Palladium-catalyzed+asymmetric+quaternary+stereocenter+formation&doi=10.1002%2Fchem.201200694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Asymmetric Quaternary Stereocenter Formation</span></div><div class="casAuthors">Gottumukkala, Aditya L.; Matcha, Kiran; Lutz, Martin; de Vries, Johannes G.; Minnaard, Adriaan J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6907-6914, S6907/1-S6907/42</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient palladium catalyst is presented for the formation of benzylic quaternary stereocenters by conjugate addn. of arylboronic acids to a variety of β,β-disubstituted carbocyclic, heterocyclic, and acyclic enones.  The catalyst is readily prepd. from PdCl2, PhBOX, and AgSbF6, and provides products in up to 99 % enantiomeric excess, with good yields.  Based on this strategy, (-)-α-cuparenone has been prepd. in only two steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNbar8BRKvO7Vg90H21EOLACvtfcHk0lgHo9U1WP4PKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFCiurY%253D&md5=c78f9884aac12ee7f8b58ee3a067ca3c</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1002%2Fchem.201200694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201200694%26sid%3Dliteratum%253Aachs%26aulast%3DGottumukkala%26aufirst%3DA.%2BL.%26aulast%3DMatcha%26aufirst%3DK.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BG.%26aulast%3DMinnaard%26aufirst%3DA.%2BJ.%26atitle%3DPalladium-catalyzed%2520asymmetric%2520quaternary%2520stereocenter%2520formation%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2012%26volume%3D18%26spage%3D6907%26epage%3D6914%26doi%3D10.1002%2Fchem.201200694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of purported cephalosporolides H and I, penisporolide B, and their stereoisomers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">4325</span>– <span class="NLM_lpage">4339</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=4325-4339&author=J.+Wangauthor=R.+Tong&title=Total+synthesis+of+purported+cephalosporolides+H+and+I%2C+penisporolide+B%2C+and+their+stereoisomers&doi=10.1021%2Facs.joc.6b00788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DR.%26atitle%3DTotal%2520synthesis%2520of%2520purported%2520cephalosporolides%2520H%2520and%2520I%252C%2520penisporolide%2520B%252C%2520and%2520their%2520stereoisomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D4325%26epage%3D4339%26doi%3D10.1021%2Facs.joc.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathya Shankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subba Rao, G. S. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis based on cyclohexadienes: Part 30—Synthesis of 2-nor-cedrene and some analogues of funebrene</span>. <i>Indian J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39B</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39B&publication_year=2000&pages=94-102&author=H.+K.+Hariprakashaauthor=P.+Sathya+Shankarauthor=G.+S.+R.+Subba+Rao&title=Synthesis+based+on+cyclohexadienes%3A+Part+30%E2%80%94Synthesis+of+2-nor-cedrene+and+some+analogues+of+funebrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DSathya%2BShankar%26aufirst%3DP.%26aulast%3DSubba%2BRao%26aufirst%3DG.%2BS.%2BR.%26atitle%3DSynthesis%2520based%2520on%2520cyclohexadienes%253A%2520Part%252030%25E2%2580%2594Synthesis%2520of%25202-nor-cedrene%2520and%2520some%2520analogues%2520of%2520funebrene%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D2000%26volume%3D39B%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivik, M. R.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of (−)-austalide B. A generic solution to elaboration of the pyran/p-cresol/butenolide triad</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">11323</span>– <span class="NLM_lpage">11334</span>, <span class="refDoi"> DOI: 10.1021/ja00104a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00104a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=11323-11334&author=L.+A.+Paquetteauthor=T.+Z.+Wangauthor=M.+R.+Sivik&title=Total+synthesis+of+%28%E2%88%92%29-austalide+B.+A+generic+solution+to+elaboration+of+the+pyran%2Fp-cresol%2Fbutenolide+triad&doi=10.1021%2Fja00104a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fja00104a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00104a012%26sid%3Dliteratum%253Aachs%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BZ.%26aulast%3DSivik%26aufirst%3DM.%2BR.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-austalide%2520B.%2520A%2520generic%2520solution%2520to%2520elaboration%2520of%2520the%2520pyran%252Fp-cresol%252Fbutenolide%2520triad%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D11323%26epage%3D11334%26doi%3D10.1021%2Fja00104a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, M.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Heck reaction–carbanion capture process. Catalytic asymmetric total synthesis of (−)-Δ9(12)-capnellene</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">7108</span>– <span class="NLM_lpage">7116</span>, <span class="refDoi"> DOI: 10.1021/ja9609359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9609359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7108-7116&author=T.+Ohshimaauthor=K.+Kagechikaauthor=M.+Adachiauthor=M.+Sodeokaauthor=M.+Shibasaki&title=Asymmetric+Heck+reaction%E2%80%93carbanion+capture+process.+Catalytic+asymmetric+total+synthesis+of+%28%E2%88%92%29-%CE%949%2812%29-capnellene&doi=10.1021%2Fja9609359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fja9609359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9609359%26sid%3Dliteratum%253Aachs%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DShibasaki%26aufirst%3DM.%26atitle%3DAsymmetric%2520Heck%2520reaction%25E2%2580%2593carbanion%2520capture%2520process.%2520Catalytic%2520asymmetric%2520total%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-%25CE%25949%252812%2529-capnellene%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7108%26epage%3D7116%26doi%3D10.1021%2Fja9609359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. S.</span></span> <span> </span><span class="NLM_article-title">Towards oleananes: geminal dimethylation at C-4</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9685</span>– <span class="NLM_lpage">9686</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(94)88359-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0040-4039%2894%2988359-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=9685-9686&author=G.+S.+Jones&title=Towards+oleananes%3A+geminal+dimethylation+at+C-4&doi=10.1016%2F0040-4039%2894%2988359-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2894%2988359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252894%252988359-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%2BS.%26atitle%3DTowards%2520oleananes%253A%2520geminal%2520dimethylation%2520at%2520C-4%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D9685%26epage%3D9686%26doi%3D10.1016%2F0040-4039%2894%2988359-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holubec, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span> <span> </span><span class="NLM_article-title">Application of reactive enols in synthesis: A versatile, efficient, and stereoselective construction of the welwitindolinone carbon skeleton</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">6326</span>– <span class="NLM_lpage">6327</span>, <span class="refDoi"> DOI: 10.1021/ja991022s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja991022s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXjslOjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=6326-6327&author=J.+L.+Woodauthor=A.+A.+Holubecauthor=B.+M.+Stoltzauthor=M.+M.+Weissauthor=J.+A.+Dixonauthor=B.+D.+Doanauthor=M.+F.+Shamjiauthor=J.+M.+Chenauthor=T.+P.+Heffron&title=Application+of+reactive+enols+in+synthesis%3A+A+versatile%2C+efficient%2C+and+stereoselective+construction+of+the+welwitindolinone+carbon+skeleton&doi=10.1021%2Fja991022s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Reactive Enols in Synthesis: A Versatile, Efficient, and Stereoselective Construction of the Welwitindolinone Carbon Skeleton</span></div><div class="casAuthors">Wood, John L.; Holubec, Alexandra A.; Stoltz, Brian M.; Weiss, Matthew M.; Dixon, Julie A.; Doan, Brian D.; Shamji, Mohammed F.; Chen, Jennifer M.; Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6326-6327</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The welwitindolinone carbon skeleton I was prepd. in 15 steps from isatin via insertion reaction of the diazoketone II in presence of Montmorillonite K10 clay to give the cyclopropane III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2epk6O0-S0bVg90H21EOLACvtfcHk0li3GbYTH6Thiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslOjt7Y%253D&md5=86d4268ea5393cd439e55a6d0c966a07</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Fja991022s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja991022s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BL.%26aulast%3DHolubec%26aufirst%3DA.%2BA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DDoan%26aufirst%3DB.%2BD.%26aulast%3DShamji%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DApplication%2520of%2520reactive%2520enols%2520in%2520synthesis%253A%2520A%2520versatile%252C%2520efficient%252C%2520and%2520stereoselective%2520construction%2520of%2520the%2520welwitindolinone%2520carbon%2520skeleton%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D6326%26epage%3D6327%26doi%3D10.1021%2Fja991022s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paxton, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitwood, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J. K.</span></span> <span> </span><span class="NLM_article-title">Gem-dimethylcyclopropanation using triisopropylsulfoxonium tetrafluoroborate: scope and limitations</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">3279</span>– <span class="NLM_lpage">3288</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1083165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1055%2Fs-0028-1083165" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=3279-3288&author=M.+G.+Edwardsauthor=R.+J.+Paxtonauthor=D.+S.+Pughauthor=A.+C.+Whitwoodauthor=R.+J.+K.+Taylor&title=Gem-dimethylcyclopropanation+using+triisopropylsulfoxonium+tetrafluoroborate%3A+scope+and+limitations&doi=10.1055%2Fs-0028-1083165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1083165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1083165%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BG.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DPugh%26aufirst%3DD.%2BS.%26aulast%3DWhitwood%26aufirst%3DA.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%2BK.%26atitle%3DGem-dimethylcyclopropanation%2520using%2520triisopropylsulfoxonium%2520tetrafluoroborate%253A%2520scope%2520and%2520limitations%26jtitle%3DSynthesis%26date%3D2008%26volume%3D2008%26spage%3D3279%26epage%3D3288%26doi%3D10.1055%2Fs-0028-1083165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papillon, J. P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beil, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaSala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksander, G. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships, pharmacokinetics, and in vivo activity of CYP11B2 and CYP11B1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4749</span>– <span class="NLM_lpage">4770</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4749-4770&author=J.+P.+N.+Papillonauthor=C.+M.+Adamsauthor=Q.+Y.+Huauthor=C.+Louauthor=A.+K.+Singhauthor=C.+Zhangauthor=J.+Carvalhoauthor=S.+Rajanauthor=A.+Amaralauthor=M.+E.+Beilauthor=F.+Fuauthor=E.+Ganglauthor=C.+W.+Huauthor=A.+Y.+Jengauthor=D.+LaSalaauthor=G.+Liangauthor=M.+Logmanauthor=W.+M.+Maniaraauthor=D.+F.+Rigelauthor=S.+A.+Smithauthor=G.+M.+Ksander&title=Structure-activity+relationships%2C+pharmacokinetics%2C+and+in+vivo+activity+of+CYP11B2+and+CYP11B1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DPapillon%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DHu%26aufirst%3DQ.%2BY.%26aulast%3DLou%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCarvalho%26aufirst%3DJ.%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DBeil%26aufirst%3DM.%2BE.%26aulast%3DFu%26aufirst%3DF.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DC.%2BW.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DKsander%26aufirst%3DG.%2BM.%26atitle%3DStructure-activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520in%2520vivo%2520activity%2520of%2520CYP11B2%2520and%2520CYP11B1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4749%26epage%3D4770%26doi%3D10.1021%2Facs.jmedchem.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical development candidate GDC-0084, a brain penetrant inhibitor of PI3K and mTOR</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=351-356&author=T.+P.+Heffronauthor=C.+O.+Ndubakuauthor=L.+Salphatiauthor=B.+Alickeauthor=J.+Cheongauthor=J.+Drobnickauthor=K.+Edgarauthor=S.+E.+Gouldauthor=L.+B.+Leeauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=J.+Nonomiyaauthor=J.+Pangauthor=E.+G.+Pliseauthor=S.+Siderisauthor=J.+Wallinauthor=L.+Wangauthor=X.+Zhangauthor=A.+G.+Olivero&title=Discovery+of+clinical+development+candidate+GDC-0084%2C+a+brain+penetrant+inhibitor+of+PI3K+and+mTOR&doi=10.1021%2Facsmedchemlett.6b00005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00005%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPlise%26aufirst%3DE.%2BG.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWallin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%2520clinical%2520development%2520candidate%2520GDC-0084%252C%2520a%2520brain%2520penetrant%2520inhibitor%2520of%2520PI3K%2520and%2520mTOR%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D351%26epage%3D356%26doi%3D10.1021%2Facsmedchemlett.6b00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Andriy I. Frolov, Eugeniy N. Ostapchuk, Alexander E. Pashenko, Yaroslav O. Chuchvera, Eduard B. Rusanov, Dmitriy M. Volochnyuk, <span class="NLM_string-name hlFld-ContribAuthor">Sergey V. Ryabukhin</span>. </span><span class="cited-content_cbyCitation_article-title">Selective α-Methylation of Ketones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (11)
                                     , 7333-7346. <a href="https://doi.org/10.1021/acs.joc.1c00148" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00148%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSelective%252B%2525CE%2525B1-Methylation%252Bof%252BKetones%26aulast%3DFrolov%26aufirst%3DAndriy%2BI.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D27052021%26volume%3D86%26issue%3D11%26spage%3D7333%26epage%3D7346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinyi Ren, Chaoren Shen, Guangzhu Wang, Zhanglin Shi, Xinxin Tian, <span class="NLM_string-name hlFld-ContribAuthor">Kaiwu Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Access to α-Cyano Carbonyls Bearing a Quaternary Carbon Center by Reductive Cyanation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2527-2532. <a href="https://doi.org/10.1021/acs.orglett.1c00465" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00465%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAccess%252Bto%252B%2525CE%2525B1-Cyano%252BCarbonyls%252BBearing%252Ba%252BQuaternary%252BCarbon%252BCenter%252Bby%252BReductive%252BCyanation%26aulast%3DRen%26aufirst%3DXinyi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07022021%26date%3D24032021%26volume%3D23%26issue%3D7%26spage%3D2527%26epage%3D2532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Philip R. D. Murray, Willem M. M. Bussink, Geraint H. M. Davies, Farid W. van der Mei, Alyssa H. Antropow, Jacob T. Edwards, Laura Akullian D’Agostino, J. Michael Ellis, Lawrence G. Hamann, Fedor Romanov-Michailidis, <span class="NLM_string-name hlFld-ContribAuthor">Robert R. Knowles</span>. </span><span class="cited-content_cbyCitation_article-title">Intermolecular Crossed [2 + 2] Cycloaddition Promoted by Visible-Light Triplet Photosensitization: Expedient Access to Polysubstituted 2-Oxaspiro[3.3]heptanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (10)
                                     , 4055-4063. <a href="https://doi.org/10.1021/jacs.1c01173" title="DOI URL">https://doi.org/10.1021/jacs.1c01173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c01173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DIntermolecular%252BCrossed%252B%25255B2%252B%25252B%252B2%25255D%252BCycloaddition%252BPromoted%252Bby%252BVisible-Light%252BTriplet%252BPhotosensitization%25253A%252BExpedient%252BAccess%252Bto%252BPolysubstituted%252B2-Oxaspiro%25255B3.3%25255Dheptanes%26aulast%3DMurray%26aufirst%3DPhilip%2BR.%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30012021%26date%3D05032021%26volume%3D143%26issue%3D10%26spage%3D4055%26epage%3D4063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Zhen Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Navigating the Pauson–Khand Reaction in Total Syntheses of Complex Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (3)
                                     , 556-568. <a href="https://doi.org/10.1021/acs.accounts.0c00709" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00709%26sid%3Dliteratum%253Aachs%26jtitle%3DCCS%2520Chem.%26date%3D2019%26volume%3D1%26spage%3D3%26epage%3D37%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DNavigating%252Bthe%252BPauson%2525E2%252580%252593Khand%252BReaction%252Bin%252BTotal%252BSyntheses%252Bof%252BComplex%252BNatural%252BProducts%26aulast%3DYang%26aufirst%3DZhen%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30102020%26date%3D07012021%26volume%3D54%26issue%3D3%26spage%3D556%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pengfei Hu, Byron K. Peters, Christian A. Malapit, Julien C. Vantourout, Pan Wang, Jinjun Li, Lucas Mele, Pierre-Georges Echeverria, Shelley D. Minteer, <span class="NLM_string-name hlFld-ContribAuthor">Phil S. Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Electroreductive Olefin–Ketone Coupling. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (50)
                                     , 20979-20986. <a href="https://doi.org/10.1021/jacs.0c11214" title="DOI URL">https://doi.org/10.1021/jacs.0c11214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c11214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c11214%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DElectroreductive%252BOlefin%2525E2%252580%252593Ketone%252BCoupling%26aulast%3DHu%26aufirst%3DPengfei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24102020%26date%3D01122020%26volume%3D142%26issue%3D50%26spage%3D20979%26epage%3D20986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Adam Ametovski, Christa Macdonald, Jamie J. Manning, S. A. Syed Haneef, Marina Santiago, Lewis Martin, Eric Sparkes, Andrew Reckers, Roy R. Gerona, Mark Connor, Michelle Glass, <span class="NLM_string-name hlFld-ContribAuthor">Samuel D. Banister</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (21)
                                     , 3672-3682. <a href="https://doi.org/10.1021/acschemneuro.0c00591" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DExploring%252BStereochemical%252Band%252BConformational%252BRequirements%252Bat%252BCannabinoid%252BReceptors%252Bfor%252BSynthetic%252BCannabinoids%252BRelated%252Bto%252BSDB-006%25252C%252B5F-SDB-006%25252C%252BCUMYL-PICA%25252C%252Band%252B5F-CUMYL-PICA%26aulast%3DAmetovski%26aufirst%3DAdam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09092020%26date%3D01102020%26date%3D15102020%26volume%3D11%26issue%3D21%26spage%3D3672%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Athri D. Rathnayake, Yunjeong Kim, Chamandi S. Dampalla, Harry Nhat Nguyen, Abdul-Rahman M. Jesri, Maithri M. Kashipathy, Gerald H. Lushington, Kevin P. Battaile, Scott Lovell, Kyeong-Ok Chang, <span class="NLM_string-name hlFld-ContribAuthor">William C. Groutas</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11945-11963. <a href="https://doi.org/10.1021/acs.jmedchem.0c01252" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01252%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BOptimization%252Bof%252BDipeptidyl%252BInhibitors%252Bof%252BNorovirus%252B3CL%252BProtease%26aulast%3DRathnayake%26aufirst%3DAthri%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D02102020%26date%3D18092020%26volume%3D63%26issue%3D20%26spage%3D11945%26epage%3D11963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Keisuke Sekine, Aina Ushiyama, Yu Endo, <span class="NLM_string-name hlFld-ContribAuthor">Koichi Mikami</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Functionalization of Difluorocyclopropenes Catalyzed by Chiral Copper Complexes: Proposal for Chiral gem-Dimethyl and tert-Butyl Analogues. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (12)
                                     , 7916-7924. <a href="https://doi.org/10.1021/acs.joc.0c00622" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00622%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnantioselective%252BFunctionalization%252Bof%252BDifluorocyclopropenes%252BCatalyzed%252Bby%252BChiral%252BCopper%252BComplexes%25253A%252BProposal%252Bfor%252BChiral%252Bgem-Dimethyl%252Band%252Btert-Butyl%252BAnalogues%26aulast%3DSekine%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09032020%26date%3D02062020%26date%3D19052020%26volume%3D85%26issue%3D12%26spage%3D7916%26epage%3D7924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao-Wang Chen, Lei Zhu, Yong-Yuan Gui, Ke Jing, Yuan-Xu Jiang, Zhi-Yu Bo, Yu Lan, Jing Li, <span class="NLM_string-name hlFld-ContribAuthor">Da-Gang Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective and Catalytic Generation of Acyclic Quaternary Carbon Stereocenters via Functionalization of 1,3-Dienes with CO2. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (47)
                                     , 18825-18835. <a href="https://doi.org/10.1021/jacs.9b09721" title="DOI URL">https://doi.org/10.1021/jacs.9b09721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b09721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b09721%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHighly%252BSelective%252Band%252BCatalytic%252BGeneration%252Bof%252BAcyclic%252BQuaternary%252BCarbon%252BStereocenters%252Bvia%252BFunctionalization%252Bof%252B1%25252C3-Dienes%252Bwith%252BCO2%26aulast%3DChen%26aufirst%3DXiao-Wang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08092019%26date%3D18112019%26date%3D08112019%26volume%3D141%26issue%3D47%26spage%3D18825%26epage%3D18835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu-Hsun Li, Pavan Sudheer Akula, Bor-Cherng Hong, Chieh-Hung Peng, <span class="NLM_string-name hlFld-ContribAuthor">Gene-Hsiang Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Transformation of Nitroalkanes to Nitriles Enabled by Visible-Light Photoredox Catalysis and a Domino Reaction Process. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (19)
                                     , 7750-7754. <a href="https://doi.org/10.1021/acs.orglett.9b02682" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02682%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirect%252BTransformation%252Bof%252BNitroalkanes%252Bto%252BNitriles%252BEnabled%252Bby%252BVisible-Light%252BPhotoredox%252BCatalysis%252Band%252Ba%252BDomino%252BReaction%252BProcess%26aulast%3DLi%26aufirst%3DYu-Hsun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30072019%26date%3D12092019%26volume%3D21%26issue%3D19%26spage%3D7750%26epage%3D7754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Uday Kiran Velagapudi, Marie-France Langelier, Cristina Delgado-Martin, Morgan E. Diolaiti, Sietske Bakker, Alan Ashworth, Bhargav A. Patel, Xuwei Shao, John M. Pascal, <span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5330-5357. <a href="https://doi.org/10.1021/acs.jmedchem.8b01709" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01709%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase%252BInhibitors%25253A%252BImpact%252Bof%252BAdenosine%252BPocket-Binding%252BMotif%252BAppendage%252Bto%252Bthe%252B3-Oxo-2%25252C3-dihydrobenzofuran-7-carboxamide%252Bon%252BPotency%252Band%252BSelectivity%26aulast%3DVelagapudi%26aufirst%3DUday%2BKiran%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D01112018%26date%3D24052019%26date%3D01052019%26volume%3D62%26issue%3D11%26spage%3D5330%26epage%3D5357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brandon
A. Wright, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Ardolino</span>. </span><span class="cited-content_cbyCitation_article-title">Surprising Reactivity in NiXantphos/Palladium-Catalyzed α-Arylation of Substituted Cyclopropyl Nitriles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4670-4679. <a href="https://doi.org/10.1021/acs.joc.8b02238" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02238%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSurprising%252BReactivity%252Bin%252BNiXantphos%25252FPalladium-Catalyzed%252B%2525CE%2525B1-Arylation%252Bof%252BSubstituted%252BCyclopropyl%252BNitriles%26aulast%3DWright%26aufirst%3DBrandon%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29082018%26date%3D19112018%26date%3D09112018%26volume%3D84%26issue%3D8%26spage%3D4670%26epage%3D4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiao Cai, Anargul Tohti, Cristian Ramirez, Hassan Harb, James C. Fettinger, Hrant P. Hratchian, <span class="NLM_string-name hlFld-ContribAuthor">Benjamin J. Stokes</span>. </span><span class="cited-content_cbyCitation_article-title">Dispersion-Controlled Regioselective Acid-Catalyzed Intramolecular Hydroindolation of cis-Methindolylstyrenes To Access Tetrahydrobenzo[cd]indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (6)
                                     , 1574-1577. <a href="https://doi.org/10.1021/acs.orglett.9b00043" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDispersion-Controlled%252BRegioselective%252BAcid-Catalyzed%252BIntramolecular%252BHydroindolation%252Bof%252Bcis-Methindolylstyrenes%252BTo%252BAccess%252BTetrahydrobenzo%25255Bcd%25255Dindoles%26aulast%3DCai%26aufirst%3DXiao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D26022019%26volume%3D21%26issue%3D6%26spage%3D1574%26epage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alicia Regueiro-Ren, Ira B. Dicker, Umesh Hanumegowda, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Second Generation Inhibitors of HIV-1 Maturation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 287-294. <a href="https://doi.org/10.1021/acsmedchemlett.8b00656" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSecond%252BGeneration%252BInhibitors%252Bof%252BHIV-1%252BMaturation%26aulast%3DRegueiro-Ren%26aufirst%3DAlicia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29122018%26date%3D28012019%26date%3D08022019%26volume%3D10%26issue%3D3%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Subhrajit Rout, Arko Das, <span class="NLM_string-name hlFld-ContribAuthor">Vinod K. Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Controlled Switching of Enantioselectivity in the Mukaiyama–Michael Reaction of α,β-Unsaturated 2-Acyl Imidazoles Catalyzed by Chiral Metal–Pybox Complexes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 5058-5071. <a href="https://doi.org/10.1021/acs.joc.8b00399" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00399%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Controlled%252BSwitching%252Bof%252BEnantioselectivity%252Bin%252Bthe%252BMukaiyama%2525E2%252580%252593Michael%252BReaction%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252B2-Acyl%252BImidazoles%252BCatalyzed%252Bby%252BChiral%252BMetal%2525E2%252580%252593Pybox%252BComplexes%26aulast%3DRout%26aufirst%3DSubhrajit%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10022018%26date%3D20042018%26date%3D16042018%26volume%3D83%26issue%3D9%26spage%3D5058%26epage%3D5071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pravin  Patil</span>, <span class="hlFld-ContribAuthor ">Bhupendra  Mishra</span>, <span class="hlFld-ContribAuthor ">Gitanjali  Sheombarsing</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kurpiewska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, and <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>  . </span><span class="cited-content_cbyCitation_article-title">Library-to-Library Synthesis of Highly Substituted α-Aminomethyl Tetrazoles via Ugi Reaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 70-74. <a href="https://doi.org/10.1021/acscombsci.7b00137" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00137%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DLibrary-to-Library%252BSynthesis%252Bof%252BHighly%252BSubstituted%252B%2525CE%2525B1-Aminomethyl%252BTetrazoles%252Bvia%252BUgi%252BReaction%26aulast%3DPatil%26aufirst%3DPravin%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D21092017%26date%3D21112017%26date%3D04012018%26date%3D12022018%26date%3D07122017%26volume%3D20%26issue%3D2%26spage%3D70%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thanh T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Diels–Alder Reactions of Oxazoles, Imidazoles, and Thiazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (07)
                                     , 1181-1199. <a href="https://doi.org/10.1055/s-0040-1705991" title="DOI URL">https://doi.org/10.1055/s-0040-1705991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705991%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DIntramolecular%252BDiels%2525E2%252580%252593Alder%252BReactions%252Bof%252BOxazoles%25252C%252BImidazoles%25252C%252Band%252BThiazoles%26aulast%3DNguyen%26aufirst%3DThanh%2BT.%26date%3D2021%26date%3D2020%26volume%3D53%26issue%3D07%26spage%3D1181%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tien-Yau  Luh</span>, <span class="hlFld-ContribAuthor ">Chih-Hsien  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-Qiao  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Thorpe-Ingold Effect on Polymer Conformations. Photophysical Behavior as a Probe for Folding of
              Alt
              -Dialkylsilylene-divinylarene Copolymers. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Chemical Society of Japan</span><span> <strong>2021,</strong> <em>94 </em>
                                    (2)
                                     , 490-501. <a href="https://doi.org/10.1246/bcsj.20200289" title="DOI URL">https://doi.org/10.1246/bcsj.20200289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/bcsj.20200289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fbcsj.20200289%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Chemical%2520Society%2520of%2520Japan%26atitle%3DThorpe-Ingold%252BEffect%252Bon%252BPolymer%252BConformations.%252BPhotophysical%252BBehavior%252Bas%252Ba%252BProbe%252Bfor%252BFolding%252Bof%252BAlt%252B-Dialkylsilylene-divinylarene%252BCopolymers%26aulast%3DLuh%26aufirst%3DTien-Yau%26date%3D2021%26volume%3D94%26issue%3D2%26spage%3D490%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eda  Karadeniz</span>, <span class="hlFld-ContribAuthor ">Yilmaz  Kelgokmen</span>, <span class="hlFld-ContribAuthor ">Metin  Zora</span>. </span><span class="cited-content_cbyCitation_article-title">A new approach for the synthesis of spiro and
              gem
              ‐dimethyl‐substituted 1,4‐oxazepines from
              N
              ‐propargylic β‐enaminones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (2)
                                     , 466-477. <a href="https://doi.org/10.1002/jhet.4183" title="DOI URL">https://doi.org/10.1002/jhet.4183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252Bnew%252Bapproach%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bspiro%252Band%252Bgem%252B%2525E2%252580%252590dimethyl%2525E2%252580%252590substituted%252B1%25252C4%2525E2%252580%252590oxazepines%252Bfrom%252BN%252B%2525E2%252580%252590propargylic%252B%2525CE%2525B2%2525E2%252580%252590enaminones%26aulast%3DKaradeniz%26aufirst%3DEda%26date%3D2021%26date%3D2020%26volume%3D58%26issue%3D2%26spage%3D466%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Serafini</span>, <span class="hlFld-ContribAuthor ">Ilaria  Murgia</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Giustiniano</span>, <span class="hlFld-ContribAuthor ">Tracey  Pirali</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>. </span><span class="cited-content_cbyCitation_article-title">The 115 Years Old Multicomponent Bargellini Reaction: Perspectives and New Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (3)
                                     , 558. <a href="https://doi.org/10.3390/molecules26030558" title="DOI URL">https://doi.org/10.3390/molecules26030558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26030558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26030558%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252B115%252BYears%252BOld%252BMulticomponent%252BBargellini%252BReaction%25253A%252BPerspectives%252Band%252BNew%252BApplications%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D3%26spage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald W.  Brown</span>, <span class="hlFld-ContribAuthor ">Ashraf M.  Abdel-Megeed</span>, <span class="hlFld-ContribAuthor ">Paul A.  Keller</span>, <span class="hlFld-ContribAuthor ">Amy J.  Jones</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Sykes</span>, <span class="hlFld-ContribAuthor ">Marcel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>, <span class="hlFld-ContribAuthor ">Christopher J. T.  Hyland</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1413-1422. <a href="https://doi.org/10.1039/D0MD00277A" title="DOI URL">https://doi.org/10.1039/D0MD00277A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00277A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00277A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthiazolyl%2525E2%252580%252593benzothiophenamides%252Bas%252Bpotential%252Bagents%252Bfor%252BAfrican%252Bsleeping%252Bsickness%26aulast%3DBrown%26aufirst%3DRonald%2BW.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D12%26spage%3D1413%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rynne A.  Hankins</span>, <span class="hlFld-ContribAuthor ">S. Israel  Suarez</span>, <span class="hlFld-ContribAuthor ">Madison A.  Kalk</span>, <span class="hlFld-ContribAuthor ">Nolan M.  Green</span>, <span class="hlFld-ContribAuthor ">Megan N.  Harty</span>, <span class="hlFld-ContribAuthor ">John C.  Lukesh</span>. </span><span class="cited-content_cbyCitation_article-title">An Innovative Hydrogen Peroxide‐Sensing Scaffold and Insight Towards its Potential as an ROS‐Activated Persulfide Donor. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (49)
                                     , 22422-22429. <a href="https://doi.org/10.1002/ange.202010530" title="DOI URL">https://doi.org/10.1002/ange.202010530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202010530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202010530%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAn%252BInnovative%252BHydrogen%252BPeroxide%2525E2%252580%252590Sensing%252BScaffold%252Band%252BInsight%252BTowards%252Bits%252BPotential%252Bas%252Ban%252BROS%2525E2%252580%252590Activated%252BPersulfide%252BDonor%26aulast%3DHankins%26aufirst%3DRynne%2BA.%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D49%26spage%3D22422%26epage%3D22429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rynne A.  Hankins</span>, <span class="hlFld-ContribAuthor ">S. Israel  Suarez</span>, <span class="hlFld-ContribAuthor ">Madison A.  Kalk</span>, <span class="hlFld-ContribAuthor ">Nolan M.  Green</span>, <span class="hlFld-ContribAuthor ">Megan N.  Harty</span>, <span class="hlFld-ContribAuthor ">John C.  Lukesh</span>. </span><span class="cited-content_cbyCitation_article-title">An Innovative Hydrogen Peroxide‐Sensing Scaffold and Insight Towards its Potential as an ROS‐Activated Persulfide Donor. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (49)
                                     , 22238-22245. <a href="https://doi.org/10.1002/anie.202010530" title="DOI URL">https://doi.org/10.1002/anie.202010530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202010530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202010530%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DAn%252BInnovative%252BHydrogen%252BPeroxide%2525E2%252580%252590Sensing%252BScaffold%252Band%252BInsight%252BTowards%252Bits%252BPotential%252Bas%252Ban%252BROS%2525E2%252580%252590Activated%252BPersulfide%252BDonor%26aulast%3DHankins%26aufirst%3DRynne%2BA.%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D49%26spage%3D22238%26epage%3D22245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohan  Seo</span>, <span class="hlFld-ContribAuthor ">Jiwon  Choi</span>, <span class="hlFld-ContribAuthor ">Jeong Hwa  Lee</span>, <span class="hlFld-ContribAuthor ">Tae Gun  Kim</span>, <span class="hlFld-ContribAuthor ">So-hyeon  Park</span>, <span class="hlFld-ContribAuthor ">Gyoonhee  Han</span>, <span class="hlFld-ContribAuthor ">Wan  Namkung</span>, <span class="hlFld-ContribAuthor ">Ikyon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-oriented generation and biological evaluation of new chemical scaffolds bearing a 2,2-dimethyl-2H-chromene unit: Discovery of novel potent ANO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 104000. <a href="https://doi.org/10.1016/j.bioorg.2020.104000" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104000%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiversity-oriented%252Bgeneration%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bchemical%252Bscaffolds%252Bbearing%252Ba%252B2%25252C2-dimethyl-2H-chromene%252Bunit%25253A%252BDiscovery%252Bof%252Bnovel%252Bpotent%252BANO1%252Binhibitors%26aulast%3DSeo%26aufirst%3DYohan%26date%3D2020%26volume%3D101%26spage%3D104000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Kalogirou</span>, <span class="hlFld-ContribAuthor ">Christopher  Asquith</span>, <span class="hlFld-ContribAuthor ">Panayiotis  Koutentis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (R) and (S)-3-Chloro-5-(2,4-dimethylpiperazin-1-yl)-4H-1,2,6-thiadiazin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (2)
                                     , M1139. <a href="https://doi.org/10.3390/M1139" title="DOI URL">https://doi.org/10.3390/M1139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1139%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3DSynthesis%252Bof%252B%252528R%252529%252Band%252B%252528S%252529-3-Chloro-5-%2525282%25252C4-dimethylpiperazin-1-yl%252529-4H-1%25252C2%25252C6-thiadiazin-4-ones%26aulast%3DKalogirou%26aufirst%3DAndreas%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D2%26spage%3DM1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Jeffries</span>, <span class="hlFld-ContribAuthor ">Zhong  Wang</span>, <span class="hlFld-ContribAuthor ">Robert I  Troup</span>, <span class="hlFld-ContribAuthor ">Anaïs  Goupille</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Le Questel</span>, <span class="hlFld-ContribAuthor ">Charlene  Fallan</span>, <span class="hlFld-ContribAuthor ">James S  Scott</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Chiarparin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Graton</span>, <span class="hlFld-ContribAuthor ">Bruno  Linclau</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilicity trends upon fluorination of isopropyl, cyclopropyl and 3-oxetanyl groups. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 2141-2150. <a href="https://doi.org/10.3762/bjoc.16.182" title="DOI URL">https://doi.org/10.3762/bjoc.16.182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.182%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLipophilicity%252Btrends%252Bupon%252Bfluorination%252Bof%252Bisopropyl%25252C%252Bcyclopropyl%252Band%252B3-oxetanyl%252Bgroups%26aulast%3DJeffries%26aufirst%3DBenjamin%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D2141%26epage%3D2150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Israel  Suarez</span>, <span class="hlFld-ContribAuthor ">Rynne  Ambrose</span>, <span class="hlFld-ContribAuthor ">Madison A.  Kalk</span>, <span class="hlFld-ContribAuthor ">John C.  Lukesh</span>. </span><span class="cited-content_cbyCitation_article-title">Selenosulfides Tethered to
              gem
              ‐Dimethyl Esters: A Robust and Highly Versatile Framework for H
              2
              S Probe Development. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (69)
                                     , 15736-15740. <a href="https://doi.org/10.1002/chem.201904133" title="DOI URL">https://doi.org/10.1002/chem.201904133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201904133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201904133%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSelenosulfides%252BTethered%252Bto%252Bgem%252B%2525E2%252580%252590Dimethyl%252BEsters%25253A%252BA%252BRobust%252Band%252BHighly%252BVersatile%252BFramework%252Bfor%252BH%252B2%252BS%252BProbe%252BDevelopment%26aulast%3DSuarez%26aufirst%3DS.%2BIsrael%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D69%26spage%3D15736%26epage%3D15740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paresh R.  Athawale</span>, <span class="hlFld-ContribAuthor ">Neeta  Kumari</span>, <span class="hlFld-ContribAuthor ">Monica R.  Dandawate</span>, <span class="hlFld-ContribAuthor ">K.  Kashinath</span>, <span class="hlFld-ContribAuthor ">D.  Srinivasa Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chiral Tetrahydrofuran Building Blocks from Pantolactones: Application in the Synthesis of Empagliflozin and Amprenavir Analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (30)
                                     , 4805-4810. <a href="https://doi.org/10.1002/ejoc.201900718" title="DOI URL">https://doi.org/10.1002/ejoc.201900718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900718%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BChiral%252BTetrahydrofuran%252BBuilding%252BBlocks%252Bfrom%252BPantolactones%25253A%252BApplication%252Bin%252Bthe%252BSynthesis%252Bof%252BEmpagliflozin%252Band%252BAmprenavir%252BAnalogs%26aulast%3DAthawale%26aufirst%3DParesh%2BR.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D30%26spage%3D4805%26epage%3D4810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritawidya</span>, <span class="hlFld-ContribAuthor ">Ludwig</span>, <span class="hlFld-ContribAuthor ">Briel</span>, <span class="hlFld-ContribAuthor ">Brust</span>, <span class="hlFld-ContribAuthor ">Scheunemann</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2791. <a href="https://doi.org/10.3390/molecules24152791" title="DOI URL">https://doi.org/10.3390/molecules24152791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152791%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252B8-Pyridinyl-Substituted%252BBenzo%25255Be%25255Dimidazo%25255B2%25252C1-c%25255D%25255B1%25252C2%25252C4%25255Dtriazines%252Bas%252BPhosphodiesterase%252B2A%252BInhibitors%26aulast%3DRitawidya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radhe  Shyam</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Gaetano  Angelici</span>, <span class="hlFld-ContribAuthor ">Olivier  Roy</span>, <span class="hlFld-ContribAuthor ">Claude  Taillefumier</span>, <span class="hlFld-ContribAuthor ">Sophie  Faure</span>. </span><span class="cited-content_cbyCitation_article-title">NC
              α‐
              gem
              ‐dimethylated peptoid side chains: A novel approach for structural control and peptide sequence mimetics. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers</span><span> <strong>2019,</strong> <em>110 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/bip.23273" title="DOI URL">https://doi.org/10.1002/bip.23273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.23273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.23273%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%26atitle%3DNC%252B%2525CE%2525B1%2525E2%252580%252590%252Bgem%252B%2525E2%252580%252590dimethylated%252Bpeptoid%252Bside%252Bchains%25253A%252BA%252Bnovel%252Bapproach%252Bfor%252Bstructural%252Bcontrol%252Band%252Bpeptide%252Bsequence%252Bmimetics%26aulast%3DShyam%26aufirst%3DRadhe%26date%3D2019%26date%3D2019%26volume%3D110%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Hu</span>, <span class="hlFld-ContribAuthor ">Hyung Min  Chi</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  DeBacker</span>, <span class="hlFld-ContribAuthor ">Xu  Gong</span>, <span class="hlFld-ContribAuthor ">Jonathan H.  Keim</span>, <span class="hlFld-ContribAuthor ">Ian Tingyung  Hsu</span>, <span class="hlFld-ContribAuthor ">Scott A.  Snyder</span>. </span><span class="cited-content_cbyCitation_article-title">Quaternary-centre-guided synthesis of complex polycyclic terpenes. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2019,</strong> <em>569 </em>
                                    (7758)
                                     , 703-707. <a href="https://doi.org/10.1038/s41586-019-1179-2" title="DOI URL">https://doi.org/10.1038/s41586-019-1179-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-019-1179-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-019-1179-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DQuaternary-centre-guided%252Bsynthesis%252Bof%252Bcomplex%252Bpolycyclic%252Bterpenes%26aulast%3DHu%26aufirst%3DPengfei%26date%3D2019%26date%3D2019%26volume%3D569%26issue%3D7758%26spage%3D703%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuelle M. D.  Allouche</span>, <span class="hlFld-ContribAuthor ">André B.  Charette</span>. </span><span class="cited-content_cbyCitation_article-title">Non-stabilized diazoalkane synthesis
              via
              the oxidation of free hydrazones by iodosylbenzene and application in
              in situ
              MIRC cyclopropanation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2019,</strong> <em>10 </em>
                                    (13)
                                     , 3802-3806. <a href="https://doi.org/10.1039/C8SC05558K" title="DOI URL">https://doi.org/10.1039/C8SC05558K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8SC05558K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8SC05558K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DNon-stabilized%252Bdiazoalkane%252Bsynthesis%252Bvia%252Bthe%252Boxidation%252Bof%252Bfree%252Bhydrazones%252Bby%252Biodosylbenzene%252Band%252Bapplication%252Bin%252Bin%252Bsitu%252BMIRC%252Bcyclopropanation%26aulast%3DAllouche%26aufirst%3DEmmanuelle%2BM.%2BD.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D13%26spage%3D3802%26epage%3D3806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yantao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Methylation: A Guide for Selecting Methylation Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (14)
                                     , 3405-3439. <a href="https://doi.org/10.1002/chem.201803642" title="DOI URL">https://doi.org/10.1002/chem.201803642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201803642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201803642%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRecent%252BAdvances%252Bin%252BMethylation%25253A%252BA%252BGuide%252Bfor%252BSelecting%252BMethylation%252BReagents%26aulast%3DChen%26aufirst%3DYantao%26date%3D2019%26date%3D2018%26volume%3D25%26issue%3D14%26spage%3D3405%26epage%3D3439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo  Gallardo-Macias</span>, <span class="hlFld-ContribAuthor ">Pradeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Mark  Jaskowski</span>, <span class="hlFld-ContribAuthor ">Todd  Richmann</span>, <span class="hlFld-ContribAuthor ">Riju  Shrestha</span>, <span class="hlFld-ContribAuthor ">Riccardo  Russo</span>, <span class="hlFld-ContribAuthor ">Eric  Singleton</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Zimmerman</span>, <span class="hlFld-ContribAuthor ">Hsin Pin  Ho</span>, <span class="hlFld-ContribAuthor ">Véronique  Dartois</span>, <span class="hlFld-ContribAuthor ">Nancy  Connell</span>, <span class="hlFld-ContribAuthor ">David  Alland</span>, <span class="hlFld-ContribAuthor ">Joel S.  Freundlich</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 601-606. <a href="https://doi.org/10.1016/j.bmcl.2018.12.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252BN-benzyl-5-nitrofuran-2-carboxamide%252Bas%252Ban%252Bantitubercular%252Bagent%26aulast%3DGallardo-Macias%26aufirst%3DRicardo%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D601%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastasiya S.  Sokolova</span>, <span class="hlFld-ContribAuthor ">Olga I.  Yarovaya</span>, <span class="hlFld-ContribAuthor ">Nikolay I.  Bormotov</span>, <span class="hlFld-ContribAuthor ">Larisa N.  Shishkina</span>, <span class="hlFld-ContribAuthor ">Nariman F.  Salakhutdinov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiviral activity of camphor-based 1,3-thiazolidin-4-one and thiazole derivatives as
              Orthopoxvirus
              -reproduction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 1746-1753. <a href="https://doi.org/10.1039/C8MD00347E" title="DOI URL">https://doi.org/10.1039/C8MD00347E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00347E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00347E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bantiviral%252Bactivity%252Bof%252Bcamphor-based%252B1%25252C3-thiazolidin-4-one%252Band%252Bthiazole%252Bderivatives%252Bas%252BOrthopoxvirus%252B-reproduction%252Binhibitors%26aulast%3DSokolova%26aufirst%3DAnastasiya%2BS.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D10%26spage%3D1746%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Werth</span>, <span class="hlFld-ContribAuthor ">Christopher  Uyeda</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt‐Catalyzed Reductive Dimethylcyclopropanation of 1,3‐Dienes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (42)
                                     , 14098-14102. <a href="https://doi.org/10.1002/ange.201807542" title="DOI URL">https://doi.org/10.1002/ange.201807542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201807542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201807542%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCobalt%2525E2%252580%252590Catalyzed%252BReductive%252BDimethylcyclopropanation%252Bof%252B1%25252C3%2525E2%252580%252590Dienes%26aulast%3DWerth%26aufirst%3DJacob%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D42%26spage%3D14098%26epage%3D14102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Werth</span>, <span class="hlFld-ContribAuthor ">Christopher  Uyeda</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt‐Catalyzed Reductive Dimethylcyclopropanation of 1,3‐Dienes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (42)
                                     , 13902-13906. <a href="https://doi.org/10.1002/anie.201807542" title="DOI URL">https://doi.org/10.1002/anie.201807542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201807542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201807542%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCobalt%2525E2%252580%252590Catalyzed%252BReductive%252BDimethylcyclopropanation%252Bof%252B1%25252C3%2525E2%252580%252590Dienes%26aulast%3DWerth%26aufirst%3DJacob%26date%3D2018%26volume%3D57%26issue%3D42%26spage%3D13902%26epage%3D13906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Yu</span>, <span class="hlFld-ContribAuthor ">Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Carsten  Bolm</span>. </span><span class="cited-content_cbyCitation_article-title">Three-Dimensional Heterocycles by Iron-Catalyzed Ring-Closing Sulfoxide Imidation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (37)
                                     , 12229-12232. <a href="https://doi.org/10.1002/ange.201804284" title="DOI URL">https://doi.org/10.1002/ange.201804284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201804284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201804284%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DThree-Dimensional%252BHeterocycles%252Bby%252BIron-Catalyzed%252BRing-Closing%252BSulfoxide%252BImidation%26aulast%3DYu%26aufirst%3DHao%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D37%26spage%3D12229%26epage%3D12232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Yu</span>, <span class="hlFld-ContribAuthor ">Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Carsten  Bolm</span>. </span><span class="cited-content_cbyCitation_article-title">Three-Dimensional Heterocycles by Iron-Catalyzed Ring-Closing Sulfoxide Imidation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (37)
                                     , 12053-12056. <a href="https://doi.org/10.1002/anie.201804284" title="DOI URL">https://doi.org/10.1002/anie.201804284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201804284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201804284%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThree-Dimensional%252BHeterocycles%252Bby%252BIron-Catalyzed%252BRing-Closing%252BSulfoxide%252BImidation%26aulast%3DYu%26aufirst%3DHao%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D37%26spage%3D12053%26epage%3D12056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailaja S.  Jawoor</span>, <span class="hlFld-ContribAuthor ">Sangamesh A.  Patil</span>, <span class="hlFld-ContribAuthor ">Mahantesh  Kumbar</span>, <span class="hlFld-ContribAuthor ">Prashant B.  Ramawadgi</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis of nano sized transition metal complexes containing heterocyclic Schiff base: Structural and morphology characterization and bioactivity study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2018,</strong> <em>1164 </em>, 378-385. <a href="https://doi.org/10.1016/j.molstruc.2018.03.084" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DGreen%252Bsynthesis%252Bof%252Bnano%252Bsized%252Btransition%252Bmetal%252Bcomplexes%252Bcontaining%252Bheterocyclic%252BSchiff%252Bbase%25253A%252BStructural%252Band%252Bmorphology%252Bcharacterization%252Band%252Bbioactivity%252Bstudy%26aulast%3DJawoor%26aufirst%3DShailaja%2BS.%26date%3D2018%26volume%3D1164%26spage%3D378%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey  Schwertz</span>, <span class="hlFld-ContribAuthor ">Matthias C.  Witschel</span>, <span class="hlFld-ContribAuthor ">Matthias  Rottmann</span>, <span class="hlFld-ContribAuthor ">Ubolsree  Leartsakulpanich</span>, <span class="hlFld-ContribAuthor ">Penchit  Chitnumsub</span>, <span class="hlFld-ContribAuthor ">Aritsara  Jaruwat</span>, <span class="hlFld-ContribAuthor ">Watcharee  Amornwatcharapong</span>, <span class="hlFld-ContribAuthor ">Wanwipa  Ittarat</span>, <span class="hlFld-ContribAuthor ">Anja  Schäfer</span>, <span class="hlFld-ContribAuthor ">Raphael A.  Aponte</span>, <span class="hlFld-ContribAuthor ">Nils  Trapp</span>, <span class="hlFld-ContribAuthor ">Pimchai  Chaiyen</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of
              Plasmodial
              Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 931-943. <a href="https://doi.org/10.1002/cmdc.201800053" title="DOI URL">https://doi.org/10.1002/cmdc.201800053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800053%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPotent%252BInhibitors%252Bof%252BPlasmodial%252BSerine%252BHydroxymethyltransferase%252B%252528SHMT%252529%252BFeaturing%252Ba%252BSpirocyclic%252BScaffold%26aulast%3DSchwertz%26aufirst%3DGeoffrey%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim  Ratushnyy</span>, <span class="hlFld-ContribAuthor ">Marvin  Parasram</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Gevorgyan</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Atom-Transfer Radical Cyclization at Remote Unactivated C(sp
              3
              )−H Sites: Hydrogen-Atom Transfer of Hybrid Vinyl Palladium Radical Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (10)
                                     , 2742-2745. <a href="https://doi.org/10.1002/ange.201712775" title="DOI URL">https://doi.org/10.1002/ange.201712775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201712775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201712775%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium-Catalyzed%252BAtom-Transfer%252BRadical%252BCyclization%252Bat%252BRemote%252BUnactivated%252BC%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BSites%25253A%252BHydrogen-Atom%252BTransfer%252Bof%252BHybrid%252BVinyl%252BPalladium%252BRadical%252BIntermediates%26aulast%3DRatushnyy%26aufirst%3DMaxim%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D10%26spage%3D2742%26epage%3D2745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim  Ratushnyy</span>, <span class="hlFld-ContribAuthor ">Marvin  Parasram</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Gevorgyan</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Atom-Transfer Radical Cyclization at Remote Unactivated C(sp
              3
              )−H Sites: Hydrogen-Atom Transfer of Hybrid Vinyl Palladium Radical Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (10)
                                     , 2712-2715. <a href="https://doi.org/10.1002/anie.201712775" title="DOI URL">https://doi.org/10.1002/anie.201712775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201712775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201712775%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium-Catalyzed%252BAtom-Transfer%252BRadical%252BCyclization%252Bat%252BRemote%252BUnactivated%252BC%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BSites%25253A%252BHydrogen-Atom%252BTransfer%252Bof%252BHybrid%252BVinyl%252BPalladium%252BRadical%252BIntermediates%26aulast%3DRatushnyy%26aufirst%3DMaxim%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D10%26spage%3D2712%26epage%3D2715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaibhav  Khose</span>, <span class="hlFld-ContribAuthor ">Marina  John</span>, <span class="hlFld-ContribAuthor ">Anita  Pandey</span>, <span class="hlFld-ContribAuthor ">Victor  Borovkov</span>, <span class="hlFld-ContribAuthor ">Anil  Karnik</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Heterocycle-Based Receptors for Enantioselective Recognition. </span><span class="cited-content_cbyCitation_journal-name">Symmetry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 34. <a href="https://doi.org/10.3390/sym10020034" title="DOI URL">https://doi.org/10.3390/sym10020034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/sym10020034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fsym10020034%26sid%3Dliteratum%253Aachs%26jtitle%3DSymmetry%26atitle%3DChiral%252BHeterocycle-Based%252BReceptors%252Bfor%252BEnantioselective%252BRecognition%26aulast%3DKhose%26aufirst%3DVaibhav%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel D.  Banister</span>, <span class="hlFld-ContribAuthor ">Mark  Connor</span>. </span><span class="cited-content_cbyCitation_article-title">The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 191-226. <a href="https://doi.org/10.1007/164_2018_144" title="DOI URL">https://doi.org/10.1007/164_2018_144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_144%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BChemistry%252Band%252BPharmacology%252Bof%252BSynthetic%252BCannabinoid%252BReceptor%252BAgonist%252BNew%252BPsychoactive%252BSubstances%25253A%252BEvolution%26aulast%3DBanister%26aufirst%3DSamuel%2BD.%26date%3D2018%26date%3D2018%26spage%3D191%26epage%3D226%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNew%252BPsychoactive%252BSubstances%26aulast%3DMaurer%26aufirst%3DHans%2BH.%26date%3D2018%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0084.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0084.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative plant-derived natural and semisynthetic products (<b>1</b>–<b>13</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative microbe-derived natural products (<b>14</b>–<b>19</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of representative marine-derived natural products (<b>20</b>–<b>22</b>) containing the <i>gem</i>-dimethyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Impact of a <i>gem</i>-dimethyl group on pharmacodynamics, structural, toxicity, and DMPK properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of β-lactam antibiotics <b>23</b>–<b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of monobactam antibacterial drug <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures and antibacterial efficacy of siderophore-conjugated monobactam antibiotics <b>30</b> and <b>31</b> and a positive reference monobactam <b>29</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0008.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of dehydropeptidase I inhibitor <b>32</b> and antibiotic <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0009.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures, in vitro potency, and DMPK properties of antitubercular compounds <b>34</b>–<b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0010.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structure of HCV NS3/4A protease inhibitor <b>37</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0011.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures and in vitro potency of HIV-1 integrase inhibitors <b>38</b>–<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0012.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures, in vitro potency, and DMPK properties of RSV fusion protein inhibitors <b>42</b>–<b>45</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0013.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures and in vitro potency of plasmepsin inhibitors <b>46</b>–<b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0014.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures and in vitro potency of AR antagonists <b>51</b>–<b>55</b>. <sup><i>a</i></sup>Reduction in luciferase activity is a desirable end point. <sup><i>b</i></sup>PSA: prostate specific antigen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0015.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures and in vitro potency of IGF-1R inhibitors <b>56</b>–<b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0016.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures, in vitro potency, and physicochemical and PK properties of MTH1 inhibitors <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0017.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures, in vitro potency, and PK profiles of SIRT inhibitors <b>63</b>–<b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0018.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures and in vitro potency of ICMT inhibitors <b>66</b>–<b>68</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0019.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures and in vitro potency of MMP inhibitors <b>69</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0020.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures and in vitro potency of MMP inhibitors <b>74</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0021.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures and in vitro potency of HSP90 inhibitors <b>76</b>–<b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0022.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures, in vitro potency, and PK profiles of HSP90 inhibitors <b>80</b> and <b>81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0023.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures, in vitro potency, and DMPK profiles of PI3K inhibitors <b>82</b>–<b>85</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0024.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures and in vitro potency of RXR selective compounds <b>86</b>–<b>88</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0025.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of retinoids <b>89</b>–<b>91</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0026.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure, in vitro potency, and CYP450 inhibition data for PI3Kδ inhibitor <b>92</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0027.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structure of <b>93</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0028.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structures and in vitro potency of nAChR antagonists <b>94</b>–<b>97</b>. <sup><i>a</i></sup>Potency relative to (rac) <b>94</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0029.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of 5-HT<sub>1A</sub> receptor agonists <b>98</b> and <b>99</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0030.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures and in vitro potency of renin inhibitors <b>100</b>–<b>102</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0031.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Structures and in vitro potency of HMG-CoA reductase inhibitors <b>103</b>–<b>105</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0032.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures and in vivo potency of potassium ion channel openers <b>106</b>–<b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0033.jpeg" id="rightTab-gr39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures, in vitro potency, and PK profiles of LXR agonists <b>112</b>–<b>115</b>. <sup><i>a</i></sup>Human whole blood ABC transporter family A1 induction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0034.jpeg" id="rightTab-gr40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures, in vitro potency, and PK profiles of NHE1 inhibitors <b>116</b> and <b>117</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0035.jpeg" id="rightTab-gr41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. Structures of mTOR inhibitors <b>118</b>–<b>120</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0036.jpeg" id="rightTab-gr42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structure, in vitro potency, and liver microsomal profile of CCR1 antagonist <b>121</b>. <sup><i>a</i></sup>MIP: macrophage inflammatory protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0037.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Structures of MDP <b>122</b> and its analogues <b>123</b> and <b>124</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0038.jpeg" id="rightTab-gr44" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structures, in vitro potency, and physicochemical properties of ITK inhibitors <b>125</b>–<b>128</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig39" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0039.jpeg" id="rightTab-gr45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. Structures, in vitro potency, physicochemical properties, and HLM clearance profiles of muscarinic M<sub>3</sub> receptor antagonists <b>129</b>–<b>132</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig40" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0040.jpeg" id="rightTab-gr46" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Structures and in vitro potency of PDE4 inhibitors <b>133</b> and <b>134</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig41" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0041.jpeg" id="rightTab-gr47" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. Structures, in vitro potency, and PK profile of cathepsin K inhibitors <b>135</b> and <b>136</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig42" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0042.jpeg" id="rightTab-gr48" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. Structures, in vitro potency, and physicochemical properties of adenoviral protease inhibitors <b>137</b>–<b>142</b>. <sup><i>a</i></sup>CPE: cytopathic effect. <sup><i>b</i></sup>PAMPA: parallel artificial membrane permeability assay. n.d.: not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig43" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0043.jpeg" id="rightTab-gr49" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. Structures and in vitro potency of PPARα agonists <b>143</b>–<b>147</b>. NA: not active.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig44" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Figure 44</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0044.jpeg" id="rightTab-gr50" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 44. Structures, in vitro potency, and PK profile of GPIIb/IIIa antagonist <b>148</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig44"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig45" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 45</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0045.jpeg" id="rightTab-gr51" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 45. Steric restriction imposed by the α-aminoisobutyric acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig45"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig46" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Figure 46</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0046.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0046.jpeg" id="rightTab-gr52" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 46. Structures, in vitro potency, and PK profiles of antimalarial compounds <b>149</b>–<b>153</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig46"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig47" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Figure 47</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0047.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0047.jpeg" id="rightTab-gr53" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 47. Structures and in vitro potency of benzoxaboroles <b>154</b> and <b>155</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0047.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig47"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig48" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Figure 48</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0048.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0048.jpeg" id="rightTab-gr54" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 48. Structures, in vitro potency, and PK profiles of Wee1 kinase inhibitors <b>156</b>–<b>158</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0048.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig48"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig49" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Figure 49</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0049.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0049.jpeg" id="rightTab-gr55" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 49. Structures, in vitro potency, and DMPK profiles of LRRK2 inhibitors <b>159</b>–<b>163</b>. <sup><i>a</i></sup>ER: efflux ratio. <sup><i>b</i></sup>TDI: time-dependent inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0049.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig49"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig50" data-index="50" class="article__inlineFigure"><h2 class="fig-label">Figure 50</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0050.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0050.jpeg" id="rightTab-gr56" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 50. Structures, in vitro potency, and PK profiles of Ca<sub>v</sub>2.2 inhibitors <b>164</b>–<b>170</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0050.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig50"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig51" data-index="51" class="article__inlineFigure"><h2 class="fig-label">Figure 51</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0051.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0051.jpeg" id="rightTab-gr57" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 51. Structures, in vitro potency, and physicochemical profiles of mGlu2 receptor allosteric modulators <b>171</b>–<b>173</b>. <sup><i>a</i></sup>PAM: positive allosteric modulator.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0051.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig51"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig52" data-index="52" class="article__inlineFigure"><h2 class="fig-label">Figure 52</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0052.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0052.jpeg" id="rightTab-gr58" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 52. Structure, in vitro potency, and physicochemical and DMPK properties of FLAP inhibitor <b>174</b>. <sup><i>a</i></sup>hWB: human whole blood. <sup><i>b</i></sup>RM: reactive metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0052.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig52"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig53" data-index="53" class="article__inlineFigure"><h2 class="fig-label">Figure 53</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0053.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0053.jpeg" id="rightTab-gr59" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 53. Structure of LTD<sub>4</sub> antagonist <b>175</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0053.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig53"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig54" data-index="54" class="article__inlineFigure"><h2 class="fig-label">Figure 54</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0054.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0054.jpeg" id="rightTab-gr60" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 54. Structures, in vitro potency, and physicochemical/PK profiles of S1P<sub>2</sub> antagonists <b>176</b>–<b>179</b>. nt: not tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0054.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig54"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig55" data-index="55" class="article__inlineFigure"><h2 class="fig-label">Figure 55</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0055.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0055.jpeg" id="rightTab-gr61" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 55. Structure of PGE<sub>1</sub> analogue <b>180</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0055.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig55"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig56" data-index="56" class="article__inlineFigure"><h2 class="fig-label">Figure 56</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0056.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0056.jpeg" id="rightTab-gr62" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 56. Structures, in vitro potency, and DMPK profiles of niacin receptor agonists <b>181</b>–<b>183</b>. <sup><i>a</i></sup>AUCN: normalized area under the curve.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0056.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig56"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig57" data-index="57" class="article__inlineFigure"><h2 class="fig-label">Figure 57</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0057.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0057.jpeg" id="rightTab-gr63" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 57. Structures, in vitro potency, and physicochemical/DMPK profiles of GK-GKRP disrupters <b>184</b>–<b>188</b>. <sup><i>a</i></sup>TL: translocation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0057.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig57"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig58" data-index="58" class="article__inlineFigure"><h2 class="fig-label">Figure 58</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0058.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0058.jpeg" id="rightTab-gr64" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 58. Structures and in vitro potency of 5-HT<sub>2C</sub> agonists <b>189</b> and <b>190</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0058.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig58"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig59" data-index="59" class="article__inlineFigure"><h2 class="fig-label">Figure 59</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0059.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0059.jpeg" id="rightTab-gr65" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 59. Structures, in vitro potency, and DMPK profiles of antifungal compounds <b>191</b>–<b>195</b>. <sup><i>a</i></sup>SGF: simulated gastric fluid. <sup><i>b</i></sup>SIF: simulated intestinal fluid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0059.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig59"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig60" data-index="60" class="article__inlineFigure"><h2 class="fig-label">Figure 60</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0060.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0060.jpeg" id="rightTab-gr66" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 60. General structure of antibody drug conjugate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0060.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig60"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig61" data-index="61" class="article__inlineFigure"><h2 class="fig-label">Figure 61</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0061.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0061.jpeg" id="rightTab-gr67" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 61. Structures, in vitro potency, and hydrolytic stability of SGLT inhibitors <b>196</b>–<b>198</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0061.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig61"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig62" data-index="62" class="article__inlineFigure"><h2 class="fig-label">Figure 62</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0062.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0062.jpeg" id="rightTab-gr68" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 62. Structures and p<i>K</i><sub>a</sub> values of benzoxaboroles <b>199</b> and <b>200</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0062.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig62"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig63" data-index="63" class="article__inlineFigure"><h2 class="fig-label">Figure 63</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0063.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0063.jpeg" id="rightTab-gr69" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 63. Structures and in vitro potency of thrombin inhibitors <b>201</b>–<b>205</b>. <sup><i>a</i></sup>b: bovine. <sup><i>b</i></sup>h: human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0063.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig63"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig64" data-index="64" class="article__inlineFigure"><h2 class="fig-label">Figure 64</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0064.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0064.jpeg" id="rightTab-gr70" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 64. Structures, in vitro potency, and physicochemical properties of GK activators <b>206</b>–<b>209</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0064.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig64"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig65" data-index="65" class="article__inlineFigure"><h2 class="fig-label">Figure 65</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0065.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0065.jpeg" id="rightTab-gr71" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 65. Structures and in vitro potency of DPP-IV inhibitors <b>210</b>–<b>212</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0065.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig65"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig66" data-index="66" class="article__inlineFigure"><h2 class="fig-label">Figure 66</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0066.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0066.jpeg" id="rightTab-gr72" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 66. Structures, in vitro potency, and DMPK profiles of mGlu1/mGlu5 negative allosteric modulators <b>213</b>–<b>215</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0066.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig66"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig67" data-index="67" class="article__inlineFigure"><h2 class="fig-label">Figure 67</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0067.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0067.jpeg" id="rightTab-gr73" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 67. Structures, in vitro/in vivo potency, and physicochemical properties of β<sub>2</sub>-adrenoceptor agonists <b>216</b>–<b>218</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0067.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig67"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig68" data-index="68" class="article__inlineFigure"><h2 class="fig-label">Figure 68</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0068.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0068.jpeg" id="rightTab-gr74" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 68. Structures and in vitro potency of apratoxin analogues <b>219</b>–<b>223</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0068.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig68"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig69" data-index="69" class="article__inlineFigure"><h2 class="fig-label">Figure 69</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0069.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0069.jpeg" id="rightTab-gr75" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 69. Thorpe–Ingold conformational effect by a <i>gem</i>-dimethyl substituent at the noncyclic methylene group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0069.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig69"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig70" data-index="70" class="article__inlineFigure"><h2 class="fig-label">Figure 70</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0070.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0070.jpeg" id="rightTab-gr76" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 70. A three methyl lock <i>o</i>-hydroxydihydrocinnamic acid-derived promoiety and its influence on the rapid formation of δ-lactone with simultaneous release of paclitaxel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0070.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig70"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig71" data-index="71" class="article__inlineFigure"><h2 class="fig-label">Figure 71</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0071.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0071.jpeg" id="rightTab-gr77" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 71. Structures of microtubule assembly disrupter <b>228</b> and its bioreductive prodrugs <b>229</b> and <b>230</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0071.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig71"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig72" data-index="72" class="article__inlineFigure"><h2 class="fig-label">Figure 72</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0072.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0072.jpeg" id="rightTab-gr78" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 72. Structures of some commercially available <i>gem</i>-dimethyl containing building blocks (<b>231</b>–<b>268</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0072.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=fig72"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="73" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0073.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0073.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Examples of Base-Catalyzed Reactions for the <i>gem</i>-Dimethylation of the Benzylic Carbon</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0073.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="74" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0074.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0074.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Base-Catalyzed <i>gem</i>-Dimethylation of the Keto-Methylene Functionality</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0074.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="75" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0075.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0075.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Regioselective Opening of a Spirocyclopropane Ring To Produce <i>gem</i>-Dimethyl Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0075.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="76" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0076.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0076.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Examples of the <i>gem</i>-Dimethylcyclopropanation of Alkenes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0076.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="77" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0077.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0077.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Addition of Methyl Anions to the Carbonyl Carbon of the Ester, Amide, and Ketone Groups</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0077.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="78" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/medium/jm-2017-003154_0078.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0078.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Examples of Installation of the Carbinol Functionality via Nucleophilic Additions to Acetone</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b00315/20180315/images/large/jm-2017-003154_0078.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00315&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 207 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.1021/np068054v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years&doi=10.1021%2Fnp068054v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0lgbGtEQH8SYyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477%26doi%3D10.1021%2Fnp068054v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural products: a continuing source of novel drug leads</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1830</i></span>,  <span class="NLM_fpage">3670</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bbagen.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23428572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=3670-3695&author=G.+M.+Craggauthor=D.+J.+Newman&title=Natural+products%3A+a+continuing+source+of+novel+drug+leads&doi=10.1016%2Fj.bbagen.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products: A continuing source of novel drug leads</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3670-3695</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nature has been a source of medicinal products for millennia, with many useful drugs developed from plant sources.  Following discovery of the penicillins, drug discovery from microbial sources occurred and diving techniques in the 1970s opened the seas.  Combinatorial chem. (late 1980s), shifted the focus of drug discovery efforts from Nature to the lab. bench.  This review traces natural products drug discovery, outlining important drugs from natural sources that revolutionized treatment of serious diseases.  It is clear Nature will continue to be a major source of new structural leads, and effective drug development depends on multidisciplinary collaborations.  The explosion of genetic information led not only to novel screens, but the genetic techniques permitted the implementation of combinatorial biosynthetic technol. and genome mining.  The knowledge gained has allowed unknown mols. to be identified.  These novel bioactive structures can be optimized by using combinatorial chem. generating new drug candidates for many diseases.  The advent of genetic techniques that permitted the isolation /expression of biosynthetic cassettes from microbes may well be the new frontier for natural products lead discovery.  It is now apparent that biodiversity may be much greater in those organisms.  The nos. of potential species involved in the microbial world are many orders of magnitude greater than those of plants and multi-celled animals.  Coupling these nos. to the no. of currently unexpressed biosynthetic clusters now identified (> 10 per species) the potential of microbial diversity remains essentially untapped.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zi-u3aGY-7Vg90H21EOLACvtfcHk0li3pFOyCUGQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D&md5=f3242db81842ceeaca0dc51a0c741c23</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%253A%2520a%2520continuing%2520source%2520of%2520novel%2520drug%2520leads%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2013%26volume%3D1830%26spage%3D3670%26epage%3D3695%26doi%3D10.1016%2Fj.bbagen.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Natural product and natural product derived drugs in clinical trials</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1039/C4NP00064A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FC4NP00064A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25204227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1612-1661&author=M.+S.+Butlerauthor=A.+A.+Robertsonauthor=M.+A.+Cooper&title=Natural+product+and+natural+product+derived+drugs+in+clinical+trials&doi=10.1039%2FC4NP00064A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product and natural product derived drugs in clinical trials</span></div><div class="casAuthors">Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1612-1661</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 2008-2013.  Previous review: 2008, 25, 475There are a significant no. of natural product (NP) drugs in development.  We review the 100 NP and NP-derived compds. and 33 Antibody Drug Conjugates (ADCs) with a NP-derived cytotoxic component being evaluated in clin. trials or in registration at the end of 2013. 38 of these compds. and 33 ADCs are being investigated as potential oncol. treatments, 26 as anti-infectives, 19 for the treatment of cardiovascular and metabolic diseases, 11 for inflammatory and related diseases and 6 for neurol.  There was a spread of the NP and NP-derived compds. through the different development phases (17 in phase I, 52 in phase II, 23 in phase III and 8 NDA and/or MAA filed), while there were 23 ADCs in phase I and 10 in phase II. 50 of these 100 compds. were either NPs or semi-synthetic (SS) NPs, which indicated the original NP still plays an important role.  NP and NP-derived compds. for which clin. trials have been halted or discontinued since 2008 are listed in the Supplementary Information.  The 25 NP and NP-derived drugs launched since 2008 are also reviewed, and late stage development candidates and new NP drug pharmacophores analyzed.  The short term prospect for new NP and NP-derived drug approvals is bright, with 31 compds. in phase III or in registration, which should ensure a steady stream of approvals for at least the next five years.  However, there could be future issues for new drug types as only five new drug pharmacophores discovered in the last 15 years are currently being evaluated in clin. trials.  The next few years will be crit. for NP-driven lead discovery, and a concerted effort is required to identify new biol. active pharmacophores and to progress these and existing compds. through pre-clin. drug development into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ZulhKpZ6PbVg90H21EOLACvtfcHk0li3pFOyCUGQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF&md5=05f9fafdbe8dd7c1407fb7b4afab0587</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FC4NP00064A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00064A%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DNatural%2520product%2520and%2520natural%2520product%2520derived%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1612%26epage%3D1661%26doi%3D10.1039%2FC4NP00064A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodycombe, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrinski, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">18787</span>– <span class="NLM_lpage">18792</span>, <span class="refDoi"> DOI: 10.1073/pnas.1012741107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1012741107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20956335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVCqsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=18787-18792&author=P.%0AA.+Clemonsauthor=N.+E.+Bodycombeauthor=H.+A.+Carrinskiauthor=J.+A.+Wilsonauthor=A.+F.+Shamjiauthor=B.+K.+Wagnerauthor=A.+N.+Koehlerauthor=S.+L.+Schreiber&title=Small+molecules+of+different+origins+have+distinct+distributions+of+structural+complexity+that+correlate+with+protein-binding+profiles&doi=10.1073%2Fpnas.1012741107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles</span></div><div class="casAuthors">Clemons, Paul A.; Bodycombe, Nicole E.; Carrinski, Hyman A.; Wilson, J. Anthony; Shamji, Alykhan F.; Wagner, Bridget K.; Koehler, Angela N.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18787-18792, S18787/1-S18787/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using a diverse collection of small mols. generated from a variety of sources, we measured protein-binding activities of each individual compd. against each of 100 diverse (sequence-unrelated) proteins using small-mol. microarrays.  We also analyzed structural features, including complexity, of the small mols.  We found that compds. from different sources (com., academic, natural) have different protein-binding behaviors and that these behaviors correlate with general trends in stereochem. and shape descriptors for these compd. collections.  Increasing the content of sp3-hybridized and stereogenic atoms relative to compds. from com. sources, which comprise the majority of current screening collections, improved binding selectivity and frequency.  The results suggest structural features that synthetic chemists can target when synthesizing screening collections for biol. discovery.  Because binding proteins selectively can be a key feature of high-value probes and drugs, synthesizing com- pounds having features identified in this study may result in improved performance of screening collections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBrE7Js72yZrVg90H21EOLACvtfcHk0ljPoRxNwWQZeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCqsb%252FN&md5=198e298ca5391d7dfd91184680e3c2ec</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1012741107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1012741107%26sid%3Dliteratum%253Aachs%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DBodycombe%26aufirst%3DN.%2BE.%26aulast%3DCarrinski%26aufirst%3DH.%2BA.%26aulast%3DWilson%26aufirst%3DJ.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DSmall%2520molecules%2520of%2520different%2520origins%2520have%2520distinct%2520distributions%2520of%2520structural%2520complexity%2520that%2520correlate%2520with%2520protein-binding%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D18787%26epage%3D18792%26doi%3D10.1073%2Fpnas.1012741107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warriner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of natural-product-like molecules with over eighty distinct scaffolds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1002/anie.200804486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.200804486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=104-109&author=D.+Mortonauthor=S.+Leachauthor=C.+Cordierauthor=S.+Warrinerauthor=A.+Nelson&title=Synthesis+of+natural-product-like+molecules+with+over+eighty+distinct+scaffolds&doi=10.1002%2Fanie.200804486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of natural-product-like molecules with over eighty distinct scaffolds</span></div><div class="casAuthors">Morton, Daniel; Leach, Stuart; Cordier, Christopher; Warriner, Stuart; Nelson, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-109</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A synthetic approach for the combinatorial variation of the scaffolds of small mols. is described.  Using just six basic reaction types, compds. with 84 distinct scaffolds were prepd.  The compds. had many natural-product-like structural features including rich stereochem., heterocyclic and unsatd. ring systems, and dense functionalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobT4OodbtpkbVg90H21EOLACvtfcHk0ljPoRxNwWQZeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFGmsQ%253D%253D&md5=a50405150961afb4a8067bf8610b6a1e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fanie.200804486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200804486%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DS.%26aulast%3DCordier%26aufirst%3DC.%26aulast%3DWarriner%26aufirst%3DS.%26aulast%3DNelson%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520natural-product-like%2520molecules%2520with%2520over%2520eighty%2520distinct%2520scaffolds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D104%26epage%3D109%26doi%3D10.1002%2Fanie.200804486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>SciFinder;
Chemical Abstracts Service: P.O. Box 3012, Columbus, OH 43210, U.S. <a href="https://scifinder.cas.org" class="extLink">https://scifinder.cas.org</a> (accessed
August 12, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SciFinder%3B%0AChemical+Abstracts+Service%3A+P.O.+Box+3012%2C+Columbus%2C+OH+43210%2C+U.S.+https%3A%2F%2Fscifinder.cas.org+%28accessed%0AAugust+12%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blunt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyzers, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsep, M. R.</span></span> <span> </span><span class="NLM_article-title">Marine natural products</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1039/C4NP00144C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FC4NP00144C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25620233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=116-211&author=J.+W.+Bluntauthor=B.+R.+Coppauthor=R.+A.+Keyzersauthor=M.+H.+Munroauthor=M.+R.+Prinsep&title=Marine+natural+products&doi=10.1039%2FC4NP00144C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Marine natural products</span></div><div class="casAuthors">Blunt, John W.; Copp, Brent R.; Keyzers, Robert A.; Munro, Murray H. G.; Prinsep, Michele R.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-211</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This review covers the literature published in 2013 for marine natural products (MNPs), with 982 citations (644 for the period Jan. to Dec. 2013) referring to compds. isolated from marine microorganisms and phytoplankton, green, brown and red algae, sponges, cnidarians, bryozoans, molluscs, tunicates, echinoderms, mangroves and other intertidal plants and microorganisms.  The emphasis is on new compds. (1163 for 2013), together with the relevant biol. activities, source organisms and country of origin.  Reviews, biosynthetic studies, first syntheses, and syntheses that lead to the revision of structures or stereochemistries, have been included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKlmlmJV9PLVg90H21EOLACvtfcHk0ljLb0XDkvgw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSju74%253D&md5=2011d5cdb341df91eeb107e44ded56e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FC4NP00144C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00144C%26sid%3Dliteratum%253Aachs%26aulast%3DBlunt%26aufirst%3DJ.%2BW.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DKeyzers%26aufirst%3DR.%2BA.%26aulast%3DMunro%26aufirst%3DM.%2BH.%26aulast%3DPrinsep%26aufirst%3DM.%2BR.%26atitle%3DMarine%2520natural%2520products%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2015%26volume%3D32%26spage%3D116%26epage%3D211%26doi%3D10.1039%2FC4NP00144C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkas, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porco, J. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R.</span></span> <span> </span><span class="NLM_article-title">Photochemical approaches to complex chemotypes: applications in natural product synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9683</span>– <span class="NLM_lpage">9747</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslWhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=9683-9747&author=M.+D.+Karkasauthor=J.+A.+Porcoauthor=C.+R.+Stephenson&title=Photochemical+approaches+to+complex+chemotypes%3A+applications+in+natural+product+synthesis&doi=10.1021%2Facs.chemrev.5b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis</span></div><div class="casAuthors">Karkas, Markus D.; Porco, John A.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9683-9747</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of photochem. transformations is a powerful strategy that allows for the formation of a high degree of mol. complexity from relatively simple building blocks in a single step.  A central feature of all light-promoted transformations is the involvement of electronically excited states, generated upon absorption of photons.  This produces transient reactive intermediates and significantly alters the reactivity of a chem. compd.  The input of energy provided by light thus offers a means to produce strained and unique target compds. that cannot be assembled using thermal protocols.  This review aims at highlighting photochem. transformations as a tool for rapidly accessing structurally and stereochem. diverse scaffolds.  Synthetic designs based on photochem. transformations have the potential to afford complex polycyclic carbon skeletons with impressive efficiency, which are of high value in total synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp-nECA9probVg90H21EOLACvtfcHk0ljLb0XDkvgw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslWhsr8%253D&md5=a8b206f9f59a2b945c0e91ae15eedf96</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00760%26sid%3Dliteratum%253Aachs%26aulast%3DKarkas%26aufirst%3DM.%2BD.%26aulast%3DPorco%26aufirst%3DJ.%2BA.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%26atitle%3DPhotochemical%2520approaches%2520to%2520complex%2520chemotypes%253A%2520applications%2520in%2520natural%2520product%2520synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D9683%26epage%3D9747%26doi%3D10.1021%2Facs.chemrev.5b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neve, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijesekera, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripper, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campitelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolakopoulos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de A. Leone, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrae, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">Euodenine A: a small-molecule agonist of human TLR4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/jm401321v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401321v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1252-1275&author=J.+E.+Neveauthor=H.+P.+Wijesekeraauthor=S.+Duffyauthor=I.+D.+Jenkinsauthor=J.+A.+Ripperauthor=S.+J.+Teagueauthor=M.+Campitelliauthor=A.+Garavelasauthor=G.+Nikolakopoulosauthor=P.+V.+Leauthor=P.+de+A.+Leoneauthor=N.+B.+Phamauthor=P.+Sheltonauthor=N.+Fraserauthor=A.+R.+Carrollauthor=V.+M.+Averyauthor=C.+McCraeauthor=N.+Williamsauthor=R.+J.+Quinn&title=Euodenine+A%3A+a+small-molecule+agonist+of+human+TLR4&doi=10.1021%2Fjm401321v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Euodenine A: A Small-Molecule Agonist of Human TLR4</span></div><div class="casAuthors">Neve, Juliette E.; Wijesekera, Hasanthi P.; Duffy, Sandra; Jenkins, Ian D.; Ripper, Justin A.; Teague, Simon J.; Campitelli, Marc; Garavelas, Agatha; Nikolapoulos, George; Le, Phuc V.; de A. Leone, Priscila; Pham, Ngoc B.; Shelton, Philip; Fraser, Neil; Carroll, Anthony R.; Avery, Vicky M.; McCrae, Christopher; Williams, Nicola; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1252-1275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small-mol. natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor.  Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure.  It was synthesized along with a series of analogs that exhibit potent and selective agonism of the TLR4 receptor.  SAR development around the cyclobutane ring resulted in a 10-fold increase in potency.  The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-κB reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy.  Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-α, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compds. like 1 could modulate the Th2 immune response without causing lung damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq274es6aNxRrVg90H21EOLACvtfcHk0lhU2AkxrqbNow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCmtro%253D&md5=7f314cfcb025af818709cf4e025cd917</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401321v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401321v%26sid%3Dliteratum%253Aachs%26aulast%3DNeve%26aufirst%3DJ.%2BE.%26aulast%3DWijesekera%26aufirst%3DH.%2BP.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DJenkins%26aufirst%3DI.%2BD.%26aulast%3DRipper%26aufirst%3DJ.%2BA.%26aulast%3DTeague%26aufirst%3DS.%2BJ.%26aulast%3DCampitelli%26aufirst%3DM.%26aulast%3DGaravelas%26aufirst%3DA.%26aulast%3DNikolakopoulos%26aufirst%3DG.%26aulast%3DLe%26aufirst%3DP.%2BV.%26aulast%3Dde%2BA.%2BLeone%26aufirst%3DP.%26aulast%3DPham%26aufirst%3DN.%2BB.%26aulast%3DShelton%26aufirst%3DP.%26aulast%3DFraser%26aufirst%3DN.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DMcCrae%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DN.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DEuodenine%2520A%253A%2520a%2520small-molecule%2520agonist%2520of%2520human%2520TLR4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1252%26epage%3D1275%26doi%3D10.1021%2Fjm401321v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(00)82054-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0968-0896%2800%2982054-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=1051-1056&author=T.+T.+Leeauthor=Y.+Kashiwadaauthor=L.+Huangauthor=J.+Sniderauthor=M.+Cosentinoauthor=K.+H.+Lee&title=Suksdorfin%3A+an+anti-HIV+principle+from+Lomatium+suksdorfii%2C+its+structure-activity+correlation+with+related+coumarins%2C+and+synergistic+effects+with+anti-AIDS+nucleosides&doi=10.1016%2FS0968-0896%2800%2982054-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2982054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252982054-4%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DSnider%26aufirst%3DJ.%26aulast%3DCosentino%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DSuksdorfin%253A%2520an%2520anti-HIV%2520principle%2520from%2520Lomatium%2520suksdorfii%252C%2520its%2520structure-activity%2520correlation%2520with%2520related%2520coumarins%252C%2520and%2520synergistic%2520effects%2520with%2520anti-AIDS%2520nucleosides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D1051%26epage%3D1056%26doi%3D10.1016%2FS0968-0896%2800%2982054-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuk, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis-Long, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span> <span> </span><span class="NLM_article-title">Novel chromenedione derivatives displaying inhibition of protein tyrosine phosphatase 1B (PTP1B) from Flemingia philippinensis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2015.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=318-321&author=Y.+Wangauthor=H.+J.+Yukauthor=J.+Y.+Kimauthor=D.+W.+Kimauthor=Y.+H.+Songauthor=X.+F.+Tanauthor=M.+J.+Curtis-Longauthor=K.+H.+Park&title=Novel+chromenedione+derivatives+displaying+inhibition+of+protein+tyrosine+phosphatase+1B+%28PTP1B%29+from+Flemingia+philippinensis&doi=10.1016%2Fj.bmcl.2015.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYuk%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DY.%2BH.%26aulast%3DTan%26aufirst%3DX.%2BF.%26aulast%3DCurtis-Long%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BH.%26atitle%3DNovel%2520chromenedione%2520derivatives%2520displaying%2520inhibition%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%2520%2528PTP1B%2529%2520from%2520Flemingia%2520philippinensis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D318%26epage%3D321%26doi%3D10.1016%2Fj.bmcl.2015.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J. H.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span> <span> </span><span class="NLM_article-title">The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2743</span>, <span class="refDoi"> DOI: 10.1021/jm00093a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00093a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK38XltVyisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2735-2743&author=Y.+Kashmanauthor=K.+R.+Gustafsonauthor=R.+W.+Fullerauthor=J.+H.+Cardellinaauthor=J.+B.+McMahonauthor=M.+J.+Currensauthor=R.+W.+Buckheitauthor=S.+H.+Hughesauthor=G.+M.+Craggauthor=M.+R.+Boyd&title=The+calanolides%2C+a+novel+HIV-inhibitory+class+of+coumarin+derivatives+from+the+tropical+rainforest+tree%2C+Calophyllum+lanigerum&doi=10.1021%2Fjm00093a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HIV inhibitory natural products.  Part 7.  The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum</span></div><div class="casAuthors">Kashman, Yoel; Gustafson, Kirk R.; Fuller, Richard W.; Cardellina, John H., II; McMahon, James B.; Currens, Michael J.; Buckheit, Robert W., Jr.; Hughes, Stephen H.; Cragg, Gordon M.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2735-43</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight new coumarin compds. were isolated by anti-HIV bioassay-guided fractionation of an ext. of C. lanigerum.  The structures of calanolide A (I), 12-acetoxycalanolide A, 12-methoxycalanolide A, calanolide B, II, 12-methoxycaloanilide B, calanolide C, and related derivs. were solved by extensive spectroscopic analyses, particularly HMQC, HMBC, and difference nOe NMR expts.  The abs. stereochem. of I and II was established by a modified Mosher's method.  I and II were completely protective against HIV-1 replication and cytopathicity (EC50 values of 0.1 and 0.4 μM, resp.), but were inactive against HIV-2.  Some of the related compds. also showed evidence of anti-HIV-1 activity.  Studies with purified bacterial recombinant reverse transcriptases (RT) revealed that the calanolides are HIV-1 specific RT inhibitors.  Moreover, I was active not only against the AZT-resistant G-9106 strain of HIV-1 but also against the pyridinone-resistant A17 strain.  This was of particular interest since the A17 virus is highly resistant to previously known HIV-1 specific, non-nucleoside RT inhibitors (e.g., TIBP; BI-RG-587l; L693,593) which comprise a structurally diverse but apparently common pharmacol. class.  The calanolides represent a substantial departure from the known class and therefore provide a novel new anti-HIV chemotype for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe79cb1KWQ3rVg90H21EOLACvtfcHk0liTgIONdbc7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVyisr8%253D&md5=fca56996f9343579501adcd20e02eea6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00093a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00093a004%26sid%3Dliteratum%253Aachs%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26aulast%3DFuller%26aufirst%3DR.%2BW.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DCurrens%26aufirst%3DM.%2BJ.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DThe%2520calanolides%252C%2520a%2520novel%2520HIV-inhibitory%2520class%2520of%2520coumarin%2520derivatives%2520from%2520the%2520tropical%2520rainforest%2520tree%252C%2520Calophyllum%2520lanigerum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2735%26epage%3D2743%26doi%3D10.1021%2Fjm00093a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewell, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, S. F.</span></span> <span> </span><span class="NLM_article-title">Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2987</span>, <span class="refDoi"> DOI: 10.1021/ja207662w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja207662w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=2981-2987&author=Z.+Fengauthor=D.+Chakrabortyauthor=S.+B.+Dewellauthor=B.+V.+Reddyauthor=S.+F.+Brady&title=Environmental+DNA-encoded+antibiotics+fasamycins+A+and+B+inhibit+FabF+in+type+II+fatty+acid+biosynthesis&doi=10.1021%2Fja207662w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Environmental DNA-encoded antibiotics fasamycins A and B inhibit FabF in type II fatty acid biosynthesis</span></div><div class="casAuthors">Feng, Zhiyang; Chakraborty, Debjani; Dewell, Scott B.; Reddy, Boojala Vijay B.; Brady, Sean F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2981-2987</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a study of polyketide biosynthetic gene clusters cloned directly from soil, the authors isolated two antibiotics, fasamycins A and B, which showed activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.  To identify the target of the fasamycins, mutants with elevated fasamycin A min. inhibitory concns. were selected from a wild-type culture of E. faecalis OG1RF.  Next-generation sequencing of these mutants, in conjunction with in vitro biochem. assays, showed that the fasamycins inhibit FabF of type II fatty acid biosynthesis (FASII).  Candidate gene overexpression studies also showed that fasamycin resistance is conferred by fabF overexpression.  On the basis of comparisons with known FASII inhibitors and in silico docking studies, the chloro-gem-dimethyl-anthracenone substructure seen in the fasamycins is predicted to represent a naturally occurring FabF-specific antibiotic pharmacophore.  Optimization of this pharmacophore should yield FabF-specific antibiotics with increased potencies and differing spectra of activity.  This study demonstrates that culture-independent antibiotic discovery methods have the potential to provide access to novel metabolites with modes of action that differ from those of antibiotics currently in clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoucmexTsiROrVg90H21EOLACvtfcHk0liTgIONdbc7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGltA%253D%253D&md5=8ee39d947dfb9dbe44d670eb5985e83a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja207662w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207662w%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DDewell%26aufirst%3DS.%2BB.%26aulast%3DReddy%26aufirst%3DB.%2BV.%26aulast%3DBrady%26aufirst%3DS.%2BF.%26atitle%3DEnvironmental%2520DNA-encoded%2520antibiotics%2520fasamycins%2520A%2520and%2520B%2520inhibit%2520FabF%2520in%2520type%2520II%2520fatty%2520acid%2520biosynthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D2981%26epage%3D2987%26doi%3D10.1021%2Fja207662w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, R.</span></span> <span> </span><span class="NLM_article-title">Elansolid A, a unique macrolide antibiotic from Chitinophaga sancti isolated as two stable atropisomers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1002/anie.201005226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.201005226" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=532-536&author=H.+Steinmetzauthor=K.+Gerthauthor=R.+Jansenauthor=N.+Schlagerauthor=R.+Dehnauthor=S.+Reineckeauthor=A.+Kirschningauthor=R.+Muller&title=Elansolid+A%2C+a+unique+macrolide+antibiotic+from+Chitinophaga+sancti+isolated+as+two+stable+atropisomers&doi=10.1002%2Fanie.201005226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201005226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201005226%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetz%26aufirst%3DH.%26aulast%3DGerth%26aufirst%3DK.%26aulast%3DJansen%26aufirst%3DR.%26aulast%3DSchlager%26aufirst%3DN.%26aulast%3DDehn%26aufirst%3DR.%26aulast%3DReinecke%26aufirst%3DS.%26aulast%3DKirschning%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DR.%26atitle%3DElansolid%2520A%252C%2520a%2520unique%2520macrolide%2520antibiotic%2520from%2520Chitinophaga%2520sancti%2520isolated%2520as%2520two%2520stable%2520atropisomers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D532%26epage%3D536%26doi%3D10.1002%2Fanie.201005226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otoguro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunazuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, Y.</span></span> <span> </span><span class="NLM_article-title">Arisugacin, a novel and selective inhibitor of acetylcholinesterase from <i>Penicillium</i> sp. FO-4259</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.48.745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7164%2Fantibiotics.48.745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1995&pages=745-746&author=S.+Omuraauthor=F.+Kunoauthor=K.+Otoguroauthor=T.+Sunazukaauthor=K.+Shiomiauthor=R.+Masumaauthor=Y.+Iwai&title=Arisugacin%2C+a+novel+and+selective+inhibitor+of+acetylcholinesterase+from+Penicillium+sp.+FO-4259&doi=10.7164%2Fantibiotics.48.745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.48.745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.48.745%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DS.%26aulast%3DKuno%26aufirst%3DF.%26aulast%3DOtoguro%26aufirst%3DK.%26aulast%3DSunazuka%26aufirst%3DT.%26aulast%3DShiomi%26aufirst%3DK.%26aulast%3DMasuma%26aufirst%3DR.%26aulast%3DIwai%26aufirst%3DY.%26atitle%3DArisugacin%252C%2520a%2520novel%2520and%2520selective%2520inhibitor%2520of%2520acetylcholinesterase%2520from%2520Penicillium%2520sp.%2520FO-4259%26jtitle%3DJ.%2520Antibiot.%26date%3D1995%26volume%3D48%26spage%3D745%26epage%3D746%26doi%3D10.7164%2Fantibiotics.48.745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, A.</span></span> <span> </span><span class="NLM_article-title">The interaction between coumarin drugs and DNA gyrase</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01728.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1365-2958.1993.tb01728.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=8231802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCjsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1993&pages=681-686&author=A.+Maxwell&title=The+interaction+between+coumarin+drugs+and+DNA+gyrase&doi=10.1111%2Fj.1365-2958.1993.tb01728.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction between coumarin drugs and DNA gyrase</span></div><div class="casAuthors">Maxwell, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">681-6</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A review with 49 refs.  The coumarin group of antibiotics have as their target bacterial DNA gyrase (I).  The drugs bind to the B subunit of I and inhibit DNA supercoiling by blocking the ATPase activity.  Recent data show that the binding site for the drugs lies within the N-terminal part of the B protein, and individual amino acids involved in coumarin interaction are being identified.  The mode of inhibition of the I ATPase reaction by coumarins is unlikely to be simple competitive inhibition, and the drugs may act by stabilizing a conformation of the enzyme with low affinity for ATP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVp_qVeuKqgbVg90H21EOLACvtfcHk0li-lBda2QlnZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCjsr8%253D&md5=936de9ec8f1f199de584ec2cedb941b6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01728.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01728.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DA.%26atitle%3DThe%2520interaction%2520between%2520coumarin%2520drugs%2520and%2520DNA%2520gyrase%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D9%26spage%3D681%26epage%3D686%26doi%3D10.1111%2Fj.1365-2958.1993.tb01728.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcote, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battershill, C. N.</span></span> <span> </span><span class="NLM_article-title">Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/jo991296y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo991296y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=445-449&author=L.+M.+Westauthor=P.+T.+Northcoteauthor=C.+N.+Battershill&title=Peloruside+A%3A+a+potent+cytotoxic+macrolide+isolated+from+the+New+Zealand+marine+sponge+Mycale+sp&doi=10.1021%2Fjo991296y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo991296y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991296y%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DL.%2BM.%26aulast%3DNorthcote%26aufirst%3DP.%2BT.%26aulast%3DBattershill%26aufirst%3DC.%2BN.%26atitle%3DPeloruside%2520A%253A%2520a%2520potent%2520cytotoxic%2520macrolide%2520isolated%2520from%2520the%2520New%2520Zealand%2520marine%2520sponge%2520Mycale%2520sp%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D445%26epage%3D449%26doi%3D10.1021%2Fjo991296y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talpir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benayahu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleyer, M.</span></span> <span> </span><span class="NLM_article-title">Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge <i>Hemiasterella minor</i> (Kirkpatrick)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4453</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)73382-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0040-4039%2800%2973382-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=4453-4456&author=R.+Talpirauthor=Y.+Benayahuauthor=Y.+Kashmanauthor=L.+Pannellauthor=M.+Schleyer&title=Hemiasterlin+and+geodiamolide+TA%3B+two+new+cytotoxic+peptides+from+the+marine+sponge+Hemiasterella+minor+%28Kirkpatrick%29&doi=10.1016%2FS0040-4039%2800%2973382-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2973382-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252973382-X%26sid%3Dliteratum%253Aachs%26aulast%3DTalpir%26aufirst%3DR.%26aulast%3DBenayahu%26aufirst%3DY.%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DPannell%26aufirst%3DL.%26aulast%3DSchleyer%26aufirst%3DM.%26atitle%3DHemiasterlin%2520and%2520geodiamolide%2520TA%253B%2520two%2520new%2520cytotoxic%2520peptides%2520from%2520the%2520marine%2520sponge%2520Hemiasterella%2520minor%2520%2528Kirkpatrick%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D4453%26epage%3D4456%26doi%3D10.1016%2FS0040-4039%2800%2973382-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Silva, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, T. M.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic peptides from the marine sponge <i>Cymbastela</i> sp</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">10653</span>– <span class="NLM_lpage">10662</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(95)00646-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0040-4020%2895%2900646-P" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=10653-10662&author=J.+E.+Colemanauthor=E.+D.+de+Silvaauthor=F.+Kongauthor=R.+J.+Andersenauthor=T.+M.+Allen&title=Cytotoxic+peptides+from+the+marine+sponge+Cymbastela+sp&doi=10.1016%2F0040-4020%2895%2900646-P"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2895%2900646-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252895%252900646-P%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DJ.%2BE.%26aulast%3Dde%2BSilva%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DF.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26atitle%3DCytotoxic%2520peptides%2520from%2520the%2520marine%2520sponge%2520Cymbastela%2520sp%26jtitle%3DTetrahedron%26date%3D1995%26volume%3D51%26spage%3D10653%26epage%3D10662%26doi%3D10.1016%2F0040-4020%2895%2900646-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doubek, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of bryostatin 1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">6846</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1021/ja00388a092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00388a092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL38XmtFejsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1982&pages=6846-6848&author=G.+R.+Pettitauthor=C.+L.+Heraldauthor=D.+L.+Doubekauthor=D.+L.+Heraldauthor=E.+Arnoldauthor=J.+Clardy&title=Isolation+and+structure+of+bryostatin+1&doi=10.1021%2Fja00388a092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of bryostatin 1</span></div><div class="casAuthors">Pettit, George R.; Herald, Cherry L.; Doubek, Dennis L.; Herald, Delbert L.; Arnold, Edward; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6846-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A new exceptionally potent antineoplastic agent designated bryostatin 1 (I) has been isolated from the marine animal Bugula neritina (phylum Bryozoa).  An x-ray crystallog. anal. led to the assignment of the novel structure I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryBD1PR44a7rVg90H21EOLACvtfcHk0ljy-LXY7LaOzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XmtFejsbs%253D&md5=70346431271c1334ea9159bd9f9c7d61</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00388a092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00388a092%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DDoubek%26aufirst%3DD.%2BL.%26aulast%3DHerald%26aufirst%3DD.%2BL.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bryostatin%25201%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1982%26volume%3D104%26spage%3D6846%26epage%3D6848%26doi%3D10.1021%2Fja00388a092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span> <span> </span><span class="NLM_article-title">Harringtonine, an inhibitor of initiation of protein biosynthesis</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1975&pages=511-519&author=M.+T.+Huang&title=Harringtonine%2C+an+inhibitor+of+initiation+of+protein+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%2BT.%26atitle%3DHarringtonine%252C%2520an%2520inhibitor%2520of%2520initiation%2520of%2520protein%2520biosynthesis%26jtitle%3DMol.%2520Pharmacol.%26date%3D1975%26volume%3D11%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coggon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, A. T.</span></span> <span> </span><span class="NLM_article-title">Plant antitumor agents. VI. the isolation and structure of taxol, a novel antileukemic and antitumor agent from <i>Taxus brevifolia</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/ja00738a045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00738a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaE3MXktVKisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1971&pages=2325-2327&author=M.+C.+Waniauthor=H.+L.+Taylorauthor=M.+E.+Wallauthor=P.+Coggonauthor=A.+T.+McPhail&title=Plant+antitumor+agents.+VI.+the+isolation+and+structure+of+taxol%2C+a+novel+antileukemic+and+antitumor+agent+from+Taxus+brevifolia&doi=10.1021%2Fja00738a045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Plant antitumor agents.  VI.  Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia</span></div><div class="casAuthors">Wani, Mansukhlal C.; Taylor, Harold Lawrence; Wall, Monroe E.; Coggon, Philip; McPhail, Andrew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2325-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Taxol (I), a complex ester with a taxane ring system exhibiting potent antileukemic and antitumor properties, was isolated from Taxus brevifolia (yew).  BzNHCH(Ph)CH(OH)CO2Me and 5β,16-epoxy-1β,-2α,4α,7β,10β,13α-hexahydroxytax-11-en-9-one 4α-acetate 2α-benzoate are obtained by methanolysis of I.  Based on chem. evidence, I is 5β,16-epoxy-1β,2α,4α,7β,10β,13α-hexahydroxytax-11-en-9-one 4α,10β-diacetate 2α-benzoate 13α-(3-benzamido-2-hydroxy-3-phenylpropionate).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpexINv4qMTjbVg90H21EOLACvtfcHk0lihjSE7lfbJFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXktVKisLc%253D&md5=50c59ef3bf2ae493408bed2a76ca0c2e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00738a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00738a045%26sid%3Dliteratum%253Aachs%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DTaylor%26aufirst%3DH.%2BL.%26aulast%3DWall%26aufirst%3DM.%2BE.%26aulast%3DCoggon%26aufirst%3DP.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DPlant%2520antitumor%2520agents.%2520VI.%2520the%2520isolation%2520and%2520structure%2520of%2520taxol%252C%2520a%2520novel%2520antileukemic%2520and%2520antitumor%2520agent%2520from%2520Taxus%2520brevifolia%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1971%26volume%3D93%26spage%3D2325%26epage%3D2327%26doi%3D10.1021%2Fja00738a045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gueritte-Voegelein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavelle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Goff, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangatal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">Relationships between the structure of taxol analogues and their antimitotic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1021/jm00107a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00107a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=992-998&author=F.+Gueritte-Voegeleinauthor=D.+Guenardauthor=F.+Lavelleauthor=M.+T.+Le+Goffauthor=L.+Mangatalauthor=P.+Potier&title=Relationships+between+the+structure+of+taxol+analogues+and+their+antimitotic+activity&doi=10.1021%2Fjm00107a017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00107a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00107a017%26sid%3Dliteratum%253Aachs%26aulast%3DGueritte-Voegelein%26aufirst%3DF.%26aulast%3DGuenard%26aufirst%3DD.%26aulast%3DLavelle%26aufirst%3DF.%26aulast%3DLe%2BGoff%26aufirst%3DM.%2BT.%26aulast%3DMangatal%26aufirst%3DL.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3DRelationships%2520between%2520the%2520structure%2520of%2520taxol%2520analogues%2520and%2520their%2520antimitotic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D992%26epage%3D998%26doi%3D10.1021%2Fjm00107a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaigneau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiery-Vuillemin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cals, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivot, X.</span></span> <span> </span><span class="NLM_article-title">Cabazitaxel: a novel microtubule inhibitor</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.2165/11591390-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2165%2F11591390-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1251-1258&author=C.+Villanuevaauthor=F.+Bazanauthor=S.+Kimauthor=M.+Demarchiauthor=L.+Chaigneauauthor=A.+Thiery-Vuilleminauthor=T.+Nguyenauthor=L.+Calsauthor=E.+Dobiauthor=X.+Pivot&title=Cabazitaxel%3A+a+novel+microtubule+inhibitor&doi=10.2165%2F11591390-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2165%2F11591390-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11591390-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DVillanueva%26aufirst%3DC.%26aulast%3DBazan%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDemarchi%26aufirst%3DM.%26aulast%3DChaigneau%26aufirst%3DL.%26aulast%3DThiery-Vuillemin%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DCals%26aufirst%3DL.%26aulast%3DDobi%26aufirst%3DE.%26aulast%3DPivot%26aufirst%3DX.%26atitle%3DCabazitaxel%253A%2520a%2520novel%2520microtubule%2520inhibitor%26jtitle%3DDrugs%26date%3D2011%26volume%3D71%26spage%3D1251%26epage%3D1258%26doi%3D10.2165%2F11591390-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedorf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irschik, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichenbach, H.</span></span> <span> </span><span class="NLM_article-title">Epothilons A and B: antifungal and cytotoxic compounds from <i>Sorangium cellulosum</i> (Myxobacteria). production, physico-chemical and biological properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.49.560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7164%2Fantibiotics.49.560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=8698639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK28XjvFSgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=560-563&author=K.+Gerthauthor=N.+Bedorfauthor=G.+Hofleauthor=H.+Irschikauthor=H.+Reichenbach&title=Epothilons+A+and+B%3A+antifungal+and+cytotoxic+compounds+from+Sorangium+cellulosum+%28Myxobacteria%29.+production%2C+physico-chemical+and+biological+properties&doi=10.7164%2Fantibiotics.49.560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics from gliding bacteria. 74. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria): production, physico-chemical and biological properties</span></div><div class="casAuthors">Gerth, Klaus; Bedorf, Norbert; Hoefle, Gerhard; Irschik, Herbert; Reichenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">560-563</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">An antifungal activity against Mucor hiemalis was detected in the culture broth of Sorangium cellulosum (Myxococcales) strain So ce90.  The activity was excreted into the supernatant during the log and early stationary phase.  When the adsorbent resin XAD-16 was added to the culture, the active metabolites were quant. bound to the resin.  The epothilons showed a high cytotoxicity for animal cells and mimic the biol. effects of taxol (Bollag, D. M., et al., 1995).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwr68sVlgUO7Vg90H21EOLACvtfcHk0ljQGnmhUQo_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFSgsr8%253D&md5=c1d3b6017f6e66b8ab83e4ed9fdcd396</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.49.560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.49.560%26sid%3Dliteratum%253Aachs%26aulast%3DGerth%26aufirst%3DK.%26aulast%3DBedorf%26aufirst%3DN.%26aulast%3DHofle%26aufirst%3DG.%26aulast%3DIrschik%26aufirst%3DH.%26aulast%3DReichenbach%26aufirst%3DH.%26atitle%3DEpothilons%2520A%2520and%2520B%253A%2520antifungal%2520and%2520cytotoxic%2520compounds%2520from%2520Sorangium%2520cellulosum%2520%2528Myxobacteria%2529.%2520production%252C%2520physico-chemical%2520and%2520biological%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1996%26volume%3D49%26spage%3D560%26epage%3D563%26doi%3D10.7164%2Fantibiotics.49.560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of ixabepilone</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1158%2F1535-7163.MCT-08-0999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19174552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=275-281&author=J.+T.+Hunt&title=Discovery+of+ixabepilone&doi=10.1158%2F1535-7163.MCT-08-0999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ixabepilone</span></div><div class="casAuthors">Hunt, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-281</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The discovery of the antineoplastic agent paclitaxel and its unique activity as a microtubule-stabilizing agent resulted in dramatic improvements in the treatment of breast, ovarian, and non-small cell lung cancers.  Despite the potent antitumor activity of taxanes such as paclitaxel, efficacy of these agents has been limited by development of taxane-resistant tumors in patients.  This review describes, with some historical context, our successful efforts to discover a next-generation microtubule-stabilizing agent for the treatment of cancer.  In collaboration with the Gesellschaft fuer Biotechnologische Forschung, we evaluated the epothilones, originally isolated from the myxobacterium Sorangium cellulosum, as potential anticancer agents.  Expts. performed at Bristol-Myers Squibb confirmed the ability of these agents to induce tubulin polymn., cell cycle arrest, and apoptosis.  Epothilones A and B showed potent cytotoxic activity toward paclitaxel-sensitive and paclitaxel-resistant cells expressing P-glycoprotein or mutant tubulin.  Because the parent epothilones were subject to inactivation via esterase cleavage, we used semisynthetic approaches to prep. analogs without this liability.  BMS-247550 (ixabepilone), the lactam analog of epothilone B, showed increased metabolic stability, potent tubulin polymn. activity, and retained activity against paclitaxel-resistant lines.  Based on its shown efficacy in clin. trials, ixabepilone was approved by the Food and Drug Administration in 2007 for treatment of drug-resistant/refractory metastatic or locally advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JCt13kq2MbVg90H21EOLACvtfcHk0ljLJge8acJx2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFams7k%253D&md5=df8576d7b3b1299d55cee362aa92ad1e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0999%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520of%2520ixabepilone%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D275%26epage%3D281%26doi%3D10.1158%2F1535-7163.MCT-08-0999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, E.</span></span> <span> </span><span class="NLM_article-title">Cocarcinogenic principles from the seed oil of <i>Croton tiglium</i> and from other <i>Euphorbiaceae</i></span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2338</span>– <span class="NLM_lpage">2349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=5723975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaF1MXksVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1968&pages=2338-2349&author=E.+Hecker&title=Cocarcinogenic+principles+from+the+seed+oil+of+Croton+tiglium+and+from+other+Euphorbiaceae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae</span></div><div class="casAuthors">Hecker, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2338-49</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A review on the isolation and identification of tumor-promoting principles of seed oil from Croton and other Euphorbiaceae.  The active principle of Croton oil was diesters of phorbol.  44 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqJ-3SuKUcrVg90H21EOLACvtfcHk0ljLJge8acJx2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXksVOruw%253D%253D&md5=a97b2452c3c8b023528250a902194660</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DE.%26atitle%3DCocarcinogenic%2520principles%2520from%2520the%2520seed%2520oil%2520of%2520Croton%2520tiglium%2520and%2520from%2520other%2520Euphorbiaceae%26jtitle%3DCancer%2520Res.%26date%3D1968%26volume%3D28%26spage%3D2338%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grue-Sorensen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedso, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogberg, T.</span></span> <span> </span><span class="NLM_article-title">Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5624</span>– <span class="NLM_lpage">5629</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2013.08.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5624-5629&author=X.+Liangauthor=G.+Grue-Sorensenauthor=K.+Manssonauthor=P.+Vedsoauthor=A.+Soorauthor=M.+Stahlhutauthor=M.+Bertelsenauthor=K.+M.+Engellauthor=T.+Hogberg&title=Syntheses%2C+biological+evaluation+and+SAR+of+ingenol+mebutate+analogues+for+treatment+of+actinic+keratosis+and+non-melanoma+skin+cancer&doi=10.1016%2Fj.bmcl.2013.08.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DGrue-Sorensen%26aufirst%3DG.%26aulast%3DMansson%26aufirst%3DK.%26aulast%3DVedso%26aufirst%3DP.%26aulast%3DSoor%26aufirst%3DA.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DBertelsen%26aufirst%3DM.%26aulast%3DEngell%26aufirst%3DK.%2BM.%26aulast%3DHogberg%26aufirst%3DT.%26atitle%3DSyntheses%252C%2520biological%2520evaluation%2520and%2520SAR%2520of%2520ingenol%2520mebutate%2520analogues%2520for%2520treatment%2520of%2520actinic%2520keratosis%2520and%2520non-melanoma%2520skin%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5624%26epage%3D5629%26doi%3D10.1016%2Fj.bmcl.2013.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span> <span> </span><span class="NLM_article-title">Fidaxomicin (OPT-80) for the treatment of <i>Clostridium difficile</i> infection</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1517/14656566.2010.485614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14656566.2010.485614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20446864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt12lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1569-1578&author=M.+Miller&title=Fidaxomicin+%28OPT-80%29+for+the+treatment+of+Clostridium+difficile+infection&doi=10.1517%2F14656566.2010.485614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection</span></div><div class="casAuthors">Miller, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Clostridium difficile infection (CDI) has become an increasingly important healthcare-assocd. complication in many countries.  CDI outbreaks, a new hypervirulent' form and increased worldwide rates have underscored four urgent unmet needs for this disease: (i) effective prevention of CDI; (ii) therapies to produce faster resoln. of CDI symptoms; (iii) therapies to treat severe CDI more effectively and reduce its mortality; and (iv) therapies to reduce the CDI recurrence rate following treatment.  Areas covered in this review: Fidaxomicin, a new macrocyclic antibiotic, has demonstrated potent in vitro activity against C. difficile with limited or no activity against normal fecal flora.  It is minimally absorbed from the intestinal tract, even in the presence of intestinal inflammation.  When tested against oral vancomycin in clin. studies of CDI therapy, it has equiv. efficacy for curing CDI at end of treatment and a comparable safety profile to that agent.  However, fidaxomicin therapy of CDI is assocd. with significantly fewer CDI recurrences in the 28 days following treatment.  Symptom resoln. is also slightly quicker in some CDI patients.  Addnl. fecal flora anal. in the CDI trials showed that fewer individuals developed intestinal colonization with vancomycin-resistant enterococci (VRE) among the fidaxomicin-treated group.  This new mol., which has just completed two large Phase III multicenter studies, successfully addresses two of the four urgent and unmet needs for dealing with CDI.  What the reader will gain: Fidaxomicin is as effective and as safe as vancomycin therapy for treating CDI but is assocd. with far fewer recurrences post-treatment and a decreased risk of VRE acquisition.  Take home message: Fidaxomicin is a potential new therapy for CDI which has the capacity to substantially decrease post-treatment recurrences and is as safe and well-tolerated as std. vancomycin treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQUooatd_u3bVg90H21EOLACvtfcHk0lgfusC5s8dsIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt12lt7w%253D&md5=1771c8a57dd04bfb4c206456d96a9bd9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.485614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.485614%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%26atitle%3DFidaxomicin%2520%2528OPT-80%2529%2520for%2520the%2520treatment%2520of%2520Clostridium%2520difficile%2520infection%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2010%26volume%3D11%26spage%3D1569%26epage%3D1578%26doi%3D10.1517%2F14656566.2010.485614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shue, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbach, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, R. A.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.1128/AAC.01045-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.01045-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1391-1395&author=Y.+K.+Shueauthor=P.+S.+Searsauthor=S.+Shangleauthor=R.+B.+Walshauthor=C.+Leeauthor=S.+L.+Gorbachauthor=F.+Okumuauthor=R.+A.+Preston&title=Safety%2C+tolerance%2C+and+pharmacokinetic+studies+of+OPT-80+in+healthy+volunteers+following+single+and+multiple+oral+doses&doi=10.1128%2FAAC.01045-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.01045-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01045-07%26sid%3Dliteratum%253Aachs%26aulast%3DShue%26aufirst%3DY.%2BK.%26aulast%3DSears%26aufirst%3DP.%2BS.%26aulast%3DShangle%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26aulast%3DOkumu%26aufirst%3DF.%26aulast%3DPreston%26aufirst%3DR.%2BA.%26atitle%3DSafety%252C%2520tolerance%252C%2520and%2520pharmacokinetic%2520studies%2520of%2520OPT-80%2520in%2520healthy%2520volunteers%2520following%2520single%2520and%2520multiple%2520oral%2520doses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1391%26epage%3D1395%26doi%3D10.1128%2FAAC.01045-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassanali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stothard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolsey, J.</span></span> <span> </span><span class="NLM_article-title">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">D668</span>– <span class="NLM_lpage">D672</span>, <span class="refDoi"> DOI: 10.1093/nar/gkj067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fnar%2Fgkj067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16381955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=D668-D672&author=D.+S.+Wishartauthor=C.+Knoxauthor=A.+C.+Guoauthor=S.+Shrivastavaauthor=M.+Hassanaliauthor=P.+Stothardauthor=Z.+Changauthor=J.+Woolsey&title=DrugBank%3A+a+comprehensive+resource+for+in+silico+drug+discovery+and+exploration&doi=10.1093%2Fnar%2Fgkj067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">DrugBank: a comprehensive resource for in silico drug discovery and exploration</span></div><div class="casAuthors">Wishart, David S.; Knox, Craig; Guo, An Chi; Shrivastava, Savita; Hassanali, Murtaza; Stothard, Paul; Chang, Zhan; Woolsey, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D668-D672</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">DrugBank is a unique bioinformatics/cheminformatics resource that combines detailed drug (i.e. chem.) data with comprehensive drug target (i.e. protein) information.  The database contains >4100 drug entries including >800 FDA approved small mol. and biotech drugs as well as >3200 exptl. drugs.  Addnl., >14 000 protein or drug target sequences are linked to these drug entries.  Each DrugCard entry contains >80 data fields with half of the information being devoted to drug/chem. data and the other half devoted to drug target or protein data.  Many data fields are hyperlinked to other databases (KEGG, PubChem, ChEBI, PDB, Swiss-Prot and GenBank) and a variety of structure viewing applets.  The database is fully searchable supporting extensive text, sequence, chem. structure and relational query searches.  Potential applications of DrugBank include in silico drug target discovery, drug design, drug docking or screening, drug metab. prediction, drug interaction prediction and general pharmaceutical education.  DrugBank is available at http://redpoll.pharmacy.ualberta.ca/drugbank/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaNy9WiVtlu7Vg90H21EOLACvtfcHk0lgfusC5s8dsIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFOrsw%253D%253D&md5=c3f4ad2fc489440be5b16f91bc9cf7db</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkj067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkj067%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DD.%2BS.%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DHassanali%26aufirst%3DM.%26aulast%3DStothard%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DWoolsey%26aufirst%3DJ.%26atitle%3DDrugBank%253A%2520a%2520comprehensive%2520resource%2520for%2520in%2520silico%2520drug%2520discovery%2520and%2520exploration%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2006%26volume%3D34%26spage%3DD668%26epage%3DD672%26doi%3D10.1093%2Fnar%2Fgkj067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span> <span> </span><span class="NLM_article-title">EC144 is a potent inhibitor of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7786</span>– <span class="NLM_lpage">7795</span>, <span class="refDoi"> DOI: 10.1021/jm300810x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300810x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7786-7795&author=J.+Shiauthor=R.+Van+de+Waterauthor=K.+Hongauthor=R.+B.+Lamerauthor=K.+W.+Weichertauthor=C.+M.+Sandovalauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=J.+Chaoauthor=K.+Lundgrenauthor=N.+Timpleauthor=R.+Loughauthor=G.+Ibanezauthor=C.+Boykinauthor=F.+J.+Burrowsauthor=M.+R.+Kehryauthor=T.+J.+Yunauthor=E.+K.+Harningauthor=C.+Ambroseauthor=J.+Thompsonauthor=S.+A.+Bixlerauthor=A.+Dunahauthor=P.+Snodgrass-Beltauthor=J.+Arndtauthor=I.+J.+Enyedyauthor=P.+Liauthor=V.+S.+Hongauthor=A.+McKenzieauthor=M.+A.+Biamonte&title=EC144+is+a+potent+inhibitor+of+the+heat+shock+protein+90&doi=10.1021%2Fjm300810x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90</span></div><div class="casAuthors">Shi, Jiandong; Van de Water, Ryan; Hong, Kevin; Lamer, Ryan B.; Weichert, Kenneth W.; Sandoval, Cristina M.; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Chao, Jianhua; Lundgren, Karen; Timple, Noelito; Lough, Rachel; Ibanez, Gerardo; Boykin, Christina; Burrows, Francis J.; Kehry, Marilyn R.; Yun, Theodore J.; Harning, Erin K.; Ambrose, Christine; Thompson, Jeffrey; Bixler, Sarah A.; Dunah, Anthone; Snodgrass-Belt, Pamela; Arndt, Joseph; Enyedy, Istvan J.; Li, Ping; Hong, Victor S.; McKenzie, Andres; Biamonte, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7786-7795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkyne 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor (BIIB021) that completed phase II clin. trials.  Alkyne (EC144) is more potent than (BIIB021) in an Hsp90α binding assay (IC50 = 1.1 vs. 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs. 38 nM).  In a mouse model of gastric tumors (N87), (EC144) stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qd×5).  Under the same conditions, (BIIB021) stops tumor growth only at 120 mg/kg, and does not induce partial regressions.  Thus, alkyne (EC144) is approx. 20-fold more efficacious than (BIIB021) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRtKyDCD2OLVg90H21EOLACvtfcHk0lgOIItfZ41G5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE&md5=201153ad61f71af267f1e1ba2ca7c2e7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300810x%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLamer%26aufirst%3DR.%2BB.%26aulast%3DWeichert%26aufirst%3DK.%2BW.%26aulast%3DSandoval%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DLough%26aufirst%3DR.%26aulast%3DIbanez%26aufirst%3DG.%26aulast%3DBoykin%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DAmbrose%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DDunah%26aufirst%3DA.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26atitle%3DEC144%2520is%2520a%2520potent%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7786%26epage%3D7795%26doi%3D10.1021%2Fjm300810x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atherall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker-Glenn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pichon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a highly selective, brain-penetrant aminopyrazole LRRK2 inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/ml3003007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=85-90&author=B.+K.+Chanauthor=A.+A.+Estradaauthor=H.+Chenauthor=J.+Atherallauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=S.+L.+Dominguezauthor=J.+Drummondauthor=A.+Gillauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=A.+D.+Medhurstauthor=X.+Liuauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=H.+Van+de+Poelauthor=S.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+a+highly+selective%2C+brain-penetrant+aminopyrazole+LRRK2+inhibitor&doi=10.1021%2Fml3003007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003007%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DVan%2Bde%2BPoel%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520highly%2520selective%252C%2520brain-penetrant%2520aminopyrazole%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D85%26epage%3D90%26doi%3D10.1021%2Fml3003007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strobel, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mseeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, D. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of LX2761, a sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor restricted to the intestinal lumen, for the treatment of diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01541</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1yqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=710-721&author=N.+C.+Goodwinauthor=Z.+M.+Dingauthor=B.+A.+Harrisonauthor=E.+D.+Strobelauthor=A.+L.+Harrisauthor=M.+Smithauthor=A.+Y.+Thompsonauthor=W.+Xiongauthor=F.+Mseehauthor=D.+J.+Bruceauthor=D.+Diazauthor=S.+Gopinathanauthor=L.+Liauthor=E.+O%E2%80%99Neillauthor=M.+Thielauthor=A.+G.+Wilsonauthor=K.+G.+Carsonauthor=D.+R.+Powellauthor=D.+B.+Rawlins&title=Discovery+of+LX2761%2C+a+sodium-dependent+glucose+cotransporter+1+%28SGLT1%29+inhibitor+restricted+to+the+intestinal+lumen%2C+for+the+treatment+of+diabetes&doi=10.1021%2Facs.jmedchem.6b01541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes</span></div><div class="casAuthors">Goodwin, Nicole C.; Ding, Zhi-Ming; Harrison, Bryce A.; Strobel, Eric D.; Harris, Angela L.; Smith, Melinda; Thompson, Andrea Y.; Xiong, Wendy; Mseeh, Faika; Bruce, Debra J.; Diaz, Damaris; Gopinathan, Suma; Li, Ling; O'Neill, Emily; Thiel, Mary; Wilson, Alan G. E.; Carson, Kenneth G.; Powell, David R.; Rawlins, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing no. of people afflicted with diabetes throughout the world is a major health issue.  Inhibitors of the sodium-dependent glucose cotransporters (SGLT) have appeared as viable therapeutics to control blood glucose levels in diabetic patients.  Herein the authors report the discovery of LX2761, a locally-acting SGLT1 inhibitor that is highly potent in vitro and delays intestinal glucose absorption in vivo to improve glycemic control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_jImP-MX5y7Vg90H21EOLACvtfcHk0lg-4sBsig7ykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1yqtA%253D%253D&md5=d07c28561e0bb9be4320391a94020d5c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01541%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DDing%26aufirst%3DZ.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BY.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DBruce%26aufirst%3DD.%2BJ.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DGopinathan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DThiel%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DA.%2BG.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DPowell%26aufirst%3DD.%2BR.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520LX2761%252C%2520a%2520sodium-dependent%2520glucose%2520cotransporter%25201%2520%2528SGLT1%2529%2520inhibitor%2520restricted%2520to%2520the%2520intestinal%2520lumen%252C%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D710%26epage%3D721%26doi%3D10.1021%2Facs.jmedchem.6b01541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chari, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widdison, W. C.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates: an emerging concept in cancer therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3796</span>– <span class="NLM_lpage">3827</span>, <span class="refDoi"> DOI: 10.1002/anie.201307628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fanie.201307628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVGmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3796-3827&author=R.+V.+Chariauthor=M.+L.+Millerauthor=W.+C.+Widdison&title=Antibody-drug+conjugates%3A+an+emerging+concept+in+cancer+therapy&doi=10.1002%2Fanie.201307628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy</span></div><div class="casAuthors">Chari, Ravi V. J.; Miller, Michael L.; Widdison, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3796-3827</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Traditional cancer chemotherapy is often accompanied by systemic toxicity to the patient.  Monoclonal antibodies against antigens on cancer cells offer an alternative tumor-selective treatment approach.  However, most monoclonal antibodies are not sufficiently potent to be therapeutically active on their own.  Antibody-drug conjugates (ADCs) use antibodies to deliver a potent cytotoxic compd. selectively to tumor cells, thus improving the therapeutic index of chemotherapeutic agents.  The recent approval of two ADCs, brentuximab vedotin and ado-trastuzumab emtansine, for cancer treatment has spurred tremendous research interest in this field.  This Review touches upon the early efforts in the field, and describes how the lessons learned from the first-generation ADCs have led to improvements in every aspect of this technol., i.e., the antibody, the cytotoxic compd., and the linker connecting them, leading to the current successes.  The design of ADCs currently in clin. development, and results from mechanistic studies and preclin. and clin. evaluation are discussed.  Emerging technologies that seek to further advance this exciting area of research are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4T2rhmji6DLVg90H21EOLACvtfcHk0lh7jPvPFG0a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVGmsr0%253D&md5=fbfb2f843f516654ea7c0eb98949604c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307628%26sid%3Dliteratum%253Aachs%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BL.%26aulast%3DWiddison%26aufirst%3DW.%2BC.%26atitle%3DAntibody-drug%2520conjugates%253A%2520an%2520emerging%2520concept%2520in%2520cancer%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D3796%26epage%3D3827%26doi%3D10.1002%2Fanie.201307628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperazinylquinoline derivatives as novel respiratory syncytial virus fusion inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVamsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=558-562&author=X.+Zhengauthor=L.+Wangauthor=B.+Wangauthor=K.+Miaoauthor=K.+Xiangauthor=S.+Fengauthor=L.+Gaoauthor=H.+C.+Shenauthor=H.+Yun&title=Discovery+of+piperazinylquinoline+derivatives+as+novel+respiratory+syncytial+virus+fusion+inhibitors&doi=10.1021%2Facsmedchemlett.5b00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors</span></div><div class="casAuthors">Zheng, Xiufang; Wang, Lisha; Wang, Baoxia; Miao, Kun; Xiang, Kunlun; Feng, Song; Gao, Lu; Shen, Hong C.; Yun, Hongying</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-562</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of piperazinylquinoline derivs. were discovered as respiratory syncytial virus (RSV) fusion inhibitors by the ligand-based screening approach.  Among 3000 hits, 1-amino-3-[[2-(4-phenyl-1-piperidyl)-4-quinolyl]amino]propan-2-ol was proven to be active against the RSV long (A) strain.  The anti-RSV activity was improved by converting piperidine to benzylcarbonyl substituted piperazine.  The basic side chain was also found to be crucial for anti-RSV activity.  The selected analogs, I and II, demonstrated anti-RSV activities up to EC50 = 0.028 μM and 0.033 μM, resp.  A direct anti-RSV effect was confirmed by a plaque redn. assay and a fusion inhibition assay.  Both I and II showed promising DMPK properties with good oral bioavailability, and could potentially lead to novel therapeutic agents targeting the RSV fusion process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr98VDNFO7a27Vg90H21EOLACvtfcHk0lh7jPvPFG0a5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVamsb8%253D&md5=086def8b4fdde5bad248aa1f65106c9e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00234%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMiao%26aufirst%3DK.%26aulast%3DXiang%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DYun%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520piperazinylquinoline%2520derivatives%2520as%2520novel%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D558%26epage%3D562%26doi%3D10.1021%2Facsmedchemlett.5b00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plonowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchgessner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, R.</span></span> <span> </span><span class="NLM_article-title">Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRbeta</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=25435151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=372-377&author=E.+Kickauthor=R.+Martinauthor=Y.+Xieauthor=B.+Flattauthor=E.+Schweigerauthor=T.+L.+Wangauthor=B.+Buschauthor=M.+Nymanauthor=X.+H.+Guauthor=G.+Yanauthor=B.+Wagnerauthor=M.+Nanaoauthor=L.+Nguyenauthor=T.+Stoutauthor=A.+Plonowskiauthor=I.+Schulmanauthor=J.+Ostrowskiauthor=T.+Kirchgessnerauthor=R.+Wexlerauthor=R.+Mohan&title=Liver+X+receptor+%28LXR%29+partial+agonists%3A+biaryl+pyrazoles+and+imidazoles+displaying+a+preference+for+LXRbeta&doi=10.1016%2Fj.bmcl.2014.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ</span></div><div class="casAuthors">Kick, Ellen; Martin, Richard; Xie, Yinong; Flatt, Brenton; Schweiger, Edwin; Wang, Tie-Lin; Busch, Brett; Nyman, Michael; Gu, Xiao-Hui; Yan, Grace; Wagner, Brandee; Nanao, Max; Nguyen, Lam; Stout, Thomas; Plonowski, Artur; Schulman, Ira; Ostrowski, Jacek; Kirchgessner, Todd; Wexler, Ruth; Mohan, Raju</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of biaryl pyrazole and imidazole Liver X Receptor (LXR) partial agonists was synthesized displaying LXRβ selectivity.  The LXRβ selective partial agonist I was identified with potent induction of ATP binding transporters ABCA1 and ABCG1 in human whole blood (EC50 = 1.2 μM, 55% efficacy).  In mice I displayed peripheral induction of ABCA1 at 3 and 10 mpk doses with no significant elevation of plasma or hepatic triglycerides at these doses, showing an improved profile compared to a full pan-agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZYnRJNuyKHbVg90H21EOLACvtfcHk0ljvBpJkepk-ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitbvO&md5=c51402388c6900b89fbe5ea21ba636c6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DKick%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DFlatt%26aufirst%3DB.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DBusch%26aufirst%3DB.%26aulast%3DNyman%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DX.%2BH.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DNanao%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSchulman%26aufirst%3DI.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DKirchgessner%26aufirst%3DT.%26aulast%3DWexler%26aufirst%3DR.%26aulast%3DMohan%26aufirst%3DR.%26atitle%3DLiver%2520X%2520receptor%2520%2528LXR%2529%2520partial%2520agonists%253A%2520biaryl%2520pyrazoles%2520and%2520imidazoles%2520displaying%2520a%2520preference%2520for%2520LXRbeta%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D372%26epage%3D377%26doi%3D10.1016%2Fj.bmcl.2014.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartingh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodzinak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magliaro, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uslaner, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillgrove, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1264</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1260-1264&author=M.+E.+Laytonauthor=A.+J.+Reifauthor=T.+J.+Hartinghauthor=K.+Rodzinakauthor=V.+Dudkinauthor=C.+Wangauthor=K.+Arringtonauthor=M.+J.+Kellyauthor=R.+M.+Garbaccioauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+5-aryl-1%2C3-dihydro-2H-imidazo%5B4%2C5-b%5Dpyridin-2-ones+as+positive+allosteric+modulators+of+metabotropic+glutamate+subtype-2+%28mGlu2%29+receptors+with+efficacy+in+a+preclinical+model+of+psychosis&doi=10.1016%2Fj.bmcl.2016.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DReif%26aufirst%3DA.%2BJ.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DRodzinak%26aufirst%3DK.%26aulast%3DDudkin%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DArrington%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%25205-aryl-1%252C3-dihydro-2H-imidazo%255B4%252C5-b%255Dpyridin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520subtype-2%2520%2528mGlu2%2529%2520receptors%2520with%2520efficacy%2520in%2520a%2520preclinical%2520model%2520of%2520psychosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1260%26epage%3D1264%26doi%3D10.1016%2Fj.bmcl.2016.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blouin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLuca, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufresne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenette, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarlane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouimet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Hutchinson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span> <span> </span><span class="NLM_article-title">The discovery of a new structural class of potent orally active leukotriene D4 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1146</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80635-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0960-894X%2800%2980635-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=1141-1146&author=M.+Labelleauthor=P.+Prasitauthor=M.+Belleyauthor=M.+Blouinauthor=E.+Championauthor=L.+Charetteauthor=J.+G.+DeLucaauthor=C.+Dufresneauthor=R.+Frenetteauthor=J.+Y.+Gauthierauthor=E.+Grimmauthor=S.+J.+Grossmanauthor=D.+Guayauthor=E.+G.+Heroldauthor=T.+R.+Jonesauthor=C.+K.+Lauauthor=Y.+Leblancauthor=S.+L%C3%A9gerauthor=A.+Lordauthor=M.+McAuliffeauthor=C.+McFarlaneauthor=P.+Massonauthor=K.+M.+Mettersauthor=N.+Ouimetauthor=D.+H.+Patrickauthor=H.+Perrierauthor=C.+B.+Pickettauthor=H.+Piechutaauthor=P.+Royauthor=H.+Williamsauthor=Z.+Wangauthor=Y.+B.+Xiangauthor=R.+J.+Zamboniauthor=A.+W.+Ford-Hutchinsonauthor=R.+N.+Young&title=The+discovery+of+a+new+structural+class+of+potent+orally+active+leukotriene+D4+antagonists&doi=10.1016%2FS0960-894X%2800%2980635-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980635-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980635-6%26sid%3Dliteratum%253Aachs%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DBlouin%26aufirst%3DM.%26aulast%3DChampion%26aufirst%3DE.%26aulast%3DCharette%26aufirst%3DL.%26aulast%3DDeLuca%26aufirst%3DJ.%2BG.%26aulast%3DDufresne%26aufirst%3DC.%26aulast%3DFrenette%26aufirst%3DR.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGrimm%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DHerold%26aufirst%3DE.%2BG.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DLau%26aufirst%3DC.%2BK.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DA.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DPatrick%26aufirst%3DD.%2BH.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DRoy%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DY.%2BB.%26aulast%3DZamboni%26aufirst%3DR.%2BJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DThe%2520discovery%2520of%2520a%2520new%2520structural%2520class%2520of%2520potent%2520orally%2520active%2520leukotriene%2520D4%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26spage%3D1141%26epage%3D1146%26doi%3D10.1016%2FS0960-894X%2800%2980635-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, L. A.</span></span> <span> </span><span class="NLM_article-title">Rate acceleration by stereopopulation control: models for enzyme action</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1147</span>, <span class="refDoi"> DOI: 10.1073/pnas.67.3.1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.67.3.1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=5274444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaE3MXktFOnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1970&pages=1143-1147&author=S.+Milstienauthor=L.+A.+Cohen&title=Rate+acceleration+by+stereopopulation+control%3A+models+for+enzyme+action&doi=10.1073%2Fpnas.67.3.1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Rate acceleration by stereopopulation control.  Models for enzyme action</span></div><div class="casAuthors">Milstien, Sheldon; Cohen, Louis Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1143-7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">As a result of alkyl substitution in both aromatic ring and side chain, the rate const. for acid-catalyzed lactonization of hydrocoumaric acid is increased by factors as high as 1011 and, in comparison with the bimol. esterification of phenol and HOAc, by ∼1016.  In the most favorable case studied, the half-life of the phenolic acid (imidazole buffer, pH 7, 30°) is 6 sec, with 90% of the total rate being due to catalysis by the buffer species.  The effect is attributed to a unique interlocking of Me groups, which produces a severe conformational restriction of the side chain and increases the population of the most productive conformer.  This phenomenon is presented as a model for the conformational restraint imposed by an enzyme on its substrate.  The magnitude of the effect suggests that the contribution of substrate freezing to total rate enhancement by an enzyme can be considerably greater than previously supposed and may in fact be sufficient to complete the justification for enzyme catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBGFOSh-Inw7Vg90H21EOLACvtfcHk0lgnH_hGxwinVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXktFOnuw%253D%253D&md5=3cb620d59a84adb1a75ec73652042bd3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.67.3.1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.67.3.1143%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DL.%2BA.%26atitle%3DRate%2520acceleration%2520by%2520stereopopulation%2520control%253A%2520models%2520for%2520enzyme%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1970%26volume%3D67%26spage%3D1143%26epage%3D1147%26doi%3D10.1073%2Fpnas.67.3.1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkilineni, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casazza, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D. M.</span></span> <span> </span><span class="NLM_article-title">Novel water soluble phosphate prodrugs of taxol® possessing in vivo antitumor activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80058-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0960-894X%2800%2980058-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=1761-1766&author=Y.+Uedaauthor=A.+B.+Mikkilineniauthor=J.+O.+Knipeauthor=W.+C.+Roseauthor=A.+M.+Casazzaauthor=D.+M.+Vyas&title=Novel+water+soluble+phosphate+prodrugs+of+taxol%C2%AE+possessing+in+vivo+antitumor+activity&doi=10.1016%2FS0960-894X%2800%2980058-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980058-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980058-X%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DCasazza%26aufirst%3DA.%2BM.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26atitle%3DNovel%2520water%2520soluble%2520phosphate%2520prodrugs%2520of%2520taxol%25C2%25AE%2520possessing%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D1761%26epage%3D1766%26doi%3D10.1016%2FS0960-894X%2800%2980058-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinozaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakuuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seko, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1209</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.01.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26794040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1elurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1209-1213&author=K.+Kusumiauthor=K.+Shinozakiauthor=Y.+Yamauraauthor=A.+Hashimotoauthor=H.+Kurataauthor=A.+Naganawaauthor=K.+Otsukiauthor=T.+Matsushitaauthor=T.+Sekiguchiauthor=A.+Kakuuchiauthor=H.+Yamamotoauthor=T.+Seko&title=Discovery+of+novel+S1P2+antagonists%2C+part+3%3A+Improving+the+oral+bioavailability+of+a+series+of+1%2C3-bis%28aryloxy%29benzene+derivatives&doi=10.1016%2Fj.bmcl.2016.01.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives</span></div><div class="casAuthors">Kusumi, Kensuke; Shinozaki, Koji; Yamaura, Yoshiyuki; Hashimoto, Ai; Kurata, Haruto; Naganawa, Atsushi; Otsuki, Kazuhiro; Matsushita, Takeshi; Sekiguchi, Tetsuya; Kakuuchi, Akito; Yamamoto, Hiroshi; Seko, Takuya</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1209-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure of the S1P2 antagonist 1 has been modified with the aim of improving its oral bioavailability.  The chem. modification of the alkyl chain and carboxylic acid moieties of 1 led to significant improvements in the oral exposure of compds. belonging to this series.  The optimization of the ring size of the urea portion of these mols. also led to remarkable improvements in the oral exposure.  Based on these changes, the pyrrolidine deriv. I was identified as a suitable candidate compd. and showed excellent pharmacokinetic profiles in rat and dog, while maintaining high levels of potency and selective antagonistic activity toward S1P2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5Oh4Cs44RLVg90H21EOLACvtfcHk0licVCxs_tmXmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1elurs%253D&md5=afaf3444a370c35cd6ec6301850bc90a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DShinozaki%26aufirst%3DK.%26aulast%3DYamaura%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DMatsushita%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DT.%26aulast%3DKakuuchi%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DSeko%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%2520S1P2%2520antagonists%252C%2520part%25203%253A%2520Improving%2520the%2520oral%2520bioavailability%2520of%2520a%2520series%2520of%25201%252C3-bis%2528aryloxy%2529benzene%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1209%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2016.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomsho, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkovic, S. J.</span></span> <span> </span><span class="NLM_article-title">Ring structure and aromatic substituent effects on the p<i>K</i><sub>a</sub> of the benzoxaborole pharmacophore</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1021/ml200215j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200215j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlems73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=48-52&author=J.+W.+Tomshoauthor=A.+Palauthor=D.+G.+Hallauthor=S.+J.+Benkovic&title=Ring+structure+and+aromatic+substituent+effects+on+the+pKa+of+the+benzoxaborole+pharmacophore&doi=10.1021%2Fml200215j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Ring Structure and Aromatic Substituent Effects on the pKa of the Benzoxaborole Pharmacophore</span></div><div class="casAuthors">Tomsho, John W.; Pal, Arnab; Hall, Dennis G.; Benkovic, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, we present an investigation into the phys. properties of a unique class of arom. boronic acids, the benzoxaboroles.  Using spectrophotometric methods, the ionization consts. of a family of substituted benzoxaboroles are detd.  Heterocyclic ring modifications are examd. to det. their effects on the ionization of the boronic acid moiety.  It is also shown that the substituent effects about the arom. ring follow a Hammett relationship with the compds.' measured pKa values.  Finally, these substituent effects are also shown to extend to the sugar binding properties of these compds. under physiol. relevant conditions.  Combined, these data will inform medicinal chemists wishing to tailor the ionization and/or ability of this class of compd. to bind diol-contg. biomols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrppQMrsyB2_7Vg90H21EOLACvtfcHk0licVCxs_tmXmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlems73I&md5=efa7f7211cc046b3b1b1bd7ab3355ec4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml200215j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200215j%26sid%3Dliteratum%253Aachs%26aulast%3DTomsho%26aufirst%3DJ.%2BW.%26aulast%3DPal%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26atitle%3DRing%2520structure%2520and%2520aromatic%2520substituent%2520effects%2520on%2520the%2520pKa%2520of%2520the%2520benzoxaborole%2520pharmacophore%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml200215j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattendi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4388</span>, <span class="refDoi"> DOI: 10.1128/AAC.00498-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.00498-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4379-4388&author=B.+Nareauthor=S.+Wringauthor=C.+Bacchiauthor=B.+Beaudetauthor=T.+Bowlingauthor=R.+Brunauthor=D.+Chenauthor=C.+Dingauthor=Y.+Freundauthor=E.+Gaukelauthor=A.+Hussainauthor=K.+Jarnaginauthor=M.+Jenksauthor=M.+Kaiserauthor=L.+Mercerauthor=E.+Mejiaauthor=A.+Noeauthor=M.+Orrauthor=R.+Parhamauthor=J.+Plattnerauthor=R.+Randolphauthor=D.+Rattendiauthor=C.+Rewertsauthor=J.+Sligarauthor=N.+Yarlettauthor=R.+Donauthor=R.+Jacobs&title=Discovery+of+novel+orally+bioavailable+oxaborole+6-carboxamides+that+demonstrate+cure+in+a+murine+model+of+late-stage+central+nervous+system+African+trypanosomiasis&doi=10.1128%2FAAC.00498-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FAAC.00498-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00498-10%26sid%3Dliteratum%253Aachs%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%26aulast%3DBacchi%26aufirst%3DC.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DK.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DL.%26aulast%3DMejia%26aufirst%3DE.%26aulast%3DNoe%26aufirst%3DA.%26aulast%3DOrr%26aufirst%3DM.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DPlattner%26aufirst%3DJ.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DRattendi%26aufirst%3DD.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DSligar%26aufirst%3DJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DDon%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520novel%2520orally%2520bioavailable%2520oxaborole%25206-carboxamides%2520that%2520demonstrate%2520cure%2520in%2520a%2520murine%2520model%2520of%2520late-stage%2520central%2520nervous%2520system%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4379%26epage%3D4388%26doi%3D10.1128%2FAAC.00498-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span> <span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1151</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0ljNt5TnlxZNAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrent, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florjancic, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasko, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterling, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penning, T. D.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1021/ml5002745</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5002745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=58-62&author=Y.+Tongauthor=M.+Torrentauthor=A.+S.+Florjancicauthor=K.+D.+Brombergauthor=F.+G.+Buchananauthor=D.+C.+Fergusonauthor=E.+F.+Johnsonauthor=L.+M.+Laskoauthor=D.+Maagauthor=P.+J.+Mertaauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=N.+Soniauthor=A.+R.+Shoemakerauthor=T.+D.+Penning&title=Pyrimidine-based+tricyclic+molecules+as+potent+and+orally+efficacious+inhibitors+of+wee1+kinase&doi=10.1021%2Fml5002745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml5002745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5002745%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DTorrent%26aufirst%3DM.%26aulast%3DFlorjancic%26aufirst%3DA.%2BS.%26aulast%3DBromberg%26aufirst%3DK.%2BD.%26aulast%3DBuchanan%26aufirst%3DF.%2BG.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DLasko%26aufirst%3DL.%2BM.%26aulast%3DMaag%26aufirst%3DD.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26atitle%3DPyrimidine-based%2520tricyclic%2520molecules%2520as%2520potent%2520and%2520orally%2520efficacious%2520inhibitors%2520of%2520wee1%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D58%26epage%3D62%26doi%3D10.1021%2Fml5002745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballo-Jane, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsie, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krsmanovic, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taggart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletti, S. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2666</span>– <span class="NLM_lpage">2670</span>, <span class="refDoi"> DOI: 10.1021/jm100022r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100022r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2666-2670&author=H.+C.+Shenauthor=F.+X.+Dingauthor=S.+Raghavanauthor=Q.+Dengauthor=S.+Luellauthor=M.+J.+Forrestauthor=E.+Carballo-Janeauthor=L.+C.+Wilsieauthor=M.+L.+Krsmanovicauthor=A.+K.+Taggartauthor=K.+K.+Wuauthor=T.+J.+Wuauthor=K.+Chengauthor=N.+Renauthor=T.+Q.+Caiauthor=Q.+Chenauthor=J.+Wangauthor=M.+S.+Wolffauthor=X.+Tongauthor=T.+G.+Holtauthor=M.+G.+Watersauthor=M.+L.+Hammondauthor=J.+R.+Tataauthor=S.+L.+Colletti&title=Discovery+of+a+biaryl+cyclohexene+carboxylic+acid+%28MK-6892%29%3A+a+potent+and+selective+high+affinity+niacin+receptor+full+agonist+with+reduced+flushing+profiles+in+animals+as+a+preclinical+candidate&doi=10.1021%2Fjm100022r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm100022r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100022r%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%2BC.%26aulast%3DDing%26aufirst%3DF.%2BX.%26aulast%3DRaghavan%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DLuell%26aufirst%3DS.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DCarballo-Jane%26aufirst%3DE.%26aulast%3DWilsie%26aufirst%3DL.%2BC.%26aulast%3DKrsmanovic%26aufirst%3DM.%2BL.%26aulast%3DTaggart%26aufirst%3DA.%2BK.%26aulast%3DWu%26aufirst%3DK.%2BK.%26aulast%3DWu%26aufirst%3DT.%2BJ.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DCai%26aufirst%3DT.%2BQ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolff%26aufirst%3DM.%2BS.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DHolt%26aufirst%3DT.%2BG.%26aulast%3DWaters%26aufirst%3DM.%2BG.%26aulast%3DHammond%26aufirst%3DM.%2BL.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520a%2520biaryl%2520cyclohexene%2520carboxylic%2520acid%2520%2528MK-6892%2529%253A%2520a%2520potent%2520and%2520selective%2520high%2520affinity%2520niacin%2520receptor%2520full%2520agonist%2520with%2520reduced%2520flushing%2520profiles%2520in%2520animals%2520as%2520a%2520preclinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2666%26epage%3D2670%26doi%3D10.1021%2Fjm100022r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doweyko, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gougoutas, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarco, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavin, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorso, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, K. S.</span></span> <span> </span><span class="NLM_article-title">Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3302</span>– <span class="NLM_lpage">3310</span>, <span class="refDoi"> DOI: 10.1021/jm010100v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010100v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3302-3310&author=S.+Ahmadauthor=L.+M.+Doweykoauthor=S.+Dugarauthor=N.+Grazierauthor=K.+Nguauthor=S.+C.+Wuauthor=K.+J.+Yostauthor=B.+C.+Chenauthor=J.+Z.+Gougoutasauthor=J.+D.+DiMarcoauthor=S.+J.+Lanauthor=B.+J.+Gavinauthor=A.+Y.+Chenauthor=C.+R.+Dorsoauthor=R.+Serafinoauthor=M.+Kirbyauthor=K.+S.+Atwal&title=Arylcyclopropanecarboxyl+guanidines+as+novel%2C+potent%2C+and+selective+inhibitors+of+the+sodium+hydrogen+exchanger+isoform-1&doi=10.1021%2Fjm010100v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm010100v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010100v%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DL.%2BM.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DGrazier%26aufirst%3DN.%26aulast%3DNgu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DS.%2BC.%26aulast%3DYost%26aufirst%3DK.%2BJ.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DLan%26aufirst%3DS.%2BJ.%26aulast%3DGavin%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DA.%2BY.%26aulast%3DDorso%26aufirst%3DC.%2BR.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26atitle%3DArylcyclopropanecarboxyl%2520guanidines%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitors%2520of%2520the%2520sodium%2520hydrogen%2520exchanger%2520isoform-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3302%26epage%3D3310%26doi%3D10.1021%2Fjm010100v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larouche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacBeth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deziel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahhab, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2514</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2015.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2514-2518&author=E.+Therrienauthor=G.+Laroucheauthor=N.+Nguyenauthor=J.+Rahilauthor=A.+M.+Lemieuxauthor=Z.+Liauthor=M.+Fournelauthor=T.+P.+Yanauthor=A.+J.+Landryauthor=S.+Lefebvreauthor=J.+J.+Wangauthor=K.+MacBethauthor=C.+Heiseauthor=A.+Nguyenauthor=J.+M.+Bestermanauthor=R.+Dezielauthor=A.+Wahhab&title=Discovery+of+bicyclic+pyrazoles+as+class+III+histone+deacetylase+SIRT1+and+SIRT2+inhibitors&doi=10.1016%2Fj.bmcl.2015.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DLarouche%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLemieux%26aufirst%3DA.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DLandry%26aufirst%3DA.%2BJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BJ.%26aulast%3DMacBeth%26aufirst%3DK.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DWahhab%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520bicyclic%2520pyrazoles%2520as%2520class%2520III%2520histone%2520deacetylase%2520SIRT1%2520and%2520SIRT2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2514%26epage%3D2518%26doi%3D10.1016%2Fj.bmcl.2015.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santella, J. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncia, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briceno, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafstrom, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caceres-Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caporuscio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7550</span>– <span class="NLM_lpage">7564</span>, <span class="refDoi"> DOI: 10.1021/jm5003167</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003167" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7550-7564&author=J.+B.+Santellaauthor=D.+S.+Gardnerauthor=J.+V.+Dunciaauthor=H.+Wuauthor=M.+Dharauthor=C.+Cavallaroauthor=A.+J.+Tebbenauthor=P.+H.+Carterauthor=J.+C.+Barrishauthor=M.+Yardeauthor=S.+W.+Bricenoauthor=M.+E.+Cvijicauthor=R.+R.+Grafstromauthor=R.+Liuauthor=S.+R.+Patelauthor=A.+J.+Watsonauthor=G.+Yangauthor=A.+V.+Roseauthor=R.+D.+Vickeryauthor=J.+Caceres-Cortesauthor=C.+Caporuscioauthor=D.+M.+Camacauthor=J.+A.+Khanauthor=Y.+Anauthor=W.+R.+Fosterauthor=P.+Daviesauthor=J.+Hynes&title=Discovery+of+the+CCR1+antagonist%2C+BMS-817399%2C+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Fjm5003167"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm5003167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003167%26sid%3Dliteratum%253Aachs%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DGardner%26aufirst%3DD.%2BS.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DDhar%26aufirst%3DM.%26aulast%3DCavallaro%26aufirst%3DC.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DBriceno%26aufirst%3DS.%2BW.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DGrafstrom%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DA.%2BV.%26aulast%3DVickery%26aufirst%3DR.%2BD.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DCaporuscio%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DFoster%26aufirst%3DW.%2BR.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHynes%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520the%2520CCR1%2520antagonist%252C%2520BMS-817399%252C%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7550%26epage%3D7564%26doi%3D10.1021%2Fjm5003167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyna, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mseeh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardenhagen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marszalek, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniatti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. T.</span></span> <span> </span><span class="NLM_article-title">Identification of potent and selective MTH1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1503</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.02.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26898335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1503-1507&author=A.+Petrocchiauthor=E.+Leoauthor=N.+J.+Reynaauthor=M.+M.+Hamiltonauthor=X.+Shiauthor=C.+A.+Parkerauthor=F.+Mseehauthor=J.+P.+Bardenhagenauthor=P.+Leonardauthor=J.+B.+Crossauthor=S.+Huangauthor=Y.+Jiangauthor=M.+Cardozoauthor=G.+Draettaauthor=J.+R.+Marszalekauthor=C.+Toniattiauthor=P.+Jonesauthor=R.+T.+Lewis&title=Identification+of+potent+and+selective+MTH1+inhibitors&doi=10.1016%2Fj.bmcl.2016.02.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potent and selective MTH1 inhibitors</span></div><div class="casAuthors">Petrocchi, Alessia; Leo, Elisabetta; Reyna, Naphtali J.; Hamilton, Matthew M.; Shi, Xi; Parker, Connor A.; Mseeh, Faika; Bardenhagen, Jennifer P.; Leonard, Paul; Cross, Jason B.; Huang, Sha; Jiang, Yongying; Cardozo, Mario; Draetta, Giulio; Marszalek, Joseph R.; Toniatti, Carlo; Jones, Philip; Lewis, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1503-1507</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure based design of a novel class of aminopyrimidine MTH1 (MutT homolog 1) inhibitors is described.  Optimization led to identification of I, a sub-nanomolar inhibitor of MTH1 with excellent cell permeability and good metabolic stability in microsomes.  This compd. robustly inhibited MTH1 activity in cells and proved to be an excellent tool for interrogation of the utility of MTH1 inhibition in the context of oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIlGQc2jKu2bVg90H21EOLACvtfcHk0lh6lTJucQOR8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVCiu7g%253D&md5=6c94121f3b47ce2a7dd4375bc5311fbb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DReyna%26aufirst%3DN.%2BJ.%26aulast%3DHamilton%26aufirst%3DM.%2BM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DC.%2BA.%26aulast%3DMseeh%26aufirst%3DF.%26aulast%3DBardenhagen%26aufirst%3DJ.%2BP.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DCross%26aufirst%3DJ.%2BB.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520MTH1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1503%26epage%3D1507%26doi%3D10.1016%2Fj.bmcl.2016.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croghan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmait, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupples, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichelt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Jean, D. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-guided optimization of diarylmethanesulfonamide disrupters of glucokinase-glucokinase regulatory protein (GK-GKRP) binding: strategic use of a N → S (n<sub>N</sub> → σ*<sub>S–X</sub>) interaction for conformational constraint</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9663</span>– <span class="NLM_lpage">9679</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9663-9679&author=L.+D.+Penningtonauthor=M.+D.+Bartbergerauthor=M.+D.+Croghanauthor=K.+L.+Andrewsauthor=K.+S.+Ashtonauthor=M.+P.+Bourbeauauthor=J.+Chenauthor=S.+Chmaitauthor=R.+Cupplesauthor=C.+Fotschauthor=J.+Helmeringauthor=F.+T.+Hongauthor=R.+W.+Hungateauthor=S.+R.+Jordanauthor=K.+Kongauthor=L.+Liuauthor=K.+Michelsenauthor=C.+Moyerauthor=N.+Nishimuraauthor=M.+H.+Normanauthor=A.+Reicheltauthor=A.+C.+Siegmundauthor=G.+Sivitsauthor=S.+Tadesseauthor=C.+M.+Tegleyauthor=G.+Vanauthor=K.+C.+Yangauthor=G.+Yaoauthor=J.+Zhangauthor=D.+J.+Lloydauthor=C.+Haleauthor=D.+J.+St.+Jean&title=Discovery+and+structure-guided+optimization+of+diarylmethanesulfonamide+disrupters+of+glucokinase-glucokinase+regulatory+protein+%28GK-GKRP%29+binding%3A+strategic+use+of+a+N+%E2%86%92+S+%28nN+%E2%86%92+%CF%83*S%E2%80%93X%29+interaction+for+conformational+constraint&doi=10.1021%2Facs.jmedchem.5b01367"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01367%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DAshton%26aufirst%3DK.%2BS.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChmait%26aufirst%3DS.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DHelmering%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DF.%2BT.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DJordan%26aufirst%3DS.%2BR.%26aulast%3DKong%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DMoyer%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DSivits%26aufirst%3DG.%26aulast%3DTadesse%26aufirst%3DS.%26aulast%3DTegley%26aufirst%3DC.%2BM.%26aulast%3DVan%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLloyd%26aufirst%3DD.%2BJ.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520and%2520structure-guided%2520optimization%2520of%2520diarylmethanesulfonamide%2520disrupters%2520of%2520glucokinase-glucokinase%2520regulatory%2520protein%2520%2528GK-GKRP%2529%2520binding%253A%2520strategic%2520use%2520of%2520a%2520N%2520%25E2%2586%2592%2520S%2520%2528nN%2520%25E2%2586%2592%2520%25CF%2583%252AS%25E2%2580%2593X%2529%2520interaction%2520for%2520conformational%2520constraint%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9663%26epage%3D9679%26doi%3D10.1021%2Facs.jmedchem.5b01367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panunzio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, S.</span></span> <span> </span><span class="NLM_article-title">Beta-lactam antibiotics renaissance</span>. <i>Antibiotics (Basel, Switz.)</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.3390/antibiotics3020193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.3390%2Fantibiotics3020193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=27025744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1CmtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=193-215&author=W.+Qinauthor=M.+Panunzioauthor=S.+Biondi&title=Beta-lactam+antibiotics+renaissance&doi=10.3390%2Fantibiotics3020193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">β-lactam antibiotics renaissance</span></div><div class="casAuthors">Qin, Wenling; Panunzio, Mauro; Biondi, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-215, 23 pp.</span>CODEN:
                <span class="NLM_cas:coden">ABSNC4</span>;
        ISSN:<span class="NLM_cas:issn">2079-6382</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Since the 1940s β-lactam antibiotics have been used to treat bacterial infections.  However, emergence and dissemination of β-lactam resistance has reached the point where many marketed β-lactams no longer are clin. effective.  The increasing prevalence of multidrug-resistant bacteria and the progressive withdrawal of pharmaceutical companies from antibiotic research have evoked a strong reaction from health authorities, who have implemented initiatives to encourage the discovery of new antibacterials.  Despite this gloomy scenario, several novel β-lactam antibiotics and β-lactamase inhibitors have recently progressed into clin. trials, and many more such compds. are being investigated.  Here we seek to provide highlights of recent developments relating to the discovery of novel β-lactam antibiotics and β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLs1Ib1L3CdrVg90H21EOLACvtfcHk0ljG-3J4ayklHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1CmtbrP&md5=1a6c0d2bea7b714af75ecb1ceff3237e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3390%2Fantibiotics3020193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantibiotics3020193%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DW.%26aulast%3DPanunzio%26aufirst%3DM.%26aulast%3DBiondi%26aufirst%3DS.%26atitle%3DBeta-lactam%2520antibiotics%2520renaissance%26jtitle%3DAntibiotics%2520%2528Basel%252C%2520Switz.%2529%26date%3D2014%26volume%3D3%26spage%3D193%26epage%3D215%26doi%3D10.3390%2Fantibiotics3020193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauvage, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josephine, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, R. F.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of complexes of bacterial DD-peptidases with peptidoglycan-mimetic ligands: the substrate specificity puzzle</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.jmb.2008.06.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2008&pages=383-393&author=E.+Sauvageauthor=A.+J.+Powellauthor=J.+Heilemannauthor=H.+R.+Josephineauthor=P.+Charlierauthor=C.+Daviesauthor=R.+F.+Pratt&title=Crystal+structures+of+complexes+of+bacterial+DD-peptidases+with+peptidoglycan-mimetic+ligands%3A+the+substrate+specificity+puzzle&doi=10.1016%2Fj.jmb.2008.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DSauvage%26aufirst%3DE.%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DHeilemann%26aufirst%3DJ.%26aulast%3DJosephine%26aufirst%3DH.%2BR.%26aulast%3DCharlier%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DPratt%26aufirst%3DR.%2BF.%26atitle%3DCrystal%2520structures%2520of%2520complexes%2520of%2520bacterial%2520DD-peptidases%2520with%2520peptidoglycan-mimetic%2520ligands%253A%2520the%2520substrate%2520specificity%2520puzzle%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D381%26spage%3D383%26epage%3D393%26doi%3D10.1016%2Fj.jmb.2008.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniewski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span> <span> </span><span class="NLM_article-title">Distinctive attributes of beta-lactam target proteins in <i>Acinetobacter baumannii</i> relevant to development of new antibiotics</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">20536</span>– <span class="NLM_lpage">20545</span>, <span class="refDoi"> DOI: 10.1021/ja208835z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja208835z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=20536-20545&author=S.+Hanauthor=N.+Caspersauthor=R.+P.+Zaniewskiauthor=B.+M.+Laceyauthor=A.+P.+Tomarasauthor=X.+Fengauthor=K.+F.+Geogheganauthor=V.+Shanmugasundaram&title=Distinctive+attributes+of+beta-lactam+target+proteins+in+Acinetobacter+baumannii+relevant+to+development+of+new+antibiotics&doi=10.1021%2Fja208835z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja208835z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja208835z%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DZaniewski%26aufirst%3DR.%2BP.%26aulast%3DLacey%26aufirst%3DB.%2BM.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26atitle%3DDistinctive%2520attributes%2520of%2520beta-lactam%2520target%2520proteins%2520in%2520Acinetobacter%2520baumannii%2520relevant%2520to%2520development%2520of%2520new%2520antibiotics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D20536%26epage%3D20545%26doi%3D10.1021%2Fja208835z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniewski, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacey, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evdokimov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span> <span> </span><span class="NLM_article-title">Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of <i>Pseudomonas aeruginosa</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">22002</span>– <span class="NLM_lpage">22007</span>, <span class="refDoi"> DOI: 10.1073/pnas.1013092107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1013092107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21135211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVKq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=22002-22007&author=S.+Hanauthor=R.+P.+Zaniewskiauthor=E.+S.+Marrauthor=B.+M.+Laceyauthor=A.+P.+Tomarasauthor=A.+Evdokimovauthor=J.+R.+Millerauthor=V.+Shanmugasundaram&title=Structural+basis+for+effectiveness+of+siderophore-conjugated+monocarbams+against+clinically+relevant+strains+of+Pseudomonas+aeruginosa&doi=10.1073%2Fpnas.1013092107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa</span></div><div class="casAuthors">Han, Seungil; Zaniewski, Richard P.; Marr, Eric S.; Lacey, Brian M.; Tomaras, Andrew P.; Evdokimov, Artem; Miller, J. Richard; Shanmugasundaram, Veerabahu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">22002-22007, S22002/1-S22002/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa is an opportunistic Gram-neg. pathogen that causes nosocomial infections for which there are limited treatment options.  Penicillin-binding protein PBP3, a key therapeutic target, is an essential enzyme responsible for the final steps of peptidoglycan synthesis and is covalently inactivated by β-lactam antibiotics.  Here we disclose the first high resoln. cocrystal structures of the P. aeruginosa PBP3 with both novel and marketed β-lactams.  These structures reveal a conformational rearrangement of Tyr532 and Phe533 and a ligand-induced conformational change of Tyr409 and Arg489.  The well-known affinity of the monobactam aztreonam for P. aeruginosa PBP3 is due to a distinct hydrophobic arom. wall composed of Tyr503, Tyr532, and Phe533 interacting with the gem-di-Me group.  The structure of MC-1, a new siderophore-conjugated monocarbam complexed with PBP3 provides mol. insights for lead optimization.  Importantly, we have identified a novel conformation that is distinct to the high-mol.-wt. class B PBP subfamily, which is identifiable by common features such as a hydrophobic arom. wall formed by Tyr503, Tyr532, and Phe533 and the structural flexibility of Tyr409 flanked by two glycine residues.  This is also the first example of a siderophore-conjugated triazolone-linked monocarbam complexed with any PBP.  Energetic anal. of tightly and loosely held computed hydration sites indicates protein desolvation effects contribute significantly to PBP3 binding, and anal. of hydration site energies allows rank ordering of the second-order acylation rate consts.  Taken together, these structural, biochem., and computational studies provide a mol. basis for recognition of P. aeruginosa PBP3 and open avenues for future design of inhibitors of this class of PBPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUiVSdnGL3r7Vg90H21EOLACvtfcHk0lizlr-K00MZrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVKq&md5=1f2733cc057fc464b7bd3570cf1f9968</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1013092107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1013092107%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DZaniewski%26aufirst%3DR.%2BP.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DLacey%26aufirst%3DB.%2BM.%26aulast%3DTomaras%26aufirst%3DA.%2BP.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26atitle%3DStructural%2520basis%2520for%2520effectiveness%2520of%2520siderophore-conjugated%2520monocarbams%2520against%2520clinically%2520relevant%2520strains%2520of%2520Pseudomonas%2520aeruginosa%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D22002%26epage%3D22007%26doi%3D10.1073%2Fpnas.1013092107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojica, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosmopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooke, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llarrull, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span> <span> </span><span class="NLM_article-title">Cross-class metallo-beta-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E3745</span>– <span class="NLM_lpage">E3754</span>, <span class="refDoi"> DOI: 10.1073/pnas.1601368113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1073%2Fpnas.1601368113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=27303030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E3745-E3754&author=P.+Hinchliffeauthor=M.+M.+Gonzalezauthor=M.+F.+Mojicaauthor=J.+M.+Gonzalezauthor=V.+Castilloauthor=C.+Saizauthor=M.+Kosmopoulouauthor=C.+L.+Tookeauthor=L.+I.+Llarrullauthor=G.+Mahlerauthor=R.+A.+Bonomoauthor=A.+J.+Vilaauthor=J.+Spencer&title=Cross-class+metallo-beta-lactamase+inhibition+by+bisthiazolidines+reveals+multiple+binding+modes&doi=10.1073%2Fpnas.1601368113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes</span></div><div class="casAuthors">Hinchliffe, Philip; Gonzalez, Mariano M.; Mojica, Maria F.; Gonzalez, Javier M.; Castillo, Valerie; Saiz, Cecilia; Kosmopoulou, Magda; Tooke, Catherine L.; Llarrull, Leticia I.; Mahler, Graciela; Bonomo, Robert A.; Vila, Alejandro J.; Spencer, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">E3745-E3754</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Metallo-β-lactamases (MBLs) hydrolyze almost all β-lactam antibiotics and are unaffected by clin. available β-lactamase inhibitors (βLIs).  Active site architecture divides MBLs into 3 classes (B1, B2, and B3), complicating the development of βLIs effective against all enzymes.  Bisthiazolidines (BTZs) are carboxylate-contg., bicyclic compds., considered as penicillin analogs with an addnl. free thiol.  Here, the authors show both L- and D-BTZ enantiomers are micromolar competitive βLIs of all MBL classes in vitro, with Ki values of 6-15 or 36-84 μM for subclass B1 MBLs (IMP-1 and BcII, resp.), and 10-12 μM for B3 enzyme L1.  Against B2 MBL Sfh-I, the L-BTZ enantiomers exhibited 100-fold lower Ki values (0.26-0.36 μM) than D-BTZs (26-29 μM).  Importantly, cell-based time-kill assays showed BTZs restored β-lactam susceptibility of Escherichia coli-producing MBLs (IMP-1, Sfh-1, BcII, and GOB-18) and, significantly, an extensively drug-resistant Stenotrophomonas maltophilia clin. isolate expressing L1.  BTZs therefore inhibit the full range of MBLs and potentiate β-lactam activity against producer pathogens.  X-ray crystal structures revealed insights into diverse BTZ binding modes, varying with orientation of the carboxylate and thiol moieties.  BTZs bound the di-zinc centers of B1 (IMP-1; BcII) and B3 (L1) MBLs via the free thiol, but oriented differently depending upon stereochem.  In contrast, the L-BTZ carboxylate dominated interactions with the mono-zinc B2 MBL Sfh-I, with the thiol uninvolved.  The D-BTZ complexes most closely resembled β-lactam binding to B1 MBLs, but featured an unprecedented disruption of the Asp-120-zinc interaction.  Cross-class MBL inhibition therefore arises from the unexpected versatility of BTZ binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql0OqimvaJmrVg90H21EOLACvtfcHk0lizlr-K00MZrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslahtbc%253D&md5=8b663adf29172ac32d41f6aad7d13513</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1601368113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1601368113%26sid%3Dliteratum%253Aachs%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DM.%2BM.%26aulast%3DMojica%26aufirst%3DM.%2BF.%26aulast%3DGonzalez%26aufirst%3DJ.%2BM.%26aulast%3DCastillo%26aufirst%3DV.%26aulast%3DSaiz%26aufirst%3DC.%26aulast%3DKosmopoulou%26aufirst%3DM.%26aulast%3DTooke%26aufirst%3DC.%2BL.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DMahler%26aufirst%3DG.%26aulast%3DBonomo%26aufirst%3DR.%2BA.%26aulast%3DVila%26aufirst%3DA.%2BJ.%26aulast%3DSpencer%26aufirst%3DJ.%26atitle%3DCross-class%2520metallo-beta-lactamase%2520inhibition%2520by%2520bisthiazolidines%2520reveals%2520multiple%2520binding%2520modes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE3745%26epage%3DE3754%26doi%3D10.1073%2Fpnas.1601368113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N. H.</span></span> <span> </span><span class="NLM_article-title">Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic Gram-negative bacteria</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1128/AAC.21.1.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.21.1.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=6979307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL38XhtFyrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1982&pages=85-92&author=R.+B.+Sykesauthor=D.+P.+Bonnerauthor=K.+Bushauthor=N.+H.+Georgopapadakou&title=Azthreonam+%28SQ+26%2C776%29%2C+a+synthetic+monobactam+specifically+active+against+aerobic+Gram-negative+bacteria&doi=10.1128%2FAAC.21.1.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria</span></div><div class="casAuthors">Sykes, R. B.; Bonner, D. P.; Bush, K.; Georgopapadakou, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-92</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">Azthreonam (I) is a synthetic monocyclic β-lactam antimicrobial agent belonging to the monobactam family, members of which are characterized by having the 2-oxoazetidine-1-sulfonic acid moiety.  I exhibits a high degree of stability to β-lactamases and is specifically active against aerobic gram-neg. bacteria, including Pseudomonas aeruginosa.  Its activity against these organisms was in general equal or superior to that obsd. with the 3rd-generation cephalosporins, cefotaxime and ceftazidime.  Like penicillins and cephalosporins, I interacts with essential penicillin-binding proteins of gram-neg. bacteria.  I protected mice against exptl. infections produced by a range of gram-neg. bacteria, exhibiting efficacy comparable to that of cefotaxime and ceftazidime.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMJm6Sw7SM7rVg90H21EOLACvtfcHk0lh-ARNh4SQm8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtFyrtrw%253D&md5=b48091de5681c798b86321fbf81752d2</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1128%2FAAC.21.1.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.21.1.85%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DR.%2BB.%26aulast%3DBonner%26aufirst%3DD.%2BP.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26atitle%3DAzthreonam%2520%2528SQ%252026%252C776%2529%252C%2520a%2520synthetic%2520monobactam%2520specifically%2520active%2520against%2520aerobic%2520Gram-negative%2520bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1982%26volume%3D21%26spage%3D85%26epage%3D92%26doi%3D10.1128%2FAAC.21.1.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, B.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasothan, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, P.</span></span> <span> </span><span class="NLM_article-title">Inhaled aztreonam</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1038/nrd3170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrd3170" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=357-358&author=B.%0AP.+O%E2%80%99Sullivanauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Inhaled+aztreonam&doi=10.1038%2Fnrd3170"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnrd3170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3170%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DB.%2BP.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DInhaled%2520aztreonam%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D357%26epage%3D358%26doi%3D10.1038%2Fnrd3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy-Benenato, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagunde, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatoum-Mokdad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uria-Nickelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of efficacious <i>Pseudomonas aeruginosa</i>-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2195</span>– <span class="NLM_lpage">2205</span>, <span class="refDoi"> DOI: 10.1021/jm501506f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501506f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2195-2205&author=K.+E.+Murphy-Benenatoauthor=P.+R.+Bhagundeauthor=A.+Chenauthor=H.+E.+Davisauthor=T.+F.+Durand-Revilleauthor=D.+E.+Ehmannauthor=V.+Galulloauthor=J.+J.+Harrisauthor=H.+Hatoum-Mokdadauthor=H.+Jahicauthor=A.+Kimauthor=M.+R.+Manjunathaauthor=E.+L.+Manyakauthor=J.+Muellerauthor=S.+Pateyauthor=O.+Quirogaauthor=M.+Rooneyauthor=L.+Shaauthor=A.+B.+Shapiroauthor=M.+Sylvesterauthor=B.+Tanauthor=A.+S.+Tsaiauthor=M.+Uria-Nickelsenauthor=Y.+Wuauthor=M.+Zambrowskiauthor=S.+X.+Zhao&title=Discovery+of+efficacious+Pseudomonas+aeruginosa-targeted+siderophore-conjugated+monocarbams+by+application+of+a+semi-mechanistic+pharmacokinetic%2Fpharmacodynamic+model&doi=10.1021%2Fjm501506f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm501506f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501506f%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DBhagunde%26aufirst%3DP.%2BR.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BE.%26aulast%3DDurand-Reville%26aufirst%3DT.%2BF.%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DJ.%2BJ.%26aulast%3DHatoum-Mokdad%26aufirst%3DH.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DManyak%26aufirst%3DE.%2BL.%26aulast%3DMueller%26aufirst%3DJ.%26aulast%3DPatey%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DO.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DA.%2BS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZambrowski%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520efficacious%2520Pseudomonas%2520aeruginosa-targeted%2520siderophore-conjugated%2520monocarbams%2520by%2520application%2520of%2520a%2520semi-mechanistic%2520pharmacokinetic%252Fpharmacodynamic%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2195%26epage%3D2205%26doi%3D10.1021%2Fjm501506f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, J. S.</span></span> <span> </span><span class="NLM_article-title">Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/0002-9343(85)90097-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0002-9343%2885%2990097-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=3859213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL2MXlvVyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1985&pages=3-21&author=J.+Birnbaumauthor=F.+M.+Kahanauthor=H.+Kroppauthor=J.+S.+MacDonald&title=Carbapenems%2C+a+new+class+of+beta-lactam+antibiotics.+Discovery+and+development+of+imipenem%2Fcilastatin&doi=10.1016%2F0002-9343%2885%2990097-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenems, a new class of beta-lactam antibiotics.  Discovery and development of imipenem/cilastatin</span></div><div class="casAuthors">Birnbaum, Jerome; Kahan, Frederick M.; Kropp, Helmut; Macdonald, James S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6A</span>),
    <span class="NLM_cas:pages">3-21</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    </div><div class="casAbstract">A review with 48 refs.  Cilastatin  [82009-34-5], coadministered with imipenem  [64221-86-9] in a 1:1 ratio, provided prolonged, reversible blockade of imipenem metab. and improved urinary recoveries to therapeutically significant levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNK07atRIa7Vg90H21EOLACvtfcHk0lgn-_ncieIvRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvVyrtb8%253D&md5=592664766841f1479bae6f0d68b46a50</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0002-9343%2885%2990097-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9343%252885%252990097-X%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DJ.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DMacDonald%26aufirst%3DJ.%2BS.%26atitle%3DCarbapenems%252C%2520a%2520new%2520class%2520of%2520beta-lactam%2520antibiotics.%2520Discovery%2520and%2520development%2520of%2520imipenem%252Fcilastatin%26jtitle%3DAm.%2520J.%2520Med.%26date%3D1985%26volume%3D78%26spage%3D3%26epage%3D21%26doi%3D10.1016%2F0002-9343%2885%2990097-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kropp, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundelof, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahan, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, J.</span></span> <span> </span><span class="NLM_article-title">MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1128/AAC.17.6.993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FAAC.17.6.993" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1980&pages=993-1000&author=H.+Kroppauthor=J.+G.+Sundelofauthor=J.+S.+Kahanauthor=F.+M.+Kahanauthor=J.+Birnbaum&title=MK0787+%28N-formimidoyl+thienamycin%29%3A+evaluation+of+in+vitro+and+in+vivo+activities&doi=10.1128%2FAAC.17.6.993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2FAAC.17.6.993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.17.6.993%26sid%3Dliteratum%253Aachs%26aulast%3DKropp%26aufirst%3DH.%26aulast%3DSundelof%26aufirst%3DJ.%2BG.%26aulast%3DKahan%26aufirst%3DJ.%2BS.%26aulast%3DKahan%26aufirst%3DF.%2BM.%26aulast%3DBirnbaum%26aufirst%3DJ.%26atitle%3DMK0787%2520%2528N-formimidoyl%2520thienamycin%2529%253A%2520evaluation%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1980%26volume%3D17%26spage%3D993%26epage%3D1000%26doi%3D10.1128%2FAAC.17.6.993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nitanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satow, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human renal dipeptidase involved in beta-lactam hydrolysis</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(02)00632-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0022-2836%2802%2900632-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2002&pages=177-184&author=Y.+Nitanaiauthor=Y.+Satowauthor=H.+Adachiauthor=M.+Tsujimoto&title=Crystal+structure+of+human+renal+dipeptidase+involved+in+beta-lactam+hydrolysis&doi=10.1016%2FS0022-2836%2802%2900632-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2802%2900632-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252802%252900632-0%26sid%3Dliteratum%253Aachs%26aulast%3DNitanai%26aufirst%3DY.%26aulast%3DSatow%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DH.%26aulast%3DTsujimoto%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520human%2520renal%2520dipeptidase%2520involved%2520in%2520beta-lactam%2520hydrolysis%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D321%26spage%3D177%26epage%3D184%26doi%3D10.1016%2FS0022-2836%2802%2900632-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The “cyclopropyl fragment” is a versatile player that frequently appears in preclinical/clinical drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%9Ccyclopropyl+fragment%E2%80%9D+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lgp-bpZpvW-QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%259Ccyclopropyl%2520fragment%25E2%2580%259D%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kondreddi, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8859</span>, <span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents</span></div><div class="casAuthors">Kondreddi, Ravinder Reddy; Jiricek, Jan; Rao, Srinivasa P. S.; Lakshminarayana, Suresh B.; Camacho, Luis R.; Rao, Ranga; Herve, Maxime; Bifani, Pablo; Ma, Ngai Ling; Kuhen, Kelli; Goh, Anne; Chatterjee, Arnab K.; Dick, Thomas; Diagana, Thierry T.; Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8849-8859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-2-carboxamides have been identified as a promising class of antituberculosis agents from phenotypic screening against mycobacteria.  One of the hits, indole-2-carboxamide analog (I), had low micromolar potency against Mycobacterium tuberculosis (Mtb), high mouse liver microsomal clearance, and low aq. soly.  Structure-activity relationship studies revealed that attaching alkyl groups to the cyclohexyl ring significantly improved Mtb activity but reduced soly.  Furthermore, chloro, fluoro, or cyano substitutions on the 4- and 6-positions of the indole ring as well as Me substitution on the cyclohexyl ring significantly improved metabolic stability.  II and III, the lead candidates, displayed improved in vitro activity compared to most of the current std. TB drugs.  The low aq. soly. could not be mitigated because of the pos. correlation of lipophilicity with Mtb potency.  However, both compds. displayed favorable oral pharmacokinetic properties in rodents and demonstrated in vivo efficacy.  Thus, indole-2-carboxamides represent a promising new class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KW8om-6fZ7Vg90H21EOLACvtfcHk0lgp-bpZpvW-QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL&md5=ab732bc84632b1f9f364e45610bcbc1b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santhanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broske, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brisson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelusky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korfmacher, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanowich-Knipp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6074</span>– <span class="NLM_lpage">6086</span>, <span class="refDoi"> DOI: 10.1021/jm060325b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlOlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.+C.+Chengauthor=Y.+Hsiehauthor=J.+M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-+3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable+hepatitis+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection&doi=10.1021%2Fjm060325b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span></div><div class="casAuthors">Venkatraman, Srikanth; Bogen, Stephane L.; Arasappan, Ashok; Bennett, Frank; Chen, Kevin; Jao, Edwin; Liu, Yi-Tsung; Lovey, Raymond; Hendrata, Siska; Huang, Yuhua; Pan, Weidong; Parekh, Tejal; Pinto, Patrick; Popov, Veljko; Pike, Russel; Ruan, Sumei; Santhanam, Bama; Vibulbhan, Bancha; Wu, Wanli; Yang, Weiying; Kong, Jianshe; Liang, Xiang; Wong, Jesse; Liu, Rong; Butkiewicz, Nancy; Chase, Robert; Hart, Andrea; Agrawal, Sony; Ingravallo, Paul; Pichardo, John; Kong, Rong; Baroudy, Bahige; Malcolm, Bruce; Guo, Zhuyan; Prongay, Andrew; Madison, Vincent; Broske, Lisa; Cui, Xiaoming; Cheng, Kuo-Chi; Hsieh, Tony Y.; Brisson, Jean-Marc; Prelusky, Danial; Korfmacher, Walter; White, Ronald; Bogdanowich-Knipp, Susan; Pavlovsky, Anastasia; Bradley, Prudence; Saksena, Anil K.; Ganguly, Ashit; Piwinski, John; Girijavallabhan, Viyyoor; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6074-6086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, which affects more than 170 million people worldwide.  Currently the only therapeutic regimens are s.c. interferon-α or polyethylene glycol (PEG)-interferon-α alone or in combination with oral ribavirin.  Although combination therapy is reasonably successful with the majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virol. response.  Herein, the SAR leading to the discovery of SCH 503034 (I), a novel, potent, selective, orally bioavailable NS3 protease inhibitor that has been advanced to clin. trials in human beings for the treatment of hepatitis C viral infections is described.  X-ray structure of I complexed with the NS3 protease and biol. data are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjAR2KjtnJV7Vg90H21EOLACvtfcHk0litJqwRM46lLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlOlsLg%253D&md5=e48b2e2d3eb19f7f28aaa76f96d03414</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.%2BM.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-%25203-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086%26doi%3D10.1021%2Fjm060325b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2225</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1021/jm070027u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070027u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFegsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2225-2239&author=P.+Paceauthor=M.+E.+Di+Francescoauthor=C.+Gardelliauthor=S.+Harperauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=A.+Petrocchiauthor=M.+Pomaauthor=M.+Rowleyauthor=R.+Scarpelliauthor=R.+Lauferauthor=O.+Gonzalez+Pazauthor=E.+Monteagudoauthor=F.+Bonelliauthor=D.+Hazudaauthor=K.+A.+Stillmockauthor=V.+Summa&title=Dihydroxypyrimidine-4-carboxamides+as+novel+potent+and+selective+HIV+integrase+inhibitors&doi=10.1021%2Fjm070027u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors</span></div><div class="casAuthors">Pace, Paola; Di Francesco, M. Emilia; Gardelli, Cristina; Harper, Steven; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Petrocchi, Alessia; Poma, Marco; Rowley, Michael; Scarpelli, Rita; Laufer, Ralph; Gonzalez Paz, Odalys; Monteagudo, Edith; Bonelli, Fabio; Hazuda, Daria; Stillmock, Kara A.; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2225-2239</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase, one of the three constitutive viral enzymes required for replication, is a rational target for chemotherapeutic intervention in the treatment of AIDS that has also recently been confirmed in the clin. setting.  We report here on the design and synthesis of N-benzyl-5,6-dihydroxypyrimidine-4-carboxamides as a class of agents which exhibits potent inhibition of the HIV-integrase-catalyzed strand transfer process.  In the current study, structural modifications on these mols. were made in order to examine effects on HIV-integrase inhibitory potencies.  One of the most interesting compds. for this series is 2-[1-(dimethylamino)-1-methylethyl]-N-(4-fluorobenzyl)-5,6-dihydroxypyrimidine-4-carboxamide, with a CIC95 of 78 nM in the cell-based assay in the presence of serum proteins.  The compd. has favorable pharmacokinetic properties in preclin. species (rats, dogs, and monkeys) and shows no liabilities in several counterscreening assays, highlighting its potential as a clin. useful antiviral agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE58S95gF84rVg90H21EOLACvtfcHk0liekAtW5a7Iaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFegsLw%253D&md5=7ce7ac1563655da2f025b5fee1e166fa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm070027u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070027u%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DPoma%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DDihydroxypyrimidine-4-carboxamides%2520as%2520novel%2520potent%2520and%2520selective%2520HIV%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2225%26epage%3D2239%26doi%3D10.1021%2Fjm070027u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrocchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescenzi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donghi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Paz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvieto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pescatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillmock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5855</span>, <span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection</span></div><div class="casAuthors">Summa, Vincenzo; Petrocchi, Alessia; Bonelli, Fabio; Crescenzi, Benedetta; Donghi, Monica; Ferrara, Marco; Fiore, Fabrizio; Gardelli, Cristina; Gonzalez Paz, Odalys; Hazuda, Daria J.; Jones, Philip; Kinzel, Olaf; Laufer, Ralph; Monteagudo, Edith; Muraglia, Ester; Nizi, Emanuela; Orvieto, Federica; Pace, Paola; Pescatore, Giovanna; Scarpelli, Rita; Stillmock, Kara; Witmer, Marc V.; Rowley, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5843-5855</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type-1 (HIV-1) integrase is one of the three virally encoded enzymes required for replication and therefore a rational target for chemotherapeutic intervention in the treatment of HIV-1 infection.  We report here the discovery of Raltegravir, the first HIV-integrase inhibitor approved by FDA for the treatment of HIV infection.  It derives from the evolution of 5,6-dihydroxypyrimidine-4-carboxamides and N-methyl-4-hydroxypyrimidinone-carboxamides, which exhibited potent inhibition of the HIV-integrase catalyzed strand transfer process.  Structural modifications on these mols. were made in order to maximize potency as HIV-integrase inhibitors against the wild type virus, a selection of mutants, and optimize the selectivity, pharmacokinetic, and metabolic profiles in preclin. species.  The good profile of Raltegravir has enabled its progression toward the end of phase III clin. trials for the treatment of HIV-1 infection and culminated with the FDA approval as the first HIV-integrase inhibitor for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYo6KKNjJRCrVg90H21EOLACvtfcHk0liekAtW5a7Iaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVymtb%252FM&md5=f90f994c7cd031a4063cbb3e91b4c3f0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dame, J. B.</span></span> <span> </span><span class="NLM_article-title">Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of <i>Plasmodium falciparum</i></span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.ijpara.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.ijpara.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17207486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFOjsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=317-327&author=J.+A.+Bonillaauthor=P.+A.+Mouraauthor=T.+D.+Bonillaauthor=C.+A.+Yowellauthor=D.+A.+Fidockauthor=J.+B.+Dame&title=Effects+on+growth%2C+hemoglobin+metabolism+and+paralogous+gene+expression+resulting+from+disruption+of+genes+encoding+the+digestive+vacuole+plasmepsins+of+Plasmodium+falciparum&doi=10.1016%2Fj.ijpara.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum</span></div><div class="casAuthors">Bonilla, J. Alfredo; Moura, Pedro A.; Bonilla, Tonya D.; Yowell, Charles A.; Fidock, David A.; Dame, John B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">317-327</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four of the plasmepsins of Plasmodium falciparum are localized in the digestive vacuole (DV) of the asexual blood stage parasite (PfPM1, PfPM2, PfPM4 and PfHAP), and each of these aspartic proteinases has been successfully targeted by gene disruption.  This study describes further characterization of the single-plasmepsin knockout mutants, and the creation and characterization of double-plasmepsin knockout mutants lacking complete copies of pfpm2 and pfpm1 or pfhap and pfpm2.  Double-plasmepsin knockout mutants were created by transfecting pre-existing knockout mutants with a second plasmid knockout construct.  PCR and Southern blot anal. demonstrate the integration of a large concatamer of each plasmid construct into the targeted gene.  All mutants have been characterized to assess the involvement of the DV plasmepsins in sustaining growth during the asexual blood stage.  Analyses reaffirmed that knockout mutants Δpfpm1 and Δpfpm4 had lower replication rates in the asexual erythrocytic stage than the parental line (Dd2), but double-plasmepsin knockout mutants lacking intact copies of either pfpm2 and pfpm1, or pfpm2 and pfhap, had normal growth rates compared with Dd2.  The amt. of cryst. hemozoin produced per parasite during the asexual cycle was measured in each single-plasmepsin knockout to est. the effect of each DV plasmepsin on Hb digestion.  Only Δpfpm4 had a statistically significant redn. in hemozoin accumulation, indicating that Hb digestion was impaired in this mutant.  In the single-plasmepsin knockouts, no statistically significant differences were found in the steady state levels of mRNA from the remaining intact DV plasmepsin genes.  Disruption of a DV plasmepsin gene does not affect the accumulation of mRNA encoding the remaining paralogous plasmepsins, and Western blot anal. confirmed that the accumulation of the paralogous plasmepsins in each knockout mutant was similar among all clones examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCHAOP3nWIXbVg90H21EOLACvtfcHk0lidt19pA9oZ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFOjsbw%253D&md5=db3469d3312bc21f9e95700de9ff96cb</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpara.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpara.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DBonilla%26aufirst%3DJ.%2BA.%26aulast%3DMoura%26aufirst%3DP.%2BA.%26aulast%3DBonilla%26aufirst%3DT.%2BD.%26aulast%3DYowell%26aufirst%3DC.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DDame%26aufirst%3DJ.%2BB.%26atitle%3DEffects%2520on%2520growth%252C%2520hemoglobin%2520metabolism%2520and%2520paralogous%2520gene%2520expression%2520resulting%2520from%2520disruption%2520of%2520genes%2520encoding%2520the%2520digestive%2520vacuole%2520plasmepsins%2520of%2520Plasmodium%2520falciparum%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2007%26volume%3D37%26spage%3D317%26epage%3D327%26doi%3D10.1016%2Fj.ijpara.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaudzems, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tars, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurops, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivdra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otikovs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanepe-Lapsa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domraceva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutule, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapencieris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirgensons, A.</span></span> <span> </span><span class="NLM_article-title">Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1021/ml4004952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=373-377&author=K.+Jaudzemsauthor=K.+Tarsauthor=G.+Mauropsauthor=N.+Ivdraauthor=M.+Otikovsauthor=J.+Leitansauthor=I.+Kanepe-Lapsaauthor=I.+Domracevaauthor=I.+Mutuleauthor=P.+Trapencierisauthor=M.+J.+Blackmanauthor=A.+Jirgensons&title=Plasmepsin+inhibitory+activity+and+structure-guided+optimization+of+a+potent+hydroxyethylamine-based+antimalarial+hit&doi=10.1021%2Fml4004952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit</span></div><div class="casAuthors">Jaudzems, Kristaps; Tars, Kaspars; Maurops, Gundars; Ivdra, Natalija; Otikovs, Martins; Leitans, Janis; Kanepe-Lapsa, Iveta; Domraceva, Ilona; Mutule, Ilze; Trapencieris, Peteris; Blackman, Michael J.; Jirgensons, Aigars</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-377</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Antimalarial hit 1SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign was evaluated for inhibitory activity against the digestive vacuole plasmepsins (Plm I, II, and IV).  It was found to be a potent Plm IV inhibitor with no selectivity over Cathepsin D.  A cocrystal structure of 1SR bound to Plm II was solved, providing structural insight for the design of more potent and selective analogs.  Structure-guided optimization led to the identification of structurally simplified analogs 17 and 18 as low nanomolar inhibitors of both, plasmepsin Plm IV activity and P. falciparum growth in erythrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodPy3QEt5GubVg90H21EOLACvtfcHk0lidt19pA9oZ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKjtA%253D%253D&md5=6ee7872a473db6d9b6020096e32a1a81</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fml4004952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004952%26sid%3Dliteratum%253Aachs%26aulast%3DJaudzems%26aufirst%3DK.%26aulast%3DTars%26aufirst%3DK.%26aulast%3DMaurops%26aufirst%3DG.%26aulast%3DIvdra%26aufirst%3DN.%26aulast%3DOtikovs%26aufirst%3DM.%26aulast%3DLeitans%26aufirst%3DJ.%26aulast%3DKanepe-Lapsa%26aufirst%3DI.%26aulast%3DDomraceva%26aufirst%3DI.%26aulast%3DMutule%26aufirst%3DI.%26aulast%3DTrapencieris%26aufirst%3DP.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26aulast%3DJirgensons%26aufirst%3DA.%26atitle%3DPlasmepsin%2520inhibitory%2520activity%2520and%2520structure-guided%2520optimization%2520of%2520a%2520potent%2520hydroxyethylamine-based%2520antimalarial%2520hit%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D373%26epage%3D377%26doi%3D10.1021%2Fml4004952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">8253</span>– <span class="NLM_lpage">8261</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.03.4777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1200%2FJCO.2005.03.4777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16278481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=8253-8261&author=H.+I.+Scherauthor=C.+L.+Sawyers&title=Biology+of+progressive%2C+castration-resistant+prostate+cancer%3A+directed+therapies+targeting+the+androgen-receptor+signaling+axis&doi=10.1200%2FJCO.2005.03.4777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis</span></div><div class="casAuthors">Scher, Howard I.; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">8253-8261</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Prostate cancers that are progressing on medical and surgical therapies designed to ablate the action of androgens continue to express androgen receptor (AR) and to depend on signaling through the receptor for growth.  A more clin. relevant classification of castration-resistant disease focuses on the mechanisms of receptor activation, which include (1) changes in the level of ligand(s) in tumor tissue; (2) increased levels of the protein due to gene amplification or altered mRNA expression; (3) activating mutations in the receptor that affect structure and function; (4) changes in coregulatory mols. including coactivators and corepressors; and (5) factors that lead to activation of the receptor independent of the level of ligand or receptor allowing kinase cross talk.  From an AR perspective, the term "hormone refractory" is inappropriate.  On the basis of this schema, we discuss strategies that are focused on the AR either directly or indirectly, as single agents or in combination, that are in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLGcoIg3SiLVg90H21EOLACvtfcHk0lhAC93On0G34g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yntbnL&md5=c07e9cfd7453af7535cbabf7529ee7dc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.4777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.4777%26sid%3Dliteratum%253Aachs%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DBiology%2520of%2520progressive%252C%2520castration-resistant%2520prostate%2520cancer%253A%2520directed%2520therapies%2520targeting%2520the%2520androgen-receptor%2520signaling%2520axis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D8253%26epage%3D8261%26doi%3D10.1200%2FJCO.2005.03.4777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slovin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span> <span> </span><span class="NLM_article-title">Steroid hormone withdrawal syndromes. pathophysiology and clinical significance</span>. <i>Urol. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1016/S0094-0143(05)70389-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0094-0143%2805%2970389-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9126240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaK2s3ntFaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1997&pages=421-431&author=W.+K.+Kellyauthor=S.+Slovinauthor=H.+I.+Scher&title=Steroid+hormone+withdrawal+syndromes.+pathophysiology+and+clinical+significance&doi=10.1016%2FS0094-0143%2805%2970389-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance</span></div><div class="casAuthors">Kelly W K; Slovin S; Scher H I</div><div class="citationInfo"><span class="NLM_cas:title">The Urologic clinics of North America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-31</span>
        ISSN:<span class="NLM_cas:issn">0094-0143</span>.
    </div><div class="casAbstract">The steroid withdrawal syndrome has brought a new dimension to the treatment of advanced prostate cancer not only in the way we treat androgen-independent disease but also in terms of insights into the development of hormonal resistance.  The data now confirm that 30% of cases have a meaningful subjective, biochemical, and objective response to the withdrawal of a steroid hormone as the first maneuver after primary hormonal therapy failure.  Larger studies are needed to define further the withdrawal effect related to the other steroid hormone family members and to determine the objective response proportions.  Although controversy surrounds the cause of the steroid withdrawal phenomenon, studies suggest that the androgen receptor plays a pivotal role.  Molecular studies of the androgen receptors involving larger number of patients are paramount if we are going to develop a better understanding of the evolution of the withdrawal effect and hormone resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8ldcF10bnhiXXDYhVZBdlfW6udTcc2eaDM2-GrcbCq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3ntFaruw%253D%253D&md5=eb4e6f84e774e98bf320d89c2c28c0e6</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0094-0143%2805%2970389-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0094-0143%252805%252970389-X%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DSlovin%26aufirst%3DS.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DSteroid%2520hormone%2520withdrawal%2520syndromes.%2520pathophysiology%2520and%2520clinical%2520significance%26jtitle%3DUrol.%2520Clin.%2520North%2520Am.%26date%3D1997%26volume%3D24%26spage%3D421%26epage%3D431%26doi%3D10.1016%2FS0094-0143%2805%2970389-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2796</span>, <span class="refDoi"> DOI: 10.1021/jm901488g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901488g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVyhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2779-2796&author=M.+E.+Jungauthor=S.+Oukauthor=D.+Yooauthor=C.+L.+Sawyersauthor=C.+Chenauthor=C.+Tranauthor=J.+Wongvipat&title=Structure-activity+relationship+for+thiohydantoin+androgen+receptor+antagonists+for+castration-resistant+prostate+cancer+%28CRPC%29&doi=10.1021%2Fjm901488g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)</span></div><div class="casAuthors">Jung, Michael E.; Ouk, Samedy; Yoo, Dongwon; Sawyers, Charles L.; Chen, Charlie; Tran, Chris; Wongvipat, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2779-2796</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-activity relationship study was carried out on a series of thiohydantoins and their analogs 14 which led to the discovery of 92 (MDV3100) as the clin. candidate for the treatment of hormone refractory prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWTaotH9EH7Vg90H21EOLACvtfcHk0lj-J787s0WIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVyhur4%253D&md5=f2f08b31060db468966d62582db81ebd</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm901488g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901488g%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DOuk%26aufirst%3DS.%26aulast%3DYoo%26aufirst%3DD.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DC.%26aulast%3DWongvipat%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520for%2520thiohydantoin%2520androgen%2520receptor%2520antagonists%2520for%2520castration-resistant%2520prostate%2520cancer%2520%2528CRPC%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2779%26epage%3D2796%26doi%3D10.1021%2Fjm901488g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clegg, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Jones, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasielewska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsbie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higano, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scher, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Development of a second-generation antiandrogen for treatment of advanced prostate cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1126/science.1168175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1126%2Fscience.1168175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19359544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=787-790&author=C.+Tranauthor=S.+Oukauthor=N.+J.+Cleggauthor=Y.+Chenauthor=P.+A.+Watsonauthor=V.+Aroraauthor=J.+Wongvipatauthor=P.+M.+Smith-Jonesauthor=D.+Yooauthor=A.+Kwonauthor=T.+Wasielewskaauthor=D.+Welsbieauthor=C.+D.+Chenauthor=C.+S.+Higanoauthor=T.+M.+Beerauthor=D.+T.+Hungauthor=H.+I.+Scherauthor=M.+E.+Jungauthor=C.+L.+Sawyers&title=Development+of+a+second-generation+antiandrogen+for+treatment+of+advanced+prostate+cancer&doi=10.1126%2Fscience.1168175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer</span></div><div class="casAuthors">Tran, Chris; Ouk, Samedy; Clegg, Nicola J.; Chen, Yu; Watson, Philip A.; Arora, Vivek; Wongvipat, John; Smith-Jones, Peter M.; Yoo, Dongwon; Kwon, Andrew; Wasielewska, Teresa; Welsbie, Derek; Chen, Charlie Degui; Higano, Celestia S.; Beer, Tomasz M.; Hung, David T.; Scher, Howard I.; Jung, Michael E.; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">787-790</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Metastatic prostate cancer is treated with drugs that antagonize androgen action, but most patients progress to a more aggressive form of the disease called castration-resistant prostate cancer, driven by elevated expression of the androgen receptor.  Here we characterize the diarylthiohydantoins RD162 and MDV3100, two compds. optimized from a screen for nonsteroidal antiandrogens that retain activity in the setting of increased androgen receptor expression.  Both compds. bind to the androgen receptor with greater relative affinity than the clin. used antiandrogen bicalutamide, reduce the efficiency of its nuclear translocation, and impair both DNA binding to androgen response elements and recruitment of coactivators.  RD162 and MDV3100 are orally available and induce tumor regression in mouse models of castration-resistant human prostate cancer.  Of the first 30 patients treated with MDV3100 in a Phase I/II clin. trial, 13 of 30 (43%) showed sustained declines (by >50%) in serum concns. of prostate-specific antigen, a biomarker of prostate cancer.  These compds. thus appear to be promising candidates for treatment of advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7UUC3dSP_LVg90H21EOLACvtfcHk0lj-J787s0WIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksro%253D&md5=1190646660b670c6d490b2c7ca73e48b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168175%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DC.%26aulast%3DOuk%26aufirst%3DS.%26aulast%3DClegg%26aufirst%3DN.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWatson%26aufirst%3DP.%2BA.%26aulast%3DArora%26aufirst%3DV.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DYoo%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DA.%26aulast%3DWasielewska%26aufirst%3DT.%26aulast%3DWelsbie%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BD.%26aulast%3DHigano%26aufirst%3DC.%2BS.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DHung%26aufirst%3DD.%2BT.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520second-generation%2520antiandrogen%2520for%2520treatment%2520of%2520advanced%2520prostate%2520cancer%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D787%26epage%3D790%26doi%3D10.1126%2Fscience.1168175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balbas, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosfield, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongvipat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyers, C. L.</span></span> <span> </span><span class="NLM_article-title">Overcoming mutation-based resistance to antiandrogens with rational drug design</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e00499</span>, <span class="refDoi"> DOI: 10.7554/eLife.00499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.7554%2FeLife.00499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23580326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e00499&author=M.+D.+Balbasauthor=M.+J.+Evansauthor=D.+J.+Hosfieldauthor=J.+Wongvipatauthor=V.+K.+Aroraauthor=P.+A.+Watsonauthor=Y.+Chenauthor=G.+L.+Greeneauthor=Y.+Shenauthor=C.+L.+Sawyers&title=Overcoming+mutation-based+resistance+to+antiandrogens+with+rational+drug+design&doi=10.7554%2FeLife.00499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming mutation-based resistance to antiandrogens with rational drug design</span></div><div class="casAuthors">Balbas, Minna D.; Evans, Michael J.; Hosfield, David J.; Wongvipat, John; Arora, Vivek K.; Watson, Philip A.; Chen, Yu; Greene, Geoffrey L.; Shen, Yang; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e00499/1-e00499/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">The second-generation antiandrogen enzalutamide was recently approved for patients with castration-resistant prostate cancer.  Despite its success, the duration of response is often limited.  For previous antiandrogens, one mechanism of resistance is mutation of the androgen receptor (AR).  To prospectively identify AR mutations that might confer resistance to enzalutamide, we performed a reporter-based mutagenesis screen and identified a novel mutation, F876L, which converted enzalutamide into an AR agonist.  Ectopic expression of AR F876L rescued the growth inhibition of enzalutamide treatment.  Mol. dynamics simulations performed on antiandrogen-AR complexes suggested a mechanism by which the F876L substitution alleviates antagonism through repositioning of the coactivator recruiting helix 12.  This model then provided the rationale for a focused chem. screen which, based on existing antiandrogen scaffolds, identified three novel compds. that effectively antagonized AR F876L (and AR WT) to suppress the growth of prostate cancer cells resistant to enzalutamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nauKhIbQtbVg90H21EOLACvtfcHk0lh4cpNaVyQs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWhug%253D%253D&md5=37385bb995c28582a86e20533c79fb93</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.7554%2FeLife.00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.00499%26sid%3Dliteratum%253Aachs%26aulast%3DBalbas%26aufirst%3DM.%2BD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHosfield%26aufirst%3DD.%2BJ.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DWatson%26aufirst%3DP.%2BA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DOvercoming%2520mutation-based%2520resistance%2520to%2520antiandrogens%2520with%2520rational%2520drug%2520design%26jtitle%3DeLife%26date%3D2013%26volume%3D2%26spage%3De00499%26doi%3D10.7554%2FeLife.00499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tognon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, P. H.</span></span> <span> </span><span class="NLM_article-title">Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1517/14728222.2011.638626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14728222.2011.638626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22239439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=33-48&author=C.+E.+Tognonauthor=P.+H.+Sorensen&title=Targeting+the+insulin-like+growth+factor+1+receptor+%28IGF1R%29+signaling+pathway+for+cancer+therapy&doi=10.1517%2F14728222.2011.638626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy</span></div><div class="casAuthors">Tognon, Cristina E.; Sorensen, Poul H. B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-48</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The IGF system controls growth, differentiation, and development at the cellular, organ and organismal levels.  IGF1 receptor (IGF1R) signaling is dysregulated in many cancers.  Numerous clin. trials are currently assessing therapies that inhibit either growth factor binding or IGF1R itself.  Therapeutic benefit, often in the form of stable disease, has been reported for many different cancer types.Areas covered: Canonical IGF signaling and non-canonical pathways involved in carcinogenesis.  Three recent insights into IGF1R signaling, namely hybrid receptor formation with insulin receptor (INSR), insulin receptor substrate 1 nuclear translocation, and evidence for IGF1R/INSR as dependence receptors.  Different approaches to targeting IGF1R and mechanisms of acquired resistance.  Possible mechanisms by which IGF1R signaling supports carcinogenesis and specific examples in different human tumors.Expert opinion: Pre-clin. data justifies IGF1R as a target and early clin. trials have shown modest efficacy in selected tumor types.  Future work will focus upon assessing the usefulness or disadvantages of simultaneously targeting the IGF1R and INSR, biomarker development to identify potentially responsive patients, and the use of IGF1R inhibitors in combination therapies or as an adjunct to conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDumNQ4RQmrVg90H21EOLACvtfcHk0lh4cpNaVyQs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1WksQ%253D%253D&md5=71848860ad474559f866b13da525f7d4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1517%2F14728222.2011.638626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2011.638626%26sid%3Dliteratum%253Aachs%26aulast%3DTognon%26aufirst%3DC.%2BE.%26aulast%3DSorensen%26aufirst%3DP.%2BH.%26atitle%3DTargeting%2520the%2520insulin-like%2520growth%2520factor%25201%2520receptor%2520%2528IGF1R%2529%2520signaling%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2012%26volume%3D16%26spage%3D33%26epage%3D48%26doi%3D10.1517%2F14728222.2011.638626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan-Jacob, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheufler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span> <span> </span><span class="NLM_article-title">Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.02.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.02.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2065-2067&author=F.+Staufferauthor=S.+W.+Cowan-Jacobauthor=C.+Scheuflerauthor=P.+Furet&title=Identification+of+a+5-%5B3-phenyl-%282-cyclic-ether%29-methylether%5D-4-aminopyrrolo%5B2%2C3-d%5Dpyrimidine+series+of+IGF-1R+inhibitors&doi=10.1016%2Fj.bmcl.2016.02.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.02.074%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DScheufler%26aufirst%3DC.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%25205-%255B3-phenyl-%25282-cyclic-ether%2529-methylether%255D-4-aminopyrrolo%255B2%252C3-d%255Dpyrimidine%2520series%2520of%2520IGF-1R%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2065%26epage%3D2067%26doi%3D10.1016%2Fj.bmcl.2016.02.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capraro, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebetanz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martiny-Baron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, F.</span></span> <span> </span><span class="NLM_article-title">In vivo antitumor activity of NVP-AEW541-a novel, potent, and selective inhibitor of the IGF-IR kinase</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(04)00051-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS1535-6108%2804%2900051-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=231-239&author=C.+Garcia-Echeverriaauthor=M.+A.+Pearsonauthor=A.+Martiauthor=T.+Meyerauthor=J.+Mestanauthor=J.+Zimmermannauthor=J.+Gaoauthor=J.+Brueggenauthor=H.+G.+Capraroauthor=R.+Cozensauthor=D.+B.+Evansauthor=D.+Fabbroauthor=P.+Furetauthor=D.+G.+Portaauthor=J.+Liebetanzauthor=G.+Martiny-Baronauthor=S.+Ruetzauthor=F.+Hofmann&title=In+vivo+antitumor+activity+of+NVP-AEW541-a+novel%2C+potent%2C+and+selective+inhibitor+of+the+IGF-IR+kinase&doi=10.1016%2FS1535-6108%2804%2900051-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900051-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900051-0%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DPearson%26aufirst%3DM.%2BA.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DCapraro%26aufirst%3DH.%2BG.%26aulast%3DCozens%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DPorta%26aufirst%3DD.%2BG.%26aulast%3DLiebetanz%26aufirst%3DJ.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DRuetz%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DF.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520NVP-AEW541-a%2520novel%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520the%2520IGF-IR%2520kinase%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D231%26epage%3D239%26doi%3D10.1016%2FS1535-6108%2804%2900051-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakabeppu, Y.</span></span> <span> </span><span class="NLM_article-title">An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">37965</span>– <span class="NLM_lpage">37973</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306201200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M306201200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=37965-37973&author=D.+Yoshimuraauthor=K.+Sakumiauthor=M.+Ohnoauthor=Y.+Sakaiauthor=M.+Furuichiauthor=S.+Iwaiauthor=Y.+Nakabeppu&title=An+oxidized+purine+nucleoside+triphosphatase%2C+MTH1%2C+suppresses+cell+death+caused+by+oxidative+stress&doi=10.1074%2Fjbc.M306201200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306201200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306201200%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DD.%26aulast%3DSakumi%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSakai%26aufirst%3DY.%26aulast%3DFuruichi%26aufirst%3DM.%26aulast%3DIwai%26aufirst%3DS.%26aulast%3DNakabeppu%26aufirst%3DY.%26atitle%3DAn%2520oxidized%2520purine%2520nucleoside%2520triphosphatase%252C%2520MTH1%252C%2520suppresses%2520cell%2520death%2520caused%2520by%2520oxidative%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D37965%26epage%3D37973%26doi%3D10.1074%2Fjbc.M306201200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripathy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posakony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loe, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalhofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span> <span> </span><span class="NLM_article-title">Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3283</span>– <span class="NLM_lpage">3294</span>, <span class="refDoi"> DOI: 10.1021/jm4018064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4018064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3283-3294&author=S.+S.+Mahajanauthor=M.+Scianauthor=S.+Sripathyauthor=J.+Posakonyauthor=U.+Laoauthor=T.+K.+Loeauthor=V.+Lekoauthor=A.+Thalhoferauthor=A.+D.+Schulerauthor=A.+Bedalovauthor=J.+A.+Simon&title=Development+of+pyrazolone+and+isoxazol-5-one+cambinol+analogues+as+sirtuin+inhibitors&doi=10.1021%2Fjm4018064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm4018064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4018064%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DS.%2BS.%26aulast%3DScian%26aufirst%3DM.%26aulast%3DSripathy%26aufirst%3DS.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLao%26aufirst%3DU.%26aulast%3DLoe%26aufirst%3DT.%2BK.%26aulast%3DLeko%26aufirst%3DV.%26aulast%3DThalhofer%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DBedalov%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520pyrazolone%2520and%2520isoxazol-5-one%2520cambinol%2520analogues%2520as%2520sirtuin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3283%26epage%3D3294%26doi%3D10.1021%2Fjm4018064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergo, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroziak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. G.</span></span> <span> </span><span class="NLM_article-title">Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">17605</span>– <span class="NLM_lpage">17610</span>, <span class="refDoi"> DOI: 10.1074/jbc.C000079200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.C000079200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=17605-17610&author=M.+O.+Bergoauthor=G.+K.+Leungauthor=P.+Ambroziakauthor=J.+C.+Ottoauthor=P.+J.+Caseyauthor=S.+G.+Young&title=Targeted+inactivation+of+the+isoprenylcysteine+carboxyl+methyltransferase+gene+causes+mislocalization+of+K-Ras+in+mammalian+cells&doi=10.1074%2Fjbc.C000079200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C000079200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C000079200%26sid%3Dliteratum%253Aachs%26aulast%3DBergo%26aufirst%3DM.%2BO.%26aulast%3DLeung%26aufirst%3DG.%2BK.%26aulast%3DAmbroziak%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DJ.%2BC.%26aulast%3DCasey%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26atitle%3DTargeted%2520inactivation%2520of%2520the%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520gene%2520causes%2520mislocalization%2520of%2520K-Ras%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D17605%26epage%3D17610%26doi%3D10.1074%2Fjbc.C000079200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Judd, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slattum, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhoite, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valppu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5047</span>, <span class="refDoi"> DOI: 10.1021/jm200249a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200249a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5031-5047&author=W.+R.+Juddauthor=P.+M.+Slattumauthor=K.+C.+Hoangauthor=L.+Bhoiteauthor=L.+Valppuauthor=G.+Albertsauthor=B.+Brownauthor=B.+Rothauthor=K.+Ostaninauthor=L.+Huangauthor=D.+Wettsteinauthor=B.+Richardsauthor=J.+A.+Willardsen&title=Discovery+and+SAR+of+methylated+tetrahydropyranyl+derivatives+as+inhibitors+of+isoprenylcysteine+carboxyl+methyltransferase+%28ICMT%29&doi=10.1021%2Fjm200249a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)</span></div><div class="casAuthors">Judd, Weston R.; Slattum, Paul M.; Hoang, Khanh C.; Bhoite, Leena; Valppu, Liisa; Alberts, Glen; Brown, Brita; Roth, Bruce; Ostanin, Kirill; Huang, Liwen; Wettstein, Daniel; Richards, Burt; Willardsen, J. Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5031-5047</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydropyranyl (THP) derivs. has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents.  Structural modification of the submicromolar hit compd. I led to the potent 3-methoxy substituted analog II [R = H].  Further SAR development around the THP ring resulted in an addnl. 10-fold increase in potency, exemplified by analog II [R = Me] with an IC50 of 1.3 nM.  Active and potent compds. demonstrated a dose-dependent increase in Ras cytosolic protein.  Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 μM.  However, none of the cellular effects obsd. using ICMT inhibitors were as pronounced as those resulting from a farnesyl-transferase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtJBz5EBh_LVg90H21EOLACvtfcHk0li09YSKE4pYoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrk%253D&md5=70c861a9d4ef4efcde4b94a2e0a88de9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm200249a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200249a%26sid%3Dliteratum%253Aachs%26aulast%3DJudd%26aufirst%3DW.%2BR.%26aulast%3DSlattum%26aufirst%3DP.%2BM.%26aulast%3DHoang%26aufirst%3DK.%2BC.%26aulast%3DBhoite%26aufirst%3DL.%26aulast%3DValppu%26aufirst%3DL.%26aulast%3DAlberts%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DWettstein%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DB.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520methylated%2520tetrahydropyranyl%2520derivatives%2520as%2520inhibitors%2520of%2520isoprenylcysteine%2520carboxyl%2520methyltransferase%2520%2528ICMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5031%26epage%3D5047%26doi%3D10.1021%2Fjm200249a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matrisian, L. M.</span></span> <span> </span><span class="NLM_article-title">Changing views of the role of matrix metalloproteinases in metastasis</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1093/jnci/89.17.1260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fjnci%2F89.17.1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9293916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1Squ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=1260-1270&author=A.+F.+Chambersauthor=L.+M.+Matrisian&title=Changing+views+of+the+role+of+matrix+metalloproteinases+in+metastasis&doi=10.1093%2Fjnci%2F89.17.1260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Changing views of the role of matrix metalloproteinases in metastasis</span></div><div class="casAuthors">Chambers, Ann F.; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1260-1270</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 127 refs. Metastatic spread of cancer continues to be the greatest barrier to cancer cure.  Understanding the mol. mechanisms of metastasis is crucial for the design and effective use of novel therapeutic strategies to combat metastases.  One class of mols. that has been repeatedly implicated in metastasis is the matrix metalloproteinases (MMPs).  In this review, we re-examine the evidence that MMPs are assocd. with metastasis and that they make a functional contribution to the process.  Initially, it was believed that the major role of MMPs in metastasis was to facilitate the breakdown of phys. barriers to metastasis, thus promoting invasion and entry into and out of blood or lymphatic vessels (intravasation, extravasation).  However, recent evidence suggests that MMPs may have a more complex role in metastasis and that they may make important contributions at other steps in the metastatic process.  Studies using intravital videomicroscopy, as well as expts. in which levels of MMPs or their inhibitors (tissue inhibitors of metalloproteinases [TIMPs]) are manipulated genetically or pharmacol., suggest that MMPs are key regulators of growth of tumors, at both primary and metastatic sites.  On the basis of this evidence, a new view of the functional role of MMPs in metastasis is presented, which suggests that MMPs are important in creating and maintaining an environment that supports the initiation and maintenance of growth of primary and metastatic tumors.  Further clarification of the mechanisms by which MMPs regulate growth of primary and metastatic tumors will be important in the development of novel therapeutic strategies against metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRMtb4MCIotbVg90H21EOLACvtfcHk0liDpRmT9USg3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1Squ7g%253D&md5=6b5d40c3ee3af13e6c66f634242219f7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F89.17.1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F89.17.1260%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DA.%2BF.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DChanging%2520views%2520of%2520the%2520role%2520of%2520matrix%2520metalloproteinases%2520in%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1997%26volume%3D89%26spage%3D1260%26epage%3D1270%26doi%3D10.1093%2Fjnci%2F89.17.1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynd, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janusz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieling, G. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4547</span>– <span class="NLM_lpage">4562</span>, <span class="refDoi"> DOI: 10.1021/jm990330y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990330y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXms1ejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4547-4562&author=N.+G.+Almsteadauthor=R.+S.+Bradleyauthor=S.+Pikulauthor=B.+Deauthor=M.+G.+Natchusauthor=Y.+O.+Taiwoauthor=F.+Guauthor=L.+E.+Williamsauthor=B.+A.+Hyndauthor=M.+J.+Januszauthor=C.+M.+Dunawayauthor=G.+E.+Mieling&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+thiazine-+and+thiazepine-based+matrix+metalloproteinase+inhibitors&doi=10.1021%2Fjm990330y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Potent Thiazine- and Thiazepine-Based Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Almstead, Neil G.; Bradley, Rimma S.; Pikul, Stanislaw; De, Biswanath; Natchus, Michael G.; Taiwo, Yetunde O.; Gu, Fei; Williams, Lisa E.; Hynd, Barbara A.; Janusz, Michael J.; Dunaway, C. Michelle; Mieling, Glen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4547-4562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and enzyme inhibition data for a series of thiazine- and thiazepine-based matrix metalloproteinase (MMP) inhibitors are described.  The thiazine- and thiazepine-based inhibitors were discovered by optimization of hetererocyclic sulfonamide-based inhibitors.  The most potent series of inhibitors was obtained by modification of the amino acid D-penicillamine.  This amino acid provides a gem-di-Me group on the thiazine or thiazepine ring which has a dramatic effect on the in vitro potency of this series.  In particular, the sulfide I [n = 0] and the sulfone I [n = 2] were potent, broad-spectrum inhibitors of the MMPs with IC50's against MMP-1 of 0.8 and 1.9 nM, resp.  The binding mode of this novel thiazepine-based series of MMP inhibitors was established based on X-ray crystallog. of the complex of stromelysin and I [n = 0].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPuU9hhJl0nLVg90H21EOLACvtfcHk0liDpRmT9USg3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXms1ejtr8%253D&md5=44effffb64806a081861133b0c0a254c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm990330y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990330y%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DBradley%26aufirst%3DR.%2BS.%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DL.%2BE.%26aulast%3DHynd%26aufirst%3DB.%2BA.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26aulast%3DDunaway%26aufirst%3DC.%2BM.%26aulast%3DMieling%26aufirst%3DG.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520thiazine-%2520and%2520thiazepine-based%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4547%26epage%3D4562%26doi%3D10.1021%2Fjm990330y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDow Dunham, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhail, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snider, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaway, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mieling, G. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, achiral matrix metalloproteinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3568</span>– <span class="NLM_lpage">3571</span>, <span class="refDoi"> DOI: 10.1021/jm980253r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980253r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3568-3571&author=S.+Pikulauthor=K.+L.+McDow+Dunhamauthor=N.+G.+Almsteadauthor=B.+Deauthor=M.+G.+Natchusauthor=M.+V.+Anastasioauthor=S.+J.+McPhailauthor=C.+E.+Sniderauthor=Y.+O.+Taiwoauthor=T.+Rydelauthor=C.+M.+Dunawayauthor=F.+Guauthor=G.+E.+Mieling&title=Discovery+of+potent%2C+achiral+matrix+metalloproteinase+inhibitors&doi=10.1021%2Fjm980253r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Pikul, Stanislaw; Dunham, Kelly L. McDow; Almstead, Neil G.; De, Biswanath; Natchus, Michael G.; Anastasio, Melanie V.; McPhail, Sara J.; Snider, Catherine E.; Taiwo, Yetunde O.; Rydel, Timothy; Dunaway, C. Michelle; Gu, Fei; Mieling, Glen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3568-3571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study the authors have introduced a symmetry element to the design of metalloproteinase (MMP) inhibitors which led to the discovery of a novel series of MMP inhibitors that are both nonchiral and very easy to synthesize.  The compds. based on the 1,3-piperazine heterocycle are potent inhibitors of collagenase, stromelysin, and gelatinase-B and moderate inhibitors of matrilysin.  On the basis of X-ray crystallog. of the inhibitor-enzyme complex, the binding of one of the compds. with stromelysin was found to involve several novel interactions at the S1/S2 pocket in addn. to the interactions commonly obsd. for an arylsulfonamide-hydroxamic acid framework.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBb-88vj3ux7Vg90H21EOLACvtfcHk0ljahEclTVaCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVKmt70%253D&md5=b8ceb9be6ac6c6a3f615ec28e41d0528</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm980253r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980253r%26sid%3Dliteratum%253Aachs%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DMcDow%2BDunham%26aufirst%3DK.%2BL.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DAnastasio%26aufirst%3DM.%2BV.%26aulast%3DMcPhail%26aufirst%3DS.%2BJ.%26aulast%3DSnider%26aufirst%3DC.%2BE.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26aulast%3DRydel%26aufirst%3DT.%26aulast%3DDunaway%26aufirst%3DC.%2BM.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DMieling%26aufirst%3DG.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252C%2520achiral%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3568%26epage%3D3571%26doi%3D10.1021%2Fjm980253r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toft, D. O.</span></span> <span> </span><span class="NLM_article-title">Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>228</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1177/153537020322800201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1177%2F153537020322800201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1amtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2003&pages=111-133&author=W.+B.+Prattauthor=D.+O.+Toft&title=Regulation+of+signaling+protein+function+and+trafficking+by+the+hsp90%2Fhsp70-based+chaperone+machinery&doi=10.1177%2F153537020322800201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery</span></div><div class="casAuthors">Pratt, William B.; Toft, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-133</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  Nearly 100 proteins are known to be regulated by hsp90.  Most of these substrates or "client proteins" are involved in signal transduction, and they are brought into complex with hsp90 by a multiprotein hsp90/hsp70-based chaperone machinery.  In addn. to binding substrate proteins at the chaperone site(s), hsp90 binds cofactors at other sites that are part of the hetero-complex assembly machinery as well as immunophilins that connect assembled substrate·hsp90 complexes to protein-trafficking systems.  In the 5 yr since we last reviewed this subject, much has been learned about hsp90 structure, nucleotide-binding, and cochaperone interactions; the most important concept is that ATP hydrolysis by an intrinsic ATPase activity results in a conformational change in hsp90 that is required to induce conformational change in a substrate protein.  The conformational change induced in steroid receptors is an opening of the steroid-binding cleft so that it can be accessed by steroid.  We have now developed a minimal system of five purified proteins-hsp90, hsp70, Hop, hsp40, and p23-that assembles stable receptor·hsp90 heterocomplexes.  An hsp90·Hop·hsp70·hsp40 complex opens the cleft in an ATP-dependent process to produce a receptor·hsp90 heterocomplex with hsp90 in its ATP-bound conformation, and p23 then interacts with the hsp90 to stabilize the complex.  Stepwise assembly expts. have shown that hsp70 and hsp40 first interact with the receptor in an ATP-dependent reaction to produce a receptor·hsp70·hsp40 complex that is "primed" to be activated to the steroid-binding state in a second ATP-dependent step with hsp90, Hop, and p23.  Successful use of the five-protein system with other substrates indicates that it can assemble signal protein·hsp90 heterocomplexes whether the substrate is a receptor, a protein kinase, or a transcription factor.  This purified system should facilitate understanding of how eukaryotic hsp70 and hsp90 work together as essential components of a process that alters the conformations of substrate proteins to states that respond in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8dwfmDdBC9bVg90H21EOLACvtfcHk0ljahEclTVaCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1amtbY%253D&md5=40af7769cad8b9d2dd13b6a5515c6656</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1177%2F153537020322800201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153537020322800201%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DToft%26aufirst%3DD.%2BO.%26atitle%3DRegulation%2520of%2520signaling%2520protein%2520function%2520and%2520trafficking%2520by%2520the%2520hsp90%252Fhsp70-based%2520chaperone%2520machinery%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2003%26volume%3D228%26spage%3D111%26epage%3D133%26doi%3D10.1177%2F153537020322800201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuBois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4288</span>– <span class="NLM_lpage">4305</span>, <span class="refDoi"> DOI: 10.1021/jm900230j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.+P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A.+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective+and+orally+active+antitumor+agents&doi=10.1021%2Fjm900230j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents</span></div><div class="casAuthors">Huang, Kenneth H.; Veal, James M.; Fadden, R. Patrick; Rice, John W.; Eaves, Jeron; Strachan, Jon-Paul; Barabasz, Amy F.; Foley, Briana E.; Barta, Thomas E.; Ma, Wei; Silinski, Melanie A.; Hu, Mei; Partridge, Jeffrey M.; Scott, Anisa; DuBois, Laura G.; Freed, Tiffany; Steed, Paul M.; Ommen, Andy J.; Smith, Emilie D.; Hughes, Philip F.; Woodward, Angela R.; Hanson, Gunnar J.; McCall, W. Stephen; Markworth, Christopher J.; Hinkley, Lindsay; Jenks, Matthew; Geng, Lifeng; Lewis, Meredith; Otto, James; Pronk, Bert; Verleysen, Katleen; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4288-4305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compd. library.  These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp90, and optimized analogs exhibited nanomolar antiproliferative activity across multiple cancer cell lines.  Heat shock protein 70 (Hsp70) induction and specific client protein degrdn. in cells on treatment with the inhibitors supported Hsp90 inhibition as the mechanism of action.  Computational chem. and X-ray crystallog. anal. of selected member compds. clearly defined the protein-inhibitor interaction and assisted the design of analogs. 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(trans-4-hydroxycyclohexyl)amino]benzamide (SNX-2112) (I) was identified as highly selective and potent (IC50 Her2 = 11 nM, HT-29 = 3 nM); its prodrug amino-acetic acid 4-[2-carbamoyl-5-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-phenylamino]-cyclohexyl ester methanesulfonate (SNX-5422) (II)was orally bioavailable and efficacious in a broad range of xenograft tumor models (e.g. 67% growth delay in a HT-29 model) and is now in multiple phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFjrhELWrFkbVg90H21EOLACvtfcHk0li236rmSO83QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Onsrk%253D&md5=99e5039e1761e9099d634acd79a15a6a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.%2BP.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305%26doi%3D10.1021%2Fjm900230j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nannini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-{3-[2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): a beta-sparing phosphoinositide 3-kinase inhibitor with high unbound exposure and robust in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4597</span>– <span class="NLM_lpage">4610</span>, <span class="refDoi"> DOI: 10.1021/jm4003632</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4003632" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4597-4610&author=C.+O.+Ndubakuauthor=T.+P.+Heffronauthor=S.+T.+Stabenauthor=M.+Baumgardnerauthor=N.+Blaquiereauthor=E.+Bradleyauthor=R.+Bullauthor=S.+Doauthor=J.+Dotsonauthor=D.+Dudleyauthor=K.+A.+Edgarauthor=L.+S.+Friedmanauthor=R.+Goldsmithauthor=R.+A.+Healdauthor=A.+Kolesnikovauthor=L.+Leeauthor=C.+Lewisauthor=M.+Nanniniauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=J.+J.+Wallinauthor=L.+Wangauthor=B.+Weiauthor=D.+Sampathauthor=A.+G.+Olivero&title=Discovery+of+2-%7B3-%5B2-%281-isopropyl-3-methyl-1H-1%2C2-4-triazol-5-yl%29-5%2C6-dihydrobenzo%5Bf%5Dimidazo%5B1%2C2-d%5D%5B1%2C4%5Doxazepin-9-yl%5D-1H-pyrazol-1-yl%7D-2-methylpropanamide+%28GDC-0032%29%3A+a+beta-sparing+phosphoinositide+3-kinase+inhibitor+with+high+unbound+exposure+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Fjm4003632"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm4003632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4003632%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDudley%26aufirst%3DD.%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNannini%26aufirst%3DM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%25202-%257B3-%255B2-%25281-isopropyl-3-methyl-1H-1%252C2-4-triazol-5-yl%2529-5%252C6-dihydrobenzo%255Bf%255Dimidazo%255B1%252C2-d%255D%255B1%252C4%255Doxazepin-9-yl%255D-1H-pyrazol-1-yl%257D-2-methylpropanamide%2520%2528GDC-0032%2529%253A%2520a%2520beta-sparing%2520phosphoinositide%25203-kinase%2520inhibitor%2520with%2520high%2520unbound%2520exposure%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4597%26epage%3D4610%26doi%3D10.1021%2Fjm4003632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badea, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mais, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2930</span>– <span class="NLM_lpage">2941</span>, <span class="refDoi"> DOI: 10.1021/jm00044a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00044a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFKjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2930-2941&author=M.+F.+Boehmauthor=L.+Zhangauthor=B.+A.+Badeaauthor=S.+K.+Whiteauthor=D.+E.+Maisauthor=E.+Bergerauthor=C.+M.+Sutoauthor=M.+E.+Goldmanauthor=R.+A.+Heyman&title=Synthesis+and+structure-activity+relationships+of+novel+retinoid+X+receptor-selective+retinoids&doi=10.1021%2Fjm00044a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids</span></div><div class="casAuthors">Boehm, Marcus F.; Zhang, Lin; Badea, Beth Ann; White, Steven K.; Mais, Dale E.; Berger, Elaine; Suto, Carla M.; Goldman, Mark E.; Heyman, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2930-41</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Two series of potent retinoid X receptor (RXR)-selective compds. were designed and synthesized based upon recent observation that(E)-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propenyl]benzoic acid binds and transactivates only the retinoic acid receptor (RAR) subtypes whereas its 3-Me deriv. binds and transactivates both the RAR and RXR subfamilies.  Functional groups in the 3-position of the tetrahydronaphthalenes I [R = H, alkyl, halo, OH, OMe; X = O, CH2] results in compds. which elicit potent and selective activation of the RXR class.  Such RXR-selective compds. offer pharmacol. tools for elucidating the biol. role of the individual retinoid receptors with which they interact.  Activation profiles in cotransfection and competitive binding assays as well as mol. modeling calcns. demonstrate crit. structural determinants that confer selectivity for members of the RXR subfamily.  The most potent compd. of these series, I [R = Me, X = CH2], is the first RXR-selective retinoid (designated as LGD1069) to enter clin. trials for cancer indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Mdx7TqZ18bVg90H21EOLACvtfcHk0lhGJoAtAfHjqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFKjt7g%253D&md5=90003c75aa4fd4934ad3aeb0773119f2</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm00044a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00044a014%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBadea%26aufirst%3DB.%2BA.%26aulast%3DWhite%26aufirst%3DS.%2BK.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DC.%2BM.%26aulast%3DGoldman%26aufirst%3DM.%2BE.%26aulast%3DHeyman%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520novel%2520retinoid%2520X%2520receptor-selective%2520retinoids%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2930%26epage%3D2941%26doi%3D10.1021%2Fjm00044a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClurg, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagoner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mais, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadzan, A. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">3146</span>– <span class="NLM_lpage">3155</span>, <span class="refDoi"> DOI: 10.1021/jm00016a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00016a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXmvF2htLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3146-3155&author=M.+F.+Boehmauthor=L.+Zhangauthor=L.+Zhiauthor=M.+R.+McClurgauthor=E.+Bergerauthor=M.+Wagonerauthor=D.+E.+Maisauthor=C.+M.+Sutoauthor=J.+A.+Daviesauthor=R.+A.+Heymanauthor=A.+M.+Nadzan&title=Design+and+synthesis+of+potent+retinoid+X+receptor+selective+ligands+that+induce+apoptosis+in+leukemia+cells&doi=10.1021%2Fjm00016a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells</span></div><div class="casAuthors">Boehm, Marcus F.; Zhang, Lin; Zhi, Lin; McClurg, Michael R.; Berger, Elain; Wagoner, Murriel; Mais, Dale E.; Suto, Carla M.; Davies, Peter J. A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3146-55</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural modifications of the retinoid X receptor (RXR) selective compd. 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl]benzoic acid (LGD1069), which is currently in phase I/IIA clin. trials for cancer and dermatol. indications, have resulted in the identification of increasingly potent retinoids with >1000-fold selectivity for the RXRs.  The prepn. of a series of RXR selective retinoids as well as the biol. data obtained from cotransfection and competitive binding assays which were used to evaluate their potency and selectivity are reported.  The most potent and selective of the analogs is 6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]nicotinic acid (I, LG100268).  This compd. has proven useful for investigating RXR-dependent biol. pathways including the induction of programmed cell death (PCD) and transglutaminase (TGase) activity.  These studies indicate that the induction of PCD and TGase in human leukemic myeloid cells is dependent upon activation of RXR-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKBnqaIZ7EkrVg90H21EOLACvtfcHk0lhGJoAtAfHjqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvF2htLg%253D&md5=c9bcc1f2449517cf62406151376ccedd</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00016a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00016a018%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhi%26aufirst%3DL.%26aulast%3DMcClurg%26aufirst%3DM.%2BR.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DWagoner%26aufirst%3DM.%26aulast%3DMais%26aufirst%3DD.%2BE.%26aulast%3DSuto%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DJ.%2BA.%26aulast%3DHeyman%26aufirst%3DR.%2BA.%26aulast%3DNadzan%26aufirst%3DA.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520retinoid%2520X%2520receptor%2520selective%2520ligands%2520that%2520induce%2520apoptosis%2520in%2520leukemia%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3146%26epage%3D3155%26doi%3D10.1021%2Fjm00016a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boerma, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo-Ruppert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccio, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrow, M. B.</span></span> <span> </span><span class="NLM_article-title">Defining the communication between agonist and coactivator binding in the retinoid X receptor alpha ligand binding domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.476861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M113.476861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24187139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=814-826&author=L.+J.+Boermaauthor=G.+Xiaauthor=C.+Quiauthor=B.+D.+Coxauthor=M.+J.+Chalmersauthor=C.+D.+Smithauthor=S.+Lobo-Ruppertauthor=P.+R.+Griffinauthor=D.+D.+Muccioauthor=M.+B.+Renfrow&title=Defining+the+communication+between+agonist+and+coactivator+binding+in+the+retinoid+X+receptor+alpha+ligand+binding+domain&doi=10.1074%2Fjbc.M113.476861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding Domain</span></div><div class="casAuthors">Boerma, LeeAnn J.; Xia, Gang; Qui, Cheng; Cox, Bryan D.; Chalmers, Michael J.; Smith, Craig D.; Lobo-Ruppert, Susan; Griffin, Patrick R.; Muccio, Donald D.; Renfrow, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-826</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Retinoid X receptors (RXRs) are obligate partners for several other nuclear receptors, and they play a key role in several signaling processes.  Despite being a promiscuous heterodimer partner, this nuclear receptor is a target of therapeutic intervention through activation using selective RXR agonists (rexinoids).  Agonist binding to RXR initiates a large conformational change in the receptor that allows for coactivator recruitment to its surface and enhanced transcription.  Here we reveal the structural and dynamical changes produced when a coactivator peptide binds to the human RXRα ligand binding domain contg. two clin. relevant rexinoids, Targretin and 9-cis-UAB30.  Our results show that the structural changes are very similar for each rexinoid and similar to those for the pan-agonist 9-cis-retinoic acid.  The four structural changes involve key residues on helix 3, helix 4, and helix 11 that move from a solvent-exposed environment to one that interacts extensively with helix 12.  Hydrogen-deuterium exchange mass spectrometry reveals that the dynamics of helixes 3, 11, and 12 are significantly decreased when the two rexinoids are bound to the receptor.  When the pan-agonist 9-cis-retinoic acid is bound to the receptor, only the dynamics of helixes 3 and 11 are reduced.  The four structural changes are conserved in all x-ray structures of the RXR ligand-binding domain in the presence of agonist and coactivator peptide.  They serve as hallmarks for how RXR changes conformation and dynamics in the presence of agonist and coactivator to initiate signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt9u19MPXxk7Vg90H21EOLACvtfcHk0lgLa3pu-2Oyaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFymtg%253D%253D&md5=b84926e04bb7b8850fca96b213fa0da8</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.476861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.476861%26sid%3Dliteratum%253Aachs%26aulast%3DBoerma%26aufirst%3DL.%2BJ.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DChalmers%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DLobo-Ruppert%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DMuccio%26aufirst%3DD.%2BD.%26aulast%3DRenfrow%26aufirst%3DM.%2BB.%26atitle%3DDefining%2520the%2520communication%2520between%2520agonist%2520and%2520coactivator%2520binding%2520in%2520the%2520retinoid%2520X%2520receptor%2520alpha%2520ligand%2520binding%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D814%26epage%3D826%26doi%3D10.1074%2Fjbc.M113.476861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chandraratna, R. A.</span></span> <span> </span><span class="NLM_article-title">Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">S12</span>– <span class="NLM_lpage">S17</span>, <span class="refDoi"> DOI: 10.1016/S0190-9622(97)80395-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0190-9622%2897%2980395-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9270551" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=S12-S17&author=R.+A.+Chandraratna&title=Tazarotene%3A+the+first+receptor-selective+topical+retinoid+for+the+treatment+of+psoriasis&doi=10.1016%2FS0190-9622%2897%2980395-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0190-9622%2897%2980395-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0190-9622%252897%252980395-7%26sid%3Dliteratum%253Aachs%26aulast%3DChandraratna%26aufirst%3DR.%2BA.%26atitle%3DTazarotene%253A%2520the%2520first%2520receptor-selective%2520topical%2520retinoid%2520for%2520the%2520treatment%2520of%2520psoriasis%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D1997%26volume%3D37%26spage%3DS12%26epage%3DS17%26doi%3D10.1016%2FS0190-9622%2897%2980395-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojadinovic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzyzanowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vouthounis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomic-Canic, M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-responsive transcriptional changes in epidermal keratinocytes</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>220</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1002/jcp.21784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fjcp.21784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=19388012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2009&pages=427-439&author=D.+D.+Leeauthor=O.+Stojadinovicauthor=A.+Krzyzanowskaauthor=C.+Vouthounisauthor=M.+Blumenbergauthor=M.+Tomic-Canic&title=Retinoid-responsive+transcriptional+changes+in+epidermal+keratinocytes&doi=10.1002%2Fjcp.21784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-responsive transcriptional changes in epidermal keratinocytes</span></div><div class="casAuthors">Lee, Ding-Dar; Stojadinovic, Olivera; Krzyzanowska, Agata; Vouthounis, Constantinos; Blumenberg, Miroslav; Tomic-Canic, Marjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-439</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Retinoids (RA) have been used as therapeutic agents for numerous skin diseases, from psoriasis to acne and wrinkles.  While RA is known to inhibit keratinocyte differentiation, the mol. effects of RA in epidermis have not been comprehensively defined.  To identify the transcriptional targets of RA in primary human epidermal keratinocytes, we compared the transcriptional profiles of cells grown in the presence or absence of all-trans retinoic acid for 1, 4, 24, 48, and 72 h, using large DNA microarrays.  As expected, RA suppresses the protein markers of cornification; however the genes responsible for biosynthesis of epidermal lipids, long-chain fatty acids, cholesterol, and sphingolipids, are also suppressed.  Importantly, the pathways of RA synthesis, esterification and metab. are activated by RA; therefore, RA regulates its own bioavailability.  Unexpectedly, RA regulates many genes assocd. with the cell cycle and programmed cell death.  This led us to reveal novel effects of RA on keratinocyte proliferation and apoptosis.  The response to RA is very fast: 315 genes were regulated already after 1 h.  More than one-third of RA-regulated genes function in signal transduction and regulation of transcription.  Using in silico anal., we identified a set of over-represented transcription factor binding sites in the RA-regulated genes.  Many psoriasis-related genes are regulated by RA, some induced, others suppressed.  These results comprehensively document the transcriptional changes caused by RA in keratinocytes, add new insights into the mol. mechanism influenced by RA in the epidermis and demonstrate the hypothesis-generating power of DNA microarray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSnti3sNXZ5rVg90H21EOLACvtfcHk0lgLa3pu-2Oyaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFags7g%253D&md5=ed59ef62de758688fe4e4d7eb44b56ad</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21784%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BD.%26aulast%3DStojadinovic%26aufirst%3DO.%26aulast%3DKrzyzanowska%26aufirst%3DA.%26aulast%3DVouthounis%26aufirst%3DC.%26aulast%3DBlumenberg%26aufirst%3DM.%26aulast%3DTomic-Canic%26aufirst%3DM.%26atitle%3DRetinoid-responsive%2520transcriptional%2520changes%2520in%2520epidermal%2520keratinocytes%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D220%26spage%3D427%26epage%3D439%26doi%3D10.1002%2Fjcp.21784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1038/nri2036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnri2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17290298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=191-201&author=C.+Rommelauthor=M.+Campsauthor=H.+Ji&title=PI3K+delta+and+PI3K+gamma%3A+partners+in+crime+in+inflammation+in+rheumatoid+arthritis+and+beyond%3F&doi=10.1038%2Fnri2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?</span></div><div class="casAuthors">Rommel, Christian; Camps, Montserrat; Ji, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-201</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated signal transduction in innate and adaptive immune cells is known to be assocd. with the development of various autoimmune and inflammatory diseases.  Consequently, targeting intracellular signaling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs.  Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signaling pathways that are known to have important roles in leukocytes.  In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, the authors discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSAduhwUrPrVg90H21EOLACvtfcHk0lhOKtY30EyMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D&md5=2fdb3507d06ddf7d5485185f4573790f</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnri2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2036%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DPI3K%2520delta%2520and%2520PI3K%2520gamma%253A%2520partners%2520in%2520crime%2520in%2520inflammation%2520in%2520rheumatoid%2520arthritis%2520and%2520beyond%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D191%26epage%3D201%26doi%3D10.1038%2Fnri2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgardner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheguillaume, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handa, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krintel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reif, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seward, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tivitmahaisoon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel PI3-kinase delta specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5887</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1021/jm3003747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5887-5900&author=B.+S.+Safinaauthor=S.+Bakerauthor=M.+Baumgardnerauthor=P.+M.+Blaneyauthor=B.+K.+Chanauthor=Y.+H.+Chenauthor=M.+W.+Cartwrightauthor=G.+Castanedoauthor=C.+Chabotauthor=A.+J.+Cheguillaumeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=B.+Goyalauthor=T.+Hancoxauthor=R.+K.+Handaauthor=P.+S.+Iyerauthor=J.+Kaurauthor=R.+Kondruauthor=J.+R.+Kennyauthor=S.+L.+Krintelauthor=J.+Liauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=S.+Mukadamauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=F.+Padillaauthor=W.+S.+Palmerauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=L.+Salphatiauthor=P.+A.+Savyauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=S.+Tayauthor=P.+Tivitmahaisoonauthor=B.+Waszkowyczauthor=B.+Weiauthor=Q.+Yueauthor=C.+Zhangauthor=D.+P.+Sutherlin&title=Discovery+of+novel+PI3-kinase+delta+specific+inhibitors+for+the+treatment+of+rheumatoid+arthritis%3A+taming+CYP3A4+time-dependent+inhibition&doi=10.1021%2Fjm3003747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm3003747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003747%26sid%3Dliteratum%253Aachs%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBaumgardner%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DCartwright%26aufirst%3DM.%2BW.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCheguillaume%26aufirst%3DA.%2BJ.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DHanda%26aufirst%3DR.%2BK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSavy%26aufirst%3DP.%2BA.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTivitmahaisoon%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520novel%2520PI3-kinase%2520delta%2520specific%2520inhibitors%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%253A%2520taming%2520CYP3A4%2520time-dependent%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5887%26epage%3D5900%26doi%3D10.1021%2Fjm3003747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nortey, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shank, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupsky, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortegon, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. enhanced potency with cyclic sulfate derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/jm970790w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970790w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1315-1343&author=B.+E.+Maryanoffauthor=M.+J.+Costanzoauthor=S.+O.+Norteyauthor=M.+N.+Grecoauthor=R.+P.+Shankauthor=J.+J.+Schupskyauthor=M.+P.+Ortegonauthor=J.+L.+Vaught&title=Structure-activity+studies+on+anticonvulsant+sugar+sulfamates+related+to+topiramate.+enhanced+potency+with+cyclic+sulfate+derivatives&doi=10.1021%2Fjm970790w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm970790w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970790w%26sid%3Dliteratum%253Aachs%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DNortey%26aufirst%3DS.%2BO.%26aulast%3DGreco%26aufirst%3DM.%2BN.%26aulast%3DShank%26aufirst%3DR.%2BP.%26aulast%3DSchupsky%26aufirst%3DJ.%2BJ.%26aulast%3DOrtegon%26aufirst%3DM.%2BP.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DStructure-activity%2520studies%2520on%2520anticonvulsant%2520sugar%2520sulfamates%2520related%2520to%2520topiramate.%2520enhanced%2520potency%2520with%2520cyclic%2520sulfate%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1315%26epage%3D1343%26doi%3D10.1021%2Fjm970790w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shytle, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanberg, P. R.</span></span> <span> </span><span class="NLM_article-title">Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine</span>. <i>Depression Anxiety</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1002/da.10035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fda.10035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=12415531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BD38nosVartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=89-92&author=R.+D.+Shytleauthor=A.+A.+Silverauthor=K.+H.+Sheehanauthor=D.+V.+Sheehanauthor=P.+R.+Sanberg&title=Neuronal+nicotinic+receptor+inhibition+for+treating+mood+disorders%3A+preliminary+controlled+evidence+with+mecamylamine&doi=10.1002%2Fda.10035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine</span></div><div class="casAuthors">Shytle R Douglas; Silver Archie A; Sheehan Kathy H; Sheehan David V; Sanberg Paul R</div><div class="citationInfo"><span class="NLM_cas:title">Depression and anxiety</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">89-92</span>
        ISSN:<span class="NLM_cas:issn">1091-4269</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTHvOKj69vImgRQsDqrjW_fW6udTcc2eYnUN4KsS30U7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nosVartw%253D%253D&md5=adb0e0961e3acd56254767e706947e0e</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fda.10035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fda.10035%26sid%3Dliteratum%253Aachs%26aulast%3DShytle%26aufirst%3DR.%2BD.%26aulast%3DSilver%26aufirst%3DA.%2BA.%26aulast%3DSheehan%26aufirst%3DK.%2BH.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520inhibition%2520for%2520treating%2520mood%2520disorders%253A%2520preliminary%2520controlled%2520evidence%2520with%2520mecamylamine%26jtitle%3DDepression%2520Anxiety%26date%3D2002%26volume%3D16%26spage%3D89%26epage%3D92%26doi%3D10.1002%2Fda.10035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suchocki, J.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/jm00107a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00107a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1003-1010&author=J.%0AA.+Suchockiauthor=E.+L.+Mayauthor=T.+J.+Martinauthor=C.+Georgeauthor=B.+R.+Martin&title=Synthesis+of+2-exo-+and+2-endo-mecamylamine+analogues.+Structure-activity+relationships+for+nicotinic+antagonism+in+the+central+nervous+system&doi=10.1021%2Fjm00107a019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm00107a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00107a019%26sid%3Dliteratum%253Aachs%26aulast%3DSuchocki%26aufirst%3DJ.%2BA.%26aulast%3DMay%26aufirst%3DE.%2BL.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520of%25202-exo-%2520and%25202-endo-mecamylamine%2520analogues.%2520Structure-activity%2520relationships%2520for%2520nicotinic%2520antagonism%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1003%26epage%3D1010%26doi%3D10.1021%2Fjm00107a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">(S)-(+)-Mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1021/cn100070s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100070s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSju7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=530-531&author=C.+W.+Lindsley&title=%28S%29-%28%2B%29-Mecamylamine+%28TC-5214%29%3A+a+neuronal+nicotinic+receptor+modulator+enters+phase+III+trials+as+an+adjunct+treatment+for+major+depressive+disorder+%28MDD%29&doi=10.1021%2Fcn100070s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-(+)-Mecamylamine (TC-5214): A Neuronal Nicotinic Receptor Modulator Enters Phase III Trials as an Adjunct Treatment for Major Depressive Disorder (MDD)</span></div><div class="casAuthors">Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">530-531</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJhp0iwDmqrVg90H21EOLACvtfcHk0lgPZLVoWtqOnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSju7vL&md5=7eb9a45f1840c9b40db4ab6a5dbd4443</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fcn100070s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100070s%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3D%2528S%2529-%2528%252B%2529-Mecamylamine%2520%2528TC-5214%2529%253A%2520a%2520neuronal%2520nicotinic%2520receptor%2520modulator%2520enters%2520phase%2520III%2520trials%2520as%2520an%2520adjunct%2520treatment%2520for%2520major%2520depressive%2520disorder%2520%2528MDD%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D530%26epage%3D531%26doi%3D10.1021%2Fcn100070s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrasiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegla, M. T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of central nervous system agents. 5. effect of the hydrocarbon chain on the affinity of 4-substituted 1-(3-chlorophenyl)piperazines for 5-HT1A receptor site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2369</span>– <span class="NLM_lpage">2374</span>, <span class="refDoi"> DOI: 10.1021/jm00091a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00091a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2369-2374&author=J.+L.+Mokroszauthor=M.+Pietrasiewiczauthor=B.+Duszynskaauthor=M.+T.+Cegla&title=Structure-activity+relationship+studies+of+central+nervous+system+agents.+5.+effect+of+the+hydrocarbon+chain+on+the+affinity+of+4-substituted+1-%283-chlorophenyl%29piperazines+for+5-HT1A+receptor+site&doi=10.1021%2Fjm00091a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm00091a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00091a004%26sid%3Dliteratum%253Aachs%26aulast%3DMokrosz%26aufirst%3DJ.%2BL.%26aulast%3DPietrasiewicz%26aufirst%3DM.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DCegla%26aufirst%3DM.%2BT.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520central%2520nervous%2520system%2520agents.%25205.%2520effect%2520of%2520the%2520hydrocarbon%2520chain%2520on%2520the%2520affinity%2520of%25204-substituted%25201-%25283-chlorophenyl%2529piperazines%2520for%25205-HT1A%2520receptor%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2369%26epage%3D2374%26doi%3D10.1021%2Fjm00091a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strekowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harden, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies of CNS agents. Part 14: structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives</span>. <i>Pharmazie</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1994&pages=801-806&author=J.+L.+Mokroszauthor=L.+Strekowskiauthor=B.+Duszynskaauthor=D.+B.+Hardenauthor=M.+J.+Mokroszauthor=A.+J.+Bojarski&title=Structure-activity+relationship+studies+of+CNS+agents.+Part+14%3A+structural+requirements+for+the+5-HT1A+and+5-HT2A+receptor+selectivity+of+simple+1-%282-pyrimidinyl%29piperazine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMokrosz%26aufirst%3DJ.%2BL.%26aulast%3DStrekowski%26aufirst%3DL.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DHarden%26aufirst%3DD.%2BB.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520CNS%2520agents.%2520Part%252014%253A%2520structural%2520requirements%2520for%2520the%25205-HT1A%2520and%25205-HT2A%2520receptor%2520selectivity%2520of%2520simple%25201-%25282-pyrimidinyl%2529piperazine%2520derivatives%26jtitle%3DPharmazie%26date%3D1994%26volume%3D49%26spage%3D801%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paluchowska, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugno, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojarski, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charakchieva-Minol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duszynska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatarczynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klodzinska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chojnacka-Wojcik, E.</span></span> <span> </span><span class="NLM_article-title">Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmc.2004.11.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1195-1200&author=M.+H.+Paluchowskaauthor=R.+Bugnoauthor=A.+J.+Bojarskiauthor=S.+Charakchieva-Minolauthor=B.+Duszynskaauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=K.+Stachowiczauthor=E.+Chojnacka-Wojcik&title=Novel%2C+flexible%2C+and+conformationally+defined+analogs+of+gepirone%3A+synthesis+and+5-HT1A%2C+5-HT2A%2C+and+D2+receptor+activity&doi=10.1016%2Fj.bmc.2004.11.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DPaluchowska%26aufirst%3DM.%2BH.%26aulast%3DBugno%26aufirst%3DR.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DDuszynska%26aufirst%3DB.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DStachowicz%26aufirst%3DK.%26aulast%3DChojnacka-Wojcik%26aufirst%3DE.%26atitle%3DNovel%252C%2520flexible%252C%2520and%2520conformationally%2520defined%2520analogs%2520of%2520gepirone%253A%2520synthesis%2520and%25205-HT1A%252C%25205-HT2A%252C%2520and%2520D2%2520receptor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1195%26epage%3D1200%26doi%3D10.1016%2Fj.bmc.2004.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1017/S1461145712000661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1017%2FS1461145712000661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22827916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=445-458&author=J.+Bergmanauthor=R.+A.+Roofauthor=C.+A.+Furmanauthor=J.+L.+Conroyauthor=N.+K.+Melloauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Modification+of+cocaine+self-administration+by+buspirone+%28buspar%C2%AE%29%3A+potential+involvement+of+D3+and+D4+dopamine+receptors&doi=10.1017%2FS1461145712000661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors</span></div><div class="casAuthors">Bergman, Jack; Roof, Rebecca A.; Furman, Cheryse A.; Conroy, Jennie L.; Mello, Nancy K.; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence indicate that elevations in synaptic dopamine levels play a pivotal role in the reinforcing effects of cocaine, which are assocd. with its abuse liability.  This evidence has led to the exploration of dopamine receptor blockers as pharmacotherapy for cocaine addiction.  While neither D1 nor D2 receptor antagonists have proven effective, medications acting at two other potential targets, D3 and D4 receptors, have yet to be explored for this indication in the clinic.  Buspirone, a 5-HT1A partial agonist approved for the treatment of anxiety, has been reported to also bind with high affinity to D3 and D4 receptors.  In view of this biochem. profile, the present research was conducted to examine both the functional effects of buspirone on these receptors and, in non-human primates, its ability to modify the reinforcing effects of i.v. cocaine in a behaviorally selective manner.  Radioligand binding studies confirmed that buspirone binds with high affinity to recombinant human D3 and D4 receptors (∼98 and ∼29 nm resp.).  Live cell functional assays also revealed that buspirone, and its metabolites, function as antagonists at both D3 and D4 receptors.  In behavioral studies, doses of buspirone that had inconsistent effects on food-maintained responding (0.1 or 0.3 mg/kg i.m.) produced a marked downward shift in the dose-effect function for cocaine-maintained behavior, reflecting substantial decreases in self-administration of one or more unit doses of i.v. cocaine in each subject.  These results support the further evaluation of buspirone as a candidate medication for the management of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69I6VSGbSerVg90H21EOLACvtfcHk0lgJJV2Y3D7sXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D&md5=977dd2218df7db5300b1e4c1865dafd9</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000661%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DModification%2520of%2520cocaine%2520self-administration%2520by%2520buspirone%2520%2528buspar%25C2%25AE%2529%253A%2520potential%2520involvement%2520of%2520D3%2520and%2520D4%2520dopamine%2520receptors%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D445%26epage%3D458%26doi%3D10.1017%2FS1461145712000661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skeggs, L. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumway, N. P.</span></span> <span> </span><span class="NLM_article-title">The preparation, purification, and amino acid sequence of a polypeptide renin substrate</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1084/jem.106.3.439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1084%2Fjem.106.3.439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=K.+Lentzauthor=N.+P.+Shumway&title=The+preparation%2C+purification%2C+and+amino+acid+sequence+of+a+polypeptide+renin+substrate&doi=10.1084%2Fjem.106.3.439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1084%2Fjem.106.3.439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.106.3.439%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%252C%2520purification%252C%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453%26doi%3D10.1084%2Fjem.106.3.439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goschke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigollier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forgiarini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruetter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Novel 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4818</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/jm070314y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070314y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4818-4831&author=R.+Goschkeauthor=S.+Stutzauthor=V.+Rasettiauthor=N.+C.+Cohenauthor=J.+Rahuelauthor=P.+Rigollierauthor=H.+P.+Baumauthor=P.+Forgiariniauthor=C.+R.+Schnellauthor=T.+Wagnerauthor=M.+G.+Gruetterauthor=W.+Fuhrerauthor=W.+Schillingauthor=F.+Cuminauthor=J.+M.+Woodauthor=J.+Maibaum&title=Novel+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamide+transition+state+peptidomimetics+are+potent+and+orally+active+inhibitors+of+human+renin&doi=10.1021%2Fjm070314y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm070314y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070314y%26sid%3Dliteratum%253Aachs%26aulast%3DGoschke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DForgiarini%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DGruetter%26aufirst%3DM.%2BG.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DNovel%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamide%2520transition%2520state%2520peptidomimetics%2520are%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4818%26epage%3D4831%26doi%3D10.1021%2Fjm070314y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goschke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigollier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhrer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruetter, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span> <span> </span><span class="NLM_article-title">Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4832</span>– <span class="NLM_lpage">4844</span>, <span class="refDoi"> DOI: 10.1021/jm070316i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4832-4844&author=J.+Maibaumauthor=S.+Stutzauthor=R.+Goschkeauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=J.+Rahuelauthor=H.+P.+Baumauthor=N.+C.+Cohenauthor=C.+R.+Schnellauthor=W.+Fuhrerauthor=M.+G.+Gruetterauthor=W.+Schillingauthor=J.+M.+Wood&title=Structural+modification+of+the+P2%E2%80%B2+position+of+2%2C7-dialkyl-substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides%3A+the+discovery+of+aliskiren%2C+a+potent+nonpeptide+human+renin+inhibitor+active+after+once+daily+dosing+in+marmosets&doi=10.1021%2Fjm070316i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DGoschke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.%2BP.%26aulast%3DCohen%26aufirst%3DN.%2BC.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGruetter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520modification%2520of%2520the%2520P2%25E2%2580%25B2%2520position%2520of%25202%252C7-dialkyl-substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%253A%2520the%2520discovery%2520of%2520aliskiren%252C%2520a%2520potent%2520nonpeptide%2520human%2520renin%2520inhibitor%2520active%2520after%2520once%2520daily%2520dosing%2520in%2520marmosets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844%26doi%3D10.1021%2Fjm070316i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, A. K.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. side chain ester derivatives of mevinolin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1021/jm00155a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00155a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=849-852&author=W.+F.+Hoffmanauthor=A.+W.+Albertsauthor=P.+S.+Andersonauthor=J.+S.+Chenauthor=R.+L.+Smithauthor=A.+K.+Willard&title=3-Hydroxy-3-methylglutaryl-coenzyme+A+reductase+inhibitors.+4.+side+chain+ester+derivatives+of+mevinolin&doi=10.1021%2Fjm00155a040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm00155a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00155a040%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BL.%26aulast%3DWillard%26aufirst%3DA.%2BK.%26atitle%3D3-Hydroxy-3-methylglutaryl-coenzyme%2520A%2520reductase%2520inhibitors.%25204.%2520side%2520chain%2520ester%2520derivatives%2520of%2520mevinolin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D849%26epage%3D852%26doi%3D10.1021%2Fjm00155a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Istvan, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deisenhofer, J.</span></span> <span> </span><span class="NLM_article-title">Structural mechanism for statin inhibition of HMG-CoA reductase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">1160</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1126/science.1059344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1126%2Fscience.1059344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11349148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1Cgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=1160-1164&author=E.+S.+Istvanauthor=J.+Deisenhofer&title=Structural+mechanism+for+statin+inhibition+of+HMG-CoA+reductase&doi=10.1126%2Fscience.1059344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for statin inhibition of HMG-CoA reductase</span></div><div class="casAuthors">Istvan, Eva S.; Deisenhofer, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5519</span>),
    <span class="NLM_cas:pages">1160-1164</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase (HMGR) catalyzes the committed step in cholesterol biosynthesis.  Statins are HMGR inhibitors with inhibition const. values in the nanomolar range that effectively lower serum cholesterol levels and are widely prescribed in the treatment of hypercholesterolemia.  We have detd. structures of the catalytic portion of human HMGR complexed with six different statins.  The statins occupy a portion of the binding site of HMG-CoA, thus blocking access of this substrate to the active site.  Near the carboxyl terminus of HMGR, several catalytically relevant residues are disordered in the enzyme-statin complexes.  If these residues were not flexible, they would sterically hinder statin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDsSOnK9675bVg90H21EOLACvtfcHk0liz8vQyYE9zoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1Cgtbo%253D&md5=235644ee8cca3d2e061093e93bd1d702</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059344%26sid%3Dliteratum%253Aachs%26aulast%3DIstvan%26aufirst%3DE.%2BS.%26aulast%3DDeisenhofer%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520statin%2520inhibition%2520of%2520HMG-CoA%2520reductase%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D1160%26epage%3D1164%26doi%3D10.1126%2Fscience.1059344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coldwell, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span> <span> </span><span class="NLM_article-title">Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. comparison with nicorandil</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">3663</span>– <span class="NLM_lpage">3669</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(87)90017-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0006-2952%2887%2990017-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=3663-3669&author=M.+C.+Coldwellauthor=D.+R.+Howlett&title=Specificity+of+action+of+the+novel+antihypertensive+agent%2C+BRL+34915%2C+as+a+potassium+channel+activator.+comparison+with+nicorandil&doi=10.1016%2F0006-2952%2887%2990017-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2887%2990017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252887%252990017-7%26sid%3Dliteratum%253Aachs%26aulast%3DColdwell%26aufirst%3DM.%2BC.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26atitle%3DSpecificity%2520of%2520action%2520of%2520the%2520novel%2520antihypertensive%2520agent%252C%2520BRL%252034915%252C%2520as%2520a%2520potassium%2520channel%2520activator.%2520comparison%2520with%2520nicorandil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1987%26volume%3D36%26spage%3D3663%26epage%3D3669%26doi%3D10.1016%2F0006-2952%2887%2990017-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, A. H.</span></span> <span> </span><span class="NLM_article-title">Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1986.tb09476.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1476-5381.1986.tb09476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=3708211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaL28XktVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1986&pages=103-111&author=T.+C.+Hamiltonauthor=S.+W.+Weirauthor=A.+H.+Weston&title=Comparison+of+the+effects+of+BRL+34915+and+verapamil+on+electrical+and+mechanical+activity+in+rat+portal+vein&doi=10.1111%2Fj.1476-5381.1986.tb09476.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein</span></div><div class="casAuthors">Hamilton, T. C.; Weir, Sheila W.; Weston, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-11</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The effects of the novel anti-hypertensive agent BRL 34915 (I)  [94470-67-4] were compared with those of verapamil  [52-53-9] on rat isolated portal vein.  I produced a concn.-dependent redn. in mech. responses to (-)-noradrenaline bitartrate  [51-40-1] monohydrate but had relatively little inhibitory effect on K+-induced contractions.  Verapamil reduced the magnitude of both noradrenaline and K+-induced mech. responses.  I delayed the appearance of the reduced noradrenaline contractions, a property not shared by verapamil.  I abolished spontaneous elec. and mech. discharges and hyperpolarized the portal vein cells close to their calcd. K equil. potential.  Verapamil inhibited spontaneous elec. and mech. discharges, effects assocd. with a small depolarization.  I produced a significant increase in the 86Rb efflux rate coeff., whereas verapamil was without effect on this parameter.  The inhibitory effects of I were rapid in onset and readily reversible by washing, whereas those of verapamil were slower in onset and only slowly reversible.  Thus, the inhibitory effects of I in rat portal vein are produced by the opening of K channels in the smooth muscle cells.  This inhibits spike activity and in sufficient concn. holds the membrane potential at or close to the K equil. potential, thereby reducing the effects of excitatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3lf_-z69xXbVg90H21EOLACvtfcHk0liz8vQyYE9zoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVSgtb4%253D&md5=bf1c1005520866e9a4a675fcb86ec1bf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb09476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb09476.x%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DWeir%26aufirst%3DS.%2BW.%26aulast%3DWeston%26aufirst%3DA.%2BH.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520BRL%252034915%2520and%2520verapamil%2520on%2520electrical%2520and%2520mechanical%2520activity%2520in%2520rat%2520portal%2520vein%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D88%26spage%3D103%26epage%3D111%26doi%3D10.1111%2Fj.1476-5381.1986.tb09476.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapham, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longman, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poyser, R. H.</span></span> <span> </span><span class="NLM_article-title">BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">798</span>– <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=798-804&author=R.+E.+Buckinghamauthor=J.+C.+Claphamauthor=T.+C.+Hamiltonauthor=S.+D.+Longmanauthor=J.+Nortonauthor=R.+H.+Poyser&title=BRL+34915%2C+a+novel+antihypertensive+agent%3A+comparison+of+effects+on+blood+pressure+and+other+haemodynamic+parameters+with+those+of+nifedipine+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DClapham%26aufirst%3DJ.%2BC.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DLongman%26aufirst%3DS.%2BD.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DPoyser%26aufirst%3DR.%2BH.%26atitle%3DBRL%252034915%252C%2520a%2520novel%2520antihypertensive%2520agent%253A%2520comparison%2520of%2520effects%2520on%2520blood%2520pressure%2520and%2520other%2520haemodynamic%2520parameters%2520with%2520those%2520of%2520nifedipine%2520in%2520animal%2520models%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1986%26volume%3D8%26spage%3D798%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckingham, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faruk, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willcocks, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2194</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/jm00161a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2194-2201&author=V.+A.+Ashwoodauthor=R.+E.+Buckinghamauthor=F.+Cassidyauthor=J.+M.+Evansauthor=E.+A.+Farukauthor=T.+C.+Hamiltonauthor=D.+J.+Nashauthor=G.+Stempauthor=K.+Willcocks&title=Synthesis+and+antihypertensive+activity+of+4-%28cyclic+amido%29-2H-1-benzopyrans&doi=10.1021%2Fjm00161a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a011%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DJ.%2BM.%26aulast%3DFaruk%26aufirst%3DE.%2BA.%26aulast%3DHamilton%26aufirst%3DT.%2BC.%26aulast%3DNash%26aufirst%3DD.%2BJ.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DWillcocks%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%25204-%2528cyclic%2520amido%2529-2H-1-benzopyrans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D2194%26epage%3D2201%26doi%3D10.1021%2Fjm00161a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macphee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billheimer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothblat, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rader, D. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.105.560177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1161%2FCIRCULATIONAHA.105.560177" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=90-97&author=S.+U.+Naikauthor=X.+Wangauthor=J.+S.+Da+Silvaauthor=M.+Jayeauthor=C.+H.+Macpheeauthor=M.+P.+Reillyauthor=J.+T.+Billheimerauthor=G.+H.+Rothblatauthor=D.+J.+Rader&title=Pharmacological+activation+of+liver+X+receptors+promotes+reverse+cholesterol+transport+in+vivo&doi=10.1161%2FCIRCULATIONAHA.105.560177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.105.560177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.105.560177%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DS.%2BU.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDa%2BSilva%26aufirst%3DJ.%2BS.%26aulast%3DJaye%26aufirst%3DM.%26aulast%3DMacphee%26aufirst%3DC.%2BH.%26aulast%3DReilly%26aufirst%3DM.%2BP.%26aulast%3DBillheimer%26aufirst%3DJ.%2BT.%26aulast%3DRothblat%26aufirst%3DG.%2BH.%26aulast%3DRader%26aufirst%3DD.%2BJ.%26atitle%3DPharmacological%2520activation%2520of%2520liver%2520X%2520receptors%2520promotes%2520reverse%2520cholesterol%2520transport%2520in%2520vivo%26jtitle%3DCirculation%26date%3D2006%26volume%3D113%26spage%3D90%26epage%3D97%26doi%3D10.1161%2FCIRCULATIONAHA.105.560177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repa, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwendner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoolen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelsdorf, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustig, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, B.</span></span> <span> </span><span class="NLM_article-title">Role of LXRs in control of lipogenesis</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2831</span>– <span class="NLM_lpage">2838</span>, <span class="refDoi"> DOI: 10.1101/gad.850400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1101%2Fgad.850400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11090131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2831-2838&author=J.+R.+Schultzauthor=H.+Tuauthor=A.+Lukauthor=J.+J.+Repaauthor=J.+C.+Medinaauthor=L.+Liauthor=S.+Schwendnerauthor=S.+Wangauthor=M.+Thoolenauthor=D.+J.+Mangelsdorfauthor=K.+D.+Lustigauthor=B.+Shan&title=Role+of+LXRs+in+control+of+lipogenesis&doi=10.1101%2Fgad.850400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Role of LXRs in control of lipogenesis</span></div><div class="casAuthors">Schultz, Joshua R.; Tu, Hua; Luk, Alvin; Repa, Joyce J.; Medina, Julio C.; Li, Leping; Schwendner, Susan; Wang, Shelley; Thoolen, Martin; Mangelsdorf, David J.; Lustig, Kevin D.; Shan, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2831-2838</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metab.  The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiol. role of LXR.  Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species.  Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo890ssLC9jpLVg90H21EOLACvtfcHk0ljS5_Q161kEng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ehsLg%253D&md5=85a46e3313f736fe71de7c0da69f51c4</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1101%2Fgad.850400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.850400%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DJ.%2BR.%26aulast%3DTu%26aufirst%3DH.%26aulast%3DLuk%26aufirst%3DA.%26aulast%3DRepa%26aufirst%3DJ.%2BJ.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSchwendner%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DThoolen%26aufirst%3DM.%26aulast%3DMangelsdorf%26aufirst%3DD.%2BJ.%26aulast%3DLustig%26aufirst%3DK.%2BD.%26aulast%3DShan%26aufirst%3DB.%26atitle%3DRole%2520of%2520LXRs%2520in%2520control%2520of%2520lipogenesis%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2831%26epage%3D2838%26doi%3D10.1101%2Fgad.850400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, P. S.</span></span> <span> </span><span class="NLM_article-title">Kinetic properties of the plasma membrane Na<sup>+</sup>-H<sup>+</sup> exchanger</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1146/annurev.ph.47.030185.002553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1146%2Fannurev.ph.47.030185.002553" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1985&pages=545-560&author=P.+S.+Aronson&title=Kinetic+properties+of+the+plasma+membrane+Na%2B-H%2B+exchanger&doi=10.1146%2Fannurev.ph.47.030185.002553"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ph.47.030185.002553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ph.47.030185.002553%26sid%3Dliteratum%253Aachs%26aulast%3DAronson%26aufirst%3DP.%2BS.%26atitle%3DKinetic%2520properties%2520of%2520the%2520plasma%2520membrane%2520Na%252B-H%252B%2520exchanger%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D1985%26volume%3D47%26spage%3D545%26epage%3D560%26doi%3D10.1146%2Fannurev.ph.47.030185.002553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoncu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efeyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">mTOR: from growth signal integration to cancer, diabetes and ageing</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nrm3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrm3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21157483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=21-35&author=R.+Zoncuauthor=A.+Efeyanauthor=D.+M.+Sabatini&title=mTOR%3A+from+growth+signal+integration+to+cancer%2C+diabetes+and+ageing&doi=10.1038%2Fnrm3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR: from growth signal integration to cancer, diabetes and ageing</span></div><div class="casAuthors">Zoncu, Roberto; Efeyan, Alejo; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors.  Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.  In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfHzFJues0NLVg90H21EOLACvtfcHk0ljS5_Q161kEng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK&md5=3631307dc34df2ecc2eb79900c10b74c</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrm3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3025%26sid%3Dliteratum%253Aachs%26aulast%3DZoncu%26aufirst%3DR.%26aulast%3DEfeyan%26aufirst%3DA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DmTOR%253A%2520from%2520growth%2520signal%2520integration%2520to%2520cancer%252C%2520diabetes%2520and%2520ageing%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D21%26epage%3D35%26doi%3D10.1038%2Fnrm3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span>; <span class="NLM_string-name">Cansfield, A.</span>; <span class="NLM_string-name">Niblock, H. S.</span>; <span class="NLM_string-name">Hardy, D.</span>; <span class="NLM_string-name">Scanlon, J. E.</span>; <span class="NLM_string-name">Adrego, R.</span>; <span class="NLM_string-name">Ramsden, N.</span></span> <span> </span><span class="NLM_article-title">4-Morpholin-4-yl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines and Related Compounds as mTOR Inhibitors and Their Preparation and Use for the Treatment of Diseases</span>. International Patent <span class="NLM_patent">WO2010/103094 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=R.+Lynch&author=A.+Cansfield&author=H.+S.+Niblock&author=D.+Hardy&author=J.+E.+Scanlon&author=R.+Adrego&author=N.+Ramsden&title=4-Morpholin-4-yl-6%2C7-dihydro-5H-pyrrolo%5B3%2C4-d%5Dpyrimidines+and+Related+Compounds+as+mTOR+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DR.%26atitle%3D4-Morpholin-4-yl-6%252C7-dihydro-5H-pyrrolo%255B3%252C4-d%255Dpyrimidines%2520and%2520Related%2520Compounds%2520as%2520mTOR%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span>; <span class="NLM_string-name">Cansfield, A.</span>; <span class="NLM_string-name">Niblock, H. S.</span>; <span class="NLM_string-name">Hardy, D.</span>; <span class="NLM_string-name">Taylor, J.</span></span> ((<span> </span><span class="NLM_article-title">Morpholinopyrimidinyl) phenyl) Urea Derivatives as mTOR Inhibitors and Their Preparation and Use for the Treatment of mTOR-Associated Diseases</span>. International Patent <span class="NLM_patent">WO2011/107585 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Lynch&author=A.+Cansfield&author=H.+S.+Niblock&author=D.+Hardy&author=J.+Taylor&title=Morpholinopyrimidinyl%29+phenyl%29+Urea+Derivatives+as+mTOR+Inhibitors+and+Their+Preparation+and+Use+for+the+Treatment+of+mTOR-Associated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DR.%26atitle%3DMorpholinopyrimidinyl%2529%2520phenyl%2529%2520Urea%2520Derivatives%2520as%2520mTOR%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%2520for%2520the%2520Treatment%2520of%2520mTOR-Associated%2520Diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladduwahetty, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruger, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feutrill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rausch, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, G.</span></span> <span> </span><span class="NLM_article-title">CZ415, a highly selective mTOR inhibitor showing in vivo efficacy in a collagen induced arthritis model</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">773</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=768-773&author=A.+D.+Cansfieldauthor=T.+Ladduwahettyauthor=M.+Sunoseauthor=K.+Ellardauthor=R.+Lynchauthor=A.+L.+Newtonauthor=A.+Lewisauthor=G.+Bennettauthor=N.+Zinnauthor=D.+W.+Thomsonauthor=A.+J.+Rugerauthor=J.+T.+Feutrillauthor=O.+Rauschauthor=A.+P.+Wattauthor=G.+Bergamini&title=CZ415%2C+a+highly+selective+mTOR+inhibitor+showing+in+vivo+efficacy+in+a+collagen+induced+arthritis+model&doi=10.1021%2Facsmedchemlett.6b00149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model</span></div><div class="casAuthors">Cansfield, Andrew D.; Ladduwahetty, Tammy; Sunose, Mihiro; Ellard, Katie; Lynch, Rosemary; Newton, Anthea L.; Lewis, Ann; Bennett, Gavin; Zinn, Nico; Thomson, Douglas W.; Ruger, Anne J.; Feutrill, John T.; Rausch, Oliver; Watt, Alan P.; Bergamini, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">768-773</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CZ415, a potent ATP-competitive mTOR inhibitor with unprecedented selectivity over any other kinase is described.  In addn. to a comprehensive characterization of its activities in vitro, in vitro ADME, and in vivo pharmacokinetic data are reported.  The suitability of this inhibitor for studying in vivo mTOR biol. is demonstrated in a mechanistic mouse model monitoring mTOR proximal downstream phosphorylation signaling.  Furthermore, the compd. reported here is the first ATP-competitive mTOR inhibitor described to show efficacy in a semitherapeutic collagen induced arthritis (CIA) mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbe5cXmsLsLVg90H21EOLACvtfcHk0lj-KL154iashw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mtr4%253D&md5=75b75c43427a76438e110251abd052b4</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00149%26sid%3Dliteratum%253Aachs%26aulast%3DCansfield%26aufirst%3DA.%2BD.%26aulast%3DLadduwahetty%26aufirst%3DT.%26aulast%3DSunose%26aufirst%3DM.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DNewton%26aufirst%3DA.%2BL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DG.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DRuger%26aufirst%3DA.%2BJ.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DRausch%26aufirst%3DO.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DBergamini%26aufirst%3DG.%26atitle%3DCZ415%252C%2520a%2520highly%2520selective%2520mTOR%2520inhibitor%2520showing%2520in%2520vivo%2520efficacy%2520in%2520a%2520collagen%2520induced%2520arthritis%2520model%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D768%26epage%3D773%26doi%3D10.1021%2Facsmedchemlett.6b00149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horuk, R.</span></span> <span> </span><span class="NLM_article-title">Targeting CCR1</span>. In  <i>Chemokine Receptors as Drug Targets</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span>, <span class="NLM_string-name">Lira, S. A.</span>, <span class="NLM_string-name">Leurs, R.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">338</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F9783527631995.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=323-338&author=R.+Horukauthor=M.+J.+Smit&author=S.+A.+Lira&author=R.+Leurs&title=Chemokine+Receptors+as+Drug+Targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2F9783527631995.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527631995.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DTargeting%2520CCR1%26btitle%3DChemokine%2520Receptors%2520as%2520Drug%2520Targets%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26pub%3DWiley-VCH%26date%3D2011%26spage%3D323%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santella, J. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncia, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kirk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briceno, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grafstrom, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cvijic, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The discovery of BMS-457, a potent and selective CCR1 antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2013.04.079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3833-3840&author=D.+S.+Gardnerauthor=J.+B.+Santellaauthor=J.+V.+Dunciaauthor=P.+H.+Carterauthor=T.+G.+Dharauthor=H.+Wuauthor=W.+Guoauthor=C.+Cavallaroauthor=K.+Van+Kirkauthor=M.+Yardeauthor=S.+W.+Bricenoauthor=R.+R.+Grafstromauthor=R.+Liuauthor=S.+R.+Patelauthor=A.+J.+Tebbenauthor=D.+Camacauthor=J.+Khanauthor=A.+Watsonauthor=G.+Yangauthor=A.+Roseauthor=W.+R.+Fosterauthor=M.+E.+Cvijicauthor=P.+Daviesauthor=J.+Hynes&title=The+discovery+of+BMS-457%2C+a+potent+and+selective+CCR1+antagonist&doi=10.1016%2Fj.bmcl.2013.04.079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.079%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DD.%2BS.%26aulast%3DSantella%26aufirst%3DJ.%2BB.%26aulast%3DDuncia%26aufirst%3DJ.%2BV.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DCavallaro%26aufirst%3DC.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DBriceno%26aufirst%3DS.%2BW.%26aulast%3DGrafstrom%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DRose%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DW.%2BR.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DHynes%26aufirst%3DJ.%26atitle%3DThe%2520discovery%2520of%2520BMS-457%252C%2520a%2520potent%2520and%2520selective%2520CCR1%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3833%26epage%3D3840%26doi%3D10.1016%2Fj.bmcl.2013.04.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hedl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, C.</span></span> <span> </span><span class="NLM_article-title">Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">26440</span>– <span class="NLM_lpage">26449</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.237495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M111.237495" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=26440-26449&author=M.+Hedlauthor=C.+Abraham&title=Distinct+roles+for+Nod2+protein+and+autocrine+interleukin-1beta+in+muramyl+dipeptide-induced+mitogen-activated+protein+kinase+activation+and+cytokine+secretion+in+human+macrophages&doi=10.1074%2Fjbc.M111.237495"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237495%26sid%3Dliteratum%253Aachs%26aulast%3DHedl%26aufirst%3DM.%26aulast%3DAbraham%26aufirst%3DC.%26atitle%3DDistinct%2520roles%2520for%2520Nod2%2520protein%2520and%2520autocrine%2520interleukin-1beta%2520in%2520muramyl%2520dipeptide-induced%2520mitogen-activated%2520protein%2520kinase%2520activation%2520and%2520cytokine%2520secretion%2520in%2520human%2520macrophages%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D26440%26epage%3D26449%26doi%3D10.1074%2Fjbc.M111.237495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, S.</span></span> <span> </span><span class="NLM_article-title">Convergent synthesis of novel muramyl dipeptide analogues: inhibition of <i>Porphyromonas gingivalis</i>-induced pro-inflammatory effects by high doses of muramyl dipeptide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6878</span>– <span class="NLM_lpage">6890</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00681</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00681" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6878-6890&author=B.+Caiauthor=J.+S.+Panekauthor=S.+Amar&title=Convergent+synthesis+of+novel+muramyl+dipeptide+analogues%3A+inhibition+of+Porphyromonas+gingivalis-induced+pro-inflammatory+effects+by+high+doses+of+muramyl+dipeptide&doi=10.1021%2Facs.jmedchem.6b00681"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00681%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DB.%26aulast%3DPanek%26aufirst%3DJ.%2BS.%26aulast%3DAmar%26aufirst%3DS.%26atitle%3DConvergent%2520synthesis%2520of%2520novel%2520muramyl%2520dipeptide%2520analogues%253A%2520inhibition%2520of%2520Porphyromonas%2520gingivalis-induced%2520pro-inflammatory%2520effects%2520by%2520high%2520doses%2520of%2520muramyl%2520dipeptide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6878%26epage%3D6890%26doi%3D10.1021%2Facs.jmedchem.6b00681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">August, A.</span></span> <span> </span><span class="NLM_article-title">Differential sensitivity to ITK kinase signals for T helper 2 cytokine production and chemokine-mediated migration</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3838</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.6.3833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.4049%2Fjimmunol.180.6.3833" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=3833-3838&author=N.+Sahuauthor=C.+Muellerauthor=A.+Fischerauthor=A.+August&title=Differential+sensitivity+to+ITK+kinase+signals+for+T+helper+2+cytokine+production+and+chemokine-mediated+migration&doi=10.4049%2Fjimmunol.180.6.3833"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.6.3833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.6.3833%26sid%3Dliteratum%253Aachs%26aulast%3DSahu%26aufirst%3DN.%26aulast%3DMueller%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DA.%26aulast%3DAugust%26aufirst%3DA.%26atitle%3DDifferential%2520sensitivity%2520to%2520ITK%2520kinase%2520signals%2520for%2520T%2520helper%25202%2520cytokine%2520production%2520and%2520chemokine-mediated%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D3833%26epage%3D3838%26doi%3D10.4049%2Fjimmunol.180.6.3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookfield, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellebrandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKinnon, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span> <span> </span><span class="NLM_article-title">Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5714</span>– <span class="NLM_lpage">5727</span>, <span class="refDoi"> DOI: 10.1021/jm500550e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500550e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Srtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5714-5727&author=J.+D.+Burchauthor=K.+Lauauthor=J.+J.+Barkerauthor=F.+Brookfieldauthor=Y.+Chenauthor=Y.+Chenauthor=C.+Eigenbrotauthor=C.+Ellebrandtauthor=M.+H.+Ismailiauthor=A.+Johnsonauthor=D.+Kordtauthor=C.+H.+MacKinnonauthor=P.+A.+McEwanauthor=D.+F.+Ortwineauthor=D.+B.+Steinauthor=X.+Wangauthor=D.+Winklerauthor=P.+W.+Yuenauthor=Y.+Zhangauthor=A.+A.+Zarrinauthor=Z.+Pei&title=Property-+and+structure-guided+discovery+of+a+tetrahydroindazole+series+of+interleukin-2+inducible+T-cell+kinase+inhibitors&doi=10.1021%2Fjm500550e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Property- and Structure-Guided Discovery of a Tetrahydroindazole Series of Interleukin-2 Inducible T-Cell Kinase Inhibitors</span></div><div class="casAuthors">Burch, Jason D.; Lau, Kevin; Barker, John J.; Brookfield, Fred; Chen, Yong; Chen, Yuan; Eigenbrot, Charles; Ellebrandt, Claire; Ismaili, M. Hicham A.; Johnson, Adam; Kordt, Daniel; MacKinnon, Colin H.; McEwan, Paul A.; Ortwine, Daniel F.; Stein, Daniel B.; Wang, Xiaolu; Winkler, Dirk; Yuen, Po-Wai; Zhang, Yamin; Zarrin, Ali A.; Pei, Zhonghua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5714-5727</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays a major role in T-cell signaling downstream of the T-cell receptor (TCR), and considerable efforts have been directed toward discovery of ITK-selective inhibitors as potential treatments of inflammatory disorders such as asthma.  Using a previously disclosed indazole series of inhibitors as a starting point, and using x-ray crystallog. and soly. forecast index (SFI) as guides, we evolved a series of tetrahydroindazole inhibitors with improved potency, selectivity, and pharmaceutical properties.  Highlights include identification of a selectivity pocket above the ligand plane, and identification of appropriate lipophilic substituents to occupy this space.  This effort culminated in identification of a potent and selective ITK inhibitor (GNE-9822) with good ADME properties in preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdD-rop1z7rVg90H21EOLACvtfcHk0liHXOulJ75qPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Srtrs%253D&md5=636420d73f6ad55bf5391b6c6aeb3dbd</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm500550e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500550e%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DBrookfield%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllebrandt%26aufirst%3DC.%26aulast%3DIsmaili%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKordt%26aufirst%3DD.%26aulast%3DMacKinnon%26aufirst%3DC.%2BH.%26aulast%3DMcEwan%26aufirst%3DP.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DStein%26aufirst%3DD.%2BB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZarrin%26aufirst%3DA.%2BA.%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DProperty-%2520and%2520structure-guided%2520discovery%2520of%2520a%2520tetrahydroindazole%2520series%2520of%2520interleukin-2%2520inducible%2520T-cell%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5714%26epage%3D5727%26doi%3D10.1021%2Fjm500550e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Torre, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Z.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2448</span>– <span class="NLM_lpage">2452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24767842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2448-2452&author=R.+M.+Pastorauthor=J.+D.+Burchauthor=S.+Magnusonauthor=D.+F.+Ortwineauthor=Y.+Chenauthor=K.+De+La+Torreauthor=X.+Dingauthor=C.+Eigenbrotauthor=A.+Johnsonauthor=M.+Liimattaauthor=Y.+Liuauthor=S.+Shiaauthor=X.+Wangauthor=L.+C.+Wuauthor=Z.+Pei&title=Discovery+and+optimization+of+indazoles+as+potent+and+selective+interleukin-2+inducible+T+cell+kinase+%28ITK%29+inhibitors&doi=10.1016%2Fj.bmcl.2014.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors</span></div><div class="casAuthors">Pastor, Richard M.; Burch, Jason D.; Magnuson, Steven; Ortwine, Daniel F.; Chen, Yuan; De La Torre, Kelly; Ding, Xiao; Eigenbrot, Charles; Johnson, Adam; Liimatta, Marya; Liu, Yichin; Shia, Steven; Wang, Xiaolu; Wu, Lawren C.; Pei, Zhonghua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2448-2452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is evidence that small mol. inhibitors of the nonreceptor tyrosine kinase ITK, a component of the T-cell receptor signaling cascade, could represent a novel asthma therapeutic class.  Moreover, given the expected chronic dosing regimen of any asthma treatment, highly selective as well as potent inhibitors would be strongly preferred in any potential therapeutic.  Here the authors report hit-to-lead optimization of a series of indazoles, e.g. I [R = Et, HOCH2, Me2NCH2CH2, etc.] that demonstrate sub-nanomolar inhibitory potency against ITK with strong cellular activity and good kinase selectivity.  The authors also elucidate the binding mode of these inhibitors by solving the x-ray crystal structures of the complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFUTanEeKSybVg90H21EOLACvtfcHk0liHXOulJ75qPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVWqsr8%253D&md5=e5dbbbfae256bcf2caae83e093f76c65</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DPei%26aufirst%3DZ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520indazoles%2520as%2520potent%2520and%2520selective%2520interleukin-2%2520inducible%2520T%2520cell%2520kinase%2520%2528ITK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2448%26epage%3D2452%26doi%3D10.1016%2Fj.bmcl.2014.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gosens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaagsma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halayko, A. J.</span></span> <span> </span><span class="NLM_article-title">Muscarinic receptor signaling in the pathophysiology of asthma and COPD</span>. <i>Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">73</span>, <span class="refDoi"> DOI: 10.1186/1465-9921-7-73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1186%2F1465-9921-7-73" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16684353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BD28zmvVaqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=73&author=R.+Gosensauthor=J.+Zaagsmaauthor=H.+Meursauthor=A.+J.+Halayko&title=Muscarinic+receptor+signaling+in+the+pathophysiology+of+asthma+and+COPD&doi=10.1186%2F1465-9921-7-73"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptor signaling in the pathophysiology of asthma and COPD</span></div><div class="casAuthors">Gosens Reinoud; Zaagsma Johan; Meurs Herman; Halayko Andrew J</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anticholinergics are widely used for the treatment of COPD, and to a lesser extent for asthma.  Primarily used as bronchodilators, they reverse the action of vagally derived acetylcholine on airway smooth muscle contraction.  Recent novel studies suggest that the effects of anticholinergics likely extend far beyond inducing bronchodilation, as the novel anticholinergic drug tiotropium bromide can effectively inhibit accelerated decline of lung function in COPD patients.  Vagal tone is increased in airway inflammation associated with asthma and COPD; this results from exaggerated acetylcholine release and enhanced expression of downstream signaling components in airway smooth muscle.  Vagally derived acetylcholine also regulates mucus production in the airways.  A number of recent research papers also indicate that acetylcholine, acting through muscarinic receptors, may in part regulate pathological changes associated with airway remodeling.  Muscarinic receptor signalling regulates airway smooth muscle thickening and differentiation, both in vitro and in vivo.  Furthermore, acetylcholine and its synthesizing enzyme, choline acetyl transferase (ChAT), are ubiquitously expressed throughout the airways.  Most notably epithelial cells and inflammatory cells generate acetylcholine, and express functional muscarinic receptors.  Interestingly, recent work indicates the expression and function of muscarinic receptors on neutrophils is increased in COPD.  Considering the potential broad role for endogenous acetylcholine in airway biology, this review summarizes established and novel aspects of muscarinic receptor signaling in relation to the pathophysiology and treatment of asthma and COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7JcCG51YgJwxyojvcjibhfW6udTcc2eb4F97HRgIy5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmvVaqsQ%253D%253D&md5=ec95fb19a9182fc8e1aa55b9e6ec1fbb</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1186%2F1465-9921-7-73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1465-9921-7-73%26sid%3Dliteratum%253Aachs%26aulast%3DGosens%26aufirst%3DR.%26aulast%3DZaagsma%26aufirst%3DJ.%26aulast%3DMeurs%26aufirst%3DH.%26aulast%3DHalayko%26aufirst%3DA.%2BJ.%26atitle%3DMuscarinic%2520receptor%2520signaling%2520in%2520the%2520pathophysiology%2520of%2520asthma%2520and%2520COPD%26jtitle%3DRespir.%2520Res.%26date%3D2006%26volume%3D7%26spage%3D73%26doi%3D10.1186%2F1465-9921-7-73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agoram, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulton, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Entwistle, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel tertiary amine muscarinic M(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6888</span>– <span class="NLM_lpage">6904</span>, <span class="refDoi"> DOI: 10.1021/jm200884j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200884j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6888-6904&author=P.+A.+Glossopauthor=C.+A.+Watsonauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=D.+S.+Middletonauthor=A.+Woodauthor=K.+Jamesauthor=D.+Robertsauthor=R.+S.+Strangauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=N.+P.+Clarkeauthor=M.+A.+Trevethickauthor=I.+Machinauthor=E.+F.+Stuartauthor=S.+M.+Evansauthor=A.+C.+Harrisonauthor=D.+A.+Fairmanauthor=B.+Agoramauthor=J.+L.+Burrowsauthor=N.+Feederauthor=C.+K.+Fultonauthor=B.+R.+Dillonauthor=D.+A.+Entwistleauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+tertiary+amine+muscarinic+M%283%29+receptor+antagonists+with+slow+off-rate+binding+kinetics+for+inhaled+once-daily+treatment+of+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm200884j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm200884j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200884j%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DMachin%26aufirst%3DI.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DEvans%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DA.%2BC.%26aulast%3DFairman%26aufirst%3DD.%2BA.%26aulast%3DAgoram%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DC.%2BK.%26aulast%3DDillon%26aufirst%3DB.%2BR.%26aulast%3DEntwistle%26aufirst%3DD.%2BA.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520tertiary%2520amine%2520muscarinic%2520M%25283%2529%2520receptor%2520antagonists%2520with%2520slow%2520off-rate%2520binding%2520kinetics%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6888%26epage%3D6904%26doi%3D10.1021%2Fjm200884j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipworth, B. J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(05)17708-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0140-6736%2805%2917708-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=167-175&author=B.+J.+Lipworth&title=Phosphodiesterase-4+inhibitors+for+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1016%2FS0140-6736%2805%2917708-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2917708-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252917708-3%26sid%3Dliteratum%253Aachs%26aulast%3DLipworth%26aufirst%3DB.%2BJ.%26atitle%3DPhosphodiesterase-4%2520inhibitors%2520for%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D167%26epage%3D175%26doi%3D10.1016%2FS0140-6736%2805%2917708-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehnart, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehrens, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belevych, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.cell.2005.07.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=25-35&author=S.+E.+Lehnartauthor=X.+H.+Wehrensauthor=S.+Reikenauthor=S.+Warrierauthor=A.+E.+Belevychauthor=R.+D.+Harveyauthor=W.+Richterauthor=S.+L.+Jinauthor=M.+Contiauthor=A.+R.+Marks&title=Phosphodiesterase+4D+deficiency+in+the+ryanodine-receptor+complex+promotes+heart+failure+and+arrhythmias&doi=10.1016%2Fj.cell.2005.07.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DLehnart%26aufirst%3DS.%2BE.%26aulast%3DWehrens%26aufirst%3DX.%2BH.%26aulast%3DReiken%26aufirst%3DS.%26aulast%3DWarrier%26aufirst%3DS.%26aulast%3DBelevych%26aufirst%3DA.%2BE.%26aulast%3DHarvey%26aufirst%3DR.%2BD.%26aulast%3DRichter%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DS.%2BL.%26aulast%3DConti%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DA.%2BR.%26atitle%3DPhosphodiesterase%25204D%2520deficiency%2520in%2520the%2520ryanodine-receptor%2520complex%2520promotes%2520heart%2520failure%2520and%2520arrhythmias%26jtitle%3DCell%26date%3D2005%26volume%3D123%26spage%3D25%26epage%3D35%26doi%3D10.1016%2Fj.cell.2005.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taltavull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavalda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordoba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6912</span>– <span class="NLM_lpage">6922</span>, <span class="refDoi"> DOI: 10.1021/jm100524j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100524j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFehu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6912-6922&author=J.+Taltavullauthor=J.+Serratauthor=J.+Graciaauthor=A.+Gavaldaauthor=M.+Andresauthor=M.+Cordobaauthor=M.+Miralpeixauthor=D.+Vilellaauthor=J.+Beletaauthor=H.+Ryderauthor=L.+Pages&title=Synthesis+and+biological+activity+of+pyrido%5B3%E2%80%B2%2C2%E2%80%B2%3A4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidines+as+phosphodiesterase+type+4+inhibitors&doi=10.1021%2Fjm100524j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Activity of Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors</span></div><div class="casAuthors">Taltavull, Joan; Serrat, Jordi; Gracia, Jordi; Gavalda, Amadeu; Andres, Miriam; Cordoba, Monica; Miralpeix, Montserrat; Vilella, Dolors; Beleta, Jorge; Ryder, Hamish; Pages, Lluis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6912-6922</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines, e.g., I, were synthesized and tested as phosphodiesterase IV inhibitors (PDE4), a target for the treatment of asthma and chronic obstructive pulmonary disease.  Structure-activity relationships within this series, leading to an increase of potency on the enzyme, were presented.  The gem-dimethylcycloalkyl moiety fused to the pyridine ring proved to be a key element of the scaffold in order to get a higher affinity with the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXI_ZU_858PLVg90H21EOLACvtfcHk0ljNPuFWkHkJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFehu7zE&md5=9c0901f43f7471f241a5636f7a39591b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm100524j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100524j%26sid%3Dliteratum%253Aachs%26aulast%3DTaltavull%26aufirst%3DJ.%26aulast%3DSerrat%26aufirst%3DJ.%26aulast%3DGracia%26aufirst%3DJ.%26aulast%3DGavalda%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DPages%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520pyrido%255B3%25E2%2580%25B2%252C2%25E2%2580%25B2%253A4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidines%2520as%2520phosphodiesterase%2520type%25204%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6912%26epage%3D6922%26doi%3D10.1021%2Fjm100524j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keysser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keyszer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromme, D.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">2167</span>– <span class="NLM_lpage">2177</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63068-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0002-9440%2810%2963068-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11733367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2001&pages=2167-2177&author=W.+S.+Houauthor=Z.+Liauthor=R.+E.+Gordonauthor=K.+Chanauthor=M.+J.+Kleinauthor=R.+Levyauthor=M.+Keysserauthor=G.+Keyszerauthor=D.+Bromme&title=Cathepsin+K+is+a+critical+protease+in+synovial+fibroblast-mediated+collagen+degradation&doi=10.1016%2FS0002-9440%2810%2963068-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation</span></div><div class="casAuthors">Hou, Wu-Shiun; Li, Zhenqiang; Gordon, Ronald E.; Chan, Kyle; Klein, Michael J.; Levy, Roger; Keysser, Martin; Keyszer, Gernot; Bromme, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2167-2177</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Synovial fibroblasts (SFs) play a crit. role in the pathogenesis of rheumatoid arthritis (RA) and are directly involved in joint destruction.  Both SF-resident matrix metalloproteases and cathepsins have been implicated in cartilage degrdn. although their identities and individual contributions remain unclear.  The aims of this study were to investigate the expression of cathepsin K in SFs, the correlation between cathepsin K expression and disease severity, and the contribution of cathepsin K to fibroblast-mediated collagen degrdn.  Immunostaining of joint specimens of 21 patients revealed high expression of cathepsin K in SFs in the synovial lining and the stroma of synovial villi, and to a lesser extent in CD68-pos. cells of the synovial lining.  Cathepsin K-pos. SFs were consistently obsd. at sites of cartilage and bone degrdn.  Expression levels of cathepsin K in the sublining and vascularized areas of inflamed synovia showed a highly significant neg. correlation with results derived from the Hannover Functional Capacity Questionnaire (r = 0.78, P = 0.003; and r = 0.70, P = 0.012, resp.) as a measure of the severity of RA in individual patients.  For comparison, there was no correlation between Hannover Functional Capacity Questionnaire and cathepsin S whose expression is limited to CD-68-pos. macrophage-like synoviocytes.  The expression of cathepsin K was also demonstrated in primary cell cultures of RA-SFs.  Co-cultures of SFs on cartilage disks revealed the ability of fibroblast-like cells to phagocytose collagen fibrils whose intralysosomal hydrolysis was prevented in the presence of a potent cathepsin K inhibitor but not by an inhibitor effective against cathepsins L, B, and S.  The selective and crit. role of cathepsin K in articular cartilage and subchondral bone erosion was further corroborated by the finding that cathepsin K has a potent aggrecan-degrading activity and that cathepsin K-generated aggrecan cleavage products specifically potentiate the collagenolytic activity of cathepsin K toward type I and II collagens.  This study demonstrates for the first time a crit. role of cathepsin K in cartilage degrdn. by SFs in RA that is comparable to its well-known activity in osteoclasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlDcWxCV2YYrVg90H21EOLACvtfcHk0lgw021gYLh4qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslaqtQ%253D%253D&md5=63086f32fbd8dbc2d53cd9655dc47bfe</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963068-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963068-4%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGordon%26aufirst%3DR.%2BE.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DM.%2BJ.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DKeysser%26aufirst%3DM.%26aulast%3DKeyszer%26aufirst%3DG.%26aulast%3DBromme%26aufirst%3DD.%26atitle%3DCathepsin%2520K%2520is%2520a%2520critical%2520protease%2520in%2520synovial%2520fibroblast-mediated%2520collagen%2520degradation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D159%26spage%3D2167%26epage%3D2177%26doi%3D10.1016%2FS0002-9440%2810%2963068-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauret, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromlish, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmarais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamontagne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRiche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venuti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span> <span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lgw021gYLh4qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J. M.</span></span> <span> </span><span class="NLM_article-title">Adenain, the adenovirus endoprotease (a review)</span>. <i>Acta Microbiol. Immunol. Hung.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1556/AMicr.50.2003.1.9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1556%2FAMicr.50.2003.1.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2003&pages=95-101&author=J.+M.+Weber&title=Adenain%2C+the+adenovirus+endoprotease+%28a+review%29&doi=10.1556%2FAMicr.50.2003.1.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1556%2FAMicr.50.2003.1.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1556%252FAMicr.50.2003.1.9%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DJ.%2BM.%26atitle%3DAdenain%252C%2520the%2520adenovirus%2520endoprotease%2520%2528a%2520review%2529%26jtitle%3DActa%2520Microbiol.%2520Immunol.%2520Hung.%26date%3D2003%26volume%3D50%26spage%3D95%26epage%3D101%26doi%3D10.1556%2FAMicr.50.2003.1.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greber, U. F.</span></span> <span> </span><span class="NLM_article-title">Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor</span>. <i>Rev. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1099-1654(1998100)8:4<213::AID-RMV225>3.0.CO;2-W</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10398510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Kgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=213-222&author=U.+F.+Greber&title=Virus+assembly+and+disassembly%3A+the+adenovirus+cysteine+protease+as+a+trigger+factor&doi=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor</span></div><div class="casAuthors">Greber, Urs F.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Medical Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">RMVIEW</span>;
        ISSN:<span class="NLM_cas:issn">1052-9276</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  Viruses are efficient carriers of genetic material between cells.  They specifically recognize a target cell and utilize host functions for genome delivery to the replication site.  A mature viral capsid emerging from an infected cell serves at least three distinct functions.  It enables virus egress from the infected cell, protects the extracellular genome against chem. and phys. stress and mediates virus entry into a non-infected cell.  How can a virus particle be stably assembled in an infected cell and moments later-after passing through the extracellular milieu-be disintegrated by a non-infected cell.  The author discusses how adenovirus, a DNA virus, recruits cellular and viral factors and makes use of its own cysteine protease to regulate capsid assembly and disassembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqwF0ihoa137Vg90H21EOLACvtfcHk0liIl83QcTXASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Kgug%253D%253D&md5=c3e5f8b97468d05a7f7d577c07a3bec2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1654%25281998100%25298%253A4%253C213%253A%253AAID-RMV225%253E3.0.CO%253B2-W%26sid%3Dliteratum%253Aachs%26aulast%3DGreber%26aufirst%3DU.%2BF.%26atitle%3DVirus%2520assembly%2520and%2520disassembly%253A%2520the%2520adenovirus%2520cysteine%2520protease%2520as%2520a%2520trigger%2520factor%26jtitle%3DRev.%2520Med.%2520Virol.%26date%3D1998%26volume%3D8%26spage%3D213%26epage%3D222%26doi%3D10.1002%2F%28SICI%291099-1654%281998100%298%3A4%3C213%3A%3AAID-RMV225%3E3.0.CO%3B2-W" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grosche, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirockin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combrink, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarousse, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, E.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and optimization of potent inhibitors of the adenoviral protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.12.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=438-443&author=P.+Groscheauthor=F.+Sirockinauthor=A.+Mac+Sweeneyauthor=P.+Ramageauthor=P.+Erbelauthor=S.+Melkkoauthor=A.+Bernardiauthor=N.+Hughesauthor=D.+Ellisauthor=K.+D.+Combrinkauthor=N.+Jarousseauthor=E.+Altmann&title=Structure-based+design+and+optimization+of+potent+inhibitors+of+the+adenoviral+protease&doi=10.1016%2Fj.bmcl.2014.12.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGrosche%26aufirst%3DP.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DCombrink%26aufirst%3DK.%2BD.%26aulast%3DJarousse%26aufirst%3DN.%26aulast%3DAltmann%26aufirst%3DE.%26atitle%3DStructure-based%2520design%2520and%2520optimization%2520of%2520potent%2520inhibitors%2520of%2520the%2520adenoviral%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D438%26epage%3D443%26doi%3D10.1016%2Fj.bmcl.2014.12.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallongeville, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auwerx, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonjans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitersdorf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2088</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.98.19.2088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1161%2F01.CIR.98.19.2088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=9808609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=2088-2093&author=B.+Staelsauthor=J.+Dallongevilleauthor=J.+Auwerxauthor=K.+Schoonjansauthor=E.+Leitersdorfauthor=J.+C.+Fruchart&title=Mechanism+of+action+of+fibrates+on+lipid+and+lipoprotein+metabolism&doi=10.1161%2F01.CIR.98.19.2088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action of fibrates on lipid and lipoprotein metabolism</span></div><div class="casAuthors">Staels, Bart; Dallongeville, Jean; Auwerx, Johan; Schoonjans, Kristina; Leitersdorf, Eran; Fruchart, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2088-2093</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 78 refs.  Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually assocd. with a moderate decrease in LDL cholesterol and an increase in HDL cholesterol concns.  Recent investigations indicate that the effects of fibrates are mediated, at least in part, through alterations in transcription of genes encoding for proteins that control lipoprotein metab.  Fibrates activate specific transcription factors belonging to the nuclear hormone receptor superfamily, termed peroxisome proliferator-activated receptors (PPARs).  The PPAR-α form mediates fibrate action on HDL cholesterol levels via transcriptional induction of synthesis of the major HDL apolipoproteins, apoA-I and apoA-II.  Fibrates lower hepatic apoC-III prodn. and increase lipoprotein lipase-mediated lipolysis via PPAR.  Fibrates stimulate cellular fatty acid uptake, conversion to acyl-CoA derivs., and catabolism by the β-oxidn. pathways, which, combined with a redn. in fatty acid and triglyceride synthesis, results in a decrease in VLDL prodn.  In summary, both enhanced catabolism of triglyceride-rich particles and reduced secretion of VLDL underlie the hypotriglyceridemic effect of fibrates, whereas their effect on HDL metab. is assocd. with changes in HDL apolipoprotein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohY0hG-dzaaLVg90H21EOLACvtfcHk0lhXJyeSTuqCqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCisr8%253D&md5=79c83a6524388cfa813c633fdbffc720</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.98.19.2088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.98.19.2088%26sid%3Dliteratum%253Aachs%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDallongeville%26aufirst%3DJ.%26aulast%3DAuwerx%26aufirst%3DJ.%26aulast%3DSchoonjans%26aufirst%3DK.%26aulast%3DLeitersdorf%26aufirst%3DE.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26atitle%3DMechanism%2520of%2520action%2520of%2520fibrates%2520on%2520lipid%2520and%2520lipoprotein%2520metabolism%26jtitle%3DCirculation%26date%3D1998%26volume%3D98%26spage%3D2088%26epage%3D2093%26doi%3D10.1161%2F01.CIR.98.19.2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorp, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, W. S.</span></span> <span> </span><span class="NLM_article-title">Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1038/194948a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2F194948a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=1962&pages=948-949&author=J.+M.+Thorpauthor=W.+S.+Waring&title=Modification+of+metabolism+and+distribution+of+lipids+by+ethyl+chlorophenoxyisobutyrate&doi=10.1038%2F194948a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2F194948a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F194948a0%26sid%3Dliteratum%253Aachs%26aulast%3DThorp%26aufirst%3DJ.%2BM.%26aulast%3DWaring%26aufirst%3DW.%2BS.%26atitle%3DModification%2520of%2520metabolism%2520and%2520distribution%2520of%2520lipids%2520by%2520ethyl%2520chlorophenoxyisobutyrate%26jtitle%3DNature%26date%3D1962%26volume%3D194%26spage%3D948%26epage%3D949%26doi%3D10.1038%2F194948a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drago, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroetz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Salguero, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3022</span>, <span class="refDoi"> DOI: 10.1128/MCB.15.6.3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1128%2FMCB.15.6.3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=7539101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXlslyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3012-3022&author=S.+S.+Leeauthor=T.+Pineauauthor=J.+Dragoauthor=E.+J.+Leeauthor=J.+W.+Owensauthor=D.+L.+Kroetzauthor=P.+M.+Fernandez-Salgueroauthor=H.+Westphalauthor=F.+J.+Gonzalez&title=Targeted+disruption+of+the+alpha+isoform+of+the+peroxisome+proliferator-activated+receptor+gene+in+mice+results+in+abolishment+of+the+pleiotropic+effects+of+peroxisome+proliferators&doi=10.1128%2FMCB.15.6.3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators</span></div><div class="casAuthors">Lee, Susanna S.-T.; Pineau, Thierry; Drago, John; Lee, Eric J.; Owens, Jennie W.; Kroetz, Deanna L.; Fernandez-Salguero, Pedro M.; Westphal, Heiner; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3012-22</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To gain insight into the function of peroxisome proliferator-activated receptor (PPAR) isoforms in rodents, we disrupted the ligand-binding domain of the α isoform of mouse PPAR (mPPARα) by homologous recombination.  Mice homozygous for the mutation lack expression of mPPARα protein and yet are viable and fertile and exhibit no detectable gross phenotypic defects.  Remarkably, these animals do not display the peroxisome proliferator pleiotropic response when challenged with the classical peroxisome proliferators, clofibrate and Wy-14,643.  Following exposure to these chems., hepatomegaly, peroxisome proliferation, and transcriptional activation of target genes were not obsd.  These results clearly demonstrate that mPPARα is the major isoform required for mediating the pleiotropic response resulting from the actions of peroxisome proliferators.  MPPARα-deficient animals should prove useful to further investigate the role of this receptor in hepatocarcinogenesis, fatty acid metab., and cell cycle regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmuvZOaH07Vg90H21EOLACvtfcHk0lgrRhQUdZn66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslyit70%253D&md5=9a0485489134ea86cd92e3e1a7eb8431</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1128%2FMCB.15.6.3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.15.6.3012%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BS.%26aulast%3DPineau%26aufirst%3DT.%26aulast%3DDrago%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DE.%2BJ.%26aulast%3DOwens%26aufirst%3DJ.%2BW.%26aulast%3DKroetz%26aufirst%3DD.%2BL.%26aulast%3DFernandez-Salguero%26aufirst%3DP.%2BM.%26aulast%3DWestphal%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520alpha%2520isoform%2520of%2520the%2520peroxisome%2520proliferator-activated%2520receptor%2520gene%2520in%2520mice%2520results%2520in%2520abolishment%2520of%2520the%2520pleiotropic%2520effects%2520of%2520peroxisome%2520proliferators%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1995%26volume%3D15%26spage%3D3012%26epage%3D3022%26doi%3D10.1128%2FMCB.15.6.3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matzkies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, G.</span></span> <span> </span><span class="NLM_article-title">Procetofen, a new lipid- and urine-acid-reducing substance</span>. <i>Fortschr. Med.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">1939</span>– <span class="NLM_lpage">1941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=700582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaE1M%252FisFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1978&pages=1939-1941&author=F.+Matzkiesauthor=D.+Schulzkyauthor=G.+Berg&title=Procetofen%2C+a+new+lipid-+and+urine-acid-reducing+substance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Procetofen, a new lipid- and urine-acid-reducing substance</span></div><div class="casAuthors">Matzkies F; Schulzky D; Berg G</div><div class="citationInfo"><span class="NLM_cas:title">Fortschritte der Medizin</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">1939-41</span>
        ISSN:<span class="NLM_cas:issn">0015-8178</span>.
    </div><div class="casAbstract">23 patients with different forms of hyperlipidemias received procetofen (3 X 100 mg/day) over a period of fourteen days.  The cholesterol concentration in blood showed a significant reduction from 322 +/- 30 mg/dl to 227 +/- 37 mg/dl, triglycerides dropped from 221 +/- 84 mg/dl to 129 +/- 34 mg/dl and uric acid diminished from 6,1 +/- 1,4 mg/dl to 4,6 +/- 0,8 mg/dl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ41fTQ3ZZ6EuWhZTslLrfffW6udTcc2ebUZ2gnVcoVhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FisFyrsg%253D%253D&md5=3d1304a47ca8a8ff66e892e868fa93be</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatzkies%26aufirst%3DF.%26aulast%3DSchulzky%26aufirst%3DD.%26aulast%3DBerg%26aufirst%3DG.%26atitle%3DProcetofen%252C%2520a%2520new%2520lipid-%2520and%2520urine-acid-reducing%2520substance%26jtitle%3DFortschr.%2520Med.%26date%3D1978%26volume%3D96%26spage%3D1939%26epage%3D1941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creger, P.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moersch, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuklis, W. A.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of gemfibrozil (CI-719) and related compounds</span>. <i>Proc. R. Soc. Med.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1976&pages=3-5&issue=Suppl.+2&author=P.%0AL.+Cregerauthor=G.+W.+Moerschauthor=W.+A.+Neuklis&title=Structure-activity+relationship+of+gemfibrozil+%28CI-719%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreger%26aufirst%3DP.%2BL.%26aulast%3DMoersch%26aufirst%3DG.%2BW.%26aulast%3DNeuklis%26aufirst%3DW.%2BA.%26atitle%3DStructure-activity%2520relationship%2520of%2520gemfibrozil%2520%2528CI-719%2529%2520and%2520related%2520compounds%26jtitle%3DProc.%2520R.%2520Soc.%2520Med.%26date%3D1976%26volume%3D69%26issue%3DSuppl.%25202%26spage%3D3%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boullay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forest, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchet, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellibert, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillot, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laroze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Grumelec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linget, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penfornis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pianetti, P. M.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. discovery of a novel series of potent HDLc raising agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/jm058056x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058056x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=685-695&author=M.+L.+Sierraauthor=V.+Benetonauthor=A.+B.+Boullayauthor=T.+Boyerauthor=A.+G.+Brewsterauthor=F.+Doncheauthor=M.+C.+Forestauthor=M.+H.+Fouchetauthor=F.+J.+Gellibertauthor=D.+A.+Grillotauthor=M.+H.+Lambertauthor=A.+Larozeauthor=C.+Le+Grumelecauthor=J.+M.+Lingetauthor=V.+G.+Montanaauthor=V.+L.+Nguyenauthor=E.+Nicodemeauthor=V.+Patelauthor=A.+Penfornisauthor=O.+Pineauauthor=D.+Pohinauthor=F.+Potvainauthor=G.+Poulainauthor=C.+B.+Ruaultauthor=M.+Saundersauthor=J.+Toumauthor=H.+E.+Xuauthor=R.+X.+Xuauthor=P.+M.+Pianetti&title=Substituted+2-%5B%284-aminomethyl%29phenoxy%5D-2-methylpropionic+acid+PPARalpha+agonists.+1.+discovery+of+a+novel+series+of+potent+HDLc+raising+agents&doi=10.1021%2Fjm058056x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents</span></div><div class="casAuthors">Sierra, Michael L.; Beneton, Veronique; Boullay, Anne-Benedict; Boyer, Thierry; Brewster, Andrew G.; Donche, Frederic; Forest, Marie-Claire; Fouchet, Marie-Helene; Gellibert, Francoise J.; Grillot, Didier A.; Lambert, Millard H.; Laroze, Alain; Le Grumelec, Christelle; Linget, Jean Michel; Montana, Valerie G.; Nguyen, Van-Loc; Nicodeme, Edwige; Patel, Vipul; Penfornis, Annie; Pineau, Olivier; Pohin, Danig; Potvain, Florent; Poulain, Geraldine; Ruault, Cecile Bertho; Saunders, Michael; Toum, Jerome; Xu, H. Eric; Xu, Robert X.; Pianetti, Pascal M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peroxisome proliferator activated receptors PPARα, PPARγ, and PPARδ are ligand-activated transcription factors that play a key role in lipid homeostasis.  The fibrates raise circulating levels of high-d. lipoprotein cholesterol and lower levels of triglycerides in part through their activity as PPARα agonists; however, the low potency and restricted selectivity of the fibrates may limit their efficacy, and it would be desirable to develop more potent and selective PPARα agonists.  Modification of the selective PPARδ agonist 1 (GW501516) so as to incorporate the 2-aryl-2-methylpropionic acid group of the fibrates led to a marked shift in potency and selectivity toward PPARα agonism.  Optimization of the series gave 25a, which shows EC50 = 4 nM on PPARα and at least 500-fold selectivity vs. PPARδ and PPARγ.  Compd. 25a (GW590735) has been progressed to clin. trials for the treatment of diseases of lipid imbalance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPdGikEnfYWrVg90H21EOLACvtfcHk0lgdFxzUYxNltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wgtw%253D%253D&md5=6ee61f7619db5025c20ff2ff83c7ba71</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm058056x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058056x%26sid%3Dliteratum%253Aachs%26aulast%3DSierra%26aufirst%3DM.%2BL.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoyer%26aufirst%3DT.%26aulast%3DBrewster%26aufirst%3DA.%2BG.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DForest%26aufirst%3DM.%2BC.%26aulast%3DFouchet%26aufirst%3DM.%2BH.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DGrillot%26aufirst%3DD.%2BA.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DLaroze%26aufirst%3DA.%26aulast%3DLe%2BGrumelec%26aufirst%3DC.%26aulast%3DLinget%26aufirst%3DJ.%2BM.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DPenfornis%26aufirst%3DA.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DPohin%26aufirst%3DD.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DRuault%26aufirst%3DC.%2BB.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DXu%26aufirst%3DR.%2BX.%26aulast%3DPianetti%26aufirst%3DP.%2BM.%26atitle%3DSubstituted%25202-%255B%25284-aminomethyl%2529phenoxy%255D-2-methylpropionic%2520acid%2520PPARalpha%2520agonists.%25201.%2520discovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520HDLc%2520raising%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D685%26epage%3D695%26doi%3D10.1021%2Fjm058056x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montana, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80467-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS1097-2765%2800%2980467-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10198642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1999&pages=397-403&author=H.+E.+Xuauthor=M.+H.+Lambertauthor=V.+G.+Montanaauthor=D.+J.+Parksauthor=S.+G.+Blanchardauthor=P.+J.+Brownauthor=D.+D.+Sternbachauthor=J.+M.+Lehmannauthor=G.+B.+Wiselyauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+V.+Milburn&title=Molecular+recognition+of+fatty+acids+by+peroxisome+proliferator-activated+receptors&doi=10.1016%2FS1097-2765%2800%2980467-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of fatty acids by peroxisome proliferator-activated receptors</span></div><div class="casAuthors">Xu, H. Eric; Lambert, Millard H.; Montana, Valerie G.; Parks, Derek J.; Blanchard, Steven G.; Brown, Peter J.; Sternbach, Daniel D.; Lehmann, Jurgen M.; Wisely, G. Bruce; Willson, Timothy M.; Kliewer, Steven A.; Milburn, Michael V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids (FAs) that regulate glucose and lipid homeostasis.  We report the crystal structure of the PPARδ ligand-binding domain (LBD) bound to either the FA eicosapentaenoic acid (EPA) or the synthetic fibrate GW2433.  The carboxylic acids of EPA and GW2433 interact directly with the activation function 2 (AF-2) helix.  The hydrophobic tail of EPA adopts two distinct conformations within the large hydrophobic cavity.  GW2433 occupies essentially the same space as EPA bound in both conformations.  These structures provide mol. insight into the propensity for PPARs to interact with a variety of synthetic and natural compds., including FAs that vary in both chain length and degree of satn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMNTuvvB2z5LVg90H21EOLACvtfcHk0lgdFxzUYxNltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit1OmsLY%253D&md5=890b5f9178bbe6ceb4959a069889fc5c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980467-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980467-0%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DMontana%26aufirst%3DV.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26atitle%3DMolecular%2520recognition%2520of%2520fatty%2520acids%2520by%2520peroxisome%2520proliferator-activated%2520receptors%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D3%26spage%3D397%26epage%3D403%26doi%3D10.1016%2FS1097-2765%2800%2980467-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charo, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, L. A.</span></span> <span> </span><span class="NLM_article-title">The platelet membrane glycoprotein IIb-IIIa complex</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1988&pages=831-843&author=D.+R.+Phillipsauthor=I.+F.+Charoauthor=L.+V.+Pariseauthor=L.+A.+Fitzgerald&title=The+platelet+membrane+glycoprotein+IIb-IIIa+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DParise%26aufirst%3DL.%2BV.%26aulast%3DFitzgerald%26aufirst%3DL.%2BA.%26atitle%3DThe%2520platelet%2520membrane%2520glycoprotein%2520IIb-IIIa%2520complex%26jtitle%3DBlood%26date%3D1988%26volume%3D71%26spage%3D831%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tachiki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asari, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span> <span> </span><span class="NLM_article-title">GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2345</span>– <span class="NLM_lpage">2360</span>, <span class="refDoi"> DOI: 10.1021/jm980126v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980126v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2345-2360&author=Y.+Hayashiauthor=J.+Katadaauthor=T.+Haradaauthor=A.+Tachikiauthor=K.+Iijimaauthor=Y.+Takiguchiauthor=M.+Muramatsuauthor=H.+Miyazakiauthor=T.+Asariauthor=T.+Okazakiauthor=Y.+Satoauthor=E.+Yasudaauthor=M.+Yanoauthor=I.+Unoauthor=I.+Ojima&title=GPIIb%2FIIIa+integrin+antagonists+with+the+new+conformational+restriction+unit%2C+trisubstituted+beta-amino+acid+derivatives%2C+and+a+substituted+benzamidine+structure&doi=10.1021%2Fjm980126v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fjm980126v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980126v%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKatada%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DTachiki%26aufirst%3DA.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DTakiguchi%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DAsari%26aufirst%3DT.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DM.%26aulast%3DUno%26aufirst%3DI.%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DGPIIb%252FIIIa%2520integrin%2520antagonists%2520with%2520the%2520new%2520conformational%2520restriction%2520unit%252C%2520trisubstituted%2520beta-amino%2520acid%2520derivatives%252C%2520and%2520a%2520substituted%2520benzamidine%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2345%26epage%3D2360%26doi%3D10.1021%2Fjm980126v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E.</span></span> <span> </span><span class="NLM_article-title">Cationic host defense (antimicrobial) peptides</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.coi.2005.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.coi.2005.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16337365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=24-30&author=K.+L.+Brownauthor=R.+E.+Hancock&title=Cationic+host+defense+%28antimicrobial%29+peptides&doi=10.1016%2Fj.coi.2005.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic host defense (antimicrobial) peptides</span></div><div class="casAuthors">Brown, Kelly L.; Hancock, Robert EW</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-30</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the cationic host defense (antimicrobial) peptide family are widely distributed in nature, existing in organisms from insects to plants to mammals and non-mammalian vertebrates.  Although many demonstrate direct antimicrobial activity against bacteria, fungi, eukaryotic parasites and/or viruses, it has been established that cationic peptides have a key modulatory role in the innate immune response.  More recent evidence suggests that host defense peptides are effective adjuvants, are synergistic with other immune effectors, polarize the adaptive response, and support wound healing.  In addn., the mechanisms of action are being unraveled, which support more effective implementation of derivs. of these endogenous peptides as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqD-PAvdCM7Vg90H21EOLACvtfcHk0lgZNx5u1fnp3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOhtQ%253D%253D&md5=a1634204d5a2b5ea3c6170ece8268ef6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2005.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2005.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%2BL.%26aulast%3DHancock%26aufirst%3DR.%2BE.%26atitle%3DCationic%2520host%2520defense%2520%2528antimicrobial%2529%2520peptides%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2006%26volume%3D18%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.coi.2005.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bally, M. B.</span></span> <span> </span><span class="NLM_article-title">In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and P-glycoprotein over-expressing tumor cell lines</span>. <i>Anti-Cancer Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10901303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=151-160&author=S.+A.+Johnstoneauthor=K.+Gelmonauthor=L.+D.+Mayerauthor=R.+E.+Hancockauthor=M.+B.+Bally&title=In+vitro+characterization+of+the+anticancer+activity+of+membrane-active+cationic+peptides.+I.+peptide-mediated+cytotoxicity+and+peptide-enhanced+cytotoxic+activity+of+doxorubicin+against+wild-type+and+P-glycoprotein+over-expressing+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines</span></div><div class="casAuthors">Johnstone, Sharon A.; Gelmon, Karen; Mayer, Lawrence D.; Hancock, Robert E.; Bally, Marcel B.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Cationic amphipathic peptides, such as the defensins and cecropins, induce cell death in prokaryotic and eukaryotic cells by increasing membrane permeability.  Increased permeability may lead to cell lysis or, alternatively, may produce subtle changes in the membrane's barrier function that promote cell death.  The in vitro cytotoxic and lytic activity of short mammalian-derived extended-helical cationic peptides and insect-derived alpha-helical peptides was measured in this study with the objective of establishing the anticancer potential of these agents.  Two specific aims were addressed: (i) to assess the activity of peptides against non-malignant cells (sheep erythrocytes and human umbilical vein endothelial cells) vs. tumor cells; and (ii) to characterize the cytotoxic activity using multidrug-resistant tumor cell lines in the presence and absence of the anthracycline doxorubicin.  Cell lysis assays demonstrated that the lytic activity of the peptides tested was 2->50 times more cytotoxic to tumor cells than to non-malignant cells.  Further, the cytotoxic activity of these peptides was equiv. when tested against sensitive and multidrug-resistant cell lines.  In addn. to their inherent cytotoxic activity, these membrane-active peptides can also augment the in vitro cytotoxic activity of doxorubicin against multidrug-resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7mmlTM9IH7Vg90H21EOLACvtfcHk0lgrTSFedRZOuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVymsb4%253D&md5=da07329282b9fa4418273bcb2cfefacd</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DS.%2BA.%26aulast%3DGelmon%26aufirst%3DK.%26aulast%3DMayer%26aufirst%3DL.%2BD.%26aulast%3DHancock%26aufirst%3DR.%2BE.%26aulast%3DBally%26aufirst%3DM.%2BB.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520the%2520anticancer%2520activity%2520of%2520membrane-active%2520cationic%2520peptides.%2520I.%2520peptide-mediated%2520cytotoxicity%2520and%2520peptide-enhanced%2520cytotoxic%2520activity%2520of%2520doxorubicin%2520against%2520wild-type%2520and%2520P-glycoprotein%2520over-expressing%2520tumor%2520cell%2520lines%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2000%26volume%3D15%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karle, I. L.</span></span> <span> </span><span class="NLM_article-title">Flexibility in peptide molecules and restraints imposed by hydrogen bonds, the Aib residue, and core inserts</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(1996)40:1<157::AID-BIP7>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=157-180&author=I.+L.+Karle&title=Flexibility+in+peptide+molecules+and+restraints+imposed+by+hydrogen+bonds%2C+the+Aib+residue%2C+and+core+inserts&doi=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%25281996%252940%253A1%253C157%253A%253AAID-BIP7%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DKarle%26aufirst%3DI.%2BL.%26atitle%3DFlexibility%2520in%2520peptide%2520molecules%2520and%2520restraints%2520imposed%2520by%2520hydrogen%2520bonds%252C%2520the%2520Aib%2520residue%252C%2520and%2520core%2520inserts%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D40%26spage%3D157%26epage%3D180%26doi%3D10.1002%2F%28SICI%291097-0282%281996%2940%3A1%3C157%3A%3AAID-BIP7%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karle, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaram, P.</span></span> <span> </span><span class="NLM_article-title">Structural characteristics of alpha-helical peptide molecules containing Aib residues</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">6747</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/bi00481a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00481a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3cXksFCnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=6747-6756&author=I.+L.+Karleauthor=P.+Balaram&title=Structural+characteristics+of+alpha-helical+peptide+molecules+containing+Aib+residues&doi=10.1021%2Fbi00481a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characteristics of α-helical peptide molecules containing Aib residues</span></div><div class="casAuthors">Karle, Isabella L.; Balaram, Padmanabhan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6747-56</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A review and discussion with 45 refs.  α-Aminoisobutyric acid (Aib) is a common residue in microbial proteins.  Replacement of the proton on the Cα atom of alanine with a Me group severely restricts the possible rotations about the N-Cα and Cα-C bonds.  Aib readily fits into right- and left-handed α and 310 helixes and stabilizes helical peptide conformation; thus, Aib is useful for construction of stereochem. rigid helical segments.  The effects of Aib residue no. and position on helix formation, hydrogen bonding, and water of hydration in Aib-contg. helical peptides are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-mpabYAClhLVg90H21EOLACvtfcHk0lgPeHke7XFQxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksFCnsr4%253D&md5=544835633a23c2fb27572c10be14c114</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fbi00481a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00481a001%26sid%3Dliteratum%253Aachs%26aulast%3DKarle%26aufirst%3DI.%2BL.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DStructural%2520characteristics%2520of%2520alpha-helical%2520peptide%2520molecules%2520containing%2520Aib%2520residues%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D6747%26epage%3D6756%26doi%3D10.1021%2Fbi00481a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moretto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formaggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaptein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broxterman, Q. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toniolo, C.</span></span> <span> </span><span class="NLM_article-title">Turn stabilization in short peptides by C(alpha)-methylated alpha-amino acids</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1002/bip.20181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fbip.20181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=279-293&author=M.+Crismaauthor=A.+Morettoauthor=M.+De+Zottiauthor=F.+Formaggioauthor=B.+Kapteinauthor=Q.+B.+Broxtermanauthor=C.+Toniolo&title=Turn+stabilization+in+short+peptides+by+C%28alpha%29-methylated+alpha-amino+acids&doi=10.1002%2Fbip.20181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fbip.20181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20181%26sid%3Dliteratum%253Aachs%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DMoretto%26aufirst%3DA.%26aulast%3DDe%2BZotti%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DKaptein%26aufirst%3DB.%26aulast%3DBroxterman%26aufirst%3DQ.%2BB.%26aulast%3DToniolo%26aufirst%3DC.%26atitle%3DTurn%2520stabilization%2520in%2520short%2520peptides%2520by%2520C%2528alpha%2529-methylated%2520alpha-amino%2520acids%26jtitle%3DBiopolymers%26date%3D2005%26volume%3D80%26spage%3D279%26epage%3D293%26doi%3D10.1002%2Fbip.20181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammill, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drory, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gussio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunger, A. T.</span></span> <span> </span><span class="NLM_article-title">Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e11378</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0011378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1371%2Fjournal.pone.0011378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e11378&author=J.+E.+Zunigaauthor=J.+T.+Hammillauthor=O.+Droryauthor=J.+E.+Nussauthor=J.+C.+Burnettauthor=R.+Gussioauthor=P.+Wipfauthor=S.+Bavariauthor=A.+T.+Brunger&title=Iterative+structure-based+peptide-like+inhibitor+design+against+the+botulinum+neurotoxin+serotype+A&doi=10.1371%2Fjournal.pone.0011378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011378%26sid%3Dliteratum%253Aachs%26aulast%3DZuniga%26aufirst%3DJ.%2BE.%26aulast%3DHammill%26aufirst%3DJ.%2BT.%26aulast%3DDrory%26aufirst%3DO.%26aulast%3DNuss%26aufirst%3DJ.%2BE.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26atitle%3DIterative%2520structure-based%2520peptide-like%2520inhibitor%2520design%2520against%2520the%2520botulinum%2520neurotoxin%2520serotype%2520A%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De11378%26doi%3D10.1371%2Fjournal.pone.0011378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dartois, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: hit to lead optimization of new antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5116</span>– <span class="NLM_lpage">5130</span>, <span class="refDoi"> DOI: 10.1021/jm2003359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2003359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5116-5130&author=T.+Wuauthor=A.+Nagleauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=A.+Gohauthor=S.+B.+Lakshminarayanaauthor=J.+Wuauthor=H.+Q.+Angauthor=P.+Zengauthor=M.+L.+Kangauthor=W.+Tanauthor=M.+Tanauthor=N.+Yeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=C.+Fischliauthor=R.+Brunauthor=M.+Rottmannauthor=V.+Dartoisauthor=T.+Kellerauthor=T.+Diaganaauthor=E.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+hit+to+lead+optimization+of+new+antimalarial+agents&doi=10.1021%2Fjm2003359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents</span></div><div class="casAuthors">Wu, Tao; Nagle, Advait; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Goh, Anne; Lakshminarayana, Suresh B.; Wu, Jeanette; Ang, Hui Qing; Zeng, Peiting; Kang, Min Low; Tan, William; Tan, Maria; Ye, Nicole; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Fischli, Christoph; Brun, Reto; Rottmann, Matthias; Dartois, Veronique; Keller, Thomas; Diagana, Thierry; Winzeler, Elizabeth; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5116-5130</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from a hit series from a GNF compd. library collection and based on a cell-based proliferation assay of Plasmodium falciparum, a novel imidazolopiperazine scaffold was optimized.  SAR for this series of compds. is discussed, focusing on optimization of cellular potency against wild-type and drug resistant parasites and improvement of physiochem. and pharmacokinetic properties.  The lead compds. in this series showed good potencies in vitro and decent oral exposure levels in vivo.  In a Plasmodium berghei mouse infection model, one lead compd. lowered the parasitemia level by 99.4% after administration of 100 mg/kg single oral dose and prolonged mice survival by an av. of 17.0 days.  The lead compds. were also well-tolerated in the preliminary in vitro toxicity studies and represents an interesting lead for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaD1QipkA-QLVg90H21EOLACvtfcHk0lhxT_Q-frcGTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFags7s%253D&md5=eab02c18fda60302ffbcc581256cf149</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm2003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003359%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DH.%2BQ.%26aulast%3DZeng%26aufirst%3DP.%26aulast%3DKang%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520hit%2520to%2520lead%2520optimization%2520of%2520new%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5116%26epage%3D5130%26doi%3D10.1021%2Fjm2003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: lead optimization of the second-generation antimalarial agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4244</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/jm300041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4244-4273&author=A.+Nagleauthor=T.+Wuauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=B.+Liuauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=T.+Chuanauthor=P.+B.+Alperauthor=C.+Fischliauthor=R.+Brunauthor=S.+B.+Lakshminarayanaauthor=M.+Rottmannauthor=T.+T.+Diaganaauthor=E.+A.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+lead+optimization+of+the+second-generation+antimalarial+agents&doi=10.1021%2Fjm300041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents</span></div><div class="casAuthors">Nagle, Advait; Wu, Tao; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Liu, Bo; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Chuan, Tiffany; Alper, Philip B.; Fischli, Christoph; Brun, Reto; Lakshminarayana, Suresh B.; Rottmann, Matthias; Diagana, Thierry T.; Winzeler, Elizabeth A.; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4244-4273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the initial success of optimization of a novel series of imidazolopiperazines, a second generation of compds. involving changes in the core piperazine ring was synthesized to improve antimalarial properties.  These changes were carried out to further improve the potency and metabolic stability of the compds. by leveraging the outcome of a set of in vitro metabolic identification studies.  The optimized 8,8-di-Me imidazolopiperazine analogs I(R = 4-F, 4-Me, 3,4-F2) and II(R = 4-Me, 3-Cl-4-F) III(R = Me, F) exhibited improved potency, in vitro metabolic stability profile and, as a result, enhanced oral exposure in vivo in mice.  The optimized compds. were found to be more efficacious than the current antimalarials in a malaria mouse model.  They exhibit moderate oral exposure in rat pharmacokinetic studies to achieve sufficient multiples of the oral exposure at the efficacious dose in toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonl3aXJKMqObVg90H21EOLACvtfcHk0lge1UEvRPJ6cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D&md5=6c46f2f5ca76ae5a5089b542ec15e2ac</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm300041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300041e%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DChuan%26aufirst%3DT.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520lead%2520optimization%2520of%2520the%2520second-generation%2520antimalarial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4244%26epage%3D4273%26doi%3D10.1021%2Fjm300041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Antimalarial drug discovery - approaches and progress towards new medicines</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrmicro3138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24217412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=849-862&author=E.+L.+Flanneryauthor=A.+K.+Chatterjeeauthor=E.+A.+Winzeler&title=Antimalarial+drug+discovery+-+approaches+and+progress+towards+new+medicines&doi=10.1038%2Fnrmicro3138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery - approaches and progress towards new medicines</span></div><div class="casAuthors">Flannery, Erika L.; Chatterjee, Arnab K.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-862</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task.  Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure.  To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compds. that target multiple parasite species at multiple stages of the parasite life cycle.  In this Review, we discuss the cell-, chem.- and target-based approaches used to discover new drug candidates that are currently in clin. trials or undergoing preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZRHIU_Rei97Vg90H21EOLACvtfcHk0lge1UEvRPJ6cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtb3L&md5=0ebf2e2f81cce7ac4de3fe19524a6ed9</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3138%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DAntimalarial%2520drug%2520discovery%2520-%2520approaches%2520and%2520progress%2520towards%2520new%2520medicines%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D849%26epage%3D862%26doi%3D10.1038%2Fnrmicro3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burri, C.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(09)60829-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2FS0140-6736%2809%2960829-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=148-159&author=R.+Brunauthor=J.+Blumauthor=F.+Chappuisauthor=C.+Burri&title=Human+African+trypanosomiasis&doi=10.1016%2FS0140-6736%2809%2960829-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960829-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960829-1%26sid%3Dliteratum%253Aachs%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DChappuis%26aufirst%3DF.%26aulast%3DBurri%26aufirst%3DC.%26atitle%3DHuman%2520African%2520trypanosomiasis%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D148%26epage%3D159%26doi%3D10.1016%2FS0140-6736%2809%2960829-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, R. R.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis: pharmacological re-engagement with a neglected disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fsj.bjp.0707354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=17618313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=1155-1171&author=M.+P.+Barrettauthor=D.+W.+Boykinauthor=R.+Brunauthor=R.+R.+Tidwell&title=Human+African+trypanosomiasis%3A+pharmacological+re-engagement+with+a+neglected+disease&doi=10.1038%2Fsj.bjp.0707354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Human African trypanosomiasis: pharmacological re-engagement with a neglected disease</span></div><div class="casAuthors">Barrett, M. P.; Boykin, D. W.; Brun, R.; Tidwell, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1155-1171</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  This review discusses the challenges of chemotherapy for human African trypanosomiasis (HAT).  The few drugs registered for use against the disease are unsatisfactory for a no. of reasons.  HAT has two stages.  In stage 1 the parasites proliferate in the hemolymphatic system.  In stage 2 they invade the central nervous system and brain provoking progressive neurol. dysfunction leading to symptoms that include the disrupted sleep wake patterns that give HAT its more common name of sleeping sickness.  Targeting drugs to the central nervous system offers many challenges.  However, it is the cost of drug development for diseases like HAT, that afflict exclusively people of the world's poorest populations, that has been the principal barrier to new drug development and has led to them becoming neglected.  Here we review drugs currently registered for HAT, and also discuss the few compds. progressing through clin. trials.  Finally we report on new initiatives that might allow progress to be made in developing new and satisfactory drugs for this terrible disease.  Published online 9 July 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq9CYvEA1bgbVg90H21EOLACvtfcHk0li14VzxmHGtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtbbE&md5=1f48697e5814d1e40fa7f54c95f8f7ff</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707354%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DHuman%2520African%2520trypanosomiasis%253A%2520pharmacological%2520re-engagement%2520with%2520a%2520neglected%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D1155%26epage%3D1171%26doi%3D10.1038%2Fsj.bjp.0707354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noorden, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurdinger, T.</span></span> <span> </span><span class="NLM_article-title">WEE1 inhibition and genomic instability in cancer</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1836</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bbcan.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23727417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1836&publication_year=2013&pages=227-235&author=L.+E.+Vriendauthor=P.+C.+De+Witt+Hamerauthor=C.+J.+Van+Noordenauthor=T.+Wurdinger&title=WEE1+inhibition+and+genomic+instability+in+cancer&doi=10.1016%2Fj.bbcan.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">WEE1 inhibition and genomic instability in cancer</span></div><div class="casAuthors">Vriend, Lianne E. M.; De Witt Hamer, Philip C.; Van Noorden, Cornelis J. F.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1836</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  One of the hallmarks of cancer is genomic instability controlled by cell cycle checkpoints.  The G1 and G2 checkpoints allow DNA damage responses, whereas the mitotic checkpoint enables correct segregation of the sister chromosomes to prevent aneuploidy.  Cancer cells often lack a functional G1 arrest and rely on G2 arrest for DNA damage responses.  WEE1 kinase is an important regulator of the G2 checkpoint and is overexpressed in various cancer types.  Inhibition of WEE1 is a promising strategy in cancer therapy in combination with DNA-damaging agents, esp. when cancer cells harbor p53 mutations, as it causes mitotic catastrophe when DNA is not repaired during G2 arrest.  Cancer cell response to WEE1 inhibition monotherapy has also been demonstrated in various types of cancer, including p53 wild-type cancers.  The authors postulate that chromosomal instability can explain tumor response to WEE1 monotherapy.  Therefore, chromosomal instability may need to be taken into account when detg. the most effective strategy for the use of WEE1 inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5xXCFyxOs7Vg90H21EOLACvtfcHk0li14VzxmHGtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWju7vL&md5=7471124cf9e92b09b0dce7e481ae05dc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DL.%2BE.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DVan%2BNoorden%26aufirst%3DC.%2BJ.%26aulast%3DWurdinger%26aufirst%3DT.%26atitle%3DWEE1%2520inhibition%2520and%2520genomic%2520instability%2520in%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1836%26spage%3D227%26epage%3D235%26doi%3D10.1016%2Fj.bbcan.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biskup, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachergus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulihan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calne, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoessl, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patenge, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajal, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieregge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Myhsok, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meitinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strom, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wszolek, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, T.</span></span> <span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology&doi=10.1016%2Fj.neuron.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0liOQDyCU1BGeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.neuron.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker-Glenn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunzner-Toste, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pichon, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9416</span>– <span class="NLM_lpage">9433</span>, <span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0liOQDyCU1BGeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. D.</span></span> <span> </span><span class="NLM_article-title">Calcium channel functions in pain processing</span>. <i>Channels</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.4161/chan.4.6.12869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.4161%2Fchan.4.6.12869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21150297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=510-517&author=J.+Parkauthor=Z.+D.+Luo&title=Calcium+channel+functions+in+pain+processing&doi=10.4161%2Fchan.4.6.12869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium channel functions in pain processing</span></div><div class="casAuthors">Park, John F.; Luo, Z. David</div><div class="citationInfo"><span class="NLM_cas:title">Channels</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">510-517</span>CODEN:
                <span class="NLM_cas:coden">CHANCC</span>;
        ISSN:<span class="NLM_cas:issn">1933-6950</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Voltage-gated calcium channels (VGCC) play obligatory physiol. roles, including modulation of neuronal functions, synaptic plasticity, neurotransmitter release and gene transcription.  Dysregulation and maladaptive changes in VGCC expression and activities may occur in the sensory pathway under various pathol. conditions that could contribute to the development of pain.  In this review, we summarized the most recent findings on the regulation of VGCC expression and physiol. functions in the sensory pathway, and in dysregulation and maladaptive changes of VGCC under pain-inducing conditions.  The implications of these changes in understanding the mechanisms of pain transduction and in new drug design are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT0bpi0sPeM7Vg90H21EOLACvtfcHk0lg2Pr422psFmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSls74%253D&md5=1e3a763bf7770fd11f45d5bd3975c2d9</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.4161%2Fchan.4.6.12869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fchan.4.6.12869%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DZ.%2BD.%26atitle%3DCalcium%2520channel%2520functions%2520in%2520pain%2520processing%26jtitle%3DChannels%26date%3D2010%26volume%3D4%26spage%3D510%26epage%3D517%26doi%3D10.4161%2Fchan.4.6.12869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugianesi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haedo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swensen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. L.</span></span> <span> </span><span class="NLM_article-title">Improved Cav2.2 channel inhibitors through a gem-dimethylsulfone bioisostere replacement of a labile sulfonamide</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1064</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1021/ml4002612</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4002612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1064-1068&author=P.+P.+Shaoauthor=F.+Yeauthor=P.+K.+Chakravartyauthor=J.+B.+Herringtonauthor=G.+Daiauthor=R.+M.+Bugianesiauthor=R.+J.+Haedoauthor=A.+M.+Swensenauthor=V.+A.+Warrenauthor=M.+M.+Smithauthor=M.+L.+Garciaauthor=O.+B.+McManusauthor=K.+A.+Lyonsauthor=X.+Liauthor=M.+Greenauthor=N.+Jochnowitzauthor=E.+McGowanauthor=S.+Mistryauthor=S.+Y.+Sunauthor=C.+Abbadieauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=Improved+Cav2.2+channel+inhibitors+through+a+gem-dimethylsulfone+bioisostere+replacement+of+a+labile+sulfonamide&doi=10.1021%2Fml4002612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fml4002612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4002612%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DP.%2BP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DHerrington%26aufirst%3DJ.%2BB.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DBugianesi%26aufirst%3DR.%2BM.%26aulast%3DHaedo%26aufirst%3DR.%2BJ.%26aulast%3DSwensen%26aufirst%3DA.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMcManus%26aufirst%3DO.%2BB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DImproved%2520Cav2.2%2520channel%2520inhibitors%2520through%2520a%2520gem-dimethylsulfone%2520bioisostere%2520replacement%2520of%2520a%2520labile%2520sulfonamide%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1064%26epage%3D1068%26doi%3D10.1021%2Fml4002612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varughese, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugianesi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haedo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swensen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J. L.</span></span> <span> </span><span class="NLM_article-title">Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9847</span>– <span class="NLM_lpage">9855</span>, <span class="refDoi"> DOI: 10.1021/jm301056k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301056k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9847-9855&author=P.+P.+Shaoauthor=F.+Yeauthor=P.+K.+Chakravartyauthor=D.+J.+Varugheseauthor=J.+B.+Herringtonauthor=G.+Daiauthor=R.+M.+Bugianesiauthor=R.+J.+Haedoauthor=A.+M.+Swensenauthor=V.+A.+Warrenauthor=M.+M.+Smithauthor=M.+L.+Garciaauthor=O.+B.+McManusauthor=K.+A.+Lyonsauthor=X.+Liauthor=M.+Greenauthor=N.+Jochnowitzauthor=E.+McGowanauthor=S.+Mistryauthor=S.+Y.+Sunauthor=C.+Abbadieauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=Aminopiperidine+sulfonamide+Cav2.2+channel+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Fjm301056k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fjm301056k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301056k%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DP.%2BP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DVarughese%26aufirst%3DD.%2BJ.%26aulast%3DHerrington%26aufirst%3DJ.%2BB.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DBugianesi%26aufirst%3DR.%2BM.%26aulast%3DHaedo%26aufirst%3DR.%2BJ.%26aulast%3DSwensen%26aufirst%3DA.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMcManus%26aufirst%3DO.%2BB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DAminopiperidine%2520sulfonamide%2520Cav2.2%2520channel%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9847%26epage%3D9855%26doi%3D10.1021%2Fjm301056k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Downing, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morozova, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayle, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J. C.</span></span> <span> </span><span class="NLM_article-title">A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia</span>. <i>BMC Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">351</span>, <span class="refDoi"> DOI: 10.1186/s12888-014-0351-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1186%2Fs12888-014-0351-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=351&author=A.+M.+Downingauthor=B.+J.+Kinonauthor=B.+A.+Millenauthor=L.+Zhangauthor=L.+Liuauthor=M.+A.+Morozovaauthor=R.+Brennerauthor=T.+J.+Rayleauthor=L.+Nisenbaumauthor=F.+Zhaoauthor=J.+C.+Gomez&title=A+double-blind%2C+placebo-controlled+comparator+study+of+LY2140023+monohydrate+in+patients+with+schizophrenia&doi=10.1186%2Fs12888-014-0351-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1186%2Fs12888-014-0351-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12888-014-0351-3%26sid%3Dliteratum%253Aachs%26aulast%3DDowning%26aufirst%3DA.%2BM.%26aulast%3DKinon%26aufirst%3DB.%2BJ.%26aulast%3DMillen%26aufirst%3DB.%2BA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DBrenner%26aufirst%3DR.%26aulast%3DRayle%26aufirst%3DT.%2BJ.%26aulast%3DNisenbaum%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGomez%26aufirst%3DJ.%2BC.%26atitle%3DA%2520double-blind%252C%2520placebo-controlled%2520comparator%2520study%2520of%2520LY2140023%2520monohydrate%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DBMC%2520Psychiatry%26date%3D2014%26volume%3D14%26spage%3D351%26doi%3D10.1186%2Fs12888-014-0351-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemurell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emtenas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broddefalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovdal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryden-Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herslof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigfridsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whatling, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.1021/jm501531v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501531v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=897-911&author=M.+Lemurellauthor=J.+Ulanderauthor=S.+Winiwarterauthor=A.+Dahlenauthor=O.+Davidssonauthor=H.+Emtenasauthor=J.+Broddefalkauthor=M.+Swansonauthor=D.+Hovdalauthor=A.+T.+Plowrightauthor=A.+Pettersenauthor=M.+Ryden-Landergrenauthor=J.+Barlindauthor=A.+Llinasauthor=M.+Herslofauthor=T.+Drmotaauthor=K.+Sigfridssonauthor=S.+Mosesauthor=C.+Whatling&title=Discovery+of+AZD6642%2C+an+inhibitor+of+5-lipoxygenase+activating+protein+%28FLAP%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Fjm501531v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Fjm501531v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501531v%26sid%3Dliteratum%253Aachs%26aulast%3DLemurell%26aufirst%3DM.%26aulast%3DUlander%26aufirst%3DJ.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDahlen%26aufirst%3DA.%26aulast%3DDavidsson%26aufirst%3DO.%26aulast%3DEmtenas%26aufirst%3DH.%26aulast%3DBroddefalk%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DM.%26aulast%3DHovdal%26aufirst%3DD.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DRyden-Landergren%26aufirst%3DM.%26aulast%3DBarlind%26aufirst%3DJ.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DHerslof%26aufirst%3DM.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DSigfridsson%26aufirst%3DK.%26aulast%3DMoses%26aufirst%3DS.%26aulast%3DWhatling%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520AZD6642%252C%2520an%2520inhibitor%2520of%25205-lipoxygenase%2520activating%2520protein%2520%2528FLAP%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D897%26epage%3D911%26doi%3D10.1021%2Fjm501531v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareau, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarlane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouimet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford-Hutchinson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00023-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0960-894X%2895%2900023-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFGnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=283-288&author=M.+Labelleauthor=M.+Belleyauthor=Y.+Gareauauthor=J.+Y.+Gauthierauthor=D.+Guayauthor=R.+Gordonauthor=S.+G.+Grossmanauthor=T.+R.+Jonesauthor=Y.+Leblancauthor=M.+McAuliffeauthor=C.+McFarlaneauthor=P.+Massonauthor=K.+M.+Mettersauthor=N.+Ouimetauthor=D.+H.+Patrickauthor=H.+Piechutaauthor=C.+Rochetteauthor=N.+Sawyerauthor=Y.+B.+Xiangauthor=C.+B.+Pickettauthor=A.+W.+Ford-Hutchinsonauthor=R.+J.+Zamboniauthor=R.+N.+Young&title=Discovery+of+MK-0476%2C+a+potent+and+orally+active+leukotriene+D4+receptor+antagonist+devoid+of+peroxisomal+enzyme+induction&doi=10.1016%2F0960-894X%2895%2900023-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction</span></div><div class="casAuthors">Labelle, M.; Belley, M.; Gareau, Y.; Gauthier, J. Y.; Guay, D.; Gordon, R.; Grossman, S. G.; Jones, T. R.; Leblanc, Y.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-8</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Structure-activity studies leading to the discovery of MK-0476 are described.  The initial compd. of this series was a potent leukotriene D4 (LTD4) antagonist, but was also a peroxisomal enzyme inducer in the mouse.  Structure-activity relationships around the thioether chain were explored to remove this undesirable feature.  It was found that alkyl substituents in the β-position relative to the carboxylic acid reduce the potency as a peroxisomal enzyme inducer while preserving the LTD4 antagonistic properties.  Dialkyl substitution essentially eliminates the enzyme induction.  The optimal styryl quinoline, MK-0476, exhibited high in vitro potency and in vivo activity on oral dosing without significant liver enzyme induction in the mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmcviqVzx4LLVg90H21EOLACvtfcHk0li4ckpr-qe3Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFGnurc%253D&md5=8a4aba26af3212766d88ff79d19f4d8e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900023-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900023-M%26sid%3Dliteratum%253Aachs%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGrossman%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DPatrick%26aufirst%3DD.%2BH.%26aulast%3DPiechuta%26aufirst%3DH.%26aulast%3DRochette%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DY.%2BB.%26aulast%3DPickett%26aufirst%3DC.%2BB.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DZamboni%26aufirst%3DR.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26atitle%3DDiscovery%2520of%2520MK-0476%252C%2520a%2520potent%2520and%2520orally%2520active%2520leukotriene%2520D4%2520receptor%2520antagonist%2520devoid%2520of%2520peroxisomal%2520enzyme%2520induction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D283%26epage%3D288%26doi%3D10.1016%2F0960-894X%2895%2900023-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyne, S.</span></span> <span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/nrc2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer&doi=10.1038%2Fnrc2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0li4ckpr-qe3Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrc2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milstien, S.</span></span> <span> </span><span class="NLM_article-title">The outs and the ins of sphingosine-1-phosphate in immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1038/nri2974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnri2974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=21546914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=403-415&author=S.+Spiegelauthor=S.+Milstien&title=The+outs+and+the+ins+of+sphingosine-1-phosphate+in+immunity&doi=10.1038%2Fnri2974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">The outs and the ins of sphingosine-1-phosphate in immunity</span></div><div class="casAuthors">Spiegel, Sarah; Milstien, Sheldon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">403-415</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The potent lipid mediator sphingosine-1-phosphate (S1P) is produced inside cells by two closely related kinases, sphingosine kinase 1 (SPHK1) and SPHK2, and has emerged as a crucial regulator of immunity.  Many of the actions of S1P in innate and adaptive immunity are mediated by its binding to five G protein-coupled receptors, designated S1PR1-5, but recent findings have also identified important roles for S1P as a second messenger during inflammation.  In this Review, we discuss recent advances in our understanding of the roles of S1P receptors and describe the newly identified intracellular targets of S1P that are crucial for immune responses.  Finally, we discuss the therapeutic potential of new drugs that target S1P signalling and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxp8-U05q-frVg90H21EOLACvtfcHk0liAYu2VMe27jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kgurk%253D&md5=b1bf1c4a321a768a12f82a1fcdeb6d69</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnri2974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2974%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26atitle%3DThe%2520outs%2520and%2520the%2520ins%2520of%2520sphingosine-1-phosphate%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26spage%3D403%26epage%3D415%26doi%3D10.1038%2Fnri2974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, D. T.</span></span> <span> </span><span class="NLM_article-title">The use of 16-16 dimethyl <i>trans</i> delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. a comparative study</span>. <i>Br. J. Obstet. Gynaecol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1111/j.1471-0528.1980.tb04605.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1471-0528.1980.tb04605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=7426533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADyaL3M%252FjvFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1980&pages=712-717&author=S.+K.+Smithauthor=D.+T.+Baird&title=The+use+of+16-16+dimethyl+trans+delta+2+PGE1+methyl+ester+%28ONO+802%29+vaginal+suppositories+for+the+termination+of+early+pregnancy.+a+comparative+study&doi=10.1111%2Fj.1471-0528.1980.tb04605.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study</span></div><div class="casAuthors">Smith S K; Baird D T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of obstetrics and gynaecology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">712-7</span>
        ISSN:<span class="NLM_cas:issn">0306-5456</span>.
    </div><div class="casAbstract">Vaginal suppositories containing the 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) were used for the induction of abortion in early pregnancy, and this non-surgical technique was compared with suction termination performed under local anaesthesia or general anaesthesia.  Ninety patients were recruited to the study and divided equally between the three groups.  Complete abortion was induced in 87 per cent of the patients treated with ONO 802 suppositories, which compared favourably with 87 and 100 per cent for the patients who had suction terminations under local anaesthesia and general anaesthesia respectively.  The vaginal suppositories induced uterine bleeding in all patients and the mean time of onset of lower abdominal pain was 2 hours 55 minutes.  The average numbers of episodes of vomiting and diarrhoea for patients given ONO 802 suppositories were 0.9 and 0.7 respectively.  Menstrual blood loss was measured objectively in all groups and no significant differences between the three methods could be found.  In selected cases, ONO 802 vaginal suppositories would seem to be safe and reasonably effective for the termination of early pregnancy.  Vaginal suppositories containing the 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) were used for the induction of abortion in early pregnancy, and this nonsurgical technique was compared with suction termination performed under local anesthesia or general anesthesia.  90 patients were recruited to the study and divided equally between the 3 groups.  Complete abortion was induced in 87% of the patients treated with ONO 802 suppositories, which compared favourably with 87 and 100% for the patients who had suction terminations under local anesthesia, and general anesthesia, respectively.  The vaginal suppositories induced uterine bleeding in all patients and the mean time of onset of lower abdominal pain was 2 hours 55 minutes.  The average numbers of episodes of vomiting and diarrhea for patients given ONO 802 suppositories were 0.9 and 0.7, respectively.  Menstrual blood loss was measured objectively in all groups and no significant differences between the 3 methods could be found.  In selected cases, ONO 802 vaginal suppositories would seem to be safe and reasonably effective for the termination of early pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQs243MjX93Is-crCu0nI_sfW6udTcc2eZlq_4cTj_y2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3M%252FjvFymtQ%253D%253D&md5=6b5ed7099c3862dcda23b3ea16f605a5</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-0528.1980.tb04605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-0528.1980.tb04605.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BK.%26aulast%3DBaird%26aufirst%3DD.%2BT.%26atitle%3DThe%2520use%2520of%252016-16%2520dimethyl%2520trans%2520delta%25202%2520PGE1%2520methyl%2520ester%2520%2528ONO%2520802%2529%2520vaginal%2520suppositories%2520for%2520the%2520termination%2520of%2520early%2520pregnancy.%2520a%2520comparative%2520study%26jtitle%3DBr.%2520J.%2520Obstet.%2520Gynaecol.%26date%3D1980%26volume%3D87%26spage%3D712%26epage%3D717%26doi%3D10.1111%2Fj.1471-0528.1980.tb04605.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bygdeman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, N. J.</span></span> <span> </span><span class="NLM_article-title">Metabolism of 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1986&pages=494-502&author=V.+Dimovauthor=K.+Greenauthor=M.+Bygdemanauthor=N.+J.+Christensen&title=Metabolism+of+16%2C16-dimethyl-trans-delta+2-prostaglandin+E1+methyl+ester+%28ONO-802%29+following+intravenous+and+vaginal+administration+to+pregnant+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDimov%26aufirst%3DV.%26aulast%3DGreen%26aufirst%3DK.%26aulast%3DBygdeman%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DN.%2BJ.%26atitle%3DMetabolism%2520of%252016%252C16-dimethyl-trans-delta%25202-prostaglandin%2520E1%2520methyl%2520ester%2520%2528ONO-802%2529%2520following%2520intravenous%2520and%2520vaginal%2520administration%2520to%2520pregnant%2520women%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1986%26volume%3D14%26spage%3D494%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foord, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elshourbagy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignar, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steplewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szekeres, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, N. B.</span></span> <span> </span><span class="NLM_article-title">Molecular identification of high and low affinity receptors for nicotinic acid</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">9869</span>– <span class="NLM_lpage">9874</span>, <span class="refDoi"> DOI: 10.1074/jbc.M210695200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1074%2Fjbc.M210695200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=12522134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvV2hsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=9869-9874&author=A.+Wiseauthor=S.+M.+Foordauthor=N.+J.+Fraserauthor=A.+A.+Barnesauthor=N.+Elshourbagyauthor=M.+Eilertauthor=D.+M.+Ignarauthor=P.+R.+Murdockauthor=K.+Steplewskiauthor=A.+Greenauthor=A.+J.+Brownauthor=S.+J.+Dowellauthor=P.+G.+Szekeresauthor=D.+G.+Hassallauthor=F.+H.+Marshallauthor=S.+Wilsonauthor=N.+B.+Pike&title=Molecular+identification+of+high+and+low+affinity+receptors+for+nicotinic+acid&doi=10.1074%2Fjbc.M210695200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular identification of high and low affinity receptors for nicotinic acid</span></div><div class="casAuthors">Wise, Alan; Foord, Steven M.; Fraser, Neil J.; Barnes, Ashley A.; Elshourbagy, Nabil; Eilert, Michelle; Ignar, Diane M.; Murdock, Paul R.; Steplewski, Klaudia; Green, Andrew; Brown, Andrew J.; Dowell, Simon J.; Szekeres, Philip G.; Hassall, David G.; Marshall, Fiona H.; Wilson, Shelagh; Pike, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">9869-9874</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nicotinic acid has been used clin. for over 40 yr in the treatment of dyslipidemia producing a desirable normalization of a range of cardiovascular risk factors, including a marked elevation of high d. lipoprotein and a redn. in mortality.  The precise mechanism of action of nicotinic acid is unknown, although it is believed that activation of a Gi-G protein-coupled receptor may contribute.  Utilizing available information on the tissue distribution of nicotinic acid receptors, the authors identified candidate orphan receptors.  The selected orphan receptors were screened for responses to nicotinic acid, in an assay for activation of Gi-G proteins.  Here the authors describe the identification of the G protein-coupled receptor HM74 as a low affinity receptor for nicotinic acid.  The authors then describe the subsequent identification of HM74A in follow-up bioinformatics searches and demonstrate that it acts as a high affinity receptor for nicotinic acid and other compds. with related pharmacol.  The discovery of HM74A as a mol. target for nicotinic acid may facilitate the discovery of superior drug mols. to treat dyslipidemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1fm8ypokRV7Vg90H21EOLACvtfcHk0lh5IKSWNJkkkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvV2hsbo%253D&md5=980d4d6a2edd6468828eecd885c2f0ca</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M210695200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M210695200%26sid%3Dliteratum%253Aachs%26aulast%3DWise%26aufirst%3DA.%26aulast%3DFoord%26aufirst%3DS.%2BM.%26aulast%3DFraser%26aufirst%3DN.%2BJ.%26aulast%3DBarnes%26aufirst%3DA.%2BA.%26aulast%3DElshourbagy%26aufirst%3DN.%26aulast%3DEilert%26aufirst%3DM.%26aulast%3DIgnar%26aufirst%3DD.%2BM.%26aulast%3DMurdock%26aufirst%3DP.%2BR.%26aulast%3DSteplewski%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DSzekeres%26aufirst%3DP.%2BG.%26aulast%3DHassall%26aufirst%3DD.%2BG.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DN.%2BB.%26atitle%3DMolecular%2520identification%2520of%2520high%2520and%2520low%2520affinity%2520receptors%2520for%2520nicotinic%2520acid%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D9869%26epage%3D9874%26doi%3D10.1074%2Fjbc.M210695200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benyo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csiky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchankova, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusing, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offermanns, S.</span></span> <span> </span><span class="NLM_article-title">GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3634</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1172/JCI23626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1172%2FJCI23626" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=3634-3640&author=Z.+Benyoauthor=A.+Gilleauthor=J.+Keroauthor=M.+Csikyauthor=M.+C.+Suchankovaauthor=R.+M.+Nusingauthor=A.+Moersauthor=K.+Pfefferauthor=S.+Offermanns&title=GPR109A+%28PUMA-G%2FHM74A%29+mediates+nicotinic+acid-induced+flushing&doi=10.1172%2FJCI23626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1172%2FJCI23626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI23626%26sid%3Dliteratum%253Aachs%26aulast%3DBenyo%26aufirst%3DZ.%26aulast%3DGille%26aufirst%3DA.%26aulast%3DKero%26aufirst%3DJ.%26aulast%3DCsiky%26aufirst%3DM.%26aulast%3DSuchankova%26aufirst%3DM.%2BC.%26aulast%3DNusing%26aufirst%3DR.%2BM.%26aulast%3DMoers%26aufirst%3DA.%26aulast%3DPfeffer%26aufirst%3DK.%26aulast%3DOffermanns%26aufirst%3DS.%26atitle%3DGPR109A%2520%2528PUMA-G%252FHM74A%2529%2520mediates%2520nicotinic%2520acid-induced%2520flushing%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D3634%26epage%3D3640%26doi%3D10.1172%2FJCI23626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandercammen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Schaftingen, E.</span></span> <span> </span><span class="NLM_article-title">The mechanism by which rat liver glucokinase is inhibited by the regulatory protein</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1990.tb19147.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1111%2Fj.1432-1033.1990.tb19147.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=2384095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFeru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1990&pages=483-489&author=A.+Vandercammenauthor=E.+Van+Schaftingen&title=The+mechanism+by+which+rat+liver+glucokinase+is+inhibited+by+the+regulatory+protein&doi=10.1111%2Fj.1432-1033.1990.tb19147.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism by which rat liver glucokinase is inhibited by the regulatory protein</span></div><div class="casAuthors">Vandercammen, Annick; Van Schaftingen, Emile</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-9</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The fructose-6-phosphate-sensitive and fructose-1-phosphate-sensitive protein that inhibits rat liver glucokinase was purified close to homogeneity by a procedure involving poly(ethyleneglycol) pptn., chromatog. on anion-exchangers and hydroxylapatite, gel filtration and chromatog. on Mono S, a cation exchanger.  In the last chromatog. step, the regulatory protein coeluted with a 62-kDa peptide.  From the elution vol. of the gel-filtration column a mol. mass of 60 kDa was detd., allowing the conclusion that the regulator is a monomer.  The decrease in the apparent affinity of glucokinase for glucose, which the regulator induced, disappeared upon sepn. of the 2 proteins.  Furthermore, the regulator did not appear to catalyze the formation of a heat-stable or a trypsin-resistant inhibitor of glucokinase.  Finally, the inhibition exerted by the regulatory protein reached a steady value 1-2 min after the addn. of the regulator.  These results indicate that the regulator does not act by causing a covalent modification of glucokinase nor by catalyzing the formation of a low-mol.-mass inhibitor.  Raising the concn. of glucokinase in the assay from 6 to 120 mU/mL caused a 2.5-fold increase in the concn. of regulator required to half-maximally inhibit the enzyme.  The apparent mass of glucokinase, as detd. by centrifugation in isokinetic sucrose gradient, was 55 kDa, and this value was unaffected by the sep. presence of fructose 6-phosphate or of the regulatory protein.  However, the apparent mass of the enzyme increased to 105 kDa when glucokinase was centrifuged together with both fructose 6-phosphate and the regulatory protein, although not when fructose 1-phosphate was also present.  Conversely, the presence of glucokinase increased the apparent mol. mass of the regulator in the presence of fructose 6-phosphate.  From these results, it is concluded that the regulatory protein inhibits glucokinase by forming a complex with this enzyme in the presence of fructose 6-phosphate, and that fructose 1-phosphate antagonizes this inhibition by preventing the formation of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop3Cq5M_P20bVg90H21EOLACvtfcHk0lj7tEBi0bcVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFeru7o%253D&md5=1705aa9bb9b757eb5b61d9220fc74c16</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1990.tb19147.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1990.tb19147.x%26sid%3Dliteratum%253Aachs%26aulast%3DVandercammen%26aufirst%3DA.%26aulast%3DVan%2BSchaftingen%26aufirst%3DE.%26atitle%3DThe%2520mechanism%2520by%2520which%2520rat%2520liver%2520glucokinase%2520is%2520inhibited%2520by%2520the%2520regulatory%2520protein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1990%26volume%3D191%26spage%3D483%26epage%3D489%26doi%3D10.1111%2Fj.1432-1033.1990.tb19147.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, B. M.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4023</span>– <span class="NLM_lpage">4034</span>, <span class="refDoi"> DOI: 10.1021/jm058240i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058240i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4023-4034&author=B.+M.+Nilsson&title=5-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents&doi=10.1021%2Fjm058240i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span></div><div class="casAuthors">Nilsson, Bjoern M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4023-4034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 5-HT 2C receptor agonists as potential antiobesity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39FDBz-7CqrVg90H21EOLACvtfcHk0lj7tEBi0bcVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D&md5=ec5788cfe273b9cf7ccbdfc39fc8a7b2</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fjm058240i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058240i%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM.%26atitle%3D5-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4023%26epage%3D4034%26doi%3D10.1021%2Fjm058240i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comery, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span> <span> </span><span class="NLM_article-title">5-HT(2C) agonists as therapeutics for the treatment of schizophrenia</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1007/978-3-642-25758-2_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1007%2F978-3-642-25758-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=23027415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2012&pages=147-165&author=S.+Rosenzweig-Lipsonauthor=T.+A.+Comeryauthor=K.+L.+Marquisauthor=J.+Grossauthor=J.+Dunlop&title=5-HT%282C%29+agonists+as+therapeutics+for+the+treatment+of+schizophrenia&doi=10.1007%2F978-3-642-25758-2_6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C agonists as therapeutics for the treatment of schizophrenia</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Comery, Thomas A.; Marquis, Karen L.; Gross, Jonathan; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">147-165</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The 5-HT2C receptor is a highly complex, highly regulated receptor which is widely distributed throughout the brain.  The 5-HT2C receptor couples to multiple signal transduction pathways leading to engagement of a no. of intracellular signaling mols.  Moreover, there are multiple allelic variants of the 5-HT2C receptor and the receptor is subject to RNA editing in the coding regions.  The complexity of this receptor is further emphasized by the studies suggesting the utility of either agonists or antagonists in the treatment of schizophrenia.  While several 5-HT2C agonists have demonstrated clin. efficacy in obesity (lorcaserin, PRX-000933), the focus of this review is on the therapeutic potential of 5-HT2C agonists in schizophrenia.  To this end, the preclin. profile of 5-HT2C agonists from a neurochem., electrophysiol., and a behavioral perspective is indicative of antipsychotic-like efficacy without extrapyramidal symptoms or wt. gain.  Recently, the selective 5-HT2C agonist vabicaserin demonstrated clin. efficacy in a Phase II trial in schizophrenia patients without wt. gain and with low EPS liability.  These data are highly encouraging and suggest that 5-HT2C agonists are potential therapeutics for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuqzYsH56GbVg90H21EOLACvtfcHk0ljuCpEz4B-iXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D&md5=17bdc34317a7d966bc6038bca83ec5b3</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3D5-HT%25282C%2529%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D213%26spage%3D147%26epage%3D165%26doi%3D10.1007%2F978-3-642-25758-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P. J.</span></span> <span> </span><span class="NLM_article-title">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.tips.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=24041919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=560-570&author=G.+A.+Higginsauthor=E.+M.+Sellersauthor=P.+J.+Fletcher&title=From+obesity+to+substance+abuse%3A+therapeutic+opportunities+for+5-HT2C+receptor+agonists&doi=10.1016%2Fj.tips.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists</span></div><div class="casAuthors">Higgins, Guy A.; Sellers, Edward M.; Fletcher, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent US Food and Drug Administration (FDA) approval of the serotonin (5-hydroxytryptamine, 5-HT) 5-HT2C receptor agonist lorcaserin for the treatment of obesity represents a new therapeutic drug class available to the clinic.  Preclin. evidence supports the potential for this drug class to treat other related conditions such as substance abuse.  In the present article we review this evidence and further suggest that overlapping neurobiol. systems may contribute to an anti-addictive and anti-obesity profile.  The availability of selective 5-HT2C agonists provides an opportunity to evaluate their potential as treatments for nicotine dependence or psychostimulant abuse, conditions for which there is significant medical need but only limited available treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjiS3n6R_5trVg90H21EOLACvtfcHk0ljuCpEz4B-iXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCltLzK&md5=cf21273e52cb1ba62821886489381717</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26atitle%3DFrom%2520obesity%2520to%2520substance%2520abuse%253A%2520therapeutic%2520opportunities%2520for%25205-HT2C%2520receptor%2520agonists%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D560%26epage%3D570%26doi%3D10.1016%2Fj.tips.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleight, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, U.</span></span> <span> </span><span class="NLM_article-title">Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2762</span>– <span class="NLM_lpage">2769</span>, <span class="refDoi"> DOI: 10.1021/jm970030l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970030l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2762-2769&author=M.+Bosauthor=F.+Jenckauthor=J.+R.+Martinauthor=J.+L.+Moreauauthor=A.+J.+Sleightauthor=J.+Wichmannauthor=U.+Widmer&title=Novel+agonists+of+5HT2C+receptors.+Synthesis+and+biological+evaluation+of+substituted+2-%28indol-1-yl%29-1-methylethylamines+and+2-%28indeno%5B1%2C2-b%5Dpyrrol-1-yl%29-1-methylethylamines.+Improved+therapeutics+for+obsessive+compulsive+disorder&doi=10.1021%2Fjm970030l"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Fjm970030l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970030l%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DSleight%26aufirst%3DA.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DWidmer%26aufirst%3DU.%26atitle%3DNovel%2520agonists%2520of%25205HT2C%2520receptors.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%2520substituted%25202-%2528indol-1-yl%2529-1-methylethylamines%2520and%25202-%2528indeno%255B1%252C2-b%255Dpyrrol-1-yl%2529-1-methylethylamines.%2520Improved%2520therapeutics%2520for%2520obsessive%2520compulsive%2520disorder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2762%26epage%3D2769%26doi%3D10.1021%2Fjm970030l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albertini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gocke, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichmann, J.</span></span> <span> </span><span class="NLM_article-title">Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay</span>. <i>Mutagenesis</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1093/mutage/13.4.397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1093%2Fmutage%2F13.4.397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=397-403&author=S.+Albertiniauthor=M.+Bosauthor=E.+Gockeauthor=S.+Kirchnerauthor=W.+Musterauthor=J.+Wichmann&title=Suppression+of+mutagenic+activity+of+a+series+of+5HT2c+receptor+agonists+by+the+incorporation+of+a+gem-dimethyl+group%3A+SAR+using+the+Ames+test+and+a+DNA+unwinding+assay&doi=10.1093%2Fmutage%2F13.4.397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2F13.4.397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252F13.4.397%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DS.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DGocke%26aufirst%3DE.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DMuster%26aufirst%3DW.%26aulast%3DWichmann%26aufirst%3DJ.%26atitle%3DSuppression%2520of%2520mutagenic%2520activity%2520of%2520a%2520series%2520of%25205HT2c%2520receptor%2520agonists%2520by%2520the%2520incorporation%2520of%2520a%2520gem-dimethyl%2520group%253A%2520SAR%2520using%2520the%2520Ames%2520test%2520and%2520a%2520DNA%2520unwinding%2520assay%26jtitle%3DMutagenesis%26date%3D1998%26volume%3D13%26spage%3D397%26epage%3D403%26doi%3D10.1093%2Fmutage%2F13.4.397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardiot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevissen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brucker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborda, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNaughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaltin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammue, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, A.</span></span> <span> </span><span class="NLM_article-title">2-(2-Oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1021/jm501814x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501814x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1502-1512&author=D.+Bardiotauthor=K.+Thevissenauthor=K.+De+Bruckerauthor=A.+Peetersauthor=P.+Cosauthor=C.+P.+Tabordaauthor=M.+McNaughtonauthor=L.+Maesauthor=P.+Chaltinauthor=B.+P.+Cammueauthor=A.+Marchand&title=2-%282-Oxo-morpholin-3-yl%29-acetamide+derivatives+as+broad-spectrum+antifungal+agents&doi=10.1021%2Fjm501814x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents</span></div><div class="casAuthors">Bardiot, Dorothee; Thevissen, Karin; De Brucker, Katrijn; Peeters, Annelies; Cos, Paul; Taborda, Carlos P.; McNaughton, Michael; Maes, Louis; Chaltin, Patrick; Cammue, Bruno P. A.; Marchand, Arnaud</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1502-1512</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a fungicidal screen, we identified 2-(2-oxo-morpholin-3-yl)-acetamide derivs. as fungicidal agents against Candida species, addnl. characterized by antifungal activity against Aspergillus species.  However, development of this series was hampered by low plasmatic stability.  Introduction of a gem-di-Me on the 6-position of the morpholin-2-one core led to considerable improvement in plasmatic stability while maintaining in vitro antifungal activity.  Further optimization of the series resulted in the discovery of N-(biphenyl-3-ylmethyl)-2-(4-ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)acetamide (I), which, in addn. to fungicidal activity against Candida species, shows promising and broad antifungal in vitro activity against various fungi species, such as molds and dermatophytes.  In vivo efficacy was also demonstrated in a murine model of systemic Candida albicans infection with a significant fungal load redn. in kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-9EVKzoxBbVg90H21EOLACvtfcHk0lhbhpLPxB6_xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGhug%253D%253D&md5=a24c883b667b0b514fd543795b319f07</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fjm501814x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501814x%26sid%3Dliteratum%253Aachs%26aulast%3DBardiot%26aufirst%3DD.%26aulast%3DThevissen%26aufirst%3DK.%26aulast%3DDe%2BBrucker%26aufirst%3DK.%26aulast%3DPeeters%26aufirst%3DA.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DTaborda%26aufirst%3DC.%2BP.%26aulast%3DMcNaughton%26aufirst%3DM.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DChaltin%26aufirst%3DP.%26aulast%3DCammue%26aufirst%3DB.%2BP.%26aulast%3DMarchand%26aufirst%3DA.%26atitle%3D2-%25282-Oxo-morpholin-3-yl%2529-acetamide%2520derivatives%2520as%2520broad-spectrum%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1502%26epage%3D1512%26doi%3D10.1021%2Fjm501814x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates for non-oncological indications</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1517/14712598.2016.1161753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1517%2F14712598.2016.1161753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=26937991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A280%3ADC%252BC28jms12guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=591-593&author=R.+Liuauthor=R.+E.+Wangauthor=F.+Wang&title=Antibody-drug+conjugates+for+non-oncological+indications&doi=10.1517%2F14712598.2016.1161753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-drug conjugates for non-oncological indications</span></div><div class="casAuthors">Liu Renhe; Wang Rongsheng E; Wang Feng</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on biological therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">591-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-E7aPT1YIc2xpATR2EQURfW6udTcc2ebkqbscVuR4U7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jms12guw%253D%253D&md5=23789ace05502869a83cfd81e2ef0263</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1517%2F14712598.2016.1161753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2016.1161753%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%2BE.%26aulast%3DWang%26aufirst%3DF.%26atitle%3DAntibody-drug%2520conjugates%2520for%2520non-oncological%2520indications%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2016%26volume%3D16%26spage%3D591%26epage%3D593%26doi%3D10.1517%2F14712598.2016.1161753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, S.</span></span> <span> </span><span class="NLM_article-title">Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">452</span>– <span class="NLM_lpage">477</span>, <span class="refDoi"> DOI: 10.2133/dmpk.20.452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2133%2Fdmpk.20.452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16415531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVOmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=452-477&author=M.+Nishimuraauthor=S.+Naito&title=Tissue-specific+mRNA+expression+profiles+of+human+ATP-binding+cassette+and+solute+carrier+transporter+superfamilies&doi=10.2133%2Fdmpk.20.452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies</span></div><div class="casAuthors">Nishimura, Masuhiro; Naito, Shinsaku</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">452-477</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society for the Study of Xenobiotics</span>)
        </div><div class="casAbstract">Pairs of forward and reverse primers and TaqMan probes specific to each of 46 human ATP-binding cassette (ABC) transporters and 108 human solute carrier (SLC) transporters were prepd.  The mRNA expression level of each target transporter was analyzed in total RNA from single and pooled specimens of various human tissues (adrenal gland, bone marrow, brain, colon, heart, kidney, liver, lung, pancreas, peripheral leukocytes, placenta, prostate, salivary gland, skeletal muscle, small intestine, spinal cord, spleen, stomach, testis, thymus, thyroid gland, trachea, and uterus) by real-time reverse transcription PCR using an ABI PRISM 7700 sequence detector system.  In contrast to previous methods for analyzing the mRNA expression of single ABC and SLC genes such as Northern blotting, the method allowed the authors' to perform sensitive, semiautomatic, rapid, and complete anal. of ABC and SLC transporters in total RNA samples.  The newly detd. expression profiles were then used to study the gene expression in 23 different human tissues, and tissues with high transcriptional activity for human ABC and SLC transporters were identified.  These results are expected to be valuable for establishing drug transport-mediated screening systems for new chem. entities in new drug development and for research concerning the clin. diagnosis of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo84NMaLwnvqrVg90H21EOLACvtfcHk0lhVqF5vXWCClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVOmsbk%253D&md5=eaa00db131c7f3335e1cbd9e89900d04</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.2133%2Fdmpk.20.452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2133%252Fdmpk.20.452%26sid%3Dliteratum%253Aachs%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DNaito%26aufirst%3DS.%26atitle%3DTissue-specific%2520mRNA%2520expression%2520profiles%2520of%2520human%2520ATP-binding%2520cassette%2520and%2520solute%2520carrier%2520transporter%2520superfamilies%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2005%26volume%3D20%26spage%3D452%26epage%3D477%26doi%3D10.2133%2Fdmpk.20.452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brundish, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janus, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kane, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howarth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyle, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of thrombin inhibitors: analogues of MD-805 with reduced stereogenicity and improved potency</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4584</span>– <span class="NLM_lpage">4603</span>, <span class="refDoi"> DOI: 10.1021/jm9811209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9811209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4584-4603&author=D.+Brundishauthor=A.+Bullauthor=V.+Donovanauthor=J.+D.+Fullertonauthor=S.+M.+Garmanauthor=J.+F.+Haylerauthor=D.+Janusauthor=P.+D.+Kaneauthor=M.+McDonnellauthor=G.+P.+Smithauthor=R.+Wakefordauthor=C.+V.+Walkerauthor=G.+Howarthauthor=W.+Hoyleauthor=M.+C.+Allenauthor=J.+Amblerauthor=K.+Butlerauthor=M.+D.+Talbot&title=Design+and+synthesis+of+thrombin+inhibitors%3A+analogues+of+MD-805+with+reduced+stereogenicity+and+improved+potency&doi=10.1021%2Fjm9811209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm9811209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9811209%26sid%3Dliteratum%253Aachs%26aulast%3DBrundish%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DA.%26aulast%3DDonovan%26aufirst%3DV.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DGarman%26aufirst%3DS.%2BM.%26aulast%3DHayler%26aufirst%3DJ.%2BF.%26aulast%3DJanus%26aufirst%3DD.%26aulast%3DKane%26aufirst%3DP.%2BD.%26aulast%3DMcDonnell%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DWakeford%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DC.%2BV.%26aulast%3DHowarth%26aufirst%3DG.%26aulast%3DHoyle%26aufirst%3DW.%26aulast%3DAllen%26aufirst%3DM.%2BC.%26aulast%3DAmbler%26aufirst%3DJ.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DTalbot%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thrombin%2520inhibitors%253A%2520analogues%2520of%2520MD-805%2520with%2520reduced%2520stereogenicity%2520and%2520improved%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4584%26epage%3D4603%26doi%3D10.1021%2Fjm9811209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hijikata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikumoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonomura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamao, Y.</span></span> <span> </span><span class="NLM_article-title">Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. the importance of stereo-structure of its hydrophobic carboxamide portion</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(81)91279-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0006-291X%2881%2991279-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1981&pages=440-446&author=S.+Okamotoauthor=A.+Hijikataauthor=R.+Kikumotoauthor=S.+Tonomuraauthor=H.+Haraauthor=K.+Ninomiyaauthor=A.+Maruyamaauthor=M.+Suganoauthor=Y.+Tamao&title=Potent+inhibition+of+thrombin+by+the+newly+synthesized+arginine+derivative+No.+805.+the+importance+of+stereo-structure+of+its+hydrophobic+carboxamide+portion&doi=10.1016%2F0006-291X%2881%2991279-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2881%2991279-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252881%252991279-1%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DHijikata%26aufirst%3DA.%26aulast%3DKikumoto%26aufirst%3DR.%26aulast%3DTonomura%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DH.%26aulast%3DNinomiya%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DSugano%26aufirst%3DM.%26aulast%3DTamao%26aufirst%3DY.%26atitle%3DPotent%2520inhibition%2520of%2520thrombin%2520by%2520the%2520newly%2520synthesized%2520arginine%2520derivative%2520No.%2520805.%2520the%2520importance%2520of%2520stereo-structure%2520of%2520its%2520hydrophobic%2520carboxamide%2520portion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1981%26volume%3D101%26spage%3D440%26epage%3D446%26doi%3D10.1016%2F0006-291X%2881%2991279-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matschinsky, F. M.</span></span> <span> </span><span class="NLM_article-title">Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.2337/diab.39.6.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.2337%2Fdiab.39.6.647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=647-652&author=F.+M.+Matschinsky&title=Glucokinase+as+glucose+sensor+and+metabolic+signal+generator+in+pancreatic+beta-cells+and+hepatocytes&doi=10.2337%2Fdiab.39.6.647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.2337%2Fdiab.39.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.39.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DMatschinsky%26aufirst%3DF.%2BM.%26atitle%3DGlucokinase%2520as%2520glucose%2520sensor%2520and%2520metabolic%2520signal%2520generator%2520in%2520pancreatic%2520beta-cells%2520and%2520hepatocytes%26jtitle%3DDiabetes%26date%3D1990%26volume%3D39%26spage%3D647%26epage%3D652%26doi%3D10.2337%2Fdiab.39.6.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaropong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komorowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWolf, W. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinklin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraser, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veniant-Ellison, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houze, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coward, P.</span></span> <span> </span><span class="NLM_article-title">Novel series of potent glucokinase activators leading to the discovery of AM-2394</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=714-718&author=P.+J.+Dransfieldauthor=V.+Pattaropongauthor=S.+Laiauthor=Z.+Fuauthor=T.+J.+Kohnauthor=X.+Duauthor=A.+Chengauthor=Y.+Xiongauthor=R.+Komorowskiauthor=L.+Jinauthor=M.+Connauthor=E.+Tienauthor=W.+E.+DeWolfauthor=R.+J.+Hinklinauthor=T.+D.+Aicherauthor=C.+F.+Kraserauthor=S.+A.+Boydauthor=W.+C.+Voegtliauthor=K.+R.+Condroskiauthor=M.+Veniant-Ellisonauthor=J.+C.+Medinaauthor=J.+Houzeauthor=P.+Coward&title=Novel+series+of+potent+glucokinase+activators+leading+to+the+discovery+of+AM-2394&doi=10.1021%2Facsmedchemlett.6b00140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00140%26sid%3Dliteratum%253Aachs%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DKohn%26aufirst%3DT.%2BJ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DConn%26aufirst%3DM.%26aulast%3DTien%26aufirst%3DE.%26aulast%3DDeWolf%26aufirst%3DW.%2BE.%26aulast%3DHinklin%26aufirst%3DR.%2BJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DKraser%26aufirst%3DC.%2BF.%26aulast%3DBoyd%26aufirst%3DS.%2BA.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DVeniant-Ellison%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DCoward%26aufirst%3DP.%26atitle%3DNovel%2520series%2520of%2520potent%2520glucokinase%2520activators%2520leading%2520to%2520the%2520discovery%2520of%2520AM-2394%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D714%26epage%3D718%26doi%3D10.1021%2Facsmedchemlett.6b00140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiravuri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, B. T.</span></span> <span> </span><span class="NLM_article-title">A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: a candidate target protease, quiescent cell proline dipeptidase</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">3092</span>– <span class="NLM_lpage">3099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=3092-3099&author=M.+Chiravuriauthor=T.+Schmitzauthor=K.+Yardleyauthor=R.+Underwoodauthor=Y.+Dayalauthor=B.+T.+Huber&title=A+novel+apoptotic+pathway+in+quiescent+lymphocytes+identified+by+inhibition+of+a+post-proline+cleaving+aminodipeptidase%3A+a+candidate+target+protease%2C+quiescent+cell+proline+dipeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiravuri%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DT.%26aulast%3DYardley%26aufirst%3DK.%26aulast%3DUnderwood%26aufirst%3DR.%26aulast%3DDayal%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DB.%2BT.%26atitle%3DA%2520novel%2520apoptotic%2520pathway%2520in%2520quiescent%2520lymphocytes%2520identified%2520by%2520inhibition%2520of%2520a%2520post-proline%2520cleaving%2520aminodipeptidase%253A%2520a%2520candidate%2520target%2520protease%252C%2520quiescent%2520cell%2520proline%2520dipeptidase%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D3092%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woollatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCaughan, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorrell, M. D.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6150</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1046%2Fj.1432-1327.2000.01617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=11012666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=6140-6150&author=C.+A.+Abbottauthor=D.+M.+Yuauthor=E.+Woollattauthor=G.+R.+Sutherlandauthor=G.+W.+McCaughanauthor=M.+D.+Gorrell&title=Cloning%2C+expression+and+chromosomal+localization+of+a+novel+human+dipeptidyl+peptidase+%28DPP%29+IV+homolog%2C+DPP8&doi=10.1046%2Fj.1432-1327.2000.01617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8</span></div><div class="casAuthors">Abbott, Catherine A.; Yu, Denise M. T.; Woollatt, Erica; Sutherland, Grant R.; McCaughan, Geoffrey W.; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6140-6150</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP) IV has roles in T-cell costimulation, chemokine biol., type-II diabetes and tumor biol.  Fibroblast activation protein (FAP) has been implicated in tumor growth and cirrhosis.  Here we describe DPP8, a novel human postproline dipeptidyl aminopeptidase that is homologous to DPPIV and FAP.  Northern-blot hybridization showed that the tissue expression of DPP8 mRNA is ubiquitous, similar to that of DPPIV.  The DPP8 gene was localized to chromosome 15q22, distinct from a closely related gene at 19p13.3 which we named DPP9.  The full-length DPP8 cDNA codes for an 882-amino-acid protein that has about 27% identity and 51% similarity to DPPIV and FAP, but no transmembrane domain and no N-linked or O-linked glycosylation.  Western blots and confocal microscopy of transfected COS-7 cells showed DPP8 to be a 100-kDa monomeric protein expressed in the cytoplasm.  Purified recombinant DPP8 hydrolyzed the DPPIV substrates Ala-Pro, Arg-Pro and Gly-Pro.  Thus recombinant DPP8 shares a postproline dipeptidyl aminopeptidase activity with DPPIV and FAP.  DPP8 enzyme activity had a neutral pH optimum consistent with it being nonlysosomal.  The similarities between DPP8 and DPPIV in tissue expression pattern and substrates suggests a potential role for DPP8 in T-cell activation and immune function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql4MaO3x94pLVg90H21EOLACvtfcHk0ljgymTFdI-8Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLk%253D&md5=fdbd2f452b82c806a36dda9e5c646fe3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01617.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%2BM.%26aulast%3DWoollatt%26aufirst%3DE.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DCloning%252C%2520expression%2520and%2520chromosomal%2520localization%2520of%2520a%2520novel%2520human%2520dipeptidyl%2520peptidase%2520%2528DPP%2529%2520IV%2520homolog%252C%2520DPP8%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D6140%26epage%3D6150%26doi%3D10.1046%2Fj.1432-1327.2000.01617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coumar, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiaang, W. T.</span></span> <span> </span><span class="NLM_article-title">2-[3-[2-[(2<i>S</i>)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1021/jm0507781</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0507781" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=373-380&author=H.+Tsuauthor=X.+Chenauthor=C.+T.+Chenauthor=S.+J.+Leeauthor=C.+N.+Changauthor=K.+H.+Kaoauthor=M.+S.+Coumarauthor=Y.+T.+Yehauthor=C.+H.+Chienauthor=H.+S.+Wangauthor=K.+T.+Linauthor=Y.+Y.+Changauthor=S.+H.+Wuauthor=Y.+S.+Chenauthor=I.+L.+Luauthor=S.+Y.+Wuauthor=T.+Y.+Tsaiauthor=W.+C.+Chenauthor=H.+P.+Hsiehauthor=Y.+S.+Chaoauthor=W.+T.+Jiaang&title=2-%5B3-%5B2-%5B%282S%29-2-Cyano-1-pyrrolidinyl%5D-2-oxoethylamino%5D-3-methyl-1-oxobutyl%5D-+1%2C2%2C3%2C4-tetrahydroisoquinoline%3A+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptide-derived+inhibitor+of+dipeptidyl+peptidase+IV&doi=10.1021%2Fjm0507781"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fjm0507781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507781%26sid%3Dliteratum%253Aachs%26aulast%3DTsu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DKao%26aufirst%3DK.%2BH.%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DYeh%26aufirst%3DY.%2BT.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DH.%2BS.%26aulast%3DLin%26aufirst%3DK.%2BT.%26aulast%3DChang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BS.%26aulast%3DLu%26aufirst%3DI.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BY.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26atitle%3D2-%255B3-%255B2-%255B%25282S%2529-2-Cyano-1-pyrrolidinyl%255D-2-oxoethylamino%255D-3-methyl-1-oxobutyl%255D-%25201%252C2%252C3%252C4-tetrahydroisoquinoline%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptide-derived%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D373%26epage%3D380%26doi%3D10.1021%2Fjm0507781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">N-Alkylpyrido[1′,2′:1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1894</span>– <span class="NLM_lpage">1900</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.03.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1894-1900&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=N-Alkylpyrido%5B1%E2%80%B2%2C2%E2%80%B2%3A1%2C5%5Dpyrazolo-%5B4%2C3-d%5Dpyrimidin-4-amines%3A+A+new+series+of+negative+allosteric+modulators+of+mGlu1%2F5+with+CNS+exposure+in+rodents&doi=10.1016%2Fj.bmcl.2016.03.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DN-Alkylpyrido%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%253A1%252C5%255Dpyrazolo-%255B4%252C3-d%255Dpyrimidin-4-amines%253A%2520A%2520new%2520series%2520of%2520negative%2520allosteric%2520modulators%2520of%2520mGlu1%252F5%2520with%2520CNS%2520exposure%2520in%2520rodents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1894%26epage%3D1900%26doi%3D10.1016%2Fj.bmcl.2016.03.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewthwaite, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeadon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros-Huguet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevethick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, F. J.</span></span> <span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting beta(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6640</span>– <span class="NLM_lpage">6652</span>, <span class="refDoi"> DOI: 10.1021/jm1005989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+beta%282%29-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup&doi=10.1021%2Fjm1005989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520beta%25282%2529-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652%26doi%3D10.1021%2Fjm1005989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, T. H.</span></span> <span> </span><span class="NLM_article-title">Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">5418</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.1021/ja010453j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja010453j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=5418-5423&author=H.+Lueschauthor=W.+Y.+Yoshidaauthor=R.+E.+Mooreauthor=V.+J.+Paulauthor=T.+H.+Corbett&title=Total+structure+determination+of+apratoxin+A%2C+a+potent+novel+cytotoxin+from+the+marine+cyanobacterium+Lyngbya+majuscula&doi=10.1021%2Fja010453j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fja010453j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja010453j%26sid%3Dliteratum%253Aachs%26aulast%3DLuesch%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DW.%2BY.%26aulast%3DMoore%26aufirst%3DR.%2BE.%26aulast%3DPaul%26aufirst%3DV.%2BJ.%26aulast%3DCorbett%26aufirst%3DT.%2BH.%26atitle%3DTotal%2520structure%2520determination%2520of%2520apratoxin%2520A%252C%2520a%2520potent%2520novel%2520cytotoxin%2520from%2520the%2520marine%2520cyanobacterium%2520Lyngbya%2520majuscula%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D5418%26epage%3D5423%26doi%3D10.1021%2Fja010453j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raya, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeJesus, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izpisua Belmonte, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A functional genomics approach to the mode of action of apratoxin A</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1038/nchembio769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1038%2Fnchembio769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=16474387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVOjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=158-167&author=H.+Lueschauthor=S.+K.+Chandaauthor=R.+M.+Rayaauthor=P.+D.+DeJesusauthor=A.+P.+Orthauthor=J.+R.+Walkerauthor=J.+C.+Izpisua+Belmonteauthor=P.+G.+Schultz&title=A+functional+genomics+approach+to+the+mode+of+action+of+apratoxin+A&doi=10.1038%2Fnchembio769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">A functional genomics approach to the mode of action of apratoxin A</span></div><div class="casAuthors">Luesch, Hendrik; Chanda, Sumit K.; Raya, R. Marina; DeJesus, Paul D.; Orth, Anthony P.; Walker, John R.; Izpisua Belmonte, Juan Carlos; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">158-167</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cyanobacterial metabolite apratoxin A (1) demonstrates potent cytotoxicity against tumor cell lines by a hitherto unknown mechanism.  We have used functional genomics to elucidate the mol. basis for this activity.  Gene expression profiling and DNA content anal. showed that apratoxin A induces G1-phase cell cycle arrest and apoptosis.  Cell-based functional assays with a genome-wide collection of expression cDNAs showed that ectopic induction of fibroblast growth factor receptor (FGFR) signaling attenuates the apoptotic activity of apratoxin A. This natural product inhibited phosphorylation and activation of STAT3, a downstream effector of FGFR signaling.  It also caused defects in FGF-dependent processes during zebrafish development, with concomitant redns. in expression levels of the FGF target gene mkp3.  We conclude that apratoxin A mediates its antiproliferative activity through the induction of G1 cell cycle arrest and an apoptotic cascade, which is at least partially initiated through antagonism of FGF signaling via STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbXPD982PdrVg90H21EOLACvtfcHk0lhzj7nVI8cKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVOjsro%253D&md5=67aa1691124ab7452986c3ad59a3020a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1038%2Fnchembio769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio769%26sid%3Dliteratum%253Aachs%26aulast%3DLuesch%26aufirst%3DH.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DRaya%26aufirst%3DR.%2BM.%26aulast%3DDeJesus%26aufirst%3DP.%2BD.%26aulast%3DOrth%26aufirst%3DA.%2BP.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DIzpisua%2BBelmonte%26aufirst%3DJ.%2BC.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520functional%2520genomics%2520approach%2520to%2520the%2520mode%2520of%2520action%2520of%2520apratoxin%2520A%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D158%26epage%3D167%26doi%3D10.1038%2Fnchembio769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Systematic chemical mutagenesis identifies a potent novel apratoxin A/E hybrid with improved in vivo antitumor activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1021/ml200176m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200176m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=861-865&author=Q.+Y.+Chenauthor=Y.+Liuauthor=H.+Luesch&title=Systematic+chemical+mutagenesis+identifies+a+potent+novel+apratoxin+A%2FE+hybrid+with+improved+in+vivo+antitumor+activity&doi=10.1021%2Fml200176m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity</span></div><div class="casAuthors">Chen, Qi-Yin; Liu, Yanxia; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">861-865</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apratoxins are cytotoxic marine natural products that prevent cotranslational translocation early in the secretory pathway.  We showed that apratoxins downregulate receptors and growth factor ligands, giving a one-two punch to cancer cells, particularly those that rely on autocrine loops.  Through total synthesis, we tested the effects of amino acid substitutions, including alanine scanning, on the downregulation of receptor tyrosine kinases and vascular endothelial growth factor A (VEGF-A) and probed the stereospecificity of target engagement by epimerization of selected chiral centers.  Differential effects on two types of secretory mols. suggest that the apratoxins' substrate selectivity with respect to inhibition of secretion may be tuned through structural modifications to provide tailored therapy.  Our structure-activity relation studies and medicinal chem. efforts led to a potent inhibitor with in vivo efficacy in a colorectal tumor xenograft model without irreversible toxicity exerted by apratoxin A, demonstrating that this novel mechanism of action has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIaTwsj3nxzrVg90H21EOLACvtfcHk0lhzj7nVI8cKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7%252FL&md5=d0eb91f607a63e065cc005b123f524bf</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fml200176m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200176m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DSystematic%2520chemical%2520mutagenesis%2520identifies%2520a%2520potent%2520novel%2520apratoxin%2520A%252FE%2520hybrid%2520with%2520improved%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D861%26epage%3D865%26doi%3D10.1021%2Fml200176m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesch, H.</span></span> <span> </span><span class="NLM_article-title">Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3011</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1021/jm4019965</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4019965" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3011-3029&author=Q.+Y.+Chenauthor=Y.+Liuauthor=W.+Caiauthor=H.+Luesch&title=Improved+total+synthesis+and+biological+evaluation+of+potent+apratoxin+S4+based+anticancer+agents+with+differential+stability+and+further+enhanced+activity&doi=10.1021%2Fjm4019965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity</span></div><div class="casAuthors">Chen, Qi-Yin; Liu, Yanxia; Cai, Weijing; Luesch, Hendrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3011-3029</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apratoxins are cytotoxic natural products originally isolated from marine cyanobacteria that act by preventing cotranslational translocation early in the secretory pathway to downregulate receptor levels and inhibit growth factor secretion, leading to potent antiproliferative activity.  Through rational design and total synthesis of an apratoxin A/E hybrid, apratoxin S4 (1a), the authors have previously improved the antitumor activity and tolerability in vivo.  Compd. 1a and newly designed analogs apratoxins S7-S9 (1b-d), with various degrees of methylation at C34 (1b,c) or epimeric configuration at C30 (1d), were efficiently synthesized utilizing improved procedures.  Optimizations have been applied to the synthesis of key intermediate aldehyde 7 and further include the application of Leighton's silanes and modifications of Kelly's methods to induce thiazoline ring formation in other crucial steps of the apratoxin synthesis.  Apratoxin S9 (1d) exhibited increased activity with subnanomolar potency.  Apratoxin S8 (1c) lacks the propensity to be deactivated by dehydration and showed efficacy in a human HCT116 xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCVt6ZWY8MirVg90H21EOLACvtfcHk0ljEZ98QVA-3Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamtL4%253D&md5=7f33d6cb7d827d4c58becd49326c4873</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm4019965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4019965%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DLuesch%26aufirst%3DH.%26atitle%3DImproved%2520total%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520potent%2520apratoxin%2520S4%2520based%2520anticancer%2520agents%2520with%2520differential%2520stability%2520and%2520further%2520enhanced%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3011%26epage%3D3029%26doi%3D10.1021%2Fjm4019965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beesley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. F.</span></span> <span> </span><span class="NLM_article-title">CXIX.—The formation and stability of spiro-compounds. Part I. spiro-compounds from cyclohexane</span>. <i>J. Chem. Soc., Trans.</i> <span class="NLM_year" style="font-weight: bold;">1915</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1080</span>– <span class="NLM_lpage">1106</span>, <span class="refDoi"> DOI: 10.1039/CT9150701080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1039%2FCT9150701080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaC2MXhvVGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1915&pages=1080-1106&author=R.+M.+Beesleyauthor=C.+K.+Ingoldauthor=J.+F.+Thorpe&title=CXIX.%E2%80%94The+formation+and+stability+of+spiro-compounds.+Part+I.+spiro-compounds+from+cyclohexane&doi=10.1039%2FCT9150701080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and stability of spiro-compounds. I. Spiro-compounds from cyclohexano</span></div><div class="casAuthors">Beesley, Richard M.; Ingold, Christopher K.; Thorpe, Jocelyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Transactions</span>
        (<span class="NLM_cas:date">1915</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1080-1106</span>CODEN:
                <span class="NLM_cas:coden">JCHTA3</span>;
        ISSN:<span class="NLM_cas:issn">0368-1645</span>.
    </div><div class="casAbstract">A series of investigations has been undertaken with the object of ascertaining "the effect produced by the alteration of the tetrahedral angle consequent on ring formation, on the formation and stability of a 2nd ring joined to the existing ring by a quaternary C atom common to both."  The hypothesis was advanced that the angle formed by the 2 side chains attached to any 1 C atom of the cyclohexane ring will be altered in proportion to any change in angle between those valencies which participate in ring formation; i. e., the groups attached to 2 side chains emanating from the same C atom of a cyclohexane deriv., type (I), will be closer together than in a corresponding compd. having the open chain structure, type (II).  Expts. show that this hypothesis is probably correct.  For example a trans-spiro-acid, derived from a compd. of type (I) is more stable than trans-caronic acid, derived from a compd. of type (II).  The above hypothesis and another untenable one are presented and discussed in some detail and diagrammatically represented by showing the effect of "strain" on the angles between the valencies (represented by the apices of an inscribed tetrahedron) of a (spherical) C atom.  The bromination of CH2(CH2)4C(CH2CO2H)2 by means of PBr5 and Br led to the formation of a mixt. containing an acid product, probably C5H10>C(CHBrCO2H)(CH2CO2Et) (A), and a neutral product (B).  The latter was shown to be a mixt. of cis-diethyl α,α'-dibromocyclohexane-1,1-diacetate (C) (not obtained in the pure state) and the trans-lactone (D), C5H10>C.CH(CO2Et).O.CO.CHBr, prisms from petroleum or alc., m. 96°, b20 225-30°. (D) was sepd. from the mixt. (B) by the addition of an equal vol. of petroleum (b. 60-70°) and was also synthesized by boiling (C) with C5H5N [whereby only the trans-form of (C) was converted into (D)] or by distg. (C), whereby both the cis- and trans-forms were converted.  The isomeric cis-lactone (D'), microneedles, m. 69-70°, was formed in 25% yield upon distg. (C) from which (D) had been previously removed by means of C5H5N.  α-Hydroxycyclohexane-1,1-diacetic acid lactone (E), C5H10>C.CH(CO2H).O.CO.CH2, b13 240-1°, crystg. after long standing and seeding, microneedles, m. 91-2° (silver salt, amorphous), was formed from (A) by the action of boiling Na2CO3.  The free acid (F) corresponding to (E) could not be isolated and was found to be stable only in the form of its salts.  The amorphous silver salt and cryst. sodium salt of (F) were prepd.  The dianilide of (F), C5H10>C(CH2CONHPh)CH(OH)CONHPh, needles, m. 97°.  The aniline salt of (E), silky needles, m. 104°.  When (A) was added to boiling concd. KOH and the reaction mixt. cooled and acidified, trans-cyclohexane-spiro-cyclopropane-1,2-dicarboxylic acid (G), C5H10>C.CH(CO2H).CHCO2H, flattened needles, m. 237°, was formed.  Its silver salt sepd. in the form of a cryst. powder: its dianilide, needles, m. 292°.  The filtrate from (G) after extn. with Et2O and fractionation under reduced pressure yielded the cis-isomer (H) of (G), needles, m. 198°, more readily formed by distg. (G) which is first converted into the anhydride (J), C5H10>C.CH.CO.O.CO.CH, needles, m. 102°, which on treatment with alkali and subsequent acidification yields (H).  (J) was also readily prepd. by the interaction of (H) and AcCl, whereas (G) is not acted upon by this reagent.  The anilic acid, C5H10>C.CH(CO2H).CHCONHPh, derived from (J), small needles,m. 207° (decompn.); the corresponding anil, m. 119°.  When heated in a sealed tube with 50% concd. HCl at 180° for 5 hrs., (H) is partially reconverted into (G).  On attempting to replace the Br in (D) by an OH group, by means of moist Ag2O, ethyl α-hydroxycyclohexane-1,1-diacetate lactone, C5H10> C.CH2CO.O.CHCO2Et, b21 210°, was obtained and yielded (E) on hydrolysis.  The following hydrolysis products were formed when (D) was treated with boiling 15% aq. NaOH:C5H10>C:CHCO2H (K), m. 92° (identical with Wallach's acid as shown by the formation of the dibromide, m. 135-6°; ref. not given), and the trans-lactonic acid of α,α'-dihydroxycyclohexane-1,1-diacetic acid (L), C5H10>C.CH(OH).CO.O.CHCO2H.H2O, prisms, 100°, anhydrous, m. 145°.  (D') when subjected to a similar hydrolysis gave rise to a mixt. of (K), the cis-isomer (M) of (L), prisms, m. 168°, and cyclohexane-spiro-cyclopropanol-2,3-dicarboxylic acid (N), C5H10>C.C(OH)(CO2H).CHCO2H, pearly plates, m. 217°.  Boiling alc. KOH, reacting with (D), yielded (K), (L) and (N).  The action of 64% aq. KOH on (D) gave rise to a mixt. of (L), (N) and Δ1-cyclohexeneacetic acid, (O), CH2(CH2)3CH:C.CH2CO2H, m. 38° (identical with Wallach's compd.; also quant. formed by boiling (K) with 64% KOH, thus indicating that it was a byproduct in the above reaction).  The Et ester of (O), b25 118-2° (cf. Auwers and Ellinger, C. A. 6, 1147).  A similar reaction between 64% KOH and (D') gave rise to (O), (M) and (N).  (K) and (N) were sepd. by treatment with dry Et2O in which (N) is insol.  (L) was ordinarily sepd. from hydrolysis mixts. by esterifying and fractionating the ethyl ester, b25 206-10°.  The following derivs. of (L) are described: disodium salt, cryst.; disilver salt, powder; aniline salt, microcrystals, m. 133-4°; dianilide, C5H10>C[CH(OH)CONHPh]2, short needles, m. 169°.  (L) does not react with AcCl, is not reduced by AgOH, and when heated with H2O in a sealed tube or when distd., passes into (M).  The isolation of (M) was effected by esterifying hydrolysis mixts. and collecting the fraction of highest b. p., which was subsequently hydrolyzed with HCl.  (M) was readily acetylated.  The following derivs. of (M) were prepd.: disilver salt; dianilide, needles, m. 169° (not identical with the dianilide derived from (L)); acetate, C5H10>CH(OAc).CO.O.CHCO2H, m. 156° (silver salt of the acetate, cryst. powder).  The spiro-acid (N), which like (L) could not be acetylated, which is not converted into the lactone on heating and is otherwise stable, gave rise to the following compds.: silver salt, cryst. powder; anilide, needles, m. 202°.  Concd. H2SO4 acting upon (L) at 95-100°, gave rise to small amts. of cyclohexane-spiro-cyclopentanone, oil (forming a semicarbazone, needles, m. 175°), and an unidentified compd., m. 105°.  When heated with an equal amt. of H2O in a sealed tube at 240° for 0.5 hr., (L) yielded the lactonic acid of α-hydroxy-α'-cyclohexan-1-olsuccinic acid, C5H10>C.O.CO.CH(OH).CHCO2H, cubical prisms, m. 131°, whose disodium salt, disilver salt and aniline salt, m. 123°, were prepd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLfaoba7kGULVg90H21EOLACvtfcHk0ljEZ98QVA-3Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaC2MXhvVGiuw%253D%253D&md5=de4306fddc79f71809a8556525abc983</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1039%2FCT9150701080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FCT9150701080%26sid%3Dliteratum%253Aachs%26aulast%3DBeesley%26aufirst%3DR.%2BM.%26aulast%3DIngold%26aufirst%3DC.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BF.%26atitle%3DCXIX.%25E2%2580%2594The%2520formation%2520and%2520stability%2520of%2520spiro-compounds.%2520Part%2520I.%2520spiro-compounds%2520from%2520cyclohexane%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Trans.%26date%3D1915%26volume%3D107%26spage%3D1080%26epage%3D1106%26doi%3D10.1039%2FCT9150701080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkilineni, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casazza, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D. M.</span></span> <span> </span><span class="NLM_article-title">Novel, water-soluble phosphate derivatives of 2′-ethoxy carbonylpaclitaxel as potential prodrugs of paclitaxel: Synthesis and antitumor evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00018-O</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0960-894X%2895%2900018-O" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=247-252&author=Y.+Uedaauthor=J.+D.+Matiskellaauthor=A.+B.+Mikkilineniauthor=V.+Farinaauthor=J.+O.+Knipeauthor=W.+C.+Roseauthor=A.+M.+Casazzaauthor=D.+M.+Vyas&title=Novel%2C+water-soluble+phosphate+derivatives+of+2%E2%80%B2-ethoxy+carbonylpaclitaxel+as+potential+prodrugs+of+paclitaxel%3A+Synthesis+and+antitumor+evaluation&doi=10.1016%2F0960-894X%2895%2900018-O"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900018-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900018-O%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatiskella%26aufirst%3DJ.%2BD.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DCasazza%26aufirst%3DA.%2BM.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26atitle%3DNovel%252C%2520water-soluble%2520phosphate%2520derivatives%2520of%25202%25E2%2580%25B2-ethoxy%2520carbonylpaclitaxel%2520as%2520potential%2520prodrugs%2520of%2520paclitaxel%253A%2520Synthesis%2520and%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D247%26epage%3D252%26doi%3D10.1016%2F0960-894X%2895%2900018-O" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trawick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, K. G.</span></span> <span> </span><span class="NLM_article-title">Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2016.11.093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=636-641&author=B.+A.+Winnauthor=Z.+Shiauthor=G.+J.+Carlsonauthor=Y.+Wangauthor=B.+L.+Nguyenauthor=E.+M.+Kellyauthor=R.+D.+Rossauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Bioreductively+activatable+prodrug+conjugates+of+phenstatin+designed+to+target+tumor+hypoxia&doi=10.1016%2Fj.bmcl.2016.11.093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.093%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DB.%2BA.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DCarlson%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DKelly%26aufirst%3DE.%2BM.%26aulast%3DRoss%26aufirst%3DR.%2BD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DBioreductively%2520activatable%2520prodrug%2520conjugates%2520of%2520phenstatin%2520designed%2520to%2520target%2520tumor%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D636%26epage%3D641%26doi%3D10.1016%2Fj.bmcl.2016.11.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knabb, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3345</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2Fj.bmcl.2014.05.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3341-3345&author=M.+J.+Orwatauthor=J.+X.+Qiaoauthor=K.+Heauthor=A.+R.+Rendinaauthor=J.+M.+Luettgenauthor=K.+A.+Rossiauthor=B.+Xinauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=P.+Y.+Lamauthor=D.+J.+Pinto&title=Orally+bioavailable+factor+Xa+inhibitors+containing+alpha-substituted+gem-dimethyl+P4+moieties&doi=10.1016%2Fj.bmcl.2014.05.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.101%26sid%3Dliteratum%253Aachs%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DQiao%26aufirst%3DJ.%2BX.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26atitle%3DOrally%2520bioavailable%2520factor%2520Xa%2520inhibitors%2520containing%2520alpha-substituted%2520gem-dimethyl%2520P4%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3341%26epage%3D3345%26doi%3D10.1016%2Fj.bmcl.2014.05.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matcha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnaard, A. J.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed asymmetric quaternary stereocenter formation</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6907</span>– <span class="NLM_lpage">6914</span>, <span class="refDoi"> DOI: 10.1002/chem.201200694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1002%2Fchem.201200694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=22532469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6907-6914&author=A.+L.+Gottumukkalaauthor=K.+Matchaauthor=M.+Lutzauthor=J.+G.+de+Vriesauthor=A.+J.+Minnaard&title=Palladium-catalyzed+asymmetric+quaternary+stereocenter+formation&doi=10.1002%2Fchem.201200694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Asymmetric Quaternary Stereocenter Formation</span></div><div class="casAuthors">Gottumukkala, Aditya L.; Matcha, Kiran; Lutz, Martin; de Vries, Johannes G.; Minnaard, Adriaan J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6907-6914, S6907/1-S6907/42</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient palladium catalyst is presented for the formation of benzylic quaternary stereocenters by conjugate addn. of arylboronic acids to a variety of β,β-disubstituted carbocyclic, heterocyclic, and acyclic enones.  The catalyst is readily prepd. from PdCl2, PhBOX, and AgSbF6, and provides products in up to 99 % enantiomeric excess, with good yields.  Based on this strategy, (-)-α-cuparenone has been prepd. in only two steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNbar8BRKvO7Vg90H21EOLACvtfcHk0ljxLJyF69tPXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFCiurY%253D&md5=c78f9884aac12ee7f8b58ee3a067ca3c</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1002%2Fchem.201200694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201200694%26sid%3Dliteratum%253Aachs%26aulast%3DGottumukkala%26aufirst%3DA.%2BL.%26aulast%3DMatcha%26aufirst%3DK.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BG.%26aulast%3DMinnaard%26aufirst%3DA.%2BJ.%26atitle%3DPalladium-catalyzed%2520asymmetric%2520quaternary%2520stereocenter%2520formation%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2012%26volume%3D18%26spage%3D6907%26epage%3D6914%26doi%3D10.1002%2Fchem.201200694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of purported cephalosporolides H and I, penisporolide B, and their stereoisomers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">4325</span>– <span class="NLM_lpage">4339</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=4325-4339&author=J.+Wangauthor=R.+Tong&title=Total+synthesis+of+purported+cephalosporolides+H+and+I%2C+penisporolide+B%2C+and+their+stereoisomers&doi=10.1021%2Facs.joc.6b00788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DR.%26atitle%3DTotal%2520synthesis%2520of%2520purported%2520cephalosporolides%2520H%2520and%2520I%252C%2520penisporolide%2520B%252C%2520and%2520their%2520stereoisomers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D4325%26epage%3D4339%26doi%3D10.1021%2Facs.joc.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hariprakasha, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathya Shankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subba Rao, G. S. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis based on cyclohexadienes: Part 30—Synthesis of 2-nor-cedrene and some analogues of funebrene</span>. <i>Indian J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39B</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39B&publication_year=2000&pages=94-102&author=H.+K.+Hariprakashaauthor=P.+Sathya+Shankarauthor=G.+S.+R.+Subba+Rao&title=Synthesis+based+on+cyclohexadienes%3A+Part+30%E2%80%94Synthesis+of+2-nor-cedrene+and+some+analogues+of+funebrene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHariprakasha%26aufirst%3DH.%2BK.%26aulast%3DSathya%2BShankar%26aufirst%3DP.%26aulast%3DSubba%2BRao%26aufirst%3DG.%2BS.%2BR.%26atitle%3DSynthesis%2520based%2520on%2520cyclohexadienes%253A%2520Part%252030%25E2%2580%2594Synthesis%2520of%25202-nor-cedrene%2520and%2520some%2520analogues%2520of%2520funebrene%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D2000%26volume%3D39B%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivik, M. R.</span></span> <span> </span><span class="NLM_article-title">Total synthesis of (−)-austalide B. A generic solution to elaboration of the pyran/p-cresol/butenolide triad</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">11323</span>– <span class="NLM_lpage">11334</span>, <span class="refDoi"> DOI: 10.1021/ja00104a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00104a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=11323-11334&author=L.+A.+Paquetteauthor=T.+Z.+Wangauthor=M.+R.+Sivik&title=Total+synthesis+of+%28%E2%88%92%29-austalide+B.+A+generic+solution+to+elaboration+of+the+pyran%2Fp-cresol%2Fbutenolide+triad&doi=10.1021%2Fja00104a012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fja00104a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00104a012%26sid%3Dliteratum%253Aachs%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BZ.%26aulast%3DSivik%26aufirst%3DM.%2BR.%26atitle%3DTotal%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-austalide%2520B.%2520A%2520generic%2520solution%2520to%2520elaboration%2520of%2520the%2520pyran%252Fp-cresol%252Fbutenolide%2520triad%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D11323%26epage%3D11334%26doi%3D10.1021%2Fja00104a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, M.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Heck reaction–carbanion capture process. Catalytic asymmetric total synthesis of (−)-Δ9(12)-capnellene</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">7108</span>– <span class="NLM_lpage">7116</span>, <span class="refDoi"> DOI: 10.1021/ja9609359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9609359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7108-7116&author=T.+Ohshimaauthor=K.+Kagechikaauthor=M.+Adachiauthor=M.+Sodeokaauthor=M.+Shibasaki&title=Asymmetric+Heck+reaction%E2%80%93carbanion+capture+process.+Catalytic+asymmetric+total+synthesis+of+%28%E2%88%92%29-%CE%949%2812%29-capnellene&doi=10.1021%2Fja9609359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Fja9609359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9609359%26sid%3Dliteratum%253Aachs%26aulast%3DOhshima%26aufirst%3DT.%26aulast%3DKagechika%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DM.%26aulast%3DSodeoka%26aufirst%3DM.%26aulast%3DShibasaki%26aufirst%3DM.%26atitle%3DAsymmetric%2520Heck%2520reaction%25E2%2580%2593carbanion%2520capture%2520process.%2520Catalytic%2520asymmetric%2520total%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-%25CE%25949%252812%2529-capnellene%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7108%26epage%3D7116%26doi%3D10.1021%2Fja9609359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. S.</span></span> <span> </span><span class="NLM_article-title">Towards oleananes: geminal dimethylation at C-4</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">9685</span>– <span class="NLM_lpage">9686</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(94)88359-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1016%2F0040-4039%2894%2988359-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=9685-9686&author=G.+S.+Jones&title=Towards+oleananes%3A+geminal+dimethylation+at+C-4&doi=10.1016%2F0040-4039%2894%2988359-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2894%2988359-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252894%252988359-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%2BS.%26atitle%3DTowards%2520oleananes%253A%2520geminal%2520dimethylation%2520at%2520C-4%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D9685%26epage%3D9686%26doi%3D10.1016%2F0040-4039%2894%2988359-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holubec, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span> <span> </span><span class="NLM_article-title">Application of reactive enols in synthesis: A versatile, efficient, and stereoselective construction of the welwitindolinone carbon skeleton</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">6326</span>– <span class="NLM_lpage">6327</span>, <span class="refDoi"> DOI: 10.1021/ja991022s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja991022s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=1%3ACAS%3A528%3ADyaK1MXjslOjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=6326-6327&author=J.+L.+Woodauthor=A.+A.+Holubecauthor=B.+M.+Stoltzauthor=M.+M.+Weissauthor=J.+A.+Dixonauthor=B.+D.+Doanauthor=M.+F.+Shamjiauthor=J.+M.+Chenauthor=T.+P.+Heffron&title=Application+of+reactive+enols+in+synthesis%3A+A+versatile%2C+efficient%2C+and+stereoselective+construction+of+the+welwitindolinone+carbon+skeleton&doi=10.1021%2Fja991022s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Reactive Enols in Synthesis: A Versatile, Efficient, and Stereoselective Construction of the Welwitindolinone Carbon Skeleton</span></div><div class="casAuthors">Wood, John L.; Holubec, Alexandra A.; Stoltz, Brian M.; Weiss, Matthew M.; Dixon, Julie A.; Doan, Brian D.; Shamji, Mohammed F.; Chen, Jennifer M.; Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6326-6327</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The welwitindolinone carbon skeleton I was prepd. in 15 steps from isatin via insertion reaction of the diazoketone II in presence of Montmorillonite K10 clay to give the cyclopropane III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2epk6O0-S0bVg90H21EOLACvtfcHk0liqgpzW3rADgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslOjt7Y%253D&md5=86d4268ea5393cd439e55a6d0c966a07</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Fja991022s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja991022s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BL.%26aulast%3DHolubec%26aufirst%3DA.%2BA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DDoan%26aufirst%3DB.%2BD.%26aulast%3DShamji%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DApplication%2520of%2520reactive%2520enols%2520in%2520synthesis%253A%2520A%2520versatile%252C%2520efficient%252C%2520and%2520stereoselective%2520construction%2520of%2520the%2520welwitindolinone%2520carbon%2520skeleton%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D6326%26epage%3D6327%26doi%3D10.1021%2Fja991022s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paxton, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitwood, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J. K.</span></span> <span> </span><span class="NLM_article-title">Gem-dimethylcyclopropanation using triisopropylsulfoxonium tetrafluoroborate: scope and limitations</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">3279</span>– <span class="NLM_lpage">3288</span>, <span class="refDoi"> DOI: 10.1055/s-0028-1083165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;key=10.1055%2Fs-0028-1083165" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=3279-3288&author=M.+G.+Edwardsauthor=R.+J.+Paxtonauthor=D.+S.+Pughauthor=A.+C.+Whitwoodauthor=R.+J.+K.+Taylor&title=Gem-dimethylcyclopropanation+using+triisopropylsulfoxonium+tetrafluoroborate%3A+scope+and+limitations&doi=10.1055%2Fs-0028-1083165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1083165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1083165%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BG.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DPugh%26aufirst%3DD.%2BS.%26aulast%3DWhitwood%26aufirst%3DA.%2BC.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%2BK.%26atitle%3DGem-dimethylcyclopropanation%2520using%2520triisopropylsulfoxonium%2520tetrafluoroborate%253A%2520scope%2520and%2520limitations%26jtitle%3DSynthesis%26date%3D2008%26volume%3D2008%26spage%3D3279%26epage%3D3288%26doi%3D10.1055%2Fs-0028-1083165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papillon, J. P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beil, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaSala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigel, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksander, G. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships, pharmacokinetics, and in vivo activity of CYP11B2 and CYP11B1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4749</span>– <span class="NLM_lpage">4770</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4749-4770&author=J.+P.+N.+Papillonauthor=C.+M.+Adamsauthor=Q.+Y.+Huauthor=C.+Louauthor=A.+K.+Singhauthor=C.+Zhangauthor=J.+Carvalhoauthor=S.+Rajanauthor=A.+Amaralauthor=M.+E.+Beilauthor=F.+Fuauthor=E.+Ganglauthor=C.+W.+Huauthor=A.+Y.+Jengauthor=D.+LaSalaauthor=G.+Liangauthor=M.+Logmanauthor=W.+M.+Maniaraauthor=D.+F.+Rigelauthor=S.+A.+Smithauthor=G.+M.+Ksander&title=Structure-activity+relationships%2C+pharmacokinetics%2C+and+in+vivo+activity+of+CYP11B2+and+CYP11B1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00407%26sid%3Dliteratum%253Aachs%26aulast%3DPapillon%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DHu%26aufirst%3DQ.%2BY.%26aulast%3DLou%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCarvalho%26aufirst%3DJ.%26aulast%3DRajan%26aufirst%3DS.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DBeil%26aufirst%3DM.%2BE.%26aulast%3DFu%26aufirst%3DF.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DC.%2BW.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DLogman%26aufirst%3DM.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DKsander%26aufirst%3DG.%2BM.%26atitle%3DStructure-activity%2520relationships%252C%2520pharmacokinetics%252C%2520and%2520in%2520vivo%2520activity%2520of%2520CYP11B2%2520and%2520CYP11B1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4749%26epage%3D4770%26doi%3D10.1021%2Facs.jmedchem.5b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical development candidate GDC-0084, a brain penetrant inhibitor of PI3K and mTOR</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=351-356&author=T.+P.+Heffronauthor=C.+O.+Ndubakuauthor=L.+Salphatiauthor=B.+Alickeauthor=J.+Cheongauthor=J.+Drobnickauthor=K.+Edgarauthor=S.+E.+Gouldauthor=L.+B.+Leeauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=J.+Nonomiyaauthor=J.+Pangauthor=E.+G.+Pliseauthor=S.+Siderisauthor=J.+Wallinauthor=L.+Wangauthor=X.+Zhangauthor=A.+G.+Olivero&title=Discovery+of+clinical+development+candidate+GDC-0084%2C+a+brain+penetrant+inhibitor+of+PI3K+and+mTOR&doi=10.1021%2Facsmedchemlett.6b00005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00005%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DK.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPlise%26aufirst%3DE.%2BG.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DWallin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DDiscovery%2520of%2520clinical%2520development%2520candidate%2520GDC-0084%252C%2520a%2520brain%2520penetrant%2520inhibitor%2520of%2520PI3K%2520and%2520mTOR%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D351%26epage%3D356%26doi%3D10.1021%2Facsmedchemlett.6b00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBS','PDB','3PBS'); return false;">PDB: 3PBS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX','PDB','3LOX'); return false;">PDB: 3LOX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BQO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BQO','PDB','1BQO'); return false;">PDB: 1BQO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP','PDB','2WXP'); return false;">PDB: 2WXP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PQN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PQN','PDB','4PQN'); return false;">PDB: 4PQN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PXS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PXS','PDB','4PXS'); return false;">PDB: 4PXS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PX5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PX5','PDB','4PX5'); return false;">PDB: 4PX5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i84"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00315">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26551"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00315">10.1021/acs.jmedchem.7b00315</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and associated biological data reported in this study (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00315/suppl_file/jm7b00315_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00315/suppl_file/jm7b00315_si_001.csv">jm7b00315_si_001.csv (24.22 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00315&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00315" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00315" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                15MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667985be8b142440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
